Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
BZLF1	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
of	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
by	IN	case	O
second	JJ	amod	O
messengers	NNS	nmod	O
in	IN	case	O
anti-immunoglobulin-treated	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
SP100	NN	compound	B-DNA
homology	NN	compound	I-DNA
regions	NNS	nmod	I-DNA
,	,	punct	O
one	CD	nummod	O
LYSP100	NN	compound	B-DNA
cDNA	NN	compound	I-DNA
isoform	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
a	DT	det	O
bromodomain	NN	dobj	B-protein
and	CC	cc	O
a	DT	det	O
PHD/TTC	NN	compound	B-protein
domain	NN	conj	I-protein
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
present	JJ	acl:relcl	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
transcriptional	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

For	IN	prep	O
that	DT	det	O
purpose	NN	pobj	O
,	,	punct	O
we	PRP	nsubj	O
established	VBD	ROOT	O
several	JJ	amod	O
lines	NNS	dobj	O
of	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
displaying	VBG	acl	O
erythroid-specific	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
thermosensitive	JJ	amod	B-protein
SV40	NN	compound	I-protein
T	NN	compound	I-protein
antigen	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
kappa	NN	compound	B-protein
B	NN	compound	I-protein
enhancer	NN	nmod	I-protein
results	VBZ	ROOT	O
in	IN	case	O
markedly	RB	advmod	O
attenuated	VBN	amod	O
activities	NNS	nmod	O
of	IN	case	O
both	DT	det	O
promoters	NNS	nmod	B-DNA
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
the	DT	det	O
constitutive	JJ	amod	O
serine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
STAT1	NN	nmod	B-protein
and	CC	cc	O
STAT3	NN	conj	B-protein
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
all	DT	det	O
CLL	NN	compound	O
samples	NNS	nmod	O
tested	VBN	acl	O
to	TO	case	O
date	NN	nmod	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
physiologic	JJ	amod	O
significance	NN	nsubj	O
of	IN	case	O
this	DT	det	O
modification	NN	nmod	O
remains	VBZ	advcl	O
to	TO	mark	O
be	VB	auxpass	O
determined	VBN	xcomp	O
.	.	punct	O

HS	NN	nsubj	B-DNA
II	CD	nummod	I-DNA
was	VBD	cop	O
weak	JJ	ROOT	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
absent	JJ	advcl	O
in	IN	case	O
Hela	NNP	nmod	B-cell_line
,	,	punct	O
and	CC	cc	O
greatly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
Jurkat	NN	nmod	B-cell_line
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
this	DT	det	O
region	NN	nsubjpass	O
might	MD	aux	O
be	VB	auxpass	O
implicated	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
cis-activation	NN	nmod	O
of	IN	case	O
tal-1	NN	compound	B-DNA
promoter	NN	compound	I-DNA
1b	NN	nmod	I-DNA
in	IN	case	O
this	DT	det	O
cell	NN	compound	O
line	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
an	DT	det	O
inducible	JJ	amod	O
T	NN	nmod:npmod	B-DNA
cell-specific	JJ	amod	I-DNA
enhancer	NN	dobj	I-DNA
14	CD	nummod	O
kb	NN	nmod:npmod	O
upstream	RB	amod	O
of	IN	case	O
the	DT	det	O
IL-3	NN	compound	B-DNA
gene	NN	nmod	I-DNA
that	WDT	nsubj	O
responded	VBD	acl:relcl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

Th1	NN	nmod:npmod	O
cell-mediated	JJ	amod	O
immune	JJ	amod	O
responses	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
inflammatory	JJ	amod	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

Both	DT	det	O
conditions	NNS	nsubjpass	O
are	VBP	auxpass	O
promoted	VBN	ROOT	O
by	IN	case	O
lysophosphatidylcholine	NN	nmod	O
(	-LRB-	punct	O
lysoPC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
missense	NN	compound	O
mutation	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
region	NN	nmod	O
coding	VBG	acl	O
for	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	O
portion	NN	nmod	O
of	IN	case	O
the	DT	det	O
gamma	NN	compound	B-DNA
c	NN	compound	I-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
three	CD	nummod	O
affected	VBN	amod	O
males	NNS	nmod	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
a	DT	det	O
normal	JJ	amod	O
brother	NN	conj	O
.	.	punct	O

None	NN	nsubj	O
of	IN	case	O
the	DT	det	O
constructs	NNS	nmod	O
influenced	VBD	ROOT	O
the	DT	det	O
anti-CD3-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
the	DT	dep	O
TCR	NN	compound	B-protein
zeta-chain	NN	nmod	I-protein
or	CC	cc	O
phospholipase	NN	compound	B-protein
Cgamma1	NN	conj	I-protein
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
Src	NN	compound	B-protein
family	NN	compound	I-protein
kinase	NN	compound	I-protein
function	NN	nsubj	O
was	VBD	cop	O
intact	JJ	ccomp	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
c-jun	NN	compound	B-DNA
transcription	NN	nmod	O
by	IN	case	O
okadaic	JJ	amod	O
acid	NN	nmod	O
is	VBZ	auxpass	O
controlled	VBN	ccomp	O
primarily	RB	advmod	O
by	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

Low	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
viral	JJ	amod	O
transcription	NN	nmod	O
(	-LRB-	punct	O
basal	JJ	amod	O
transcription	NN	appos	O
)	-RRB-	punct	O
occur	VBP	ROOT	O
before	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
virally	RB	advmod	B-protein
encoded	VBN	amod	I-protein
Tax	NN	compound	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
Tax	NN	compound	B-protein
-mediated	JJ	amod	O
transcription	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
repetitive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
priming	NN	appos	O
)	-RRB-	punct	O
enhances	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
many	JJ	amod	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
IL-4	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
others	NNS	conj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
IL-2	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
A-myb	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
encodes	VBZ	ROOT	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	dobj	I-protein
that	WDT	nsubj	O
is	VBZ	cop	O
related	JJ	acl:relcl	O
both	CC	dep	O
functionally	RB	advmod	O
and	CC	cc	O
structurally	RB	advmod	O
to	TO	case	O
the	DT	det	O
v-myb	NN	compound	B-DNA
oncogene	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
two	CD	nummod	O
types	NNS	nsubj	O
of	IN	case	O
estrogen	NN	compound	O
binding	NN	compound	O
sites	NNS	nmod	O
existed	VBD	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
marked	JJ	amod	O
reduction	NN	nmod	O
in	IN	case	O
CD11b	NN	compound	B-protein
integrin	NN	compound	B-protein
expression	NN	nmod	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
treated	VBN	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Although	IN	mark	O
IFN-gamma	NN	nsubj	B-protein
alone	RB	advmod	O
did	VBD	aux	O
not	RB	neg	O
induce	VB	advcl	O
CD23	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
transcription	NN	dobj	O
,	,	punct	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
transient	JJ	amod	O
up-regulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-4-induced	JJ	amod	B-RNA
CD23	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
by	IN	case	O
IFN-gamma	NN	nmod	B-protein
within	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
IFN-gamma	NN	compound	B-protein
treatment	NN	nmod	O
in	IN	case	O
these	DT	det	O
tonsillar	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
3H-thymidine	JJ	amod	O
uptake	NN	compound	O
procedure	NN	nsubjpass	O
was	VBD	auxpass	O
employed	VBN	ROOT	O
,	,	punct	O
incorporating	VBG	xcomp	O
multiple	JJ	amod	O
microbiological	JJ	amod	B-protein
antigens	NNS	dobj	I-protein
.	.	punct	O

One	CD	nummod	O
consequence	NN	nsubj	O
of	IN	case	O
MEF2C	NN	compound	B-protein
activation	NN	nmod	O
is	VBZ	cop	O
increased	VBN	amod	O
c-jun	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	ROOT	O
.	.	punct	O

The	DT	det	O
variability	NN	nsubj	O
of	IN	case	O
response	NN	nmod	O
even	RB	advmod	O
to	TO	case	O
the	DT	det	O
most	RBS	advmod	O
narrowly	RB	amod	O
targeted	VBN	amod	O
agents	NNS	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
these	DT	det	O
diseases	NNS	nsubj	O
are	VBP	cop	O
far	RB	advmod	O
more	RBR	advmod	O
heterogeneous	JJ	ccomp	O
in	IN	case	O
humans	NNS	nmod	O
than	IN	case	O
in	IN	case	O
their	PRP$	nmod:poss	O
murine	JJ	amod	O
counterparts	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
observations	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
intracellular	JJ	amod	O
redox	NN	compound	O
status	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
determining	VBG	amod	O
factor	NN	ccomp	O
in	IN	case	O
Tax	NN	compound	B-protein
-mediated	JJ	amod	O
DNA	NN	compound	O
damage	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
selection	NN	conj	O
against	IN	case	O
the	DT	det	O
long-term	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Tax	NN	compound	B-protein
function	NN	nmod	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
in	IN	case	O
a	DT	det	O
T-lymphocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
by	IN	case	O
hypochlorous	JJ	amod	O
acid	NN	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
potential	JJ	amod	O
relevance	NN	dobj	O
of	IN	case	O
this	DT	det	O
mechanism	NN	nmod	O
in	IN	case	O
acute	JJ	amod	O
myocardial	JJ	amod	O
infarction	NN	nmod	O
(	-LRB-	punct	O
AMI	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
cytokine	NN	compound	B-protein
induction	NN	dobj	O
by	IN	case	O
leukocyte-platelet	JJ	amod	O
adhesion	NN	nmod	O
and	CC	cc	O
the	DT	det	O
occurrence	NN	conj	O
of	IN	case	O
leukocyte-platelet	JJ	amod	O
conjugates	NNS	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
AMI	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
VDR	NN	compound	B-protein
polymorphism	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
affect	VB	ccomp	O
the	DT	det	O
abundance	NN	dobj	O
of	IN	case	O
the	DT	det	O
VDR	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Several	JJ	amod	O
lipoproteins	NNS	nsubj	O
stimulated	VBD	ROOT	O
TLR-dependent	JJ	amod	O
transcription	NN	dobj	O
of	IN	case	O
inducible	JJ	amod	O
nitric	JJ	amod	B-protein
oxide	NN	compound	I-protein
synthase	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
production	NN	conj	O
of	IN	case	O
nitric	JJ	amod	O
oxide	NN	nmod	O
,	,	punct	O
a	DT	det	O
powerful	JJ	amod	O
microbicidal	JJ	compound	O
pathway	NN	appos	O
.	.	punct	O

LysoPC	NN	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
TF	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
Mono	NN	compound	B-cell_line
Mac-6	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
to	TO	case	O
a	DT	det	O
similar	JJ	amod	O
extent	NN	nmod	O
as	IN	case	O
in	IN	case	O
the	DT	det	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
replicative	JJ	amod	O
form	NN	nsubjpass	O
of	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
DNA	NN	nmod	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
two	CD	nummod	O
lymphoblastoid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dobj	I-cell_line
,	,	punct	O
X50-7	NN	appos	O
and	CC	cc	O
6F11	NN	conj	O
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
latently	RB	advmod	O
infected	VBN	acl:relcl	O
by	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
.	.	punct	O

Mutation	NN	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
binding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
inducible	JJ	amod	O
factor	NN	nmod	O
to	TO	case	O
the	DT	det	O
-120	CD	nummod	B-DNA
region	NN	nmod	I-DNA
is	VBZ	cop	O
crucial	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
biological	JJ	amod	O
function	NN	nmod	O
of	IN	case	O
the	DT	det	O
CD95L	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
upon	IN	case	O
T	NN	compound	O
cell	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
IL-2	NN	nsubj	B-protein
induces	VBZ	ccomp	O
gene	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
M-CSF	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
blood-derived	JJ	amod	I-cell_type
Mo	NN	nmod	I-cell_type
and	CC	cc	O
provide	VBP	conj	O
evidence	NN	dobj	O
for	IN	case	O
involvement	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
a	DT	det	O
model	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
binding	NN	nsubj	O
of	IN	case	O
a	DT	det	O
myeloid-specific	JJ	amod	B-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
PU.1	NN	appos	B-protein
)	-RRB-	punct	O
allows	VBZ	acl:relcl	O
a	DT	det	O
general	JJ	amod	O
factor	NN	dobj	O
(	-LRB-	punct	O
Sp1	NN	appos	B-protein
)	-RRB-	punct	O
to	TO	mark	O
bind	VB	xcomp	O
in	IN	case	O
a	DT	det	O
tissue-specific	JJ	amod	O
fashion	NN	nmod	O
thereby	RB	advmod	O
contributing	VBG	advcl	O
to	TO	case	O
the	DT	det	O
myeloid-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
CD11b	NN	nmod	B-cell_line
.	.	punct	O

To	TO	mark	O
find	VB	advcl	O
new	JJ	amod	O
regulatory	JJ	amod	B-DNA
regions	NNS	dobj	I-DNA
of	IN	case	O
the	DT	det	O
IL-2R	NN	compound	B-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
8.5	CD	nummod	O
kb	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
5	CD	nummod	O
'	''	punct	O
end	VB	compound	O
noncoding	JJ	compound	O
sequence	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2R	NN	compound	B-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
sequenced	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
biochemical	JJ	amod	O
findings	NNS	nsubj	O
correlate	VBP	ROOT	O
perfectly	RB	advmod	O
with	IN	case	O
the	DT	det	O
selective	JJ	amod	O
ability	NN	nmod	O
of	IN	case	O
c-ErbB	NN	nmod	B-protein
to	TO	mark	O
cause	VB	acl	O
sustained	JJ	amod	O
self	NN	compound	O
renewal	NN	dobj	O
in	IN	case	O
erythroid	JJ	amod	B-cell_type
progenitors	NNS	nmod	I-cell_type
.	.	punct	O

As	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
,	,	punct	O
B-lymphoid	JJ	amod	O
tissues	NNS	nsubj	O
are	VBP	cop	O
mosaic	JJ	ROOT	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
the	DT	det	O
transcribed	VBN	amod	O
allele	NN	nmod	B-DNA
,	,	punct	O
and	CC	cc	O
heterozygous	JJ	amod	O
mutation	NN	nsubj	O
of	IN	case	O
Pax5	NN	nmod	B-protein
therefore	RB	advmod	O
results	VBZ	conj	O
in	IN	case	O
deletion	NN	nmod	O
of	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
expressing	VBG	acl	O
only	RB	advmod	O
the	DT	det	O
mutant	JJ	amod	B-DNA
allele	NN	dobj	I-DNA
.	.	punct	O

The	DT	det	O
fact	NN	nsubj	O
that	IN	mark	O
BCL-6	NN	compound	B-protein
rearrangements	NNS	nsubj	O
identify	VBP	ccomp	O
biologically	RB	advmod	O
and	CC	advmod	O
clinically	RB	advmod	O
distinct	JJ	amod	O
subsets	NNS	dobj	O
of	IN	case	O
DLCL	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
these	DT	det	O
lesions	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	ccomp	O
as	IN	case	O
markers	NNS	nmod	O
in	IN	case	O
selection	NN	nmod	O
of	IN	case	O
differential	JJ	amod	O
therapeutic	JJ	amod	O
strategies	NNS	nmod	O
based	VBN	case	O
on	IN	case	O
different	JJ	amod	O
risk	NN	compound	O
groups	NNS	nmod	O
.	.	punct	O

Glucocorticoid-induced	JJ	amod	O
cell	NN	compound	O
death	NN	nsubj	O
requires	VBZ	ROOT	O
autoinduction	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
leukemic	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Once	RB	case	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
NF-ATc	NN	nsubj	B-protein
interacts	VBZ	ROOT	O
with	IN	case	O
NF-ATn	NN	nmod	B-protein
to	TO	mark	O
form	VB	xcomp	O
an	DT	det	O
active	JJ	amod	B-protein
transcriptional	JJ	amod	I-protein
complex	NN	dobj	I-protein
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
dissect	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
of	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
developed	VBN	ROOT	O
a	DT	det	O
subtractive	JJ	amod	O
hybridisation	NN	compound	O
method	NN	dobj	O
based	VBN	case	O
on	IN	case	O
a	DT	det	O
simplified	VBN	amod	O
'representational	JJ	amod	O
difference	NN	compound	O
analysis'	NN	advcl	O
.	.	punct	O

Intimate	JJ	amod	O
interactions	NNS	ROOT	O
between	IN	case	O
multipotential	JJ	amod	O
hemopoietic	JJ	amod	B-cell_type
stem	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
their	PRP$	nmod:poss	O
microenvironment	NN	amod	O
work	NN	conj	O
towards	IN	prep	O
redefining	VBG	pcomp	O
the	DT	det	O
identity	NN	dobj	O
and	CC	cc	O
the	DT	det	O
differentiative	JJ	amod	O
fate	NN	conj	O
of	IN	case	O
these	DT	det	O
primitive	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

During	IN	case	O
studies	NNS	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
T	NN	compound	O
cell-receptor	NN	amod	O
engagement	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
ALG-4F	NN	dobj	B-protein
,	,	punct	O
a	DT	det	O
truncated	VBN	amod	B-protein
transcript	NN	appos	I-protein
that	WDT	nsubj	O
prevents	VBZ	acl:relcl	O
T	NN	nmod:npmod	O
cell-receptor-induced	JJ	amod	O
FasL	NN	compound	B-protein
upregulation	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
death	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
NFATc.beta	NN	nsubj	B-protein
neither	CC	cc:preconj	O
bound	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
kappa3	NN	compound	B-DNA
element	NN	nmod	I-DNA
(	-LRB-	punct	O
an	DT	det	O
NFAT-binding	JJ	amod	B-DNA
site	NN	appos	I-DNA
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	B-DNA
necrosis	NN	compound	I-DNA
factor-alpha	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
nor	CC	cc	O
activated	VBD	conj	O
the	DT	det	O
tumor	NN	compound	B-DNA
necrosis	NN	compound	I-DNA
factor-alpha	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
in	IN	case	O
cotransfection	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
activation	NN	nsubjpass	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
new	JJ	amod	O
protein	NN	compound	O
synthesis	NN	conj	O
,	,	punct	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
IL-2	NN	compound	B-protein
induction	NN	nmod	O
of	IN	case	O
IFN-gamma	NN	nmod	B-RNA
and	CC	cc	I-RNA
GM-CSF	NN	conj	I-RNA
cytoplasmic	JJ	amod	I-RNA
mRNA	NN	dep	I-RNA
.	.	punct	O

IL-1	NN	nsubj	B-protein
induces	VBZ	ROOT	O
a	DT	det	O
rapid	JJ	amod	O
,	,	punct	O
protein	NN	nmod:npmod	O
synthesis-independent	JJ	dep	O
appearance	NN	dobj	O
of	IN	case	O
IL-2R	NN	compound	B-RNA
alpha	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
blocked	VBN	acl:relcl	O
by	IN	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

In	IN	case	O
response	NN	dep	O
to	TO	case	O
hypoxia	NN	nmod	O
,	,	punct	O
sickle	JJ	amod	B-cell_type
red	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
SS	NN	compound	B-cell_type
RBC	NNS	appos	I-cell_type
)	-RRB-	punct	O
and	CC	cc	O
leukocytes	NNS	conj	B-cell_type
exhibit	VBP	ROOT	O
increased	VBN	amod	O
adherence	NN	dobj	O
to	TO	case	O
the	DT	det	O
vascular	JJ	amod	O
endothelium	NN	nmod	O
,	,	punct	O
while	IN	mark	O
diapedesis	NN	nsubj	O
of	IN	case	O
leukocytes	NNS	nmod	B-cell_type
through	IN	case	O
the	DT	det	O
blood	NN	compound	O
vessel	NN	nmod	O
increases	VBZ	advcl	O
.	.	punct	O

Retinoid	NN	compound	B-protein
X	NN	compound	I-protein
receptor	NN	nsubj	I-protein
and	CC	cc	O
c-cerbA/thyroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptor	NN	conj	I-protein
regulate	VBP	ROOT	O
erythroid	JJ	amod	O
cell	NN	dobj	O
growth	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Efficient	JJ	amod	O
gene	NN	compound	O
activation	NN	nsubj	O
requires	VBZ	ROOT	O
the	DT	det	O
heterodimerization	NN	dobj	O
of	IN	case	O
VDR	NN	nmod	B-protein
with	IN	case	O
Retinoid	NN	compound	B-protein
X	NN	compound	I-protein
Receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
RXR	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
TGF-beta	NN	nsubj	B-protein
1	CD	nummod	I-protein
did	VBD	aux	O
not	RB	neg	O
induce	VB	ROOT	O
dephosphorylation	NN	dobj	O
of	IN	case	O
pRb	NN	nmod	B-protein
in	IN	case	O
EBV	NN	nmod	B-cell_line
(	-LRB-	punct	I-cell_line
or	CC	cc	I-cell_line
LMP-1	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-positive	JJ	amod	I-cell_line
cells	NNS	conj	I-cell_line
as	IN	mark	O
opposed	VBN	advcl	O
to	TO	case	O
EBV-negative	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
dichotomy	NN	dobj	O
in	IN	case	O
the	DT	det	O
TGF-beta	NN	compound	B-protein
1	CD	nummod	I-protein
signaling	NN	compound	O
pathway	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
separable	JJ	amod	O
gene	NN	nmod:npmod	O
regulatory	JJ	amod	O
and	CC	cc	O
growth	NN	conj	O
inhibitory	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
complex	NN	nmod	O
requires	VBZ	ROOT	O
ATP	NN	dobj	O
.	.	punct	O

In	IN	case	O
nonlymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
epidermal	JJ	amod	B-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
receptor	NN	nsubj	I-protein
displayed	VBD	ROOT	O
increased	VBN	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
within	IN	case	O
seconds	NNS	nmod	O
of	IN	case	O
UV	NN	compound	O
irradiation	NN	nmod	O
.	.	punct	O

Anti-rheumatic	JJ	amod	O
compound	NN	compound	O
aurothioglucose	NN	nsubj	O
inhibits	VBZ	ROOT	O
tumor	NN	nmod:npmod	B-protein
necrosis	NN	nmod:npmod	I-protein
factor-alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
HIV-1	NN	compound	O
replication	NN	dobj	O
in	IN	case	O
latently	RB	advmod	O
infected	JJ	amod	O
OM10.1	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
Ach2	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
Ro	NN	nmod	O
09-2210	CD	nummod	O
,	,	punct	O
we	PRP	nsubj	O
set	VBD	ROOT	O
up	RP	prt	O
a	DT	det	O
transient	JJ	amod	O
expression	NN	compound	O
system	NN	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
using	VBG	xcomp	O
a	DT	det	O
variety	NN	dobj	O
of	IN	case	O
reporter	NN	compound	O
gene	NN	compound	O
constructs	NNS	nmod	O
and	CC	cc	O
showed	VBD	conj	O
effective	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
phorbol	NN	nmod:npmod	O
ester/ionomycin-induced	JJ	amod	O
NF-AT	NN	compound	B-protein
activation	NN	nmod	O
and	CC	cc	O
anti-CD3	NN	conj	O
induced	VBD	conj	O
NF-AT	NN	dobj	B-protein
with	IN	case	O
IC50	NN	nmod	O
=	JJ	conj	O
7.7	CD	nummod	O
and	CC	cc	O
10	CD	conj	O
nM	NN	dobj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Dithiothreitol	NN	nsubj	O
,	,	punct	O
a	DT	det	O
sulfhydryl	NN	compound	O
agent	NN	appos	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
reduce	VB	ROOT	O
specific	JJ	amod	O
aldosterone	NN	compound	O
binding	NN	dobj	O
indicating	VBG	advcl	O
the	DT	det	O
absence	NN	dobj	O
of	IN	case	O
SH-groups	NNS	nmod	B-protein
in	IN	case	O
the	DT	det	O
binding	NN	compound	B-protein
domain	NN	nmod	I-protein
or	CC	cc	O
sensitive	JJ	amod	O
structures	NNS	conj	O
of	IN	case	O
the	DT	det	O
receptors	NNS	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
expression	NN	compound	O
pattern	NN	dobj	O
of	IN	case	O
LAZ3/BCL6	NN	nmod	B-protein
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
with	IN	case	O
synthetic	JJ	amod	O
oligonucleotide	NN	compound	O
probes	NNS	nmod	O
in	IN	case	O
frozen	JJ	amod	O
tissue	NN	compound	O
sections	NNS	nmod	O
from	IN	case	O
five	CD	nummod	O
reactive	JJ	amod	O
lymph	NN	compound	O
nodes	NNS	nmod	O
and	CC	cc	O
38	CD	nummod	O
B	NN	compound	O
cell	NN	conj	O
and	CC	cc	O
non-B	JJ	amod	O
NHL	NN	conj	O
.	.	punct	O

First	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
gives	VBZ	ROOT	O
no	DT	neg	O
information	NN	dobj	O
on	IN	case	O
memory	NN	nmod	O
to	TO	case	O
lytic	JJ	amod	B-protein
cycle	NN	compound	I-protein
antigens	NNS	nmod	I-protein
;	:	punct	O
second	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
preferentially	RB	advmod	O
amplifies	VBZ	parataxis	O
the	DT	det	O
dominant	JJ	amod	O
components	NNS	dobj	O
of	IN	case	O
latent	JJ	amod	O
antigen-specific	JJ	amod	O
memory	NN	nmod	O
at	IN	case	O
the	DT	det	O
expense	NN	nmod	O
of	IN	case	O
key	JJ	amod	O
subdominant	JJ	amod	O
reactivities	NNS	nmod	O
.	.	punct	O

Cell	NN	compound	O
activation	NN	ROOT	O
and	CC	cc	O
apoptosis	NN	conj	O
by	IN	case	O
bacterial	JJ	amod	B-protein
lipoproteins	NNS	nmod	I-protein
through	IN	case	O
toll-like	JJ	amod	B-protein
receptor-2	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
whereas	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
MDS1/EVI1	NN	nmod	B-DNA
has	VBZ	advcl	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
granulocytic	JJ	amod	O
differentiation	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
G-CSF	NN	nmod	B-protein
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
AML1/MDS1/EVI1	NN	nmod	B-protein
blocks	VBZ	ccomp	O
differentiation	NN	dobj	O
resulting	VBG	acl	O
in	IN	case	O
cell	NN	compound	O
death	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
TPCK	NN	nsubj	O
and	CC	cc	O
TLCK	NN	conj	O
did	VBD	aux	O
not	RB	neg	O
block	VB	ROOT	O
induction	NN	dobj	O
of	IN	case	O
an	DT	det	O
immediate-early	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
encoding	VBG	acl	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	dobj	I-protein
,	,	punct	O
Egr-1	NN	appos	B-protein
.	.	punct	O

As	IN	mark	O
HSF1	NN	nsubj	B-protein
can	MD	aux	O
function	VB	advcl	O
as	IN	case	O
both	CC	cc:preconj	O
an	DT	det	O
activator	NN	nmod	O
of	IN	case	O
heat	NN	compound	B-DNA
shock	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
a	DT	det	O
repressor	NN	conj	O
of	IN	case	O
non-heat	JJ	amod	B-DNA
shock	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
such	JJ	case	O
as	IN	mwe	O
IL1B	NN	nmod	O
and	CC	cc	O
c-	NN	amod	O
fos	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
potential	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
HSF1	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
NSAIDs	NNS	nmod	O
on	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
a	DT	det	O
human	JJ	amod	O
monocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
THP-1	NN	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
support	NN	nmod	O
of	IN	case	O
this	DT	det	O
model	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-4	NN	compound	I-DNA
promoter	NN	nsubj	I-DNA
exists	VBZ	ccomp	O
in	IN	case	O
multiple	JJ	amod	O
allelic	JJ	amod	O
forms	NNS	nmod	O
that	WDT	nsubj	O
exhibit	VBP	acl:relcl	O
distinct	JJ	amod	O
transcriptional	JJ	amod	O
activities	NNS	dobj	O
in	IN	case	O
IL-4-positive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
20	CD	nummod	O
%	NN	dep	O
to	TO	quantmod	O
25	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
adhesion	NN	compound	B-protein
protein	NN	compound	I-protein
Mac-1	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
NADPH-oxidase	NN	compound	B-protein
component	NN	compound	I-protein
cytochrome	NN	compound	I-protein
b558	NN	conj	B-protein
is	VBZ	aux	O
localized	JJ	ccomp	O
in	IN	case	O
gelatinase	NN	compound	B-protein
granules	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
a	DT	det	O
simple	JJ	amod	O
and	CC	cc	O
rapid	JJ	conj	O
strategy	NN	dobj	O
to	TO	mark	O
detect	VB	acl	O
the	DT	det	O
precise	JJ	amod	O
number	NN	dobj	O
of	IN	case	O
the	DT	det	O
CAGs	NNS	nmod	O
.	.	punct	O

T	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
express	VBP	ROOT	O
several	JJ	amod	O
low	JJ	amod	B-protein
molecular	JJ	amod	I-protein
weight	NN	compound	I-protein
transmembrane	JJ	compound	I-protein
adaptor	NN	compound	I-protein
proteins	NNS	dobj	I-protein
that	WDT	nsubj	O
recruit	VBP	acl:relcl	O
src	NN	compound	B-protein
homology	NN	compound	I-protein
(	-LRB-	punct	I-protein
SH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2	CD	nummod	I-protein
domain-containing	JJ	amod	I-protein
intracellular	JJ	amod	I-protein
molecules	NNS	dobj	I-protein
to	TO	case	O
the	DT	det	O
cell	NN	compound	O
membrane	NN	nmod	O
via	IN	case	O
tyrosine-based	JJ	amod	O
signaling	NN	compound	O
motifs	NNS	nmod	O
.	.	punct	O

Jak2	NN	compound	B-protein
kinase	NN	nsubjpass	I-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
phosphorylate	VB	xcomp	O
STAT	NN	compound	B-protein
nuclear	JJ	amod	I-protein
proteins	NNS	dobj	I-protein
.	.	punct	O

The	DT	det	O
locus	NN	compound	B-DNA
control	NN	compound	I-DNA
region	NN	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
beta-globin	NN	compound	B-DNA
cluster	NN	nmod	I-DNA
contains	VBZ	ROOT	O
five	CD	nummod	O
DNase	NN	compound	B-DNA
I	CD	nummod	I-DNA
hypersensitive	JJ	amod	I-DNA
sites	NNS	dobj	I-DNA
(	-LRB-	punct	O
5'HS1-5	NN	appos	B-DNA
)	-RRB-	punct	O
required	VBN	acl	O
for	IN	case	O
locus	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
EBF	NN	nsubj	B-protein
represents	VBZ	ccomp	O
a	DT	det	O
novel	JJ	amod	O
regulator	NN	dobj	O
of	IN	case	O
B	NN	nmod:npmod	O
lymphocyte-specific	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
LTB4	NN	nsubj	O
induces	VBZ	ccomp	O
synthesis	NN	dobj	O
of	IN	case	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-6	CD	nummod	I-protein
by	IN	case	O
human	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
through	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

To	TO	mark	O
identify	VB	ROOT	O
other	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
LMP-1	NN	compound	B-DNA
EBNA-2	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
(	-LRB-	punct	O
E2RE	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
-236/-145	CD	nummod	B-DNA
minimal	JJ	amod	I-DNA
E2RE	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
used	VBN	parataxis	O
as	IN	case	O
a	DT	det	O
probe	NN	nmod	O
in	IN	case	O
an	DT	det	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
PMA	NN	nsubj	O
exerts	VBZ	ccomp	O
its	PRP$	nmod:poss	O
inhibitory	JJ	amod	O
effects	NNS	dobj	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
a	DT	det	O
tyrosine	NN	compound	B-protein
phosphatase	NN	nmod	I-protein
which	WDT	nsubj	O
selectively	RB	advmod	O
regulates	VBZ	acl:relcl	O
Tyk2	NN	compound	B-protein
but	CC	cc	O
not	RB	cc	O
Jak1	NN	conj	B-protein
activity	NN	dobj	O
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
secretion	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
proinflammatory	JJ	amod	B-protein
lymphokine	NN	compound	I-protein
interleukin-1beta	NN	nmod	I-protein
was	VBD	auxpass	O
severely	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
dissociated	VBN	amod	O
glucocorticoids	NNS	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
THP	NN	compound	I-cell_line
1	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
PKC-epsilon	NN	nmod	B-protein
to	TO	mark	O
induce	VB	acl	O
transactivation	NN	dobj	O
of	IN	case	O
NF-AT-1	NN	nmod	B-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
was	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
stimulatory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
a	DT	det	O
constitutively	RB	advmod	B-protein
activated	VBN	amod	I-protein
p21ras	NN	nmod	I-protein
.	.	punct	O

These	DT	det	O
bHLH	JJ	amod	B-protein
antagonists	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
induced	VBN	ROOT	O
during	IN	case	O
a	DT	det	O
mitogenic	JJ	amod	O
signalling	NN	amod	O
response	NN	nmod	O
,	,	punct	O
and	CC	cc	O
they	PRP	nsubj	O
function	VBP	conj	O
by	IN	mark	O
sequestering	VBG	advcl	O
their	PRP$	nmod:poss	O
bHLH	JJ	amod	B-protein
targets	NNS	dobj	I-protein
in	IN	case	O
inactive	JJ	amod	B-protein
heterodimers	NNS	nmod	I-protein
that	WDT	nsubj	O
are	VBP	cop	O
unable	JJ	acl:relcl	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
specific	JJ	amod	O
gene	NN	compound	B-DNA
regulatory	JJ	amod	I-DNA
(	-LRB-	punct	I-DNA
E	NN	compound	I-DNA
box	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
sequences	NNS	nmod	I-DNA
.	.	punct	O

In	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
stably	RB	advmod	O
transfected	VBN	acl	O
with	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
tat	NN	compound	I-DNA
gene	NN	nmod	I-DNA
(	-LRB-	punct	O
HeLa-tat	NN	compound	B-cell_line
cells	NNS	appos	I-cell_line
)	-RRB-	punct	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Tat	NN	compound	B-protein
protein	NN	nmod	I-protein
enhanced	VBD	ROOT	O
both	CC	cc:preconj	O
TNF	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
TNF	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
cytotoxicity	NN	conj	O
.	.	punct	O

NFAT1	NN	nsubj	B-protein
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
major	JJ	amod	O
NFAT	NN	compound	B-protein
family	NN	compound	I-protein
member	NN	xcomp	I-protein
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
initial	JJ	amod	O
increased	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
IL-4	NN	nmod	B-protein
by	IN	case	O
primed	VBN	amod	O
CD4	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
support	NN	nmod	O
of	IN	case	O
this	DT	det	O
interpretation	NN	nmod	O
,	,	punct	O
mutation	NN	nsubj	O
of	IN	case	O
putative	JJ	amod	O
nuclear	JJ	amod	B-protein
localization	NN	compound	I-protein
sequences	NNS	nmod	I-protein
decreased	VBD	ROOT	O
nuclear	JJ	amod	O
localization	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
transcriptional	JJ	amod	O
activation	NN	conj	O
by	IN	case	O
membrane-bound	JJ	amod	B-protein
DeltaE	NN	nmod	I-protein
.	.	punct	O

Although	IN	mark	O
NF-ATp	NN	nsubj	B-protein
copurifies	VBZ	advcl	O
with	IN	case	O
NF-ATc	NN	nmod	B-protein
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
as	RB	advmod	O
yet	RB	advmod	O
no	DT	neg	O
understanding	NN	nsubj	O
of	IN	mark	O
how	WRB	advmod	O
NF-ATp	NN	nsubj	B-protein
is	VBZ	aux	O
functioning	VBG	acl	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
cell	NN	compound	O
type-specific	JJ	amod	O
permissiveness	NN	dobj	O
to	TO	case	O
replication	NN	nmod	O
of	IN	case	O
some	DT	det	O
mutant	JJ	amod	O
viruses	NNS	nmod	O
.	.	punct	O

Studies	NNS	nsubj	O
with	IN	case	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
segments	NNS	nmod	O
exposed	VBN	acl	O
to	TO	case	O
hypoxia	NN	nmod	O
also	RB	advmod	O
demonstrated	VBD	ROOT	O
increased	VBN	amod	O
elaboration	NN	dobj	O
of	IN	case	O
IL-8	NN	compound	B-protein
antigen	NN	nmod	I-protein
compared	VBN	case	O
with	IN	case	O
normoxic	JJ	amod	O
controls	NNS	advcl	O
.	.	punct	O

These	DT	det	O
activated	VBN	amod	B-protein
kinases	NNS	nsubj	I-protein
then	RB	advmod	O
induce	VBP	ROOT	O
the	DT	det	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
multiple	JJ	amod	B-protein
intracellular	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
eventually	RB	advmod	O
leading	VBG	advcl	O
to	TO	case	O
T-cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

mRNA	NN	compound	B-RNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
after	IN	case	O
RNA	NN	compound	O
extraction	NN	nmod	O
using	VBG	acl	O
RNAzol	NN	dobj	O
and	CC	cc	O
analysed	VBN	conj	O
after	IN	case	O
reverse	JJ	amod	B-protein
transcriptase	NN	nmod	I-protein
,	,	punct	O
by	IN	case	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
using	VBG	acl	O
a	DT	det	O
semiquantitative	JJ	amod	O
competitive	JJ	amod	O
hybridization	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
reveal	VBP	ROOT	O
that	IN	mark	O
monocyte-derived	JJ	amod	B-protein
IL-1beta	NN	nsubj	I-protein
inhibits	VBZ	ccomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
androgen-responsive	JJ	amod	B-cell_type
prostate	NN	compound	I-cell_type
tumour	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
reduces	VBZ	conj	O
AR	NN	compound	B-protein
and	CC	cc	O
PSA	NN	conj	B-protein
levels	NNS	dobj	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
the	DT	det	O
up-regulation	NN	nsubjpass	O
of	IN	case	O
CD80	NN	compound	B-protein
Ag	NN	nmod	I-protein
,	,	punct	O
found	VBN	acl	O
on	IN	case	O
monocytes	NNS	nmod	B-cell_type
obtained	VBN	acl	O
from	IN	case	O
PBMC	NN	nmod	B-cell_type
incubated	VBN	acl	O
with	IN	case	O
OKT3	NN	nmod	B-protein
,	,	punct	O
is	VBZ	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
after	IN	case	O
addition	NN	nmod	O
of	IN	case	O
IL-10	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
anti-CD28	JJ	amod	B-protein
mAb	NN	nsubj	I-protein
CLB-CD28/1	NN	nsubj	B-protein
restores	VBZ	conj	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B/Rel	NN	compound	I-protein
nuclear	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
IL-10-inhibited	JJ	amod	B-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Tolerance	NN	nsubj	O
to	TO	case	O
lipopolysaccharide	NN	nmod	O
involves	VBZ	ROOT	O
mobilization	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
with	IN	case	O
predominance	NN	nmod	O
of	IN	case	O
p50	NN	compound	B-protein
homodimers	NNS	nmod	O
.	.	punct	O

Resting	VBG	amod	B-cell_type
B	NN	compound	I-cell_type
and	CC	cc	I-cell_type
T	NN	conj	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
contain	VBP	ROOT	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
BCL-6	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
JAK2	NN	compound	B-protein
/STAT5	NN	compound	B-protein
activation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
common	JJ	amod	O
JAK	NN	compound	B-protein
/STAT	NN	compound	B-protein
pathway	NN	ccomp	O
for	IN	case	O
hIL-5	NN	compound	B-protein
-mediated	JJ	amod	O
signal	NN	nmod	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
L132	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
transfected	VBN	acl	O
with	IN	case	O
the	DT	det	O
C/EBP	NN	compound	B-protein
alpha	NN	compound	I-protein
expression	NN	compound	O
vector	NN	nmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
C/EBP	NN	compound	B-protein
alpha	NN	nsubj	I-protein
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
enhance	VB	xcomp	O
MRP14	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
the	DT	det	O
whole	JJ	amod	O
genome	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
sialoadhesin	NN	compound	B-protein
expression	NN	nmod	O
on	IN	case	O
rat	NN	compound	B-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

Glucocorticoid-mediated	JJ	amod	O
inhibition	NN	ROOT	O
of	IN	case	O
RANTES	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
element	NN	nsubj	O
includes	VBZ	ROOT	O
binding	VBG	amod	O
sites	NNS	dobj	O
for	IN	case	O
NF-E2	NN	nmod	B-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
GATA-1	NN	conj	B-protein
and	CC	cc	O
Sp-1	NN	conj	B-protein
.	.	punct	O

Despite	IN	case	O
this	DT	det	O
drastic	JJ	amod	O
effect	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
immortalization	NN	nsubj	O
of	IN	case	O
erythropoietin-dependent	JJ	amod	B-cell_type
erythroid	JJ	amod	I-cell_type
progenitors	NNS	nmod	I-cell_type
unexpectedly	RB	advmod	O
occurred	VBD	ROOT	O
at	IN	case	O
low	JJ	amod	O
frequency	NN	nmod	O
,	,	punct	O
and	CC	cc	O
all	DT	det	O
four	CD	nummod	O
cell	NN	compound	B-cell_line
lines	NNS	nsubj	I-cell_line
established	VBN	acl	O
expressed	VBD	conj	O
both	CC	cc:preconj	O
erythrocytic	JJ	dobj	B-protein
(	-LRB-	punct	I-protein
globins	NNS	dep	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	I-protein
megakaryocytic	JJ	amod	I-protein
markers	NNS	conj	I-protein
(	-LRB-	punct	O
glycoprotein	NN	compound	B-protein
IIb	NN	dep	I-protein
,	,	punct	O
platelet	NN	compound	B-protein
factor	NN	appos	I-protein
4	CD	nummod	I-protein
)	-RRB-	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
Spi-1	NN	compound	B-protein
and	CC	cc	O
Fli-1	NN	conj	B-protein
transcripts	NNS	conj	I-protein
at	IN	case	O
permissive	JJ	amod	O
temperature	NN	nmod	O
.	.	punct	O

cDNA	NN	compound	B-DNA
cloning	NN	ROOT	O
of	IN	case	O
a	DT	det	O
NGFI-B/nur77-related	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
from	IN	case	O
an	DT	det	O
apoptotic	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

An	DT	det	O
81	CD	compound	O
%	NN	compound	O
increment	NN	nsubjpass	O
in	IN	case	O
promoter	NN	compound	O
activity	NN	nmod	O
was	VBD	auxpass	O
obtained	VBN	ROOT	O
when	WRB	advmod	O
a	DT	det	O
mutation	NN	nsubjpass	O
was	VBD	auxpass	O
introduced	VBN	advcl	O
in	IN	case	O
the	DT	det	O
GATA-3	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
bp	NN	compound	B-DNA
-267	CD	compound	I-DNA
to	TO	dep	I-DNA
+12	CD	nummod	I-DNA
construct	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
comparable	JJ	acl:relcl	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
bp	NN	compound	B-DNA
-245	CD	nummod	I-DNA
to	TO	dep	I-DNA
+12	CD	nummod	I-DNA
construct	NN	nmod	I-DNA
.	.	punct	O

Inorganic	JJ	amod	O
lead	NN	nsubj	O
activates	VBZ	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
CD4+	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
significance	NN	nsubj	O
of	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
remains	VBZ	ROOT	O
unclear	JJ	xcomp	O
.	.	punct	O

Inactivation	NN	ROOT	O
of	IN	case	O
IkappaBbeta	NN	nmod	B-protein
by	IN	case	O
the	DT	det	O
tax	NN	compound	B-protein
protein	NN	nmod	I-protein
of	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
:	:	punct	O
a	DT	det	O
potential	JJ	amod	O
mechanism	NN	dep	O
for	IN	case	O
constitutive	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
.	.	punct	O

Binding	VBG	nsubj	O
to	TO	case	O
RBD	NN	nmod	B-protein
increased	VBD	ROOT	O
from	IN	case	O
undetectable	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
resting	VBG	amod	B-cell_type
platelets	NNS	nmod	I-cell_type
to	TO	case	O
>	NN	nmod	O
50	CD	nummod	O
%	NN	dep	O
of	IN	case	O
total	JJ	amod	O
Rap1	NN	nmod	B-protein
within	IN	case	O
30	CD	nummod	O
s	NNS	nmod	O
after	IN	case	O
stimulation	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	O
C/EBP	NN	compound	B-protein
beta	NN	nsubjpass	I-protein
was	VBD	auxpass	O
also	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
rheumatoid	JJ	amod	B-cell_type
synovial	JJ	amod	I-cell_type
fluid	NN	nmod	I-cell_type
monocytes/macrophages	NNS	dep	I-cell_type
,	,	punct	I-cell_type
but	CC	cc	I-cell_type
not	RB	neg	I-cell_type
in	IN	case	I-cell_type
lymphocytes	NNS	conj	I-cell_type
or	CC	cc	I-cell_type
neutrophils	NNS	conj	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
VDR	NN	compound	B-protein
concentration	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
in	IN	case	O
A-CRF	NN	compound	O
(	-LRB-	punct	O
0.8	CD	nummod	O
+/-	CC	cc	O
0.5	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	dep	O
)	-RRB-	punct	O
cells	NNS	nmod	O
vs.	CC	cc	O
2.3	CD	nummod	O
+/-	CC	cc	O
0.9	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	conj	O
in	IN	case	O
controls	NNS	nmod	O
,	,	punct	O
p	NN	dep	O
<	-LRB-	parataxis	O
0.001	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
seen	VBN	parataxis	O
in	IN	case	O
M-CRF	NN	nmod	O
(	-LRB-	punct	O
1.7	CD	nummod	O
+/-	CC	cc	O
0.7	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	dep	O
)	-RRB-	punct	O
cells	NNS	nmod	O
vs.	CC	cc	O
2.3	CD	nummod	O
+/-	CC	cc	O
0.9	CD	conj	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	conj	O
in	IN	case	O
controls	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Human	JJ	amod	B-protein
T-cell	NN	compound	I-protein
leukemia	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	I-protein
HTLV-1	NN	compound	I-protein
)	-RRB-	punct	I-protein
Tax	NN	nsubj	I-protein
transforms	VBZ	ROOT	O
normal	JJ	amod	O
T-cells	NNS	dobj	B-cell_type
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-2	CD	nummod	I-protein
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
a	DT	det	O
substantial	JJ	amod	O
decrease	NN	nsubjpass	O
of	IN	case	O
AML1/ETO	NN	compound	B-RNA
transcripts	NNS	nmod	I-RNA
was	VBD	auxpass	O
seen	VBN	ROOT	O
following	VBG	case	O
autologous	JJ	amod	O
PBSCT	NN	nmod	O
.	.	punct	O

DNase	NN	compound	B-protein
I	CD	nummod	I-protein
footprinting	NN	nsubj	O
identified	VBD	ROOT	O
several	JJ	amod	O
protected	VBN	amod	O
areas	NNS	dobj	O
including	VBG	case	O
Sp1	NN	nmod	B-DNA
,	,	punct	I-DNA
Sp1/AP-2	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
cAMP	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	conj	I-DNA
(	-LRB-	punct	I-DNA
CRE	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
within	IN	case	O
the	DT	det	O
201-bp	JJ	amod	O
core	NN	compound	O
promoter	NN	compound	O
region	NN	nmod	O
and	CC	cc	O
Sp1	NN	conj	B-DNA
,	,	punct	I-DNA
NRE-2a	NN	conj	I-DNA
,	,	punct	I-DNA
TCF-1/LEF-1	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
Sp1/NF-AT	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
in	IN	case	O
the	DT	det	O
upstream	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
region	NN	nmod	I-DNA
.	.	punct	O

A	DT	det	O
large	JJ	amod	O
prospective	JJ	amod	O
trial	NN	nsubjpass	O
is	VBZ	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
if	IN	mark	O
one	CD	dobj	O
or	CC	cc	O
more	JJR	conj	O
of	IN	case	O
these	DT	det	O
biomarkers	NNS	nmod	O
,	,	punct	O
is	VBZ	cop	O
predictive	JJ	conj	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
development	NN	nmod	O
.	.	punct	O

T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
TCR	NN	appos	B-protein
)	-RRB-	punct	O
cross-linking	NN	nsubj	O
is	VBZ	cop	O
in	IN	case	O
part	NN	ROOT	O
required	VBN	acl	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
dependent	JJ	acl:relcl	O
on	IN	case	O
the	DT	dep	O
phosphorylation	NN	nmod	O
and	CC	cc	O
degradation	NN	conj	O
of	IN	case	O
IkappaBalpha	NN	nmod	B-protein
.	.	punct	O

Disruption	NN	nsubj	O
of	IN	case	O
a	DT	det	O
GATA	NN	compound	B-DNA
motif	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
Duffy	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
abolishes	VBZ	ROOT	O
erythroid	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
in	IN	case	O
Duffy-negative	JJ	amod	O
individuals	NNS	nmod	O
.	.	punct	O

The	DT	det	O
signaling	NN	compound	O
capabilities	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
IL-10R	NN	nmod	B-protein
for	IN	mark	O
activating	VBG	acl	O
specific	JJ	amod	O
STAT	NN	compound	B-protein
proteins	NNS	dobj	I-protein
and	CC	cc	O
inducing	VBG	conj	O
gene	NN	compound	O
transcription	NN	dobj	O
were	VBD	auxpass	O
defined	VBN	ROOT	O
by	IN	case	O
reconstitution	NN	nmod	O
of	IN	case	O
receptor	NN	compound	O
functions	NNS	nmod	O
in	IN	case	O
transfected	VBN	amod	B-cell_line
tissue	NN	compound	I-cell_line
culture	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
IL-10	NN	nsubj	B-protein
stimulates	VBZ	ccomp	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
the	DT	det	O
signal	NN	compound	B-protein
transducers	NNS	nmod	I-protein
and	CC	cc	O
activators	NNS	compound	B-protein
of	IN	case	I-protein
transcription	NN	conj	I-protein
,	,	punct	O
STAT1	NN	compound	B-protein
alpha	NN	conj	I-protein
and	CC	cc	O
STAT3	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
a	DT	det	O
differential	JJ	amod	O
manner	NN	nmod	O
such	IN	mark	O
that	IN	mark	O
the	DT	det	O
relative	JJ	amod	O
formation	NN	nsubj	O
of	IN	case	O
homo-	JJ	nmod	B-protein
and	CC	cc	I-protein
heterodimers	NNS	conj	I-protein
varies	VBZ	advcl	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
adherence/contact	NN	nsubj	O
of	IN	case	O
SS	NN	compound	B-cell_type
RBC	NNS	nmod	I-cell_type
to	TO	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
large	JJ	amod	O
vessel	NN	nmod	O
can	MD	aux	O
generate	VB	ccomp	O
enhanced	VBN	amod	O
oxidant	JJ	amod	O
stress	NN	dobj	O
leading	VBG	acl	O
to	TO	case	O
increased	VBN	amod	O
adhesion	NN	nmod	O
and	CC	cc	O
diapedesis	NN	conj	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
heightened	VBN	amod	O
adherence	NN	conj	O
of	IN	case	O
SS	NN	compound	B-cell_type
reticulocytes	NNS	nmod	I-cell_type
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
injury/activation	NN	nsubj	O
of	IN	case	O
endothelium	NN	nmod	O
can	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
vaso-occlusion	NN	nmod	O
in	IN	case	O
SCD	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
tested	VBN	ROOT	O
a	DT	det	O
variety	NN	dobj	O
of	IN	case	O
Oct2	NN	compound	B-protein
isoforms	VBZ	nmod	I-protein
generated	VBN	acl	O
by	IN	case	O
alternative	JJ	amod	O
splicing	NN	nmod	O
for	IN	case	O
the	DT	det	O
capability	NN	nmod	O
to	TO	mark	O
activate	VB	acl	O
an	DT	det	O
octamer	NN	compound	B-DNA
enhancer	NN	dobj	I-DNA
in	IN	case	O
nonlymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
a	DT	det	O
B-cell	NN	compound	B-cell_line
line	NN	conj	I-cell_line
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
work	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	dep	O
that	IN	mark	O
human	JJ	amod	B-cell_type
fetal	JJ	amod	I-cell_type
and	CC	cc	I-cell_type
adult	JJ	conj	I-cell_type
erythroid	JJ	amod	I-cell_type
progenitors	NNS	nsubj	I-cell_type
are	VBP	cop	O
distinct	JJ	ccomp	O
in	IN	case	O
their	PRP$	nmod:poss	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
commitment	NN	nsubj	O
to	TO	case	O
fetal	JJ	nmod	O
or	CC	cc	O
adult	JJ	conj	O
program	NN	dep	O
occurs	VBZ	conj	O
at	IN	case	O
a	DT	det	O
very	RB	advmod	O
early	JJ	amod	O
differentiation	NN	compound	O
stage	NN	nmod	O
.	.	punct	O

Dopamine	NN	nsubj	O
stimulates	VBZ	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
via	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
decreased	VBN	amod	O
sensitivity	NN	nsubjpass	O
to	TO	case	O
cortisol	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
renin	NN	compound	B-protein
suppression	NN	nmod	O
.	.	punct	O

The	DT	det	O
exon	NN	nsubj	O
:	:	punct	O
intron	NN	compound	O
structure	NN	nsubj	O
of	IN	case	O
chicken	NN	compound	B-protein
IL2	NN	nmod	I-protein
corresponds	VBZ	ROOT	O
almost	RB	advmod	O
exactly	RB	advmod	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
mammalian	JJ	amod	O
IL2s	NNS	nmod	B-protein
with	IN	case	O
the	DT	det	O
exceptions	NNS	nmod	O
of	IN	case	O
exon	NN	nmod	B-DNA
2	CD	nummod	I-DNA
and	CC	cc	O
introns	NNS	conj	B-DNA
2	CD	nummod	O
and	CC	cc	O
3	CD	conj	O
which	WDT	nsubj	O
are	VBP	cop	O
shorter	JJR	advcl	O
.	.	punct	O

Few	JJ	advmod	O
,	,	punct	O
if	IN	mark	O
any	DT	dep	O
,	,	punct	O
studies	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
made	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
impact	NN	nmod	O
of	IN	case	O
these	DT	det	O
compounds	NNS	nmod	O
on	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Comparison	NN	nsubj	O
of	IN	case	O
the	DT	det	O
dose	NN	compound	O
response	NN	nmod	O
to	TO	case	O
anti-CD3	JJ	amod	B-protein
stimulation	NN	nmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
half-maximal	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
IL-2	NN	nmod	B-protein
was	VBD	auxpass	O
achieved	VBN	ccomp	O
using	VBG	xcomp	O
the	DT	det	O
same	JJ	amod	O
dose	NN	dobj	O
of	IN	case	O
anti-CD3	NN	nmod	B-protein
for	IN	case	O
both	CC	cc:preconj	O
freshly	RB	advmod	B-cell_type
isolated	VBN	amod	I-cell_type
and	CC	cc	O
cultured	VBN	conj	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
anti-CD28	JJ	amod	B-protein
monoclonal	JJ	amod	I-protein
antibody	NN	conj	I-protein
(	-LRB-	punct	O
mAb	NN	appos	B-protein
)	-RRB-	punct	O
results	VBZ	ROOT	O
in	IN	case	O
augmentation	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
c-Rel	NN	nmod	I-protein
,	,	punct	O
p50	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p65	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
this	DT	det	O
augmentation	NN	nsubj	O
can	MD	aux	O
occur	VB	conj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
the	DT	det	O
immunosuppressant	JJ	amod	O
cyclosporin	NN	compound	O
A	NN	nmod	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
this	DT	det	O
effect	NN	nmod	O
is	VBZ	ROOT	O
that	IN	mark	O
Bcl-2	NN	nsubj	B-protein
prevents	VBZ	ccomp	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
NFAT	NN	nmod	B-protein
(	-LRB-	punct	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
lymphocytes	NNS	dep	I-protein
,	,	punct	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	appos	I-protein
activated	VBN	acl	O
by	IN	case	O
microtubule	JJ	compound	B-protein
damage	NN	nmod	O
)	-RRB-	punct	O
by	IN	case	O
binding	NN	nmod	O
and	CC	cc	O
sequestering	VBG	conj	O
calcineurin	NN	conj	O
,	,	punct	O
a	DT	det	O
calcium-dependent	JJ	amod	O
phosphatase	NN	appos	O
that	WDT	nsubj	O
must	MD	aux	O
dephosphorylate	VB	acl:relcl	O
NFAT	NN	dobj	B-protein
to	TO	mark	O
move	VB	xcomp	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

The	DT	det	O
receptor	NN	nsubj	O
from	IN	case	O
OKT3	NN	compound	B-protein
and	CC	cc	O
OKT3	NN	conj	B-protein
+	CC	cc	O
phorbol	NN	nmod:npmod	O
myristate	NN	nmod:npmod	O
acetate	NN	nmod:npmod	O
-activated	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
exhibited	VBD	ROOT	O
decreased	VBN	amod	O
binding	NN	dobj	O
to	TO	case	O
DNA-cellulose	NN	nmod	O
compared	VBN	case	O
to	TO	case	O
PHA-activated	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Cells	NNS	nsubj	O
within	IN	case	O
each	DT	det	O
category	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
give	VB	ROOT	O
any	DT	det	O
aberrant	JJ	amod	O
results	NNS	dobj	O
.	.	punct	O

PU.1	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
at	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
mast	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
megakaryocytes	NNS	conj	B-cell_type
,	,	punct	O
macrophages	NNS	conj	B-cell_type
,	,	punct	O
neutrophils	NNS	conj	B-cell_type
,	,	punct	O
and	CC	cc	O
immature	JJ	amod	B-cell_type
erythroid	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
and	CC	cc	O
at	IN	case	O
lower	JJR	amod	O
levels	NNS	conj	O
in	IN	case	O
mature	JJ	amod	B-cell_type
erythrocytes	NNS	nmod	I-cell_type
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
TGF-alpha	NN	compound	B-protein
production	NN	nsubjpass	O
by	IN	case	O
eosinophils	NNS	nmod	B-cell_type
was	VBD	auxpass	O
up-regulated	VBN	ROOT	O
by	IN	case	O
IL-3	NN	nmod	B-protein
and	CC	cc	O
IL-5	NN	conj	B-protein
but	CC	cc	O
was	VBD	auxpass	O
down-regulated	VBN	conj	O
by	IN	case	O
IL-4	NN	nmod	B-protein
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
two	CD	nummod	O
NF-kappaB-binding	JJ	amod	B-DNA
sites	NNS	nsubj	I-DNA
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
located	JJ	acl:relcl	O
between	IN	case	O
-3134	CD	nmod	B-DNA
and	CC	cc	I-DNA
-3059	CD	conj	I-DNA
,	,	punct	O
are	VBP	cop	O
critical	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
proIL-1beta	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
.	.	punct	O

This	DT	det	O
cis	NN	compound	B-DNA
element	NN	nsubj	I-DNA
binds	VBZ	ROOT	O
a	DT	det	O
protein	NN	compound	O
complex	NN	dobj	O
referred	VBN	acl	O
to	TO	nmod	O
as	IN	case	O
HRF	NN	nmod	B-protein
(	-LRB-	punct	O
heme-responsive	JJ	amod	B-protein
factor	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
greatly	RB	advmod	O
enhanced	VBN	acl:relcl	O
both	CC	cc:preconj	O
in	IN	case	O
heme-treated	JJ	amod	O
FLCs	NNS	nmod	B-cell_line
and	CC	cc	O
during	IN	case	O
monocyte-to-macrophage	JJ	amod	O
differentiation	NN	conj	O
.	.	punct	O

Pax-5a	NN	nsubj	B-protein
was	VBD	cop	O
detectable	JJ	ROOT	O
in	IN	case	O
pro-	NN	amod	B-cell_line
,	,	punct	I-cell_line
pre-	JJ	conj	I-cell_line
,	,	punct	I-cell_line
and	CC	cc	I-cell_line
mature	JJ	conj	I-cell_line
B-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
two	CD	nummod	O
plasmacytomas	NNS	conj	O
;	:	punct	O
Pax-5b	NN	nsubjpass	B-protein
was	VBD	auxpass	O
shown	VBN	parataxis	O
to	TO	mark	O
be	VB	cop	O
present	JJ	xcomp	O
at	IN	case	O
low	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
mature	JJ	amod	B-cell_line
B-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
,	,	punct	O
unexpectedly	RB	advmod	O
,	,	punct	O
in	IN	case	O
one	CD	nummod	O
plasma	NN	compound	O
cell	NN	compound	O
line	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
pro-B-cell	JJ	conj	B-cell_line
or	CC	cc	I-cell_line
T-cell	NN	conj	I-cell_line
lines	NNS	dep	I-cell_line
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
Aiolos-binding	JJ	amod	B-DNA
sites	NNS	nmod	I-DNA
within	IN	case	O
the	DT	det	O
Bcl-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
inhibits	VBZ	ROOT	O
transactivation	NN	dobj	O
of	IN	case	O
the	DT	det	O
reporter	NN	compound	B-DNA
gene	NN	compound	I-DNA
luciferase	NN	nmod	I-DNA
,	,	punct	O
suggesting	VBG	advcl	O
direct	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
Bcl-2	NN	compound	B-protein
expression	NN	nmod	O
by	IN	case	O
Aiolos	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
A-MYB	NN	nmod	B-protein
in	IN	case	O
B	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
not	RB	cc	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
was	VBD	auxpass	O
observed	VBN	ROOT	O
when	WRB	advmod	O
either	CC	cc:preconj	O
an	DT	det	O
artificial	JJ	amod	O
construct	NN	nsubjpass	O
or	CC	cc	O
the	DT	det	O
c-MYC	NN	compound	B-DNA
promoter	NN	conj	I-DNA
was	VBD	auxpass	O
used	VBN	advcl	O
as	IN	case	O
a	DT	det	O
reporter	NN	nmod	O
.	.	punct	O

The	DT	det	O
NS-Meg	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
were	VBD	cop	O
positive	JJ	ROOT	O
for	IN	case	O
alpha-naphthyl	JJ	amod	B-protein
acetate	NN	compound	I-protein
esterase	NN	nmod	I-protein
and	CC	cc	O
periodic	JJ	amod	O
acid-Schiff	NN	compound	O
(	-LRB-	punct	O
PAS	NN	appos	O
)	-RRB-	punct	O
staining	NN	conj	O
and	CC	cc	O
for	IN	case	O
surface	NN	compound	O
CD4	NN	conj	B-protein
,	,	punct	O
CD7	NN	conj	B-protein
,	,	punct	O
CD13	NN	conj	B-protein
,	,	punct	O
CD34	NN	conj	B-protein
,	,	punct	O
CD41a	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
glycophorin	NN	compound	B-protein
A	NN	compound	I-protein
antigens	NNS	conj	I-protein
.	.	punct	O

T	NN	compound	O
cell	NN	compound	O
response	NN	ROOT	O
to	TO	case	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
transactivators	NNS	nmod	I-protein
in	IN	case	O
chronic	JJ	amod	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
.	.	punct	O

Transfection	NN	nsubj	O
of	IN	case	O
a	DT	det	O
GRbeta	NN	compound	B-protein
expression	NN	compound	O
vector	NN	nmod	O
alone	RB	advmod	O
did	VBD	aux	O
not	RB	neg	O
result	VB	ROOT	O
in	IN	case	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
repression	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

The	DT	det	O
DQB	NN	compound	B-DNA
X2-box	NN	nsubj	I-DNA
was	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
restore	VB	xcomp	O
expression	NN	dobj	O
to	TO	case	O
the	DT	det	O
silent	JJ	amod	B-DNA
DRA	NN	compound	I-DNA
reporter	NN	compound	I-DNA
construct	NN	nmod	I-DNA
.	.	punct	O

IL-4	NN	nsubj	B-protein
enhanced	VBD	ROOT	O
CD11b	NN	dobj	B-protein
,	,	punct	O
but	CC	cc	O
inhibited	VBD	conj	O
CD26	NN	compound	B-protein
expression	NN	dobj	O
and	CC	cc	O
delayed	VBN	conj	O
CD13	NN	compound	B-protein
loss	NN	dobj	O
.	.	punct	O

This	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
CIITA	NN	nmod	B-protein
to	TO	mark	O
facilitate	VB	acl	O
promoter	NN	compound	O
occupation	NN	dobj	O
is	VBZ	cop	O
undissociable	JJ	ROOT	O
from	IN	case	O
its	PRP$	nmod:poss	O
transactivation	NN	compound	O
potential	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
detected	VBN	ROOT	O
variant	JJ	amod	O
ER	NN	dobj	B-protein
in	IN	case	O
these	DT	det	O
samples	NNS	nmod	O
and	CC	cc	O
have	VBP	aux	O
compared	VBN	conj	O
the	DT	det	O
variant	JJ	amod	O
profile	NN	dobj	O
to	TO	case	O
that	DT	nmod	O
observed	VBN	acl	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
potential	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
stress	NN	nmod	O
on	IN	case	O
TH1/TH2	NN	compound	O
balance	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
three	CD	nummod	O
prototype	NN	compound	O
stress	NN	compound	O
hormones-dexamethasone	NN	nmod	O
(	-LRB-	punct	O
a	DT	det	O
synthetic	JJ	amod	O
glucocorticoid	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
catecholamines	NNS	conj	O
norepinephrine	NN	dep	O
and	CC	cc	O
epinephrine-to	NN	conj	O
alter	VBP	conj	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
IL-12	NN	nmod	B-protein
(	-LRB-	punct	O
p70	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
IL-10	NN	conj	B-protein
induced	VBN	acl	O
by	IN	case	O
bacterial	JJ	amod	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	O
whole	JJ	amod	O
blood	NN	nmod	O
.	.	punct	O

Several	JJ	amod	O
DNA	NN	compound	B-DNA
clones	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
obtained	VBN	ROOT	O
by	IN	case	O
this	DT	det	O
procedure	NN	nmod	O
,	,	punct	O
one	CD	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
,	,	punct	O
clone	NN	appos	B-DNA
18	CD	nummod	I-DNA
,	,	punct	O
is	VBZ	auxpass	O
reported	VBN	parataxis	O
and	CC	cc	O
characterized	VBN	conj	O
here	RB	advmod	O
.	.	punct	O

5.	LS	ROOT	O
One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
signaling	VBG	compound	B-protein
molecules	NNS	nmod	I-protein
which	WDT	nsubj	O
mediates	VBZ	acl:relcl	O
programmed	VBN	amod	O
cell	NN	compound	O
death	NN	dobj	O
is	VBZ	cop	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
Kappa-B	NN	dep	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Interdomain	NN	compound	B-protein
B	NN	nsubj	I-protein
in	IN	case	O
ZAP-70	NN	nmod	B-protein
regulates	VBZ	ROOT	O
but	CC	cc	O
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	conj	O
for	IN	case	O
ZAP-70	NN	compound	B-protein
signaling	NN	compound	O
function	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
calcium	NN	compound	O
ionophore	NN	compound	O
A23187	NN	nmod	O
increased	VBD	ROOT	O
Zp	NN	compound	B-DNA
activity	NN	dobj	O
.	.	punct	O

The	DT	det	O
Tat	NN	compound	B-protein
protein	NN	nsubj	I-protein
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
activator	NN	ROOT	O
of	IN	case	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
-directed	JJ	amod	O
transcription	NN	nmod	O
.	.	punct	O

This	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
products	NNS	nmod	O
from	IN	case	O
the	DT	det	O
fos	NN	compound	B-protein
and	CC	cc	I-protein
jun	NN	compound	I-protein
proto-oncogene	NN	conj	I-protein
family	NN	nmod	I-protein
and	CC	cc	O
is	VBZ	auxpass	O
believed	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
important	JJ	xcomp	O
in	IN	mark	O
regulating	VBG	advcl	O
cell	NN	dobj	O
growth	NN	dep	O
and	CC	cc	O
proliferation	NN	conj	O
.	.	punct	O

(	-LRB-	punct	O
2E	NN	amod	O
)	-RRB-	punct	O
-3-	JJ	nsubj	O
[	-LRB-	punct	O
5-	CD	dep	O
(	-LRB-	punct	O
2	CD	nummod	O
,	,	punct	O
3-Dimethoxy-6-methyl-1	NN	conj	O
,	,	punct	O
4-benzoquinoyl	NN	appos	O
)	-RRB-	punct	O
]	-RRB-	punct	O
-2-nonyl-2-	NN	amod	O
propenoic	JJ	amod	O
acid	NN	appos	O
(	-LRB-	punct	O
E3330	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
agent	NN	ROOT	O
with	IN	case	O
hepatoprotective	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Together	RB	advmod	O
the	DT	det	O
Act-1	NN	compound	B-DNA
and	CC	cc	O
CBF	NN	conj	B-DNA
sites	NNS	nsubj	I-DNA
form	VBP	ROOT	O
a	DT	det	O
functional	JJ	amod	B-DNA
unit	NN	dobj	I-DNA
(	-LRB-	punct	O
AC	NN	compound	B-DNA
unit	NN	appos	I-DNA
)	-RRB-	punct	O
with	IN	case	O
dual	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Direct	JJ	amod	O
suppression	NN	ROOT	O
of	IN	case	O
Stat1	NN	compound	B-protein
function	NN	nmod	O
during	IN	case	O
adenoviral	JJ	amod	O
infection	NN	nmod	O
.	.	punct	O

Neutrophils	NNS	nsubj	B-cell_type
and	CC	cc	O
monocytes	NNS	conj	B-cell_type
express	VBP	ROOT	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
PU.1	NN	nmod	B-protein
(	-LRB-	punct	O
Spi-1	NN	appos	B-protein
)	-RRB-	punct	O
but	CC	cc	O
not	RB	cc	O
Spi-B	NN	conj	B-protein
.	.	punct	O

Clone	NN	compound	B-cell_line
C3/5	NN	nsubj	I-cell_line
showed	VBD	ROOT	O
specific	JJ	amod	O
proliferation	NN	dobj	O
,	,	punct	O
cytotoxicity	NN	conj	O
,	,	punct	O
and	CC	cc	O
cytokine	NN	compound	O
(	-LRB-	punct	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	dep	I-protein
,	,	punct	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	appos	I-protein
)	-RRB-	punct	O
production	NN	conj	O
when	WRB	advmod	O
challenged	VBN	advcl	O
with	IN	case	O
autologous	JJ	amod	B-cell_line
lymphoblastic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
pulsed	VBN	acl	O
with	IN	case	O
peptide	NN	compound	O
BCR1/25	NN	nmod	O
.	.	punct	O

Sensitivity	NN	nsubj	O
(	-LRB-	punct	O
ID50	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
lymphocytes	NNS	nmod	B-cell_type
for	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
was	VBD	cop	O
the	DT	det	O
same	JJ	ROOT	O
in	IN	case	O
all	DT	det	O
groups	NNS	nmod	O
.	.	punct	O

Sequence	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
a	DT	det	O
previously	RB	advmod	O
unrecognized	JJ	amod	B-DNA
composite	JJ	amod	I-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
for	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
Sp1	NN	nmod	B-protein
and	CC	cc	O
NF-kappaB	NN	compound	B-protein
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
at	IN	case	O
positions	NNS	nmod	B-DNA
-295	CD	nummod	I-DNA
to	TO	dep	I-DNA
-286	CD	nummod	I-DNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
MOLT4	NN	dep	B-cell_line
(	-LRB-	punct	O
T	NN	compound	B-cell_type
cell	NN	appos	I-cell_type
)	-RRB-	punct	O
and	CC	cc	O
BALL1	NN	conj	B-cell_line
(	-LRB-	punct	O
B	NN	compound	B-cell_type
cell	NN	appos	I-cell_type
)	-RRB-	punct	O
,	,	punct	O
nor	CC	cc	O
in	IN	case	O
K562	NN	compound	B-cell_line
erythroblasts	NNS	conj	I-cell_line
.	.	punct	O

Eosinophils	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
purified	VBN	ROOT	O
from	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
by	IN	case	O
discontinuous	JJ	amod	O
Percoll	NN	compound	O
gradients	NNS	nmod	O
and	CC	cc	O
stimulated	VBN	conj	O
with	IN	case	O
IL-5	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
the	DT	det	O
six	CD	nummod	O
patients	NNS	nmod	O
presented	VBN	acl	O
,	,	punct	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
different	JJ	amod	O
forms	NNS	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
recognized	VBN	ROOT	O
.	.	punct	O

Although	IN	mark	O
both	DT	det	O
promoters	NNS	nsubj	O
lack	VBP	advcl	O
any	DT	det	O
TATA	NN	compound	B-DNA
box	NN	dobj	I-DNA
,	,	punct	O
they	PRP	nsubj	O
contain	VBP	ROOT	O
two	CD	nummod	O
CAAT	NN	compound	B-DNA
box-like	JJ	amod	I-DNA
motifs	NNS	dobj	I-DNA
and	CC	cc	O
three	CD	nummod	O
binding	VBG	amod	B-DNA
sites	NNS	conj	I-DNA
of	IN	case	O
GA-binding	JJ	amod	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
GABP	NN	compound	I-protein
)	-RRB-	punct	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
underlying	VBG	csubj	O
aberrancies	NNS	dobj	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
c-fos/c-jun	NN	nmod	B-DNA
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
their	PRP$	nmod:poss	O
nuclear	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
proteins	NNS	conj	I-protein
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
the	DT	det	O
age-related	JJ	amod	O
impairments	NNS	nmod	O
of	IN	case	O
AP-1	NN	compound	B-protein
activation	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Interleukin-3	NN	nsubj	B-protein
(	-LRB-	punct	O
IL-3	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
cytokine	NN	ROOT	B-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
primarily	RB	advmod	O
in	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

As	IN	mark	O
judged	VBN	advcl	O
by	IN	mark	O
supershifting	VBG	advcl	O
the	DT	det	O
DNA-protein	JJ	amod	B-protein
complexes	NNS	dobj	I-protein
with	IN	case	O
Abs	NNS	nmod	B-protein
recognizing	VBG	acl	O
specific	JJ	amod	O
components	NNS	dobj	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B/Rel	NN	compound	I-protein
protein	NN	compound	I-protein
family	NN	nmod	I-protein
,	,	punct	O
the	DT	det	O
p50/p65	NN	compound	B-protein
(	-LRB-	punct	O
Rel	NN	compound	B-protein
A	NN	appos	I-protein
)	-RRB-	punct	O
heterodimeric	JJ	amod	O
form	NN	nsubjpass	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
is	VBZ	auxpass	O
primarily	RB	advmod	O
affected	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
phenotypic	JJ	amod	O
differences	NNS	nsubj	O
observed	VBN	acl	O
were	VBD	cop	O
attributable	JJ	ROOT	O
,	,	punct	O
in	IN	case	O
large	JJ	amod	O
part	NN	nmod	O
,	,	punct	O
to	TO	case	O
changes	NNS	nmod	O
affecting	VBG	acl	O
the	DT	det	O
viral	JJ	amod	B-DNA
LTR	NN	dobj	I-DNA
.	.	punct	O

The	DT	det	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
to	TO	case	O
those	DT	nmod	O
obtained	VBN	acl	O
with	IN	case	O
the	DT	det	O
parental	JJ	amod	B-cell_line
granulocyte-macrophage	JJ	amod	I-cell_line
colony-stimulating	JJ	amod	I-cell_line
factor	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
GM-CSF	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-dependent	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
UT-7	NN	appos	B-cell_line
,	,	punct	O
which	WDT	nsubj	O
has	VBZ	acl:relcl	O
a	DT	det	O
predominantly	RB	advmod	O
megakaryoblastic	JJ	amod	O
phenotype	NN	dobj	O
and	CC	cc	O
is	VBZ	cop	O
unable	JJ	conj	O
to	TO	mark	O
proliferate	VB	xcomp	O
continuously	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
Epo	NN	nmod	B-protein
.	.	punct	O

Hemoglobin	NN	compound	B-protein
switching	NN	nsubjpass	O
in	IN	case	O
humans	NNS	nmod	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
ratio	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
GATA-1	NN	appos	B-protein
and	CC	cc	O
SP1	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
Bmax	NNP	nsubj	O
in	IN	case	O
these	DT	det	O
subjects	NNS	nmod	O
significantly	RB	advmod	O
increased	VBD	ROOT	O
to	TO	case	O
6.61	CD	nmod	O
+/-	CC	cc	O
2.02	CD	conj	O
(	-LRB-	punct	O
257.7	CD	nummod	O
+/-	CC	cc	O
107.8	CD	conj	O
%	NN	appos	O
)	-RRB-	punct	O
after	IN	case	O
24	CD	nummod	O
h	NN	compound	O
stimulation	NN	nmod	O
with	IN	case	O
concanavalin	NN	compound	O
A	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
<	JJR	dep	O
0.01	CD	nummod	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
Kd	NN	compound	O
change	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
significant	JJ	advcl	O
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
p21	NN	compound	B-protein
(	-LRB-	punct	I-protein
WAF1/CIP1	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
p27	NN	compound	B-protein
(	-LRB-	punct	I-protein
KIP1	NN	appos	I-protein
)	-RRB-	punct	I-protein
transcripts	NNS	nsubjpass	O
were	VBD	auxpass	O
induced	VBN	ccomp	O
after	IN	case	O
6	CD	nummod	O
hours	NNS	nmod:poss	O
'	POS	case	O
exposure	NN	nmod	O
to	TO	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
and	CC	cc	O
then	RB	advmod	O
decreased	VBD	conj	O
to	TO	case	O
basal	JJ	amod	O
levels	NNS	nmod	O
over	IN	case	O
48	CD	nummod	O
hours	NNS	nmod	O
.	.	punct	O

This	DT	det	O
effect	NN	nsubj	O
is	VBZ	cop	O
independent	JJ	ROOT	O
of	IN	case	O
differentiation	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
RAR	NN	compound	B-protein
alpha	NN	nmod	I-protein
in	IN	case	O
HL-60	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
similar	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
RAR	NN	compound	B-protein
alpha	NN	nmod	I-protein
in	IN	case	O
CD38	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
other	JJ	amod	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
third	JJ	amod	O
site	NN	nsubjpass	O
was	VBD	auxpass	O
occupied	VBN	ROOT	O
in	IN	case	O
quiescent	JJ	amod	O
cells	NNS	nmod	O
or	CC	cc	O
in	IN	case	O
cells	NNS	conj	O
stimulated	VBN	acl	O
by	IN	case	O
anti	JJ	amod	B-protein
CD2	NN	nmod	I-protein
or	CC	cc	O
anti	JJ	amod	B-protein
CD28	NN	conj	I-protein
alone	RB	advmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
STAT1	NN	nmod	B-RNA
,	,	punct	I-RNA
STAT3	NN	conj	I-RNA
and	CC	cc	I-RNA
STAT5	NN	conj	I-RNA
mRNAs	NNS	dep	I-RNA
were	VBD	auxpass	O
also	RB	advmod	O
induced	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
T-cell	NN	compound	B-protein
mitogen	NN	nmod	I-protein
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
the	DT	det	O
DM	NN	compound	B-DNA
genes	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
regulated	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
similar	JJ	amod	O
manner	NN	nmod	O
as	IN	case	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
a	DT	det	O
series	NN	nsubjpass	O
of	IN	case	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vitro	FW	dep	O
analyses	NNS	nmod	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
sharply	RB	advmod	O
reduced	VBD	amod	O
NF-AT	NN	compound	B-protein
activity	NN	nsubjpass	O
produced	VBN	acl	O
by	IN	mark	O
co-transfecting	VBG	advcl	B-DNA
BKO	NN	dobj	I-DNA
could	MD	aux	O
be	VB	auxpass	O
``	``	punct	O
rescued	VBN	ROOT	O
''	''	punct	O
by	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
transfected	VBN	amod	O
B	NN	compound	B-protein
subunit	NN	nmod	I-protein
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
depletion	NN	nsubj	O
of	IN	case	O
this	DT	det	O
subunit	NN	nmod	O
was	VBD	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
.	.	punct	O

1	CD	nummod	O
alpha	NN	compound	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
inhibited	VBD	ROOT	O
CD23	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
yet	RB	advmod	O
failed	VBD	advcl	O
to	TO	mark	O
modulate	VB	xcomp	O
CD23	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

IL-4	NN	nsubj	B-protein
conducts	VBZ	ROOT	O
its	PRP$	nmod:poss	O
biological	JJ	amod	O
activities	NNS	dobj	O
through	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
the	DT	det	O
IL-4	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
IL-4R	NN	appos	B-protein
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
target	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
lymphocyte-specific	JJ	amod	B-DNA
immunoglobulin	NN	compound	I-DNA
mu	NN	compound	I-DNA
heavy-chain	NN	amod	I-DNA
gene	NN	compound	I-DNA
intronic	JJ	amod	I-DNA
enhancer	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
multiple	JJ	amod	O
nuclear	JJ	amod	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
basis	NN	nsubj	O
of	IN	case	O
GC	NN	compound	O
insensitivity	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

Binding	NN	nsubj	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
to	TO	case	O
hGR	NN	nmod	B-protein
down-regulates	VBZ	ROOT	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
inflammatory	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
that	WDT	nsubj	O
can	MD	aux	O
propagate	VB	acl:relcl	O
IBD	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
find	VBP	ROOT	O
significant	JJ	amod	O
differences	NNS	dobj	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
germline	NN	nmod	B-DNA
and	CC	cc	O
V	NN	conj	B-DNA
region	NN	compound	I-DNA
promoters	NNS	dep	I-DNA
by	IN	case	O
kappa	NN	compound	B-DNA
enhancers	NNS	nmod	I-DNA
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
L.	FW	compound	O
pneumophila	FW	compound	O
RpoS	NN	nmod	B-protein
increased	VBD	ccomp	O
in	IN	case	O
stationary	JJ	amod	O
phase	NN	nmod	O
.	.	punct	O

Interleukin-3	NN	nsubjpass	B-protein
(	-LRB-	punct	O
IL-3	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
exclusively	RB	advmod	O
expressed	VBN	ROOT	O
by	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	nmod	I-cell_type
and	CC	cc	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
a	DT	det	O
function	NN	dobj	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
tightly	RB	advmod	O
controlled	VBN	acl:relcl	O
both	CC	cc:preconj	O
in	IN	case	O
a	DT	det	O
lineage-specific	JJ	nmod	O
and	CC	cc	O
in	IN	case	O
a	DT	det	O
stimulation-dependent	JJ	amod	O
manner	NN	conj	O
.	.	punct	O

Previous	JJ	amod	O
reports	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
BA-induced	JJ	amod	O
overexpression	NN	nsubj	O
of	IN	case	O
erythroid	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
occurred	VBD	ccomp	O
at	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
level	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
erythroid	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Germinal	JJ	amod	O
center	NN	compound	O
(	-LRB-	punct	O
GC	NN	appos	O
)	-RRB-	punct	O
formation	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
ILFs	NNS	nmod	O
was	VBD	auxpass	O
frequently	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
HCV-positive	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
an	DT	det	O
inducible	JJ	amod	O
protein	NN	compound	B-protein
complex	NN	nsubj	I-protein
(	-LRB-	punct	O
Band	NN	compound	B-protein
A	NN	appos	I-protein
)	-RRB-	punct	O
binds	VBZ	ccomp	O
to	TO	case	O
SRE	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
within	IN	case	O
10	CD	nummod	O
min	NN	nmod	O
after	IN	case	O
mitogenic	JJ	amod	O
stimulation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_line
PBL-T	NN	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
becomes	VBZ	conj	O
nondetectable	JJ	xcomp	O
by	IN	case	O
60	CD	nummod	O
min	NN	nmod	O
.	.	punct	O

Few	JJ	amod	O
known	JJ	amod	O
genes	NNS	nsubjpass	B-DNA
(	-LRB-	punct	O
IL-2	NN	dep	B-protein
,	,	punct	O
members	NNS	appos	O
of	IN	case	O
the	DT	det	O
IL-8	NN	compound	B-DNA
family	NN	nmod	I-DNA
,	,	punct	O
interferon-gamma	NN	appos	B-DNA
)	-RRB-	punct	O
are	VBP	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
only	RB	advmod	O
through	IN	case	O
the	DT	det	O
combined	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
phorbol	NN	compound	O
myristic	JJ	amod	O
acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	amod	O
)	-RRB-	punct	O
-ionophore	NN	conj	O
,	,	punct	O
and	CC	cc	O
expression	NN	nsubjpass	O
of	IN	case	O
only	RB	advmod	O
these	DT	det	O
genes	NNS	nmod	B-DNA
can	MD	aux	O
be	VB	auxpass	O
fully	RB	advmod	O
suppressed	VBN	conj	O
by	IN	case	O
Cyclosporin	NN	compound	O
A	NN	nmod	O
(	-LRB-	punct	O
CyA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

pIL-5	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
-511	CD	appos	I-DNA
)	-RRB-	punct	I-DNA
Luc	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
transcribed	VBN	ROOT	O
by	IN	case	O
T-cell	NN	compound	B-cell_line
hybridomas	NNS	nmod	I-cell_line
derived	VBN	acl	O
from	IN	case	O
fusion	NN	nmod	O
between	IN	case	O
IL-5-producing	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
clones	NNS	nmod	I-cell_line
and	CC	cc	O
an	DT	det	O
IL-5	NN	compound	B-cell_line
gene-nonexpressing	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
hybridomas	NNS	conj	B-cell_line
derived	VBN	acl	O
from	IN	case	O
IL-5-nonproducing	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
clones	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
agents	NNS	nsubj	O
that	WDT	nsubj	O
elevate	VBP	acl:relcl	O
intracellular	JJ	amod	O
cAMP	NN	dobj	O
inhibit	VBP	acl:relcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNFalpha	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
tissue	NN	compound	B-protein
factor	NN	conj	I-protein
,	,	punct	O
endothelial	JJ	amod	B-protein
leukocyte	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-DNA
cell	NN	compound	I-DNA
adhesion	NN	compound	I-DNA
molecule-1	NN	compound	I-DNA
genes	NNS	conj	I-DNA
.	.	punct	O

The	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
enhancer	NN	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
encoding	VBG	acl	O
the	DT	det	O
interleukin-2	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL-2	NN	appos	I-protein
)	-RRB-	punct	I-protein
receptor	NN	compound	I-protein
alpha	NN	compound	I-protein
chain	NN	dobj	I-protein
(	-LRB-	punct	O
IL-2R	NN	compound	B-protein
alpha	NN	appos	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
functional	JJ	ROOT	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
hybrids	NNS	nmod	B-cell_line
expressing	VBG	acl	O
nuclear	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	dobj	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
differential	JJ	amod	O
hybridization	NN	compound	O
analysis	NN	dobj	O
of	IN	case	O
a	DT	det	O
cDNA	NN	compound	B-DNA
library	NN	nmod	I-DNA
constructed	VBN	acl	O
from	IN	case	O
the	DT	det	O
murine	JJ	amod	O
RA-inducible	JJ	amod	B-cell_line
MPRO	NN	compound	I-cell_line
promyelocyte	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
to	TO	mark	O
identify	VB	advcl	O
immediate-early	JJ	amod	B-DNA
genes	NNS	dobj	I-DNA
induced	VBN	acl	O
by	IN	case	O
RA	NN	nmod	O
during	IN	case	O
granulocytic	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Estrogen	NN	compound	B-protein
receptor	NN	nsubj	I-protein
diminishes	VBZ	ROOT	O
DNA-binding	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
chicken	NN	compound	B-protein
GATA-1	NN	nmod	I-protein
and	CC	cc	O
CACCC-binding	JJ	amod	B-protein
proteins	NNS	conj	I-protein
.	.	punct	O

One	CD	nummod	O
possibility	NN	nsubj	O
toward	IN	prep	O
this	DT	det	O
goal	NN	pobj	O
is	VBZ	ROOT	O
to	TO	aux	O
try	VB	xcomp	O
to	TO	aux	O
dissociate	VB	xcomp	O
two	CD	nummod	O
main	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
,	,	punct	O
i.e.	FW	advmod	O
transactivation	NN	appos	O
and	CC	cc	O
transrepression	NN	conj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
from	IN	case	O
9	CD	nummod	O
healthy	JJ	amod	O
volunteers	NNS	nmod	O
(	-LRB-	punct	O
average	JJ	amod	O
GR	NN	compound	B-protein
concentration	NN	dep	O
7131	CD	nummod	O
+/-	CC	cc	O
1256	CD	conj	O
sites/cell	NNS	appos	O
)	-RRB-	punct	O
correlated	VBD	ROOT	O
excellently	RB	advmod	O
with	IN	case	O
those	DT	nmod	O
obtained	VBN	acl	O
by	IN	case	O
the	DT	det	O
Scatchard	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
identify	VBP	ROOT	O
a	DT	det	O
pre-existing	JJ	amod	B-protein
NF-AT-binding	JJ	amod	I-protein
factor	NN	dobj	I-protein
that	WDT	nsubj	O
is	VBZ	cop	O
present	JJ	acl:relcl	O
in	IN	case	O
hypotonic	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
unstimulated	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
during	IN	case	O
hypoxia	NN	nmod	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
proximal	JJ	amod	O
step	NN	ccomp	O
which	WDT	nsubj	O
precedes	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
dissociation	NN	dobj	O
and	CC	cc	O
degradation	NN	conj	O
from	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
demonstrated	VBD	ROOT	O
in	IN	case	O
earlier	JJR	amod	O
studies	NNS	nmod	O
that	IN	mark	O
the	DT	det	O
upstream	JJ	amod	B-DNA
region	NN	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
mouse	NN	compound	B-DNA
GM-CSF	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
at	IN	case	O
positions	NNS	nmod	O
between	IN	case	O
-95	CD	nmod	B-DNA
and	CC	cc	I-DNA
-73	CD	conj	I-DNA
is	VBZ	cop	O
essential	JJ	acl:relcl	O
for	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
PMA/A23187	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
C26	NN	compound	B-DNA
element	NN	nsubjpass	I-DNA
itself	PRP	dep	O
was	VBD	auxpass	O
profoundly	RB	advmod	O
activated	VBN	ROOT	O
upon	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
12-O-tetradecanoylphorbol-13-acetate	NN	nmod	O
.	.	punct	O

The	DT	det	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
EBV	NN	nsubj	O
can	MD	aux	O
up-regulate	VB	ccomp	O
IL-1beta	NN	compound	B-protein
expression	NN	dobj	O
,	,	punct	O
possibly	RB	advmod	O
by	IN	mark	O
using	VBG	advcl	O
RBP	NN	dobj	B-protein
,	,	punct	O
NF-kappaB	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
both	DT	conj	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
negative	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
VDR	NN	compound	B-protein
and	CC	cc	O
serum	NN	conj	O
creatinine	NN	compound	O
values	NNS	nmod	O
when	WRB	advmod	O
A-CRF	NN	nsubjpass	O
and	CC	cc	O
M-CRF	NN	conj	O
were	VBD	auxpass	O
considered	VBN	advcl	O
altogether	RB	advmod	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
-0.63	CD	dobj	O
;	:	punct	O
p	NN	dep	O
<	JJR	parataxis	O
0.01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Dexamethasone	NN	nsubj	O
,	,	punct	O
up	IN	advmod	O
to	TO	case	O
a	DT	det	O
concentration	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
mumol/L	NN	nmod	O
,	,	punct	O
neither	CC	cc:preconj	O
affected	VBD	ROOT	O
significantly	RB	advmod	O
the	DT	det	O
release	NN	dobj	O
of	IN	case	O
granule	NN	compound	B-protein
enzymes	NNS	nmod	I-protein
nor	CC	cc	O
interfered	VBD	conj	O
with	IN	case	O
PAF	NN	compound	B-protein
binding	VBG	nmod	O
to	TO	case	O
its	PRP$	nmod:poss	O
membrane	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

A	DT	det	O
less	RBR	advmod	O
pronounced	JJ	amod	O
reduction	NN	nsubjpass	O
in	IN	case	O
lambda	NN	compound	B-protein
L	NN	compound	I-protein
chain	NN	nmod	I-protein
and	CC	cc	O
microH	NN	compound	B-protein
chain	NN	conj	I-protein
was	VBD	auxpass	O
also	RB	advmod	O
noted	VBN	ROOT	O
.	.	punct	O

Under	IN	prep	O
these	DT	det	O
conditions	NNS	pobj	O
,	,	punct	O
about	RB	advmod	O
0.5	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
47.10	CD	nummod	B-cell_line
cells	NNS	nmod	I-cell_line
formed	VBD	ROOT	O
large	JJ	amod	O
14-day	JJ	amod	O
colonies	NNS	dobj	O
(	-LRB-	punct	O
>	NN	dep	O
1	CD	nummod	O
mm	NN	appos	O
)	-RRB-	punct	O
composed	VBN	acl	O
of	IN	case	O
mature	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
and	CC	cc	O
granulocytes	NNS	conj	B-cell_type
,	,	punct	O
reflecting	VBG	advcl	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
progenitors	NNS	nmod	O
endowed	JJ	acl	O
with	IN	case	O
high	JJ	amod	O
proliferative	JJ	amod	O
potential	NN	nmod	O
(	-LRB-	punct	O
HPP-47.10	CD	nummod	B-cell_line
cells	NNS	appos	I-cell_line
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
other	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nsubjpass	I-protein
or	CC	cc	O
coactivators	NNS	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
tax	NN	compound	B-protein
activation	NN	nmod	O
but	CC	cc	O
these	DT	nsubj	O
remain	VBP	conj	O
to	TO	mark	O
be	VB	auxpass	O
identified	VBN	xcomp	O
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
VCAM-1	NN	nmod	B-protein
and	CC	cc	O
E-selectin	NN	conj	B-protein
surface	NN	compound	O
expression	NN	dep	O
by	IN	case	O
TNF	NN	nmod	B-protein
was	VBD	auxpass	O
dose-dependently	RB	advmod	O
reduced	VBN	ROOT	O
by	IN	case	O
aspirin	NN	nmod	O
over	IN	case	O
the	DT	det	O
same	JJ	amod	O
range	NN	nmod	O
,	,	punct	O
while	IN	mark	O
induction	NN	nsubjpass	O
of	IN	case	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
(	-LRB-	punct	O
ICAM-1	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
hardly	RB	advmod	O
affected	VBN	advcl	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
eosinophilic	JJ	amod	I-cell_line
sublines	NNS	nmod	I-cell_line
with	IN	case	O
either	CC	cc:preconj	O
interleukin-5	NN	nmod	B-protein
or	CC	cc	O
butyric	JJ	amod	O
acid	NN	conj	O
increased	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
GATA-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
concomitant	JJ	acl	O
with	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
eosinophil-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
whereas	IN	dep	O
levels	NNS	nsubj	O
of	IN	case	O
GATA-2	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
remained	VBD	parataxis	O
relatively	RB	advmod	O
constant	JJ	xcomp	O
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
highly	RB	advmod	B-cell_type
purified	VBN	amod	I-cell_type
human	JJ	amod	I-cell_type
T-cells	NNS	nmod	I-cell_type
via	IN	case	O
CD2	NN	compound	B-protein
and	CC	cc	I-protein
CD28	NN	conj	I-protein
adhesion	NN	compound	I-protein
molecules	NNS	nmod	I-protein
induces	VBZ	ROOT	O
and	CC	cc	O
maintains	VBZ	conj	O
proliferation	NN	dobj	O
for	IN	prep	O
more	JJR	amod	O
than	IN	quantmod	O
3	CD	nummod	O
weeks	NNS	pobj	O
.	.	punct	O

To	TO	mark	O
validate	VB	advcl	O
the	DT	det	O
method	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
made	VBD	ROOT	O
use	NN	dobj	O
of	IN	case	O
earlier	JJR	amod	O
receptor	NN	compound	O
binding	NN	compound	O
studies	NNS	nmod	O
indicating	VBG	acl	O
that	IN	mark	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
monocytes	NNS	nsubj	I-cell_type
and	CC	cc	O
activated	VBN	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
resting	VBG	conj	O
,	,	punct	O
lymphocytes	NNS	nsubj	B-cell_type
expressed	VBD	ccomp	O
the	DT	det	O
VDR	NN	dobj	B-protein
.	.	punct	O

TRADD	NN	ROOT	B-protein
associated	VBN	acl	O
with	IN	case	O
wild-type	JJ	amod	B-protein
LMP1	NN	nmod	I-protein
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
isoleucine-mutated	JJ	amod	O
LMP1	NN	conj	B-protein
in	IN	case	O
mammalian	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
TRADD	NN	conj	B-protein
constitutively	RB	advmod	O
associated	VBN	acl	O
with	IN	case	O
LMP1	NN	nmod	B-protein
in	IN	case	O
EBV-transformed	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Minimal	JJ	amod	O
residual	JJ	amod	O
disease	NN	ROOT	O
in	IN	case	O
acute	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	nmod	O
with	IN	case	O
PML/RAR	NN	compound	B-RNA
alpha	NN	nmod	I-RNA
or	CC	cc	I-RNA
AML1/ETO	NN	compound	I-RNA
mRNA	NN	conj	I-RNA
and	CC	cc	O
phenotypic	JJ	amod	O
analysis	NN	conj	O
of	IN	case	O
possible	JJ	amod	B-cell_type
T	NN	nmod	I-cell_type
and	CC	cc	I-cell_type
natural	JJ	amod	I-cell_type
killer	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
in	IN	case	O
bone	NN	compound	O
marrow	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
groups	NNS	nsubjpass	O
of	IN	case	O
U937	NN	compound	B-cell_line
promonocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
were	VBD	auxpass	O
obtained	VBN	ROOT	O
by	IN	mark	O
limiting	VBG	advcl	O
dilution	NN	compound	O
cloning	NN	dobj	O
which	WDT	nsubj	O
differed	VBD	acl:relcl	O
strikingly	RB	advmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
support	VB	acl	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
replication	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
the	DT	det	O
defects	NNS	dobj	O
in	IN	case	O
B-	NN	intj	O
and	CC	cc	O
T-	NN	conj	O
lymphocyte	NN	compound	O
development	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	O
carrying	VBG	acl	O
targeted	VBN	amod	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
E-protein	JJ	compound	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
discuss	VB	conj	O
our	PRP$	nmod:poss	O
current	JJ	amod	O
understanding	NN	dobj	O
of	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
in	IN	case	O
lymphoid	JJ	amod	O
development	NN	nmod	O

Under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
rapid	JJ	amod	O
and	CC	cc	O
transient	JJ	conj	O
response	NN	xcomp	O
,	,	punct	O
reaching	VBG	xcomp	O
a	DT	det	O
maximum	NN	dobj	O
by	IN	case	O
10-15	CD	nummod	O
min	NN	nmod	O
,	,	punct	O
and	CC	cc	O
returning	VBG	conj	O
to	TO	case	O
near-basal	JJ	amod	O
levels	NNS	nmod	O
by	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
.	.	punct	O

Platelet-activating	JJ	amod	B-protein
factor	NN	nsubj	I-protein
stimulates	VBZ	ROOT	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
heparin-binding	JJ	amod	B-protein
epidermal	JJ	amod	I-protein
growth	NN	compound	I-protein
factor-like	JJ	amod	I-protein
growth	NN	compound	I-protein
factor	NN	nmod	I-protein
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

HIV1	NN	compound	O
infection	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
promotes	VBZ	ROOT	O
induction	NN	dobj	O
or	CC	cc	O
translocation	NN	conj	O
of	IN	case	O
NF-KB-related	JJ	amod	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
ATF-2	NN	nmod	B-protein
in	IN	case	O
S.	FW	compound	O
cerevisiae	FW	nmod	O
did	VBD	aux	O
not	RB	neg	O
activate	VB	ROOT	O
TRE-1	NN	dobj	B-DNA
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
Tax	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
when	WRB	advmod	O
SOCS-3	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
rapidly	RB	advmod	O
induced	VBN	advcl	O
by	IN	case	O
IL-2	NN	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
it	PRP	nsubj	O
acts	VBZ	ccomp	O
to	TO	mark	O
inhibit	VB	xcomp	O
IL-2	NN	compound	B-protein
responses	NNS	dobj	O
in	IN	case	O
a	DT	det	O
classical	JJ	amod	O
negative	JJ	amod	O
feedback	NN	compound	O
loop	NN	nmod	O
.	.	punct	O

Gel-shift	JJ	amod	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
examined	VBN	ROOT	O
to	TO	mark	O
show	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
Stat1alpha-DNA	NN	compound	B-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
CD40	NN	nsubjpass	B-protein
also	RB	advmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
expressed	VBN	xcomp	O
by	IN	case	O
mesenchymal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
including	VBG	case	O
human	JJ	amod	B-cell_type
fibroblasts	NNS	nmod	I-cell_type
.	.	punct	O

Protein	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	compound	I-protein
activity	NN	nsubjpass	O
,	,	punct	O
NF-kappaB	NN	compound	B-protein
activity	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
synthesis	NN	nsubjpass	O
of	IN	case	O
cytokine-specific	JJ	amod	B-RNA
mRNA	NN	nmod	I-RNA
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
antioxidants	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
compared	VBN	case	O
to	TO	case	O
VD	NN	nmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
antiproliferative	JJ	amod	O
effect	NN	nsubj	O
is	VBZ	cop	O
up	RB	advmod	O
to	TO	dep	O
30-fold	RB	advmod	O
higher	JJR	ROOT	O
on	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
even	RB	advmod	O
up	RB	advmod	O
to	TO	dep	O
300-fold	RB	advmod	O
higher	JJR	conj	O
on	IN	case	O
human	JJ	amod	B-cell_line
breast	NN	compound	I-cell_line
cancer	NN	compound	I-cell_line
MCF-7	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Primary	JJ	amod	O
(	-LRB-	punct	O
partial	JJ	amod	O
)	-RRB-	punct	O
cortisol	NN	compound	B-protein
receptor	NN	compound	I-protein
resistance	NN	nsubjpass	O
was	VBD	auxpass	O
previously	RB	advmod	O
reported	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
total	NN	nmod	O
of	IN	case	O
7	CD	nummod	O
patients	NNS	nmod	O
and	CC	cc	O
14	CD	nummod	O
asymptomatic	JJ	amod	O
family	NN	compound	O
members	NNS	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
purely	RB	advmod	O
enhancer-dependent	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
such	JJ	case	O
as	IN	mwe	O
TNF	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
regulatory	JJ	amod	I-DNA
region	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
okadaic	JJ	amod	O
acid	NN	nsubj	O
(	-LRB-	punct	O
OKA	NN	appos	O
)	-RRB-	punct	O
activates	VBZ	ccomp	O
HIV	NN	compound	O
transcription	NN	dobj	O
through	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
enhancer	NN	nmod	O
,	,	punct	O
responding	VBG	acl	O
to	TO	case	O
the	DT	det	O
factor	NN	compound	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
promoter	NN	compound	B-DNA
domain	NN	conj	I-DNA
of	IN	case	O
the	DT	det	O
LTR	NN	nmod	B-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
RXR-alpha	NN	nsubj	B-protein
has	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
mediating	VBG	acl	O
growth	NN	compound	O
inhibition	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
adhesion	NN	conj	O
during	IN	case	O
myelomonocytic	JJ	amod	O
differentiation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
different	JJ	amod	O
species	NNS	nsubj	O
of	IN	case	O
heterodimers	NNS	nmod	B-protein
involving	VBG	acl	O
RXR-alpha	NN	dobj	B-protein
may	MD	aux	O
control	VB	ccomp	O
the	DT	det	O
acquisition	NN	dobj	O
of	IN	case	O
different	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
mature	JJ	amod	O
monocyte/macrophage	JJ	compound	O
function	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
DNA-binding	JJ	amod	O
activities	NNS	nsubjpass	O
of	IN	case	O
Jun-Fos	NN	compound	B-protein
heterodimers	NNS	nmod	I-protein
were	VBD	auxpass	O
observed	VBN	ROOT	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
during	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	case	O
natural	JJ	amod	O
cytotoxicity	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
IL-1R	NN	nsubj	I-protein
does	VBZ	aux	O
not	RB	neg	O
mediate	VB	ccomp	O
gene	NN	compound	O
activation	NN	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Transfection	NN	compound	O
studies	NNS	nsubj	O
of	IN	case	O
LTR	NN	compound	B-DNA
reporter	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
indicated	VBD	ROOT	O
that	IN	mark	O
mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
DSE	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
abrogated	VBD	ccomp	O
the	DT	det	O
LTR	NN	compound	B-DNA
-mediated	JJ	amod	O
synergy	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
Ctx	NN	nmod	B-protein
and	CC	cc	O
TNFalpha	NN	conj	B-protein
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
synergy	NN	nsubj	O
induced	VBN	acl	O
by	IN	case	O
Ctx	NN	nmod	B-protein
and	CC	cc	O
IL-1beta	NN	conj	B-protein
was	VBD	cop	O
unaffected	JJ	parataxis	O
,	,	punct	O
suggesting	VBG	advcl	O
TNFalpha	NN	nsubj	B-protein
and	CC	cc	O
IL-1beta	NN	conj	B-protein
cooperate	VBP	ccomp	O
differently	RB	advmod	O
with	IN	case	O
the	DT	det	O
cAMP	NN	compound	O
/PKA	NN	compound	B-protein
activation	NN	compound	O
pathway	NN	nmod	O
to	TO	mark	O
induce	VB	xcomp	O
HIV-1	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
U1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Two	CD	nummod	O
cDNA	NN	compound	B-DNA
clones	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
sequenced	VBN	ROOT	O
and	CC	cc	O
provided	VBN	conj	O
2	CD	nummod	O
,	,	punct	O
250	CD	nummod	O
nucleotides	NNS	dobj	O
(	-LRB-	punct	O
nt	NNS	appos	O
)	-RRB-	punct	O
of	IN	case	O
DNA	NN	compound	B-DNA
sequence	NN	compound	I-DNA
information	NN	nmod	O
.	.	punct	O

Substantial	JJ	amod	O
decreases	NNS	nsubjpass	O
of	IN	case	O
IL-2	NN	compound	B-protein
production	NN	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
for	IN	case	O
cell	NN	compound	O
cultures	NNS	nmod	O
from	IN	case	O
7	CD	nummod	O
of	IN	advmod	O
12	CD	nummod	O
elderly	JJ	amod	O
individuals	NNS	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
the	DT	det	O
different	JJ	amod	O
stimuli	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
produced	VBN	acl	O
by	IN	case	O
stimulated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
other	JJ	amod	O
elderly	JJ	amod	O
individuals	NNS	nmod	O
were	VBD	cop	O
equivalent	JJ	parataxis	O
to	TO	case	O
those	DT	nmod	O
observed	VBN	acl	O
for	IN	case	O
stimulated	VBN	amod	O
T	NN	compound	O
cells	NNS	nmod	O
of	IN	case	O
young	JJ	amod	O
subjects	NNS	nmod	O
.	.	punct	O

Hypoxic	JJ	amod	O
induction	NN	ROOT	O
of	IN	case	O
interleukin-8	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
provide	VBP	appos	O
further	JJ	amod	O
evidence	NN	dobj	O
for	IN	case	O
a	DT	det	O
dysregulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
HPA	JJ	amod	O
axis	NN	nmod	O
in	IN	case	O
PTSD	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
we	PRP	nsubj	O
mutated	VBD	advcl	O
the	DT	det	O
Sp1	NN	compound	B-DNA
site	NN	dobj	I-DNA
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
a	DT	det	O
marked	JJ	amod	O
decrease	NN	nmod	O
in	IN	case	O
hEpoR	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
could	MD	aux	O
restore	VB	ROOT	O
transactivation	NN	dobj	O
by	IN	mark	O
increasing	VBG	advcl	O
GATA-1	NN	compound	B-protein
levels	NNS	dobj	O
in	IN	case	O
OCIM1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

IL-10	NN	compound	B-protein
inhibitory	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
exerted	VBN	ROOT	O
on	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
inactive	JJ	amod	B-DNA
X	NN	nmod:npmod	I-DNA
specific	JJ	amod	O
methylation	NN	nmod	O
at	IN	case	O
the	DT	det	O
androgen	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
showed	VBD	ROOT	O
unbalanced	JJ	amod	O
inactivation	NN	dobj	O
in	IN	case	O
the	DT	det	O
twins	NNS	nmod:poss	O
'	POS	case	O
fibroblasts	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
opposite	JJ	amod	O
directions	NNS	conj	O
.	.	punct	O

Peripheral	JJ	amod	O
blood	NN	compound	O
mononuclear	JJ	amod	O
cells	NNS	nsubjpass	O
from	IN	case	O
seventeen	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
primary	JJ	amod	O
myelodysplastic	JJ	amod	O
syndromes	NNS	nmod	O
(	-LRB-	punct	O
MDS	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
advanced	JJ	amod	O
stage	NN	nmod	O
were	VBD	auxpass	O
enriched	VBN	ROOT	O
for	IN	case	O
blasts	NNS	nmod	B-cell_type
and	CC	cc	O
tested	VBN	conj	O
for	IN	case	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
karyotype	NN	nmod	O
,	,	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
genomic	JJ	amod	O
configuration	NN	conj	O
and	CC	cc	O
(	-LRB-	punct	O
3	LS	conj	O
)	-RRB-	punct	O
expression	NN	conj	O
of	IN	case	O
IL-3	NN	nmod	B-DNA
,	,	punct	I-DNA
GM-CSF	NN	conj	I-DNA
,	,	punct	I-DNA
FMS	NN	conj	I-DNA
and	CC	cc	I-DNA
EGR-1	NN	conj	I-DNA
genes	NNS	dep	I-DNA
which	WDT	nsubj	O
are	VBP	cop	O
all	RB	advmod	O
located	JJ	acl:relcl	O
on	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
arm	NN	compound	I-DNA
of	IN	case	I-DNA
chromosome	NN	nmod	I-DNA
5	CD	nummod	I-DNA
.	.	punct	O

LPS-induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
inhibited	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
mutant	NN	nmod	O
of	IN	case	O
TRAF2	NN	nmod	B-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
TNF	NN	compound	B-protein
signaling	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
system	NN	nmod	O
,	,	punct	O
late	JJ	amod	O
gene	NN	compound	O
expression	NN	nsubj	O
is	VBZ	cop	O
sensitive	JJ	ROOT	O
to	TO	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	B-protein
DNA	NN	compound	I-protein
polymerase	NN	nmod	I-protein
such	JJ	case	O
as	IN	mwe	O
phosphonoacetic	JJ	amod	O
acid	NN	nmod	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
reporters	NNS	nsubj	O
lack	VBP	advcl	O
a	DT	det	O
eukaryotic	JJ	amod	O
origin	NN	dobj	O
of	IN	case	O
replication	NN	nmod	O
and	CC	cc	O
are	VBP	auxpass	O
not	RB	neg	O
replicated	VBN	conj	O
under	IN	case	O
the	DT	det	O
assay	NN	compound	O
conditions	NNS	nmod	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
HTLV-1	NN	compound	O
Tax	NN	nsubj	B-protein
targets	VBZ	ccomp	O
IkappaBalpha	NN	dobj	B-protein
to	TO	case	O
the	DT	det	O
ubiquitin-proteasome	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
phosphorylated	VBN	amod	B-protein
pRB	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
constitutively	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
MM	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
that	IN	mark	O
IL-6	NN	nsubj	B-protein
further	RB	advmod	O
shifts	VBZ	conj	O
pRB	NN	dobj	B-protein
from	IN	case	O
its	PRP$	nmod:poss	O
dephosphorylated	JJ	nmod	O
to	TO	case	O
its	PRP$	nmod:poss	O
phosphorylated	JJ	amod	O
form	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
promoting	VBG	advcl	O
MM	NN	compound	O
cell	NN	compound	O
growth	NN	dobj	O
via	IN	case	O
two	CD	nummod	O
mechanisms	NNS	nmod	O
;	:	punct	O
by	IN	mark	O
decreasing	VBG	advcl	O
the	DT	det	O
amount	NN	dobj	O
of	IN	case	O
E2F	NN	nmod	O
bound	VBN	acl	O
by	IN	case	O
dephosphorylated	VBN	amod	B-protein
pRB	NN	nmod	I-protein
due	IN	case	O
to	TO	case	O
reduced	VBN	amod	O
dephosphorylated	VBN	amod	B-protein
pRB	NN	nmod	I-protein
,	,	punct	O
thereby	RB	advmod	O
releasing	VBG	advcl	O
growth	NN	compound	O
arrest	NN	dobj	O
;	:	punct	O
and	CC	cc	O
by	IN	mark	O
upregulating	VBG	conj	O
IL-6	NN	compound	B-protein
secretion	NN	dobj	O
by	IN	case	O
MM	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
related	JJ	amod	O
IL-6	NN	compound	B-protein
-mediated	JJ	amod	O
autocrine	JJ	amod	O
tumor	NN	compound	O
cell	NN	compound	O
growth	NN	conj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
the	DT	det	O
three	CD	nummod	O
proximal	JJ	amod	O
cis-acting	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
may	MD	aux	O
constitute	VB	ccomp	O
a	DT	det	O
minimal	JJ	amod	O
region	NN	dobj	O
responsible	JJ	amod	O
for	IN	case	O
CTL-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
perforin	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
IFN-alpha/beta	NN	nsubj	B-protein
act	VBP	ccomp	O
directly	RB	advmod	O
on	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
to	TO	mark	O
drive	VB	xcomp	O
Th1	NN	compound	O
development	NN	dobj	O
,	,	punct	O
bypassing	VBG	advcl	O
the	DT	det	O
need	NN	dobj	O
for	IN	case	O
IL-12	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
signaling	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
IFN-alpha	NN	nsubj	B-protein
can	MD	aux	O
not	RB	neg	O
substitute	VB	parataxis	O
IL-12	NN	dobj	B-protein
for	IN	case	O
mouse	NN	compound	O
Th1	NN	compound	O
development	NN	nmod	O
.	.	punct	O

The	DT	det	O
subjects	NNS	nsubjpass	O
were	VBD	auxpass	O
exposed	VBN	ROOT	O
to	TO	case	O
cold	JJ	amod	O
air	NN	nmod	O
(	-LRB-	punct	O
4	CD	nummod	O
degrees	NNS	compound	O
C	NN	appos	O
)	-RRB-	punct	O
twice/d	RB	nmod	O
,	,	punct	O
30	CD	nummod	O
min/exposure	NN	appos	O
,	,	punct	O
for	IN	case	O
a	DT	det	O
total	NN	nmod	O
of	IN	case	O
80	CD	nummod	O
exposures	NNS	nmod	O
.	.	punct	O

Germline	NN	compound	B-protein
transcripts	NNS	nsubj	I-protein
initiate	VBP	ROOT	O
from	IN	case	O
promoters	NNS	nmod	B-DNA
upstream	RB	amod	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
switch	NN	compound	I-DNA
region	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
are	VBP	cop	O
necessary	JJ	conj	O
to	TO	mark	O
target	VB	xcomp	O
the	DT	det	O
appropriate	JJ	amod	O
switch	NN	compound	O
region	NN	dobj	O
for	IN	case	O
recombination	NN	nmod	O
and	CC	cc	O
switching	NN	conj	O
.	.	punct	O

The	DT	det	O
shift	NN	nsubjpass	O
in	IN	case	O
pRB	NN	compound	B-protein
molecular	JJ	amod	O
weight	NN	nmod	O
was	VBD	auxpass	O
reproduced	VBN	ROOT	O
by	IN	mark	O
adding	VBG	advcl	O
exogenous	JJ	amod	O
purified	VBN	amod	O
tTG	NN	dobj	O
to	TO	case	O
extracts	NNS	nmod	O
obtained	VBN	acl	O
from	IN	case	O
viable	JJ	amod	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
was	VBD	auxpass	O
prevented	VBN	conj	O
by	IN	case	O
dansylcadaverine	NN	nmod	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
enzyme	NN	compound	O
inhibitor	NN	appos	O
.	.	punct	O

Because	IN	mark	O
STAT6	NN	compound	B-protein
activation	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	advcl	O
for	IN	case	O
IL-4	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
type	NN	nmod	O
I	CD	nummod	O
and	CC	cc	O
type	NN	compound	O
II	CD	nummod	O
IFNs	NNS	conj	B-protein
to	TO	mark	O
regulate	VB	acl	O
activation	NN	dobj	O
of	IN	case	O
STAT6	NN	nmod	B-protein
by	IN	case	O
IL-4	NN	nmod	B-protein
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
differentiation	NN	nsubjpass	O
of	IN	case	O
myeloid	JJ	amod	B-cell_type
precursors	NNS	nmod	I-cell_type
into	IN	case	O
mature	JJ	amod	O
myelomonocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
encoding	VBG	acl	O
the	DT	det	O
beta2	NN	compound	B-protein
integrin	NN	compound	I-protein
CD11b	NN	dobj	B-protein
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
E2A-HLF	NN	nmod	B-protein
to	TO	mark	O
prolong	VB	acl	O
the	DT	det	O
survival	NN	dobj	O
of	IN	case	O
interleukin-3	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
IL-3	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-dependent	JJ	amod	I-cell_line
murine	JJ	amod	I-cell_line
pro-B	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
after	IN	case	O
IL-3	NN	compound	B-protein
withdrawal	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
it	PRP	nsubj	O
disrupts	VBZ	ccomp	O
signaling	NN	compound	O
pathways	NNS	dobj	O
normally	RB	advmod	O
responsible	JJ	amod	O
for	IN	case	O
cell	NN	compound	O
suicide	NN	nmod	O
,	,	punct	O
allowing	VBG	advcl	O
the	DT	det	O
cells	NNS	dobj	O
to	TO	mark	O
accumulate	VB	acl	O
as	IN	case	O
transformed	VBN	amod	B-cell_type
lymphoblasts	NNS	nmod	I-cell_type
.	.	punct	O

Mutational	JJ	amod	O
studies	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
-236	CD	compound	B-DNA
to	TO	dep	I-DNA
-96	CD	dep	I-DNA
sequence	NN	nmod	I-DNA
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
-130	CD	nummod	B-DNA
AP-1-like	JJ	amod	I-DNA
site	NN	nmod	I-DNA
(	-LRB-	punct	O
-187	CD	nummod	B-DNA
to	TO	dep	I-DNA
-181	CD	nummod	I-DNA
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
-150	CD	nummod	B-DNA
proximal	JJ	amod	I-DNA
AP-1	NN	compound	I-DNA
site	NN	conj	I-DNA
were	VBD	cop	O
necessary	JJ	ccomp	O
to	TO	mark	O
observe	VB	xcomp	O
anergy	NN	dobj	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
Nef	NN	nsubj	B-protein
affects	VBZ	ccomp	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
cellular	JJ	amod	B-protein
factors	NNS	nmod	I-protein
implicated	VBN	acl	O
in	IN	case	O
HIV-1	NN	compound	O
regulation	NN	nmod	O
,	,	punct	O
32P-labeled	JJ	amod	O
oligonucleotides	NNS	nsubjpass	O
corresponding	VBG	acl	O
to	TO	case	O
the	DT	det	O
binding	VBG	amod	O
sites	NNS	nmod	O
were	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
prepared	VBN	acl	O
from	IN	case	O
Nef-expressing	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
that	WDT	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
stimulated	VBN	acl:relcl	O
or	CC	cc	O
were	VBD	auxpass	O
stimulated	VBN	conj	O
with	IN	case	O
T-cell	NN	compound	B-protein
mitogens	NNS	nmod	I-protein
.	.	punct	O

Suppression	NN	ROOT	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
in	IN	case	O
normal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
supernatant	JJ	amod	O
fluid	NN	nmod	O
from	IN	case	O
human	JJ	amod	O
renal	JJ	amod	O
cell	NN	compound	O
carcinomas	NNS	nmod	O
.	.	punct	O

This	DT	det	O
atrophy	NN	compound	O
induction	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
involve	VB	ROOT	O
apoptotic	JJ	amod	O
mechanisms	NNS	dobj	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
affected	VBN	acl	O
by	IN	case	O
the	DT	det	O
bcl-2	NN	compound	B-DNA
proto-oncogene	NN	nmod	I-DNA
.	.	punct	O

Delineation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
CD28	NN	compound	B-protein
signaling	NN	compound	O
cascade	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
protein	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	compound	I-protein
activity	NN	dobj	O
,	,	punct	O
followed	VBN	advcl	O
by	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
phospholipase	NN	compound	B-protein
A2	NN	nmod	I-protein
and	CC	cc	O
5-lipoxygenase	NN	conj	B-protein
.	.	punct	O

MNDA	NN	nsubjpass	B-protein
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
in	IN	case	O
normal	JJ	amod	O
tissue	NN	compound	O
histiocytes	NNS	nmod	O
but	CC	cc	O
was	VBD	auxpass	O
found	VBN	conj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
and	CC	cc	O
foreign	JJ	amod	B-cell_type
body	NN	compound	I-cell_type
giant	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
associated	VBN	acl	O
with	IN	case	O
inflammation	NN	nmod	O
.	.	punct	O

This	DT	det	O
sequence	NN	compound	B-DNA
element	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
referred	VBN	ROOT	O
to	TO	nmod	O
as	IN	case	O
the	DT	det	O
BAT	NN	compound	B-DNA
box	NN	nmod	I-DNA
and	CC	cc	O
its	PRP$	nmod:poss	O
deletion	NN	nsubj	O
significantly	RB	advmod	O
reduced	VBD	conj	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
a	DT	det	O
CD20	NN	compound	O
promoter-CAT	JJ	amod	O
construct	NN	nmod	O
in	IN	case	O
B	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

No	DT	det	O
relationship	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
established	VBN	ROOT	O
between	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
binding	NN	nmod	O
and	CC	cc	O
antidepressant	JJ	amod	O
medication	NN	conj	O
.	.	punct	O

SIT	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
disulfide-linked	JJ	amod	B-protein
homodimeric	JJ	amod	I-protein
glycoprotein	NN	ROOT	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
evaluated	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
MAP	NN	compound	B-protein
kinase	NN	compound	I-protein
extracellular	JJ	amod	I-protein
signal-regulated	JJ	amod	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	I-protein
ERK	NN	nmod	I-protein
)	-RRB-	punct	I-protein
2	CD	nummod	I-protein
by	IN	case	O
the	DT	det	O
phorbol	NN	compound	O
ester	NN	compound	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
MIP-1	NN	compound	B-protein
alpha	NN	nmod	I-protein
is	VBZ	auxpass	O
induced	VBN	ROOT	O
during	IN	case	O
cellular	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
T-cells	NNS	nmod	I-cell_type
and	CC	cc	O
monocytes	NNS	conj	B-cell_type
.	.	punct	O

Translocated	VBN	amod	B-protein
hormone/receptor	NN	compound	I-protein
complexes	NNS	nsubj	I-protein
compete	VBP	ROOT	O
for	IN	case	O
a	DT	det	O
limited	JJ	amod	O
number	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
nuclear	JJ	amod	O
binding	VBG	compound	O
sites	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
Paul	NNP	compound	O
Scholl	NN	nsubj	O
and	CC	cc	O
Raif	NN	compound	O
Geha	NN	conj	O
discuss	VBP	ROOT	O
recent	JJ	amod	O
advances	NNS	dobj	O
in	IN	case	O
our	PRP$	nmod:poss	O
understanding	NN	nmod	O
of	IN	case	O
mechanisms	NNS	nmod	O
of	IN	case	O
MHC	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
signaling	NN	nmod	O
and	CC	cc	O
analyse	VBZ	conj	O
their	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	case	O
human	JJ	amod	O
B-cell	NN	compound	B-cell_type
activation	NN	nmod	O
.	.	punct	O

Induction	NN	ROOT	O
of	IN	case	O
CD8	NN	compound	B-protein
antigen	NN	nmod	I-protein
and	CC	cc	O
suppressor	NN	conj	O
activity	NN	conj	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
in	IN	case	O
a	DT	det	O
CEM	NN	compound	B-cell_line
human	JJ	amod	I-cell_line
leukemic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
clone	NN	nmod	I-cell_line
.	.	punct	O

Bipotential	JJ	amod	B-cell_type
T/natural	JJ	amod	I-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
progenitor	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
are	VBP	cop	O
present	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	O
thymus	NN	nmod	O
.	.	punct	O

This	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
p50	NN	compound	B-protein
homodimers	NNS	nmod	I-protein
coincides	VBZ	ROOT	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
p105	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
suggestive	JJ	xcomp	O
of	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
up-regulation	NN	nmod	O
of	IN	case	O
p50	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
binding	NN	compound	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
X1	NN	compound	B-protein
box	NN	compound	I-protein
DNA-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
RFX	NN	nmod	B-protein
was	VBD	auxpass	O
examined	VBN	ROOT	O
and	CC	cc	O
found	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
present	JJ	xcomp	O
in	IN	case	O
wild-type	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
the	DT	det	O
mutant	JJ	amod	O
RJ2.2.5	NN	conj	B-cell_line
but	CC	cc	O
was	VBD	cop	O
absent	JJ	conj	O
in	IN	case	O
SJO	NN	nmod	B-cell_line
and	CC	cc	O
Jurkat	NN	conj	B-cell_line
.	.	punct	O

We	PRP	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
in	IN	case	O
monocytes	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
both	CC	cc:preconj	O
IL-4	NN	nsubj	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
activate	VBP	ccomp	O
the	DT	det	O
same	JJ	amod	O
recently	RB	advmod	O
identified	VBN	amod	O
transcription	NN	compound	B-protein
factor	NN	dobj	I-protein
NF-IL4	NN	dep	B-protein
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
specific	JJ	amod	B-DNA
responsive	JJ	amod	I-DNA
element	NN	compound	I-DNA
IL-4RE	NN	nmod	I-DNA
.	.	punct	O

Primary	JJ	amod	O
resting	VBG	amod	O
T	NN	compound	O
lymphocytes	NNS	nsubj	O
produced	VBD	ROOT	O
TNF-alpha	NN	dobj	B-protein
and	CC	cc	O
supported	VBD	conj	O
HIV	NN	compound	O
replication	NN	dobj	O
after	IN	case	O
T-cell	NN	compound	O
receptor	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Recombinant	JJ	amod	B-protein
OTF-2	NN	compound	I-protein
protein	NN	nsubj	I-protein
produced	VBN	acl	O
by	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
transcription/translation	NN	nmod	O
could	MD	aux	O
also	RB	advmod	O
enhance	VB	ROOT	O
DRA	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
with	IN	case	O
the	DT	det	O
cytokine	NN	compound	B-protein
IL-4	NN	nmod	B-protein
(	-LRB-	punct	O
IL-4	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
the	DT	dep	O
absence	NN	dep	O
of	IN	case	O
prior	JJ	amod	O
activation	NN	nmod	O
,	,	punct	O
induces	VBZ	ROOT	O
a	DT	det	O
weak	JJ	amod	O
up-regulation	NN	dobj	O
of	IN	case	O
VDR	NN	compound	B-protein
expression	NN	nmod	O
but	CC	cc	O
fails	VBZ	conj	O
to	TO	mark	O
generate	VB	xcomp	O
vitamin	NN	compound	B-protein
D-responsive	JJ	amod	I-protein
element	NN	compound	I-protein
(	-LRB-	punct	I-protein
VDRE	NN	compound	I-protein
)	-RRB-	punct	I-protein
-reactive	JJ	amod	I-protein
nuclear	JJ	amod	I-protein
protein	NN	compound	I-protein
complexes	NNS	dobj	I-protein
or	CC	cc	O
to	TO	mark	O
initiate	VB	conj	O
the	DT	det	O
genomic	JJ	amod	O
transcription	NN	dobj	O
of	IN	case	O
25-hydroxyvitamin	NN	compound	B-protein
D3	NN	compound	I-protein
24-hydroxylase	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
B2	NN	compound	B-protein
factor	NN	nsubjpass	I-protein
was	VBD	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
only	RB	advmod	O
upon	IN	case	O
HIV1	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

Monocytic	JJ	amod	O
differentiation	NN	nsubj	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
promyelocytic	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
correlates	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
Bcl-xL	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
identified	VBD	ROOT	O
the	DT	det	O
TCL1	NN	compound	B-DNA
oncogene	NN	dobj	I-DNA
from	IN	case	O
a	DT	det	O
set	NN	nmod	O
of	IN	case	O
AIDS	NN	compound	B-DNA
IBLP-associated	JJ	amod	I-DNA
cDNA	NN	compound	I-DNA
fragments	NNS	nmod	I-DNA
generated	VBN	acl	O
by	IN	case	O
subtractive	JJ	amod	O
hybridization	NN	nmod	O
with	IN	case	O
non-AIDS	JJ	amod	O
IBLP	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
first	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
an	DT	det	O
HIV-1	NN	compound	O
provirus	NN	nsubj	O
(	-LRB-	punct	O
SF-2	NN	compound	O
strain	NN	appos	O
)	-RRB-	punct	O
very	RB	advmod	O
effectively	RB	advmod	O
replicates	VBZ	ccomp	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
cocultured	VBN	acl	O
with	IN	case	O
TEC	NNS	nmod	B-cell_type
whereas	IN	mark	O
this	DT	det	O
provirus	NN	nsubj	O
,	,	punct	O
with	IN	case	O
kappaB	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
deleted	VBN	acl	O
,	,	punct	O
fails	VBZ	advcl	O
to	TO	mark	O
replicate	VB	xcomp	O
.	.	punct	O

Purified	VBN	amod	B-protein
SR-BP	NN	nsubj	I-protein
retained	VBD	ROOT	O
its	PRP$	nmod:poss	O
binding	NN	compound	O
properties	NNS	dobj	O
and	CC	cc	O
migrated	VBD	conj	O
on	IN	case	O
SDS-polyacrylamide	NN	compound	O
gel	NN	nmod	O
as	IN	case	O
a	DT	det	O
Mr	NNP	compound	B-protein
28	CD	nummod	I-protein
,	,	punct	I-protein
000	CD	nummod	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

Inhibition	NN	nsubjpass	O
of	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
by	IN	case	O
PBMC	NN	nmod	B-cell_type
was	VBD	auxpass	O
observed	VBN	ROOT	O
also	RB	advmod	O
when	WRB	advmod	O
other	JJ	amod	O
inducers	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	advcl	O
(	-LRB-	punct	O
staphylococci	NNS	dep	O
,	,	punct	O
silica	NN	conj	O
,	,	punct	O
zymosan	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
reported	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
histogenesis	NN	nsubjpass	O
of	IN	case	O
HD	NN	nmod	O
of	IN	case	O
the	DT	det	O
general	JJ	amod	O
population	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
assessed	VBN	ccomp	O
by	IN	mark	O
monitoring	VBG	advcl	O
the	DT	det	O
expression	NN	compound	O
pattern	NN	dobj	O
of	IN	case	O
BCL-6	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	appos	I-protein
expressed	VBN	acl	O
in	IN	case	O
germinal	JJ	amod	B-cell_line
center	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
GC	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
B	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
of	IN	case	O
CD138/syndecan-1	NN	conj	B-protein
(	-LRB-	punct	O
syn-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
proteoglycan	NN	appos	O
associated	VBN	acl	O
with	IN	case	O
post-GC	JJ	amod	O
,	,	punct	O
terminal	JJ	dep	O
B-cell	NN	compound	B-cell_type
differentiation	NN	nmod	O
.	.	punct	O

Uncoupling	NN	ROOT	O
of	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
arrest	NN	nmod	O
from	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	compound	O
markers	NNS	nmod	O
in	IN	case	O
HL60	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
variants	NNS	nmod	I-cell_line
.	.	punct	O

CTLA-4	NN	compound	B-protein
-Mediated	JJ	compound	O
inhibition	NN	ROOT	O
of	IN	case	O
early	JJ	amod	O
events	NNS	nmod	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	nmod	O
.	.	punct	O

These	DT	nsubj	O
include	VBP	ROOT	O
Fc	NN	compound	B-protein
epsilonRII	NN	dobj	I-protein
(	-LRB-	punct	O
CD23	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
15-lipoxygenase	NN	conj	B-protein
,	,	punct	O
IL-1	NN	compound	B-protein
receptor	NN	compound	I-protein
antagonist	NN	conj	I-protein
(	-LRB-	punct	O
IL-1ra	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
type	NN	compound	B-protein
I	CD	nummod	I-protein
and	CC	cc	I-protein
type	NN	conj	I-protein
II	CD	nummod	I-protein
IL-1	NN	compound	I-protein
receptors	NNS	conj	I-protein
(	-LRB-	punct	O
IL-1R	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Recent	JJ	amod	O
work	NN	nsubj	O
has	VBZ	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
IL-10	NN	nsubj	B-protein
induces	VBZ	ccomp	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
JAK	NN	compound	B-protein
-STAT	JJ	amod	B-protein
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Alveolar	JJ	amod	B-cell_type
macrophages	NNS	nsubjpass	I-cell_type
and	CC	cc	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	conj	I-cell_type
are	VBP	auxpass	O
activated	VBN	ROOT	O
when	WRB	advmod	O
IgE/allergen	JJ	amod	B-protein
immune	JJ	amod	I-protein
complexes	NNS	nsubj	I-protein
bind	VBP	advcl	O
to	TO	case	O
the	DT	det	O
CD23	NN	compound	B-protein
receptor	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
leads	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
inflammatory	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
.	.	punct	O

VDR	NN	nsubj	B-protein
is	VBZ	cop	O
functionally	RB	advmod	O
active	JJ	ROOT	O
in	IN	case	O
ATRA-treated	JJ	amod	O
Kasumi-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
because	IN	mark	O
it	PRP	nsubj	O
efficiently	RB	advmod	O
heterodimerizes	VBZ	advcl	O
with	IN	case	O
retinoid	NN	compound	B-protein
X	NN	compound	I-protein
receptor	NN	nmod	I-protein
,	,	punct	O
binds	VBZ	conj	O
to	TO	case	O
a	DT	det	O
DR3-type	JJ	amod	B-DNA
vitamin	NN	compound	I-DNA
D-responsive	JJ	amod	I-DNA
element	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
activates	VBZ	conj	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
a	DT	det	O
vitamin	NN	compound	B-DNA
D-responsive	JJ	amod	I-DNA
element-regulated	JJ	amod	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
the	DT	det	O
case	NN	nmod	O
of	IN	case	O
thymic	JJ	amod	O
selection	NN	nmod	O
the	DT	det	O
mechanism	NN	nsubj	O
is	VBZ	cop	O
more	RBR	advmod	O
subtle	JJ	ROOT	O
depending	VBG	case	O
on	IN	case	O
the	DT	det	O
mutual	JJ	amod	O
repression	NN	nmod	O
of	IN	case	O
Nur77	NN	nmod	B-protein
and	CC	cc	O
GR	NN	conj	B-protein
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
analyses	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
151-bp	JJ	amod	B-DNA
region	NN	nsubj	I-DNA
contains	VBZ	ccomp	O
nuclear	JJ	amod	B-DNA
protein	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
Sp1	NN	nmod	B-protein
,	,	punct	O
PU.1	NN	conj	B-protein
,	,	punct	O
and/or	CC	cc	O
Elf-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
novel	JJ	amod	B-protein
factor	NN	conj	I-protein
.	.	punct	O

Nuclear	JJ	amod	B-protein
Rel-A	NN	compound	I-protein
and	CC	cc	I-protein
c-Rel	NN	conj	I-protein
protein	NN	compound	I-protein
complexes	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
differentially	RB	advmod	O
distributed	VBN	ROOT	O
within	IN	case	O
human	JJ	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
identified	VBD	ROOT	O
a	DT	det	O
physical	JJ	amod	O
interaction	NN	dobj	O
between	IN	case	O
Tax	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
HsN3	NN	compound	B-protein
subunit	NN	conj	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
proteasome	NN	nmod	I-protein
.	.	punct	O

Using	VBG	advcl	O
the	DT	det	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
thymidine	NN	compound	O
proliferation	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
determined	VBD	ROOT	O
reactivity	NN	dobj	O
to	TO	case	O
purified	VBN	amod	B-protein
recombinant	JJ	amod	I-protein
SSB	NN	nmod	I-protein
(	-LRB-	punct	O
rSSB	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
20	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
SS	NN	nmod	O
and	CC	cc	O
19	CD	nummod	O
controls	NNS	conj	O
.	.	punct	O

Tyrosine	NN	compound	O
phosphorylation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
mandatory	JJ	amod	O
proximal	JJ	amod	O
step	NN	ROOT	O
in	IN	case	O
radiation-induced	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
signaling	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
B-lymphocyte	NN	compound	I-cell_type
precursors	NNS	nmod	I-cell_type
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	dep	O
in	IN	case	O
Proc	NNP	compound	O
Natl	NNP	compound	O
Acad	NNP	compound	O
Sci	NNP	compound	O
U	NNP	compound	O
S	NNP	compound	O
A	NNP	compound	O
1993	CD	nummod	O
Apr	NNP	nmod	O
15	CD	nummod	O
;	:	punct	O
90	CD	nummod	O
(	-LRB-	punct	O
8	CD	appos	O
)	-RRB-	punct	O
:	:	punct	O
3775	CD	nummod	O
]	-RRB-	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
alternative	JJ	amod	O
RNA	NN	compound	O
splicing	NN	nsubj	O
generates	VBZ	ccomp	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
gamma	NN	compound	I-protein
isoforms	NNS	dobj	I-protein
with	IN	case	O
properties	NNS	nmod	O
different	JJ	amod	O
from	IN	case	O
those	DT	nmod	O
of	IN	case	O
p70	NN	nmod	B-protein
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
aspirin	NN	nsubj	O
inhibits	VBZ	ccomp	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
mobilization	NN	dobj	O
,	,	punct	O
induction	NN	appos	O
of	IN	case	O
VCAM-1	NN	nmod	B-protein
and	CC	cc	O
E-selectin	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
subsequent	JJ	amod	O
monocyte	NN	compound	O
adhesion	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
stimulated	VBN	acl	O
by	IN	case	O
TNF	NN	nmod	B-protein
,	,	punct	O
thereby	RB	advmod	O
providing	VBG	advcl	O
an	DT	det	O
additional	JJ	amod	O
mechanism	NN	dobj	O
for	IN	case	O
therapeutic	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
aspirin	NN	nmod	O
.	.	punct	O

From	IN	case	O
these	DT	det	O
results	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
CD38	NN	nsubj	B-protein
is	VBZ	cop	O
ATRA	NN	nmod:npmod	O
inducible	JJ	ccomp	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
normal	JJ	amod	B-cell_type
CD34+	JJ	amod	I-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

rel	NN	nsubjpass	B-protein
Is	VBZ	auxpass	O
rapidly	RB	advmod	O
tyrosine-phosphorylated	JJ	ROOT	O
following	VBG	case	O
granulocyte-colony	JJ	amod	B-protein
stimulating	NN	compound	I-protein
factor	NN	compound	I-protein
treatment	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
neutrophils	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
this	DT	det	O
change	NN	nsubj	O
in	IN	case	O
phosphorylation	NN	compound	O
status	NN	nmod	O
correlates	VBZ	ccomp	O
with	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-DNA
MHC	NN	compound	I-DNA
HLA-DRA	NN	compound	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
gene	NN	nmod	I-DNA
can	MD	aux	O
be	VB	auxpass	O
up-regulated	VBN	ROOT	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
Ig	NN	compound	O
cross-linking	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
by	IN	case	O
phorbol	NN	compound	O
esters	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
12-O-tetradecanoyl	NN	compound	O
phorbol	NN	compound	O
13-acetate	NN	nmod	O
(	-LRB-	punct	O
TPA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
defective	JJ	amod	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
due	JJ	xcomp	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
to	TO	case	O
a	DT	det	O
selective	JJ	amod	O
block	NN	nmod	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-protein
Fos	NN	compound	I-protein
and	CC	cc	I-protein
Jun	NN	conj	I-protein
family	NN	compound	I-protein
members	NNS	nmod	I-protein
in	IN	case	O
anergic	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
Tax	NN	compound	B-protein
protein	NN	nsubj	I-protein
,	,	punct	O
encoded	VBN	acl	O
by	IN	case	O
HTLV-I	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
transcription	NN	compound	O
activator	NN	ROOT	O
of	IN	case	O
viral	JJ	amod	O
and	CC	cc	O
several	JJ	conj	O
cellular	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
Tax1	NN	nsubj	B-protein
activated	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
other	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
having	VBG	acl	O
zinc	NN	compound	B-protein
finger	NN	compound	I-protein
motifs	NNS	dobj	I-protein
,	,	punct	O
Egr-1	NN	appos	B-protein
and	CC	cc	O
Egr-2	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
and	CC	cc	O
despite	IN	case	O
a	DT	det	O
lack	NN	nmod	O
of	IN	case	O
sequence	NN	compound	O
homology	NN	nmod	O
,	,	punct	O
the	DT	det	O
promoters	NNS	nsubj	O
of	IN	case	O
IL-3	NN	nmod	B-protein
and	CC	cc	O
IL-2	NN	conj	B-protein
share	VBP	ROOT	O
an	DT	det	O
organizational	JJ	amod	O
pattern	NN	dobj	O
of	IN	case	O
regulatory	JJ	amod	O
elements	NNS	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
likely	JJ	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
important	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
T-cell-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
.	.	punct	O

c-myc	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nsubjpass	O
,	,	punct	O
constitutively	RB	advmod	O
high	JJ	amod	O
in	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
MDHM-stimulated	JJ	amod	O
PBMo	NN	nmod	B-cell_type
.	.	punct	O

It	PRP	nsubj	O
may	MD	aux	O
be	VB	ROOT	O
possible	JJ	acomp	O
to	TO	mark	O
produce	VB	xcomp	O
such	JJ	amod	O
cells	NNS	dobj	O
by	IN	mark	O
first	RB	advmod	O
expressing	VBG	advcl	O
the	DT	det	O
Epo	NN	compound	B-protein
receptor	NN	dobj	I-protein
under	IN	case	O
the	DT	det	O
influence	NN	nmod	O
of	IN	case	O
a	DT	det	O
constitutive	JJ	amod	O
promoter	NN	nmod	O
and	CC	cc	O
then	RB	advmod	O
targeting	VBG	conj	O
the	DT	det	O
GATA-1	NN	compound	B-DNA
gene	NN	dobj	I-DNA
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
CD2	NN	nmod	B-protein
or	CC	cc	O
T	NN	compound	O
cell	NN	compound	O
receptor	NN	compound	O
(	-LRB-	punct	O
TCR	NN	compound	B-protein
)	-RRB-	punct	O
/CD3	NN	conj	O
on	IN	case	O
Tcells	NNS	nmod	O
by	IN	case	O
monoclonal	JJ	amod	O
antibody-mediated	JJ	amod	O
cross-linking	NN	nmod	O
induced	VBD	ROOT	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
Itk	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
maximal	JJ	acl:relcl	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
1	CD	nummod	O
min	NN	nmod	O
after	IN	case	O
stimulation	NN	nmod	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
PKC-epsilon	NN	nsubj	B-protein
and	CC	cc	O
,	,	punct	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	appos	O
PKC-alpha	NN	dep	B-protein
but	CC	cc	O
not	RB	cc	O
-zeta	NN	conj	B-protein
,	,	punct	O
can	MD	aux	O
regulate	VB	ccomp	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
AP-1	NN	dep	B-protein
and	CC	cc	O
nuclear	JJ	amod	O
factor	NN	compound	B-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	conj	I-protein
(	-LRB-	punct	O
NF-AT-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Through	IN	case	O
activation	NN	nmod	O
of	IN	case	O
this	DT	nmod	O
and	CC	cc	O
other	JJ	amod	O
NF-Y	NN	compound	B-protein
driven	JJ	amod	O
promoters	NNS	conj	B-DNA
,	,	punct	O
the	DT	det	O
Tax1	NN	compound	B-protein
-NF-Y	NN	amod	B-protein
interaction	NN	nsubj	O
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
causing	VBG	advcl	O
cellular	JJ	amod	O
transformation	NN	dobj	O
and	CC	cc	O
HTLV-1	NN	compound	O
pathogenesis	NN	conj	O
.	.	punct	O

Several	JJ	amod	O
mammalian	JJ	amod	O
responses	NNS	nsubjpass	O
to	TO	case	O
UV	NN	compound	O
irradiation	NN	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
are	VBP	auxpass	O
believed	VBN	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
HIV-TF1	NN	nsubjpass	B-protein
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
a	DT	det	O
region	NN	nmod	O
about	IN	case	O
60	CD	nummod	B-DNA
bp	NN	nmod	I-DNA
upstream	JJ	amod	I-DNA
from	IN	case	O
the	DT	det	O
enhancer	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus-1	NN	nmod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
purified	VBN	ROOT	O
from	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
structure/function	NN	compound	O
analyses	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
IL-7R	NN	compound	B-protein
complex	NN	nmod	I-protein
using	VBG	acl	O
a	DT	det	O
chimeric	JJ	amod	B-protein
receptor	NN	compound	I-protein
system	NN	dobj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
gamma	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
c	NN	appos	I-protein
)	-RRB-	punct	I-protein
is	VBZ	cop	O
indeed	RB	advmod	O
critical	JJ	ccomp	O
for	IN	case	O
IL-7R	NN	compound	B-protein
function	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
representing	VBG	acl	O
different	JJ	amod	O
activation	NN	dobj	O
and/or	CC	cc	O
differentiation	NN	compound	O
stages	NNS	conj	O
can	MD	aux	O
be	VB	cop	O
differentially	RB	advmod	O
responsive	JJ	ccomp	O
to	TO	case	O
ROI-mediated	JJ	amod	O
signals	NNS	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
&	CC	cc	O
AIMS	NNS	conj	O
:	:	punct	O
Entamoeba	FW	compound	O
histolytica	NN	compound	O
infection	NN	nsubj	O
of	IN	case	O
the	DT	det	O
intestine	NN	nmod	O
can	MD	aux	O
induce	VB	dep	O
severe	JJ	amod	O
gut	NN	compound	O
inflammation	NN	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	appos	O
that	IN	mark	O
the	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
cushingoid	JJ	amod	O
features	NNS	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
anorexia	NN	compound	O
nervosa	NN	nmod	O
is	VBZ	cop	O
not	RB	neg	O
ascribable	JJ	ccomp	O
to	TO	case	O
a	DT	det	O
reduced	VBN	amod	O
sensitivity	NN	nmod	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
but	CC	cc	O
is	VBZ	cop	O
more	RBR	advmod	O
likely	RB	conj	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
paucity	NN	nmod	O
of	IN	case	O
metabolic	JJ	amod	O
substrates	NNS	nmod	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
assay	NN	nsubj	O
involves	VBZ	advcl	O
the	DT	det	O
dramatic	JJ	amod	O
loss	NN	dobj	O
of	IN	case	O
red	JJ	amod	O
cell	NN	compound	O
production	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
should	MD	aux	O
be	VB	cop	O
possible	JJ	ROOT	O
to	TO	mark	O
define	VB	xcomp	O
important	JJ	amod	O
regulatory	JJ	amod	O
domains	NNS	dobj	O
that	WDT	nsubjpass	O
can	MD	aux	O
then	RB	advmod	O
be	VB	auxpass	O
assayed	VBN	acl:relcl	O
using	VBG	xcomp	O
less	RBR	advmod	O
stringent	JJ	amod	O
systems	NNS	dobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
cell-free	JJ	amod	O
extracts	NNS	nmod	O
for	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
cellular	JJ	amod	O
functions	NNS	nsubj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
role	NN	conj	O
in	IN	case	O
inflammation	NN	nmod	O
,	,	punct	O
for	IN	case	O
example	NN	nmod	O
,	,	punct	O
rheumatoid	JJ	amod	O
synovitis	NN	nmod	O
,	,	punct	O
are	VBP	cop	O
currently	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

One	CD	nummod	O
63-kDa	JJ	amod	B-protein
isoform	NN	nsubj	I-protein
,	,	punct	O
termed	VBN	acl	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
gamma-1	NN	xcomp	I-protein
,	,	punct	O
which	WDT	nsubj	O
lacks	VBZ	acl:relcl	O
59	CD	nummod	O
amino	NN	compound	O
acids	NNS	dobj	O
C-terminal	JJ	amod	O
to	TO	case	O
ankyrin	NN	compound	B-protein
repeat	NN	nmod	I-protein
7	CD	nummod	I-protein
,	,	punct	O
has	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
35-amino	NN	compound	B-protein
acid	NN	compound	I-protein
C	NN	compound	I-protein
terminus	NN	dobj	I-protein
encoded	VBN	acl	O
by	IN	case	O
an	DT	det	O
alternative	JJ	amod	B-DNA
reading	NN	compound	I-DNA
frame	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
p105	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

TFIIDs	NNS	nsubj	B-protein
from	IN	case	O
all	DT	det	O
three	CD	nummod	O
organisms	NNS	nmod	O
are	VBP	cop	O
interchangeable	JJ	ROOT	O
among	IN	case	O
all	DT	det	O
three	CD	nummod	O
systems	NNS	nmod	O
.	.	punct	O

A-myb	NN	compound	B-protein
expression	NN	nsubjpass	O
has	VBZ	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
range	NN	nmod	O
of	IN	case	O
neoplastic	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
representing	VBG	advcl	O
the	DT	det	O
whole	JJ	amod	O
spectrum	NN	dobj	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
constitutive	JJ	amod	O
association	NN	dobj	O
of	IN	case	O
STAT3	NN	nmod	B-protein
with	IN	case	O
each	DT	det	O
STAT5	NN	compound	B-protein
isomer	NN	nmod	I-protein
.	.	punct	O

Glucocorticoid	NN	compound	O
pharmacokinetics	NNS	ROOT	O
,	,	punct	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
characteristics	NNS	conj	O
,	,	punct	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	nmod	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

This	DT	det	O
cell	NN	compound	O
line	NN	nsubj	O
stably	RB	advmod	O
transfected	VBN	acl	O
with	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
estrogen	NN	compound	I-protein
receptor	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
an	DT	det	O
IL-1beta	NN	compound	B-DNA
promoter	NN	compound	I-DNA
construct	NN	conj	O
fused	VBN	acl	O
to	TO	case	O
the	DT	det	O
CAT	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
allows	VBZ	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
monitor	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
estrogenic	JJ	amod	O
compounds	NNS	nmod	O
on	IN	case	O
IL-1beta	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

A	DT	det	O
high-affinity	JJ	amod	O
calcineurin	NN	compound	B-protein
-binding	JJ	amod	O
peptide	NN	nsubjpass	O
was	VBD	auxpass	O
selected	VBN	ROOT	O
from	IN	case	O
combinatorial	JJ	amod	O
peptide	NN	compound	O
libraries	NNS	nmod	O
based	VBN	case	O
on	IN	case	O
the	DT	det	O
calcineurin	NN	compound	B-protein
docking	NN	compound	I-protein
motif	NN	nmod	I-protein
of	IN	case	O
NFAT	NN	nmod	B-protein
.	.	punct	O

Flow	NN	compound	O
cytometric	JJ	amod	O
cell	NN	compound	O
sorting	NN	nsubj	O
of	IN	case	O
normal	JJ	amod	O
bone	NN	compound	O
marrow	NN	nmod	O
established	VBD	ROOT	O
that	IN	mark	O
MNDA	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
initially	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
blast	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
earlier	RBR	advmod	O
that	IN	mark	O
the	DT	det	O
crosslinkage	NN	nsubj	O
of	IN	case	O
the	DT	det	O
CD3/TCR	NN	compound	B-protein
complex	NN	nmod	I-protein
with	IN	case	O
the	DT	det	O
CD2	NN	compound	B-protein
antigen	NN	nmod	I-protein
results	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
proliferation	NN	nmod	O
of	IN	case	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Heterogeneous	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
the	DT	det	O
lipocalin	NN	compound	B-protein
NGAL	NN	nmod	I-protein
in	IN	case	O
primary	JJ	amod	O
breast	NN	compound	O
cancers	NNS	nmod	O
.	.	punct	O

Bacterial	JJ	amod	O
vaginosis	NN	nsubjpass	O
(	-LRB-	punct	O
BV	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
an	DT	det	O
increased	VBN	amod	O
rate	NN	nmod	O
of	IN	case	O
sexual	JJ	amod	O
transmission	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
HIV	NN	compound	O
)	-RRB-	punct	O
type	NN	nmod	O
1	CD	nummod	O
,	,	punct	O
and	CC	cc	O
Gardnerella	FW	compound	O
vaginalis	FW	nsubjpass	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
isolated	VBN	conj	O
from	IN	case	O
the	DT	det	O
genital	JJ	amod	O
tracts	NNS	nmod	O
of	IN	case	O
women	NNS	nmod	O
with	IN	case	O
BV	NN	nmod	O
.	.	punct	O

Among	IN	case	O
T-cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
investigated	VBN	acl	O
,	,	punct	O
ICSAT	NN	nsubjpass	B-protein
was	VBD	auxpass	O
abundantly	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
leukemia	NN	compound	I-cell_line
virus	NN	compound	I-cell_line
type	NN	compound	I-cell_line
1	CD	nummod	I-cell_line
(	-LRB-	punct	I-cell_line
HTLV-1	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-infected	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

To	TO	mark	O
gain	VB	advcl	O
a	DT	det	O
better	JJR	amod	O
understanding	NN	dobj	O
of	IN	case	O
the	DT	det	O
impact	NN	nmod	O
of	IN	case	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
sequence	NN	compound	O
diversity	NN	nmod	O
on	IN	case	O
LTR-directed	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	nmod	O
(	-LRB-	punct	O
CNS	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
immune	JJ	amod	O
system	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
amplified	VBD	ROOT	O
and	CC	cc	O
cloned	VBN	conj	O
LTRs	NNS	dobj	B-DNA
from	IN	case	O
proviral	JJ	amod	B-DNA
DNA	NN	nmod	I-DNA
in	IN	case	O
HIV-1-infected	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
GC-receptor	NN	compound	O
(	-LRB-	punct	O
GC-R	NN	appos	O
)	-RRB-	punct	O
parameters	NNS	nmod	O
in	IN	case	O
peripheral-blood	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
PBMC	NN	compound	B-cell_type
resistance	NN	conj	O
to	TO	case	O
GC	NN	nmod	O
in	IN	case	O
21	CD	nummod	O
CRF	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
18	CD	nummod	O
healthy	JJ	amod	O
subjects	NNS	conj	O
.	.	punct	O

This	DT	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
gelatinase	NN	compound	B-protein
granules	NNS	nsubj	O
are	VBP	cop	O
functionally	RB	advmod	O
important	JJ	ccomp	O
relative	JJ	dep	O
to	TO	case	O
specific	JJ	amod	O
granules	NNS	nmod	O
in	IN	mark	O
mediating	VBG	advcl	O
early	JJ	amod	O
inflammatory	JJ	amod	O
responses	NNS	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
PGG-Glucan	NN	nsubj	O
enhances	VBZ	ccomp	O
neutrophil	NN	compound	O
anti-microbial	JJ	amod	O
functions	NNS	dobj	O
and	CC	cc	O
that	IN	mark	O
interaction	NN	nsubjpass	O
between	IN	case	O
this	DT	det	O
beta-glucan	NN	nmod	O
and	CC	cc	O
human	JJ	amod	B-cell_type
neutrophils	NNS	conj	I-cell_type
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
the	DT	det	O
glycosphingolipid	NN	compound	O
lactosylceramide	NN	nmod	O
present	JJ	amod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
each	DT	det	O
Tax1	NN	nmod:npmod	B-protein
-inducible	JJ	amod	O
transcriptional	JJ	amod	O
pathway	NN	nmod	O
in	IN	case	O
T-cell	NN	compound	O
transformation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
introduced	VBD	ROOT	O
Tax1	NN	compound	B-protein
mutants	NNS	dobj	I-protein
with	IN	case	O
different	JJ	amod	O
trans-activating	JJ	amod	O
phenotypes	NNS	nmod	O
into	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBL	NN	appos	B-cell_type
)	-RRB-	punct	O
by	IN	case	O
retroviral	JJ	amod	O
vectors	NNS	nmod	O
.	.	punct	O

Sequencing	NN	nsubj	O
of	IN	case	O
the	DT	det	O
genomic	JJ	amod	O
region	NN	nmod	O
between	IN	case	O
the	DT	det	O
exons	NNS	nmod	B-DNA
1	CD	dep	I-DNA
and	CC	cc	I-DNA
2	CD	conj	I-DNA
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
alternative	JJ	amod	B-DNA
5'-end	NN	nsubj	I-DNA
is	VBZ	cop	O
a	DT	det	O
part	NN	ccomp	O
of	IN	case	O
the	DT	det	O
intron	NN	nmod	B-DNA
.	.	punct	O

The	DT	det	O
regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
tumor	NN	compound	I-DNA
necrosis	NN	compound	I-DNA
factor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
region	NN	nmod	I-DNA
in	IN	case	O
macrophage	NN	nmod	B-cell_line
,	,	punct	O
T	NN	compound	B-cell_line
cell	NN	conj	I-cell_line
,	,	punct	O
and	CC	cc	O
B	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
unexpected	JJ	ROOT	O
that	IN	mark	O
this	DT	det	O
versatile	JJ	amod	O
cellular	JJ	amod	O
homeostatic	JJ	amod	O
switch	NN	nsubjpass	O
would	MD	aux	O
be	VB	auxpass	O
affected	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
viral	JJ	amod	O
pathogens	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
have	VBP	aux	O
evolved	VBN	acl:relcl	O
mechanisms	NNS	dobj	O
to	TO	mark	O
utilize	VB	acl	O
various	JJ	amod	O
aspects	NNS	dobj	O
of	IN	case	O
Rel/NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
to	TO	mark	O
facilitate	VB	advcl	O
their	PRP$	nmod:poss	O
replication	NN	dobj	O
,	,	punct	O
cell	NN	compound	O
survival	NN	conj	O
and	CC	cc	O
possibly	RB	advmod	O
evasion	NN	conj	O
of	IN	case	O
immune	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
evolutionarily	RB	advmod	O
conserved	VBN	amod	O
physical	JJ	amod	O
interactions	NNS	nsubj	O
between	IN	case	O
Ets	NN	nmod	B-protein
and	CC	cc	I-protein
NF-kappaB/NFAT	NN	conj	I-protein
proteins	NNS	dep	I-protein
are	VBP	cop	O
important	JJ	ccomp	O
in	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
inducible	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
T-cell	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
viruses	NNS	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
A6H	NN	nsubj	B-protein
costimulated	VBD	ccomp	O
cell	NN	compound	O
proliferation	NN	dobj	O
and	CC	cc	O
cytokine	NN	compound	B-protein
production	NN	conj	O
in	IN	case	O
purified	VBN	amod	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
GM-CSF	NN	compound	B-DNA
locus	NN	nsubj	I-DNA
may	MD	aux	O
represent	VB	ROOT	O
one	CD	dobj	O
of	IN	case	O
several	JJ	amod	O
target	NN	compound	O
genes	NNS	nmod	B-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
dysregulated	VBN	acl:relcl	O
in	IN	case	O
acute	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
infection	NN	nmod	O
on	IN	case	O
cellular	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	conj	O
have	VBP	aux	O
been	VBN	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
new	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
myeloid	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

BSAP	NN	nsubjpass	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
previously	RB	advmod	O
to	TO	mark	O
be	VB	cop	O
important	JJ	xcomp	O
for	IN	case	O
B	NN	nmod:npmod	O
cell-specific	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
blk	NN	compound	B-DNA
gene	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
explored	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
dopamine	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
or	CC	cc	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
known	VBN	acl	O
to	TO	mark	O
activate	VB	xcomp	O
NF-kappaB	NN	dobj	B-protein
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
paper	NN	nsubj	O
studies	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
NM23.H1	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
which	WDT	nsubj	O
derive	VBP	acl:relcl	O
from	IN	case	O
primary	JJ	amod	O
or	CC	cc	O
metastatic	JJ	conj	O
human	JJ	amod	O
malignant	JJ	amod	O
melanomas	NNS	nmod	O
in	IN	case	O
relation	NN	nmod	O
to	TO	case	O
staging	NN	nmod	O
,	,	punct	O
infiltration	NN	compound	O
degree	NN	conj	O
,	,	punct	O
lymphocytic	JJ	amod	O
infiltration	NN	conj	O
,	,	punct	O
cell	NN	compound	O
morphology	NN	conj	O
,	,	punct	O
cell	NN	compound	O
pigmentation	NN	conj	O
,	,	punct	O
karyotype	NN	conj	O
,	,	punct	O
and	CC	cc	O
disease-free	JJ	amod	O
survival	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Bcl-3	NN	nsubj	B-protein
can	MD	aux	O
aid	VB	ccomp	O
kappa	NN	nmod:npmod	B-DNA
B	NN	nmod:npmod	I-DNA
site	NN	nmod:npmod	I-DNA
-dependent	JJ	amod	O
transcription	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
counteracting	VBG	advcl	O
the	DT	det	O
inhibitory	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
p50/NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
homodimers	NNS	nmod	I-protein
.	.	punct	O

CAT	NN	compound	O
expression	NN	nsubj	O
directed	VBN	acl	O
by	IN	case	O
the	DT	det	O
IL2	NN	compound	B-DNA
regulatory	JJ	amod	I-DNA
region	NN	nmod	I-DNA
or	CC	cc	O
by	IN	case	O
a	DT	det	O
multimer	NN	conj	O
of	IN	case	O
the	DT	det	O
NF-AT-binding	JJ	amod	B-DNA
site	NN	nmod	I-DNA
was	VBD	cop	O
markedly	RB	advmod	O
lower	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
patient	NN	nmod	O
relative	JJ	case	O
to	TO	case	O
controls	NNS	nmod	O
.	.	punct	O

Phorbol	NN	compound	O
activation	NN	nsubjpass	O
was	VBD	auxpass	O
positively	RB	advmod	O
modulated	VBN	ROOT	O
by	IN	case	O
Ca2+	NN	compound	O
influx	NN	nmod	O
while	IN	mark	O
TNF	NN	compound	B-protein
alpha	NN	compound	I-protein
activation	NN	nsubj	O
was	VBD	advcl	O
not	RB	neg	O
.	.	punct	O

Only	RB	advmod	O
stably	RB	advmod	O
transfected	VBN	amod	B-cell_line
target	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
exhibited	VBD	ROOT	O
cytolytic	JJ	amod	O
susceptibility	NN	dobj	O
,	,	punct	O
despite	IN	case	O
expression	NN	nmod	O
of	IN	case	O
equivalent	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
E1A	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
Ad-infected	JJ	amod	B-cell_line
targets	NNS	nmod	I-cell_line
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
these	DT	det	O
data	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
concluded	VBD	ROOT	O
that	IN	mark	O
interdomain	NN	compound	B-protein
B	NN	nsubj	I-protein
regulates	VBZ	ccomp	O
but	CC	cc	O
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	conj	O
for	IN	case	O
ZAP-70	NN	compound	B-protein
signaling	NN	compound	O
function	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
cellular	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

These	DT	det	O
differences	NNS	nsubjpass	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
molecularly	RB	advmod	O
defined	VBN	ROOT	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
inflammatory	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
gamma-IFN	NN	compound	B-protein
signaling	NN	nmod	O
could	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
foam	NN	compound	O
cell	NN	compound	O
formation	NN	nmod	O
and	CC	cc	O
xanthomatosis	NN	conj	O
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
the	DT	det	O
regulatory	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
gp91phox	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
in	IN	case	O
eosinophils	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
transiently	RB	advmod	O
transfected	VBD	ROOT	O
eosinophil-committed	JJ	amod	B-cell_line
HL-60-C15	NN	compound	I-cell_line
cells	NNS	dobj	I-cell_line
with	IN	case	O
gp91phox	NN	compound	B-DNA
promoter	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
identified	VBD	conj	O
a	DT	det	O
negative	JJ	amod	B-DNA
element	NN	dobj	I-DNA
from	IN	case	O
bp	NN	nmod	O
-267	CD	nummod	B-DNA
to	TO	dep	I-DNA
-246	CD	nummod	I-DNA
of	IN	case	O
the	DT	det	O
gp91phox	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
the	DT	det	O
deletion	NN	nsubj	O
of	IN	case	O
which	WDT	nmod	O
caused	VBD	parataxis	O
an	DT	det	O
83	CD	compound	O
%	NN	amod	O
increase	NN	dobj	O
in	IN	case	O
promoter	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

This	DT	det	O
unidentified	JJ	amod	O
factor	NN	nsubj	O
binds	VBZ	ROOT	O
immediately	RB	advmod	O
3	CD	dobj	O
'	''	punct	O
of	IN	case	O
the	DT	det	O
PU.1/Elf-1	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
and	CC	cc	O
appears	VBZ	conj	O
to	TO	mark	O
be	VB	cop	O
myeloid	JJ	amod	O
cell	NN	nmod:npmod	O
specific	JJ	xcomp	O
.	.	punct	O

I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
inhibit	VBP	ROOT	O
DNA	NN	compound	O
binding	NN	dobj	O
and	CC	cc	O
prevent	VB	conj	O
nuclear	JJ	amod	O
uptake	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

PML	NN	nsubj	B-protein
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
transcriptionally	RB	advmod	O
regulated	VBN	xcomp	O
by	IN	case	O
class	NN	compound	B-protein
I	CD	nummod	I-protein
and	CC	cc	I-protein
II	CD	conj	I-protein
interferons	NNS	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
raises	VBZ	acl:relcl	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
interferons	NNS	nsubj	O
modulate	VBP	ccomp	O
the	DT	det	O
function	NN	dobj	O
and	CC	cc	O
growth	NN	conj	O
and	CC	cc	O
differentiation	NN	conj	O
potential	NN	dep	O
of	IN	case	O
normal	JJ	amod	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
precursors	NNS	conj	O
by	IN	mark	O
activating	VBG	advcl	O
PML	NN	compound	B-protein
-dependent	JJ	amod	O
pathways	NNS	dobj	O
.	.	punct	O

Globin	NN	compound	O
gene	NN	compound	O
switching	NN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
identify	VBP	ROOT	O
a	DT	det	O
potential	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
IL-7	NN	compound	B-protein
signaling	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
v-Abl	NN	nmod	B-protein
while	IN	mark	O
demonstrating	VBG	advcl	O
that	IN	mark	O
a	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
IL-4	NN	compound	B-protein
and	CC	cc	O
IL-7	NN	conj	B-protein
signaling	NN	nmod	O
can	MD	aux	O
not	RB	neg	O
substitute	VB	ccomp	O
for	IN	case	O
an	DT	det	O
active	JJ	amod	O
v-Abl	NN	compound	B-protein
kinase	NN	nmod	O
in	IN	case	O
transformed	VBN	amod	B-cell_type
pre-B	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

An	DT	det	O
overexpression	NN	nsubjpass	O
of	IN	case	O
p50	NN	nmod	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
in	IN	case	O
follicular	JJ	amod	B-cell_type
dendritic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
FDC	NN	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
characterize	VBP	ROOT	O
the	DT	det	O
putative	JJ	amod	B-protein
human	JJ	amod	I-protein
homolog	NN	dobj	I-protein
of	IN	case	O
NRL	NN	nmod	B-protein
,	,	punct	O
neutrophil	NN	compound	B-protein
gelatinase-associated	JJ	amod	I-protein
lipocalin	NN	conj	I-protein
(	-LRB-	punct	O
NGAL	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
ALD	NN	compound	O
stimulus	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
capable	JJ	ROOT	O
of	IN	mark	O
causing	VBG	advcl	O
complete	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

From	IN	case	O
these	DT	det	O
cellular	JJ	amod	O
changes	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
can	MD	aux	O
infer	VB	ROOT	O
that	IN	mark	O
the	DT	det	O
cell	NN	compound	O
growth	NN	nsubjpass	O
was	VBD	auxpass	O
modulated	VBN	ccomp	O
along	IN	case	O
with	IN	case	O
induction	NN	nmod	O
of	IN	case	O
terminal	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

As2O3	NN	nsubjpass	O
was	VBD	auxpass	O
administered	VBN	ROOT	O
intravenously	RB	advmod	O
at	IN	case	O
the	DT	det	O
dose	NN	nmod	O
of	IN	case	O
10	CD	nummod	O
mg/d	NN	nmod	O
.	.	punct	O

The	DT	det	O
squirrel	NN	compound	O
monkey	NN	compound	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nsubj	I-protein
is	VBZ	cop	O
approximately	RB	advmod	O
97	CD	nummod	O
%	NN	nmod:npmod	O
identical	JJ	ROOT	O
in	IN	case	O
nucleotide	NN	nmod	O
and	CC	cc	O
amino	NN	compound	O
acid	NN	compound	O
sequence	NN	conj	O
to	TO	case	O
the	DT	det	O
human	JJ	amod	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

FK506	NN	nsubj	O
,	,	punct	O
an	DT	det	O
immunosuppressant	NN	appos	O
,	,	punct	O
inhibits	VBZ	ROOT	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
cytokines	NNS	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Super-shift	JJ	amod	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complex	NN	nsubj	I-protein
of	IN	case	O
costimulated	VBN	amod	B-cell_line
CD4+	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
contained	VBD	ccomp	O
large	JJ	amod	O
amounts	NNS	dobj	O
of	IN	case	O
p50	NN	nmod	B-protein
,	,	punct	O
substantial	JJ	amod	O
amounts	NNS	conj	O
of	IN	case	O
p65	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
marginal	JJ	amod	O
levels	NNS	conj	O
of	IN	case	O
c-Rel	NN	compound	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptor	NN	nmod:npmod	I-protein
(	-LRB-	punct	O
RAR	NN	nmod:npmod	B-protein
)	-RRB-	punct	O
-selective	JJ	amod	O
antagonist	NN	nsubj	O
inhibits	VBZ	ROOT	O
differentiation	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
:	:	punct	O
implications	NNS	dep	O
of	IN	case	O
RARalpha	NN	compound	B-protein
-mediated	JJ	amod	O
signals	NNS	nmod	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
leukemic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Pathological	JJ	amod	O
evaluation	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
high-grade	JJ	amod	O
vulvar	JJ	amod	O
leiomyosarcoma	NN	dobj	O
.	.	punct	O

Tissue	NN	nmod:npmod	O
transglutaminase-dependent	JJ	amod	O
posttranslational	JJ	amod	O
modification	NN	ROOT	O
of	IN	case	O
the	DT	det	O
retinoblastoma	NN	compound	B-protein
gene	NN	compound	I-protein
product	NN	nmod	I-protein
in	IN	case	O
promonocytic	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
undergoing	VBG	acl	O
apoptosis	NN	dobj	O
.	.	punct	O

In	IN	case	O
the	DT	dep	O
absence	NN	dep	O
of	IN	case	O
tetracycline	NN	nmod	O
,	,	punct	O
GR	NN	compound	B-RNA
mRNA	NN	nsubj	I-RNA
and	CC	cc	O
protein	NN	compound	O
expression	NN	conj	O
increased	VBD	ROOT	O
2-3-fold	RB	advmod	O
,	,	punct	O
and	CC	cc	O
cells	NNS	nsubj	O
expressed	VBD	conj	O
48	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
receptors	NNS	dobj	O
,	,	punct	O
a	DT	det	O
level	NN	appos	O
nearly	RB	advmod	O
equivalent	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
present	JJ	amod	O
in	IN	case	O
6TG1.1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
after	IN	case	O
18	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
autoinduction	NN	nmod	O
.	.	punct	O

An	DT	det	O
attempt	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
undertaken	VBN	ROOT	O
to	TO	mark	O
use	VB	xcomp	O
a	DT	det	O
cell	NN	compound	O
harvester	NN	dobj	O
for	IN	case	O
the	DT	det	O
separation	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
from	IN	case	O
unbound	JJ	amod	O
ligand	NN	nmod	O
.	.	punct	O

Linked	VBN	advcl	O
to	IN	case	O
these	DT	det	O
events	NNS	nmod	O
,	,	punct	O
antibodies	NNS	nsubjpass	B-protein
to	TO	case	O
T-antigen	NN	nmod	B-protein
,	,	punct	O
DNA	NN	conj	O
,	,	punct	O
TBP	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
CREB	NN	conj	B-protein
were	VBD	auxpass	O
detected	VBN	ROOT	O
,	,	punct	O
identical	JJ	xcomp	O
to	TO	mark	O
what	WP	dobj	O
we	PRP	nsubj	O
observed	VBD	nmod	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
work	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
glucocorticoid	NN	compound	O
dexamethasone	NN	nsubj	O
inhibits	VBZ	ccomp	O
TPA-induced	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
c-jun	NN	compound	O
and	CC	cc	O
c-fos	NN	conj	O
mRNA	NN	compound	O
levels	NNS	nmod	O
in	IN	case	O
U-937	NN	compound	B-cell_line
leukemia	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
LPS-mediated	JJ	amod	O
nuclear	JJ	amod	O
binding	NN	nsubjpass	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB/Rel	NN	nmod	I-protein
to	TO	case	O
a	DT	det	O
TF-specific	JJ	amod	B-DNA
kappaB	NN	compound	I-DNA
site	NN	nmod	I-DNA
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
lysoPC	NN	nmod	O
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
H-7-sensitive	JJ	amod	B-protein
kinases	NNS	nsubj	I-protein
do	VBP	aux	O
not	RB	neg	O
regulate	VB	ccomp	O
STAT3	NN	compound	B-protein
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
or	CC	cc	O
phosphorylation	NN	conj	O
of	IN	case	O
serine	NN	nmod	O
727	CD	nummod	O
.	.	punct	O

Constitutive	JJ	amod	O
dephosphorylation	NN	ROOT	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
a	DT	det	O
member	NN	nmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
,	,	punct	O
NF-AT1	NN	appos	B-protein
,	,	punct	O
in	IN	case	O
Tax-expressing	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
type	NN	conj	I-cell_type
I	CD	nummod	I-cell_type
human	JJ	amod	I-cell_type
T-cell	NN	compound	I-cell_type
leukemia	NN	nmod:npmod	I-cell_type
virus-infected	JJ	amod	I-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
AP-1	NN	nsubj	B-protein
from	IN	case	O
PHA-activated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
contains	VBZ	ROOT	O
c-Jun	NN	dobj	B-protein
and	CC	cc	O
low	JJ	amod	O
levels	NNS	conj	O
of	IN	case	O
c-Fos	NN	nmod	B-protein
.	.	punct	O

Ten	CD	nummod	O
mutants	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
simian	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
SIV	NN	appos	O
)	-RRB-	punct	O
SIVmac239	NN	amod	O
bearing	NN	compound	O
deletions	NNS	nmod	O
(	-LRB-	punct	O
delta	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
substitutions	NNS	conj	O
(	-LRB-	punct	O
subst	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-DNA
and/or	CC	cc	O
Sp1	NN	conj	B-DNA
binding	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
were	VBD	auxpass	O
created	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
replicative	JJ	amod	O
capacities	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
mutants	NNS	nmod	O
were	VBD	auxpass	O
analyzed	VBN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
two	CD	nummod	O
adjacent	JJ	amod	O
cis-acting	JJ	amod	O
regulatory	JJ	amod	O
elements	NNS	dobj	O
,	,	punct	O
both	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	cop	O
part	NN	acl:relcl	O
of	IN	case	O
an	DT	det	O
Alu	NN	compound	O
repeat	NN	nmod	O
.	.	punct	O

Dehydroepiandrosterone	NN	nsubjpass	O
(	-LRB-	punct	O
DHEA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
predominant	JJ	amod	O
androgen	NN	appos	O
secreted	VBN	acl	O
by	IN	case	O
the	DT	det	O
adrenal	JJ	amod	O
cortex	NN	nmod	O
,	,	punct	O
can	MD	aux	O
be	VB	auxpass	O
converted	VBN	ROOT	O
to	TO	case	O
both	CC	cc:preconj	O
potent	JJ	amod	O
androgens	NNS	nmod	O
and	CC	cc	O
estrogens	NNS	conj	O
.	.	punct	O

ICSAT	NN	nsubj	B-protein
(	-LRB-	punct	O
Interferon	NN	compound	B-protein
Consensus	NN	compound	I-protein
Sequence	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	dep	I-protein
for	IN	case	I-protein
Activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
lymphocyte-specific	JJ	amod	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
interferon	NN	compound	B-protein
regulatory	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
IRF	NN	compound	I-protein
)	-RRB-	punct	I-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
,	,	punct	O
originally	RB	advmod	O
identified	VBN	acl	O
through	IN	case	O
Southwestern	NN	compound	O
screening	NN	nmod	O
of	IN	case	O
the	DT	det	O
ATL	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
Adult	JJ	amod	I-DNA
T-cell	NN	compound	I-DNA
leukemia	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-16T	JJ	amod	I-DNA
expression	NN	compound	I-DNA
library	NN	nmod	I-DNA
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
the	DT	det	O
findings	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
a	DT	det	O
role	NN	nmod	O
for	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
A/R	NN	compound	O
tolerance	NN	nmod	O
(	-LRB-	punct	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
PMN	NN	compound	B-cell_type
adhesion	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
perhaps	RB	advmod	O
by	IN	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
GTP-cyclohydrolase	NN	nmod	B-protein
.	.	punct	O

Similar	JJ	case	O
to	TO	case	O
Mono	NN	compound	B-cell_line
Mac	NN	compound	I-cell_line
6	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
primary	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nsubj	I-cell_type
,	,	punct	O
when	WRB	advmod	O
precultured	VBN	acl	O
with	IN	case	O
a	DT	det	O
low	JJ	amod	O
dose	NN	nmod	O
of	IN	case	O
LPS	NN	nmod	O
,	,	punct	O
also	RB	advmod	O
become	VBP	ROOT	O
tolerant	JJ	xcomp	O
and	CC	cc	O
produce	VB	conj	O
little	JJ	amod	O
TNF	NN	dobj	B-protein
after	IN	case	O
LPS	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Strikingly	RB	advmod	O
,	,	punct	O
deletion	NN	nsubj	O
of	IN	case	O
346	CD	nummod	B-protein
C-terminal	JJ	amod	I-protein
residues	NNS	nmod	I-protein
augmented	VBD	ROOT	O
this	DT	det	O
activity	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
removal	NN	nsubj	O
of	IN	case	O
20	CD	nummod	O
additional	JJ	amod	O
residues	NNS	nmod	O
abolished	VBD	parataxis	O
it	PRP	dobj	O
.	.	punct	O

This	DT	det	O
ANG	NN	compound	B-protein
II	CD	nummod	I-protein
effect	NN	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
angiotensin	NN	compound	O
AT1	NN	compound	O
receptor	NN	compound	O
antagonist	NN	compound	O
losartan	NN	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
BDP	NN	nmod	O
on	IN	case	O
IL-1	NN	nmod	B-protein
and	CC	cc	O
tumour	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNF	NN	compound	B-protein
alpha	NN	compound	I-protein
)	-RRB-	punct	O
-induced	JJ	amod	O
changes	NNS	attr	O
of	IN	case	O
gcRs	NNS	nmod	B-protein
.	.	punct	O

Immune	JJ	amod	O
responses	NNS	ROOT	O
to	TO	case	O
adenoviruses	NNS	nmod	O
:	:	punct	O
viral	JJ	amod	O
evasion	NN	compound	O
mechanisms	NNS	dep	O
and	CC	cc	O
their	PRP$	nmod:poss	O
implications	NNS	conj	O
for	IN	case	O
the	DT	det	O
clinic	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
similar	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cytosols	NNS	nmod	O
of	IN	case	O
unactivated	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
both	CC	cc:preconj	O
young	JJ	amod	O
and	CC	cc	O
elderly	JJ	conj	O
donors	NNS	nmod	O
suggesting	VBG	xcomp	O
that	IN	mark	O
precursor	NN	compound	O
levels	NNS	nsubj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
remain	VBP	ccomp	O
unaltered	JJ	xcomp	O
during	IN	case	O
aging	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
HL60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
various	JJ	amod	O
combinations	NNS	nmod	O
of	IN	case	O
retinoids	NNS	nmod	O
and	CC	cc	O
1	CD	compound	O
alpha	NN	compound	O
,	,	punct	O
25	CD	nummod	O
dihydroxyvitamin	NN	compound	O
D3	NN	conj	O
results	VBZ	ROOT	O
in	IN	case	O
differentiation	NN	nmod	O
towards	IN	case	O
neutrophils	NNS	nmod	B-cell_type
or	CC	cc	O
monocytes	NNS	conj	B-cell_type
or	CC	cc	O
a	DT	det	O
failure	NN	conj	O
to	TO	mark	O
differentiate	VB	acl	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

Highly	RB	advmod	O
polarized	VBN	amod	O
HLA	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
antigen	NN	compound	I-protein
processing	NN	ROOT	O
and	CC	cc	O
presentation	NN	conj	O
by	IN	case	O
human	JJ	amod	B-cell_type
intestinal	JJ	amod	I-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
CD8	NN	nsubj	B-protein
+	CC	cc	O
CD28	NN	conj	B-protein
+	CC	cc	O
population	NN	conj	O
showed	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
tendency	NN	dobj	O
(	-LRB-	punct	O
p	NN	dep	O
<	CD	amod	O
.01-.02	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Correspondingly	RB	advmod	O
,	,	punct	O
transfection	NN	nsubj	O
of	IN	case	O
p50	NN	nmod	B-protein
and	CC	cc	O
p65	NN	conj	B-protein
provided	VBD	ROOT	O
considerable	JJ	amod	O
protection	NN	dobj	O
from	IN	case	O
TCR-mediated	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
capacity	NN	nsubj	O
of	IN	case	O
Syk	NN	nmod	B-protein
to	TO	mark	O
reconstitute	VB	acl	O
the	DT	det	O
MAPK	NN	compound	B-protein
response	NN	dobj	O
required	VBD	ROOT	O
the	DT	det	O
catalytic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Syk	NN	nmod	B-protein
,	,	punct	O
an	DT	det	O
intact	JJ	amod	O
autophosphorylation	NN	compound	B-protein
site	NN	appos	I-protein
(	-LRB-	punct	O
Y518	NN	dep	O
and	CC	cc	O
Y519	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
both	DT	cc:preconj	O
Src	NN	compound	B-protein
homology	NN	compound	I-protein
2	CD	nummod	I-protein
domains	NNS	nmod	I-protein
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	conj	O
by	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	B-protein
N17-mutated	JJ	amod	I-protein
dominant-negative	JJ	amod	I-protein
Ras	NN	compound	I-protein
construct	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
0.1-0.5	CD	dep	O
microM	NN	compound	O
DMDTC	NN	nsubj	O
inhibits	VBZ	ccomp	O
intracellular	JJ	amod	O
IL-2	NN	compound	B-protein
production	NN	dobj	O
and	CC	cc	O
decreases	VBZ	conj	O
surface	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
CD25	NN	nmod	B-protein
(	-LRB-	punct	O
the	DT	det	O
alpha	NN	compound	B-protein
subunit	NN	dep	I-protein
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-protein
receptor	NN	nmod	I-protein
)	-RRB-	punct	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
stimulated	VBN	acl	O
with	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
.	.	punct	O

The	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	nsubj	I-protein
2	CD	nummod	I-protein
interacts	VBZ	ROOT	O
with	IN	case	O
an	DT	det	O
EBNA2	NN	nmod:npmod	B-DNA
responsive	JJ	amod	I-DNA
cis-element	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
terminal	JJ	amod	B-DNA
protein	NN	compound	I-DNA
1	CD	nummod	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Differentiation	NN	nsubj	O
generally	RB	advmod	O
leads	VBZ	ROOT	O
to	TO	case	O
cell	NN	compound	O
cycle	NN	compound	O
arrest	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
growth	NN	nsubjpass	O
of	IN	case	O
most	JJS	advmod	O
mutated	VBN	amod	O
viruses	NNS	nmod	O
was	VBD	auxpass	O
suppressed	VBN	ccomp	O
in	IN	case	O
primary	JJ	amod	B-cell_type
rhesus	NN	compound	I-cell_type
monkey	NN	compound	I-cell_type
alveolar	JJ	amod	I-cell_type
macrophages	NNS	nmod	I-cell_type
(	-LRB-	punct	O
SIVmacMER	NN	dep	O
approximately	RB	advmod	O
2xNFkappaB	CD	dep	B-protein
approximately	RB	advmod	O
substNFkappaB	NN	compound	B-protein
>	NN	amod	O
deltaNFkappaB	NN	dep	B-protein
>	NN	dep	O
deltaNFkappaB	NN	nsubj	B-protein
deltaSpl234	VBD	conj	B-protein
approximately	RB	advmod	O
deltaNFkappaBdeltaSpl	VB	amod	B-protein
>	NN	nsubj	O
deltaSpl234	:	ROOT	B-protein
approximately	RB	advmod	O
substSpl2	JJ	xcomp	B-protein
>	NN	dep	O
substSp23	NN	dep	B-protein
approximately	RB	advmod	O
substSp34	NN	nmod	B-protein
approximately	RB	advmod	O
substSpl234	.	xcomp	B-protein
>	NN	dep	O
or	CC	cc	O
=	JJ	amod	O
SIVmac239	NN	conj	O
)	-RRB-	punct	O
.	.	punct	O

c-Maf	NN	nsubj	B-protein
induces	VBZ	ROOT	O
monocytic	JJ	amod	O
differentiation	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
bipotent	JJ	amod	B-cell_type
myeloid	JJ	amod	I-cell_type
progenitors	NNS	nmod	I-cell_type
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
MZF-1	NN	nsubj	B-RNA
and	CC	cc	I-RNA
MZF-2	NN	conj	I-RNA
mRNAs	NNS	dep	I-RNA
seem	VBP	dep	O
to	TO	mark	O
be	VB	auxpass	O
produced	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
alternative	JJ	amod	O
use	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
of	IN	case	O
the	DT	det	O
mitogenic	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
high	JJ	amod	O
molecular	JJ	amod	O
weight	NN	compound	O
dextran	NN	compound	O
sulfate	NN	nmod	O
(	-LRB-	punct	O
HMDS	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
monocyte-derived	JJ	amod	B-cell_type
macrophages	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
transfected	VBN	ROOT	O
with	IN	case	O
recombinant	JJ	amod	B-DNA
plasmid	NN	nmod	I-DNA
containing	VBG	acl	O
chloramphenicol	NN	compound	B-DNA
acetyl	NN	compound	I-DNA
transferase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CAT	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
reporter	NN	compound	I-DNA
gene	NN	dobj	I-DNA
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
LTR	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappaB	NN	nmod	B-protein
.	.	punct	O

Immunoblot	NN	nsubj	O
and	CC	cc	O
flow	NN	compound	O
cytometry	NN	compound	O
analysis	NN	conj	O
revealed	VBD	ROOT	O
a	DT	det	O
limited	JJ	amod	O
proteolysis	NN	dobj	O
of	IN	case	O
the	DT	det	O
carboxyl	NN	compound	B-protein
terminus	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
alphaIIb	NN	compound	B-protein
subunit	NN	compound	I-protein
heavy	JJ	amod	I-protein
chain	NN	nmod	I-protein
(	-LRB-	punct	O
alphaIIbH	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
as	IN	mark	O
judged	VBN	advcl	O
by	IN	case	O
the	DT	det	O
disappearance	NN	nmod	O
of	IN	case	O
the	DT	det	O
epitope	NN	nmod	O
for	IN	case	O
the	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	compound	I-protein
PMI-1	NN	nmod	I-protein
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
TF	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
by	IN	case	O
LPS	NN	nmod	O
tended	VBD	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
partially	RB	advmod	O
reduced	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
lysophospholipid	NN	nmod	O
.	.	punct	O

Specific	JJ	amod	O
glucocorticoid	NN	compound	O
binding	NN	ROOT	O
at	IN	case	O
different	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
human	JJ	amod	O
motor	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
despite	IN	case	O
an	DT	det	O
efficient	JJ	amod	O
entry	NN	nmod	O
of	IN	case	O
the	DT	det	O
virus	NN	nmod	O
in	IN	case	O
all	PDT	cc:preconj	O
the	DT	det	O
CD4	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
subpopulations	NNS	nmod	I-cell_type
,	,	punct	O
a	DT	det	O
high	JJ	amod	O
viral	JJ	amod	O
load	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
generated	VBN	ccomp	O
exclusively	RB	advmod	O
within	IN	case	O
the	DT	det	O
mature	JJ	amod	B-cell_type
CD4	NN	nmod	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
CD8	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
-	:	punct	I-cell_type
)	-RRB-	punct	I-cell_type
CD3	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	dep	I-cell_type
)	-RRB-	punct	I-cell_type
subset	NN	dep	I-cell_type
of	IN	case	I-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

Induction	NN	ROOT	O
of	IN	case	O
ICAM-1	NN	nmod	B-protein
and	CC	cc	O
LFA-3	NN	conj	B-protein
by	IN	case	O
Tax1	NN	nmod	B-protein
of	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
and	CC	cc	O
mechanism	NN	conj	O
of	IN	case	O
down-regulation	NN	nmod	O
of	IN	case	O
ICAM-1	NN	nmod	B-protein
or	CC	cc	O
LFA-1	NN	conj	B-protein
in	IN	case	O
adult-T-cell-leukemia	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Remixing	NN	nsubj	O
of	IN	case	O
purified	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
showed	VBD	ROOT	O
that	IN	mark	O
naive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
do	VBP	aux	O
not	RB	neg	O
suppress	VB	ccomp	O
LAI	NN	compound	O
replication	NN	dobj	O
in	IN	case	O
memory	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
that	IN	mark	O
memory	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
do	VBP	aux	O
not	RB	neg	O
restore	VB	conj	O
LAI	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
naive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

HS	NN	nsubjpass	B-DNA
I-III	CD	nummod	I-DNA
,	,	punct	O
located	JJ	amod	O
5	CD	dep	O
'	''	punct	O
from	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-DNA
initiation	NN	compound	I-DNA
site	NN	nmod	I-DNA
,	,	punct	O
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
hematopoietic	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
non-hematopoietic	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
,	,	punct	O
whereas	IN	dep	O
HS	NN	nsubjpass	B-DNA
IV-VII	CD	dep	I-DNA
,	,	punct	O
located	JJ	amod	O
3	CD	dep	O
'	''	punct	O
from	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
,	,	punct	O
were	VBD	auxpass	O
exclusively	RB	advmod	O
observed	VBN	parataxis	O
in	IN	case	O
T-cells	NNS	nmod	B-cell_type
.	.	punct	O

In	IN	case	O
three	CD	nummod	O
unrelated	JJ	amod	O
Japanese	JJ	amod	O
children	NNS	nmod	O
with	IN	case	O
combined	JJ	amod	O
pituitary	JJ	amod	O
hormone	NN	compound	O
deficiency	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
three	CD	nummod	O
point	NN	compound	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
Pit-1	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
Pro24Leu	NN	dobj	B-DNA
,	,	punct	O
Arg143Gln	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
Arg271Trp	NN	conj	B-DNA
,	,	punct	O
located	JJ	amod	O
on	IN	case	O
the	DT	det	O
major	JJ	amod	B-DNA
transactivation	NN	compound	I-DNA
region	NN	nmod	I-DNA
,	,	punct	O
POU-specific	JJ	amod	B-DNA
domain	NN	conj	I-DNA
,	,	punct	O
and	CC	cc	O
POU-homeodomain	NN	conj	B-DNA
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Site-directed	JJ	amod	O
mutagenesis	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cis	NN	compound	B-DNA
elements	NNS	nmod	I-DNA
demonstrated	VBD	ROOT	O
that	IN	mark	O
Cp	NN	compound	B-DNA
activity	NN	nsubj	O
is	VBZ	cop	O
highly	RB	advmod	O
dependent	JJ	ccomp	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
properly	RB	advmod	O
positioned	JJ	amod	O
CCAAT	NN	compound	B-DNA
box	NN	nmod	I-DNA
,	,	punct	O
with	IN	case	O
the	DT	det	O
dependence	NN	nmod	O
on	IN	case	O
the	DT	det	O
distal	JJ	amod	B-DNA
CCAAT	NN	compound	I-DNA
box	NN	nmod	I-DNA
apparent	JJ	amod	O
only	RB	advmod	O
when	WRB	advmod	O
the	DT	det	O
proximal	JJ	amod	B-DNA
CCAAT	NN	compound	I-DNA
box	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
deleted	VBN	advcl	O
or	CC	cc	O
mutated	VBN	conj	O
.	.	punct	O

Inducible	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
cellular	JJ	amod	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	appos	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
transfection	NN	nsubj	O
with	IN	case	O
LMP1	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
into	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
Daudi	NN	appos	B-cell_line
,	,	punct	O
led	VBD	ROOT	O
to	TO	case	O
p40	NN	compound	B-protein
production	NN	nmod	O
with	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappaB	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

HTLV-I-infected	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
exhibit	VBP	ROOT	O
an	DT	det	O
initial	JJ	amod	O
phase	NN	dobj	O
of	IN	case	O
interleukin-2	NN	nmod:npmod	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
-dependent	JJ	amod	O
growth	NN	nmod	O
;	:	punct	O
over	IN	case	O
time	NN	nmod	O
,	,	punct	O
by	IN	case	O
an	DT	det	O
unknown	JJ	amod	O
mechanism	NN	nmod	O
,	,	punct	O
the	DT	det	O
cells	NNS	nsubj	O
become	VBP	parataxis	O
IL-2	NN	compound	B-protein
-independent	JJ	xcomp	O
.	.	punct	O

Paradoxically	RB	advmod	O
,	,	punct	O
APL	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
express	VBP	ROOT	O
PML-RAR	NN	dobj	B-protein
,	,	punct	O
an	DT	det	O
aberrant	JJ	amod	O
form	NN	appos	O
of	IN	case	O
the	DT	det	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptor	NN	compound	I-protein
type	NN	compound	I-protein
alpha	NN	nmod	I-protein
(	-LRB-	punct	O
RAR	NN	compound	B-protein
alpha	NN	appos	I-protein
)	-RRB-	punct	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
leukemia-specific	JJ	amod	B-DNA
t	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
15	CD	nummod	I-DNA
;	:	punct	I-DNA
17	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
chromosomal	JJ	amod	I-DNA
translocation	NN	nmod	I-DNA
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
in	FW	amod	O
vivo	FW	dep	O
regulatory	JJ	amod	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
control	VBP	acl:relcl	O
the	DT	det	O
population	NN	dobj	O
of	IN	case	O
type	NN	compound	B-cell_type
2	CD	nummod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
disease	NN	compound	O
susceptibility	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
created	VBN	ROOT	O
lines	NNS	dobj	O
of	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
in	IN	case	O
which	WDT	nmod	O
expression	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
chimeric	JJ	amod	B-protein
cytokine	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
the	DT	det	O
mouse	NN	compound	B-protein
interleukin	NN	compound	I-protein
2	CD	nummod	I-protein
receptor	NN	compound	I-protein
beta	NN	compound	I-protein
chain	NN	compound	I-protein
[	-LRB-	punct	I-protein
IL-2Rbeta	NN	compound	I-protein
]	-RRB-	punct	I-protein
extracellular	JJ	amod	I-protein
domain	NN	dep	I-protein
fused	VBN	acl	O
to	TO	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
tail	NN	nmod	I-protein
of	IN	case	O
IL-4Ralpha	NN	nmod	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
targeted	VBN	acl:relcl	O
to	TO	case	O
the	DT	det	O
T	NN	compound	B-cell_type
lymphoid	JJ	amod	I-cell_type
lineage	NN	nmod	I-cell_type
using	VBG	xcomp	O
the	DT	det	O
proximal	JJ	amod	B-DNA
lck	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

A	DT	det	O
dominant-negative	JJ	amod	B-protein
form	NN	nsubj	I-protein
of	IN	case	I-protein
Stat3	NN	nmod	I-protein
inhibited	VBD	ROOT	O
both	CC	cc:preconj	O
macrophage-differentiation	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
IL-6	NN	nmod	B-protein
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
functional	JJ	amod	O
complexes	NNS	nsubj	O
encompassing	VBG	acl	O
both	CC	cc:preconj	O
the	DT	det	O
CD28RE	NN	dobj	B-DNA
and	CC	cc	O
the	DT	det	O
AP-1-binding	JJ	amod	B-DNA
sites	NNS	conj	I-DNA
influence	VBP	ccomp	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
in	IN	case	O
CD28	NN	compound	B-protein
-costimulated	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Certain	JJ	amod	O
interactions	NNS	nsubjpass	O
between	IN	case	O
TBP	NN	nmod	B-protein
and	CC	cc	O
general	JJ	amod	B-protein
factors	NNS	conj	I-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
specifically	RB	advmod	O
required	VBN	acl:relcl	O
for	IN	case	O
acidic	JJ	amod	B-protein
activation	NN	compound	I-protein
domains	NNS	nmod	I-protein
were	VBD	auxpass	O
also	RB	advmod	O
required	VBN	ROOT	O
for	IN	case	O
CIITA	NN	compound	B-protein
-mediated	JJ	amod	O
transactivation	NN	nmod	O
to	TO	mark	O
reach	VB	xcomp	O
its	PRP$	nmod:poss	O
full	JJ	amod	O
potential	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubjpass	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
receptor	NN	compound	O
down-regulation	NN	nmod	O
due	JJ	case	O
to	TO	case	O
higher	JJR	amod	O
level	NN	nmod	O
of	IN	case	O
mineralocorticoids	NNS	nmod	O
of	IN	case	O
the	DT	det	O
zona	NN	compound	O
glomerulosa	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
analyses	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NFkappaB	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
activated	VBN	amod	O
memory	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
CD45RO+	JJ	appos	I-cell_type
)	-RRB-	punct	I-cell_type
and	CC	cc	I-cell_type
naive	JJ	amod	I-cell_type
(	-LRB-	punct	I-cell_type
CD45RA+	JJ	amod	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
subsets	NNS	conj	I-cell_type
from	IN	case	O
young	JJ	amod	O
and	CC	cc	O
elderly	JJ	conj	O
donors	NNS	nmod	O
has	VBZ	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
,	,	punct	O
regardless	RB	advmod	O
of	IN	case	O
donor	NN	amod	O
age	NN	nmod	O
,	,	punct	O
memory	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
not	RB	neg	O
significantly	RB	advmod	O
altered	VBN	ccomp	O
in	IN	case	O
their	PRP$	nmod:poss	O
responsiveness	NN	nmod	O
to	TO	case	O
TNF-alpha	NN	compound	B-protein
-mediated	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
NFkappaB	NN	nmod	B-protein
.	.	punct	O

Although	IN	mark	O
subtle	JJ	amod	O
gene	NN	compound	O
movements	NNS	nsubjpass	O
within	IN	case	O
those	DT	nmod	O
defined	VBN	amod	O
topographical	JJ	amod	O
regions	NNS	nsubjpass	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
excluded	VBN	advcl	O
by	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
tissue	NN	compound	O
specificity	NN	nsubjpass	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
accompanied	VBN	ccomp	O
by	IN	case	O
drastic	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
gene	NN	compound	O
nuclear	JJ	amod	O
topography	NN	nmod	O
,	,	punct	O
rather	RB	advmod	O
suggesting	VBG	advcl	O
that	IN	mark	O
gene	NN	compound	O
organization	NN	nsubj	O
within	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
primarily	RB	advmod	O
dependent	JJ	ccomp	O
on	IN	case	O
structural	JJ	amod	O
constraints	NNS	nmod	O
imposed	VBN	acl	O
on	IN	case	O
the	DT	det	O
respective	JJ	amod	O
chromosomes	NNS	nmod	B-DNA
.	.	punct	O

The	DT	det	O
mycotoxins	NNS	nsubj	O
alpha-zearalenol	NN	dep	O
and	CC	cc	O
zearalenone	NN	conj	O
both	DT	nsubj	O
exhibited	VBD	ROOT	O
full	JJ	amod	O
agonist	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
but	CC	cc	O
at	IN	case	O
lower	JJR	amod	O
potencies	NNS	conj	O
,	,	punct	O
with	IN	case	O
EC50	NN	compound	O
values	NNS	nmod	O
of	IN	case	O
1.8	CD	nummod	O
and	CC	cc	O
54	CD	conj	O
nM	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
compared	VBN	prep	O
with	IN	case	O
E2	NN	nmod	O
at	IN	case	O
0.5	CD	nummod	O
nM	NN	nmod	O
.	.	punct	O

Virtually	RB	advmod	O
all	DT	det	O
B-cell	NN	compound	B-cell_line
lines	NNS	nsubj	I-cell_line
,	,	punct	O
with	IN	case	O
the	DT	det	O
exception	NN	nmod	O
of	IN	case	O
some	DT	det	O
myeloma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
are	VBP	cop	O
positive	JJ	ROOT	O
for	IN	case	O
BSAP	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	acl:relcl	I-protein
for	IN	case	O
promoters	NNS	nmod	B-DNA
for	IN	case	O
several	JJ	amod	O
B-cell	NN	compound	B-protein
markers	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
VpreB1	NN	nmod	B-protein
,	,	punct	O
lambda	NN	conj	B-protein
5	CD	nummod	I-protein
,	,	punct	O
CD19	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
CD20	NN	conj	B-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
IL-12	NN	nsubj	B-protein
induces	VBZ	ccomp	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
a	DT	det	O
recently	RB	advmod	O
identified	VBN	amod	O
STAT	NN	compound	B-protein
family	NN	compound	I-protein
member	NN	nmod	I-protein
,	,	punct	O
STAT4	NN	appos	B-protein
,	,	punct	O
and	CC	cc	O
show	VBP	conj	O
that	IN	mark	O
STAT4	NN	compound	B-protein
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ccomp	O
by	IN	case	O
T-cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-cell_line
monoblastic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubjpass	I-cell_line
,	,	punct	O
U937	NN	nsubjpass	B-cell_line
was	VBD	auxpass	O
differentiated	VBN	ROOT	O
to	TO	case	O
macrophages	NNS	nmod	B-cell_type
by	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
with	IN	case	O
either	CC	cc:preconj	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
retinoic	JJ	amod	O
acid	NN	conj	O
(	-LRB-	punct	O
RA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
vitamin	NN	compound	O
D3	NN	conj	O
(	-LRB-	punct	O
VitD3	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
accumulation	NN	dobj	O
of	IN	case	O
cyclic	JJ	amod	O
AMP	NN	nmod	O
(	-LRB-	punct	O
cAMP	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
hydrolysis	NN	appos	O
of	IN	case	O
inositol	NN	compound	O
phosphates	NNS	nmod	O
,	,	punct	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
(	-LRB-	punct	O
PKC	NN	appos	B-protein
)	-RRB-	punct	O
activity	NN	nmod	O
and	CC	cc	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
Egr-1	NN	compound	O
and	CC	cc	O
c-fos	NN	conj	O
mRNA	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
sIgM-	NN	nmod	O
and	CC	cc	O
sIgD-crosslinking	NN	conj	O
to	TO	mark	O
examine	VB	acl	O
differences	NNS	dobj	O
in	IN	case	O
the	DT	det	O
signals	NNS	nmod	O
mediated	VBN	acl	O
through	IN	case	O
sIgM	NN	nmod	B-protein
and	CC	cc	O
sIgD	NN	conj	B-protein
in	IN	case	O
B104	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
both	CC	cc:preconj	O
transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor-beta	NN	nsubj	I-protein
and	CC	cc	O
genistein	NN	conj	O
,	,	punct	O
a	DT	det	O
tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
could	MD	aux	O
suppress	VB	ROOT	O
IL-2	NN	compound	B-protein
and	CC	cc	O
IL-12	NN	conj	B-protein
signaling	NN	dobj	O
but	CC	cc	O
CsA	NN	conj	O
was	VBD	cop	O
generally	RB	advmod	O
inactive	JJ	conj	O
.	.	punct	O

Paradoxically	RB	advmod	O
,	,	punct	O
NAC	NN	nsubj	O
exerted	VBD	ROOT	O
a	DT	det	O
positive	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
low	JJ	amod	O
shear-induced	JJ	amod	O
VCAM-1	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
EC-Mn	NN	compound	O
adhesion	NN	conj	O
and	CC	cc	O
only	RB	advmod	O
slightly	RB	advmod	O
downregulated	VBD	conj	O
NF-kappaB	NN	compound	B-protein
activation	NN	dobj	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	dep	O
better	RBR	advmod	O
characterize	VB	advcl	O
the	DT	det	O
human	JJ	amod	B-DNA
gammac	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
and	CC	cc	O
define	VB	conj	O
the	DT	det	O
minimal	JJ	amod	B-DNA
tissue-specific	JJ	amod	I-DNA
promoter	NN	compound	I-DNA
region	NN	dobj	I-DNA
,	,	punct	O
progressive	JJ	amod	O
5'-deletion	JJ	amod	B-DNA
constructs	NNS	nsubjpass	I-DNA
of	IN	case	O
a	DT	det	O
segment	NN	nmod	O
extending	VBG	acl	O
1053	CD	nummod	B-DNA
base	NN	compound	I-DNA
pairs	NNS	dobj	I-DNA
upstream	JJ	advmod	I-DNA
of	IN	case	O
the	DT	det	O
major	JJ	amod	B-DNA
transcription	NN	compound	I-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
were	VBD	auxpass	O
generated	VBN	ROOT	O
and	CC	cc	O
tested	VBN	conj	O
for	IN	case	O
promoter	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
various	JJ	amod	O
hematopoietic	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
nonhematopoietic	JJ	conj	I-cell_type
cell	NN	compound	I-cell_type
types	NNS	dep	I-cell_type
.	.	punct	O

When	WRB	advmod	O
endothelial	JJ	amod	O
cells	NNS	nsubjpass	O
are	VBP	auxpass	O
incubated	VBN	advcl	O
with	IN	case	O
this	DT	det	O
lipoprotein	NN	nmod	O
in	IN	case	O
pathophysiologic	JJ	amod	O
amounts	NNS	nmod	O
,	,	punct	O
the	DT	det	O
cells	NNS	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
astrocytes	NNS	nmod	B-cell_type
,	,	punct	O
IFN-gamma	NN	compound	B-protein
treatment	NN	nsubj	O
induced	VBD	ROOT	O
increased	VBN	amod	O
occupancy	NN	dobj	O
of	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
.	.	punct	O

The	DT	det	O
C-terminal	JJ	amod	B-protein
half	NN	nsubj	I-protein
of	IN	case	O
human	JJ	amod	B-protein
MZF-2	NN	nmod	I-protein
,	,	punct	O
carrying	VBG	acl	O
the	DT	det	O
zinc	NN	compound	B-protein
finger	NN	compound	I-protein
domains	NNS	dobj	I-protein
,	,	punct	O
was	VBD	cop	O
completely	RB	advmod	O
identical	JJ	ROOT	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
human	JJ	amod	B-protein
MZF-1	NN	nmod	I-protein
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
half	NN	nsubj	I-protein
of	IN	case	O
MZF-2	NN	nmod	B-protein
was	VBD	cop	O
different	JJ	parataxis	O
from	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
region	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
MZF-1	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
was	VBD	auxpass	O
coded	VBN	conj	O
by	IN	case	O
distinct	JJ	amod	O
exons	NNS	nmod	B-DNA
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
in	IN	case	O
HIV	NN	compound	O
infection	NN	nmod	O
,	,	punct	O
elevated	JJ	amod	O
cortisol	NN	compound	O
levels	NNS	nsubj	O
suppress	VBP	ROOT	O
cell-mediated	JJ	amod	O
immunity	NN	dobj	O
and	CC	cc	O
stimulate	VB	conj	O
humoral	JJ	amod	O
immunity	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
this	DT	det	O
response	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
detected	VBN	parataxis	O
in	IN	case	O
cortisol-resistant	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

The	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nsubj	I-protein
was	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
further	RB	advmod	O
enhance	VB	xcomp	O
IL-4	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
gene	NN	compound	O
transcription	NN	dobj	O
through	IN	case	O
the	DT	det	O
action	NN	nmod	O
of	IN	case	O
Stat6	NN	nmod	B-protein
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
c-myb	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
erythroid	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
K562	NN	compound	B-cell_line
cell	NN	nmod	I-cell_line
induced	VBN	acl	O
by	IN	case	O
hemin	NN	nmod	B-protein
(	-LRB-	punct	O
Hm	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
erythropoietin	NN	conj	B-protein
(	-LRB-	punct	O
Epo	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
recombinant	JJ	amod	B-DNA
plasmid	NN	dobj	I-DNA
that	WDT	nsubj	O
could	MD	aux	O
produce	VB	acl:relcl	O
antisense	JJ	amod	B-RNA
myb	VBN	compound	I-RNA
RNA	NN	dobj	I-RNA
after	IN	case	O
induction	NN	nmod	O
with	IN	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
wat	VBD	ROOT	O
found	VBN	xcomp	O
that	IN	mark	O
the	DT	det	O
contents	NNS	nsubj	O
of	IN	case	O
leucocytic	JJ	amod	B-protein
ER	NN	nmod	I-protein
in	IN	case	O
climacteric	JJ	amod	O
syndrome	NN	compound	O
patients	NNS	nmod	O
were	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	ccomp	O
than	IN	case	O
normal	JJ	amod	O
child-bearing-age	JJ	amod	O
women	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
CaM-K	NN	nmod	B-protein
II	CD	nummod	I-protein
remains	VBZ	ROOT	O
unknown	JJ	xcomp	O
.	.	punct	O

Inefficient	JJ	amod	O
termination	NN	ROOT	O
of	IN	case	O
antigen	NN	compound	O
responses	NNS	nmod	O
in	IN	case	O
NF-ATp	NN	compound	B-protein
-deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

The	DT	det	O
maintenance	NN	nsubj	O
of	IN	case	O
lymphocyte	NN	compound	O
homeostasis	NN	nmod	O
by	IN	case	O
apoptosis	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
regulatory	JJ	amod	O
mechanism	NN	ROOT	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Transcription	NN	compound	O
factor	NN	compound	O
NF-kappaB	NN	compound	B-protein
regulation	NN	ROOT	O
of	IN	case	O
renal	JJ	amod	O
fibrosis	NN	nmod	O
during	IN	case	O
ureteral	JJ	amod	O
obstruction	NN	nmod	O
.	.	punct	O

All	DT	det	O
groups	NNS	nsubj	O
contain	VBP	ROOT	O
cysteine-	NN	amod	B-protein
and	CC	cc	I-protein
histidine-rich	JJ	conj	I-protein
putative	JJ	amod	I-protein
zinc	NN	compound	I-protein
finger	NN	compound	I-protein
domains	NNS	dobj	I-protein
and	CC	cc	O
a	DT	det	O
serine-phenylalanine	JJ	amod	B-protein
``	``	punct	I-protein
SFS	NNS	compound	I-protein
''	''	punct	I-protein
domain	NN	conj	I-protein
similar	JJ	amod	O
to	TO	case	O
part	NN	nmod	O
of	IN	case	O
the	DT	det	O
large	JJ	amod	O
subunit	NN	nmod	O
of	IN	case	O
eukaryotic	JJ	amod	B-protein
RNA	NN	compound	I-protein
polymerase	NN	nmod	I-protein
II	CD	nummod	I-protein
.	.	punct	O

The	DT	det	O
GR	NN	nsubj	B-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
aged	JJ	amod	O
runner	NN	nmod	O
was	VBD	cop	O
65	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
the	DT	det	O
control	NN	nmod	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Purified	VBN	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
eosinophils	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
IFN-gamma	NN	nmod	B-protein
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
for	IN	case	O
1-60	CD	nummod	O
min	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
on	IN	case	O
both	CC	cc:preconj	O
basal	JJ	amod	O
and	CC	cc	O
IL-4	NN	conj	B-protein
/	:	punct	O
IL-13	NN	nmod:npmod	B-protein
-induced	JJ	dep	O
IL-1R	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
in	IN	case	O
primary	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
transient	JJ	amod	O
expression	NN	nmod	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
degradation	NN	compound	O
experiments	NNS	conj	O
,	,	punct	O
the	DT	det	O
stability	NN	nsubjpass	O
of	IN	case	O
c-Fos	NN	nmod	B-protein
was	VBD	auxpass	O
decreased	VBN	ROOT	O
when	WRB	advmod	O
the	DT	det	O
protein	NN	nsubjpass	O
was	VBD	auxpass	O
dimerized	VBN	advcl	O
with	IN	case	O
phosphorylated	VBN	amod	B-protein
c-Jun	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
part	NN	nmod	O
,	,	punct	O
this	DT	nsubj	O
may	MD	aux	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
altered	JJ	amod	O
intercellular	JJ	amod	O
signalling	NN	amod	O
systems	NNS	ROOT	O
and	CC	cc	O
intracellular	JJ	amod	O
signal	NN	compound	O
transduction	NN	conj	O
.	.	punct	O

In	IN	case	O
transfection	NN	compound	O
experiments	NNS	nmod	O
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
wild	JJ	amod	O
type	NN	compound	O
IKK1	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
dominant	JJ	amod	B-protein
negative	JJ	amod	I-protein
mutant	JJ	amod	I-protein
IKK1	NN	appos	I-protein
(	-LRB-	punct	O
K44M	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
wild	JJ	amod	B-protein
type	NN	compound	I-protein
IKK2	NN	conj	I-protein
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
LPS-induced	JJ	amod	O
kappaB	NN	compound	B-protein
-dependent	JJ	amod	O
transcription	NN	dobj	O
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Restimulation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
blasts	NNS	nmod	I-cell_type
up-regulates	VBZ	ROOT	O
Fas	NN	dobj	B-protein
and	CC	cc	O
Fas	NN	compound	B-protein
ligand	NN	compound	O
expression	NN	conj	O
,	,	punct	O
with	IN	case	O
subsequent	JJ	amod	O
interaction	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
cell	NN	compound	O
death	NN	nmod	O
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
two	CD	nummod	O
cleavage	NN	compound	O
products	NNS	dobj	O
of	IN	case	O
approximately	RB	advmod	O
68	CD	nummod	B-protein
kDa	NN	nmod	I-protein
and	CC	cc	O
45	CD	nummod	B-protein
kDa	NN	conj	I-protein
after	IN	case	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

This	DT	det	O
nonresponsiveness	NN	nsubj	O
occurs	VBZ	ROOT	O
because	IN	case	O
of	IN	mwe	O
a	DT	det	O
lack	NN	nmod	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
beta-	NN	amod	B-protein
chain	NN	nmod	I-protein
(	-LRB-	punct	O
accessory	JJ	amod	O
factor	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
IFN-gamma	NN	compound	B-protein
receptor	NN	nmod	I-protein
,	,	punct	O
while	IN	mark	O
at	IN	case	O
the	DT	det	O
same	JJ	amod	O
time	NN	nmod	O
maintaining	VBG	advcl	O
IFN-gamma	NN	compound	B-protein
receptor	NN	compound	I-protein
alpha-chain	NN	compound	I-protein
expression	NN	dobj	O
.	.	punct	O

Most	JJS	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
have	VBP	aux	O
rearranged	VBN	ROOT	O
their	PRP$	nmod:poss	O
heavy-chain	JJ	amod	B-DNA
locus	NN	dobj	I-DNA
but	CC	cc	O
not	RB	cc	O
their	PRP$	nmod:poss	O
light	JJ	amod	B-DNA
chain	NN	compound	I-DNA
genes	NNS	conj	I-DNA
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
an	DT	det	O
active	JJ	amod	O
v-abl	JJ	amod	B-protein
protein	NN	nsubj	I-protein
interferes	VBZ	ccomp	O
with	IN	case	O
this	DT	det	O
differentiation	NN	compound	O
step	NN	nmod	O
.	.	punct	O

The	DT	det	O
interactions	NNS	nsubj	O
of	IN	case	O
Hsp60-specific	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
arterial	JJ	amod	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
EC	NN	appos	B-cell_type
)	-RRB-	punct	O
require	VBP	ROOT	O
expression	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
Hsp60	NN	nmod	B-protein
and	CC	cc	O
certain	JJ	amod	O
adhesion	NN	compound	B-protein
molecules	NNS	conj	I-protein
shown	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
induced	VBN	xcomp	O
simultaneously	RB	advmod	O
in	IN	case	O
EC	NN	nmod	B-cell_type
by	IN	case	O
mechanical	JJ	amod	O
and	CC	cc	O
other	JJ	conj	O
types	NNS	nmod	O
of	IN	case	O
stress	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
U937	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
infected	VBN	advcl	O
with	IN	case	O
HIV-1	NN	nmod	O
,	,	punct	O
no	DT	neg	O
induction	NN	nsubjpass	O
of	IN	case	O
NF-KB	NN	compound	B-protein
factor	NN	nmod	I-protein
was	VBD	auxpass	O
detected	VBN	ROOT	O
,	,	punct	O
whereas	IN	dep	O
high	JJ	amod	O
level	NN	nsubjpass	O
of	IN	case	O
progeny	NN	compound	O
virions	NNS	nmod	O
was	VBD	auxpass	O
produced	VBN	parataxis	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
this	DT	det	O
factor	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
required	VBN	ccomp	O
for	IN	case	O
viral	JJ	amod	O
replication	NN	nmod	O
.	.	punct	O

Elevated	JJ	amod	O
cyclic	JJ	amod	O
AMP	NN	nsubj	O
inhibits	VBZ	ROOT	O
NF-kappaB	NN	compound	B-protein
-mediated	JJ	amod	O
transcription	NN	dobj	O
in	IN	case	O
human	JJ	amod	O
monocytic	JJ	amod	O
cells	NNS	nmod	O
and	CC	cc	O
endothelial	JJ	amod	O
cells	NNS	conj	O
.	.	punct	O

HIV-1	NN	compound	O
harboring	NN	compound	O
mutations	NNS	nsubjpass	O
within	IN	case	O
two	CD	nummod	O
C/EBP	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
were	VBD	auxpass	O
crippled	VBN	ROOT	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
replicate	VB	acl	O
in	IN	case	O
U937	NN	compound	B-cell_line
promonocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
these	DT	det	O
sites	NNS	nsubjpass	O
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
replication	NN	nmod	O
.	.	punct	O

HLA-DMA	NN	nsubj	O
and	CC	cc	O
HLA-DMB	NN	conj	O
gene	NN	compound	O
expression	NN	nsubj	O
functions	VBZ	ROOT	O
through	IN	case	O
the	DT	det	O
conserved	VBN	amod	O
S-X-Y	NN	amod	B-DNA
region	NN	nmod	I-DNA
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
DEM	NN	nsubj	O
abolished	VBD	ROOT	O
phorbol	NN	nmod:npmod	O
12-myristate	NN	nmod:npmod	O
13-acetate-induced	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
AP-1	NN	dep	B-protein
and	CC	cc	O
Egr-1	NN	conj	B-protein
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
differentiation	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
due	JJ	ccomp	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
to	TO	case	O
redox	NN	compound	O
modifications	NNS	nmod	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	B-protein
.	.	punct	O

To	TO	mark	O
characterize	VB	advcl	O
the	DT	det	O
protein-DNA	JJ	amod	O
interactions	NNS	dobj	O
important	JJ	amod	O
for	IN	case	O
the	DT	det	O
developmental	JJ	amod	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
beta-globin	NN	compound	I-DNA
locus	NN	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
by	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
dimethyl	JJ	amod	O
sulfate	JJ	compound	O
footprinting	NN	compound	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
expressing	VBG	acl	O
either	CC	cc:preconj	O
the	DT	det	O
fetal	JJ	dobj	O
or	CC	cc	O
the	DT	det	O
adult	JJ	amod	O
globin	NN	compound	O
developmental	JJ	amod	O
program	NN	conj	O
.	.	punct	O

MDS1/EVI1	NN	nsubj	B-DNA
enhances	VBZ	ROOT	O
TGF-beta1	NN	compound	B-protein
signaling	NN	dobj	O
and	CC	cc	O
strengthens	VBZ	conj	O
its	PRP$	nmod:poss	O
growth-inhibitory	JJ	amod	O
effect	NN	dobj	O
but	CC	cc	O
the	DT	det	O
leukemia-associated	JJ	amod	B-protein
fusion	NN	compound	I-protein
protein	NN	compound	I-protein
AML1/MDS1/EVI1	NN	nsubj	B-protein
,	,	punct	O
product	NN	appos	O
of	IN	case	O
the	DT	det	O
t	NN	nmod	O
(	-LRB-	punct	O
3	CD	dep	O
;	:	punct	O
21	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
abrogates	VBZ	conj	O
growth-inhibition	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
TGF-beta1	NN	nmod	B-protein
.	.	punct	O

Tax1	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
bind	VB	ROOT	O
DNA	NN	dobj	O
directly	RB	advmod	O
but	CC	cc	O
regulates	VBZ	conj	O
transcription	NN	dobj	O
through	IN	case	O
protein-protein	JJ	amod	O
interactions	NNS	nmod	O
with	IN	case	O
sequence-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
factor	NN	nsubjpass	O
responsible	JJ	amod	O
for	IN	case	O
this	DT	det	O
activity	NN	nmod	O
was	VBD	auxpass	O
designated	VBN	ROOT	O
Oct	NN	compound	B-protein
coactivator	NN	xcomp	I-protein
from	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
OCA-B	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
fusion	NN	compound	O
protein	NN	nsubjpass	O
composed	VBN	acl	O
of	IN	case	O
a	DT	det	O
C-terminal	JJ	amod	O
Hsp70	NN	compound	B-protein
peptide	NN	nmod	O
and	CC	cc	O
the	DT	det	O
p50	NN	compound	B-protein
subunit	NN	conj	I-protein
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
was	VBD	auxpass	O
directed	VBN	ccomp	O
into	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
,	,	punct	O
could	MD	aux	O
bind	VB	ccomp	O
DNA	NN	dobj	O
specifically	RB	advmod	O
,	,	punct	O
and	CC	cc	O
activated	VBD	conj	O
Igkappa	NN	compound	B-protein
expression	NN	dobj	O
and	CC	cc	O
TNFalpha	NN	compound	B-protein
production	NN	conj	O
.	.	punct	O

Transcriptional	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
RAR	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
alpha	NN	nmod	I-RNA
)	-RRB-	punct	I-RNA
and	CC	cc	I-RNA
PML-RAR	NN	compound	I-RNA
mRNAs	NNS	conj	I-RNA
is	VBZ	cop	O
rapid	JJ	ROOT	O
and	CC	cc	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
parallelled	VBN	conj	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
proteins	NNS	nmod	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
conceivable	JJ	ROOT	O
that	IN	mark	O
GC	NN	nsubj	O
exert	VBP	ccomp	O
their	PRP$	nmod:poss	O
anti-inflammatory	JJ	amod	O
capacity	NN	dobj	O
in	IN	case	O
various	JJ	amod	O
diseases	NNS	nmod	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
major	JJ	amod	O
inducible	JJ	amod	B-protein
protein	NN	compound	I-protein
complex	NN	nsubj	I-protein
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
human	JJ	amod	B-DNA
CLEO	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
hCLEO	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
element	NN	nmod	I-DNA
is	VBZ	cop	O
an	DT	det	O
AP-1-like	JJ	amod	B-protein
complex	NN	ROOT	I-protein
that	WDT	nsubj	O
is	VBZ	cop	O
inducible	JJ	acl:relcl	O
by	IN	case	O
PMA	NN	nmod	O
alone	RB	advmod	O
,	,	punct	O
but	CC	cc	O
shows	VBZ	conj	O
increased	VBN	amod	O
binding	NN	dobj	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
PMA	NN	nmod	O
together	RB	advmod	O
with	IN	case	O
Ca2+	NN	compound	O
ionophore	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
corresponding	JJ	amod	O
mutations	NNS	nsubj	O
in	IN	case	O
murine	JJ	amod	O
calcineurin	NN	nmod	B-protein
render	VBP	ccomp	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
signal	NN	compound	O
transduction	NN	compound	O
cascade	NN	compound	O
CsA	NN	dobj	O
resistant	JJ	amod	O
in	IN	case	O
human	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Charybdotoxin-sensitive	JJ	amod	O
,	,	punct	O
Ca	NN	dep	O
(	-LRB-	punct	O
2+	NN	dep	O
)	-RRB-	punct	O
-dependent	JJ	amod	O
membrane	NN	compound	O
potential	JJ	amod	O
changes	NNS	nsubjpass	O
are	VBP	auxpass	O
not	RB	neg	O
involved	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	O
T	NN	nmod	B-cell_type
or	CC	cc	I-cell_type
B	NN	compound	I-cell_type
cell	NN	conj	I-cell_type
activation	NN	dep	O
and	CC	cc	O
proliferation	NN	conj	O
.	.	punct	O

Transcriptional	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-DNA
cell	NN	compound	I-DNA
adhesion	NN	compound	I-DNA
molecule-1	NN	compound	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
expressing	VBG	acl	O
human	JJ	amod	B-protein
T-cell	NN	compound	I-protein
leukemia	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
Tax	NN	compound	I-protein
protein	NN	dobj	I-protein
.	.	punct	O

This	DT	det	O
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
translocation	NN	conj	O
of	IN	case	O
STAT6	NN	nmod	B-protein
and	CC	cc	O
was	VBD	cop	O
not	RB	neg	O
evident	JJ	conj	O
unless	IN	mark	O
the	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
preincubated	VBN	advcl	O
with	IN	case	O
IFN	NN	nmod	B-protein
for	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
1	CD	nummod	O
hr	NN	nmod	O
before	IN	case	O
IL-4	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
underlined	VBN	acl	O
in	IN	case	O
this	DT	det	O
regulation	NN	nmod	O
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
analysed	VBN	ROOT	O
in	FW	amod	O
vivo	FW	dep	O
protein-DNA	JJ	amod	O
interactions	NNS	dobj	O
at	IN	case	O
the	DT	det	O
Cyclin	NNP	compound	B-protein
A	NN	compound	I-protein
locus	NN	nmod	O
in	IN	case	O
primary	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
defective	JJ	amod	O
recruitment	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
may	MD	aux	O
underlie	VB	ccomp	O
Nef	NN	nmod:poss	B-protein
's	POS	case	O
negative	JJ	amod	O
transcriptional	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	dep	O
HIV-1	NN	nmod	B-DNA
and	CC	cc	I-DNA
interleukin	NN	compound	I-DNA
2	CD	nummod	I-DNA
promoters	NNS	conj	I-DNA
.	.	punct	O

METHODS	NNS	nsubj	O
AND	CC	cc	O
RESULTS	NNS	conj	O
:	:	punct	O
Immunohistochemistry	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
human	JJ	amod	B-cell_type
carotid	NN	compound	I-cell_type
artery	NN	compound	I-cell_type
ECs	NNS	nsubj	I-cell_type
express	VBP	ccomp	O
PPARalpha	NN	dobj	B-protein
.	.	punct	O

Data	NNS	nsubj	O
reported	VBN	csubj	O
herein	RB	advmod	O
support	VBP	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
cognate	JJ	amod	O
interactions	NNS	nsubj	O
between	IN	case	O
tissue	NN	compound	B-cell_type
fibroblasts	NNS	nmod	I-cell_type
and	CC	cc	O
infiltrating	VBG	amod	O
T	NN	compound	O
lymphocytes	NNS	conj	O
,	,	punct	O
via	IN	case	O
the	DT	det	O
CD40	NN	compound	B-protein
/CD40L	NN	compound	B-protein
pathway	NN	nmod	O
,	,	punct	O
augment	VBP	ccomp	O
inflammation	NN	dobj	O
and	CC	cc	O
may	MD	aux	O
promote	VB	conj	O
fibrogenesis	NN	dobj	O
by	IN	mark	O
activating	VBG	advcl	O
both	DT	det	O
cell	NN	compound	O
types	NNS	dobj	O
.	.	punct	O

Long-lasting	JJ	amod	O
IL-2	NN	compound	B-protein
receptivity	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
high-level	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
inducible	JJ	amod	O
IL-2	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
chain	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IL-2R	NN	compound	I-DNA
alpha	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	acl:relcl	O
at	IN	case	O
both	CC	cc:preconj	O
transcriptional	JJ	amod	O
and	CC	cc	O
posttranscriptional	JJ	conj	O
levels	NNS	nmod	O
.	.	punct	O

Sequence-specific	JJ	amod	O
DNA	NN	compound	O
binding	NN	ROOT	O
of	IN	case	O
the	DT	det	O
B-cell-specific	JJ	amod	B-protein
coactivator	NN	compound	I-protein
OCA-B	NN	nmod	B-protein
.	.	punct	O

Altogether	RB	advmod	O
,	,	punct	O
the	DT	det	O
CD4	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
several	JJ	amod	O
positive	JJ	nmod	O
and	CC	cc	O
negative	JJ	conj	O
regulatory	JJ	amod	O
mechanisms	NNS	dep	O
which	WDT	nsubj	O
come	VBP	acl:relcl	O
into	IN	case	O
play	NN	nmod	O
in	IN	prep	O
a	DT	det	O
developmentally	RB	advmod	O
coordinated	VBN	amod	O
manner	NN	pobj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
CD27	NN	compound	B-protein
/CD70	NN	compound	O
interaction	NN	nmod	O
in	IN	case	O
B	NN	compound	O
cell	NN	compound	O
IgE	NN	compound	B-protein
synthesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
AR	NNS	nsubj	B-protein
are	VBP	cop	O
not	RB	neg	O
detectable	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
intact	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
when	WRB	advmod	O
using	VBG	advcl	O
anti-AR	JJ	amod	B-protein
antibodies	NNS	dobj	I-protein
directed	VBN	acl	O
against	IN	case	O
the	DT	det	O
amino	NN	compound	B-protein
and	CC	cc	I-protein
carboxy	NN	conj	I-protein
terminus	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
AR	NNS	nmod	B-protein
,	,	punct	O
although	IN	mark	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
contain	VBP	advcl	O
AR	NNS	dobj	B-protein
,	,	punct	O
as	IN	mark	O
revealed	VBN	advcl	O
by	IN	case	O
reverse	JJ	amod	O
transcription-polymerase	JJ	amod	O
chain	NN	compound	O
reactions	NNS	nmod	O
and	CC	cc	O
Western	NN	compound	O
blotting	NN	conj	O
.	.	punct	O

The	DT	det	O
suppression	NN	nsubj	O
of	IN	case	O
productive	JJ	amod	O
LAI	NN	compound	O
replication	NN	nmod	O
in	IN	case	O
naive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
not	RB	neg	O
due	JJ	case	O
to	TO	mwe	O
differential	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
viral	JJ	amod	B-protein
coreceptors	NNS	nmod	I-protein
,	,	punct	O
nor	CC	cc	O
is	VBZ	cop	O
it	PRP	nsubj	O
due	JJ	case	O
to	TO	case	O
inhibition	NN	conj	O
of	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
important	JJ	amod	O
HIV	NN	compound	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	appos	I-protein
and	CC	cc	O
activator	NN	compound	B-protein
protein-1	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
activity	NN	nsubj	O
was	VBD	cop	O
heat	NN	nmod:npmod	O
labile	JJ	ROOT	O
and	CC	cc	O
trypsin	NN	compound	B-protein
sensitive	JJ	conj	O
.	.	punct	O

T-lineage	JJ	amod	O
precursor	NN	compound	O
populations	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
adult	JJ	amod	O
mouse	NN	compound	O
thymus	NN	nmod	O
,	,	punct	O
prior	JJ	case	O
to	TO	mwe	O
T-cell	NN	compound	O
receptor	NN	compound	O
gene	NN	compound	O
rearrangement	NN	nmod	O
,	,	punct	O
display	VBP	ROOT	O
a	DT	det	O
capacity	NN	dobj	O
to	TO	mark	O
produce	VB	acl	O
DC	NNS	dobj	B-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
,	,	punct	O
and	CC	cc	O
are	VBP	cop	O
very	RB	advmod	O
efficient	JJ	amod	O
precursors	NNS	conj	O
of	IN	case	O
DC	NN	nmod	B-cell_type
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

High	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
UDG	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
a	DT	det	O
transient	JJ	amod	O
transfection	NN	compound	O
assay	NN	nmod	O
result	VBP	ROOT	O
in	IN	case	O
the	DT	det	O
down-regulation	NN	nmod	O
of	IN	case	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
through	IN	case	O
elements	NNS	nmod	B-DNA
specific	JJ	amod	O
for	IN	case	O
E2F	NN	compound	B-protein
-mediated	JJ	amod	O
transcription	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Protein	NN	compound	O
production	NN	nsubjpass	O
in	IN	case	O
supernatants	NNS	nmod	O
was	VBD	auxpass	O
assessed	VBN	dep	O
by	IN	case	O
ELISA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
mRNA	NN	compound	B-RNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
evaluated	VBN	conj	O
by	IN	case	O
semiquantitative	JJ	amod	O
RT-PCR	NN	nmod	O
.	.	punct	O

CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
costimulated	VBN	acl	O
with	IN	case	O
the	DT	det	O
A6H	NN	compound	B-protein
mAb	NN	nmod	I-protein
upregulated	VBD	ROOT	O
CD80	NN	dobj	B-protein
,	,	punct	O
CD86	NN	conj	B-protein
,	,	punct	O
CD71	NN	conj	B-protein
,	,	punct	O
interleukin-2	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL-2	NN	appos	I-protein
)	-RRB-	punct	I-protein
R	NN	compound	I-protein
alpha	NN	conj	I-protein
,	,	punct	O
IL-2R	NN	compound	B-protein
beta	NN	conj	I-protein
and	CC	cc	O
IL-2R	NN	compound	B-protein
gamma	NN	conj	I-protein
,	,	punct	O
while	IN	mark	O
no	DT	neg	O
corresponding	JJ	amod	O
up-regulation	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
molecules	NNS	nmod	I-protein
was	VBD	auxpass	O
seen	VBN	advcl	O
in	IN	case	O
CD8+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
karyotypic	JJ	amod	O
abnormalities	NNS	nmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
no	DT	neg	O
specific	JJ	amod	O
test	NN	nsubj	O
to	TO	mark	O
detect	VB	acl	O
clonal	JJ	amod	O
eosinophilia	NN	dobj	O
in	IN	case	O
IHES	NN	nmod	O
.	.	punct	O

The	DT	det	O
maximum	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
markers	NNS	nmod	O
induced	VBN	acl	O
by	IN	case	O
ML-9	NN	nmod	O
were	VBD	cop	O
comparable	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
induced	VBN	acl	O
by	IN	case	O
VD3	NN	nmod	O
,	,	punct	O
but	CC	cc	O
after	IN	case	O
removal	NN	nmod	O
of	IN	case	O
ML-9	NN	nmod	O
from	IN	case	O
the	DT	det	O
medium	NN	nmod	O
by	IN	mark	O
washing	VBG	acl	O
the	DT	det	O
cells	NNS	dobj	O
,	,	punct	O
the	DT	det	O
expressions	NNS	nsubj	O
of	IN	case	O
theses	DT	compound	O
markers	NNS	nmod	O
decreased	VBD	conj	O
within	IN	case	O
4	CD	nummod	O
hours	NNS	nmod	O
and	CC	cc	O
reached	VBD	conj	O
basal	JJ	amod	O
levels	NNS	dobj	O
in	IN	case	O
1	CD	nummod	O
day	NN	nmod	O
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
ML-9	NN	nmod:poss	O
's	POS	case	O
induction	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
differentiation-associated	JJ	amod	O
phenotypes	NNS	nmod	O
was	VBD	cop	O
reversible	JJ	ccomp	O
.	.	punct	O

IFN-gamma	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
and	CC	cc	O
protein	NN	conj	O
are	VBP	auxpass	O
expressed	VBN	ROOT	O
predominantly	RB	advmod	O
by	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
large	JJ	amod	B-cell_type
granular	JJ	amod	I-cell_type
lymphocytes	NNS	conj	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
hydrophobic	JJ	amod	B-protein
C-terminal	JJ	amod	I-protein
tail	NN	nsubj	I-protein
of	IN	case	O
CAML	NN	nmod	B-protein
forms	VBZ	ccomp	O
its	PRP$	nmod:poss	O
effector	NN	compound	O
domain	NN	dobj	O
,	,	punct	O
thus	RB	advmod	O
implicating	VBG	advcl	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
hydrophilic	JJ	amod	I-protein
domain	NN	dobj	I-protein
in	IN	case	O
a	DT	det	O
regulatory	JJ	amod	O
role	NN	nmod	O
.	.	punct	O

In	IN	prep	O
a	DT	det	O
sample	NN	pobj	O
from	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
,	,	punct	O
c-fos-positive	JJ	amod	B-protein
lymphocytes	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
CD4	NN	nmod:npmod	O
positive	JJ	nmod	O
and	CC	cc	O
CD8	NN	conj	O
negative	JJ	dep	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
interferon	NN	compound	B-protein
regulatory	JJ	amod	I-protein
factor	NN	compound	I-protein
family	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	ROOT	I-protein
,	,	punct	O
ICSAT/Pip/LSIRF	NN	appos	B-protein
,	,	punct	O
that	WDT	nsubj	O
negatively	RB	advmod	O
regulates	VBZ	acl:relcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
interferon-regulated	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

CD30	NN	nsubjpass	B-protein
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
has	VBZ	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
apoptotic	JJ	amod	O
cell	NN	compound	O
death	NN	nmod	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Selective	JJ	amod	O
effects	NNS	ROOT	O
of	IN	case	O
DNA	NN	compound	O
damaging	NN	compound	O
agents	NNS	nmod	O
on	IN	case	O
HIV	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
activation	NN	nmod	O
and	CC	cc	O
virus	NN	compound	O
replication	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
distribution	NN	nsubjpass	O
of	IN	case	O
myeloid	JJ	amod	B-protein
lineage-associated	JJ	amod	I-protein
cytokine	NN	compound	I-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
lysosomal	JJ	amod	B-protein
proteins	NNS	conj	I-protein
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_line
CD34+	JJ	amod	I-cell_line
cord	NN	compound	I-cell_line
blood	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
CB	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
subsets	NNS	nmod	I-cell_line
at	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
myeloid	JJ	amod	O
commitment	NN	nmod	O
by	IN	case	O
reverse-transcriptase	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
(	-LRB-	punct	O
RT-PCR	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
proximal	JJ	amod	B-DNA
element	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
the	DT	det	O
sequence	NN	compound	O
5'-GGCCAATGGG-3	NN	dobj	O
'	''	punct	O
,	,	punct	O
which	WDT	nsubj	O
closely	RB	advmod	O
resembles	VBZ	acl:relcl	O
the	DT	det	O
consensus	NN	compound	O
binding	NN	compound	O
motif	NN	dobj	O
for	IN	case	O
the	DT	det	O
CCAAT-binding	JJ	amod	B-DNA
factor	NN	compound	I-DNA
NF-Y	NN	nmod	B-protein
(	-LRB-	punct	O
CBF	NN	dep	B-protein
,	,	punct	O
CP1	NN	conj	B-protein
,	,	punct	O
alpha	NN	compound	B-protein
CP1	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
Rta	NN	nmod	B-protein
is	VBZ	cop	O
also	RB	advmod	O
sufficient	JJ	ccomp	O
for	IN	case	O
disruption	NN	nmod	O
of	IN	case	O
latency	NN	nmod	O
in	IN	case	O
a	DT	det	O
permissive	JJ	amod	B-cell_line
B-cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Our	PRP$	nmod:poss	O
previous	JJ	amod	O
investigations	NNS	nsubj	O
on	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
LCR	NN	compound	B-DNA
HS4	NN	nmod	I-DNA
demonstrated	VBD	ROOT	O
that	IN	mark	O
NF-E2	NN	nsubjpass	B-DNA
and	CC	cc	I-DNA
tandem	JJ	conj	I-DNA
,	,	punct	I-DNA
inverted	JJ	amod	I-DNA
GATA	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
the	DT	det	O
native	JJ	amod	B-DNA
HS	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
association	NN	nsubj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
IL-1	NN	compound	B-protein
receptor-associated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
IRAK	NN	appos	B-protein
)	-RRB-	punct	O
to	TO	case	O
the	DT	det	O
IL-1	NN	compound	B-protein
receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
earliest	JJS	amod	O
events	NNS	nmod	O
detectable	JJ	amod	O
in	IN	case	O
IL-1	NN	compound	B-protein
signal	NN	compound	O
transduction	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
some	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
associated	VBN	acl	O
with	IN	case	O
cytokine	NN	compound	B-protein
signalling	NN	nmod	O
can	MD	aux	O
also	RB	advmod	O
activate	VB	ccomp	O
the	DT	det	O
CRH	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

To	TO	mark	O
clarify	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
developmental	JJ	amod	O
control	NN	nmod	O
of	IN	case	O
hemoglobin-encoding	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
we	PRP	nsubj	O
have	VBP	aux	O
been	VBN	aux	O
studying	VBG	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	B-DNA
in	IN	case	O
human	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
continuous	JJ	amod	O
culture	NN	nmod	O
.	.	punct	O

High	JJ	amod	O
affinity	NN	compound	O
binding	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
radioligand	NN	nmod	O
with	IN	case	O
an	DT	det	O
apparent	JJ	amod	O
Kd	NN	nmod	O
of	IN	case	O
approximately	RB	advmod	O
0.1	CD	nummod	O
nM	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
.	.	punct	O

Several	JJ	amod	O
recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
interleukin	NN	compound	O
(	-LRB-	punct	O
IL	NN	nsubjpass	O
)	-RRB-	punct	O
-6	CD	nummod	O
may	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
to	TO	mark	O
detect	VB	xcomp	O
both	CC	cc:preconj	O
infection	NN	dobj	O
and	CC	cc	O
rejection	NN	conj	O
after	IN	case	O
lung	NN	compound	O
transplantation	NN	nmod	O
.	.	punct	O

In	IN	case	O
our	PRP$	nmod:poss	O
previous	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
major	JJ	amod	O
positive	JJ	amod	O
regulatory	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
GATA-1	NN	nmod	B-protein
and	CC	cc	O
a	DT	det	O
negative	JJ	amod	O
regulatory	JJ	amod	O
role	NN	conj	O
for	IN	case	O
GATA-2	NN	nmod	B-protein
in	IN	case	O
MBP	NN	compound	B-protein
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

IL-13	NN	compound	B-protein
activation	NN	nsubjpass	O
of	IN	case	O
STAT6	NN	nmod	B-protein
was	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
MDMac	NN	nmod	B-cell_line
which	WDT	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
diminished	VBN	amod	O
IL-13	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
CD23	NN	nmod	B-protein
and	CC	cc	O
MHC	NN	compound	B-protein
class	NN	conj	I-protein
II	CD	nummod	I-protein
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
by	IN	case	O
Ags	NNS	nmod	B-protein
or	CC	cc	O
cytokines	NNS	conj	B-protein
results	VBZ	ROOT	O
in	IN	case	O
translocation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
NF-kappa	NN	compound	B-protein
B	NN	dep	I-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
NFAT	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
STAT	NN	conj	B-protein
from	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
into	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
IL-1	NN	compound	B-protein
receptor-associated	JJ	amod	I-protein
kinase	NN	nmod	I-protein
on	IN	case	O
NFkappaB	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
IL-2	NN	compound	B-protein
production	NN	conj	O
and	CC	cc	O
stress-activated	JJ	amod	O
protein	NN	compound	O
kinases	NNS	conj	O
in	IN	case	O
the	DT	det	O
murine	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
EL4	NN	nmod	I-cell_line
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
Y319	NN	nsubj	O
also	RB	advmod	O
positively	RB	advmod	O
regulate	VBP	ccomp	O
ZAP-70	NN	compound	B-protein
function	NN	dobj	O
.	.	punct	O

For	IN	case	O
this	DT	det	O
expression	NN	compound	O
pattern	NN	nmod	O
the	DT	det	O
first	JJ	amod	O
280	CD	nummod	B-DNA
bp	NN	nsubj	I-DNA
upstream	RB	advmod	I-DNA
of	IN	case	O
the	DT	det	O
major	JJ	amod	B-DNA
transcriptional	JJ	amod	I-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
seems	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
sufficient	JJ	xcomp	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
TRE-like	JJ	amod	B-DNA
cAMP-responsive	JJ	amod	I-DNA
DSE	NN	compound	I-DNA
sites	NNS	nsubj	I-DNA
within	IN	case	O
the	DT	det	O
5'-untranslated	JJ	amod	B-DNA
leader	NN	nmod	I-DNA
can	MD	aux	O
mediate	VB	ccomp	O
the	DT	det	O
transcriptional	JJ	amod	O
cooperativity	NN	dobj	O
between	IN	case	O
TNFalpha	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
cAMP	NN	compound	O
/PKA	NN	compound	B-protein
pathway	NN	conj	O
.	.	punct	O

In	IN	case	O
another	DT	det	O
group	NN	nmod	O
of	IN	case	O
28	CD	nummod	O
patients	NNS	nmod	O
(	-LRB-	punct	O
three	CD	nummod	O
individuals	NNS	dep	O
from	IN	case	O
the	DT	det	O
first	JJ	amod	O
group	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
frequency	NN	nsubjpass	O
of	IN	case	O
abnormal	JJ	amod	O
NFkappaB	NN	compound	B-protein
activation	NN	nmod	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	dobj	O
after	IN	case	O
activation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate/ionomycin	NN	nmod	O
or	CC	cc	O
anti-CD3	JJ	amod	B-protein
monoclonal	JJ	amod	I-protein
antibody	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
tumor	NN	compound	B-DNA
necrosis	NN	compound	I-DNA
factor-alpha	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
TNF	NN	compound	I-DNA
alpha	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nsubj	I-DNA
is	VBZ	cop	O
an	DT	det	O
immediate	JJ	amod	O
early	JJ	amod	O
gene	NN	ROOT	O
in	IN	case	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
in	IN	case	O
that	IN	nmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
induced	VBN	acl:relcl	O
without	IN	case	O
a	DT	det	O
requirement	NN	nmod	O
for	IN	case	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	DT	mark	O
C3a	NN	nsubj	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
C3a	NN	conj	B-protein
(	-LRB-	punct	I-protein
desArg	CD	appos	I-protein
)	-RRB-	punct	I-protein
enhanced	VBD	ccomp	O
LPS	NN	nmod:npmod	O
-induced	JJ	amod	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	dobj	O
for	IN	case	O
IL-6	NN	nmod	B-protein
.	.	punct	O

Type	NN	compound	O
I	CD	nummod	O
interferons	NNS	nsubj	B-protein
(	-LRB-	punct	O
IFNs	NNS	appos	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
a	DT	det	O
family	NN	ROOT	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
that	WDT	nsubj	O
have	VBP	acl:relcl	O
antiviral	JJ	amod	O
and	CC	cc	O
antiproliferative	JJ	conj	O
effects	NNS	dobj	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
alpha	NN	compound	B-protein
A1	NN	dobj	I-protein
(	-LRB-	punct	O
an	DT	det	O
alpha	NN	compound	B-protein
A-gene	NN	compound	I-protein
product	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
alpha	NN	compound	B-protein
B1	NN	conj	I-protein
and	CC	cc	O
alpha	NN	compound	B-protein
B2	NN	conj	I-protein
(	-LRB-	punct	O
two	CD	nummod	O
alpha	NN	nmod:npmod	B-protein
B-encoded	JJ	amod	I-protein
isomers	NNS	appos	I-protein
)	-RRB-	punct	O
for	IN	case	O
their	PRP$	nmod:poss	O
effects	NNS	nmod	O
on	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Recombinant	JJ	amod	B-protein
murine	JJ	amod	I-protein
and	CC	cc	I-protein
human	JJ	conj	I-protein
TCF-1	NN	nsubj	I-protein
recognized	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
sequence	NN	compound	O
motif	NN	dobj	O
in	IN	case	O
the	DT	det	O
CD3-epsilon	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
as	IN	mark	O
judged	VBN	advcl	O
by	IN	case	O
gel	NN	compound	O
retardation	NN	nmod	O
and	CC	cc	O
methylation	NN	compound	O
interference	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

The	DT	det	O
unusual	JJ	amod	O
CD56+	JJ	amod	B-cell_type
CD16-	JJ	amod	I-cell_type
eGLs	NNS	nsubjpass	I-cell_type
present	JJ	amod	O
in	IN	case	O
large	JJ	amod	O
numbers	NNS	nmod	O
in	IN	case	O
late	JJ	amod	O
secretory	JJ	amod	O
phase	NN	compound	O
eutopic	JJ	amod	O
endometrium	NN	nmod	O
were	VBD	auxpass	O
highly	RB	advmod	O
purified	VBN	ROOT	O
(	-LRB-	punct	O
>	NN	intj	O
98	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
by	IN	case	O
immunomagnetic	JJ	amod	O
separation	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
RFX1	NN	nsubj	B-protein
can	MD	aux	O
bind	VB	ROOT	O
simultaneously	RB	advmod	O
,	,	punct	O
most	RBS	advmod	O
likely	RB	advmod	O
as	IN	case	O
a	DT	det	O
heterodimer	NN	nmod	B-protein
,	,	punct	O
with	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
MIBP1	NN	nmod	B-protein
to	TO	case	O
NRE	NN	compound	B-DNA
gamma	NN	nmod	I-DNA
.	.	punct	O

Cytomegalovirus	NN	compound	O
(	-LRB-	punct	O
CMV	NN	appos	O
)	-RRB-	punct	O
infection	NN	nsubj	O
is	VBZ	cop	O
nonpermissive	JJ	ROOT	O
or	CC	cc	O
persistent	JJ	conj	O
in	IN	case	O
many	JJ	amod	O
lymphoid	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
myeloid	JJ	conj	I-cell_type
cell	NN	compound	I-cell_type
types	NNS	dep	I-cell_type
but	CC	cc	O
can	MD	aux	O
be	VB	auxpass	O
activated	VBN	conj	O
in	IN	case	O
differentiated	VBN	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

Gangliosides	NNS	nsubj	O
suppress	VBP	ROOT	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
production	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
1	CD	nsubj	O
,	,	punct	O
25-dihydroxycholecalciferol	NN	conj	O
[	-LRB-	punct	O
1	CD	compound	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	dep	O
]	-RRB-	punct	O
enhances	VBZ	ccomp	O
the	DT	det	O
replication	NN	dobj	O
of	IN	case	O
monocyte-	NN	amod	O
and	CC	cc	O
lymphocyte-tropic	JJ	conj	O
strains	NNS	nmod	O
of	IN	case	O
HIV-1	NN	nmod	O
up	IN	advmod	O
to	TO	dep	O
10	CD	nmod	O
,	,	punct	O
000-fold	RB	dep	O
in	IN	case	O
monocyte	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
unfractionated	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

This	DT	det	O
method	NN	nsubjpass	O
was	VBD	auxpass	O
successfully	RB	advmod	O
extended	VBN	ROOT	O
to	TO	case	O
human	JJ	amod	B-protein
retinoic	JJ	amod	I-protein
X	NN	compound	I-protein
receptor	NN	compound	I-protein
alpha	NN	nmod	I-protein
,	,	punct	O
glucocorticoid	NN	compound	B-protein
receptor	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
progesterone	NN	compound	B-protein
receptor	NN	conj	I-protein
,	,	punct	O
thus	RB	advmod	O
providing	VBG	xcomp	O
a	DT	det	O
basis	NN	dobj	O
for	IN	case	O
a	DT	det	O
new	JJ	amod	O
,	,	punct	O
faster	JJR	dep	O
assay	NN	nmod	O
to	TO	mark	O
determine	VB	acl	O
simultaneously	RB	advmod	O
the	DT	dep	O
affinity	NN	dobj	O
and	CC	cc	O
conformation	NN	conj	O
of	IN	case	O
receptors	NNS	nmod	O
when	WRB	advmod	O
bound	VBN	advcl	O
to	TO	case	O
a	DT	det	O
given	JJ	amod	O
ligand	NN	nmod	O
.	.	punct	O

Protein-DNA	JJ	amod	O
complexes	NNS	nsubj	O
of	IN	case	O
constitutive	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
are	VBP	cop	O
similar	JJ	ROOT	O
in	IN	case	O
mobility	NN	nmod	O
to	TO	case	O
the	DT	det	O
LPS-induced	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
both	DT	nsubjpass	O
are	VBP	auxpass	O
recognized	VBN	conj	O
by	IN	case	O
an	DT	det	O
antibody	NN	nmod	O
specific	JJ	amod	O
to	TO	case	O
the	DT	det	O
p50	NN	compound	B-protein
subunit	NN	nmod	I-protein
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
latently	RB	advmod	O
HIV-infected	JJ	amod	B-cell_line
myelomonocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
OM-10.1	NN	nmod	O
with	IN	case	O
C.	FW	compound	O
neoformans	FW	nmod	O
and	CC	cc	O
C.	FW	compound	O
albicans	FW	conj	O
in	IN	case	O
the	DT	det	O
presence	NN	intj	O
of	IN	case	O
pooled	JJ	amod	O
human	JJ	amod	O
serum	NN	nmod	O
caused	VBD	ROOT	O
a	DT	det	O
ratio-dependent	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
HIV	NN	compound	O
production	NN	nmod	O
.	.	punct	O

MATERIALS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Formalin-fixed	JJ	amod	O
paraffin	NN	compound	O
sections	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	dep	O
for	IN	case	O
immunostaining	NN	nmod	O
of	IN	case	O
Bcl-6	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	nsubj	O
and	CC	cc	O
supershift	NN	compound	O
assays	NNS	conj	O
revealed	VBD	ROOT	O
that	IN	mark	O
important	JJ	amod	O
NF-kappaB	NN	compound	B-protein
binding	NN	compound	O
activity	NN	nsubj	O
composed	VBN	acl	O
of	IN	case	O
at	IN	case	O
least	JJS	advmod	O
p50	NN	nmod	B-protein
,	,	punct	O
p65	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
c-Rel	NN	compound	B-protein
NF-kappaB	NN	compound	B-protein
subunits	NNS	conj	I-protein
was	VBD	cop	O
present	JJ	ccomp	O
in	IN	case	O
nuclei	NNS	nmod	O
of	IN	case	O
CD40-stimulated	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
Duffy	NN	compound	B-protein
polymorphic	JJ	amod	I-protein
antigens	NNS	nsubj	I-protein
,	,	punct	O
Fya	NN	appos	B-protein
and	CC	cc	O
Fyb	NN	conj	B-protein
(	-LRB-	punct	O
coded	VBN	acl	O
by	IN	case	O
the	DT	det	O
FY*A	NN	compound	B-DNA
and	CC	cc	I-DNA
FY*B	NN	conj	I-DNA
alleles	NNS	nmod	I-DNA
)	-RRB-	punct	O
,	,	punct	O
are	VBP	cop	O
present	JJ	ROOT	O
on	IN	case	O
erythrocyte	NN	compound	B-protein
membranes	NNS	nmod	I-protein
.	.	punct	O

Deletion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	O
response	NN	compound	O
elements	NNS	nmod	O
located	JJ	amod	O
at	IN	case	O
ca.	FW	compound	B-DNA
bp	NN	nmod	I-DNA
-850	CD	nummod	I-DNA
upstream	RB	advmod	O
of	IN	case	O
Cp	NN	nmod	B-DNA
did	VBD	aux	O
not	RB	neg	O
result	VB	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
loss	NN	nmod	O
in	IN	case	O
activity	NN	nmod	O
.	.	punct	O

p21ras	NN	nsubj	B-protein
plays	VBZ	ROOT	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

A	DT	det	O
fragment	NN	nsubjpass	O
of	IN	case	O
Oct-2	NN	nmod	B-protein
containing	NN	acl	O
POUHD	NN	dobj	B-protein
and	CC	cc	O
an	DT	det	O
adjoining	JJ	amod	O
linker	NN	conj	O
was	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
Escherichia	FW	compound	O
coli	FW	nmod	O
and	CC	cc	O
characterized	VBN	conj	O
by	IN	case	O
three-dimensional	JJ	amod	O
nuclear	JJ	amod	O
magnetic	JJ	amod	O
resonance	NN	compound	O
(	-LRB-	punct	O
3D-NMR	NN	appos	O
)	-RRB-	punct	O
spectroscopy	NN	nmod	O
.	.	punct	O

Tissue	NN	compound	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
TF	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	nsubj	O
by	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
monocyte/macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
represents	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
mechanism	NN	dobj	O
underlying	VBG	acl	O
the	DT	det	O
initiation	NN	dobj	O
of	IN	case	O
fibrin	NN	compound	B-protein
deposition	NN	nmod	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
extravascular	JJ	amod	O
inflammation	NN	nmod	O
.	.	punct	O

The	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
third	JJ	amod	B-DNA
intron	NN	nmod	I-DNA
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
to	TO	case	O
this	DT	det	O
construct	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
an	DT	det	O
enhancement	NN	nmod	O
of	IN	case	O
CAT	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
IL-2	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
IL-2	NN	nsubj	B-protein
may	MD	aux	O
act	VB	ccomp	O
in	IN	case	O
a	DT	det	O
paracrine	JJ	amod	O
manner	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
unambiguously	RB	advmod	O
demonstrated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
fact	NN	nmod	O
that	IN	mark	O
plasmacytoma	NN	compound	B-cell_line
x	NN	cc	I-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
hybrids	NNS	nsubj	I-cell_line
carrying	VBG	acl	O
an	DT	det	O
AIR-1	NN	compound	B-DNA
locus	NN	dobj	I-DNA
derived	VBN	acl	O
from	IN	case	O
CIITA-expressing	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
do	VBP	aux	O
not	RB	neg	O
express	VB	ccomp	O
CIITA-specific	JJ	amod	B-RNA
transcripts	NNS	dobj	I-RNA
.	.	punct	O

Administration	NN	nsubj	O
of	IN	case	O
dexamethasone	NN	nmod	O
to	TO	case	O
temporal	JJ	amod	B-cell_line
artery-SCID	NN	compound	I-cell_line
chimeras	NNS	nmod	I-cell_line
for	IN	case	O
1	CD	nummod	O
wk	NN	nmod	O
induced	VBD	ROOT	O
a	DT	det	O
partial	JJ	amod	O
suppression	NN	dobj	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
and	CC	cc	O
macrophage	NN	conj	O
function	NN	nmod	O
as	IN	mark	O
indicated	VBN	advcl	O
by	IN	case	O
the	DT	det	O
reduced	VBN	amod	O
tissue	NN	compound	O
concentrations	NNS	nmod	O
of	IN	case	O
IL-2	NN	nmod	B-RNA
,	,	punct	I-RNA
IL-1beta	NN	conj	I-RNA
,	,	punct	I-RNA
and	CC	cc	I-RNA
IL-6	NN	conj	I-RNA
mRNA	NN	conj	I-RNA
,	,	punct	O
and	CC	cc	O
by	IN	case	O
the	DT	det	O
diminished	VBN	amod	O
expression	NN	conj	O
of	IN	case	O
inducible	JJ	amod	O
NO	NN	compound	B-protein
synthase	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
ATF/CRE	NN	compound	B-DNA
site	NN	nsubj	I-DNA
is	VBZ	cop	O
also	RB	advmod	O
essential	JJ	ROOT	O
for	IN	case	O
CD4	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activation	NN	nmod	O
by	IN	case	O
forskolin	NN	nmod	O
,	,	punct	O
an	DT	det	O
activator	NN	appos	O
of	IN	case	O
adenylate	JJ	compound	O
cyclase	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
here	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
(	-LRB-	punct	O
i	LS	nsubj	O
)	-RRB-	punct	O
like	IN	case	O
PML-RAR	NN	compound	B-protein
alpha	NN	compound	I-protein
expression	NN	nmod	O
,	,	punct	O
PLZF-RAR	NN	compound	B-protein
alpha	NN	compound	I-protein
expression	NN	nsubj	O
blocks	VBZ	ccomp	O
terminal	JJ	amod	O
differentiation	NN	dobj	O
of	IN	case	O
hematopoietic	JJ	amod	O
precursor	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
(	-LRB-	punct	O
U937	NN	dep	B-cell_line
and	CC	cc	O
HL-60	NN	conj	B-cell_line
)	-RRB-	punct	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
different	JJ	amod	O
stimuli	NNS	nmod	O
(	-LRB-	punct	O
vitamin	NN	compound	O
D3	NN	dep	O
,	,	punct	O
transforming	VBG	amod	O
growth	NN	compound	O
factor	NN	compound	O
beta1	NN	conj	O
,	,	punct	O
and	CC	cc	O
dimethyl	JJ	amod	O
sulfoxide	NN	conj	O
)	-RRB-	punct	O
;	:	punct	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
PML-RAR	NN	compound	B-protein
alpha	NN	dep	I-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
PLZF-RAR	NN	compound	B-protein
alpha	NN	conj	I-protein
,	,	punct	O
increases	VBZ	conj	O
RA	NN	compound	O
sensitivity	NN	dobj	O
of	IN	case	O
hematopoietic	JJ	amod	B-cell_type
precursor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
restores	VBZ	conj	O
RA	NN	compound	O
sensitivity	NN	dobj	O
of	IN	case	O
RA-resistant	JJ	amod	B-cell_type
hematopoietic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
;	:	punct	O
(	-LRB-	punct	O
iii	LS	dep	O
)	-RRB-	punct	O
PML-RAR	NN	compound	B-protein
alpha	NN	nsubj	I-protein
and	CC	cc	O
PLZF-RAR	NN	compound	B-protein
alpha	NN	conj	I-protein
have	VBP	parataxis	O
similar	JJ	amod	O
RA	NN	compound	O
binding	NN	compound	O
affinities	NNS	dobj	O
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
iv	LS	dep	O
)	-RRB-	punct	O
PML-RAR	NN	compound	B-protein
alpha	NN	nsubj	I-protein
enhances	VBZ	conj	O
the	DT	det	O
RA	NN	compound	O
response	NN	dobj	O
of	IN	case	O
RA	NN	compound	B-DNA
target	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
(	-LRB-	punct	O
those	DT	dep	O
for	IN	case	O
RAR	NN	compound	B-protein
beta	NN	nmod	I-protein
,	,	punct	O
RAR	NN	compound	B-protein
gamma	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
transglutaminase	NN	compound	B-protein
type	NN	conj	I-protein
II	CD	nummod	I-protein
[	-LRB-	punct	O
TGase	NN	appos	B-protein
]	-RRB-	punct	O
)	-RRB-	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
while	IN	mark	O
PLZF-RAR	NN	compound	B-protein
alpha	NN	compound	I-protein
expression	NN	nsubj	O
has	VBZ	advcl	O
either	CC	cc:preconj	O
no	DT	neg	O
effect	NN	dobj	O
(	-LRB-	punct	O
RAR	NN	compound	B-protein
beta	NN	appos	I-protein
)	-RRB-	punct	O
or	CC	cc	O
an	DT	det	O
inhibitory	JJ	amod	O
activity	NN	conj	O
(	-LRB-	punct	O
RAR	NN	compound	B-protein
gamma	NN	dep	I-protein
and	CC	cc	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
TGase	NN	conj	I-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
single	JJ	amod	O
Ala	NN	nsubj	O
--	:	punct	O
>	NN	amod	O
Asp	NN	compound	O
amino	NN	compound	O
acid	NN	compound	O
57	CD	nummod	O
substitution	NN	nsubj	O
in	IN	case	O
an	DT	det	O
HLA-DQ3.2	NN	compound	O
molecule	NN	nmod	O
regulated	VBD	ccomp	O
binding	NN	dobj	O
of	IN	case	O
an	DT	det	O
HSV-2	NN	compound	O
VP-16-derived	JJ	amod	O
peptide	NN	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
phorbol	NN	nmod:npmod	O
ester-induced	JJ	amod	O
production	NN	nsubj	O
of	IN	case	O
O2-	NN	nmod	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
cells	NNS	nmod	O
treated	VBN	acl	O
with	IN	nmod	O
and	CC	cc	O
without	IN	case	O
gangliosides	NNS	nmod	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
SCL	NN	compound	B-protein
expression	NN	nsubjpass	O
was	VBD	auxpass	O
up-regulated	VBN	ROOT	O
by	IN	case	O
Epo	NN	nmod	B-protein
and	CC	cc	O
further	RB	advmod	O
increased	VBN	conj	O
by	IN	case	O
haemin	NN	nmod	O
and	CC	cc	O
delta-ALA	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
hexamethylene	NN	compound	O
bisacetamide	NN	nsubj	O
(	-LRB-	punct	O
HMBA	NN	appos	O
)	-RRB-	punct	O
induced	VBD	ccomp	O
K562	NN	compound	B-cell_line
cells	NNS	dobj	I-cell_line
to	TO	mark	O
differentiate	VB	xcomp	O
along	IN	case	O
a	DT	det	O
third	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

The	DT	det	O
immunoregulatory	JJ	amod	B-protein
properties	NNS	nsubj	O
of	IN	case	O
prolactin	NN	nmod	O
,	,	punct	O
a	DT	det	O
pituitary	JJ	amod	O
peptide	NN	compound	O
hormone	NN	appos	O
,	,	punct	O
have	VBP	aux	O
received	VBN	ROOT	O
renewed	JJ	amod	O
attention	NN	dobj	O
.	.	punct	O

Comparison	NN	nsubj	O
of	IN	case	O
these	DT	det	O
sequences	NNS	nmod	O
to	TO	case	O
those	DT	nmod	O
required	VBN	acl	O
to	TO	mark	O
mediate	VB	xcomp	O
virus	NN	compound	O
or	CC	cc	O
lipopolysaccharide	NN	conj	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
induction	NN	dobj	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
reveal	VBP	ROOT	O
significant	JJ	amod	O
differences	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
sequence	NN	compound	O
requirements	NNS	nsubj	O
for	IN	case	O
PMA	NN	compound	O
induction	NN	nmod	O
are	VBP	cop	O
distinct	JJ	parataxis	O
from	IN	case	O
those	DT	nmod	O
that	WDT	nsubj	O
mediate	VBP	acl:relcl	O
induction	NN	dobj	O
by	IN	case	O
virus	NN	nmod	O
or	CC	cc	O
LPS	NN	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
TCR	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
activation	NN	nmod	O
,	,	punct	O
Vpr	NN	nsubj	B-protein
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
whereas	IN	mark	O
in	IN	case	O
its	PRP$	nmod:poss	O
presence	NN	nmod	O
,	,	punct	O
Vpr	NN	nsubj	B-protein
interrupts	VBZ	advcl	O
the	DT	det	O
expected	VBN	amod	O
induction	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

A	DT	det	O
critical	JJ	amod	O
issue	NN	nsubj	O
concerns	VBZ	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
CD14	NN	nsubj	B-protein
,	,	punct	O
which	WDT	nsubj	O
has	VBZ	acl:relcl	O
no	DT	neg	O
transmembrane	JJ	amod	B-protein
domain	NN	dobj	I-protein
,	,	punct	O
transduces	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
signal	NN	dobj	O
following	VBG	case	O
LPS	NN	compound	O
binding	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
HTLV-1	NN	compound	B-protein
transactivator	NN	compound	I-protein
protein	NN	nsubj	I-protein
,	,	punct	O
tax	NN	appos	B-protein
,	,	punct	O
acts	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
costimulatory	JJ	amod	O
signal	NN	nmod	O
for	IN	case	O
GM-CSF	NN	nmod	O
and	CC	cc	O
IL-2	NN	conj	O
gene	NN	compound	O
transcription	NN	dep	O
,	,	punct	O
in	IN	mark	O
that	IN	mark	O
it	PRP	nsubj	O
can	MD	aux	O
cooperate	VB	advcl	O
with	IN	case	O
TCR	NN	compound	B-protein
signals	NNS	nmod	O
to	TO	mark	O
mediate	VB	xcomp	O
high	JJ	amod	O
level	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Its	PRP$	poss	O
50	CD	nummod	O
%	NN	compound	O
effective	JJ	amod	O
and	CC	cc	O
cytotoxic	JJ	conj	O
concentrations	NNS	nsubj	O
were	VBD	cop	O
0.016	CD	nummod	O
and	CC	cc	O
2.2	CD	conj	O
microg/ml	NN	ROOT	O
in	IN	case	O
PMA-stimulated	JJ	amod	B-cell_line
U1	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
blockade	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
Ca	NN	compound	B-protein
(	-LRB-	punct	I-protein
2+	NN	intj	I-protein
)	-RRB-	punct	I-protein
-activated	JJ	amod	I-protein
K+	NN	compound	I-protein
channel	NN	nmod	I-protein
is	VBZ	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
cell-cycle	JJ	amod	O
gene	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
IL-2	NN	compound	B-protein
production	NN	conj	O
,	,	punct	O
IL-2R	NN	compound	B-protein
expression	NN	conj	O
or	CC	cc	O
B	NN	compound	O
and	CC	cc	O
T	NN	conj	O
cell	NN	compound	O
mitogenesis	NN	conj	O
.	.	punct	O

Wortmannin	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
interfere	VB	ROOT	O
with	IN	case	O
NFAT	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
although	IN	mark	O
it	PRP	nsubj	O
inhibited	VBD	advcl	O
PI3-K	NN	compound	B-protein
and	CC	cc	O
Erk2	NN	conj	B-protein
activation	NN	dobj	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
experiment	NN	nmod	O
.	.	punct	O

The	DT	det	O
11	CD	nummod	O
beta-methyl	NN	compound	O
analog	NN	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
greater	JJR	amod	O
than	IN	case	O
10-fold	RB	advmod	O
lower	JJR	amod	O
activity	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
secretion	NN	nsubj	O
of	IN	case	O
PGE2	NN	nmod	O
by	IN	case	O
macrophages	NNS	nmod	B-cell_type
in	IN	case	O
response	NN	dep	O
to	TO	case	O
infection	NN	nmod	O
or	CC	cc	O
inflammatory	JJ	amod	O
activators	NNS	conj	O
could	MD	aux	O
induce	VB	ccomp	O
signaling	NN	compound	O
events	NNS	dobj	O
resulting	VBG	acl	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
proviral	JJ	amod	O
DNA	NN	nmod	O
present	JJ	amod	O
into	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
latently	RB	advmod	O
infected	VBN	acl	O
with	IN	case	O
HIV-1	NN	nmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
CMV	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
cofactor	NN	ccomp	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
rejection	NN	nmod	O
and	CC	cc	O
infection	NN	conj	O
after	IN	case	O
transplantation	NN	nmod	O
through	IN	case	O
its	PRP$	nmod:poss	O
effects	NNS	nmod	O
on	IN	case	O
IL-6	NN	nmod	B-protein
.	.	punct	O

Phosphorylated	VBN	amod	O
Bcl-2	NN	nsubj	B-protein
can	MD	aux	O
not	RB	neg	O
bind	VB	ROOT	O
calcineurin	NN	dobj	B-protein
,	,	punct	O
and	CC	cc	O
NFAT	NN	compound	B-protein
activation	NN	dep	O
,	,	punct	O
FasL	NN	compound	B-protein
expression	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
can	MD	aux	O
occur	VB	conj	O
after	IN	case	O
Bcl-2	NN	compound	B-protein
phosphorylation	NN	nmod	O
.	.	punct	O

The	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Oct2	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
with	IN	case	O
the	DT	det	O
cognate	JJ	amod	B-DNA
octamer	NN	compound	I-DNA
motif	NN	compound	I-DNA
ATGCAAAT	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
determinant	NN	ROOT	O
of	IN	case	O
the	DT	det	O
lymphoid-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Therefore	RB	advmod	O
oxygen	NN	compound	O
therapy	NN	nsubj	O
is	VBZ	cop	O
helpful	JJ	ROOT	O
in	IN	mark	O
raising	VBG	advcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
controlling	VBG	conj	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
3BP2	NN	nsubj	B-protein
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
adaptor	NN	ROOT	O
that	WDT	nsubj	O
may	MD	aux	O
couple	VB	acl:relcl	O
activated	VBN	amod	O
Zap-70/Syk	NN	dobj	B-protein
to	TO	case	O
a	DT	det	O
LAT-containing	JJ	amod	B-protein
signaling	NN	compound	I-protein
complex	NN	nmod	I-protein
involved	VBN	acl	O
in	IN	case	O
TCR-mediated	JJ	amod	O
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

CD27	NN	compound	B-protein
/CD70	.	compound	O
interaction	NN	nsubj	O
enhanced	VBD	ROOT	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	dobj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
IL-4	NN	nmod	B-protein
or	CC	cc	O
IL-4	NN	conj	B-protein
plus	CC	cc	O
anti-CD40	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
human	JJ	amod	O
myeloid	JJ	amod	O
cell	NN	compound	O
nuclear	JJ	amod	O
differentiation	NN	compound	O
antigen	NN	nsubj	O
(	-LRB-	punct	O
MNDA	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
nuclear	JJ	amod	O
antigen	NN	ROOT	O
known	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
expressed	VBN	xcomp	O
in	IN	case	O
mature	JJ	amod	O
myelomonocytic	JJ	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O

Giant	JJ	amod	O
cell	NN	compound	O
arteritis	NN	nsubj	O
(	-LRB-	punct	O
GCA	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
vasculitic	JJ	amod	O
syndrome	NN	ROOT	O
that	WDT	nsubj	O
preferentially	RB	advmod	O
affects	VBZ	acl:relcl	O
medium	NN	dobj	O
and	CC	cc	O
large-sized	JJ	conj	O
arteries	NNS	dep	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
the	DT	det	O
FECa2+	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
Vmax	NN	conj	O
of	IN	case	O
the	DT	det	O
SERCA	NN	nmod	B-protein
are	VBP	cop	O
reliable	JJ	amod	O
indicators	NNS	dobj	O
of	IN	case	O
Ca2+	NN	compound	O
load	NN	nmod	O
in	IN	case	O
platelets	NNS	nmod	B-cell_type
from	IN	case	O
women	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
describe	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
the	DT	det	O
rapid	JJ	amod	O
modulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
NT3R	NN	nmod	B-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
the	DT	det	O
combined	JJ	amod	O
influence	NN	nmod	O
of	IN	case	O
cold	JJ	amod	O
exposure	NN	nmod	O
and	CC	cc	O
reduced	VBN	amod	O
circulating	VBG	amod	O
T4	NN	conj	O
and	CC	cc	O
TSH	NN	conj	O
.	.	punct	O

During	IN	case	O
recent	JJ	amod	O
years	NNS	nmod	O
,	,	punct	O
studies	NNS	nsubj	O
of	IN	case	O
insulin-gene	JJ	amod	B-DNA
regulation	NN	nmod	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
the	DT	det	O
tissue-specific	JJ	amod	O
transcriptional	JJ	amod	O
control	NN	nsubj	O
of	IN	case	O
insulin-gene	JJ	amod	B-DNA
activity	NN	nmod	O
have	VBP	aux	O
provided	VBN	ROOT	O
information	NN	dobj	O
on	IN	case	O
pancreas	NN	compound	O
development	NN	nmod	O
in	IN	prep	O
general	NN	pobj	O
.	.	punct	O

Cipro	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
nuclear	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	dobj	I-protein
AP-1	NN	dep	B-protein
or	CC	cc	O
NFIL-2A	NN	conj	B-protein
.	.	punct	O

This	DT	det	O
strategy	NN	nsubj	O
depends	VBZ	ROOT	O
on	IN	case	O
a	DT	det	O
separation	NN	nmod	O
of	IN	case	O
latency	NN	nmod	O
and	CC	cc	O
the	DT	det	O
lytic	JJ	amod	O
replication	NN	conj	O
,	,	punct	O
either	CC	cc:preconj	O
by	IN	case	O
time	NN	nmod	O
due	JJ	case	O
to	TO	case	O
differentiation-dependent	JJ	amod	O
mechanisms	NNS	nmod	O
or	CC	cc	O
by	IN	case	O
spatial	JJ	amod	O
separation	NN	conj	O
as	IN	case	O
the	DT	det	O
result	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
host	NN	compound	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

C5a	NN	compound	B-protein
and	CC	cc	O
C3a	NN	conj	B-protein
stimulation	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
resulted	VBD	ROOT	O
in	IN	case	O
nuclear	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
with	IN	case	O
specificity	NN	nmod	O
to	TO	case	O
the	DT	det	O
kappaB	NN	compound	B-DNA
sequence	NN	nmod	I-DNA
.	.	punct	O

ATF1	NN	nsubj	B-protein
and	CC	cc	O
CREB	NN	conj	B-protein
trans-activate	VBP	ROOT	O
a	DT	det	O
cell	NN	compound	B-DNA
cycle	NN	compound	I-DNA
regulated	JJ	amod	I-DNA
histone	NN	compound	I-DNA
H4	NN	compound	I-DNA
gene	NN	dobj	I-DNA
at	IN	case	O
a	DT	det	O
distal	JJ	amod	B-DNA
nuclear	JJ	amod	I-DNA
matrix	NN	compound	I-DNA
associated	JJ	amod	I-DNA
promoter	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
based	VBN	ROOT	O
on	IN	case	O
reports	NNS	nmod	O
that	IN	mark	O
antioxidants	NNS	nsubj	O
which	WDT	nsubj	O
eliminate	VBP	acl:relcl	O
ROS	NN	dobj	O
should	MD	aux	O
block	VB	ccomp	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
subsequently	RB	advmod	O
HIV	NN	compound	O
transcription	NN	conj	O
,	,	punct	O
and	CC	cc	O
thus	RB	advmod	O
antioxidants	NNS	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
used	VBN	conj	O
as	IN	case	O
therapeutic	JJ	amod	O
agents	NNS	nmod	O
for	IN	case	O
AIDS	NN	nmod	O
.	.	punct	O

E-selectin	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
induced	VBN	ROOT	O
within	IN	case	O
1-2	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
peaks	VBZ	conj	O
at	IN	case	O
4-6	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
and	CC	cc	O
gradually	RB	advmod	O
returns	VBZ	conj	O
to	TO	case	O
basal	JJ	amod	O
level	NN	nmod	O
by	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
epsilon	NN	compound	O
germline	NN	compound	B-DNA
transcription	NN	nmod	O
:	:	punct	O
role	NN	dep	O
of	IN	case	O
B-cell-specific	JJ	amod	B-protein
activator	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
intracellular	JJ	amod	O
localization	NN	nsubjpass	O
of	IN	case	O
NFkappaB	NN	nmod	B-protein
after	IN	case	O
TNFalpha	NN	compound	B-protein
simulation	NN	nmod	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
confocal	JJ	amod	O
immunocytochemistry	NN	nmod	O
using	VBG	acl	O
an	DT	det	O
anti-p65	JJ	amod	B-protein
antibody	NN	dobj	I-protein
.	.	punct	O

This	DT	nsubj	O
implicates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
SRG3	NN	nsubj	B-DNA
may	MD	aux	O
play	VB	ccomp	O
an	DT	det	O
important	JJ	amod	O
regulatory	JJ	amod	O
role	NN	dobj	O
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
in	IN	case	O
thymus	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
biochemical	JJ	amod	O
and	CC	cc	O
mutagenesis	NN	conj	O
analyses	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
determined	VBD	ROOT	O
that	IN	mark	O
multiple	JJ	amod	O
nuclear	JJ	amod	B-protein
factors	NNS	nsubj	I-protein
bind	VBP	ccomp	O
to	TO	case	O
these	DT	det	O
independent	JJ	amod	O
sites	NNS	nmod	O
.	.	punct	O

Rather	RB	advmod	O
,	,	punct	O
IFN-gamma	NN	nsubj	B-protein
antagonized	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
IL-4	NN	nmod	B-protein
and	CC	cc	O
suppressed	VBD	conj	O
the	DT	det	O
DC	NN	dobj	B-cell_type
and	CC	cc	O
MGC	NN	compound	B-cell_type
formation	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
GM-CSF	NN	nmod	B-protein
+	CC	cc	O
IL-4	NN	conj	B-protein
and	CC	cc	O
M-CSF	NN	conj	B-protein
+	CC	cc	O
IL-4	NN	conj	B-protein
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
Tcf-1	NN	nsubj	B-protein
also	RB	advmod	O
becomes	VBZ	ccomp	O
transcriptionally	RB	advmod	O
active	JJ	xcomp	O
through	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
beta-catenin	NN	nmod	B-protein
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
Wnt	NN	compound	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nsubj	O
is	VBZ	cop	O
operational	JJ	ccomp	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
as	RB	advmod	O
well	RB	mwe	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
further	RB	advmod	O
support	VBP	ROOT	O
the	DT	det	O
concept	NN	dobj	O
that	IN	mark	O
NLPHD	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
histogenetically	RB	advmod	O
distinct	JJ	amod	O
,	,	punct	O
B-cell-derived	JJ	amod	O
subtype	NN	ccomp	O
of	IN	case	O
HD	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
BCL-6	NN	nmod	B-protein
in	IN	case	O
its	PRP$	nmod:poss	O
development	NN	nmod	O
.	.	punct	O

The	DT	det	O
proband	NN	nsubj	O
had	VBD	ROOT	O
no	DT	neg	O
detectable	JJ	amod	O
DPD	NN	compound	B-protein
activity	NN	dobj	O
.	.	punct	O

Kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	compound	I-protein
proteins	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
constitutively	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
an	DT	det	O
IL-2	NN	compound	B-cell_line
autocrine	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

These	DT	det	O
constructs	NNS	nsubjpass	O
were	VBD	auxpass	O
transfected	VBN	ROOT	O
into	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
,	,	punct	O
either	CC	appos	O
alone	RB	advmod	O
or	CC	cc	O
together	RB	advmod	O
,	,	punct	O
with	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
expression	NN	compound	O
vectors	NNS	nmod	O
.	.	punct	O

Under	IN	prep	O
these	DT	det	O
conditions	NNS	pobj	O
,	,	punct	O
etoposide	NN	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
biphasic	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
consisted	VBD	acl:relcl	O
in	IN	case	O
an	DT	det	O
early	JJ	amod	O
transient	JJ	amod	O
activation	NN	nmod	O
(	-LRB-	punct	O
from	IN	case	O
hours	NNS	dep	O
1	CD	nummod	O
to	TO	dep	O
6	CD	nummod	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
membrane-bound	JJ	amod	B-protein
enzyme	NN	nmod	I-protein
followed	VBN	acl	O
by	IN	case	O
a	DT	det	O
later	JJ	amod	O
activation	NN	nmod	O
(	-LRB-	punct	O
hour	NN	dep	O
48	CD	nummod	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
total	JJ	nmod	O
,	,	punct	O
membrane-bound	JJ	conj	B-protein
and	CC	cc	I-protein
cytosolic	JJ	conj	I-protein
enzyme	NN	dep	I-protein
.	.	punct	O

IL-10	NN	nsubj	B-protein
inhibits	VBZ	ROOT	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B/Rel	NN	compound	I-protein
nuclear	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
CD3-stimulated	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
peripheral	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
crux	NN	nsubj	O
of	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
is	VBZ	ROOT	O
how	WRB	advmod	O
the	DT	det	O
locus	NN	compound	B-DNA
control	NN	compound	I-DNA
region	NN	nsubj	I-DNA
communicates	VBZ	ccomp	O
with	IN	case	O
the	DT	det	O
gene-proximal	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

While	IN	mark	O
there	EX	expl	O
was	VBD	advcl	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nsubj	O
in	IN	case	O
plasma	NN	compound	O
cortisol	NN	compound	O
levels	NNS	nmod	O
in	IN	case	O
the	DT	det	O
depressed	JJ	amod	O
group	NN	nmod	O
,	,	punct	O
there	EX	expl	O
were	VBD	ROOT	O
no	DT	neg	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
lymphocyte	NN	compound	O
GR	NN	compound	B-protein
binding	NN	compound	O
parameters	NNS	nmod	O
(	-LRB-	punct	O
K	NN	appos	O
(	-LRB-	punct	O
m	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
Bmax	NN	conj	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
first	JJ	amod	O
male	JJ	amod	O
patient	NN	nmod	O
,	,	punct	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
receptors	NNS	nmod	O
was	VBD	cop	O
very	RB	advmod	O
low	JJ	ROOT	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
affinity	NN	nsubj	O
was	VBD	cop	O
lower	JJR	advcl	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

On	IN	case	O
this	DT	det	O
basis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
all-trans	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nmod	O
(	-LRB-	punct	O
ATRA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
isomer	NN	compound	O
9-cis	JJ	amod	O
RA	NN	conj	O
in	IN	case	O
FL	NN	compound	O
hematopoiesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
presented	VBN	acl	O
here	RB	advmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
12-lipoxygenase	NN	compound	B-protein
activity	NN	nsubjpass	O
of	IN	case	O
murine	JJ	amod	O
macrophages	NNS	nmod	O
is	VBZ	auxpass	O
upregulated	VBN	ccomp	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	case	O
IL-4	NN	nmod	B-protein
and/or	CC	cc	O
IL-13	NN	conj	B-protein
,	,	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
this	DT	det	O
upregulation	NN	nsubj	O
requires	VBZ	advcl	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
STAT6	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
constitutive	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
enzyme	NN	nmod	O
appears	VBZ	conj	O
to	TO	mark	O
be	VB	cop	O
STAT6	NN	nmod:npmod	B-protein
independent	JJ	xcomp	O
.	.	punct	O

Tip	NN	nsubj	O
of	IN	case	O
herpesvirus	NN	compound	O
saimiri	NN	nmod	O
associates	VBZ	ROOT	O
with	IN	case	O
Lck	NN	nmod	B-protein
and	CC	cc	O
down-regulates	VBZ	conj	O
Lck	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
activation	NN	dobj	O
.	.	punct	O

Large	JJ	amod	O
germline	NN	compound	O
deletions	NNS	nsubj	O
of	IN	case	O
TSC2	NN	nmod	B-DNA
occur	VBP	ROOT	O
in	IN	case	O
<	$	nmod	O
5	CD	nummod	O
%	NN	dep	O
of	IN	case	O
cases	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
small	JJ	amod	O
intragenic	JJ	amod	O
mutations	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
monocyte/B-cell-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
PU.1	NN	nsubj	B-protein
and	CC	cc	O
the	DT	det	O
Mono	NN	compound	B-protein
A	NN	conj	I-protein
and	CC	cc	I-protein
Mono	NN	compound	I-protein
B	NN	compound	I-protein
protein	NN	compound	I-protein
complexes	NNS	conj	I-protein
act	VBP	ccomp	O
in	IN	case	O
concert	NN	dep	O
to	TO	mark	O
regulate	VB	xcomp	O
monocyte-specific	JJ	amod	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
CSF-1	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

CIITA	NN	nsubj	B-DNA
is	VBZ	cop	O
a	DT	det	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
gene	NN	compound	I-DNA
transactivator	NN	ROOT	I-DNA
known	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
defective	JJ	xcomp	O
in	IN	case	O
one	CD	nummod	O
form	NN	nmod	O
of	IN	case	O
BLS	NN	nmod	O
and	CC	cc	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	conj	O
for	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
MHC	NN	compound	B-protein
class	NN	nmod	I-protein
II	CD	nummod	I-protein
by	IN	case	O
IFN-gamma	NN	nmod	B-protein
.	.	punct	O

Enhanced	VBN	amod	O
responsiveness	NN	nsubj	O
to	TO	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
contributes	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
unique	JJ	amod	O
phenotype	NN	nmod	O
of	IN	case	O
simian	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
variant	JJ	amod	O
SIVsmmPBj14	NN	nmod	O
.	.	punct	O

Transfection	NN	nsubj	O
of	IN	case	O
an	DT	det	O
AP-2	NN	compound	B-DNA
expression	NN	compound	I-DNA
construct	NN	nmod	I-DNA
into	IN	case	O
T-lymphocytes	NNS	nmod	B-cell_type
activated	VBD	ROOT	O
gene	NN	compound	O
expression	NN	dobj	O
from	IN	case	O
the	DT	det	O
HTLV-I	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	compound	I-protein
(	-LRB-	punct	O
mAb	NN	appos	B-protein
)	-RRB-	punct	O
J393	NN	nsubj	B-protein
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T-cells	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
forced	JJ	amod	O
exogenous	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
four	CD	nummod	O
different	JJ	amod	O
isoforms	NNS	nmod	O
of	IN	case	O
WT1	NN	nmod	B-DNA
in	IN	case	O
K562	NN	nmod	B-cell_line
does	VBZ	aux	O
not	RB	neg	O
affect	VB	ccomp	O
the	DT	det	O
differentiation	NN	compound	O
response	NN	dobj	O
,	,	punct	O
as	IN	mark	O
judged	VBN	advcl	O
by	IN	case	O
accumulation	NN	nmod	O
of	IN	case	O
hemoglobin	NN	nmod	B-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
hemin	NN	nmod	B-protein
or	CC	cc	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
megakaryocytic	JJ	amod	B-protein
cell	NN	compound	I-protein
surface	NN	compound	I-protein
markers	NNS	nmod	I-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
12-O-tetradecanoylphorbol-13-acetate	NN	nmod	O
(	-LRB-	punct	O
TPA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Galectin-3	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
beta-galactoside-binding	JJ	amod	B-protein
lectin	NN	ROOT	I-protein
previously	RB	advmod	O
designated	VBN	acl	O
as	IN	case	O
epsilon	NN	compound	B-protein
BP	NN	nmod	I-protein
(	-LRB-	punct	O
IgE-binding	JJ	amod	B-protein
protein	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
CBP35	NN	conj	B-protein
,	,	punct	O
Mac-2	NN	conj	B-protein
,	,	punct	O
L-29	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
L-34	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	conj	O
with	IN	case	O
various	JJ	amod	O
physiological	JJ	nmod	O
and	CC	cc	O
pathological	JJ	conj	O
processes	NNS	dep	O
,	,	punct	O
including	VBG	case	O
cell	NN	compound	O
growth	NN	nmod	O
,	,	punct	O
tumor	NN	compound	O
transformation	NN	conj	O
,	,	punct	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

This	DT	det	O
putative	JJ	amod	O
human	JJ	amod	B-DNA
IL-2rE	NN	nsubj	I-DNA
,	,	punct	O
designated	VBN	acl	O
PRRIII	NN	xcomp	B-DNA
,	,	punct	O
confers	VBZ	ROOT	O
IL-2	NN	compound	B-protein
responsiveness	NN	dobj	O
on	IN	case	O
a	DT	det	O
heterologous	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
analysed	VBD	ROOT	O
IL-2	NN	compound	B-protein
production	NN	dobj	O
in	IN	case	O
purified	VBN	amod	O
neonatal	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
adult	JJ	conj	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
using	VBG	acl	O
polyclonal	JJ	amod	O
activator	NN	compound	O
phorbol	NN	compound	O
ester	NN	dobj	O
+	CC	cc	O
calcium	NN	compound	O
ionophore	NN	conj	O
(	-LRB-	punct	O
PDBu	NN	dep	O
+	CC	cc	O
iono	NN	conj	O
)	-RRB-	punct	O
or	CC	cc	O
receptor-mediated	JJ	amod	O
anti-CD3	JJ	amod	B-protein
/anti-CD3+	:	amod	O
anti-CD28	JJ	amod	B-protein
stimulation	NN	conj	O
.	.	punct	O

The	DT	det	O
element	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
activated	VBN	ROOT	O
upon	IN	case	O
infection	NN	nmod	O
of	IN	case	O
established	JJ	amod	O
EBV-negative	JJ	amod	B-cell_line
B-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
EBV	NN	nsubj	O
fails	VBZ	ccomp	O
to	TO	mark	O
drive	VB	xcomp	O
these	DT	det	O
cells	NNS	dobj	O
to	TO	case	O
a	DT	det	O
fully	RB	advmod	O
lymphoblastoid	JJ	amod	B-cell_type
phenotype	NN	nmod	I-cell_type
.	.	punct	O

Cotransfection	NN	compound	O
experiments	NNS	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
hGATA-4	NN	compound	B-protein
and	CC	cc	O
PMA/A23187	NN	conj	O
stimulation	NN	nsubj	O
are	VBP	cop	O
necessary	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
IL-5	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activation	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
thus	RB	advmod	O
reveal	VBP	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
a	DT	det	O
second	JJ	amod	O
inducible	JJ	amod	O
autoregulated	JJ	amod	O
inhibitory	JJ	amod	O
pathway	NN	nmod	O
that	WDT	nsubj	O
helps	VBZ	acl:relcl	O
ensure	VB	conj	O
the	DT	det	O
rapid	JJ	amod	O
but	CC	cc	O
transient	JJ	conj	O
action	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

To	TO	aux	O
help	VB	advcl	O
elucidate	VB	xcomp	O
further	RB	advmod	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
ZAP-70	NN	nsubj	B-protein
regulates	VBZ	acl:relcl	O
these	DT	det	O
initial	JJ	amod	O
events	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
dominant-negative	JJ	amod	O
mutant	JJ	amod	O
approach	NN	dobj	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
identified	VBD	ROOT	O
5	CD	nummod	O
protein	NN	compound	B-DNA
binding	NN	compound	I-DNA
regions	NNS	dobj	I-DNA
(	-LRB-	punct	O
BRs	NNS	appos	B-DNA
)	-RRB-	punct	O
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
hIL-5	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Sialoadhesin	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
macrophage-restricted	JJ	amod	B-protein
member	NN	ROOT	I-protein
of	IN	case	O
the	DT	det	O
Ig	NN	compound	B-protein
superfamily	NN	nmod	I-protein
that	WDT	nsubj	O
mediates	VBZ	acl:relcl	O
adhesion	NN	dobj	O
with	IN	case	O
lymphoid	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
myeloid	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

The	DT	det	O
resultant	JJ	amod	O
primer	NN	compound	B-DNA
products	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
analysed	VBN	ROOT	O
by	IN	case	O
denaturing	VBG	amod	O
polyacrylamide	NN	compound	O
gel	NN	compound	O
electrophoresis	NN	nmod	O
and	CC	cc	O
autoradiography	NN	conj	O
.	.	punct	O

OCA-B	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
functional	JJ	amod	O
analog	NN	ROOT	O
of	IN	case	O
VP16	NN	nmod	B-protein
but	CC	cc	O
targets	VBZ	conj	O
a	DT	det	O
separate	JJ	amod	O
surface	NN	dobj	O
of	IN	case	O
the	DT	det	O
Oct-1	NN	compound	B-protein
POU	NN	compound	I-protein
domain	NN	nmod	I-protein
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	dep	O
in	IN	case	O
Mol	NNP	compound	O
Cell	NNP	compound	O
Biol	NNP	compound	O
1998	CD	nummod	O
Apr	NNP	nmod	O
;	:	punct	O
18	CD	nummod	O
(	-LRB-	punct	O
4	CD	dep	O
)	-RRB-	punct	O
:	:	punct	O
2430	CD	dep	O
]	-RRB-	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
AP-1	NN	dep	B-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
may	MD	aux	O
be	VB	cop	O
important	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
modulatory	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
cytokine	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
activated	VBN	amod	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Cortivazol	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
phenylpyrazolo	JJ	amod	O
glucocorticoid	NN	ROOT	O
of	IN	case	O
high	JJ	amod	O
potency	NN	nmod	O
and	CC	cc	O
unusual	JJ	amod	O
structure	NN	conj	O
.	.	punct	O

Overall	RB	advmod	O
therefore	RB	advmod	O
,	,	punct	O
exposure	NN	nsubj	O
to	TO	case	O
NSAIDs	NNS	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
profound	JJ	amod	O
switch	NN	nmod	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
with	IN	case	O
suppression	NN	nsubj	O
of	IN	case	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
macrophage	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
stress	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
HSF1	NN	conj	B-protein
appears	VBZ	parataxis	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
regulatory	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
these	DT	det	O
effects	NNS	nmod	O
.	.	punct	O

Problems	NNS	nsubjpass	O
of	IN	case	O
antihypertensive	JJ	amod	O
therapy	NN	nmod	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
and	CC	cc	O
the	DT	det	O
first	JJ	amod	O
results	NNS	nsubjpass	O
of	IN	case	O
a	DT	det	O
pilot	NN	compound	O
study	NN	nmod	O
with	IN	case	O
Urapidil	NN	nmod	O
are	VBP	auxpass	O
presented	VBN	conj	O
.	.	punct	O

It	PRP	nsubjpass	O
also	RB	advmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
that	IN	mark	O
suppression	NN	nsubj	O
of	IN	case	O
cytokine	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
by	IN	case	O
these	DT	det	O
agents	NNS	nmod	O
was	VBD	cop	O
independent	JJ	ccomp	O
of	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
CREB	NN	nmod	B-protein
inhibited	VBD	ROOT	O
GAL4	NN	compound	B-protein
-p65	NN	compound	O
(	-LRB-	punct	O
286-551	CD	appos	O
)	-RRB-	punct	O
-mediated	JJ	amod	O
transcription	NN	dobj	O
.	.	punct	O

Epstein-Barr	JJ	amod	O
viral	JJ	amod	O
latency	NN	nsubjpass	O
is	VBZ	auxpass	O
disrupted	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
immediate-early	JJ	amod	B-protein
BRLF1	NN	compound	I-protein
protein	NN	nmod	I-protein
through	IN	case	O
a	DT	det	O
cell-specific	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
many	JJ	amod	O
second	JJ	amod	O
messengers	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
necessary	JJ	xcomp	O
and	CC	cc	O
sufficient	JJ	conj	O
for	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
model	NN	compound	O
systems	NNS	nmod	O
,	,	punct	O
the	DT	det	O
rate-limiting	JJ	amod	O
step	NN	nsubjpass	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
functional	JJ	amod	O
synergy	NN	nsubjpass	O
between	IN	case	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
IL-12	NN	conj	B-protein
is	VBZ	auxpass	O
also	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
prominent	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
STAT1	NN	compound	B-protein
and	CC	cc	O
STAT3	NN	conj	B-protein
serine	NN	compound	O
phosphorylation	NN	nmod	O
over	IN	case	O
that	DT	nmod	O
observed	VBN	acl	O
with	IN	case	O
IL-12	NN	nmod	B-protein
or	CC	cc	O
IL-2	NN	conj	B-protein
alone	RB	advmod	O
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
androgen	NN	compound	I-DNA
receptor	NN	compound	I-DNA
gene	NN	dep	I-DNA
(	-LRB-	punct	O
HUMARA	NN	appos	B-DNA
)	-RRB-	punct	O
assay	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
newest	JJS	ROOT	O
of	IN	case	O
such	JJ	amod	O
methods	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
majority	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
female	JJ	amod	O
population	NN	nmod	O
can	MD	aux	O
be	VB	auxpass	O
assessed	VBN	conj	O
by	IN	case	O
this	DT	det	O
relatively	RB	advmod	O
simple	JJ	amod	O
procedure	NN	nmod	O
.	.	punct	O

Aldosterone	NN	nsubj	O
displaced	VBD	ROOT	O
the	DT	det	O
tracer	NN	dobj	O
at	IN	case	O
a	DT	det	O
similar	JJ	amod	O
Kd	NN	nmod	O
.	.	punct	O

GATA-1	NN	nsubj	B-protein
and	CC	cc	O
erythropoietin	NN	conj	B-protein
cooperate	VBP	ROOT	O
to	TO	mark	O
promote	VB	xcomp	O
erythroid	JJ	amod	O
cell	NN	compound	O
survival	NN	dobj	O
by	IN	mark	O
regulating	VBG	advcl	O
bcl-xL	NN	compound	B-protein
expression	NN	dobj	O
.	.	punct	O

TRAF2	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
signal	NN	compound	B-protein
transducing	NN	compound	I-protein
adaptor	NN	compound	I-protein
molecule	NN	ROOT	I-protein
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
CD40	NN	compound	B-protein
cytoplasmic	JJ	amod	I-protein
domain	NN	nmod	I-protein
.	.	punct	O

First	RB	advmod	O
,	,	punct	O
STAT4	NN	nsubjpass	B-protein
was	VBD	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
IL-12	NN	compound	B-protein
-dependent	JJ	amod	O
transactivation	NN	nmod	O
of	IN	case	O
an	DT	det	O
IRF-1	NN	compound	B-DNA
reporter	NN	compound	I-DNA
construct	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
second	RB	conj	O
,	,	punct	O
STAT4	NN	nsubjpass	B-protein
binding	VBG	acl	O
to	TO	case	O
the	DT	det	O
IRF-1	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
was	VBD	auxpass	O
shown	VBN	parataxis	O
using	VBG	xcomp	O
EMSA	NN	dobj	O
.	.	punct	O

The	DT	det	O
absence	NN	nsubjpass	O
of	IN	case	O
GATA-3	NN	nmod	B-protein
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
in	IN	case	O
H-RS	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
in	IN	case	O
tissues	NNS	nmod	O
by	IN	case	O
an	DT	det	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
technique	NN	nmod	O
.	.	punct	O

The	DT	det	O
ligand-binding	JJ	amod	B-protein
domain	NN	nsubj	I-protein
(	-LRB-	punct	O
amino	NN	compound	B-protein
acids	NNS	appos	I-protein
528-777	CD	nummod	I-protein
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
squirrel	NN	compound	O
monkey	NN	compound	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
contains	VBZ	ROOT	O
four	CD	nummod	O
amino	NN	compound	O
acid	NN	compound	O
differences	NNS	dobj	O
(	-LRB-	punct	O
Ser551	NN	dep	O
to	TO	case	O
Thr	NN	nmod	O
,	,	punct	O
Ser616	NN	appos	O
to	TO	case	O
Ala	NN	nmod	O
,	,	punct	O
Ala618	NN	appos	O
to	TO	case	O
Ser	NN	nmod	O
,	,	punct	O
and	CC	cc	O
Ile761	NN	conj	O
to	TO	case	O
Leu	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
all	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	cop	O
present	JJ	acl:relcl	O
in	IN	case	O
owl	JJ	amod	B-protein
monkey	NN	compound	I-protein
and	CC	cc	I-protein
cotton-top	NN	conj	I-protein
tamarin	NN	compound	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
(	-LRB-	punct	O
EMSA	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
a	DT	det	O
43-mer	JJ	amod	B-DNA
oligonucleotide	NN	nmod	I-DNA
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
functionally	RB	advmod	O
identified	VBN	amod	O
cis-acting	JJ	amod	B-DNA
element	NN	nmod	I-DNA
revealed	VBD	ROOT	O
specific	JJ	amod	O
complexes	NNS	dobj	O
.	.	punct	O

Three	CD	nummod	O
overlapping	VBG	amod	O
PCR	NN	compound	B-DNA
products	NNS	nsubjpass	I-DNA
,	,	punct	O
covering	VBG	acl	O
the	DT	det	O
complete	JJ	amod	O
coding	VBG	amod	O
sequence	NN	dobj	O
of	IN	case	O
mRNA	NN	nmod	B-RNA
,	,	punct	O
were	VBD	auxpass	O
generated	VBN	ROOT	O
from	IN	case	O
lymphoblastoid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
translated	VBN	acl	O
into	IN	case	O
35S-methionine	NN	compound	B-protein
labelled	JJ	amod	I-protein
protein	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
analysed	VBN	conj	O
by	IN	case	O
SDS-PAGE	NN	nmod	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
E1A	NN	compound	B-protein
gene	NN	compound	I-protein
products	NNS	nmod	I-protein
inhibited	VBD	ROOT	O
IFN	NN	compound	B-protein
-MCP	CD	dobj	O
independently	RB	advmod	O
of	IN	case	O
virus	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
TRAF2	NN	nmod	B-protein
inhibits	VBZ	ROOT	O
binding	NN	dobj	O
to	TO	case	O
the	DT	det	O
CD40	NN	compound	B-protein
cytoplasmic	JJ	amod	I-protein
domain	NN	nmod	I-protein
.	.	punct	O

Anoxia/reoxygenation-induced	JJ	amod	O
tolerance	NN	ROOT	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
polymorphonuclear	JJ	amod	O
leukocyte	NN	compound	O
adhesion	NN	nmod	O
to	TO	case	O
cultured	VBN	amod	B-cell_line
endothelial	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
B	NN	compound	B-protein
cell-associated	VBD	amod	I-protein
surface	NN	compound	I-protein
molecule	NN	nsubj	I-protein
CD40	NN	nsubj	I-protein
functions	VBZ	ROOT	O
to	TO	mark	O
regulate	VB	xcomp	O
B	NN	compound	O
cell	NN	compound	O
responses	NNS	dobj	O
.	.	punct	O

Tissue	NN	compound	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
TF	NN	appos	O
)	-RRB-	punct	O
expression	NN	nsubj	O
by	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
during	IN	case	O
sepsis	NN	nmod	O
initiates	VBZ	ROOT	O
intravascular	JJ	amod	O
thrombosis	NN	dobj	O
.	.	punct	O

TNF	NN	nsubj	B-protein
stimulated	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
and	CC	cc	O
E-selectin	NN	conj	B-protein
in	IN	case	O
HUVECs	NNS	nmod	B-cell_type
,	,	punct	O
but	CC	cc	O
in	IN	case	O
HUAECs	NNS	nmod	B-cell_type
,	,	punct	O
only	RB	advmod	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nsubjpass	I-protein
was	VBD	auxpass	O
increased	VBN	conj	O
.	.	punct	O

NFATc	NN	nsubj	B-protein
overcame	VBD	ROOT	O
a	DT	det	O
blockade	NN	dobj	O
at	IN	case	O
reverse	JJ	amod	O
transcription	NN	nmod	O
and	CC	cc	O
permitted	VBD	conj	O
active	JJ	amod	O
HIV-1	NN	compound	O
replication	NN	dobj	O
.	.	punct	O

MBP	NN	nsubj	B-protein
stimulated	VBD	ROOT	O
2-fold	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
IL-8	NN	compound	B-RNA
messenger	NN	compound	I-RNA
RNA	NN	nmod	I-RNA
(	-LRB-	punct	O
mRNA	NN	appos	B-RNA
)	-RRB-	punct	O
after	IN	case	O
1	CD	nummod	O
and	CC	cc	O
3	CD	conj	O
h	NN	nmod	O
of	IN	case	O
incubation	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
blocked	VBN	acl:relcl	O
by	IN	case	O
pretreatment	NN	nmod	O
with	IN	case	O
actinomycin	NN	compound	O
D	NN	nmod	O
.	.	punct	O

While	IN	mark	O
dexamethasone	NN	nsubj	O
(	-LRB-	punct	O
0.1	CD	nummod	O
nmol/L	NN	dep	O
to	TO	case	O
100	CD	nummod	O
mumol/L	NN	nmod	O
)	-RRB-	punct	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	advcl	O
expression	NN	dobj	O
of	IN	case	O
adhesion	NN	compound	B-protein
molecules	NNS	nmod	I-protein
on	IN	case	O
resting	VBG	amod	B-cell_type
neutrophils	NNS	nmod	I-cell_type
,	,	punct	O
it	PRP	nsubj	O
attenuated	VBD	ROOT	O
the	DT	det	O
PAF	NN	compound	B-protein
-induced	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
L-selectin	NN	nmod	B-protein
and	CC	cc	O
CD18	NN	conj	B-protein
expression	NN	dep	O
in	IN	case	O
a	DT	det	O
time-	NN	amod	O
and	CC	cc	O
concentration-dependent	JJ	conj	O
fashion	NN	nmod	O
with	IN	case	O
IC50	NN	compound	O
values	NNS	nmod	O
of	IN	case	O
31	CD	nummod	O
and	CC	cc	O
13	CD	conj	O
nmol/L	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
Id3	NN	nsubj	B-protein
impedes	VBZ	ROOT	O
expression	NN	dobj	O
of	IN	case	O
recombination	NN	compound	O
activating	NN	compound	O
genes	NNS	nmod	O
and	CC	cc	O
downregulates	VBZ	conj	O
pre-Talpha	JJ	amod	B-RNA
mRNA	NN	dobj	I-RNA
.	.	punct	O

The	DT	det	O
mapping	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cis-acting	JJ	amod	B-DNA
genetic	JJ	amod	I-DNA
cis-acting	JJ	amod	I-DNA
segment	NN	nmod	I-DNA
(	-LRB-	punct	O
oriP	NN	appos	B-DNA
)	-RRB-	punct	O
required	VBN	acl	O
for	IN	case	O
viral	JJ	amod	O
episomal	JJ	amod	O
maintenance	NN	nmod	O
is	VBZ	auxpass	O
reported	VBN	ROOT	O
here	RB	advmod	O
.	.	punct	O

Low	JJ	amod	O
dose	NN	compound	O
dexamethasone	NN	compound	O
therapy	NN	nsubj	O
(	-LRB-	punct	O
1-1.5	CD	nummod	O
mg/day	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
of	IN	case	O
clinical	JJ	amod	O
benefit	NN	ROOT	O
in	IN	case	O
these	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

Circadian	JJ	amod	O
rhythm	NN	nsubjpass	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
rat	NN	compound	B-cell_type
liver	NN	nmod	I-cell_type
and	CC	cc	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
leukocytes	NNS	conj	I-cell_type
.	.	punct	O

HIV-1	NN	compound	B-DNA
proviral	JJ	amod	I-DNA
DNA	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
two	CD	nummod	O
binding	VBG	amod	B-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
this	DT	det	O
latently	RB	advmod	O
infected	JJ	amod	O
cell	NN	compound	O
line	NN	nsubj	O
with	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
at	IN	case	O
42	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
for	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
resulted	VBD	ccomp	O
in	IN	case	O
a	DT	det	O
high	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
production	NN	nmod	O
without	IN	case	O
addition	NN	nmod	O
of	IN	case	O
any	DT	det	O
cytokines	NNS	nmod	B-protein
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
antiviral	JJ	amod	O
action	NN	nmod	O
of	IN	case	O
S9a	NN	nmod	O
was	VBD	cop	O
on	IN	case	O
the	DT	det	O
host	NN	compound	O
cell	NN	ccomp	O
,	,	punct	O
by	IN	mark	O
blocking	VBG	advcl	O
TNF-alpha	NN	compound	B-protein
transcription	NN	dobj	O
via	IN	case	O
a	DT	det	O
Tat	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
tar-independent	JJ	amod	O
loop	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
decreases	VBZ	acl:relcl	O
downstream	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	dobj	O
of	IN	case	O
HIV-1	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
.	.	punct	O

Resistance	NN	nsubj	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
implies	VBZ	ROOT	O
a	DT	det	O
complex	JJ	amod	O
change	NN	dobj	O
in	IN	case	O
immune-endocrine	JJ	amod	O
function	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
important	JJ	acl:relcl	O
in	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	case	O
immunodeficiency	NN	compound	O
syndrome	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
transcription	NN	compound	O
factor	NN	ROOT	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
consensus	NN	compound	B-DNA
DNA	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
cis-acting	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
of	IN	case	O
various	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
M-CSF	NN	nsubj	B-protein
activates	VBZ	ccomp	O
and	CC	cc	O
translocates	VBZ	conj	O
PKC	NN	dobj	B-protein
.	.	punct	O

Tat	NN	nsubj	B-protein
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
activator	NN	appos	O
of	IN	case	O
HIV-1	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
serves	VBZ	ROOT	O
to	TO	mark	O
greatly	RB	advmod	O
increase	VB	xcomp	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
transcription	NN	nmod	O
directed	VBN	acl	O
by	IN	case	O
the	DT	det	O
viral	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Communication	NN	nsubj	O
between	IN	case	O
resident	JJ	amod	O
tissue	NN	compound	O
fibroblasts	NNS	nmod	B-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
is	VBZ	cop	O
necessary	JJ	ROOT	O
for	IN	case	O
normal	JJ	amod	O
wound	NN	compound	O
healing	NN	nmod	O
,	,	punct	O
and	CC	cc	O
can	MD	aux	O
be	VB	cop	O
pathologic	JJ	conj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
tissue	NN	compound	O
fibrosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
the	DT	det	O
utility	NN	dobj	O
of	IN	case	O
this	DT	det	O
FISH	NN	compound	O
technique	NN	nmod	O
for	IN	case	O
a	DT	det	O
better	JJR	amod	O
definition	NN	nmod	O
of	IN	case	O
the	DT	det	O
biological	JJ	amod	O
characteristics	NNS	nmod	O
of	IN	case	O
ductal	JJ	amod	O
carcinomas	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
AML1/ETO	NN	nsubj	B-protein
can	MD	aux	O
also	RB	advmod	O
synergize	VB	ROOT	O
with	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AML1	NN	nmod	B-protein
to	TO	mark	O
enhance	VB	xcomp	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
M-CSF	NN	compound	B-DNA
receptor	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Previously	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
(	-LRB-	punct	O
W.Q.	NNP	compound	O
Jiang	NNP	dobj	O
,	,	punct	O
L.Szekely	NNP	appos	O
,	,	punct	O
V.Wendel-Hansen	NNP	conj	O
,	,	punct	O
N.Ringertz	NNP	conj	O
,	,	punct	O
G.Klein	NNP	conj	O
,	,	punct	O
and	CC	cc	O
A.	NNP	compound	O
Rosen	NNP	conj	O
,	,	punct	O
Exp.Cell	NNP	compound	O
Res	NNP	appos	O
.	.	punct	O

Lipopolysaccharide	NN	compound	O
induction	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-DNA
necrosis	NN	compound	I-DNA
factor-alpha	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Detection	NN	nsubjpass	O
of	IN	case	O
various	JJ	amod	O
other	JJ	amod	O
intracellular	JJ	amod	B-protein
signaling	NN	compound	I-protein
proteins	NNS	nmod	I-protein
is	VBZ	auxpass	O
also	RB	advmod	O
described	VBN	ROOT	O
.	.	punct	O

Immortalization	NN	ROOT	O
of	IN	case	O
CD4	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
and	CC	cc	I-cell_type
CD8	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	conj	I-cell_type
by	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
Tax	NN	compound	B-protein
mutants	NNS	nmod	I-protein
expressed	VBN	acl	O
in	IN	case	O
a	DT	det	O
functional	JJ	amod	B-cell_line
molecular	JJ	amod	I-cell_line
clone	NN	nmod	I-cell_line
.	.	punct	O

Calcineurin	NN	nsubj	B-protein
acts	VBZ	ROOT	O
in	IN	case	O
synergy	NN	nmod	O
with	IN	case	O
PMA	NN	nmod	O
to	TO	mark	O
inactivate	VB	xcomp	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B/MAD3	NN	dobj	I-protein
,	,	punct	O
an	DT	det	O
inhibitor	NN	appos	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
HVS	NN	compound	O
STP-C488	NN	compound	B-protein
P10	NN	nsubj	O
--	:	punct	O
>	NN	amod	O
R	NN	compound	O
mutant	NN	nsubj	O
was	VBD	cop	O
deficient	JJ	ROOT	O
in	IN	case	O
human	JJ	amod	O
T-lymphocyte	NN	compound	O
transformation	NN	nmod	O
to	TO	case	O
interleukin-2-independent	JJ	amod	O
growth	NN	nmod	O
but	CC	cc	O
showed	VBD	conj	O
wild-type	JJ	amod	O
phenotype	NN	dobj	O
for	IN	case	O
marmoset	NN	compound	O
T-lymphocyte	NN	compound	O
transformation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

This	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
could	MD	aux	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
differences	NNS	ROOT	O
in	IN	case	O
cell	NN	compound	O
surface	NN	nmod	O
(	-LRB-	punct	O
UT-7	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
are	VBP	cop	O
20	CD	nummod	O
%	NN	nmod:npmod	O
smaller	JJR	conj	O
than	IN	case	O
the	DT	det	O
parental	JJ	amod	O
UT-7	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
)	-RRB-	punct	O
or	CC	cc	O
in	IN	case	O
receptor	NN	compound	O
turnover	NN	conj	O
.	.	punct	O

The	DT	det	O
son	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
unaffected	JJ	amod	O
twin	NN	compound	O
sister	NN	nmod	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
hemizygous	JJ	xcomp	O
.	.	punct	O

A	DT	det	O
21.4-kb	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
clone	NN	nsubj	I-DNA
,	,	punct	O
pZVB70	NN	appos	B-DNA
,	,	punct	O
showed	VBD	ROOT	O
the	DT	det	O
highest	JJS	amod	O
transactivating	NN	compound	O
ability	NN	dobj	O
,	,	punct	O
while	IN	mark	O
two	CD	nummod	O
other	JJ	amod	O
DNA	NN	compound	B-DNA
fragments	NNS	nsubj	I-DNA
,	,	punct	O
pZVB10	NN	appos	B-DNA
(	-LRB-	punct	O
6.2	CD	nummod	O
kb	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
pZVH14	NN	conj	B-DNA
(	-LRB-	punct	O
8.7	CD	nummod	O
kb	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
showed	VBD	advcl	O
lower	JJR	amod	O
activity	NN	dobj	O
.	.	punct	O

Interphase	NN	compound	O
fluorescence	NN	compound	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nsubjpass	O
(	-LRB-	punct	O
FISH	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
with	IN	case	O
2	CD	nummod	O
YACs	NNS	nmod	B-DNA
flanking	VBG	acl	O
the	DT	det	O
CALM	NN	compound	B-DNA
region	NN	dobj	I-DNA
,	,	punct	O
a	DT	det	O
YAC	NN	compound	B-DNA
contig	NN	appos	I-DNA
of	IN	case	O
the	DT	det	O
MLL	NN	compound	B-DNA
region	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
a	DT	det	O
YAC	NN	conj	B-DNA
spanning	VBG	acl	O
the	DT	det	O
AF10	NN	compound	B-DNA
breakpoint	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
Bcl-2	NN	compound	B-protein
overexpression	NN	nsubj	O
leads	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
prevention	NN	nmod	O
of	IN	case	O
chemotherapy	NN	compound	O
(	-LRB-	punct	O
paclitaxel	NN	appos	O
)	-RRB-	punct	O
-induced	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
FasL	NN	nmod	B-protein
and	CC	cc	O
blocks	VBZ	conj	O
paclitaxel-induced	JJ	amod	O
apoptosis	NN	dobj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
raised	VBN	dep	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
could	MD	aux	O
diminish	VB	ccomp	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	mark	O
direct	VB	acl	O
leukocyte	NN	compound	O
traffic	NN	dobj	O
into	IN	case	O
inflamed	JJ	amod	O
tissues	NNS	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	B-protein
molecules	NNS	nmod	I-protein
endothelial-leukocyte	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	dep	I-protein
and	CC	cc	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
contribution	NN	dobj	O
of	IN	case	O
BRCA1	NN	compound	B-DNA
and	CC	cc	O
BRCA2	NN	conj	B-DNA
mutations	NNS	nmod	O
to	TO	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
male	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
in	IN	case	O
Hungary	NNP	nmod	O
,	,	punct	O
the	DT	det	O
country	NN	nsubjpass	O
with	IN	prep	O
the	DT	det	O
highest	JJS	amod	O
male	JJ	amod	O
breast	NN	compound	O
cancer	NN	compound	O
mortality	NN	compound	O
rates	NNS	pobj	O
in	IN	prep	O
continental	JJ	amod	O
Europe	NNP	pobj	O
,	,	punct	O
a	DT	det	O
series	NN	nsubjpass	O
of	IN	case	O
18	CD	nummod	O
male	JJ	amod	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
three	CD	nummod	O
patients	NNS	conj	O
with	IN	case	O
gynecomastia	NN	nmod	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
for	IN	case	O
germ-line	NN	compound	O
mutations	NNS	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
BRCA1	NN	nmod	B-DNA
and	CC	cc	O
BRCA2	NN	conj	B-DNA
.	.	punct	O

Bcl6	NN	compound	O
mutation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
13	CD	compound	O
of	IN	advmod	O
24	CD	nummod	O
(	-LRB-	punct	O
54	CD	nummod	O
%	NN	intj	O
)	-RRB-	punct	O
clones	NNS	nmod	O
from	IN	case	O
the	DT	det	O
germinal	JJ	amod	O
centre	NN	nmod	O
but	CC	cc	O
only	RB	advmod	O
in	IN	case	O
1	CD	compound	O
of	IN	advmod	O
24	CD	nummod	O
(	-LRB-	punct	O
4	CD	nummod	O
%	NN	intj	O
)	-RRB-	punct	O
clones	NNS	conj	O
from	IN	case	O
the	DT	det	O
naive	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
the	DT	det	O
mantle	NN	compound	O
zone	NN	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
Ad2	NN	nsubjpass	O
was	VBD	auxpass	O
internalized	VBN	ROOT	O
by	IN	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
characterize	VBP	ROOT	O
which	WDT	mark	O
AP1	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	nsubj	I-protein
can	MD	aux	O
assume	VB	ccomp	O
this	DT	det	O
role	NN	dobj	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
Mycobacterium	NN	nmod:npmod	O
tuberculosis	FW	nmod:npmod	O
-induced	JJ	amod	O
interleukin-2	NN	compound	B-protein
receptor	NN	compound	I-protein
expression	NN	nmod	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
,	,	punct	O
by	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
DNase	NN	compound	B-protein
I	CD	nummod	I-protein
footprinting	NN	nmod	O
,	,	punct	O
that	IN	mark	O
the	DT	det	O
AIR-1	NN	compound	B-DNA
locus	NN	compound	I-DNA
defect	NN	nsubj	I-DNA
correlates	VBZ	ccomp	O
with	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
DRA	NN	compound	B-DNA
promoter	NN	compound	I-DNA
occupancy	NN	nmod	O
.	.	punct	O

Most	JJS	amod	O
B	NN	compound	B-cell_line
lymphocyte	NN	compound	I-cell_line
lines	NNS	nsubj	I-cell_line
expressed	VBD	ROOT	O
negligible	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
1	CD	nummod	B-RNA
,	,	punct	I-RNA
25	CD	conj	I-RNA
(	-LRB-	punct	I-RNA
OH	NN	appos	I-RNA
)	-RRB-	punct	I-RNA
2D3	NN	compound	I-RNA
receptor	NN	compound	I-RNA
RNA	NN	nmod	I-RNA
and	CC	cc	O
protein	NN	conj	O
;	:	punct	O
however	RB	advmod	O
;	:	punct	O
analysis	NN	nsubj	O
of	IN	case	O
a	DT	det	O
lymphoid/myeloid	JJ	amod	B-cell_line
somatic	JJ	amod	I-cell_line
hybrid	NN	nmod	I-cell_line
suggested	VBD	parataxis	O
that	IN	mark	O
suppression	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
1	CD	nummod	B-RNA
,	,	punct	I-RNA
25	CD	conj	I-RNA
(	-LRB-	punct	I-RNA
OH	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
2D3	NN	compound	I-RNA
receptor	NN	compound	I-RNA
RNA	NN	nmod	I-RNA
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
dominant	JJ	amod	O
characteristic	NN	ccomp	O
.	.	punct	O

Eosinophil	NN	compound	B-cell_type
priming	NN	ROOT	O
by	IN	case	O
cytokines	NNS	nmod	B-protein
:	:	punct	O
from	IN	case	O
cellular	JJ	amod	O
signal	NN	nmod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
modulation	NN	nmod	O
.	.	punct	O

That	IN	mark	O
the	DT	det	O
c-myb	NN	compound	B-protein
oncogene	NN	compound	I-protein
product	NN	nsubj	I-protein
can	MD	aux	O
interact	VB	advcl	O
synergistically	RB	advmod	O
with	IN	case	O
an	DT	det	O
EBV-encoded	JJ	amod	B-protein
member	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
leucine	NN	compound	B-protein
zipper	NN	compound	I-protein
protein	NN	compound	I-protein
family	NN	nmod	I-protein
suggests	VBZ	ROOT	O
c-myb	NN	nsubj	B-DNA
is	VBZ	cop	O
likely	JJ	ccomp	O
to	TO	mark	O
engage	VB	xcomp	O
in	IN	case	O
similar	JJ	amod	O
interactions	NNS	nmod	O
with	IN	case	O
cellularly	RB	advmod	B-protein
encoded	VBN	amod	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
ATRA-induced	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
IRF-1	NN	nmod	B-protein
,	,	punct	O
an	DT	det	O
activator	NN	appos	O
of	IN	case	O
transcription	NN	nmod	O
and	CC	cc	O
repressor	NN	conj	O
of	IN	case	O
transformation	NN	nmod	O
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
ATRA-induced	JJ	amod	O
growth	NN	compound	O
inhibition	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
basis	NN	conj	O
for	IN	case	O
the	DT	det	O
synergistic	JJ	amod	O
actions	NNS	nmod	O
of	IN	case	O
ATRA	NN	nmod	O
and	CC	cc	O
IFNs	NNS	conj	B-protein
in	IN	case	O
myeloid	JJ	amod	B-cell_line
leukemia	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

This	DT	det	O
region	NN	nsubj	O
contains	VBZ	ROOT	O
elements	NNS	dobj	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
shared	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-DNA
enhancers	NNS	nmod	I-DNA
of	IN	case	O
other	JJ	amod	O
genes	NNS	nmod	O
including	VBG	case	O
interferon	NN	compound	B-protein
regulatory	JJ	amod	I-protein
factor	NN	nmod	I-protein
1	CD	nummod	I-protein
,	,	punct	O
interferon	NN	compound	B-protein
beta	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
interferon-inducible	JJ	amod	B-DNA
genes	NNS	conj	I-DNA
.	.	punct	O

Serum	NN	compound	O
osteocalcin	NN	nsubj	B-protein
decreased	VBD	ROOT	O
significantly	RB	advmod	O
during	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
both	CC	cc:preconj	O
BUD	NN	nmod	O
and	CC	cc	O
FP	NN	conj	O
.	.	punct	O

The	DT	det	O
RanQ69L	NN	compound	B-protein
preincubation	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
accumulation	NN	nmod	O
of	IN	case	O
CRM1	NN	nmod	B-protein
at	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	O
periphery	NN	nmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
pore	NN	compound	I-protein
complex	NN	nmod	I-protein
(	-LRB-	punct	O
NPC	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
association	NN	nmod	O
with	IN	case	O
the	DT	det	O
p62	NN	compound	B-protein
complex	NN	nmod	I-protein
and	CC	cc	O
Can/Nup214	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
,	,	punct	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
TCL1	NN	nmod	B-protein
occurs	VBZ	ccomp	O
in	IN	case	O
leukaemic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
A-T	NN	compound	O
patients	NNS	nmod	O
with	IN	case	O
chromosome	NN	compound	B-DNA
14	CD	nummod	I-DNA
rearrangements	NNS	nmod	O
.	.	punct	O

Using	VBG	advcl	O
this	DT	det	O
technique	NN	dobj	O
we	PRP	nsubj	O
have	VBP	aux	O
isolated	VBN	ROOT	O
several	JJ	amod	O
differentially	RB	advmod	B-DNA
expressed	VBN	amod	I-DNA
sequence	NN	compound	I-DNA
tags	NNS	dobj	I-DNA
(	-LRB-	punct	O
DESTs	NNS	appos	B-DNA
)	-RRB-	punct	O
from	IN	case	O
the	DT	det	O
mouse	NN	compound	B-cell_line
thymocyte	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
WEHI	NN	dep	B-cell_line
7.2	CD	nummod	I-cell_line
.	.	punct	O

Cooperation	NN	nsubj	O
of	IN	case	O
Spi-1/PU.1	NN	nmod	B-protein
with	IN	case	O
an	DT	det	O
activated	VBN	amod	B-protein
erythropoietin	NN	compound	I-protein
receptor	NN	nmod	I-protein
inhibits	VBZ	ROOT	O
apoptosis	NN	dobj	O
and	CC	cc	O
Epo	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
differentiation	NN	conj	O
in	IN	case	O
primary	JJ	amod	B-cell_type
erythroblasts	NNS	nmod	I-cell_type
and	CC	cc	O
induces	VBZ	conj	O
their	PRP$	nmod:poss	O
Kit	NN	compound	O
ligand-dependent	JJ	amod	O
proliferation	NN	dobj	O
.	.	punct	O

Human	JJ	amod	B-cell_type
phagocytes	NNS	nsubj	I-cell_type
recognize	VBP	ROOT	O
bacterial	JJ	amod	O
LPS	NN	dobj	O
(	-LRB-	punct	O
endotoxin	NN	appos	O
)	-RRB-	punct	O
through	IN	case	O
membrane	NN	compound	B-protein
CD14	NN	nmod	I-protein
(	-LRB-	punct	O
mCD14	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
proinflammatory	JJ	amod	B-protein
LPS	NN	compound	I-protein
receptor	NN	appos	I-protein
.	.	punct	O

NAC	NN	nsubj	O
not	RB	neg	O
only	RB	cc:preconj	O
blocks	VBZ	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
TPCK	NN	nmod	O
but	CC	cc	O
enhances	VBZ	conj	O
mitogenesis	NN	dobj	O
and	CC	cc	O
cytokine	NN	compound	B-protein
production	NN	conj	O
(	-LRB-	punct	O
>	NN	dep	O
2.5-fold	RB	amod	O
in	IN	case	O
some	DT	det	O
cases	NNS	nmod	O
)	-RRB-	punct	O
upon	IN	case	O
activation	NN	nmod	O
of	IN	case	O
unsuppressed	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

It	PRP	nsubj	O
,	,	punct	O
thus	RB	advmod	O
,	,	punct	O
appears	VBZ	ROOT	O
as	IN	case	O
an	DT	det	O
integral	JJ	amod	B-protein
membrane	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
cooperation	NN	nsubjpass	O
among	IN	case	O
NF-kappa	NN	compound	B-DNA
B-	NN	nmod	I-DNA
,	,	punct	I-DNA
AP-1-	NN	conj	I-DNA
and	CC	cc	I-DNA
NF-AT-binding	JJ	conj	I-DNA
sequences	NNS	dep	I-DNA
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
through	IN	case	O
PKC-	NN	nmod	O
and	CC	cc	O
Ca2+-	NN	conj	O
signaling	NN	compound	O
pathways	NNS	dep	O
downstream	RB	amod	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
a	DT	det	O
constitutively	RB	advmod	O
active	JJ	amod	O
calcineurin	NN	nmod	B-protein
(	-LRB-	punct	O
CN	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
Ca2+/calmodulin-dependent	JJ	amod	B-protein
protein	NN	compound	I-protein
phosphatase	NN	appos	I-protein
,	,	punct	O
potentiated	VBD	acl	O
by	IN	case	O
two	CD	nummod	O
fold	NN	nmod	O
the	DT	det	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
by	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
/AP-1	NN	nmod	B-protein
.	.	punct	O

ISG15	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
accumulation	NN	nsubj	O
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	cop	O
not	RB	neg	O
detectable	JJ	ROOT	O
before	IN	case	O
6	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
IFN-alpha	NN	compound	B-protein
treatment	NN	nmod	O
,	,	punct	O
peaks	VBZ	conj	O
at	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
and	CC	cc	O
requires	VBZ	conj	O
protein	NN	compound	O
synthesis	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
CD40	NN	compound	B-protein
-mediated	JJ	amod	O
cell	NN	compound	O
survival	NN	nsubj	O
proceeds	VBZ	ccomp	O
through	IN	case	O
NF-kappaB	NN	compound	B-protein
-dependent	JJ	amod	O
up-regulation	NN	nmod	O
of	IN	case	O
Bcl-2	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	nmod	I-protein
.	.	punct	O

Despite	IN	case	O
their	PRP$	nmod:poss	O
bipotential	JJ	amod	O
capacity	NN	nmod	O
,	,	punct	O
these	DT	det	O
progenitors	NNS	nsubj	O
develop	VBP	ROOT	O
predominantly	RB	advmod	O
to	TO	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
expressed	VBD	ROOT	O
these	DT	det	O
factors	NNS	dobj	O
in	IN	case	O
S.	FW	compound	O
cerevisiae	FW	nmod	O
and	CC	cc	O
observed	VBD	conj	O
greater	JJR	amod	O
than	IN	dep	O
5-fold	JJ	dep	O
stimulation	NN	dobj	O
of	IN	case	O
a	DT	det	O
lacZ	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
only	RB	advmod	O
with	IN	case	O
Oct-2	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
membrane	NN	compound	B-protein
proximal	JJ	amod	I-protein
proline-rich	JJ	amod	I-protein
domain	NN	nsubj	I-protein
and	CC	cc	O
adjacent	JJ	amod	B-protein
16	CD	nummod	I-protein
residues	NNS	conj	I-protein
are	VBP	cop	O
essential	JJ	ccomp	O
for	IN	case	O
both	CC	det	O
hGM-CSF	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
cell	NN	nmod	O
proliferation	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
therefore	RB	advmod	O
reexamined	VBD	ROOT	O
this	DT	det	O
issue	NN	dobj	O
by	IN	mark	O
using	VBG	advcl	O
two	CD	nummod	O
different	JJ	amod	O
experimental	JJ	amod	O
approaches	NNS	dobj	O
that	WDT	nsubj	O
allowed	VBD	acl:relcl	O
LMP1	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
effects	NNS	dobj	O
to	TO	mark	O
be	VB	auxpass	O
monitored	VBN	xcomp	O
immediately	RB	advmod	O
following	VBG	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	O
protein	NN	nmod	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
absence	NN	conj	O
of	IN	case	O
selective	JJ	amod	O
pressures	NNS	nmod	O
;	:	punct	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
and	CC	cc	O
upregulation	NN	conj	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-protein
adhesion	NN	compound	I-protein
molecule	NN	nmod	I-protein
ICAM-1	NN	dep	B-protein
were	VBD	auxpass	O
used	VBN	parataxis	O
as	IN	case	O
early	JJ	amod	O
indices	NNS	nmod	O
of	IN	case	O
LMP1	NN	compound	B-protein
function	NN	nmod	O
.	.	punct	O

EMSA	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
constitutive	JJ	amod	O
and	CC	cc	O
inducible	JJ	conj	O
complexes	NNS	nsubj	O
bound	VBD	ccomp	O
to	TO	case	O
CLE0	NN	nmod	B-DNA
,	,	punct	O
P	NN	conj	B-DNA
,	,	punct	O
P2	NN	conj	B-DNA
and	CC	cc	O
P4	NN	conj	B-DNA
,	,	punct	O
whereas	IN	dep	O
only	RB	advmod	O
a	DT	det	O
constitutive	JJ	amod	O
complex	NN	nmod	O
bound	VBN	acl	O
to	TO	case	O
P3	NN	nmod	B-DNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	nsubj	O
by	IN	case	O
which	WDT	nmod	O
E	NN	nsubj	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
downregulates	VBZ	acl:relcl	O
TNF	NN	compound	B-protein
production	NN	dobj	O
is	VBZ	cop	O
presently	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
this	DT	nsubj	O
could	MD	aux	O
lead	VB	ROOT	O
to	TO	mark	O
inappropriate	VB	xcomp	O
binding	NN	dobj	O
of	IN	case	O
cortisol	NN	nmod	O
to	TO	case	O
mineralocorticoid	NN	compound	O
receptors	NNS	nmod	O
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
MAP	NN	compound	B-protein
kinases	NNS	nsubjpass	I-protein
ERK1	NN	dep	B-protein
and	CC	cc	O
ERK2	NN	conj	B-protein
were	VBD	auxpass	O
fully	RB	advmod	O
activated	VBN	ROOT	O
by	IN	case	O
TPA	NN	compound	O
or	CC	cc	O
TCR	NN	conj	B-protein
stimulation	NN	nmod	O
and	CC	cc	O
were	VBD	auxpass	O
not	RB	neg	O
affected	VBN	conj	O
by	IN	case	O
Ca2+	NN	nmod	O
,	,	punct	O
CD28	NN	conj	O
,	,	punct	O
or	CC	cc	O
CsA	NN	conj	O
.	.	punct	O

Six	CD	nummod	O
patients	NNS	nsubjpass	O
were	VBD	auxpass	O
reinvestigated	VBN	ROOT	O
after	IN	case	O
a	DT	det	O
significant	JJ	amod	O
weight	NN	compound	O
gain	NN	nmod	O
.	.	punct	O

The	DT	det	O
recent	JJ	amod	O
discovery	NN	nsubj	O
of	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
common	JJ	amod	B-DNA
gamma	NN	compound	I-DNA
chain	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
gamma	NN	compound	I-DNA
c	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
a	DT	det	O
constituent	NN	appos	O
of	IN	case	O
several	JJ	amod	O
cytokine	NN	compound	B-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
in	IN	case	O
XSCID	NN	nmod	O
provided	VBD	ROOT	O
an	DT	det	O
opportunity	NN	dobj	O
to	TO	mark	O
test	VB	acl	O
directly	RB	advmod	O
whether	IN	mark	O
a	DT	det	O
previously	RB	advmod	O
unrecognized	JJ	amod	O
mutation	NN	nsubj	O
in	IN	case	O
this	DT	det	O
same	JJ	amod	O
gene	NN	nmod	O
was	VBD	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
XCID	NN	nmod	O
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	O
suffering	VBG	acl	O
from	IN	case	O
Cushing	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	nmod	O
,	,	punct	O
the	DT	det	O
circadian	JJ	amod	O
rhythm	NN	nsubj	O
of	IN	case	O
plasma	NN	compound	O
cortisol	NN	nmod	O
either	CC	cc:preconj	O
disappeared	VBD	ROOT	O
or	CC	cc	O
was	VBD	auxpass	O
inverted	VBN	conj	O
while	IN	mark	O
that	DT	nsubj	O
of	IN	case	O
GR	NN	nmod	B-protein
did	VBD	aux	O
not	RB	neg	O
significantly	RB	advmod	O
deviate	VB	advcl	O
from	IN	case	O
the	DT	det	O
normal	JJ	amod	O
subjects	NNS	nmod	O
.	.	punct	O

In	IN	case	O
fact	NN	nmod	O
,	,	punct	O
heat	NN	compound	B-protein
shock	NN	compound	I-protein
protein	NN	compound	I-protein
association	NN	nsubjpass	O
(	-LRB-	punct	O
hsp	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
high	JJ	amod	O
affinity	NN	compound	O
ligand-binding	JJ	nmod	O
of	IN	case	O
the	DT	det	O
MR	NN	nmod	B-protein
.	.	punct	O

Cross-linking	JJ	amod	O
CD40	NN	nsubj	B-protein
on	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
can	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
homotypic	JJ	amod	O
cell	NN	compound	O
adhesion	NN	nmod	O
,	,	punct	O
IL-6	NN	compound	B-protein
production	NN	conj	O
,	,	punct	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
to	TO	case	O
Ig	NN	compound	O
isotype	NN	compound	O
switching	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
both	DT	det	O
copies	NNS	nsubjpass	O
of	IN	case	O
BRCA1	NN	nmod	B-DNA
were	VBD	auxpass	O
retained	VBN	ROOT	O
in	IN	case	O
tumor	NN	nmod	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
IL-4R	NN	compound	B-protein
alpha	NN	compound	I-protein
cytoplasmic	JJ	amod	I-protein
domain	NN	nsubj	I-protein
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
activate	VB	xcomp	O
JAK-1	NN	dobj	B-protein
and	CC	cc	O
STAT6	NN	conj	B-protein
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
expression	NN	dobj	O
of	IN	case	O
IL-4	NN	compound	B-DNA
target	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
thus	RB	advmod	O
identifying	VBG	xcomp	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
IL-4	NN	compound	B-protein
signaling	NN	nsubj	O
can	MD	aux	O
proceed	VB	acl:relcl	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
JAK-3	NN	nmod	B-protein
and	CC	cc	O
gamma	NN	conj	B-protein
(	-LRB-	punct	I-protein
c	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
IL-5	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
fundamentally	RB	advmod	O
involved	VBN	dep	O
in	IN	case	O
eosinophilic	JJ	amod	O
inflammation	NN	nmod	O
.	.	punct	O

In	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
chronically	RB	advmod	B-cell_line
HIV-infected	JJ	amod	I-cell_line
cells	NNS	nsubj	I-cell_line
of	IN	case	O
the	DT	det	O
lymphoid	JJ	amod	B-cell_line
CEM	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
displayed	VBD	ROOT	O
resistance	NN	dobj	O
to	TO	case	O
glucocorticoid-induced	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Serum	NN	compound	O
ACTH	NN	nsubjpass	O
and	CC	cc	O
IgE	NN	conj	B-protein
were	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
immunoradiometric	JJ	amod	O
assay	NN	nmod	O
,	,	punct	O
and	CC	cc	O
IL-2	NN	conj	B-protein
,	,	punct	O
IL-4	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-10	NN	conj	B-protein
cytokines	NNS	dep	B-protein
and	CC	cc	O
interferon-gamma	NN	conj	B-protein
were	VBD	auxpass	O
measured	VBN	conj	O
by	IN	case	O
enzyme-linked	JJ	amod	O
immunosorbent	JJ	amod	O
assay	NN	nmod	O
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
Pax-5	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
during	IN	case	O
the	DT	det	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
B-cell	NN	compound	O
differentiation	NN	nmod	O
and	CC	cc	O
influences	VBZ	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
B-cell-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

IL-10	NN	nsubj	B-protein
also	RB	advmod	O
prevented	VBD	ROOT	O
the	DT	det	O
upregulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
G1	NN	compound	B-protein
cyclins	NNS	nmod	I-protein
D2	NN	dep	B-protein
and	CC	cc	O
D3	NN	conj	B-protein
,	,	punct	O
proteins	NNS	appos	O
necessary	JJ	amod	O
for	IN	case	O
entry	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
through	IN	case	O
the	DT	det	O
G1	NN	compound	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
.	.	punct	O

Like	IN	case	O
the	DT	det	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
the	DT	det	O
HLA-DM	NN	compound	B-DNA
genes	NNS	nsubj	I-DNA
contain	VBP	ROOT	O
upstream	JJ	amod	O
regulatory	JJ	amod	O
sequences	NNS	dobj	O
similar	JJ	amod	O
to	TO	case	O
the	DT	det	O
S-X-Y	NN	amod	B-DNA
regulatory	JJ	amod	I-DNA
region	NN	nmod	I-DNA
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
additional	JJ	amod	O
putative	JJ	amod	O
regulatory	JJ	amod	O
sites	NNS	conj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
transcription	NN	compound	B-protein
factors	NNS	nsubjpass	I-protein
known	VBN	acl	O
as	IN	case	O
STATs	NNS	nmod	B-protein
(	-LRB-	punct	O
signal	NN	compound	B-protein
transducers	NNS	dep	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
tyrosine	NN	nmod:npmod	O
phosphorylated	JJ	xcomp	O
and	CC	cc	O
activated	VBN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
hematopoietin	NN	compound	B-protein
receptors	NNS	dobj	I-protein
and	CC	cc	O
activate	VBP	conj	O
JAK	NN	compound	B-protein
kinases	NNS	dobj	I-protein
.	.	punct	O

In	IN	case	O
21	CD	compound	O
of	IN	advmod	O
27	CD	nummod	O
informative	JJ	amod	O
female	JJ	amod	O
patients	NNS	nmod	O
the	DT	det	O
majority	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
granulocytes	NNS	nmod	B-cell_type
were	VBD	auxpass	O
clonally	RB	advmod	O
derived	VBN	ROOT	O
.	.	punct	O

Comparison	NN	nsubj	O
of	IN	case	O
the	DT	det	O
derived	VBN	amod	O
protein	NN	compound	O
sequence	NN	nmod	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
rodent	JJ	amod	O
homologs	NNS	nmod	O
allows	VBZ	ROOT	O
classification	NN	dobj	O
into	IN	case	O
three	CD	nummod	O
groups	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	B-DNA
gene	NN	dobj	I-DNA
,	,	punct	O
GR6	NN	appos	B-DNA
,	,	punct	O
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
leukemia	NN	compound	O
breakpoint	NN	compound	O
region	NN	nmod	O
of	IN	case	O
3q21	NN	nmod	B-DNA
,	,	punct	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
normally	RB	advmod	O
expressed	VBN	acl:relcl	O
in	IN	case	O
early	JJ	amod	O
fetal	JJ	amod	O
development	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
adult	JJ	amod	O
peripheral	JJ	amod	O
blood	NN	conj	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
CIF	NN	nsubj	B-protein
blocks	NNS	ccomp	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
IL2	NN	compound	B-protein
transcription	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
introduced	VBD	ROOT	O
reporter	NN	compound	O
plasmids	NNS	dobj	O
into	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
leukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
Jurkat	NN	nmod	I-cell_line
by	IN	case	O
transient	JJ	amod	O
transfection	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
(	-LRB-	punct	O
NF-AT	NN	appos	B-protein
)	-RRB-	punct	O
to	TO	case	O
its	PRP$	nmod:poss	O
response	NN	compound	O
element	NN	nmod	O
in	IN	case	O
the	DT	det	O
IL2	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
and	CC	cc	O
to	TO	case	O
an	DT	det	O
NF-AT-like	JJ	amod	B-DNA
response	NN	compound	I-DNA
element	NN	conj	I-DNA
present	JJ	amod	O
in	IN	case	O
the	DT	det	O
IL4	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
was	VBD	cop	O
abnormal	JJ	ROOT	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
progressive	JJ	amod	O
decline	NN	nsubj	O
in	IN	case	O
the	DT	det	O
heat	NN	compound	O
shock	NN	compound	O
response	NN	nmod	O
of	IN	case	O
cultured	VBN	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
correlates	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
percent	JJ	amod	O
proliferative	JJ	amod	O
life	NN	compound	O
span	NN	nmod	O
completed	VBN	acl	O
rather	RB	advmod	O
than	IN	mwe	O
with	IN	prep	O
the	DT	det	O
actual	JJ	amod	O
proliferative	JJ	amod	O
activity	NN	pobj	O
at	IN	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	aux	O
measure	VB	advcl	O
small	JJ	amod	O
differences	NNS	dobj	O
in	IN	case	O
virus	NN	compound	O
production	NN	nmod	O
more	RBR	advmod	O
accurately	RB	advmod	O
,	,	punct	O
equal	JJ	amod	O
amounts	NNS	nsubjpass	O
of	IN	case	O
a	DT	det	O
size	NN	compound	O
variant	NN	nmod	O
and	CC	cc	O
the	DT	det	O
wild-type	JJ	amod	B-DNA
plasmid	NN	conj	I-DNA
were	VBD	auxpass	O
cotransfected	VBN	ROOT	O
into	IN	case	O
T-cells	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
cell	NN	nmod:npmod	O
type-specific	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
LAL	NN	compound	B-protein
expression	NN	nmod	O
is	VBZ	auxpass	O
further	RB	advmod	O
investigated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
THP-1	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
changes	NNS	nsubj	O
in	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
GSSG/GSH	NN	nmod	O
cause	VBP	ccomp	O
transcription-independent	JJ	amod	O
and	CC	cc	O
transcription-dependent	JJ	conj	O
surface	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
different	JJ	amod	O
endothelial	JJ	amod	B-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecules	NNS	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
leads	VBZ	acl:relcl	O
to	TO	case	O
a	DT	det	O
2-phase	JJ	amod	O
neutrophil	NN	compound	B-cell_type
-endothelial	JJ	amod	O
adhesion	NN	compound	O
response	NN	nmod	O
.	.	punct	O

Signaling	VBG	nsubj	O
through	IN	case	O
CD40	NN	nmod	B-protein
with	IN	case	O
soluble	JJ	amod	O
CD40	NN	compound	B-protein
ligand	NN	nmod	O
stimulated	VBD	ROOT	O
fibroblast	NN	compound	O
activation	NN	dobj	O
,	,	punct	O
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
mobilization	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	O
factor-kappaB	NN	nmod	O
and	CC	cc	O
by	IN	case	O
induction	NN	conj	O
of	IN	case	O
the	DT	dep	O
proinflammatory	JJ	nmod	O
and	CC	cc	O
chemoattractant	JJ	conj	O
cytokines	NNS	dep	B-protein
IL-6	NN	dep	B-protein
and	CC	cc	O
IL-8	NN	conj	B-protein
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
EPO	NN	nsubj	B-protein
did	VBD	aux	O
not	RB	neg	O
activate	VB	ccomp	O
Stat1alpha	NN	dobj	B-protein
or	CC	cc	O
Stat3	NN	conj	B-protein
in	IN	case	O
UT-7/GM	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
glucocorticoid-induced	JJ	amod	O
membrane	NN	compound	O
perturbation	NN	nsubj	O
,	,	punct	O
the	DT	det	O
possibility	NN	appos	O
to	TO	mark	O
inhibit	VB	acl	O
it	PRP	dobj	O
by	IN	case	O
RU	NN	nmod	O
486	CD	nummod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
inactivity	NN	conj	O
of	IN	case	O
the	DT	det	O
structurally	RB	advmod	O
related	JJ	amod	O
progesterone	NN	nmod	O
,	,	punct	O
refer	VBP	ROOT	O
to	TO	case	O
relatively	RB	advmod	O
specific	JJ	amod	O
binding	VBG	amod	B-DNA
sites	NNS	nmod	I-DNA
for	IN	case	O
the	DT	det	O
glucocorticoids	NNS	nmod	O
in	IN	case	O
the	DT	det	O
membrane	NN	nmod	O
of	IN	case	O
erythrocyte	NN	compound	B-cell_type
ghosts	NNS	nmod	I-cell_type
.	.	punct	O

Both	CC	cc:preconj	O
Dex	NN	nsubj	O
and	CC	cc	O
CsA	NN	conj	O
inhibited	VBD	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
AP-1	NN	dep	B-protein
and	CC	cc	O
NF-AT	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
NF-kB	NN	conj	B-protein
and	CC	cc	O
OCT-1/OAF	NN	conj	B-protein
,	,	punct	O
to	TO	case	O
their	PRP$	nmod:poss	O
corresponding	JJ	amod	O
sites	NNS	nmod	O
on	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
signaling	NN	compound	O
events	NNS	nsubj	O
mediating	VBG	acl	O
this	DT	det	O
effect	NN	dobj	O
appeared	VBD	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
the	DT	det	O
release	NN	dobj	O
of	IN	case	O
H2O2	NN	nmod	O
,	,	punct	O
since	IN	mark	O
LTB4	NN	nsubj	O
failed	VBD	advcl	O
to	TO	mark	O
induce	VB	xcomp	O
NF-chi	NN	compound	B-protein
B	NN	dobj	I-protein
or	CC	cc	O
NF-IL6	NN	conj	B-protein
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
the	DT	det	O
scavenger	NN	nmod	O
of	IN	case	O
H2O2	NN	nmod	O
,	,	punct	O
N-acetyl-L-cysteine	NN	appos	O
.	.	punct	O

No	DT	neg	O
correlations	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
for	IN	case	O
these	DT	det	O
variables	NNS	nmod	O
with	IN	case	O
blood	NN	compound	O
pressure	NN	nmod	O
or	CC	cc	O
serum	NN	compound	B-protein
lipoproteins	NNS	conj	I-protein
.	.	punct	O

Modulation	NN	ROOT	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
activity	NN	nmod	O
by	IN	case	O
intracellular	JJ	amod	O
glutathione	NN	compound	O
levels	NNS	nmod	O
and	CC	cc	O
by	IN	case	O
variations	NNS	conj	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
cysteine	NN	compound	O
supply	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
IL-2	NN	compound	B-protein
production	NN	nsubjpass	O
by	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
elderly	JJ	amod	O
(	-LRB-	punct	O
mean	NN	intj	O
78	CD	nummod	O
years	NNS	dep	O
)	-RRB-	punct	O
and	CC	cc	O
young	JJ	conj	O
(	-LRB-	punct	O
mean	NN	dep	O
37	CD	nummod	O
years	NNS	dep	O
)	-RRB-	punct	O
humans	NNS	nmod	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
cultures	NNS	nmod	O
stimulated	VBN	acl	O
with	IN	case	O
PHA	NN	nmod	B-protein
,	,	punct	O
PHA	NN	conj	B-protein
plus	CC	cc	O
PMA	NN	conj	O
,	,	punct	O
crosslinked	VBN	amod	O
anti-CD3	JJ	amod	O
mAB	NN	compound	O
OKT3	NN	conj	O
plus	CC	cc	O
PMA	NN	conj	O
,	,	punct	O
or	CC	cc	O
PMA	NN	conj	O
plus	CC	cc	O
ionomycin	NN	conj	O
.	.	punct	O

Role	NN	ROOT	O
for	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	nmod	I-protein
2	CD	nummod	I-protein
in	IN	case	O
viral	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
switching	NN	nmod	O
during	IN	case	O
initial	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
infection	NN	nmod	O
.	.	punct	O

Translocations	NNS	nsubj	O
involving	VBG	acl	O
the	DT	det	O
BCL-6	NN	compound	B-DNA
gene	NN	dobj	I-DNA
are	VBP	cop	O
common	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
diffuse	JJ	amod	O
large	JJ	amod	O
cell	NN	compound	O
subtype	NN	nmod	O
of	IN	case	O
non-Hodgkin	JJ	nmod:poss	O
's	POS	case	O
lymphoma	NN	nmod	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
v-abl	NN	nsubj	B-DNA
may	MD	aux	O
be	VB	aux	O
inhibiting	VBG	ccomp	O
the	DT	det	O
differentiation	NN	dobj	O
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	mark	O
blocking	VBG	advcl	O
these	DT	det	O
two	CD	nummod	O
crucial	JJ	amod	O
elements	NNS	dobj	O
in	IN	case	O
the	DT	det	O
maturation	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
decrease	NN	nsubj	O
of	IN	case	O
ER	NN	compound	B-protein
levels	NNS	nmod	O
in	IN	case	O
cell	NN	nmod	O
may	MD	aux	O
involve	VB	ccomp	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
climacteric	JJ	amod	O
syndrome	NN	nmod	O
.	.	punct	O

The	DT	det	O
purified	VBN	amod	O
homodimer	NN	nsubj	B-protein
(	-LRB-	punct	O
two	CD	nummod	O
p50s	NNS	appos	B-protein
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
DNA-binding	JJ	amod	B-protein
subunit	NN	nmod	I-protein
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
binds	VBZ	ROOT	O
the	DT	det	O
B2	NN	compound	B-DNA
site	NN	dobj	O
of	IN	case	O
proenkephalin	NN	nmod	O
relatively	RB	advmod	O
better	JJR	advmod	O
than	IN	mark	O
does	VBZ	advcl	O
the	DT	det	O
heterotetramer	NN	compound	B-protein
(	-LRB-	punct	O
two	CD	nummod	O
p65s	NNS	dep	B-protein
plus	CC	cc	O
two	CD	nummod	O
p50s	NNS	conj	B-protein
)	-RRB-	punct	O
form	NN	nsubj	O
of	IN	case	O
the	DT	det	O
factor	NN	nmod	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
mechanism	NN	nsubjpass	O
underlying	VBG	acl	O
IL-2	NN	compound	B-protein
transcriptional	JJ	amod	O
blockade	NN	dobj	O
in	IN	case	O
anergic	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
clones	NNS	nmod	I-cell_line
is	VBZ	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O

A	DT	det	O
decreased	VBN	amod	O
number	NN	nsubjpass	O
of	IN	case	O
calcitriol	NN	nmod	B-protein
(	-LRB-	punct	I-protein
1	CD	nummod	I-protein
,	,	punct	I-protein
25	CD	conj	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	dep	I-protein
)	-RRB-	punct	I-protein
receptors	NNS	nsubjpass	I-protein
has	VBZ	aux	O
been	VBN	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
parathyroid	JJ	amod	O
glands	NNS	nmod	O
of	IN	case	O
uremic	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

Previously	RB	advmod	O
,	,	punct	O
the	DT	det	O
action	NN	nsubjpass	O
of	IN	case	O
MC903	NN	nmod	O
and	CC	cc	O
KH1060	NN	conj	O
was	VBD	auxpass	O
presumed	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
vitamin	NN	compound	I-protein
D	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
VDRnuc	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Modulation	NN	ROOT	O
of	IN	case	O
mRNA	NN	compound	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	B-DNA
human	JJ	amod	I-DNA
myeloid-selective	JJ	amod	I-DNA
CCAAT/enhancer	NN	compound	I-DNA
binding	NN	compound	I-DNA
protein	NN	compound	I-DNA
gene	NN	nmod	I-DNA
(	-LRB-	punct	O
C/EBP	NN	compound	B-DNA
epsilon	NN	appos	I-DNA
)	-RRB-	punct	O
.	.	punct	O

Molecular	JJ	amod	O
mechanisms	NNS	ROOT	O
of	IN	case	O
steroid	NN	compound	O
action	NN	nmod	O
:	:	punct	O
a	DT	det	O
novel	JJ	amod	O
type	NN	dep	O
of	IN	case	O
cross-talk	NN	nmod	O
between	IN	case	O
glucocorticoids	NNS	nmod	O
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

Staurosporine	NN	nsubj	O
,	,	punct	O
a	DT	det	O
nonspecific	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
PKC	NN	nmod	B-protein
,	,	punct	O
partially	RB	advmod	O
blocked	VBD	ROOT	O
TPA-induced	JJ	amod	O
adherence	NN	dobj	O
and	CC	cc	O
growth	NN	compound	O
inhibition	NN	conj	O
and	CC	cc	O
concomitantly	RB	advmod	O
prevented	VBD	conj	O
TPA-induced	JJ	amod	O
c-fos	NN	compound	O
and	CC	cc	O
c-jun	NN	conj	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Phenylarsine	NN	compound	O
oxide	NN	nsubj	O
inhibits	VBZ	ROOT	O
ex	FW	amod	O
vivo	FW	dep	O
HIV-1	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
LMP1	NN	nmod	B-protein
activates	VBZ	ccomp	O
transcription	NN	dobj	O
from	IN	case	O
p50/p65-	NN	amod	B-DNA
and	CC	cc	I-DNA
c-Rel-	CD	conj	I-DNA
responsive	JJ	amod	I-DNA
promoters	NNS	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
activity	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
completely	RB	advmod	O
inhibited	VBN	conj	O
by	IN	case	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
inhibitory	JJ	amod	B-protein
IkappaB	NN	compound	I-protein
mutant	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
promoters	NNS	nsubjpass	B-DNA
were	VBD	auxpass	O
used	VBN	ROOT	O
without	IN	case	O
enhancers	NNS	nmod	B-DNA
,	,	punct	O
or	CC	cc	O
with	IN	case	O
enhancers	NNS	conj	B-DNA
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
beta-globin	NN	compound	B-DNA
locus	NN	compound	I-DNA
control	NN	compound	I-DNA
region	NN	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
alpha-globin	NN	compound	B-DNA
HS-40	NN	compound	I-DNA
enhancer	NN	conj	I-DNA
.	.	punct	O

No	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
c-myc	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
and	CC	cc	O
B	NN	compound	O
lymphocyte	NN	conj	O
monoclonicity	NN	dep	O
or	CC	cc	O
lymphoma	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
IL-2	NN	nsubj	B-protein
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
inducing	VBG	advcl	O
the	DT	det	O
nuclear	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
primary	JJ	amod	B-cell_line
CD8+	JJ	amod	I-cell_line
T-PLL	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
at	IN	case	O
a	DT	det	O
pretranslational	JJ	amod	O
level	NN	nmod	O

Abnormalities	NNS	nsubjpass	O
of	IN	case	O
retinoblastoma	NN	compound	B-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
pRB	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
mutations	NNS	conj	O
of	IN	case	O
RB	NN	compound	O
gene	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
in	IN	case	O
up	RB	advmod	O
to	TO	dep	O
70	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
MM	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
80	CD	nummod	O
%	NN	conj	O
of	IN	case	O
MM-derived	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
other	JJ	amod	O
,	,	punct	O
CIITA	NN	nsubj	B-protein
,	,	punct	O
encodes	VBZ	ROOT	O
a	DT	det	O
large	JJ	amod	O
protein	NN	dobj	O
with	IN	case	O
a	DT	det	O
defined	VBN	amod	O
acidic	JJ	amod	B-protein
transcriptional	JJ	amod	I-protein
activation	NN	compound	I-protein
domain	NN	nmod	I-protein
;	:	punct	O
this	DT	det	O
protein	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
interact	VB	parataxis	O
with	IN	case	O
DNA	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
address	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
of	IN	case	O
rapid	JJ	amod	O
mutational	JJ	amod	O
analysis	NN	nmod	O
of	IN	case	O
the	DT	det	O
androgen	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
for	IN	case	O
initial	JJ	amod	O
diagnosis	NN	nmod	O
,	,	punct	O
genetic	JJ	amod	O
counseling	NN	conj	O
,	,	punct	O
and	CC	cc	O
molecular	JJ	amod	O
subclassification	NN	conj	O
of	IN	case	O
affected	VBN	amod	O
patients	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
families	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
cloned	VBN	ROOT	O
and	CC	cc	O
sequenced	VBN	conj	O
a	DT	det	O
portion	NN	dobj	O
of	IN	case	O
the	DT	det	O
ER	NN	compound	B-protein
upstream	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
region	NN	nmod	I-DNA
from	IN	case	O
the	DT	det	O
ER-positive	JJ	amod	B-cell_line
MCF-7	NN	nmod	I-cell_line
and	CC	cc	O
the	DT	det	O
ER-negative	JJ	amod	B-cell_line
MDA-MB-231	NN	compound	I-cell_line
breast	NN	compound	I-cell_line
cancer	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
to	TO	mark	O
determine	VB	xcomp	O
if	IN	mark	O
sequence	NN	compound	O
alterations	NNS	nsubj	O
in	IN	case	O
this	DT	det	O
region	NN	nmod	O
account	VBP	ccomp	O
for	IN	case	O
the	DT	det	O
ER	NN	compound	B-protein
-negative	JJ	amod	O
phenotype	NN	nmod	O
of	IN	case	O
some	DT	det	O
tumors	NNS	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
NFAT	NN	nmod	B-protein
is	VBZ	cop	O
MAPK	NN	nmod:npmod	B-protein
-dependent	JJ	advcl	O
these	DT	det	O
findings	NNS	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
MAPK	NN	nmod	B-protein
by	IN	case	O
Tpl-2	NN	nmod	B-protein
is	VBZ	cop	O
either	CC	cc:preconj	O
independent	JJ	ccomp	O
or	CC	cc	O
only	RB	advmod	O
partially	RB	advmod	O
dependent	JJ	conj	O
on	IN	case	O
MEK1	NN	nmod	B-protein
and	CC	cc	O
MEK2	NN	conj	B-protein
.	.	punct	O

Both	CC	cc:preconj	O
CHO-CD80	NN	nsubj	B-protein
and	CC	cc	O
CHO-CD86	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
the	DT	dep	O
presence	NN	dep	O
of	IN	case	O
anti-CD3	JJ	amod	B-protein
mAb	NN	nmod	I-protein
,	,	punct	O
costimulated	VBD	amod	O
NFAT	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
transcriptional	JJ	amod	O
activation	NN	ROOT	O
.	.	punct	O

Activation	NN	nsubjpass	O
is	VBZ	auxpass	O
delayed	VBN	ROOT	O
a	DT	det	O
further	JJ	amod	O
1-2	CD	nummod	O
hr	NN	dobj	O
when	WRB	advmod	O
mononuclear	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
cultures	NNS	nsubjpass	I-cell_line
are	VBP	auxpass	O
stimulated	VBN	advcl	O
by	IN	case	O
an	DT	det	O
antigen	NN	nmod	O
which	WDT	nsubj	O
requires	VBZ	acl:relcl	O
processing	NN	dobj	O
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
AP-1	NN	compound	B-protein
-dependent	JJ	amod	O
luciferase	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
two	CD	nummod	O
specific	JJ	amod	O
inhibitors	NNS	dobj	O
of	IN	case	O
serine/threonine	NN	compound	B-protein
phosphatases-1	NN	nmod	I-protein
and	CC	cc	I-protein
-2A	NN	conj	I-protein
:	:	punct	O
okadaic	JJ	amod	O
acid	NN	dobj	O
and	CC	cc	O
calyculin	NN	compound	O
A	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
a	DT	det	O
lack	NN	dobj	O
of	IN	case	O
involvement	NN	nmod	O
of	IN	case	O
Jak	NN	compound	B-protein
kinases	NNS	nmod	I-protein
in	IN	case	O
signaling	NN	nmod	O
by	IN	case	O
the	DT	det	O
G-CSFR	NN	nmod	B-protein
in	IN	case	O
neutrophils	NNS	nmod	B-cell_type
,	,	punct	O
and	CC	cc	O
suggest	VBP	conj	O
utilization	NN	dobj	O
of	IN	case	O
alternative	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
distinct	JJ	amod	O
from	IN	case	O
those	DT	nmod	O
in	IN	case	O
proliferating	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

EBV	NN	compound	O
nuclear	JJ	amod	O
antigen	NN	nsubj	O
2	CD	nummod	O
(	-LRB-	punct	O
EBNA2	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
genes	NNS	nmod	O
expressed	VBN	acl	O
after	IN	case	O
EBV	NN	compound	O
infection	NN	nmod	O
of	IN	case	O
B-cells	NNS	nmod	B-cell_type
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
transcriptional	JJ	amod	O
activator	NN	ROOT	O
of	IN	case	O
viral	JJ	amod	B-DNA
and	CC	cc	I-DNA
cellular	JJ	conj	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
is	VBZ	cop	O
essential	JJ	conj	O
for	IN	case	O
the	DT	det	O
transforming	VBG	amod	O
potential	NN	nmod	O
of	IN	case	O
the	DT	det	O
virus	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
compared	VBD	ROOT	O
the	DT	det	O
nucleotide	NN	compound	B-DNA
sequences	NNS	dobj	I-DNA
of	IN	case	O
the	DT	det	O
CD11a	NN	nmod	B-DNA
,	,	punct	I-DNA
CD11b	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
CD11c	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoters	NNS	conj	I-DNA
to	TO	mark	O
identify	VB	xcomp	O
common	JJ	amod	O
elements	NNS	dobj	O
that	WDT	nsubj	O
might	MD	aux	O
contribute	VB	acl:relcl	O
to	TO	case	O
inducible	JJ	amod	O
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
control	NN	ROOT	O
of	IN	case	O
lytic	JJ	amod	O
replication	NN	nmod	O
of	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
Review	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
IL-12	NN	nsubj	B-protein
had	VBD	ccomp	O
a	DT	det	O
direct	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
IRF-1	NN	nmod	B-protein
,	,	punct	O
an	DT	det	O
effect	NN	appos	O
not	RB	neg	O
mediated	VBN	acl	O
indirectly	RB	advmod	O
by	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
IFN-gamma	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

The	DT	det	O
PEBP2	NN	compound	B-DNA
alpha	NN	compound	I-DNA
A	NN	nsubj	I-DNA
and	CC	cc	I-DNA
PEBP2	NN	compound	I-DNA
alpha	NN	compound	I-DNA
B	NN	compound	I-DNA
genes	NNS	conj	I-DNA
encode	VBP	ROOT	O
the	DT	det	O
DNA-binding	JJ	amod	B-protein
subunit	NN	dobj	I-protein
of	IN	case	O
a	DT	det	O
murine	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
PEBP2	NN	appos	B-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
implicated	VBN	acl:relcl	O
as	IN	case	O
a	DT	det	O
T-cell-specific	JJ	amod	B-protein
transcriptional	JJ	amod	I-protein
regulator	NN	nmod	I-protein
.	.	punct	O

Nuclear	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
occurs	VBZ	ROOT	O
after	IN	case	O
its	PRP$	nmod:poss	O
induced	VBN	amod	O
dissociation	NN	nmod	O
from	IN	case	O
its	PRP$	nmod:poss	O
cytoplasmic	JJ	amod	O
inhibitor	NN	compound	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

Identification	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pathways	NNS	nmod	O
activated	VBN	acl	O
by	IN	case	O
LMP-1	NN	nmod	B-protein
to	TO	mark	O
result	VB	acl	O
in	IN	case	O
posttranslational	JJ	amod	O
modifications	NNS	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
will	MD	aux	O
aid	VB	ROOT	O
in	IN	mark	O
determining	VBG	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
this	DT	det	O
virus-host	JJ	amod	O
cell	NN	compound	O
protein	NN	compound	O
interaction	NN	nmod	O
in	IN	case	O
Epstein-Barr	JJ	amod	O
virus-mediated	JJ	amod	O
oncogenesis	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
a	DT	det	O
direct	JJ	amod	O
interaction	NN	nsubjpass	O
between	IN	case	O
RFX5	NN	nmod	B-protein
and	CC	cc	O
CIITA	NN	conj	B-protein
was	VBD	auxpass	O
detected	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
yeast	NN	compound	O
two-hybrid	JJ	amod	O
and	CC	cc	O
far-Western	JJ	conj	O
blot	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

In	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
these	DT	det	O
drugs	NNS	nsubj	O
disrupt	VBP	ROOT	O
an	DT	det	O
unknown	JJ	amod	O
step	NN	dobj	O
in	IN	case	O
the	DT	det	O
transmission	NN	nmod	O
of	IN	case	O
signals	NNS	nmod	O
from	IN	case	O
the	DT	det	O
T-cell	NN	compound	B-protein
antigen	NN	compound	I-protein
receptor	NN	nmod	I-protein
to	TO	case	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
that	WDT	nsubj	O
coordinate	VBP	acl:relcl	O
the	DT	det	O
immune	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
TR55	NN	compound	B-protein
expression	NN	nsubj	O
was	VBD	cop	O
unaltered	JJ	advcl	O
during	IN	case	O
TNF-alpha	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
HIV	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
this	DT	det	O
receptor	NN	nsubjpass	O
was	VBD	auxpass	O
still	RB	advmod	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
viral	JJ	amod	O
activation	NN	compound	O
process	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
and	CC	cc	O
others	NNS	conj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
SAA	NN	compound	B-protein
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	ccomp	O
in	IN	case	O
monocyte/macrophage	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Clinical	JJ	amod	O
remissions	NNS	nsubjpass	O
induced	VBN	acl	O
with	IN	case	O
all-trans	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	compound	O
(	-LRB-	punct	O
RA	NN	appos	O
)	-RRB-	punct	O
treatment	NN	nmod	O
in	IN	case	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukemia	NN	nmod	O
are	VBP	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
PML/RARalpha	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
IFN-gamma	NN	nsubj	B-protein
enhanced	VBD	ROOT	O
the	DT	det	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Stat1alpha	NN	nmod	B-protein
.	.	punct	O

When	WRB	advmod	O
bound	VBN	advcl	O
to	TO	case	O
cyclophilin	NN	nmod	B-protein
,	,	punct	O
cyclosporin	NN	compound	O
A	NN	nsubj	O
binds	VBZ	ROOT	O
and	CC	cc	O
inactivates	VBZ	conj	O
the	DT	det	O
key	JJ	amod	O
signalling	NN	amod	O
intermediate	JJ	amod	O
calcineurin	NN	dobj	B-protein
.	.	punct	O

The	DT	det	O
observation	NN	nsubjpass	O
that	IN	mark	O
human	JJ	amod	O
herpesvirus	NN	nsubj	O
6	CD	nummod	O
(	-LRB-	punct	O
HHV-6	NN	appos	O
)	-RRB-	punct	O
can	MD	aux	O
induce	VB	ccomp	O
CD4	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	dobj	O
and	CC	cc	O
expression	NN	conj	O
in	IN	case	O
CD4	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
-	:	punct	I-cell_line
)	-RRB-	punct	I-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
reported	VBN	ROOT	O
several	JJ	amod	O
years	NNS	nmod:npmod	O
ago	RB	advmod	O
(	-LRB-	punct	O
P.Lusso	NNP	dep	O
,	,	punct	O
A.De	NNP	compound	O
Maria	NNP	conj	O
,	,	punct	O
M.Malnati	NNP	conj	O
,	,	punct	O
F.Lori	NNP	conj	O
,	,	punct	O
S.E.DeRocco	NNP	conj	O
,	,	punct	O
M.	NNP	compound	O
Baseler	NNP	conj	O
,	,	punct	O
and	CC	cc	O
R.C.Gallo	NNP	conj	O
,	,	punct	O
Nature	NNP	appos	O
349	CD	nummod	O
:	:	punct	O
533-535	CD	nummod	O
,	,	punct	O
1991	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
subsequently	RB	advmod	O
confirmed	VBN	conj	O
(	-LRB-	punct	O
P.Lusso	NNP	dep	O
,	,	punct	O
M.S.Malnati	NNP	conj	O
,	,	punct	O
A.Garzino-Demo	NNP	conj	O
,	,	punct	O
R.W.Crowley	NNP	conj	O
,	,	punct	O
E.	NNP	compound	O
O.Long	NNP	conj	O
,	,	punct	O
and	CC	cc	O
R.C.Gallo	NNP	conj	O
,	,	punct	O
Nature	NNP	appos	O
362	CD	nummod	O
:	:	punct	O
458-462	CD	dep	O
,	,	punct	O
1993	CD	amod	O
;	:	punct	O
G.Furlini	NNP	dep	O
,	,	punct	O
M.	NNP	compound	O
Vignoli	NNP	conj	O
,	,	punct	O
E.Ramazzotti	NNP	conj	O
,	,	punct	O
M.C.Re	NNP	conj	O
,	,	punct	O
G.Visani	NNP	conj	O
,	,	punct	O
and	CC	cc	O
M.LaPlaca	NNP	conj	O
,	,	punct	O
Blood	NNP	appos	O
87	CD	nummod	O
:	:	punct	O
4737-4745	CD	dep	O
,	,	punct	O
1996	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Strikingly	RB	advmod	O
,	,	punct	O
despite	IN	case	O
the	DT	det	O
observed	VBN	amod	O
repertoire	NN	compound	O
heterogeneity	NN	nmod	O
,	,	punct	O
all	DT	det	O
clones	NNS	nsubj	O
displayed	VBD	ROOT	O
a	DT	det	O
narrow	JJ	amod	O
range	NN	dobj	O
of	IN	case	O
MHC	NN	compound	B-protein
/peptide	NN	compound	O
density	NN	compound	O
requirements	NNS	nmod	O
in	IN	case	O
cytotoxicity	NN	compound	O
assays	NNS	nmod	O
(	-LRB-	punct	O
ED50	NN	dep	O
between	IN	case	O
9	CD	nmod	O
and	CC	cc	O
36	CD	conj	O
nM	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

They	PRP	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
function	NN	nsubj	O
of	IN	case	O
Spi-1/PU.1	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
late	JJ	amod	O
phase	NN	nmod	O
of	IN	case	O
Friend	NN	compound	O
leukemia	NN	nmod	O
requires	VBZ	ccomp	O
specific	JJ	amod	O
signaling	NN	dobj	O
from	IN	case	O
the	DT	det	O
gp55-modified	JJ	amod	B-protein
EpoR	NN	nmod	I-protein
generated	VBN	acl	O
during	IN	case	O
the	DT	det	O
early	JJ	amod	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
TNF	NN	nmod:npmod	B-protein
alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
by	IN	case	O
none	NN	nmod	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
signal-mediating	JJ	amod	B-protein
kinases	NNS	nmod	I-protein
such	JJ	case	O
as	IN	mwe	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
(	-LRB-	punct	O
PKC	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
A	NN	conj	I-protein
,	,	punct	O
or	CC	cc	O
Ca	NN	compound	B-protein
(	-LRB-	punct	I-protein
2+	NN	amod	I-protein
)	-RRB-	punct	I-protein
-regulated	JJ	amod	I-protein
kinases	NNS	conj	I-protein
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
genes	NNS	nmod	O
that	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
a	DT	det	O
CBF	NN	compound	B-protein
alpha	NN	compound	I-protein
subunit	NN	dobj	I-protein
is	VBZ	cop	O
AML1	NN	ROOT	B-protein
,	,	punct	O
also	RB	advmod	O
called	VBN	acl	O
Cbf	NN	compound	B-protein
alpha	NN	xcomp	I-protein
2	CD	nummod	I-protein
.	.	punct	O

Three	CD	nummod	O
subtypes	NNS	nsubjpass	O
of	IN	case	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
RAR	NNS	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
termed	VBN	acl	O
RAR	NN	compound	B-protein
alpha	NN	xcomp	I-protein
,	,	punct	O
RAR	NN	compound	B-protein
beta	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
RAR	NN	compound	B-protein
gamma	NN	conj	I-protein
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

Mouse	NN	nsubjpass	B-cell_type
,	,	punct	I-cell_type
rat	NN	conj	I-cell_type
,	,	punct	I-cell_type
hamster	NN	conj	I-cell_type
,	,	punct	I-cell_type
and	CC	cc	I-cell_type
human	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
that	WDT	nsubjpass	O
were	VBD	auxpass	O
rendered	VBN	acl:relcl	O
cytolytic	JJ	amod	O
susceptible	JJ	dobj	O
by	IN	case	O
E1A	NN	nmod	B-protein
were	VBD	auxpass	O
also	RB	advmod	O
sensitized	VBN	ROOT	O
to	TO	case	O
CL-induced	JJ	amod	O
and	CC	cc	O
chemically	RB	advmod	O
induced	VBN	conj	O
apoptosis	NN	nmod	O
.	.	punct	O

In	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
lipopolysaccharide	NN	nsubj	O
induces	VBZ	ROOT	O
synthesis	NN	dobj	O
and	CC	cc	O
activity	NN	conj	O
of	IN	case	O
the	DT	det	O
85-kDa	JJ	amod	O
cytosolic	JJ	amod	B-protein
phospholipase	NN	compound	I-protein
A2	NN	nmod	I-protein
.	.	punct	O

Ligand	NN	compound	O
activation	NN	nsubj	O
of	IN	case	O
c-ErbB	NN	nmod	B-protein
induced	VBD	ROOT	O
the	DT	det	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
,	,	punct	O
DNA-binding	NN	conj	O
,	,	punct	O
and	CC	cc	O
reporter	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	conj	O
of	IN	case	O
Stat	NN	compound	B-protein
5b	NN	nmod	I-protein
in	IN	case	O
erythroblasts	NNS	nmod	B-cell_type
.	.	punct	O

PML	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
and	CC	cc	O
protein	NN	conj	B-protein
,	,	punct	O
while	IN	mark	O
barely	RB	advmod	O
detectable	JJ	dep	O
in	IN	case	O
quiescent	JJ	amod	O
HPCs	NNS	nmod	B-cell_type
,	,	punct	O
are	VBP	auxpass	O
consistently	RB	advmod	O
induced	VBN	ROOT	O
by	IN	case	O
growth	NN	compound	B-protein
factor	NN	compound	I-protein
stimulation	NN	nmod	O
through	IN	case	O
the	DT	det	O
erythroid	JJ	amod	O
or	CC	cc	O
granulocytic	JJ	conj	O
lineage	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
Stat1alpha	NN	nsubjpass	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Stat3	NN	conj	B-protein
,	,	punct	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
EPO	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
cellular	JJ	amod	O
proliferation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
identified	VBD	ROOT	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha/MAD-3	NN	dobj	I-protein
as	IN	case	O
an	DT	det	O
immediate-early	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
signals	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
adhesion	NN	nmod	O
,	,	punct	O
lipopolysaccharide	NN	conj	O
,	,	punct	O
and	CC	cc	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	conj	O
.	.	punct	O

The	DT	det	O
leukocyte-specific	JJ	amod	O
,	,	punct	O
cytoskeleton-binding	JJ	dep	O
pp52	NN	compound	O
(	-LRB-	punct	O
LSP-1	NN	compound	O
,	,	punct	O
WP-34	NN	appos	O
)	-RRB-	punct	O
protein	NN	nsubjpass	O
is	VBZ	auxpass	O
widely	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
multiple	JJ	amod	O
leukocyte	NN	compound	O
lineages	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
B	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
T	NN	conj	I-cell_type
lymphocytes	NNS	dep	I-cell_type
,	,	punct	O
granulocytes	NNS	conj	B-cell_type
,	,	punct	O
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
IFN-gamma	NN	compound	B-protein
priming	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
p105	NN	compound	B-RNA
transcripts	NNS	nmod	I-RNA
but	CC	cc	O
enhanced	VBD	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
p65	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
(	-LRB-	punct	O
two-fold	RB	appos	O
)	-RRB-	punct	O
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
Mono	NN	compound	B-cell_line
Mac	NN	nmod	I-cell_line
6	CD	nummod	I-cell_line
with	IN	case	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
leads	VBZ	ROOT	O
to	TO	case	O
rapid	JJ	amod	O
and	CC	cc	O
transient	JJ	conj	O
expression	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
like	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
TNF	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
although	IN	mark	O
PBSC	NN	compound	B-cell_type
harvests	NNS	nsubj	O
collected	VBN	advcl	O
after	IN	case	O
consolidation	NN	compound	O
chemotherapy	NN	nmod	O
are	VBP	auxpass	O
contaminated	VBN	ccomp	O
by	IN	case	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
degree	NN	nsubj	O
of	IN	case	O
leukemic	JJ	amod	O
cell	NN	compound	O
contamination	NN	nmod	O
decreases	VBZ	ccomp	O
with	IN	case	O
repeated	VBN	amod	O
cycles	NNS	nmod	O
of	IN	case	O
chemotherapy	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
activation	NN	compound	O
mechanism	NN	nsubj	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
through	IN	case	O
the	DT	det	O
GM2/GC-box	JJ	amod	B-DNA
sequence	NN	nmod	I-DNA
is	VBZ	cop	O
different	JJ	ccomp	O
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
genes	NNS	nmod	O
carrying	VBG	acl	O
the	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
enhancer	NN	dobj	I-DNA
alone	RB	advmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
overexpression	NN	nsubj	O
of	IN	case	O
Syk	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
Lck-negative	JJ	amod	B-cell_line
JCaM1	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
enabled	VBD	ccomp	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
antigen	NN	compound	I-protein
receptor/CD3	NN	compound	I-protein
complex	NN	dobj	I-protein
to	TO	mark	O
induce	VB	xcomp	O
a	DT	det	O
normal	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
pathway	NN	nmod	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
a	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	compound	I-protein
reporter	NN	compound	O
construct	NN	nmod	O
.	.	punct	O

Tepoxalin	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
dual	JJ	amod	O
enzyme	NN	compound	O
inhibitor	NN	nsubjpass	O
of	IN	case	O
cyclooxygenase	NN	nmod	B-protein
and	CC	cc	O
5-lipoxygenase	NN	conj	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
T-cell	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
a	DT	det	O
suitably	RB	advmod	O
located	JJ	amod	O
TATA	NN	compound	B-DNA
box	NN	nsubj	I-DNA
,	,	punct	O
but	CC	cc	O
potential	JJ	amod	O
sites	NNS	nsubj	O
for	IN	case	O
CCAAT-box	NN	compound	B-protein
binding	NN	compound	I-protein
factors	NNS	nmod	I-protein
are	VBP	cop	O
far	RB	advmod	O
upstream	JJ	conj	O
,	,	punct	O
embedded	JJ	advcl	O
in	IN	case	O
a	DT	det	O
42-nucleotide	JJ	amod	B-DNA
repeat	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

LP	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
exhibit	VBP	ROOT	O
enhanced	VBN	amod	O
IL-2	NN	compound	B-protein
secretion	NN	dobj	O
when	WRB	advmod	O
activated	VBN	advcl	O
through	IN	case	O
the	DT	det	O
CD2	NN	compound	B-protein
pathway	NN	nmod	O
.	.	punct	O

Deletion	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
-70	CD	compound	B-DNA
to	TO	dep	I-DNA
-65	CD	nmod	I-DNA
and	CC	cc	I-DNA
-121	CD	compound	I-DNA
to	TO	dep	I-DNA
-103	CD	conj	I-DNA
regions	NNS	nmod	I-DNA
of	IN	case	O
the	DT	det	O
CD11c	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
loss	NN	nmod	O
of	IN	case	O
activation	NN	nmod	O
by	IN	case	O
Sp3	NN	nmod	B-protein
.	.	punct	O

Values	NNS	nsubjpass	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
benign	JJ	amod	O
tumors	NNS	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
4	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
undergoing	VBG	conj	O
a	DT	det	O
mammary	JJ	amod	O
reduction	NN	dobj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
7	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
DNA	NN	compound	O
variation	NN	nsubj	O
,	,	punct	O
233G	NN	nsubj	O
--	:	punct	O
>	NN	amod	O
A	NN	appos	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
result	VB	ROOT	O
in	IN	case	O
an	DT	det	O
amino	NN	compound	O
acid	NN	compound	O
change	NN	nmod	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
considered	VBN	conj	O
a	DT	det	O
benign	JJ	amod	O
polymorphism	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
demonstrated	VBD	ROOT	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
,	,	punct	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	conj	O
with	IN	case	O
antibody	NN	nmod	O
,	,	punct	O
UV	NN	compound	O
cross-linking	NN	conj	O
followed	VBN	acl	O
by	IN	case	O
SDS-gel	NN	compound	O
electrophoresis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
Western	NN	compound	O
analysis	NN	conj	O
that	IN	mark	O
Nm23H2	NN	nsubj	B-protein
in	IN	case	O
B	NN	compound	O
cell	NN	compound	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
bound	VBD	ccomp	O
to	TO	case	O
the	DT	det	O
c-myc	NN	compound	O
PuF	NN	compound	B-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Soluble	JJ	amod	B-protein
factors	NNS	nsubj	I-protein
secreted	VBN	acl	O
by	IN	case	O
activated	VBN	amod	B-cell_type
T-lymphocytes	NNS	nmod	I-cell_type
modulate	VBP	ROOT	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
immunosuppressive	JJ	amod	B-protein
cytokine	NN	compound	I-protein
TGF-beta	NN	nmod	B-protein
2	CD	nummod	I-protein
in	IN	case	O
glial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Nonadherent	JJ	amod	O
neutrophils	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
removed	VBN	ROOT	O
by	IN	mark	O
sealing	VBG	advcl	O
and	CC	cc	O
inverting	VBG	conj	O
the	DT	det	O
culture	NN	dobj	O
well	RB	advmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
confirm	VBP	ROOT	O
at	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
level	NN	nmod	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
HIV-1	NN	nmod	O
to	TO	mark	O
replicate	VB	acl	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
strongly	RB	advmod	O
associated	VBN	conj	O
with	IN	case	O
NF-kappaB	NN	nmod	B-protein
.	.	punct	O

This	DT	det	O
enzyme	NN	nsubj	O
releases	VBZ	ROOT	O
arachidonic	JJ	amod	O
acid	NN	dobj	O
and	CC	cc	O
lyso-phospholipids	NNS	conj	O
from	IN	case	O
membranes	NNS	nmod	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
metabolized	VBN	acl:relcl	O
to	TO	case	O
eicosanoids	NNS	nmod	O
and	CC	cc	O
platelet-activating-factor	NN	conj	O
.	.	punct	O

PNU156804	NN	compound	O
action	NN	nsubj	O
is	VBZ	cop	O
restricted	JJ	ROOT	O
to	TO	case	O
some	DT	det	O
signaling	NN	compound	O
pathways	NNS	nmod	O
;	:	punct	O
it	PRP	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
affect	VB	parataxis	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
by	IN	case	O
PMA	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
blocks	VBZ	conj	O
that	DT	dobj	O
induced	VBN	acl	O
by	IN	case	O
CD40	NN	compound	B-protein
cross-linking	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Within	IN	case	O
the	DT	det	O
upstream	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
region	NN	nmod	I-DNA
of	IN	case	O
Bcl-x	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
potential	JJ	amod	O
NF-kappaB-binding	JJ	amod	B-DNA
sequence	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
support	VB	xcomp	O
NF-kappaB	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
c-fos	NN	nmod	B-DNA
,	,	punct	O
c-jun	NN	conj	B-DNA
and	CC	cc	O
jun	NN	compound	B-DNA
B	NN	conj	I-DNA
in	IN	case	O
peripheral	JJ	amod	O
blood	NN	compound	O
lymphocytes	NNS	nmod	O
from	IN	case	O
young	JJ	amod	O
and	CC	cc	O
elderly	JJ	conj	O
adults	NNS	nmod	O
.	.	punct	O

The	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
LT-293	NN	compound	B-DNA
CAT	NN	compound	B-protein
activity	NN	nmod	O
mirrored	VBD	ROOT	O
the	DT	det	O
increase	NN	dobj	O
in	IN	case	O
LT	NN	compound	B-protein
biologic	JJ	amod	O
activity	NN	nmod	O
seen	VBN	acl	O
under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
.	.	punct	O

p21ras	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
antigen	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
TCR	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
then	RB	advmod	O
co-ordinates	VBZ	conj	O
important	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	dobj	O
for	IN	case	O
T	NN	compound	B-protein
lymphocyte	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

Negative	JJ	ROOT	O
,	,	punct	O
positive	JJ	conj	O
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
effects	NNS	nsubjpass	O
of	IN	case	O
Nef	NN	nmod	B-protein
have	VBP	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
reported	VBN	conj	O
on	IN	case	O
viral	JJ	amod	O
replication	NN	nmod	O
in	IN	case	O
cells	NNS	nmod	O
.	.	punct	O

Haplotypes	NNS	nsubjpass	O
containing	VBG	acl	O
HLA	NN	compound	B-DNA
DQA1*0501	NN	dobj	I-DNA
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
HLA	NN	compound	B-DNA
DQA1*0201	NN	conj	I-DNA
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
HLA	NN	compound	B-DNA
DQB1*0201	NN	nsubjpass	I-DNA
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
Grave	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
and	CC	cc	O
celiac	JJ	amod	O
sprue	NN	conj	O
.	.	punct	O

A	DT	det	O
human	JJ	amod	O
homologue	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Drosophila	FW	compound	B-protein
Toll	NN	compound	I-protein
protein	NN	compound	I-protein
signals	VBZ	compound	O
activation	NN	nmod	O
of	IN	case	O
adaptive	JJ	amod	O
immunity	NN	nmod	O
[	-LRB-	punct	O
see	VB	ROOT	O
comments	NNS	dobj	O
]	-RRB-	punct	O

In	IN	case	O
humans	NNS	nmod	O
,	,	punct	O
studies	NNS	nsubj	O
carried	VBN	ROOT	O
out	RP	prt	O
in	IN	case	O
surgically	RB	advmod	O
removed	VBN	amod	O
parathyroid	JJ	amod	O
glands	NNS	nmod	O
have	VBP	aux	O
shown	VBN	conj	O
that	IN	mark	O
calcitriol	NN	compound	O
binding	NN	nsubj	O
is	VBZ	cop	O
higher	JJR	ccomp	O
in	IN	case	O
primary	JJ	nmod	O
than	IN	case	O
in	IN	case	O
secondary	JJ	amod	O
hyperparathyroidism	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Age-related	JJ	amod	O
changes	NNS	ROOT	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
and	CC	cc	I-protein
mineralocorticoid	NN	conj	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
of	IN	case	O
healthy	JJ	amod	O
persons	NNS	nmod	O
and	CC	cc	O
patients	NNS	conj	O
with	IN	case	O
hypertension	NN	nmod	O
]	-RRB-	punct	O

The	DT	det	O
PML	NN	compound	B-protein
gene	NN	compound	I-protein
product	NN	nsubj	I-protein
has	VBZ	aux	O
been	VBN	aux	O
localized	JJ	ROOT	O
to	TO	case	O
subnuclear	JJ	amod	B-cell_line
dot-like	JJ	amod	I-cell_line
structures	NNS	nmod	I-cell_line
variously	RB	advmod	O
termed	VBN	acl	O
PODs	NNS	xcomp	O
,	,	punct	O
ND10s	NNS	conj	O
,	,	punct	O
Kr	NN	compound	O
bodies	NNS	conj	O
,	,	punct	O
or	CC	cc	O
PML	NN	compound	O
nuclear	JJ	amod	O
bodies	NNS	conj	O
(	-LRB-	punct	O
PML	NN	compound	O
NBs	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

She	PRP	nsubj	O
had	VBD	aux	O
generalized	VBN	ROOT	O
lymphadenopathy	NN	dobj	O
and	CC	cc	O
the	DT	det	O
bone	NN	compound	O
marrow	NN	nsubjpass	O
was	VBD	auxpass	O
infiltrated	VBN	conj	O
by	IN	case	O
lymphoma	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
at	IN	case	O
presentation	NN	nmod	O
.	.	punct	O

The	DT	det	O
NM23	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
proposed	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
metastasis-suppressor	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
use	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	conj	O
as	IN	case	O
prognostic	JJ	amod	O
factor	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
developed	VBN	ROOT	O
a	DT	det	O
reporter	NN	compound	O
assay	NN	dobj	O
to	TO	mark	O
begin	VB	advcl	O
characterizing	VBG	xcomp	O
the	DT	det	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
late	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Cyclosporin	NN	compound	O
A	NN	nsubj	O
impaired	VBD	ROOT	O
not	RB	neg	O
only	RB	cc:preconj	O
early	JJ	advmod	O
and	CC	cc	O
late	JJ	conj	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
immediate	JJ	amod	O
events	NNS	dobj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
addition	NN	nsubj	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
prevented	VBD	parataxis	O
all	DT	det	O
inhibition	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
IL-4	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
evoked	VBN	acl	O
by	IN	case	O
other	JJ	amod	O
T-helper	NN	compound	B-protein
cell	NN	compound	I-protein
cytokines	NNS	nmod	I-protein
:	:	punct	O
IL-2	NN	dep	B-protein
,	,	punct	O
IL-3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
GM-CSF	NN	conj	B-protein
.	.	punct	O

Circulating	VBG	amod	B-cell_type
T-cells	NNS	nsubj	I-cell_type
from	IN	case	O
individuals	NNS	nmod	O
with	IN	case	O
filaria-induced	JJ	amod	O
lymphatic	JJ	amod	O
pathology	NN	nmod	O
(	-LRB-	punct	O
LP	NN	appos	O
)	-RRB-	punct	O
had	VBD	ROOT	O
significantly	RB	advmod	O
greater	JJR	amod	O
migration	NN	dobj	O
through	IN	case	O
unstimulated	JJ	amod	O
HUVEC	NN	compound	B-cell_type
monolayers	NNS	nmod	I-cell_type
than	IN	mark	O
did	VBD	advcl	O
T-cells	NNS	nsubj	O
from	IN	case	O
asymptomatic	JJ	amod	O
infected	JJ	amod	O
(	-LRB-	punct	O
MF	NN	appos	O
)	-RRB-	punct	O
individuals	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0.04	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
compounds	NNS	nsubj	O
also	RB	advmod	O
inhibited	VBD	ROOT	O
beta-galactosidase	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	dobj	O
.	.	punct	O

PPARgamma	NN	nsubj	B-protein
induces	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
many	JJ	amod	O
genes	NNS	nmod	B-DNA
involved	VBN	acl	O
in	IN	case	O
lipid	NN	compound	O
anabolism	NN	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
adipocyte	NN	compound	B-protein
fatty	JJ	amod	I-protein
acid	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
aP2	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	conj	O
of	IN	case	O
adipocyte	NN	compound	B-cell_type
differentiation	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
protein-DNA	JJ	amod	O
interactions	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
beta-globin	NN	compound	I-DNA
locus	NN	nmod	I-DNA
in	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
expressing	VBG	acl	O
the	DT	det	O
fetal	JJ	dobj	O
or	CC	cc	O
the	DT	det	O
adult	JJ	amod	O
globin	NN	compound	B-DNA
gene	NN	compound	I-DNA
program	NN	dep	O
.	.	punct	O

Certain	JJ	amod	O
subpopulations	NNS	nsubj	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
synthesize	VBP	ROOT	O
and	CC	cc	O
secrete	VB	conj	O
biologically	RB	advmod	O
active	JJ	amod	O
prolactin	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
suggests	VBZ	ccomp	O
that	IN	mark	O
prolactin	NN	nsubj	O
can	MD	aux	O
act	VB	ccomp	O
as	IN	case	O
an	DT	det	O
autocrine	JJ	amod	O
and/or	CC	cc	O
paracrine	NN	conj	O
factor	NN	nmod	O
to	TO	mark	O
modulate	VB	xcomp	O
the	DT	det	O
activities	NNS	dobj	O
of	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

The	DT	det	O
Bcd	NN	compound	B-DNA
proto-oncogene	NN	nsubjpass	B-DNA
was	VBD	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
truncation	NN	nmod	O
in	IN	case	O
the	DT	det	O
5	CD	nummod	B-DNA
'	''	punct	I-DNA
UTR	NNP	nmod	I-DNA
.	.	punct	O

In	IN	case	O
EMSAs	NNS	nmod	O
,	,	punct	O
this	DT	det	O
substitution	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
a	DT	det	O
markedly	RB	advmod	O
enhanced	VBN	amod	O
affinity	NN	nmod	O
for	IN	case	O
sequence-specific	JJ	amod	O
complexes	NNS	nmod	O
exhibiting	VBG	acl	O
an	DT	det	O
AP-1	NN	compound	B-protein
specificity	NN	dobj	O
.	.	punct	O

Gel	NN	compound	O
shift	NN	compound	O
analyses	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
nuclear	JJ	amod	O
translocation	NN	nsubjpass	O
is	VBZ	auxpass	O
stimulated	VBN	ccomp	O
primarily	RB	advmod	O
by	IN	case	O
IL-1	NN	nmod	B-protein
rather	RB	cc	O
than	IN	mwe	O
by	IN	case	O
antigen	NN	compound	B-protein
receptor	NN	compound	I-protein
signals	NNS	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
functional	JJ	amod	O
activity	NN	nsubj	O
of	IN	case	O
ligands	NNS	nmod	O
built	VBN	acl	O
from	IN	case	O
the	DT	det	O
binding	VBG	amod	B-protein
site	NN	nmod	I-protein
of	IN	case	O
G28-5	NN	nmod	B-protein
is	VBZ	cop	O
highly	RB	advmod	O
dependent	JJ	ccomp	O
upon	IN	case	O
the	DT	det	O
size	NN	nmod	O
and	CC	cc	O
physical	JJ	amod	O
properties	NNS	conj	O
of	IN	case	O
the	DT	det	O
molecule	NN	nmod	O
both	CC	cc:preconj	O
in	IN	case	O
solution	NN	nmod	O
and	CC	cc	O
on	IN	case	O
the	DT	det	O
cell	NN	compound	O
surfaces	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
trophic	JJ	amod	O
effect	NN	dobj	O
resulting	VBG	acl	O
from	IN	case	O
activation	NN	nmod	O
of	IN	case	O
such	PDT	det:predet	O
a	DT	det	O
receptor	NN	nmod	O
by	IN	mark	O
using	VBG	advcl	O
the	DT	det	O
reporter	NN	compound	B-DNA
gene	NN	compound	I-DNA
strategy	NN	dobj	O
.	.	punct	O

RNA	NN	nsubjpass	B-RNA
was	VBD	auxpass	O
extracted	VBN	ROOT	O
by	IN	case	O
phenol/chloroform	NN	nmod	O
and	CC	cc	O
c-fos	NN	conj	B-DNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
analyzed	VBN	conj	O
by	IN	case	O
PCR	NN	compound	O
assisted	JJ	amod	O
mRNA	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

In	IN	case	O
parallel	NN	nmod	O
,	,	punct	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
dexamethasone	NN	nmod	O
on	IN	case	O
3-O-methyl-D-glucose	NN	compound	O
uptake	NN	nmod	O
was	VBD	auxpass	O
assayed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

Cell	NN	compound	O
cycle-dependent	JJ	amod	O
initiation	NN	ROOT	O
and	CC	cc	O
lineage-dependent	JJ	amod	O
abrogation	NN	conj	O
of	IN	case	O
GATA-1	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
pure	JJ	amod	B-cell_type
differentiating	VBG	amod	I-cell_type
hematopoietic	JJ	amod	I-cell_type
progenitors	NNS	nmod	I-cell_type
.	.	punct	O

Cross-linking	NN	nsubj	O
of	IN	case	O
FcR	NNS	nmod	B-protein
with	IN	case	O
immune	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
leads	VBZ	ROOT	O
,	,	punct	O
first	RB	advmod	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
protein-tyrosine	JJ	amod	B-protein
kinases	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
Oct	NN	compound	O
1	CD	nummod	O
transcription	NN	compound	B-protein
factor	NN	nsubjpass	I-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
very	RB	advmod	O
close	JJ	amod	O
homologue	NN	conj	O
,	,	punct	O
KIAA0144	NN	appos	B-DNA
,	,	punct	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
using	VBG	xcomp	O
the	DT	det	O
POU	NN	compound	O
family	NN	compound	O
primers	NNS	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
activity	NN	nsubj	O
of	IN	case	O
a	DT	det	O
bHLH	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
is	VBZ	cop	O
necessary	JJ	ROOT	O
for	IN	case	O
T	NN	compound	O
lineage	NN	compound	O
differentiation	NN	nmod	O
of	IN	case	O
bipotential	JJ	amod	B-cell_type
precursors	NNS	nmod	I-cell_type
,	,	punct	O
in	IN	mark	O
the	DT	det	O
absence	NN	intj	O
of	IN	case	O
which	WDT	nmod	O
a	DT	det	O
default	NN	amod	O
pathway	NN	nsubjpass	O
leading	VBG	acl	O
to	TO	case	O
NK	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
is	VBZ	auxpass	O
chosen	VBN	advcl	O
.	.	punct	O

Peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
PBL	NN	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
alloreactive	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
of	IN	case	O
two	CD	nummod	O
male	JJ	amod	O
infants	NNS	nmod	O
born	VBN	acl	O
to	TO	case	O
consanguinous	JJ	amod	O
parents	NNS	nmod	O
and	CC	cc	O
presenting	VBG	conj	O
with	IN	case	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	nmod	O
(	-LRB-	punct	O
SCID	NN	appos	O
)	-RRB-	punct	O
showed	VBD	ROOT	O
a	DT	det	O
pronounced	JJ	amod	O
deficiency	NN	dobj	O
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
recruitment	NN	nsubj	O
of	IN	case	O
EKLF	NN	nmod	B-protein
to	TO	case	O
5'HS2	NN	nmod	B-DNA
requires	VBZ	ccomp	O
the	DT	det	O
TATA	NN	compound	B-DNA
box	NN	dobj	I-DNA
,	,	punct	O
but	CC	cc	O
recruitment	NN	nsubj	O
to	TO	case	O
5'HS3	NN	nmod	B-DNA
depends	VBZ	conj	O
on	IN	case	O
the	DT	dep	O
CACCC	NN	nmod	O
and	CC	cc	O
TATA	NN	conj	B-DNA
boxes	NNS	dep	I-DNA
of	IN	case	O
the	DT	det	O
beta-globin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
illustrate	VBP	ROOT	O
gain-of-function	NN	dobj	O
as	IN	case	O
a	DT	det	O
feasible	JJ	amod	O
strategy	NN	nsubjpass	O
for	IN	mark	O
developing	VBG	acl	O
safer	JJR	amod	O
live-attenuated	JJ	amod	O
HIVs	NNS	dobj	O
to	TO	mark	O
be	VB	auxpass	O
tested	VBN	conj	O
as	IN	case	O
candidates	NNS	nmod	O
for	IN	case	O
AIDS	NN	compound	O
vaccine	NN	nmod	O
.	.	punct	O

After	IN	case	O
LPS	NN	compound	O
stimulation	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
,	,	punct	O
IkappaB-alpha	NN	compound	B-protein
protein	NN	compound	O
levels	NNS	nsubj	O
decreased	VBD	ROOT	O
,	,	punct	O
and	CC	cc	O
NF-kappaB	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	nsubj	O
increased	VBD	conj	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
Tax	NN	compound	B-protein
protein	NN	nmod	I-protein
in	IN	case	O
19D	NN	nmod	B-cell_line
and	CC	cc	O
9J	NN	conj	B-cell_line
resulted	VBD	ROOT	O
in	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
NF-kappa	NN	nmod:npmod	I-DNA
B-dependent	JJ	amod	I-DNA
granulocyte-macrophage	JJ	amod	I-DNA
colony	NN	compound	I-DNA
stimulating	NN	compound	I-DNA
factor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
increased	VBD	amod	O
basal	JJ	amod	O
level	NN	compound	O
expression	NN	conj	O
of	IN	case	O
transfected	VBN	amod	O
NF-kappa	NN	nmod:npmod	B-DNA
B-regulated	JJ	amod	I-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
wished	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
if	IN	mark	O
this	DT	det	O
developmentally	RB	advmod	O
related	JJ	amod	O
interaction	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
consequence	NN	ccomp	O
of	IN	case	O
myeloid	JJ	amod	O
differentiation	NN	nmod	O
or	CC	cc	O
an	DT	det	O
intrinsic	JJ	amod	O
differentiating	VBG	amod	O
stimulus	NN	conj	O
.	.	punct	O

Several	JJ	amod	O
forms	NNS	nsubjpass	O
of	IN	case	O
EGR-1	NN	compound	B-protein
protein	NN	nmod	I-protein
are	VBP	auxpass	O
found	VBN	ROOT	O
within	IN	case	O
the	DT	det	O
different	JJ	amod	O
groups	NNS	nmod	O
of	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
binding	NN	compound	O
activity	NN	nsubjpass	O
to	TO	case	O
DNA	NN	compound	B-DNA
consensus	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
was	VBD	auxpass	O
investigated	VBN	conj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
binding	NN	nmod	O
by	IN	case	O
anti-P	NN	amod	B-protein
selectin	NN	compound	I-protein
antibodies	NNS	nmod	I-protein
reduced	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
activated	VBN	amod	B-cell_type
platelets	NNS	nmod	I-cell_type
on	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
their	PRP$	nmod:poss	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
controlled	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
non-clonal	JJ	amod	O
,	,	punct	O
or	CC	cc	O
innate	JJ	conj	O
,	,	punct	O
component	NN	nmod	O
of	IN	case	O
immunity	NN	nmod	O
that	WDT	nsubj	O
preceded	VBD	acl:relcl	O
in	IN	case	O
evolution	NN	nmod	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
an	DT	det	O
adaptive	JJ	amod	O
immune	JJ	amod	O
system	NN	nmod	O
in	IN	case	O
vertebrates	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
55	CD	nummod	B-protein
kd	NN	compound	I-protein
TNFR	NN	nsubj	I-protein
plays	VBZ	ROOT	O
a	DT	det	O
decisive	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
host	NN	nmod:poss	O
's	POS	case	O
defense	NN	nmod	O
against	IN	case	O
microorganisms	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
pathogenic	JJ	amod	O
factors	NNS	conj	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
weight	NN	nmod	O
,	,	punct	O
DNA-binding	JJ	amod	O
characteristics	NNS	conj	O
,	,	punct	O
and	CC	cc	O
in	FW	amod	O
vivo	FW	dep	O
transactivation	NN	compound	O
activity	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
previously	RB	advmod	O
identified	VBN	amod	O
DRE	NN	compound	B-DNA
1	CD	nummod	I-DNA
-binding	JJ	amod	O
protein	NN	nsubj	O
,	,	punct	O
p37	NN	appos	B-protein
,	,	punct	O
is	VBZ	cop	O
YB-1	NN	ccomp	B-protein
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
IL-4	NN	nsubj	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
markedly	RB	advmod	O
and	CC	dep	O
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
HIV	NN	compound	O
replication	NN	dobj	O
at	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
level	NN	nmod	O
in	IN	case	O
monocyte-derived	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
this	DT	nsubj	O
occurred	VBD	conj	O
whether	IN	mark	O
these	DT	det	O
cytokines	NNS	nsubjpass	B-protein
were	VBD	auxpass	O
added	VBN	ccomp	O
before	IN	nmod	O
or	CC	cc	O
after	IN	conj	O
HIV	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
are	VBP	cop	O
the	DT	det	O
first	JJ	ROOT	O
to	TO	mark	O
demonstrate	VB	acl	O
the	DT	det	O
structural	JJ	amod	O
organization	NN	dobj	O
of	IN	case	O
a	DT	det	O
vertebrate	NN	compound	B-DNA
gene	NN	nmod	I-DNA
encoding	VBG	acl	O
an	DT	det	O
integral	JJ	amod	B-protein
membrane	NN	compound	I-protein
protein	NN	dobj	I-protein
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
envelope	NN	nmod	O
that	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
member	NN	acl:relcl	O
of	IN	case	O
a	DT	det	O
family	NN	nmod	O
of	IN	case	O
polypeptides	NNS	nmod	O
conserved	VBN	acl	O
in	IN	case	O
evolution	NN	nmod	O
.	.	punct	O

Stat3	NN	compound	B-protein
recruitment	NN	ROOT	O
by	IN	case	O
two	CD	nummod	O
distinct	JJ	amod	O
ligand-induced	JJ	amod	B-protein
,	,	punct	I-protein
tyrosine-phosphorylated	JJ	dep	I-protein
docking	NN	compound	I-protein
sites	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
interleukin-10	NN	compound	B-protein
receptor	NN	compound	I-protein
intracellular	JJ	amod	I-protein
domain	NN	nmod	I-protein
.	.	punct	O

CD2	NN	compound	B-protein
cross-linking	NN	nsubj	O
concurrently	RB	advmod	O
increased	VBD	ROOT	O
phosphorylation	NN	dobj	O
of	IN	case	O
CREB	NN	nmod	B-protein
detected	VBN	acl	O
by	IN	case	O
immunoblot	NN	compound	O
assay	NN	nmod	O
eightfold	RB	advmod	O
.	.	punct	O

Patients	NNS	nsubjpass	O
with	IN	case	O
steroid-resistant	JJ	amod	O
asthma	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
a	DT	det	O
reduced	VBN	amod	O
GCR	NN	compound	B-protein
binding	NN	compound	O
affinity	NN	dobj	O
.	.	punct	O

The	DT	det	O
requirements	NNS	nsubj	O
for	IN	case	O
induction	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
reflected	VBD	ROOT	O
the	DT	det	O
requirements	NNS	dobj	O
for	IN	case	O
the	DT	det	O
secretion	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
including	VBG	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
TNF-alpha	NN	conj	B-protein
,	,	punct	O
IFN-gamma	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
granulocyte	NN	compound	B-protein
macrophage-CSF	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
estrogen-dependent	JJ	amod	O
and	CC	cc	O
tissue-specific	JJ	conj	O
regulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
Xenopus	NN	compound	O
laevis	NN	amod	O
vitellogenin	NN	compound	B-DNA
gene	NN	compound	I-DNA
B1	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
studied	VBN	ROOT	O
by	IN	case	O
lipid-mediated	JJ	amod	O
DNA	NN	compound	O
transfer	NN	nmod	O
into	IN	case	O
Xenopus	NN	compound	B-cell_type
hepatocytes	NNS	nmod	I-cell_type
in	IN	case	O
primary	JJ	amod	O
culture	NN	nmod	O
.	.	punct	O

RFX-B	NN	nsubj	B-DNA
is	VBZ	cop	O
the	DT	det	O
gene	NN	ROOT	O
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
cause	NN	nmod	O
of	IN	case	O
the	DT	det	O
bare	JJ	amod	O
lymphocyte	NN	compound	O
syndrome	NN	nmod	O
,	,	punct	O
an	DT	det	O
MHC	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
immunodeficiency	NN	appos	O
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	dep	O
in	IN	case	O
Immunity	NN	compound	O
1999	CD	nummod	O
Mar	NNP	nmod	O
;	:	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
3	CD	dep	O
)	-RRB-	punct	O
:	:	punct	O
399	CD	dep	O
]	-RRB-	punct	O

Using	VBG	advcl	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
TPCK	NN	nsubj	O
virtually	RB	advmod	O
abolishes	VBZ	ccomp	O
(	-LRB-	punct	O
to	TO	case	O
less	JJR	advmod	O
than	IN	quantmod	O
1	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
the	DT	det	O
levels	NNS	dobj	O
of	IN	case	O
NF	NN	compound	B-protein
(	-LRB-	punct	I-protein
kappa	NN	compound	I-protein
)	-RRB-	punct	I-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
but	CC	cc	O
not	RB	cc	O
Oct-1	NN	conj	B-protein
)	-RRB-	punct	O
found	VBN	acl	O
in	IN	case	O
nuclear	JJ	amod	O
and	CC	cc	O
whole	JJ	conj	O
cell	NN	compound	O
extracts	NNS	nmod	O
of	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Fas/	NN	compound	O
FasL	NN	compound	B-protein
interaction	NN	nsubj	O
initiates	VBZ	ROOT	O
cell	NN	compound	O
death	NN	dobj	O
in	IN	case	O
many	JJ	amod	O
other	JJ	amod	O
systems	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
dysregulation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
mechanism	NN	conj	O
by	IN	case	O
which	WDT	nmod	O
several	JJ	amod	O
pathologic	JJ	amod	O
conditions	NNS	nsubj	O
arise	VBP	acl:relcl	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
Smad6	NN	nsubj	B-protein
and	CC	cc	O
Smad7	NN	conj	B-protein
are	VBP	cop	O
human	JJ	amod	B-protein
bone	NN	compound	I-protein
morphogenetic	JJ	amod	I-protein
protein-2	NN	compound	I-protein
(	-LRB-	punct	O
hBMP-2	NN	appos	B-protein
)	-RRB-	punct	O
-inducible	JJ	amod	O
antagonists	NNS	ccomp	O
of	IN	case	O
hBMP-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
growth	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
mouse	NN	compound	B-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
hybridoma	NN	compound	I-cell_line
HS-72	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	dep	O
six	CD	compound	O
5	CD	nummod	B-DNA
'	''	punct	I-DNA
upstream	JJ	amod	I-DNA
and	CC	cc	O
one	CD	nummod	O
intronic	JJ	amod	B-DNA
DHS	NN	nsubjpass	I-DNA
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
only	RB	advmod	O
perforin-expressing	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
DTCs	NNS	nsubj	O
inhibited	VBD	ccomp	O
both	CC	cc:preconj	O
interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
synthesis	NN	dobj	O
and	CC	cc	O
membrane	NN	compound	O
expression	NN	conj	O
of	IN	case	O
antigens	NNS	nmod	B-protein
which	WDT	nsubjpass	O
are	VBP	auxpass	O
induced	VBN	acl:relcl	O
during	IN	case	O
T-cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
the	DT	det	O
chimera	NN	compound	B-protein
PMLRAR	NN	compound	I-protein
alpha	NN	nsubj	I-protein
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
leukemogenesis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
expressed	VBD	ROOT	O
a	DT	det	O
PMLRAR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
cDNA	NN	dobj	I-DNA
in	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

A	DT	det	O
study	NN	ROOT	O
on	IN	case	O
the	DT	det	O
circadian	JJ	amod	O
rhythm	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Reversible	JJ	amod	O
differentiation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-cell_line
monoblastic	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
U937	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
ML-9	NN	nmod	O
,	,	punct	O
an	DT	det	O
inhibitor	NN	appos	O
of	IN	case	O
myosin	JJ	compound	B-protein
light	JJ	amod	I-protein
chain	NN	compound	I-protein
kinase	NN	nmod	I-protein
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
the	DT	det	O
Egr-1-expressing	JJ	amod	B-cell_line
Ramos	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
showed	VBD	ROOT	O
reduced	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
CD95	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
genes	NNS	nmod	O
for	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
involved	VBN	acl	O
in	IN	case	O
myeloid	JJ	amod	O
differentiation	NN	nmod	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
Mycoplasma	NN	compound	B-protein
fermentans	NNS	compound	I-protein
lipid-associated	JJ	amod	I-protein
membrane	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
(	-LRB-	punct	O
LAMPf	NN	appos	B-protein
)	-RRB-	punct	O
induce	VBP	ccomp	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
IL-8	NN	nmod	B-protein
by	IN	case	O
THP-1	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
human	JJ	amod	I-cell_line
monocyte	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
PMN	NN	conj	B-cell_type
at	IN	case	O
the	DT	det	O
same	JJ	amod	O
extent	NN	nmod	O
as	IN	case	O
LPS	NN	nmod	O
.	.	punct	O

Chronic	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	nsubj	O
evolves	VBZ	ROOT	O
in	IN	case	O
two	CD	nummod	O
clinically	RB	advmod	O
distinct	JJ	amod	O
stages	NNS	nmod	O
:	:	punct	O
a	DT	det	O
chronic	JJ	dep	O
and	CC	cc	O
a	DT	det	O
blast	NN	compound	O
crisis	NN	compound	O
phase	NN	dep	O
.	.	punct	O

The	DT	det	O
modified	VBN	amod	O
vectors	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
transduce	VB	xcomp	O
human	JJ	amod	B-cell_line
hematopoietic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dobj	I-cell_line
,	,	punct	O
cord	NN	compound	B-cell_type
blood-derived	JJ	amod	I-cell_type
CD34	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
stem/progenitor	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
murine	JJ	amod	B-cell_line
bone	NN	compound	I-cell_line
marrow	NN	compound	I-cell_line
repopulating	VBG	amod	I-cell_line
stem	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
regulation	NN	nsubj	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
CD8	NN	compound	B-protein
or	CC	cc	O
CD4	NN	conj	B-protein
antigens	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
leukemic	JJ	amod	B-cell_line
clone	NN	compound	I-cell_line
CEM	NN	compound	I-cell_line
C1	NN	nmod	I-cell_line
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
CD3	NN	compound	O
ligation	NN	nsubj	O
by	IN	case	O
mAb	NN	nmod	O
and	CC	cc	O
Staphylococcal	JJ	amod	O
enterotoxin	NN	conj	O
(	-LRB-	punct	O
SE	NN	appos	O
)	-RRB-	punct	O
induce	VBP	ccomp	O
a	DT	det	O
rapid	JJ	amod	O
,	,	punct	O
gradually	RB	advmod	O
accumulating	VBG	dep	O
,	,	punct	O
long-lasting	JJ	dep	O
tyrosine	NN	dobj	O
,	,	punct	O
and	CC	cc	O
serine	NN	compound	O
phosphorylation	NN	conj	O
of	IN	case	O
Stat3	NN	nmod	B-protein
(	-LRB-	punct	O
but	CC	cc	O
not	RB	cc	O
Stat5	NN	conj	B-protein
)	-RRB-	punct	O
in	IN	case	O
allogen-specific	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
CD4+	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Copyright	NN	compound	O
1997	CD	nummod	O
Academic	NNP	compound	O
Press	NNP	ROOT	O
.	.	punct	O

Progesterone	NN	nsubj	O
had	VBD	ROOT	O
little	JJ	amod	O
or	CC	cc	O
no	DT	conj	O
effect	NN	dobj	O
on	IN	case	O
a	DT	det	O
cloned	VBN	amod	B-protein
voltage-gated	JJ	amod	I-protein
Na+	NN	compound	I-protein
channel	NN	nmod	I-protein
,	,	punct	O
an	DT	det	O
inward	JJ	amod	O
rectifier	NN	compound	O
K+	NN	compound	B-protein
channel	NN	appos	I-protein
,	,	punct	O
or	CC	cc	O
on	IN	case	O
lymphocyte	NN	compound	B-protein
Ca2+	NN	compound	I-protein
and	CC	cc	I-protein
Cl-	NN	conj	I-protein
channels	NNS	conj	I-protein
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
the	DT	det	O
NH	NN	compound	B-protein
(	-LRB-	punct	I-protein
2	CD	nummod	I-protein
)	-RRB-	punct	I-protein
-terminal	JJ	amod	I-protein
domain	NN	nsubj	I-protein
of	IN	case	O
N-WASP	NN	nmod	B-protein
interacts	VBZ	ROOT	O
with	IN	case	O
F-actin	NN	nmod	B-protein
,	,	punct	O
mediating	VBG	advcl	O
the	DT	det	O
attachment	NN	dobj	O
of	IN	case	O
the	DT	det	O
actin	NN	compound	B-protein
tail	NN	nmod	I-protein
to	TO	case	O
the	DT	det	O
bacterium	NN	compound	O
surface	NN	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
a	DT	det	O
clearly	RB	advmod	O
defined	VBN	amod	O
and	CC	cc	O
substantial	JJ	conj	O
role	NN	attr	O
for	IN	case	O
free	JJ	amod	O
radicals	NNS	nmod	O
or	CC	cc	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	conj	O
(	-LRB-	punct	O
ROS	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
periodontitis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
little	JJ	amod	O
research	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
performed	VBN	conj	O
in	IN	prep	O
this	DT	det	O
area	NN	pobj	O
.	.	punct	O

The	DT	det	O
expression	NN	compound	O
patterns	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
RBTN-2	NN	nsubj	B-protein
normally	RB	advmod	O
interacts	VBZ	ccomp	O
equally	RB	advmod	O
with	IN	case	O
elf-2a	NN	nmod	B-protein
and	CC	cc	O
elf-2b	NN	conj	B-protein
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
behavior	NN	dobj	O
of	IN	case	O
Bcl-2	NN	nmod	B-protein
in	IN	case	O
normal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
blasts	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
transiently	RB	advmod	O
transfected	VBN	ROOT	O
with	IN	case	O
Bcl-2	NN	nmod	B-protein
and	CC	cc	O
related	JJ	amod	O
gene	NN	compound	B-protein
products	NNS	conj	I-protein
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
on	IN	case	O
apoptotic	JJ	amod	O
signaling	NN	nmod	O
.	.	punct	O

To	IN	prep	O
date	NN	pobj	O
,	,	punct	O
a	DT	det	O
large	JJ	amod	O
number	NN	nsubjpass	O
of	IN	case	O
receptors	NNS	nmod	O
for	IN	case	O
IL-12	NN	nmod	B-protein
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
only	RB	advmod	O
on	IN	case	O
PBMC	NN	nmod	B-cell_type
following	VBG	case	O
activation	NN	nmod	O
with	IN	case	O
PHA	NN	nmod	B-protein
or	CC	cc	O
IL-2	NN	conj	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
with	IN	case	O
endometriosis	NN	nmod	O
,	,	punct	O
adenomyotic	JJ	amod	O
lesions	NNS	nsubj	O
showed	VBD	ROOT	O
identical	JJ	amod	O
steroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptor	NN	compound	I-protein
expression	NN	dobj	O
,	,	punct	O
proliferative	JJ	amod	O
activity	NN	conj	O
,	,	punct	O
bcl-2	NN	compound	B-protein
expression	NN	conj	O
and	CC	cc	O
leukocyte	NN	compound	O
subpopulations	NNS	conj	O
to	TO	case	O
eutopic	JJ	amod	O
endometrium	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
different	JJ	amod	O
aetiologies	NNS	dobj	O
for	IN	case	O
these	DT	det	O
disorders	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
STATs	NNS	nmod	B-protein
in	IN	case	O
the	DT	det	O
transformation	NN	nmod	O
of	IN	case	O
T-cells	NNS	nmod	B-cell_type
by	IN	case	O
HTLV-1	NN	nmod	O
.	.	punct	O

CD19	NN	compound	B-protein
expression	NN	nsubj	O
begins	VBZ	ROOT	O
at	IN	case	O
the	DT	det	O
pro-B	JJ	amod	O
cell	NN	compound	O
stage	NN	nmod	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Resting	VBG	amod	O
T-cell	NN	compound	O
nuclear	JJ	amod	O
extracts	NNS	nsubj	O
contained	VBD	ROOT	O
KBF1/p50	NN	compound	B-protein
homodimer	NN	dobj	I-protein
.	.	punct	O

Transcription	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
minimal	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
from	IN	case	O
the	DT	det	O
NF-IL6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
CREB/ATF	NN	nmod	B-protein
and	CC	cc	O
SP1	NN	conj	B-protein
proteins	NNS	dep	I-protein
in	IN	case	O
U937	NN	compound	B-cell_line
promonocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
NH2Cl-treated	JJ	amod	B-cell_line
neutrophils	NNS	nsubj	I-cell_line
showed	VBD	ROOT	O
a	DT	det	O
decrease	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
PKC	NN	compound	B-protein
activity	NN	nmod	O
and	CC	cc	O
PMA-induced	JJ	amod	O
phosphorylation	NN	conj	O
of	IN	case	O
a	DT	det	O
47-kDa	JJ	amod	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
corresponds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
cytosolic	JJ	amod	B-protein
factor	NN	nmod	I-protein
of	IN	case	O
NADPH	NN	compound	B-protein
oxidase	NN	nmod	I-protein
,	,	punct	O
p47	NN	appos	B-protein
(	-LRB-	punct	I-protein
phox	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

The	DT	det	O
recombinant	JJ	amod	B-protein
polypeptide	NN	nsubj	I-protein
formed	VBD	ROOT	O
sequence-specific	JJ	amod	O
complexes	NNS	dobj	O
with	IN	case	O
the	DT	det	O
EBF-binding	JJ	amod	B-DNA
site	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
mb-1	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

No	DT	neg	O
modification	NN	nsubjpass	O
of	IN	case	O
c-myc	NN	compound	B-DNA
expression	NN	nmod	O
could	MD	aux	O
be	VB	auxpass	O
detected	VBN	ROOT	O
on	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
histamine	NN	nmod	O
or	CC	cc	O
its	PRP$	nmod:poss	O
analogues	NNS	conj	O
.	.	punct	O

Using	VBG	advcl	O
transfection	NN	dobj	O
and	CC	cc	O
reporter	NN	compound	O
gene	NN	compound	O
assays	NNS	conj	O
specifically	RB	advmod	O
designed	VBN	dep	O
for	IN	case	O
primary	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
conjunction	NN	dep	O
with	IN	case	O
gel	NN	compound	O
retardation	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
Western	NN	compound	O
blot	NN	compound	O
analyses	NNS	dobj	O
and	CC	cc	O
UV	NN	compound	O
cross-linking	JJ	amod	O
studies	NNS	conj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
c-Jun	NN	nsubj	B-protein
,	,	punct	O
c-Fos	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
octamer-binding	JJ	amod	B-protein
proteins	NNS	conj	I-protein
play	VBP	ccomp	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL3	NN	compound	B-DNA
gene	NN	nmod	I-DNA
via	IN	case	O
their	PRP$	nmod:poss	O
interaction	NN	nmod	O
with	IN	case	O
two	CD	nummod	O
specific	JJ	amod	O
regions	NNS	nmod	O
contained	VBN	acl	O
within	IN	case	O
the	DT	det	O
IL3	NN	compound	B-DNA
5'-flanking	JJ	amod	I-DNA
sequence	NN	nmod	I-DNA
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
defect	NN	nsubjpass	O
in	IN	case	O
viral	JJ	amod	O
replication	NN	nmod	O
could	MD	aux	O
be	VB	auxpass	O
complemented	VBN	ROOT	O
by	IN	case	O
dl312	NN	compound	O
virus	NN	nmod	O
defective	JJ	amod	O
in	IN	case	O
E1A	NN	compound	B-protein
expression	NN	nmod	O
4	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
infection	NN	nmod	O
with	IN	case	O
E1B	NN	compound	O
mutants	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
persistence	NN	dobj	O
of	IN	case	O
the	DT	det	O
E1B	NN	compound	B-DNA
mutant	JJ	amod	I-DNA
genome	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
infected	JJ	amod	O
cells	NNS	nmod	O
despite	IN	case	O
defective	JJ	amod	O
onset	NN	nmod	O
of	IN	case	O
the	DT	det	O
late	JJ	amod	O
phase	NN	nmod	O
of	IN	case	O
replication	NN	nmod	O
.	.	punct	O

Stat	NN	compound	B-protein
(	-LRB-	punct	O
signal	NN	compound	B-protein
transducers	NNS	nsubj	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
)	-RRB-	punct	O
and	CC	cc	O
Jak	NN	compound	B-protein
(	-LRB-	punct	O
Janus	NN	compound	B-protein
kinases	NNS	appos	I-protein
)	-RRB-	punct	O
proteins	NNS	conj	O
are	VBP	cop	O
central	JJ	amod	O
components	NNS	ROOT	O
in	IN	case	O
the	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
events	NNS	nmod	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
epithelial	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
,	,	punct	O
through	IN	case	O
the	DT	det	O
deletion	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
UDG	NN	compound	I-DNA
promoter	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
,	,	punct	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
E2F-1	NN	nmod	B-protein
activates	VBZ	ccomp	O
the	DT	det	O
UDG	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
through	IN	case	O
several	JJ	amod	O
E2F	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
.	.	punct	O

Corticosteroid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
:	:	punct	O
a	DT	det	O
possible	JJ	amod	O
marker	NN	dep	O
of	IN	prep	O
brain	NN	compound	O
involution	NN	pobj	O
?	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
engagement	NN	nsubj	O
of	IN	case	O
CD15	NN	nmod	O
on	IN	case	O
monocytes	NNS	nmod	O
results	VBZ	ccomp	O
in	IN	case	O
monocyte	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
sialoadhesin	NN	compound	B-protein
expression	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
show	VBP	conj	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
(	-LRB-	punct	O
GC	NN	appos	O
)	-RRB-	punct	O
induce	VBP	ccomp	O
sialoadhesin	NN	compound	B-protein
expression	NN	dobj	O
on	IN	case	O
freshly	RB	advmod	O
isolated	VBN	amod	O
rat	NN	compound	B-cell_type
macrophages	NNS	nmod	I-cell_type
and	CC	cc	O
the	DT	det	O
rat	NN	compound	B-cell_line
macrophage	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
R2	NN	conj	I-cell_line
.	.	punct	O

Site	NN	compound	B-DNA
B	NN	nsubj	I-DNA
(	-LRB-	punct	O
nt	NNS	appos	B-DNA
4519	CD	nummod	I-DNA
to	TO	dep	I-DNA
4545	CD	nummod	I-DNA
)	-RRB-	punct	O
specifically	RB	advmod	O
bound	VBD	ROOT	O
four	CD	nummod	O
distinct	JJ	amod	O
nuclear	JJ	amod	B-protein
protein	NN	compound	I-protein
complexes	NNS	dobj	I-protein
:	:	punct	O
a	DT	det	O
ubiquitous	JJ	amod	B-protein
factor	NN	dep	I-protein
,	,	punct	O
a	DT	det	O
T-cell-specific	JJ	amod	B-protein
factor	NN	appos	I-protein
,	,	punct	O
a	DT	det	O
B-cell-specific	JJ	amod	B-protein
factor	NN	appos	I-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
monocyte/macrophage-	NN	conj	B-protein
and	CC	cc	I-protein
B-cell-specific	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	conj	I-protein
PU.1/Spi-1	NN	dep	B-protein
.	.	punct	O

The	DT	det	O
balance	NN	nsubj	O
between	IN	case	O
repression	NN	nmod	O
by	IN	case	O
ZEB	NN	nmod	B-protein
and	CC	cc	O
transcriptional	JJ	amod	O
activation	NN	conj	O
by	IN	case	O
c-Myb	NN	compound	B-protein
/Ets	NN	nmod	B-protein
provides	VBZ	ROOT	O
a	DT	det	O
flexible	JJ	amod	O
regulatory	JJ	amod	O
mechanism	NN	dobj	O
for	IN	mark	O
controlling	VBG	acl	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
potential	JJ	amod	O
targets	NNS	nsubj	O
of	IN	case	O
regulation	NN	nmod	O
by	IN	case	O
the	DT	det	O
zinc-finger	NN	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
encoded	VBN	acl	O
by	IN	case	O
egr-1	NN	nmod	B-DNA
include	VBP	ROOT	O
the	DT	det	O
interleukin-2	NN	dobj	B-DNA
,	,	punct	I-DNA
CD44	NN	conj	I-DNA
,	,	punct	I-DNA
ICAM-1	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
tumor	NN	compound	I-DNA
necrosis	NN	compound	I-DNA
factor	NN	compound	I-DNA
genes	NNS	conj	I-DNA
.	.	punct	O

Such	JJ	amod	O
alterations	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
clinical	JJ	amod	O
consequences	NNS	dobj	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
possibility	NN	nmod	O
of	IN	case	O
a	DT	det	O
relatively	RB	advmod	O
longer	JJR	amod	O
life	NN	compound	O
span	NN	nmod	O
of	IN	case	O
infected	JJ	amod	B-cell_type
CD4+	JJ	amod	I-cell_type
T-lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
systemic	JJ	amod	O
effects	NNS	conj	O
of	IN	case	O
chronically	RB	advmod	O
elevated	JJ	amod	O
cortisol	NN	compound	O
level	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
a	DT	det	O
previous	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
PBMC	NN	nsubj	B-cell_type
are	VBP	cop	O
not	RB	neg	O
a	DT	det	O
common	JJ	amod	O
site	NN	ccomp	O
of	IN	case	O
persistent	JJ	amod	O
group	NN	compound	O
C	NN	compound	O
adenoviral	JJ	amod	O
infection	NN	nmod	O
.	.	punct	O

Cell-mediated	JJ	amod	O
immunity	NN	nsubj	O
plays	VBZ	ROOT	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
infection	NN	nmod	O
with	IN	case	O
the	DT	det	O
human	JJ	amod	O
cytomegalovirus	NN	nmod	O
(	-LRB-	punct	O
HCMV	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Initiation	NN	nsubjpass	O
of	IN	case	O
proliferation	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
differentiation	NN	conj	O
was	VBD	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
20-	CD	compound	O
to	TO	dep	O
25-fold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
DNA	NN	compound	B-protein
polymerase-associated	JJ	amod	I-protein
processivity	NN	compound	I-protein
factor	NN	compound	I-protein
PCNA	NN	nmod	I-protein
and	CC	cc	O
of	IN	case	O
the	DT	det	O
proliferation-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
E2F1	NN	conj	I-protein
.	.	punct	O

Using	VBG	advcl	O
these	DT	det	O
drugs	NNS	dobj	O
as	IN	case	O
probes	NNS	nmod	O
,	,	punct	O
chemists	NNS	nsubj	O
and	CC	cc	O
biologists	NNS	conj	O
have	VBP	aux	O
uncovered	VBN	ROOT	O
several	JJ	amod	O
intracellular	JJ	amod	O
signalling	VBG	amod	O
molecules	NNS	dobj	O
bridging	VBG	acl	O
the	DT	det	O
generation	NN	dobj	O
of	IN	case	O
second-messenger	NN	amod	O
Ca2+	NN	compound	O
ions	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
transcriptional	JJ	amod	O
activation	NN	conj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
among	IN	case	O
which	WDT	nmod	O
are	VBP	cop	O
calmodulin	NN	acl:relcl	B-protein
,	,	punct	O
calcineurin	NN	conj	B-protein
and	CC	cc	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	conj	I-protein
(	-LRB-	punct	O
NF-AT	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
thymic	JJ	amod	O
cellularity	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
mice	NNS	nmod	O
was	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
p38	NN	compound	B-protein
MAPK	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
activated	VBN	ROOT	O
strongly	RB	advmod	O
and	CC	advmod	O
synergistically	RB	advmod	O
by	IN	case	O
either	CC	cc:preconj	O
CD3/CD28	NN	compound	B-protein
coligation	NN	nmod	O
or	CC	cc	O
PMA/Ca2+	NN	compound	O
ionophore	NN	compound	O
stimulation	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
mimics	VBZ	acl:relcl	O
TCR	NN	nmod:npmod	B-protein
-	:	punct	O
CD3/CD28	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
signaling	NN	dobj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
BA	NN	nsubj	O
is	VBZ	cop	O
currently	RB	advmod	O
under	IN	case	O
clinical	JJ	amod	O
investigation	NN	ROOT	O
as	IN	case	O
a	DT	det	O
potential	JJ	amod	O
therapy	NN	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
sickle	JJ	amod	O
cell	NN	compound	O
disease	NN	nmod	O
and	CC	cc	O
cancer	NN	conj	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
delta-globin	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
primary	JJ	amod	B-cell_type
adult	JJ	amod	I-cell_type
erythroid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

17beta-estradiol	NN	nsubj	O
(	-LRB-	punct	O
E2	NN	appos	O
)	-RRB-	punct	O
markedly	RB	advmod	O
enhanced	VBD	ROOT	O
lipopolysaccharide	NN	nmod:npmod	O
-	:	punct	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
induced	JJ	dep	O
IL-1beta	NN	compound	B-DNA
promoter	NN	nmod:npmod	I-DNA
-driven	JJ	amod	O
CAT	NN	compound	B-protein
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
these	DT	det	O
observations	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
possible	JJ	ROOT	O
that	IN	mark	O
the	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
Sp	NN	nmod	B-protein
and	CC	cc	O
ATF/CREB	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	conj	I-protein
with	IN	case	O
the	DT	det	O
pp	NN	compound	B-DNA
repeat	NN	nmod	I-DNA
during	IN	case	O
basal	JJ	mwe	O
and	CC	cc	O
Tax	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
transcription	NN	nmod	O
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
viral	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
during	IN	case	O
the	DT	det	O
initial	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
virus	NN	compound	O
infection	NN	nmod	O
or	CC	cc	O
during	IN	case	O
activation	NN	conj	O
of	IN	case	O
a	DT	det	O
latent	JJ	amod	O
infection	NN	nmod	O
.	.	punct	O

The	DT	det	O
transcriptional	JJ	amod	O
response	NN	nsubj	O
of	IN	case	O
the	DT	det	O
IL-2R	NN	compound	B-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
to	TO	case	O
stimulation	NN	nmod	O
by	IN	case	O
IL-1	NN	nmod	B-protein
+	CC	cc	O
IL-2	NN	conj	B-protein
is	VBZ	cop	O
biphasic	JJ	ROOT	O
.	.	punct	O

When	WRB	advmod	O
dexamethasone	NN	nsubjpass	O
was	VBD	auxpass	O
added	VBN	advcl	O
to	TO	case	O
the	DT	det	O
cultures	NNS	nmod	O
3	CD	nummod	O
hours	NNS	dep	O
after	IN	case	O
the	DT	det	O
stimulators	NNS	pobj	O
,	,	punct	O
it	PRP	nsubj	O
clearly	RB	advmod	O
decreased	VBD	ROOT	O
the	DT	det	O
interleukin-1	NN	compound	B-RNA
beta	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	dobj	O
regardless	RB	advmod	O
of	IN	case	O
the	DT	det	O
stimulator	NN	nmod	O
used	VBN	acl	O
(	-LRB-	punct	O
although	IN	mark	O
the	DT	det	O
effect	NN	nsubj	O
was	VBD	cop	O
clearly	RB	advmod	O
weaker	JJR	advcl	O
on	IN	case	O
the	DT	det	O
PMA-induced	JJ	amod	B-RNA
mRNA	NN	nmod	I-RNA
)	-RRB-	punct	O
.	.	punct	O

Interleukin	NN	compound	B-protein
1beta	NN	nsubj	I-protein
mediates	VBZ	ROOT	O
the	DT	det	O
modulatory	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
on	IN	case	O
LNCaP	NN	compound	B-cell_type
human	JJ	amod	I-cell_type
prostate	NN	compound	I-cell_type
cancer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
diverse	JJ	amod	O
agents	NNS	nsubj	O
thought	VBN	acl	O
to	TO	mark	O
activate	VB	xcomp	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
by	IN	case	O
distinct	JJ	amod	O
intracellular	JJ	amod	O
pathways	NNS	nmod	O
might	MD	aux	O
all	RB	advmod	O
act	VB	ccomp	O
through	IN	case	O
a	DT	det	O
common	JJ	amod	O
mechanism	NN	nmod	O
involving	VBG	acl	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
ROI	NN	nmod	O
.	.	punct	O

Pyrrolidine	NN	compound	O
dithiocarbamate	NN	nsubj	O
(	-LRB-	punct	O
PDTC	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
inhibitor	NN	ROOT	O
of	IN	case	O
NF	NN	compound	B-protein
kappaB	NN	nmod	I-protein
in	IN	case	O
most	JJS	amod	O
cells	NNS	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	parataxis	O
that	IN	mark	O
PDTC	NN	nsubj	O
is	VBZ	cop	O
also	RB	advmod	O
a	DT	det	O
potent	JJ	amod	O
scavenger	NN	ccomp	O
of	IN	case	O
NO	NN	nmod	O
through	IN	case	O
formation	NN	nmod	O
of	IN	case	O
mononitrosyl	NN	compound	O
iron	NN	compound	O
complexes	NNS	nmod	O
with	IN	case	O
PDTC	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
okadaic	JJ	amod	O
acid	NN	nsubj	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
protein	NN	compound	O
phosphatase	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
prolongs	VBZ	advcl	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
the	DT	det	O
binding	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
phosphorylation	NN	compound	O
events	NNS	nsubj	O
are	VBP	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
occur	VB	xcomp	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
fludarabine	NN	nsubj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
immunosuppressant	JJ	amod	O
cyclosporine	NN	compound	O
A	NN	conj	O
,	,	punct	O
inhibits	VBZ	ccomp	O
the	DT	det	O
cytokine	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
STAT1	NN	nmod	B-protein
and	CC	cc	O
STAT1	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
gene	NN	compound	O
transcription	NN	nmod	O
in	IN	case	O
normal	JJ	amod	B-cell_type
resting	VBG	amod	I-cell_type
or	CC	cc	I-cell_type
activated	VBN	conj	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
PML/RAR	NN	compound	B-DNA
alpha	NN	compound	I-DNA
fusion	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
resulting	VBG	acl	O
from	IN	case	O
the	DT	det	O
t	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
15	CD	nummod	I-DNA
;	:	punct	I-DNA
17	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
translocation	NN	nmod	I-DNA
is	VBZ	cop	O
a	DT	det	O
specific	JJ	amod	O
marker	NN	ROOT	O
for	IN	case	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
APL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Structural	JJ	amod	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
mouse	NN	compound	B-DNA
CPO	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
spans	VBZ	ccomp	O
approximately	RB	advmod	O
11	CD	nummod	O
kb	NN	dobj	O
and	CC	cc	O
consists	VBZ	conj	O
of	IN	case	O
seven	CD	nummod	B-DNA
exons	NNS	nmod	I-DNA
,	,	punct	O
just	RB	advmod	O
like	IN	case	O
its	PRP$	nmod:poss	O
human	JJ	amod	O
counterpart	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
describe	VBP	ROOT	O
another	DT	det	O
series	NN	dobj	O
(	-LRB-	punct	O
B	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
such	JJ	amod	O
variants	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
differ	VBP	acl:relcl	O
from	IN	case	O
A	DT	compound	O
series	NN	compound	O
cells	NNS	nmod	O
grown	VBN	acl	O
in	IN	case	O
similar	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
1	CD	nmod	O
,	,	punct	O
25D3	NN	dep	O
in	IN	case	O
that	IN	nmod	O
they	PRP	nsubj	O
express	VBP	acl:relcl	O
the	DT	det	O
CD14	NN	compound	B-protein
antigen	NN	dobj	I-protein
and	CC	cc	O
nonspecific	JJ	amod	O
esterase	NN	conj	B-protein
,	,	punct	O
characteristic	NN	amod	O
of	IN	case	O
the	DT	det	O
monocyte	NN	nmod	O
,	,	punct	O
while	IN	mark	O
continuing	VBG	advcl	O
to	TO	aux	O
proliferate	VB	xcomp	O
and	CC	cc	O
they	PRP	nsubj	O
develop	VBP	conj	O
hypotetraploid	NN	amod	O
DNA	NN	compound	O
(	-LRB-	punct	O
4C	NN	appos	O
)	-RRB-	punct	O
content	NN	dobj	O
at	IN	case	O
higher	JJR	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
ambient	NN	nmod	O
1	CD	nummod	O
,	,	punct	O
25D3	NN	dep	O
than	IN	case	O
the	DT	det	O
A	NN	compound	O
series	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
IFN-gamma	NN	nsubj	B-protein
affects	VBZ	ccomp	O
eosinophils	NNS	dobj	B-cell_type
through	IN	case	O
its	PRP$	nmod:poss	O
specific	JJ	amod	O
receptor	NN	nmod	O
and	CC	cc	O
utilizes	VBZ	conj	O
the	DT	det	O
Jak/Stat	NN	compound	B-protein
pathway	NN	dobj	O
as	IN	case	O
its	PRP$	nmod:poss	O
mode	NN	nmod	O
of	IN	case	O
signaling	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
IL-2Ralpha	NN	compound	B-protein
expression	NN	dobj	O
to	TO	mark	O
be	VB	auxpass	O
increased	VBN	xcomp	O
in	IN	case	O
BAL	NN	compound	O
cells	NNS	nmod	O
from	IN	case	O
involved	VBN	amod	O
sites	NNS	nmod	O
of	IN	case	O
active	JJ	amod	O
pulmonary	JJ	amod	O
tuberculosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
identify	VBP	ROOT	O
LIF	NN	dobj	B-protein
as	IN	case	O
a	DT	det	O
stimulus	NN	nmod	O
of	IN	case	O
HIV	NN	compound	O
replication	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
growth	NN	compound	O
inhibition	NN	nsubj	O
of	IN	case	O
established	JJ	amod	O
B	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
function	NN	ccomp	O
of	IN	case	O
EBNA2	NN	nmod	B-protein
which	WDT	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
detected	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
an	DT	det	O
inducible	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
a	DT	det	O
decreased	VBN	amod	O
affinity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
regulation	NN	nsubj	O
of	IN	case	O
HIV	NN	nmod	O
by	IN	case	O
retinoic	JJ	amod	O
acid	NN	nmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
cellular	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
genistein	NN	nsubj	O
was	VBD	cop	O
a	DT	det	O
very	RB	advmod	O
low-potency	JJ	amod	O
agonist	NN	ROOT	O
,	,	punct	O
having	VBG	acl	O
an	DT	det	O
EC50	NN	dobj	O
of	IN	case	O
1.5	CD	nummod	O
microM	NN	nmod	O
.	.	punct	O

CD30	NN	compound	B-protein
-dependent	JJ	amod	O
degradation	NN	ROOT	O
of	IN	case	O
TRAF2	NN	nmod	B-protein
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
negative	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
TRAF	NN	compound	B-protein
signaling	NN	nmod	O
and	CC	cc	O
the	DT	det	O
control	NN	conj	O
of	IN	case	O
cell	NN	compound	O
survival	NN	nmod	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
Trx	NN	nmod	B-protein
in	IN	case	O
intact	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
performed	VBD	ROOT	O
transient	JJ	amod	O
assay	NN	dobj	O
with	IN	case	O
a	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase-expressing	JJ	amod	I-DNA
plasmid	NN	nmod	I-DNA
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
HIV	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
and	CC	cc	O
an	DT	det	O
effector	NN	compound	B-DNA
plasmid	NN	conj	I-DNA
expressing	VBG	acl	O
human	JJ	amod	B-protein
Trx	NN	dobj	I-protein
.	.	punct	O

Coexpression	NN	nsubj	O
of	IN	case	O
alpha	NN	compound	B-protein
B1	NN	nmod	I-protein
and	CC	cc	O
alpha	NN	compound	B-protein
B2	NN	conj	I-protein
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
promoter	NN	compound	O
activity	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
determined	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
alpha	NN	compound	B-protein
B1	NN	compound	I-protein
/alpha	NN	compound	B-protein
B2	NN	compound	I-protein
ratio	NN	nmod	O
.	.	punct	O

For	IN	prep	O
the	DT	det	O
moment	NN	pobj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
field	NN	nsubj	O
of	IN	case	O
pharmacogenetics	NNS	nmod	O
is	VBZ	cop	O
embryonic	JJ	ROOT	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
cytokine	NN	nmod	B-protein
and	CC	cc	O
cytokine	NN	compound	B-protein
receptor	NN	compound	I-protein
expression	NN	conj	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

Nonetheless	RB	advmod	O
,	,	punct	O
CREB	NN	nsubj	B-protein
,	,	punct	O
Ets-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
AML1	NN	conj	B-protein
bind	VBP	ROOT	O
and	CC	cc	O
activate	VBP	conj	O
cooperatively	RB	advmod	O
and	CC	cc	O
very	RB	advmod	O
efficiently	RB	advmod	O
through	IN	case	O
the	DT	det	O
nonconsensus	JJ	amod	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
at	IN	case	O
the	DT	det	O
core	NN	compound	B-DNA
promoter	NN	compound	I-DNA
region	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
binding	VBG	amod	B-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
nuclear	JJ	amod	B-protein
factors	NNS	nmod	I-protein
including	VBG	case	O
NFAT-1	NN	nmod	B-protein
,	,	punct	O
Oct	NN	conj	B-protein
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
AP-1	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
all	DT	advmod	O
potentially	RB	advmod	O
sensitive	JJ	acl:relcl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
PKC	NN	nmod	B-protein
.	.	punct	O

Recently	RB	advmod	O
it	PRP	nsubj	O
has	VBZ	aux	O
become	VBN	ROOT	O
clear	JJ	xcomp	O
that	IN	mark	O
these	DT	det	O
cytokines	NNS	nsubj	B-protein
activate	VBP	ccomp	O
a	DT	det	O
number	NN	dobj	O
of	IN	case	O
important	JJ	amod	O
intracellular	JJ	amod	B-protein
signaling	VBG	compound	I-protein
molecules	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
the	DT	det	O
Janus	NN	compound	B-protein
kinases	NNS	nmod	I-protein
JAK1	NN	dep	B-protein
and	CC	cc	O
JAK3	NN	conj	B-protein
and	CC	cc	O
members	NNS	conj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
family	NN	nmod	I-protein
of	IN	case	O
signal	NN	compound	B-protein
transducers	NNS	nmod	I-protein
and	CC	cc	O
activators	NNS	compound	B-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
(	-LRB-	punct	O
STATs	NNS	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
cyclic	JJ	amod	B-protein
AMP	NN	compound	I-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
CREB	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
CREB	NN	conj	B-protein
fused	VBN	acl	O
to	TO	case	O
the	DT	det	O
GAL4	NN	compound	B-protein
activation	NN	compound	I-protein
domain	NN	nmod	I-protein
(	-LRB-	punct	O
GAD	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
this	DT	det	O
strain	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
modify	VB	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
reporter	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
Aiolos	NN	nmod	B-DNA
,	,	punct	O
a	DT	det	O
lymphoid-restricted	JJ	amod	B-DNA
and	CC	cc	I-DNA
structurally	RB	advmod	I-DNA
related	JJ	conj	I-DNA
gene	NN	appos	I-DNA
,	,	punct	O
in	IN	case	O
lymphoid	JJ	amod	O
differentiation	NN	nmod	O
is	VBZ	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
these	DT	det	O
immature	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
differentiated	VBD	ROOT	O
terminally	RB	advmod	O
into	IN	case	O
mature	JJ	amod	O
granulocytes	NNS	nmod	O
by	IN	mark	O
adding	VBG	advcl	O
with	IN	case	O
RA	NN	nmod	O
(	-LRB-	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
-6	CD	appos	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
extent	NN	nsubjpass	O
to	TO	case	O
which	WDT	nmod	O
peptides	NNS	nsubjpass	O
containing	VBG	acl	O
chemically	RB	advmod	O
and	CC	cc	O
post-translationally	RB	advmod	O
modified	VBN	amod	O
amino	NN	compound	B-protein
acid	NN	compound	I-protein
side	NN	compound	I-protein
chains	NNS	dobj	I-protein
are	VBP	auxpass	O
recognized	VBN	acl:relcl	O
by	IN	case	O
primed	VBN	amod	B-cell_line
CTL	NN	nmod	I-cell_line
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
defined	VBN	ROOT	O
.	.	punct	O

Such	JJ	amod	O
differentiation	NN	compound	O
block	NN	nsubjpass	O
by	IN	case	O
AML1a	NNS	nmod	B-protein
was	VBD	auxpass	O
canceled	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
concomitant	JJ	amod	O
overexpression	NN	nmod	O
of	IN	case	O
AML1b	NNS	nmod	B-protein
.	.	punct	O

The	DT	det	O
active	JJ	amod	O
ingredients	NNS	nsubj	O
mediating	VBG	acl	O
the	DT	det	O
pharmacological	JJ	amod	O
effect	NN	dobj	O
are	VBP	cop	O
mainly	RB	advmod	O
sesquiterpene	NN	compound	O
lactones	NNS	ROOT	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
helenalin	NN	nmod	O
,	,	punct	O
11alpha	NN	conj	O
,	,	punct	O
13-dihydrohelenalin	NN	conj	O
,	,	punct	O
chamissonolid	NN	conj	O
and	CC	cc	O
their	PRP$	nmod:poss	O
ester	NN	compound	O
derivatives	NNS	conj	O
.	.	punct	O

This	DT	det	O
element	NN	nsubj	O
requires	VBZ	ROOT	O
GATA-1	NN	dobj	B-protein
and	CC	cc	O
additional	JJ	amod	B-protein
unknown	JJ	amod	I-protein
factors	NNS	conj	I-protein
for	IN	case	O
maximal	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
anti-MHC	JJ	amod	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
Ab	NNS	nsubj	I-protein
,	,	punct	O
L227	NN	appos	B-protein
and	CC	cc	O
2.06	CD	conj	B-protein
,	,	punct	O
inhibited	VBD	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
B104	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
although	IN	mark	O
2.06	CD	nsubj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
L227	NN	conj	B-protein
,	,	punct	O
needed	VBD	advcl	O
to	TO	mark	O
be	VB	auxpass	O
further	RB	advmod	O
cross-linked	VBN	xcomp	O
with	IN	case	O
a	DT	det	O
goat	NN	compound	B-protein
anti-mouse	JJ	compound	I-protein
IgG	NN	compound	I-protein
Ab	NN	nmod	I-protein
(	-LRB-	punct	O
GAM	NN	appos	B-protein
)	-RRB-	punct	O
to	TO	mark	O
show	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
salicylates	NNS	nsubj	O
affect	VBP	acl:relcl	O
cytokine	NN	compound	B-protein
gene	NN	compound	O
transcription	NN	dobj	O
,	,	punct	O
the	DT	det	O
amount	NN	nsubjpass	O
of	IN	case	O
active	JJ	amod	O
and	CC	cc	O
inactive	JJ	conj	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
NF-kappa	NN	compound	B-RNA
B	NN	compound	I-RNA
mRNA	NN	conj	I-RNA
,	,	punct	O
in	IN	case	O
Porphyromonas	NN	compound	O
gingivalis	NN	compound	O
lipopolysaccharide-stimulated	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
monocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
assessed	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
PPARgamma	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nsubj	O
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
increased	VBD	ROOT	O
during	IN	case	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13	CD	nummod	O
acetate-induced	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
priming	NN	nsubj	O
of	IN	case	O
CD4	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
selectively	RB	advmod	O
enhances	VBZ	ccomp	O
IL-4	NN	compound	B-protein
expression	NN	dobj	O
relative	JJ	case	O
to	TO	case	O
IL-2	NN	compound	B-protein
expression	NN	nmod	O
by	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
mechanism	NN	nmod	O
involving	VBG	acl	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	compound	I-protein
(	-LRB-	punct	I-protein
NFAT	NN	compound	I-protein
)	-RRB-	punct	I-protein
proteins	NNS	dobj	I-protein
.	.	punct	O

Binding	NN	ROOT	O
of	IN	case	O
YY1	NN	nmod	B-protein
and	CC	cc	O
Oct1	NN	conj	B-protein
to	TO	case	O
a	DT	det	O
novel	JJ	amod	O
element	NN	nmod	O
that	WDT	nsubj	O
downregulates	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
IL-5	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
Ca2+	NN	compound	O
redistribution	NN	nmod	O
by	IN	case	O
an	DT	det	O
inhibitor	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	O
Ca2+	NN	compound	O
mobilization	NN	nmod	O
,	,	punct	O
8-	CD	compound	O
(	-LRB-	punct	O
diethylamino	NN	compound	O
)	-RRB-	punct	O
-octyl-3	CD	conj	O
,	,	punct	O
4	CD	nummod	O
,	,	punct	O
5-trimethoxybenzoate	JJ	amod	O
hydrochloride	NN	conj	O
,	,	punct	O
inhibited	VBD	advcl	O
TCR-induced	JJ	amod	B-protein
FasL	NN	dobj	I-protein
but	CC	cc	O
not	RB	cc	O
Fas	NN	conj	B-protein
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
Fas	NN	nmod	B-protein
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
independent	JJ	xcomp	O
of	IN	case	O
Ca2+	NN	compound	O
mobilization	NN	nmod	O
.	.	punct	O

Thirty	CD	nummod	O
percent	NN	nsubj	O
of	IN	case	O
GC	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
naive	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
displayed	VBD	ROOT	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
742	CD	nummod	B-DNA
bp	NN	compound	I-DNA
region	NN	nmod	I-DNA
analyzed	VBN	acl	O
within	IN	case	O
the	DT	det	O
first	JJ	amod	O
intron	NN	nmod	O
of	IN	case	O
BCL-6	NN	nmod	B-protein
(	-LRB-	punct	O
overall	JJ	amod	O
frequency	NN	appos	O
:	:	punct	O
5	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-4	CD	dep	O
)	-RRB-	punct	O
/bp	NN	nummod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
p50	NN	nsubj	I-protein
alone	RB	advmod	O
fails	VBZ	ROOT	O
to	TO	mark	O
stimulate	VB	xcomp	O
kappa	NN	nmod:npmod	O
B-directed	JJ	amod	O
transcription	NN	dobj	O
,	,	punct	O
and	CC	cc	O
based	VBN	conj	O
on	IN	case	O
prior	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
studies	NNS	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
not	RB	neg	O
directly	RB	advmod	O
regulated	VBN	conj	O
by	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
function	NN	nsubj	O
of	IN	case	O
SSB	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
in	IN	case	O
controls	NNS	nmod	O
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
defined	VBN	xcomp	O
.	.	punct	O

AIMS	NNS	nsubjpass	O
AND	CC	cc	O
BACKGROUND	NN	conj	O
:	:	punct	O
Structurally	RB	advmod	O
altered	JJ	amod	O
proteins	NNS	dep	O
(	-LRB-	punct	O
derived	VBN	acl	O
from	IN	case	O
chromosomal	JJ	amod	O
translocations	NNS	nmod	O
or	CC	cc	O
gene	NN	compound	O
mutations	NNS	conj	O
)	-RRB-	punct	O
can	MD	aux	O
be	VB	auxpass	O
considered	VBN	ROOT	O
tumor	NN	compound	O
specific	JJ	amod	O
antigens	NNS	dobj	O
and	CC	cc	O
represent	VBP	conj	O
an	DT	det	O
attractive	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
a	DT	det	O
T-cell	NN	compound	O
mediated	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Marked	JJ	amod	O
basophilia	NN	ROOT	O
in	IN	case	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukaemia	NN	nmod	O
treated	VBN	acl	O
with	IN	case	O
all-trans	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nmod	O
:	:	punct	O
molecular	JJ	amod	O
analysis	NN	dep	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
origin	NN	nmod	O
of	IN	case	O
the	DT	det	O
basophils	NNS	nmod	B-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
an	DT	det	O
activation-deficient	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	compound	I-protein
mutant	NN	nsubj	I-protein
is	VBZ	cop	O
as	RB	advmod	O
effective	JJ	ccomp	O
as	IN	case	O
the	DT	det	O
wild-type	JJ	amod	B-protein
receptor	NN	nmod	I-protein
in	IN	case	O
repression	NN	nmod	O
of	IN	case	O
AP-1	NN	compound	B-protein
activity	NN	nmod	O
,	,	punct	O
inhibition	NN	conj	O
of	IN	case	O
interleukin-2	NN	compound	B-protein
production	NN	nmod	O
,	,	punct	O
inhibition	NN	appos	O
of	IN	case	O
c-myc	NN	compound	B-DNA
expression	NN	nmod	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
beneficial	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
ketoconazole	NN	nmod	O
in	IN	case	O
Cushing	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
are	VBP	cop	O
due	JJ	case	O
to	TO	case	O
adrenal	JJ	amod	O
cortisol	NN	compound	O
suppression	NN	ccomp	O
and	CC	cc	O
not	RB	neg	O
to	TO	case	O
interaction	NN	conj	O
with	IN	case	O
GcR	NN	nmod	B-protein
of	IN	case	O
target	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
process	NN	nsubj	O
of	IN	case	O
GcR	NN	compound	B-protein
regulation	NN	nmod	O
in	IN	case	O
hMNL	NN	nmod	B-cell_type
is	VBZ	cop	O
a	DT	det	O
complex	JJ	amod	O
phenomenon	NN	conj	O
awaiting	VBG	acl	O
further	JJ	amod	O
elucidation	NN	dobj	O
.	.	punct	O

Using	VBG	advcl	O
flow	NN	compound	O
cytometry	NN	compound	O
analysis	NN	dobj	O
,	,	punct	O
NE	NN	nsubjpass	B-protein
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
trigger	VB	xcomp	O
a	DT	det	O
time-dependent	JJ	amod	O
binding	NN	dobj	O
of	IN	case	O
PAC-1	NN	nmod	B-protein
and	CC	cc	O
AP-5	NN	conj	B-protein
,	,	punct	O
two	CD	nummod	O
monoclonal	JJ	amod	B-protein
antibodies	NNS	appos	I-protein
specific	JJ	amod	O
for	IN	case	O
the	DT	det	O
activated	VBN	amod	O
and	CC	cc	O
ligand-occupied	JJ	conj	O
conformers	NNS	nmod	O
of	IN	case	O
alphaIIbbeta3	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
luciferase	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	nsubjpass	I-DNA
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
region	NN	nmod	I-DNA
of	IN	case	O
0.7	CD	nummod	O
kb	NN	nmod	O
was	VBD	auxpass	O
strongly	RB	advmod	O
induced	VBN	ROOT	O
upon	IN	case	O
activation	NN	nmod	O
with	IN	case	O
anti-CD3	NN	nmod	B-protein
or	CC	cc	O
PHA	NN	conj	B-protein
plus	CC	cc	O
PMA	NN	conj	O
only	RB	advmod	O
in	IN	case	O
SCM-1-producer	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
through	IN	case	O
a	DT	det	O
cyclosporin	NN	compound	O
A-sensitive	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

5	CD	nsubj	O
'	''	punct	O
to	TO	case	O
the	DT	det	O
identified	VBN	amod	O
transcription	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
are	VBP	cop	O
two	CD	nummod	O
CCAAT	NN	compound	B-DNA
sequences	NNS	ROOT	I-DNA
and	CC	cc	O
potential	JJ	amod	B-DNA
recognition	NN	compound	I-DNA
sites	NNS	conj	I-DNA
for	IN	case	O
several	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
including	VBG	case	O
Sp1	NN	nmod	B-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
AP-2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
NF-kB	NN	conj	B-protein
.	.	punct	O

Intragenic	JJ	amod	O
deletions	NNS	nsubjpass	O
of	IN	case	O
TSG101	NN	nmod	B-DNA
,	,	punct	O
the	DT	det	O
human	JJ	amod	O
homolog	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
mouse	NN	compound	B-DNA
gene	NN	nmod	I-DNA
(	-LRB-	punct	O
tsg101	NN	appos	B-DNA
)	-RRB-	punct	O
that	WDT	nsubj	O
acts	VBZ	acl:relcl	O
to	TO	mark	O
suppress	VB	xcomp	O
malignant	JJ	amod	O
cell	NN	compound	O
growth	NN	dobj	O
,	,	punct	O
were	VBD	auxpass	O
reported	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
breast	NN	compound	I-cell_type
tumours	NNS	nmod	I-cell_type
.	.	punct	O

When	WRB	advmod	O
two	CD	nummod	O
4-trifluoromethyl	NN	compound	O
salicylate	NN	compound	O
derivatives	NNS	nsubjpass	O
[	-LRB-	punct	O
2-acetoxy-4-trifluoromethyl-benzoic	JJ	amod	O
acid	NN	dep	O
(	-LRB-	punct	O
triflusal	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
deacetylated	VBN	amod	O
metabolite	NN	compound	O
2-hydroxy-4-trifluoromethylbenzoic	JJ	amod	O
acid	NN	conj	O
(	-LRB-	punct	O
HTB	NN	appos	O
)	-RRB-	punct	O
]	-RRB-	punct	O
were	VBD	auxpass	O
compared	VBN	advcl	O
with	IN	case	O
aspirin	NN	nmod	O
and	CC	cc	O
sodium	NN	compound	O
salicylate	NN	conj	O
as	IN	case	O
cyclooxygenase-2	NN	compound	B-protein
(	-LRB-	punct	O
COX-2	NN	appos	O
)	-RRB-	punct	O
inhibitors	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
in	IN	case	O
bacterial	JJ	amod	O
lipopolysaccharide-activated	JJ	amod	O
human	JJ	amod	O
blood	NN	nmod	O
,	,	punct	O
triflusal	NN	nsubj	O
,	,	punct	O
aspirin	NN	conj	O
,	,	punct	O
and	CC	cc	O
HTB	NN	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
sodium	NN	compound	O
salicylate	NN	conj	O
,	,	punct	O
inhibited	VBD	ccomp	O
COX-2-mediated	JJ	amod	O
prostaglandin	NN	compound	O
E2	NN	compound	O
(	-LRB-	punct	O
PGE2	NN	appos	O
)	-RRB-	punct	O
production	NN	dobj	O
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	acl:relcl	O
0.16	CD	nummod	O
,	,	punct	O
0.18	CD	conj	O
,	,	punct	O
0.39	CD	dobj	O
,	,	punct	O
and	CC	cc	O
>	NN	conj	O
10	CD	nummod	O
mM	NN	dep	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
active	JJ	amod	O
metabolite	NN	nsubj	O
of	IN	case	O
vitamin	NN	compound	O
D	NN	nmod	O
,	,	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
dihydroxyvitamin	NN	compound	O
D3	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
immunoregulatory	JJ	amod	O
hormone	NN	ROOT	O
[	-LRB-	punct	O
1	CD	dep	O
]	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
transient-transfection	JJ	amod	O
assay	NN	nmod	O
,	,	punct	O
ICP0	NN	nsubj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
ICP4	NN	conj	B-protein
,	,	punct	O
activated	VBD	ROOT	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
promoter	NN	compound	I-DNA
region	NN	dobj	I-DNA
and	CC	cc	O
the	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
ICP0	NN	nmod	B-protein
was	VBD	auxpass	O
greatly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	O
provirus	NN	nmod	O
involves	VBZ	ccomp	O
cooperation	NN	dobj	O
between	IN	case	O
the	DT	det	O
HSV-1-activated	JJ	amod	B-protein
cellular	JJ	amod	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
virus-encoded	JJ	amod	B-protein
transactivator	NN	conj	I-protein
,	,	punct	O
ICP0	NN	appos	B-protein
.	.	punct	O

In	IN	case	O
both	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
LIF	NN	nsubj	B-protein
increased	VBD	ROOT	O
NF-kB	NN	compound	B-protein
activity	NN	dobj	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
by	IN	case	O
I	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
alpha	NN	nmod	O
and	CC	cc	O
I	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
beta	NN	compound	O
stability	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
B7	NN	nsubj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
LFA-3	NN	conj	B-protein
,	,	punct	O
strongly	RB	advmod	O
costimulated	VBD	ccomp	O
IL-2	NN	compound	B-protein
transcription	NN	dobj	O
and	CC	cc	O
mRNA	NN	compound	O
expression	NN	conj	O
in	IN	case	O
CD4+	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_line
neuroblastoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
by	IN	case	O
bacterial	JJ	amod	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
induces	VBZ	ROOT	O
transcription	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
that	WDT	nsubj	O
encode	VBP	acl:relcl	O
for	IN	case	O
proinflammatory	JJ	amod	B-protein
regulators	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Nondividing	JJ	amod	O
macrophages	NNS	nsubj	B-cell_type
from	IN	case	O
normal	JJ	amod	O
individuals	NNS	nmod	O
also	RB	advmod	O
expressed	VBD	ROOT	O
1	CD	nummod	B-RNA
,	,	punct	I-RNA
25	CD	nummod	I-RNA
(	-LRB-	punct	I-RNA
OH	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
2D3	NN	compound	I-RNA
receptor	NN	compound	I-RNA
RNA	NN	dobj	I-RNA
.	.	punct	O

Epstein-Barr	JJ	amod	O
virus	NN	compound	O
replicative	JJ	amod	O
gene	NN	compound	O
transcription	NN	ROOT	O
during	IN	case	O
de	FW	amod	O
novo	FW	dep	O
infection	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
:	:	punct	O
simultaneous	JJ	amod	O
early	JJ	amod	O
expression	NN	dep	O
of	IN	case	O
BZLF-1	NN	nmod	B-protein
and	CC	cc	O
its	PRP$	nmod:poss	O
repressor	NN	conj	O
RAZ	NN	dep	B-protein
.	.	punct	O

IL-13	NN	nsubj	B-protein
induces	VBZ	ROOT	O
phosphorylation	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
JAK2	NN	compound	B-protein
Janus	NN	compound	I-protein
kinase	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_line
colon	NN	compound	I-cell_line
carcinoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
:	:	punct	O
similarities	NNS	dep	O
between	IN	case	O
IL-4	NN	compound	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
signaling	NN	nmod	O
.	.	punct	O

These	DT	det	O
RelB+	NN	compound	B-cell_type
APC	NN	nsubj	I-cell_type
were	VBD	cop	O
potent	JJ	amod	O
stimulators	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
MLR	NN	nmod	B-protein
.	.	punct	O

Immune	JJ	amod	O
induction	NN	nsubjpass	O
is	VBZ	auxpass	O
effected	VBN	ROOT	O
through	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
of	IN	case	O
antigen-presenting	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
specific	JJ	amod	O
receptors	NNS	nmod	B-protein
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
thymus-derived	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

None	NN	nsubj	O
of	IN	prep	O
the	DT	det	O
other	JJ	amod	O
leukemias	NNS	pobj	O
were	VBD	cop	O
RT-PCR	NN	nmod:npmod	O
positive	JJ	ROOT	O
.	.	punct	O

Uncoupling	NN	ROOT	O
of	IN	case	O
nonreceptor	JJ	compound	O
tyrosine	NN	compound	B-protein
kinases	NNS	nmod	I-protein
from	IN	case	O
PLC-gamma1	NN	nmod	B-protein
in	IN	case	O
an	DT	det	O
SLP-76-deficient	JJ	amod	O
T	NN	compound	O
cell	NN	nmod	O
.	.	punct	O

Incubation	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
MM-LDL	NN	nmod	B-protein
caused	VBD	ROOT	O
a	DT	det	O
173	CD	compound	O
%	NN	amod	O
increase	NN	dobj	O
in	IN	case	O
intracellular	JJ	amod	O
cAMP	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
DZA	NN	nsubj	O
promotes	VBZ	ROOT	O
the	DT	det	O
proteolytic	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
IkappaBalpha	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
IkappaBbeta	NN	conj	B-protein
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
an	DT	det	O
increase	NN	nmod	O
of	IN	case	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
RAW	NN	compound	B-cell_line
264.7	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Resistance	NN	nsubjpass	O
to	TO	case	O
glucocorticoid	NN	compound	O
therapy	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
autoimmune/inflammatory	JJ	amod	O
diseases	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
be	VB	cop	O
related	JJ	conj	O
to	TO	case	O
the	DT	det	O
inflammatory	JJ	amod	O
process	NN	nmod	O
itself	PRP	dep	O
.	.	punct	O

These	DT	det	O
events	NNS	nsubjpass	O
are	VBP	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
marked	JJ	amod	O
increases	NNS	nmod	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
RAG-1	NN	compound	B-RNA
and	CC	cc	I-RNA
RAG-2	NN	conj	I-RNA
RNAs	NNS	nmod	I-RNA
.	.	punct	O

Study	NN	nsubj	O
of	IN	case	O
Aldh1	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nmod	O
during	IN	case	O
spleen	NN	compound	O
development	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
Aldh1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
inversely	RB	advmod	O
correlated	VBD	ccomp	O
with	IN	case	O
Hox11	NN	nmod	B-protein
.	.	punct	O

Analysis	NN	nsubjpass	O
of	IN	case	O
X-chromosome	NN	compound	B-DNA
inactivation	NN	compound	O
patterns	NNS	nmod	O
can	MD	aux	O
be	VB	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
proliferative	JJ	amod	O
disorders	NNS	nsubj	O
are	VBP	cop	O
clonal	JJ	ccomp	O
in	IN	case	O
origin	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
context	NN	dep	O
of	IN	case	O
T	NN	nmod:npmod	O
cell-dependent	JJ	amod	O
B	NN	compound	O
cell	NN	compound	O
immunopoiesis	NN	nmod	O
occurring	VBG	acl	O
in	IN	case	O
FDC	NN	compound	B-cell_type
clusters	NNS	nmod	O
,	,	punct	O
p50	NN	nsubj	B-protein
is	VBZ	cop	O
mainly	RB	advmod	O
related	JJ	ccomp	O
to	TO	case	O
FDC	NN	nmod	B-cell_type
with	IN	case	O
a	DT	det	O
massive	JJ	amod	O
overexpression	NN	nmod	O
in	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
p65	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
expressed	VBN	parataxis	O
in	IN	case	O
a	DT	det	O
scattered	VBN	amod	O
manner	NN	nmod	O
in	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
and	CC	cc	O
c-Rel	NN	compound	O
protein	NN	conj	O
exclusively	RB	advmod	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
from	IN	case	O
FDC	NN	compound	B-cell_type
clusters	NNS	nmod	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
transcribed	VBN	amod	O
5'-untranslated	JJ	amod	B-DNA
leader	NN	compound	I-DNA
region	NN	nsubj	I-DNA
(	-LRB-	punct	O
5'-UTR	NN	appos	B-DNA
)	-RRB-	punct	O
also	RB	advmod	O
contains	VBZ	ccomp	O
important	JJ	amod	O
transcriptional	JJ	amod	B-DNA
elements	NNS	dobj	I-DNA
.	.	punct	O

Isolation	NN	ROOT	O
of	IN	case	O
a	DT	det	O
rel-related	JJ	amod	B-DNA
human	JJ	amod	I-DNA
cDNA	NN	nmod	I-DNA
that	WDT	nsubj	O
potentially	RB	advmod	O
encodes	VBZ	acl:relcl	O
the	DT	det	O
65-kD	JJ	amod	B-protein
subunit	NN	dobj	I-protein
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	dep	O
in	IN	case	O
Science	NNP	compound	O
1991	CD	nummod	O
Oct	NNP	nmod	O
4	CD	nummod	O
;	:	punct	O
254	CD	nummod	O
(	-LRB-	punct	O
5028	CD	dep	O
)	-RRB-	punct	O
:	:	punct	O
11	CD	dep	O
]	-RRB-	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
interrelationships	NNS	dobj	O
between	IN	case	O
CD45	NN	nmod	B-protein
and	CC	cc	O
HIV-1	NN	conj	O
further	RB	advmod	O
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
germline	NN	compound	B-DNA
Cepsilon	NN	compound	O
transcription	NN	nmod	O
by	IN	mark	O
using	VBG	advcl	O
two	CD	nummod	O
human	JJ	amod	B-cell_line
Burkitt	NN	nmod:poss	I-cell_line
's	POS	case	I-cell_line
lymphoma	NN	compound	I-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dobj	I-cell_line
,	,	punct	O
DND39	NN	appos	B-cell_line
and	CC	cc	O
DG75	NN	conj	B-cell_line
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
neutrophils	NNS	nmod	I-cell_type
with	IN	case	O
chemoattractants	NNS	nmod	B-protein
FMLP	NN	dep	B-protein
or	CC	cc	O
platelet	NN	compound	B-protein
activating	NN	compound	I-protein
factor	NN	conj	I-protein
(	-LRB-	punct	O
PAF	NN	appos	B-protein
)	-RRB-	punct	O
results	VBZ	ROOT	O
in	IN	case	O
different	JJ	amod	O
but	CC	cc	O
overlapping	VBG	conj	O
functional	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

The	DT	det	O
enhancer	NN	nsubj	O
also	RB	advmod	O
appeared	VBD	ROOT	O
to	TO	mark	O
mediate	VB	xcomp	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	compound	O
induction	NN	dobj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
IL-1	NN	compound	B-protein
responsiveness	NN	conj	O
in	IN	case	O
fibroblasts	NNS	nmod	B-cell_type
.	.	punct	O

A	DT	det	O
negative	JJ	amod	O
regulatory	JJ	amod	O
region	NN	ROOT	O
containing	VBG	acl	O
a	DT	det	O
glucocorticosteroid	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	dobj	I-DNA
(	-LRB-	punct	O
nGRE	NN	appos	B-DNA
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
interleukin-1beta	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
the	DT	det	O
sulfhydryl	NN	compound	O
agent	NN	compound	O
dithiothreitol	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
results	NNS	dobj	O
suggesting	VBG	acl	O
the	DT	det	O
absence	NN	dobj	O
of	IN	case	O
disulfide	NN	compound	B-protein
bridges	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
steroid	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
.	.	punct	O

Inhibition	NN	compound	O
effects	NNS	nsubjpass	O
versus	CC	cc	O
time	NN	conj	O
were	VBD	auxpass	O
described	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
pharmacodynamic	JJ	amod	O
model	NN	nmod	O
using	VBG	acl	O
MPL	NN	compound	O
concentrations	NNS	dobj	O
in	IN	case	O
plasma	NN	nmod	B-cell_type
as	IN	case	O
an	DT	det	O
input	NN	compound	O
function	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
three	CD	nummod	O
linear	NN	nmod	O
or	CC	cc	O
two	CD	nummod	O
loop	NN	compound	O
peptides	NNS	dep	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
V3	NN	compound	B-protein
region	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
HTLV-III	NN	compound	O
BH10	NN	compound	O
clone	NN	nmod	O
or	CC	cc	O
the	DT	det	O
SF2	NN	compound	O
strain	NN	conj	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
on	IN	case	O
IL-2	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	nmod	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
imply	VBP	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
a	DT	det	O
complex	JJ	amod	O
family	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B-like	JJ	amod	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Eicosanoids	NNS	ROOT	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
mastectomy	NN	nmod	O
.	.	punct	O

Interleukin	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
IL	NN	appos	I-protein
)	-RRB-	punct	I-protein
-10	CD	nummod	I-protein
inhibits	VBZ	ROOT	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
(	-LRB-	punct	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
activation	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

LTR	NN	compound	B-DNA
-directed	JJ	amod	O
transcription	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
luciferase	NN	compound	B-DNA
reporter	NN	compound	I-DNA
constructs	NNS	dobj	I-DNA
that	WDT	nsubjpass	O
were	VBD	auxpass	O
transiently	RB	advmod	O
transfected	VBN	acl:relcl	O
into	IN	case	O
cultured	VBN	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
CAML	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
calcium-modulator	NN	compound	I-protein
and	CC	cc	I-protein
cyclophilin	NN	compound	I-protein
ligand	NN	conj	I-protein
)	-RRB-	punct	I-protein
protein	NN	nmod	I-protein
is	VBZ	cop	O
a	DT	det	O
coinducer	NN	ROOT	O
of	IN	case	O
NF-AT	NN	compound	B-protein
activation	NN	nmod	O
when	WRB	advmod	O
overexpressed	VBN	advcl	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
establish	VBP	ROOT	O
that	IN	mark	O
Rel	NN	nsubj	B-protein
can	MD	aux	O
function	VB	ccomp	O
as	IN	case	O
an	DT	det	O
activator	NN	nmod	O
or	CC	cc	O
repressor	NN	conj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
by	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
for	IN	case	O
production	NN	nmod	O
of	IN	case	O
IL-3	NN	nmod	B-protein
and	CC	cc	O
GM-CSF	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
pRB	NN	compound	B-protein
posttranslational	JJ	amod	O
modification	NN	nmod	O
during	IN	case	O
apoptosis	NN	nmod	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
by	IN	mark	O
determining	VBG	advcl	O
the	DT	det	O
E2F-1	NN	compound	B-protein
levels	NNS	dobj	O
and	CC	cc	O
by	IN	case	O
isolating	VBG	conj	O
and	CC	cc	O
characterizing	VBG	conj	O
pRB-null	JJ	nummod	B-cell_line
clones	NNS	conj	I-cell_line
from	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Induced	VBN	amod	O
MIP-1alpha	NN	compound	B-protein
expression	NN	nsubj	O
and	CC	cc	O
secretion	NN	conj	O
in	IN	case	O
PMA/PHA	NN	compound	B-cell_line
stimulated	JJ	amod	I-cell_line
tax	NN	compound	I-cell_line
transfected	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
correlate	VBP	ROOT	O
with	IN	case	O
the	DT	det	O
noninduction	NN	nmod	O
of	IN	case	O
MNP-1	NN	compound	B-protein
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
intimately	RB	advmod	O
involved	VBN	acl:relcl	O
in	IN	mark	O
downmodulating	VBG	advcl	O
the	DT	det	O
MIP-1alpha	NN	compound	B-DNA
gene	NN	dobj	I-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
a	DT	det	O
new	JJ	amod	O
combination	NN	compound	O
isoform	NN	nsubjpass	O
containing	VBG	acl	O
Oct2a	NN	nmod:poss	B-protein
's	POS	case	I-protein
amino	NN	compound	I-protein
terminal	JJ	amod	I-protein
insert	NN	dobj	I-protein
(	-LRB-	punct	O
exon	NN	compound	B-DNA
7a	NN	appos	I-DNA
)	-RRB-	punct	O
and	CC	cc	O
Oct2b	NN	nmod:poss	B-protein
's	POS	case	I-protein
carboxy	NN	compound	I-protein
terminal	JJ	amod	I-protein
insert	NN	conj	I-protein
(	-LRB-	punct	O
exon	NN	appos	B-DNA
13	CD	nummod	I-DNA
)	-RRB-	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	WDT	nsubj	O
created	VBD	ccomp	O
a	DT	det	O
novel	JJ	amod	O
large	JJ	amod	O
isoform	NN	dobj	O
,	,	punct	O
Oct2ab	NN	appos	B-protein
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
tal-1	NN	compound	B-protein
and	CC	cc	O
GATA-binding	JJ	conj	B-protein
proteins	NNS	nmod	I-protein
during	IN	case	O
human	JJ	amod	O
hematopoiesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
Sp1	NN	dep	B-protein
and	CC	cc	O
PU.1	NN	conj	B-protein
prime	VBP	ROOT	I-protein
the	DT	det	O
CD11b	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
,	,	punct	O
but	CC	cc	O
the	DT	det	O
nature	NN	nsubj	O
of	IN	case	O
the	DT	det	O
factors	NNS	nmod	O
responsible	JJ	amod	O
for	IN	case	O
its	PRP$	nmod:poss	O
inducible	JJ	amod	O
expression	NN	nmod	O
are	VBP	cop	O
unknown	JJ	conj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
paternal	JJ	amod	B-DNA
X	NN	compound	I-DNA
chromosome	NN	nsubj	I-DNA
carries	VBZ	ccomp	O
the	DT	det	O
de	FW	amod	O
novo	FW	dep	O
alpha-galactosidase	NN	compound	B-protein
A	NN	compound	I-protein
mutation	NN	dobj	O
and	CC	cc	O
that	IN	mark	O
uneven	JJ	amod	O
X	NN	compound	O
inactivation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
underlying	VBG	amod	O
mechanism	NN	conj	O
for	IN	case	O
disease	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
this	DT	det	O
novel	JJ	amod	O
female	JJ	amod	O
MZ	JJ	compound	O
twin	NN	compound	O
pair	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
proximal	JJ	amod	O
steps	NNS	nsubj	O
in	IN	case	O
CD8+	JJ	amod	O
T-cell	NN	compound	O
activation	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
later	JJ	amod	O
phases	NNS	conj	O
are	VBP	cop	O
unresponsive	JJ	ccomp	O
to	TO	case	O
A6H	NN	compound	B-protein
ligation	NN	nmod	O
.	.	punct	O

Physical	JJ	amod	O
interactions	NNS	nsubj	O
between	IN	case	O
Ets	NN	nmod	B-protein
and	CC	cc	I-protein
NF-kappaB/NFAT	NN	conj	I-protein
proteins	NNS	dep	I-protein
play	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
their	PRP$	nmod:poss	O
cooperative	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
parallel	NN	nmod	O
with	IN	case	O
the	DT	det	O
decreased	VBN	amod	O
cytokine	NN	compound	B-protein
generation	NN	nmod	O
,	,	punct	O
each	DT	det	O
cytokine	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
less	RBR	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
10	CD	compound	O
(	-LRB-	punct	O
-5	CD	dep	O
)	-RRB-	punct	O
M	NN	compound	O
Azeptin	NN	nmod	O
.	.	punct	O

Anti-CD28-stimulated	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
produced	VBD	ROOT	O
significant	JJ	amod	O
amounts	NNS	dobj	O
of	IN	case	O
IL-8	NN	nmod	B-protein
;	:	punct	O
additionally	RB	advmod	O
,	,	punct	O
costimulation	NN	nsubj	O
with	IN	case	O
anti-CD3	JJ	nmod	B-protein
and	CC	cc	O
anti-CD28	JJ	amod	B-protein
Abs	NNS	conj	I-protein
resulted	VBD	parataxis	O
in	IN	case	O
a	DT	det	O
synergistic	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
IL-8	NN	compound	B-protein
secretion	NN	nmod	O
.	.	punct	O

The	DT	det	O
other	JJ	amod	O
glucocorticoids	NNS	nsubj	O
tested	VBN	acl	O
,	,	punct	O
methylprednisolone	NN	conj	O
and	CC	cc	O
corticosterone	NN	conj	O
,	,	punct	O
were	VBD	cop	O
also	RB	advmod	O
effective	JJ	ROOT	O
at	IN	case	O
concentrations	NNS	nmod	O
of	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-5	CD	appos	O
)	-RRB-	punct	O
M	NN	nmod	O
or	CC	cc	O
greater	JJR	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
no	DT	neg	O
transcription	NN	compound	O
deficiency	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
either	CC	cc:preconj	O
XP-B	NN	nmod	O
or	CC	cc	O
XP-D	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
dominant	JJ	amod	B-protein
negative	JJ	amod	I-protein
Rac	NN	nsubj	I-protein
and	CC	cc	I-protein
Cdc42	NN	conj	I-protein
proteins	NNS	dep	I-protein
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
monocyte	NN	compound	O
adhesion	NN	dobj	O
or	CC	cc	O
spreading	NN	conj	O
.	.	punct	O

Additional	JJ	amod	O
work	NN	nsubj	O
,	,	punct	O
employing	VBG	acl	O
sequential	JJ	amod	O
and	CC	cc	O
internal	JJ	conj	O
deletions	NNS	dobj	O
of	IN	case	O
ZEBRA	NN	nmod:poss	B-protein
's	POS	case	O
N-terminal	JJ	amod	B-protein
activation	NN	compound	I-protein
domain	NN	nmod	I-protein
,	,	punct	O
indicates	VBZ	ROOT	O
that	IN	mark	O
its	PRP$	nmod:poss	O
separate	JJ	amod	O
activities	NNS	nsubj	O
are	VBP	cop	O
not	RB	neg	O
attributable	JJ	ccomp	O
to	TO	case	O
specific	JJ	amod	O
subdomains	NNS	nmod	B-protein
but	CC	cc	O
are	VBP	auxpass	O
spread	VBN	conj	O
throughout	IN	case	O
its	PRP$	poss	O
N	NN	compound	B-protein
terminus	NN	nmod	I-protein
and	CC	cc	O
therefore	RB	advmod	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
inactivated	VBN	conj	O
by	IN	mark	O
deleting	VBG	advcl	O
localized	JJ	amod	O
regions	NNS	dobj	O
.	.	punct	O

Lipopolysaccharide	NN	compound	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
stimulation	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-cell_type
neutrophils	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
result	VB	xcomp	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
p38	NN	compound	B-protein
mitogen-activated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
MAPk	NN	appos	B-protein
)	-RRB-	punct	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
upstream	JJ	amod	B-protein
activator	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
of	IN	case	O
p38	NN	compound	B-protein
MAPk	NN	nmod	I-protein
is	VBZ	cop	O
unknown	JJ	parataxis	O
,	,	punct	O
and	CC	cc	O
consequences	NNS	nsubj	O
of	IN	case	O
p38	NN	compound	B-protein
MAPk	NN	compound	I-protein
activation	NN	nmod	O
remain	VBP	conj	O
largely	RB	advmod	O
undefined	JJ	xcomp	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
IL-12	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
IL-12R	NN	compound	I-protein
)	-RRB-	punct	I-protein
beta	NN	compound	I-protein
2	CD	nummod	I-protein
subunit	NN	nsubjpass	I-protein
,	,	punct	O
a	DT	det	O
recently	RB	advmod	O
cloned	VBN	amod	O
binding	NN	appos	B-protein
and	CC	cc	I-protein
signal	NN	compound	I-protein
transducing	NN	compound	I-protein
component	NN	conj	I-protein
of	IN	case	O
the	DT	det	O
IL-12R	NN	nmod	B-protein
,	,	punct	O
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
on	IN	case	O
human	JJ	amod	B-cell_line
Th1	NN	nmod	I-cell_line
but	CC	cc	I-cell_line
not	RB	cc	I-cell_line
Th2	NN	compound	I-cell_line
clones	NNS	dep	I-cell_line
and	CC	cc	O
is	VBZ	auxpass	O
induced	VBN	conj	O
during	IN	case	O
differentiation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
naive	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
along	IN	case	O
the	DT	det	O
Th1	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
Th2	NN	compound	O
pathway	NN	conj	O
.	.	punct	O

HIV	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
protease	NN	compound	B-protein
activation	NN	ROOT	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
within	IN	case	O
T	NN	compound	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
this	DT	det	O
deletion	NN	compound	O
mutation	NN	nsubj	O
prevented	VBD	ROOT	O
the	DT	det	O
induced	VBN	amod	O
phosphorylation	NN	dobj	O
,	,	punct	O
degradative	JJ	amod	O
loss	NN	conj	O
,	,	punct	O
and	CC	cc	O
functional	JJ	amod	O
release	NN	conj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
from	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
Tax-expressing	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
multiple	JJ	amod	O
alterations	NNS	nsubj	O
observed	VBN	acl	O
on	IN	case	O
the	DT	det	O
various	JJ	amod	O
biochemical	JJ	amod	O
pathways	NNS	nmod	O
may	MD	aux	O
appear	VB	ROOT	O
as	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
of	IN	case	O
a	DT	det	O
unique	JJ	amod	O
deleterious	JJ	amod	O
mechanism	NN	nmod	O
more	RBR	advmod	O
fundamentally	RB	advmod	O
related	JJ	amod	O
to	TO	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
senescence	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
inability	NN	nmod	O
to	TO	mark	O
cope	VB	xcomp	O
with	IN	case	O
oxidative	JJ	amod	O
stress	NN	nmod	O
.	.	punct	O

STAT1	NN	compound	B-protein
activity	NN	nsubj	O
was	VBD	cop	O
evident	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
STAT	NN	compound	B-DNA
binding	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
(	-LRB-	punct	O
SBE	NNS	appos	B-DNA
)	-RRB-	punct	O
present	JJ	amod	O
in	IN	case	O
the	DT	det	O
promoters	NNS	nmod	B-DNA
of	IN	case	O
genes	NNS	nmod	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
up-regulated	VBN	acl:relcl	O
during	IN	case	O
monocyte	NN	compound	O
to	TO	dep	O
macrophage	NN	compound	O
maturation	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
FcgammaRI	NN	nmod	B-DNA
and	CC	cc	O
ICAM-1	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
promoter	NN	conj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
factor	NN	compound	I-DNA
IFN	NN	compound	I-DNA
regulatory	JJ	amod	I-DNA
factor-1	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
cells	NNS	nmod	O
preincubated	VBN	acl	O
for	IN	case	O
a	DT	det	O
day	NN	nmod	O
,	,	punct	O
levels	NNS	nsubj	O
of	IN	case	O
FOS	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
reach	VBP	ROOT	O
a	DT	det	O
maximum	NN	amod	O
20	CD	nummod	O
min	NN	dobj	O
after	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
lectin	NN	nmod	B-protein
and	CC	cc	O
decline	NN	conj	O
to	TO	mark	O
control	VB	advcl	O
levels	NNS	dobj	O
over	IN	case	O
the	DT	det	O
next	JJ	amod	O
3	CD	nummod	O
hr	NN	nmod	O
.	.	punct	O

From	IN	case	O
nuclear	JJ	amod	O
runoff	JJ	compound	O
experiments	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
one	CD	nummod	O
subunit	NN	nsubjpass	O
in	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
the	DT	det	O
B2	NN	compound	B-protein
isoform	NN	appos	I-protein
(	-LRB-	punct	O
Mr	NN	dep	O
=	JJ	amod	O
56	CD	dep	O
,	,	punct	O
000	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
amplified	VBN	ccomp	O
primarily	RB	advmod	O
by	IN	case	O
transcriptional	JJ	amod	O
means	NNS	nmod	O
.	.	punct	O

Now	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
nature	NN	nmod	O
of	IN	case	O
the	DT	det	O
monocyte	NN	compound	O
activating	NN	compound	O
signal	NN	nmod	O
on	IN	case	O
these	DT	det	O
two	CD	nummod	O
inhibitory	JJ	amod	O
mechanims	NNS	nmod	O
.	.	punct	O

Renal	JJ	amod	O
cell	NN	nmod:npmod	O
carcinoma-derived	JJ	amod	O
gangliosides	NNS	nsubj	O
suppress	VBP	ROOT	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	compound	I-protein
activation	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Twenty-two	CD	nummod	O
differences	NNS	nsubjpass	O
from	IN	case	O
the	DT	det	O
human	JJ	amod	O
sequence	NN	nmod	O
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
region	NN	nmod	I-protein
(	-LRB-	punct	O
amino	NN	compound	B-protein
acids	NNS	appos	I-protein
1-421	CD	nummod	I-protein
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
squirrel	NN	compound	O
monkey	NN	compound	O
receptor	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
danazol	NN	nsubj	O
has	VBZ	ccomp	O
an	DT	det	O
anti-estrogenic	JJ	amod	O
action	NN	dobj	O
to	TO	case	O
the	DT	det	O
monocytes	NNS	nmod	O
through	IN	case	O
the	DT	det	O
competition	NN	nmod	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
estrogen	NN	compound	O
binding	NN	compound	O
sites	NNS	nmod	O
as	IN	mark	O
seen	VBN	advcl	O
in	IN	case	O
the	DT	det	O
estrogen	NN	compound	O
target	NN	compound	O
organ	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
translation	NN	nsubj	O
of	IN	case	O
NFATc	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
apparently	RB	advmod	O
initiates	VBZ	ROOT	O
at	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
AUG	NN	compound	B-DNA
codons	NNS	nmod	I-DNA
,	,	punct	O
giving	VBG	xcomp	O
rise	NN	dobj	O
to	TO	case	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
differ	VBP	acl:relcl	O
in	IN	case	O
size	NN	nmod	O
by	IN	case	O
36	CD	nummod	O
amino	NN	compound	O
acids	NNS	nmod	O
.	.	punct	O

Partial	JJ	amod	O
cortisol	NN	compound	O
receptor	NN	compound	O
resistance	NN	nsubj	O
might	MD	aux	O
be	VB	cop	O
less	RBR	advmod	O
rare	JJ	ROOT	O
than	IN	mark	O
previously	RB	advmod	O
thought	VBN	advcl	O
.	.	punct	O

Increasing	VBG	amod	O
success	NN	nsubj	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
childhood	NN	compound	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	case	O
increasing	VBG	amod	O
awareness	NN	nmod	O
of	IN	case	O
avascular	JJ	amod	O
necrosis	NN	nmod	O
of	IN	case	O
bone	NN	nmod	O
as	IN	case	O
a	DT	det	O
potentially	RB	advmod	O
disabling	JJ	amod	O
sequela	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
therapy	NN	nmod	O
,	,	punct	O
especially	RB	advmod	O
in	IN	case	O
adolescent	JJ	nmod	O
and	CC	cc	O
young	JJ	amod	O
adult	JJ	amod	O
patients	NNS	conj	O
.	.	punct	O

Using	VBG	advcl	O
immunological	JJ	amod	O
cross-linking	NN	dobj	O
to	TO	case	O
mimic	JJ	amod	O
receptor	NN	compound	O
engagement	NN	nmod	O
by	IN	case	O
natural	JJ	amod	O
ligands	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
CD15	NN	nsubj	O
(	-LRB-	punct	O
Lewis	NN	compound	O
X	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
monocyte	NN	compound	B-protein
counter-receptor	NN	appos	I-protein
for	IN	case	O
endothelial	JJ	amod	B-protein
selectins	NNS	nmod	I-protein
may	MD	aux	O
participate	VB	ccomp	O
in	IN	case	O
this	DT	det	O
response	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
IL-2	NN	nsubj	B-protein
but	CC	cc	O
not	RB	cc	O
IL-12	NN	conj	B-protein
induced	VBD	ROOT	O
nuclear	JJ	amod	B-protein
factors	NNS	dobj	I-protein
NF-kappa	NN	compound	B-protein
B	NN	dep	I-protein
and	CC	cc	O
AP1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
regulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
these	DT	det	O
two	CD	nummod	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
protein	NN	compound	I-protein
complexes	NNS	nmod	I-protein
is	VBZ	auxpass	O
correlated	VBN	conj	O
with	IN	case	O
IFN-gamma	NN	nmod	O
and	CC	cc	O
GM-CSF	NN	conj	O
gene	NN	compound	O
expression	NN	dep	O
.	.	punct	O

The	DT	det	O
BZLF1	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	nsubjpass	I-DNA
(	-LRB-	punct	O
Zp	NN	appos	B-DNA
)	-RRB-	punct	O
was	VBD	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
crosslinking	VBG	nmod	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
immunoglobulin	NN	nmod	I-protein
(	-LRB-	punct	O
Ig	NN	appos	B-protein
)	-RRB-	punct	O
with	IN	case	O
anti-Ig	JJ	amod	B-protein
antibody	NN	nmod	I-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
other	JJ	amod	O
viral	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

By	IN	mark	O
isolating	VBG	advcl	O
Daudi	NN	nmod	B-cell_line
x	NN	cc	I-cell_line
HeLa	NN	conj	I-cell_line
heterokaryons	VBZ	dobj	I-cell_line
a	DT	det	O
few	JJ	amod	O
hours	NNS	dobj	O
after	IN	prep	O
fusion	NN	pobj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
the	DT	det	O
initial	JJ	amod	O
fate	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
B	NN	nmod:npmod	B-protein
cell-specific	JJ	amod	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
involved	VBN	acl	O
in	IN	case	O
Ig	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
,	,	punct	O
Oct-2	NN	conj	B-DNA
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
C-terminus	NN	nsubj	B-protein
of	IN	case	O
Oct-2	NN	nmod	B-protein
is	VBZ	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
confer	VB	xcomp	O
activation	NN	compound	O
potential	NN	dobj	O
to	TO	case	O
nonactive	JJ	amod	O
DNA-binding	JJ	amod	B-DNA
fragments	NNS	nmod	I-DNA
in	IN	case	O
yeast	NN	nmod	O
.	.	punct	O

Macrophages	NNS	nsubj	B-cell_type
in	IN	case	O
human	JJ	amod	O
atheroma	NN	nmod	O
contain	VBP	ROOT	O
PPARgamma	NN	dobj	B-protein
:	:	punct	O
differentiation-dependent	JJ	amod	B-protein
peroxisomal	JJ	amod	I-protein
proliferator-activated	JJ	amod	I-protein
receptor	NN	compound	I-protein
gamma	NN	compound	I-protein
(	-LRB-	punct	O
PPARgamma	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	dep	O
and	CC	cc	O
reduction	NN	conj	O
of	IN	case	O
MMP-9	NN	compound	B-protein
activity	NN	nmod	O
through	IN	case	O
PPARgamma	NN	compound	B-protein
activation	NN	nmod	O
in	IN	case	O
mononuclear	JJ	amod	O
phagocytes	NNS	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Sequence	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
nineteen	CD	nummod	O
LTRs	NNS	nmod	B-DNA
cloned	VBN	acl	O
from	IN	case	O
2	CD	nummod	O
adult	JJ	nmod	O
and	CC	cc	O
3	CD	nummod	O
pediatric	JJ	amod	O
patients	NNS	conj	O
revealed	VBD	ROOT	O
an	DT	det	O
average	NN	dobj	O
of	IN	case	O
33	CD	nummod	O
nucleotide	NN	compound	O
changes	NNS	nmod	O
(	-LRB-	punct	O
with	IN	case	O
respect	NN	dep	O
to	TO	case	O
the	DT	det	O
sequence	NN	nmod	O
of	IN	case	O
the	DT	det	O
LAI	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
)	-RRB-	punct	O
within	IN	case	O
the	DT	det	O
455-bp	JJ	amod	B-DNA
U3	NN	compound	I-DNA
region	NN	nmod	I-DNA
.	.	punct	O

Given	IN	case	O
the	DT	det	O
deleterious	JJ	amod	O
effects	NNS	nmod	O
to	TO	case	O
the	DT	det	O
host	NN	nmod	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
,	,	punct	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
postulated	VBN	ROOT	O
that	IN	mark	O
TNF-alpha	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nsubjpass	O
must	MD	aux	O
be	VB	auxpass	O
tightly	RB	advmod	O
regulated	VBN	ccomp	O
.	.	punct	O

We	PRP	nsubj	O
recently	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
garlic	JJ	amod	O
compound	NN	nsubj	O
,	,	punct	O
S-allyl	JJ	amod	O
cysteine	NN	appos	O
(	-LRB-	punct	O
SAC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
protects	VBZ	ccomp	O
bovine	JJ	amod	B-cell_type
pulmonary	JJ	amod	I-cell_type
artery	NN	compound	I-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	dobj	I-cell_type
from	IN	case	O
oxidant	JJ	amod	O
injury	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
hydrogen	NN	compound	O
peroxide	NN	nmod	O
(	-LRB-	punct	O
H2O2	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Modulation	NN	nsubj	O
of	IN	case	O
endogenous	JJ	amod	O
IL-1	NN	compound	B-protein
beta	NN	nmod	I-protein
and	CC	cc	O
IL-1	NN	compound	B-protein
receptor	NN	compound	I-protein
antagonist	NN	conj	O
results	VBZ	ROOT	O
in	IN	case	O
opposing	VBG	amod	O
effects	NNS	nmod	O
on	IN	case	O
HIV	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
chronically	RB	advmod	B-cell_line
infected	JJ	amod	I-cell_line
monocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Some	DT	nsubj	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	amod	O
antiinflammatory	JJ	amod	O
and	CC	cc	O
immunosuppressive	JJ	conj	O
agents	NNS	nmod	O
are	VBP	cop	O
synthetic	JJ	amod	O
glucocorticoids	NNS	ROOT	O
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nsubjpass	I-protein
,	,	punct	O
Nuclear	JJ	amod	B-protein
Factor	NN	compound	I-protein
of	IN	amod	I-protein
Activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nsubj	I-protein
(	-LRB-	punct	O
NFAT	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
target	NN	appos	O
for	IN	case	O
p21ras	NN	compound	B-protein
and	CC	cc	O
calcium	NN	compound	O
signalling	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
p21ras	NN	compound	B-protein
signals	NNS	nmod	O
acting	VBG	acl	O
in	IN	case	O
synergy	NN	nmod	O
with	IN	case	O
calcium	NN	compound	O
/calcineurin	NN	compound	B-protein
signals	NNS	nmod	O
.	.	punct	O

Fibrinogen	NN	nsubj	B-protein
also	RB	advmod	O
caused	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
AP-1	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
SP1	NN	conj	B-protein
or	CC	cc	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
CREB	NN	compound	I-protein
)	-RRB-	punct	I-protein
factors	NNS	conj	I-protein
.	.	punct	O

Additional	JJ	amod	O
major	JJ	amod	O
protein-DNA	JJ	amod	O
interactions	NNS	nsubj	O
do	VBP	aux	O
not	RB	neg	O
occur	VB	ROOT	O
within	IN	case	O
the	DT	det	O
promoter	NN	compound	O
region	NN	nmod	O
after	IN	case	O
T	NN	compound	O
lymphocyte	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
a	DT	det	O
requirement	NN	dobj	O
for	IN	case	O
additional	JJ	amod	O
protein-protein	JJ	amod	O
interactions	NNS	nmod	O
and/or	CC	cc	O
post-translational	JJ	amod	O
modifications	NNS	conj	O
of	IN	case	O
pre-bound	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
to	TO	mark	O
account	VB	acl	O
for	IN	case	O
the	DT	det	O
observed	VBN	amod	O
increase	NN	nmod	O
in	IN	case	O
IMPDH	NN	compound	O
type	NN	compound	O
II	CD	nummod	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
CD8+	JJ	amod	O
cytotoxic	JJ	amod	O
T	NN	compound	O
lymphocyte	NN	compound	O
(	-LRB-	punct	O
CTL	NN	appos	O
)	-RRB-	punct	O
response	NN	nsubjpass	O
to	TO	case	O
latently	RB	advmod	B-cell_type
infected	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
well	RB	advmod	O
characterized	VBN	advcl	O
,	,	punct	O
very	RB	advmod	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
T	NN	compound	O
cell	NN	compound	O
controls	NNS	nmod	O
over	IN	case	O
lytic	JJ	amod	O
infection	NN	nmod	O
;	:	punct	O
this	DT	det	O
imbalance	NN	nsubj	O
in	IN	case	O
our	PRP$	nmod:poss	O
understanding	NN	compound	O
belies	VBZ	parataxis	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
virus-replicative	JJ	amod	O
lesions	NNS	nmod	O
in	IN	case	O
several	JJ	amod	O
aspects	NNS	nmod	O
of	IN	case	O
EBV	NN	compound	O
disease	NN	compound	O
pathogenesis	NN	nmod	O
.	.	punct	O

HIV-TF1	NN	nsubj	B-protein
had	VBD	ROOT	O
a	DT	det	O
molecular	JJ	amod	O
weight	NN	dobj	O
of	IN	case	O
39	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
mature	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
TCR	NN	compound	B-protein
engagement	NN	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
signals	NNS	nmod	O
that	WDT	nsubj	O
drive	VBP	acl:relcl	O
induction	NN	dobj	O
of	IN	case	O
cytokine	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
clonal	JJ	amod	O
expansion	NN	conj	O
.	.	punct	O

The	DT	det	O
identification	NN	nsubj	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
opens	VBZ	ROOT	O
the	DT	det	O
way	NN	dobj	O
to	IN	case	O
studies	NNS	nmod	O
of	IN	case	O
the	DT	det	O
physiologic	JJ	amod	O
mechanisms	NNS	nmod	O
controlling	VBG	acl	O
reactvation	NN	dobj	O
of	IN	case	O
KSHV	NN	nmod	O
from	IN	case	O
latency	NN	nmod	O
.	.	punct	O

4.	LS	dep	O
Fluorescence	NN	compound	O
HPLC	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
SMX-NHOH	NN	nsubj	O
and	CC	cc	O
SMX-NO	NN	conj	O
depleted	VBD	ccomp	O
CYS	NN	dobj	O
and	CC	cc	O
GSH	NN	conj	O
in	IN	case	O
buffer	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	conj	O
,	,	punct	O
in	IN	case	O
cells	NNS	nmod	O
and	CC	cc	O
plasma	NN	conj	O
.	.	punct	O

Second	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
NAC	NN	nmod	O
on	IN	case	O
IgE	NN	compound	B-protein
synthesis	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
normal	JJ	amod	O
B	NN	compound	O
cells	NNS	nmod	O
costimulated	VBN	acl	O
with	IN	case	O
IL-4	NN	nmod	B-protein
and	CC	cc	O
anti-CD40	JJ	amod	B-protein
mAb	NN	conj	I-protein
.	.	punct	O

Tap	NN	ROOT	B-protein
:	:	punct	O
a	DT	det	O
novel	JJ	amod	O
cellular	JJ	amod	B-protein
protein	NN	dep	I-protein
that	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
tip	NN	nmod	O
of	IN	case	O
herpesvirus	NN	compound	O
saimiri	NN	nmod	O
and	CC	cc	O
induces	VBZ	conj	O
lymphocyte	NN	compound	B-cell_type
aggregation	NN	dobj	O
.	.	punct	O

NAC	NN	nsubj	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
half-life	NN	nmod	O
of	IN	case	O
E-selectin	NN	compound	B-RNA
or	CC	cc	I-RNA
VCAM-1	NN	conj	I-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
factors	NNS	nsubjpass	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
are	VBP	auxpass	O
required	VBN	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
HIV-2	NN	compound	O
transcription	NN	dobj	O
in	IN	case	O
infected	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
contact	NN	nsubj	O
of	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
foreign	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
with	IN	case	O
certain	JJ	amod	O
virus-infected	JJ	conj	B-cell_type
or	CC	cc	I-cell_type
tumor	NN	conj	I-cell_type
cells	NNS	dep	I-cell_type
triggers	VBZ	ROOT	O
the	DT	det	O
cytolytic	JJ	amod	O
machinery	NN	dobj	O
of	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

YM268	NN	nsubj	O
facilitated	VBD	ROOT	O
the	DT	det	O
insulin-stimulated	JJ	amod	O
triglyceride	NN	compound	O
accumulation	NN	dobj	O
in	IN	case	O
3T3-L1	NN	compound	B-cell_type
adipocytes	NNS	nmod	I-cell_type
and	CC	cc	O
increased	VBD	conj	O
the	DT	det	O
mRNA	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
fatty	JJ	amod	B-protein
acid-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

This	DT	det	O
CD16	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
FasL	NN	compound	B-protein
expression	NN	nsubjpass	O
was	VBD	auxpass	O
suppressed	VBN	ROOT	O
by	IN	case	O
oxidative	JJ	amod	O
stress	NN	nmod	O
,	,	punct	O
including	VBG	case	O
thiol	NN	compound	O
deprivation	NN	nmod	O
or	CC	cc	O
treatment	NN	conj	O
with	IN	case	O
hydrogen	NN	compound	O
peroxide	NN	nmod	O
(	-LRB-	punct	O
H2O2	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Monocytic	JJ	amod	O
cell	NN	compound	O
adhesion	NN	nsubjpass	O
to	TO	case	O
EC	NN	nmod	B-cell_type
in	IN	case	O
response	NN	dep	O
to	TO	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
lipopolysaccharide	NN	conj	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alpha-thrombin	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	conj	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
similarly	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
NAC	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Mechanism	NN	ROOT	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
steroid	NN	compound	O
hormones.	CD	compound	O
I.	NNP	compound	O
Estrogens	NNP	nmod	O
]	-RRB-	punct	O

Both	DT	det	O
patients	NNS	nsubj	O
presented	VBD	ROOT	O
with	IN	case	O
a	DT	det	O
salt-losing	JJ	amod	O
episode	NN	compound	O
simulating	VBG	compound	O
adrenal	JJ	amod	O
insufficiency	NN	nmod	O
.	.	punct	O

Interleukin-9	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
IL-9R	NN	compound	I-protein
)	-RRB-	punct	I-protein
complex	NN	nsubj	I-protein
consists	VBZ	ROOT	O
of	IN	case	O
a	DT	det	O
ligand-specific	JJ	amod	B-protein
alpha	NN	compound	I-protein
chain	NN	nmod	I-protein
and	CC	cc	O
IL-2R	NN	compound	B-protein
gamma	NN	compound	I-protein
chain	NN	conj	I-protein
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
unexpectedly	RB	advmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
another	DT	det	O
viral	JJ	amod	B-protein
immediate-early	JJ	amod	I-protein
protein	NN	nmod	I-protein
,	,	punct	O
BRLF1	NN	appos	B-protein
,	,	punct	O
can	MD	aux	O
disrupt	VB	ccomp	O
viral	JJ	amod	O
latency	NN	dobj	O
in	IN	case	O
an	DT	det	O
epithelial	JJ	amod	O
cell-specific	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O

The	DT	det	O
affected	VBN	amod	O
tyrosine	NN	compound	O
residue	NN	nsubjpass	O
located	JJ	amod	O
at	IN	case	O
the	DT	det	O
C	NN	compound	B-protein
terminus	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
is	VBZ	auxpass	O
evolutionarily	RB	advmod	O
strongly	RB	advmod	O
conserved	VBN	ROOT	O
among	IN	case	O
the	DT	det	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
HMG	NN	compound	B-protein
box	NN	compound	I-protein
containing	VBG	amod	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
expression	NN	nsubjpass	O
of	IN	case	O
c-jun	NN	compound	B-DNA
,	,	punct	O
jun	NN	compound	B-DNA
B	NN	conj	I-DNA
and	CC	cc	O
jun	NN	compound	B-DNA
D	NN	conj	I-DNA
genes	NNS	nmod	I-DNA
might	MD	aux	O
be	VB	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
terminal	JJ	amod	B-cell_type
granulocyte	NN	compound	I-cell_type
differentiation	NN	nmod	O
or	CC	cc	O
in	IN	mark	O
regulating	VBG	conj	O
granulocyte	NN	compound	B-cell_type
functionality	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
dominant	JJ	amod	B-protein
negative	JJ	amod	I-protein
mutants	NNS	nmod	I-protein
of	IN	case	O
Ras	NN	nmod	B-protein
and	CC	cc	O
Raf-1	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
have	VB	ROOT	O
any	DT	det	O
effect	NN	dobj	O
on	IN	case	O
FcR	NNS	nmod:npmod	B-protein
-mediated	JJ	amod	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
activation	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	dep	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
signaling	NN	compound	O
pathway	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
used	VBN	ccomp	O
by	IN	case	O
these	DT	det	O
receptors	NNS	nmod	O
.	.	punct	O

Distinctive	JJ	amod	O
gene	NN	compound	O
expression	NN	compound	O
patterns	NNS	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
mammary	JJ	amod	I-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
breast	NN	compound	O
cancers	NNS	conj	O
.	.	punct	O

In	IN	case	O
THP-1	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
TPA	NN	nsubj	O
also	RB	advmod	O
induced	VBD	ROOT	O
a	DT	det	O
new	JJ	amod	O
,	,	punct	O
faster-migrating	JJ	dep	B-protein
NF	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
species	NNS	dobj	I-protein
not	RB	neg	O
induced	VBN	acl	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
biological	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
PNU156804	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
is	VBZ	cop	O
indistinguishable	JJ	ccomp	O
from	IN	case	O
UP	NN	nmod	O
:	:	punct	O
PNU156804	NN	nsubj	O
blocks	VBZ	parataxis	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	dobj	O
in	IN	case	O
mid-late	JJ	amod	O
G1	NN	nmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
expression	NN	dobj	O
of	IN	case	O
cyclins	NNS	nmod	B-protein
,	,	punct	O
and	CC	cc	O
cyclin-dependent	JJ	amod	B-protein
kinases	NNS	conj	I-protein
and	CC	cc	O
retinoblastoma	NN	compound	O
phosphorylation	NN	conj	O
.	.	punct	O

By	IN	case	O
deleted	JJ	amod	O
and	CC	cc	O
mutated	VBN	conj	O
analysis	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-8	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
,	,	punct	O
the	DT	dep	O
AP-1	NN	compound	B-DNA
and	CC	cc	I-DNA
kappa	NN	nmod:npmod	I-DNA
B-like	JJ	amod	I-DNA
sites	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
responsive	JJ	amod	O
elements	NNS	nmod	O
for	IN	case	O
PMA	NN	nmod	O
and	CC	cc	O
ionomycin	NN	conj	O
.	.	punct	O

Co-transfection	NN	compound	O
experiments	NNS	nsubj	O
confirm	VBP	ROOT	O
that	IN	mark	O
Aiolos	NN	nsubj	B-protein
induces	VBZ	ccomp	O
Bcl-2	NN	compound	B-protein
expression	NN	dobj	O
and	CC	cc	O
prevents	VBZ	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
IL-2-deprived	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
IL-10	NN	nmod	B-protein
on	IN	case	O
lipopolysaccharide	NN	compound	O
(	-LRB-	punct	O
LPS	NN	compound	O
)	-RRB-	punct	O
-induced	JJ	amod	O
human	JJ	amod	O
monocyte	NN	compound	O
TNF-alpha	NN	compound	B-protein
production	NN	nmod	O
,	,	punct	O
NF-kappaB	NN	compound	B-protein
activation	NN	conj	O
,	,	punct	O
and	CC	cc	O
IkappaB-alpha	NN	compound	B-protein
degradation	NN	conj	O
.	.	punct	O

To	TO	mark	O
analyze	VB	advcl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
ectopic	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
spi-1	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
proliferation/differentiation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
myeloid	JJ	amod	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
K562	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
stably	RB	advmod	O
transfected	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
spi-1	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
IL-10	NN	nsubj	B-protein
,	,	punct	O
in	IN	case	O
addition	NN	dep	O
to	TO	mark	O
down-regulating	VBG	acl	O
the	DT	det	O
cellular	JJ	amod	O
immune	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
HIV-1	NN	nmod	O
,	,	punct	O
may	MD	aux	O
also	RB	advmod	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
TNF-alpha	NN	compound	B-protein
-mediated	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
in	IN	case	O
the	DT	det	O
monocyte/macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

Imbalanced	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
isoforms	NNS	nmod	I-protein
in	IN	case	O
cultured	VBN	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
from	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
systemic	JJ	amod	O
glucocorticoid	NN	compound	O
resistance	NN	nmod	O
and	CC	cc	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	conj	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
p16	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
E2F-dependent	JJ	amod	B-protein
thymidine	NN	compound	I-protein
kinase	NN	compound	I-protein
regulation	NN	nmod	O
.	.	punct	O

While	IN	mark	O
one	CD	nsubjpass	O
of	IN	case	O
the	DT	det	O
twins	NNS	nmod	O
was	VBD	auxpass	O
clinically	RB	advmod	O
affected	VBN	advcl	O
,	,	punct	O
the	DT	det	O
other	JJ	nsubj	O
was	VBD	ROOT	O
asymptomatic	JJ	acomp	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
biologic	JJ	amod	O
functions	NNS	nsubjpass	O
are	VBP	auxpass	O
modulated	VBN	ROOT	O
,	,	punct	O
in	IN	case	O
that	IN	nmod	O
the	DT	det	O
hormone	NN	nsubj	O
inhibits	VBZ	ccomp	O
proliferation	NN	dobj	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
mAbs	NNS	nmod	B-protein
against	IN	case	O
endothelial	JJ	nmod	B-protein
and/or	CC	cc	I-protein
leukocyte	NN	conj	I-protein
adhesion	NN	compound	I-protein
molecules	NNS	dep	I-protein
(	-LRB-	punct	O
beta1	NN	dep	B-protein
and	CC	cc	I-protein
beta2	NN	conj	I-protein
integrins	NNS	dep	I-protein
)	-RRB-	punct	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
constitutive	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
Rev	NN	compound	B-protein
M10	NN	nmod	I-protein
did	VBD	aux	O
not	RB	neg	O
alter	VB	ROOT	O
the	DT	det	O
secretion	NN	dobj	O
of	IN	case	O
interleukin	NN	nmod	B-protein
2	CD	nummod	I-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
mitogen	NN	compound	O
stimulation	NN	nmod	O
of	IN	case	O
EL-4	NN	compound	B-cell_line
and	CC	cc	O
Jurkat	NN	conj	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

These	DT	det	O
analyses	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
[	-LRB-	punct	O
3H	NN	preconj	O
]	-RRB-	punct	O
aldosterone-	JJ	amod	O
MBP-HBD	NN	compound	B-protein
complex	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
at	IN	advmod	O
least	JJS	advmod	O
associated	VBN	ccomp	O
with	IN	case	O
hsp90	NN	nmod	B-protein
in	IN	case	O
reticulocyte	NN	compound	O
lysate	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
HBD	NN	nsubj	B-protein
of	IN	case	O
hMR	NN	nmod	B-protein
is	VBZ	cop	O
sufficient	JJ	conj	O
to	TO	mark	O
bind	VB	xcomp	O
hsp90	NN	dobj	B-protein
.	.	punct	O

In	IN	prep	O
this	DT	det	O
way	NN	pobj	O
,	,	punct	O
diversity	NN	nsubj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
Stat3	NN	compound	B-protein
proteins	NNS	nmod	I-protein
may	MD	aux	O
provide	VB	ROOT	O
additional	JJ	amod	O
means	NNS	dobj	O
of	IN	mark	O
regulating	VBG	acl	O
cytokine	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
responses	NNS	dobj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Rho	NN	nsubj	B-protein
potentiates	VBZ	ccomp	O
AP-1	NN	compound	B-protein
transcription	NN	dobj	O
during	IN	case	O
T-cell	NN	compound	O
activation	NN	nmod	O

To	TO	mark	O
ascertain	VB	advcl	O
this	DT	det	O
possibility	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
markers	NNS	nmod	O
for	IN	case	O
B-cell	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
,	,	punct	O
and	CC	cc	O
proliferation	NN	conj	O
in	IN	case	O
ILFs	NNS	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
hepatitis	NN	compound	O
C	NN	nmod	O
using	VBG	acl	O
surgically	RB	advmod	O
resected	JJ	amod	O
specimens	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
compared	VBD	conj	O
them	PRP	dobj	O
with	IN	case	O
specimens	NNS	nmod	O
of	IN	case	O
perihepatic	JJ	amod	O
lymph	NN	compound	O
nodes	NNS	nmod	O
by	IN	case	O
an	DT	det	O
immunohistochemical	JJ	amod	O
technique	NN	nmod	O
.	.	punct	O

Adenovirus	NN	compound	B-protein
E1B	NN	compound	I-protein
19K	NN	compound	I-protein
protein	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
efficient	JJ	amod	O
DNA	NN	compound	O
replication	NN	nmod	O
in	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
increased	VBN	amod	O
transcription	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NF-IL6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
is	VBZ	cop	O
responsible	JJ	ccomp	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
for	IN	case	O
induction	NN	nmod	O
of	IN	case	O
NF-IL6	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
following	VBG	case	O
activation	NN	nmod	O
of	IN	case	O
U937	NN	compound	B-cell_line
promonocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Uninduced	JJ	amod	O
or	CC	cc	O
Sendai	NN	compound	O
virus	NN	conj	O
induced	JJ	dep	O
HeLa	NN	compound	O
extracts	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
transcription	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
using	VBG	xcomp	O
a	DT	det	O
series	NN	dobj	O
of	IN	case	O
IFN	NN	compound	B-DNA
beta	NN	compound	I-DNA
promoter	NN	compound	I-DNA
deletions	NNS	nmod	I-DNA
.	.	punct	O

eGLs	NNS	nsubj	B-cell_type
from	IN	case	O
non-pregnant	JJ	amod	O
endometrium	NN	nmod	O
and	CC	cc	O
early	JJ	amod	O
pregnancy	NN	conj	O
showed	VBD	ROOT	O
a	DT	det	O
variable	JJ	amod	O
proliferative	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
5	CD	nummod	O
and	CC	cc	O
100	CD	conj	O
U/ml	NN	dep	O
interleukin-2	NN	nmod	B-protein
over	IN	case	O
48-h	JJ	amod	O
and	CC	cc	O
120-h	JJ	conj	O
time	NN	compound	O
courses	NNS	nmod	O
.	.	punct	O

TINUR	NN	nsubj	B-DNA
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
DNA	NN	compound	B-DNA
sequence	NN	nmod	I-DNA
as	IN	case	O
NGFI-B/nur77	NN	nmod	B-protein
.	.	punct	O

Chemokines	NNS	nsubj	O
are	VBP	cop	O
a	DT	det	O
group	NN	ROOT	O
of	IN	case	O
chemotactic	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
recruitment	NN	nmod	O
of	IN	case	O
inflammatory	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
``	``	punct	O
estrogen	NN	nmod:npmod	O
receptor-related	JJ	amod	O
protein	NN	nsubj	O
''	''	punct	O
is	VBZ	cop	O
HSP27	NN	ROOT	B-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
three	CD	nummod	O
major	JJ	amod	O
29-kDa	JJ	amod	B-protein
proteins	NNS	nsubj	I-protein
phosphorylated	VBN	acl	O
in	IN	case	O
thrombin-activated	JJ	amod	B-cell_type
platelets	NNS	nmod	I-cell_type
are	VBP	cop	O
forms	NNS	conj	O
of	IN	case	O
HSP27	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
NB4	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
ATRA	NN	nsubj	O
also	RB	advmod	O
activated	VBD	ROOT	O
IRF-1	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
in	IN	case	O
HL-60	NN	nmod	B-cell_line
,	,	punct	O
U937	NN	conj	B-cell_line
,	,	punct	O
and	CC	cc	O
THP-1	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
which	WDT	nsubj	O
all	DT	nsubj	O
respond	VBP	acl:relcl	O
to	TO	case	O
ATRA	NN	nmod	O
by	IN	case	O
growth	NN	compound	O
inhibition	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	O
hormone	NN	compound	O
suppression	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
neutrophil	NN	compound	B-cell_type
-mediated	JJ	amod	O
tumor	NN	compound	O
cell	NN	compound	O
cytostasis	NN	nmod	O
.	.	punct	O

Intracellular	JJ	amod	O
adhesion	NN	compound	O
molecule-1	NN	compound	O
induction	NN	nsubj	O
by	IN	case	O
PMA	NN	nmod	O
was	VBD	aux	O
unaffected	JJ	ROOT	O
by	IN	case	O
any	DT	nmod	O
of	IN	case	O
the	DT	det	O
molecules	NNS	nmod	O
tested	VBN	acl	O
.	.	punct	O

These	DT	det	O
responses	NNS	nsubjpass	O
were	VBD	auxpass	O
completely	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
tyrosine	NN	compound	B-protein
kinase	NN	compound	I-protein
inhibitors	NNS	nmod	O
.	.	punct	O

A	DT	det	O
cell	NN	compound	O
cycle	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
Stat1alpha	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Stat3	NN	conj	B-protein
,	,	punct	O
shortened	VBD	ccomp	O
the	DT	det	O
period	NN	dobj	O
of	IN	case	O
G0/G1	NN	compound	O
prolongation	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
EPO	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Western	NN	compound	O
blotting	NN	compound	O
analysis	NN	nsubj	O
with	IN	case	O
anti-I	JJ	amod	B-protein
kappa	NN	compound	I-protein
B-alpha	NN	compound	I-protein
antibody	NN	nmod	I-protein
indicated	VBD	ROOT	O
that	IN	mark	O
E3330	NN	nsubj	O
inhibited	VBD	ccomp	O
degradation	NN	dobj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B-alpha	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
an	DT	det	O
inhibitory	JJ	amod	B-protein
protein	NN	acl:relcl	I-protein
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
in	IN	case	O
LPS-stimulated	JJ	amod	B-cell_line
monocytes	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
CD28	NN	compound	B-protein
costimulation	NN	nsubj	O
can	MD	aux	O
cause	VB	ccomp	O
substantial	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
driven	VBN	acl:relcl	O
by	IN	case	O
a	DT	det	O
soluble	JJ	amod	B-protein
factor	NN	nmod	I-protein
independent	JJ	amod	O
of	IN	case	O
NF-AT	NN	compound	B-protein
transactivation	NN	nmod	O
.	.	punct	O

CD14	NN	nsubj	B-protein
,	,	punct	O
a	DT	det	O
glycosylphosphatidylinositol-linked	JJ	amod	B-protein
antigen	NN	appos	I-protein
,	,	punct	O
functions	VBZ	ROOT	O
as	IN	case	O
an	DT	det	O
LPS	NN	compound	B-protein
signaling	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

For	IN	prep	O
example	NN	pobj	O
,	,	punct	O
the	DT	det	O
analysis	NN	nsubj	O
of	IN	case	O
only	RB	advmod	O
1	CD	nummod	O
signaling	VBG	compound	B-protein
molecule	NN	nmod	I-protein
may	MD	aux	O
allow	VB	ROOT	O
patients	NNS	dobj	O
with	IN	case	O
significant	JJ	amod	O
defects	NNS	nmod	O
in	IN	case	O
T-cell	NN	compound	O
signaling	NN	nmod	O
to	TO	mark	O
go	VB	xcomp	O
unnoticed	JJ	xcomp	O
.	.	punct	O

Signal	NN	compound	B-protein
transducers	NNS	nsubjpass	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
(	-LRB-	punct	O
STATs	NNS	appos	B-protein
)	-RRB-	punct	O
are	VBP	auxpass	O
rapidly	RB	advmod	O
phosphorylated	VBN	ROOT	O
on	IN	case	O
tyrosine	NN	compound	O
residues	NNS	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
cytokine	NN	nmod	B-protein
and	CC	cc	O
growth	NN	compound	B-protein
factor	NN	compound	I-protein
stimulation	NN	conj	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
temporal	JJ	amod	O
control	NN	nsubjpass	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
and	CC	cc	O
c-Fos	NN	conj	B-protein
may	MD	aux	O
be	VB	auxpass	O
regulated	VBN	ccomp	O
through	IN	case	O
the	DT	det	O
ubiquitinylation	NN	compound	O
pathways	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
ubiquitinylation	NN	nsubjpass	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
and	CC	cc	O
c-Fos	NN	conj	B-protein
may	MD	aux	O
in	IN	case	O
turn	NN	nmod	O
be	VB	auxpass	O
regulated	VBN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
the	DT	det	O
heterodimerization	NN	nmod	O
between	IN	case	O
them	PRP	nmod	O
and	CC	cc	O
the	DT	det	O
cooperation	NN	conj	O
between	IN	case	O
E220K	NN	nmod	B-protein
and	CC	cc	O
E3	NN	conj	O
mediated	JJ	amod	O
polyubiquitinylation	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
activation-dependent	JJ	amod	B-protein
cell	NN	compound	I-protein
surface	NN	compound	I-protein
markers	NNS	nmod	I-protein
CD25	NN	dep	B-protein
and	CC	cc	O
CD69	NN	conj	B-protein
was	VBD	cop	O
within	IN	case	O
normal	JJ	amod	O
limits	NNS	ROOT	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
cloning	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NFAT	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
has	VBZ	aux	O
facilitated	VBN	ROOT	O
rapid	JJ	amod	O
progress	NN	dobj	O
in	IN	case	O
the	DT	det	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
signalling	NN	amod	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
control	VBP	acl:relcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
NFAT	NN	nmod	B-protein
.	.	punct	O

HS	NN	nsubj	B-DNA
III	CD	nummod	I-DNA
was	VBD	cop	O
weak	JJ	ROOT	O
in	IN	case	O
HEL	NN	nmod	B-cell_line
and	CC	cc	O
Jurkat	NN	conj	B-cell_line
,	,	punct	O
and	CC	cc	O
greatly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
DU528	NN	nmod	B-cell_line
,	,	punct	O
a	DT	det	O
T-cell	NN	compound	B-cell_line
line	NN	appos	I-cell_line
that	WDT	nsubj	O
bears	VBZ	acl:relcl	O
a	DT	det	B-DNA
t	NN	dobj	I-DNA
(	-LRB-	punct	I-DNA
1	CD	dep	I-DNA
;	:	punct	I-DNA
14	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
and	CC	cc	O
initiates	VBZ	conj	O
tal-1	NN	compound	B-DNA
transcription	NN	dobj	O
within	IN	case	O
exon	NN	nmod	B-DNA
4	CD	nummod	I-DNA
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
TPO	NN	nsubj	B-protein
has	VBZ	ccomp	O
a	DT	det	O
distinct	JJ	amod	O
action	NN	dobj	O
on	IN	case	O
erythropoiesis	NN	nmod	O
.	.	punct	O

A	DT	det	O
single	JJ	amod	B-DNA
point	NN	compound	I-DNA
mutation	NN	nsubj	I-DNA
in	IN	case	O
the	DT	det	O
SRE	NN	nmod	B-DNA
completely	RB	advmod	O
abrogated	VBD	ROOT	O
the	DT	det	O
responsiveness	NN	dobj	O
to	TO	case	O
tat/S	NN	nmod	B-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	nsubjpass	O
of	IN	case	O
HIV	NN	compound	O
inhibition	NN	nmod	O
by	IN	case	O
ascorbate	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
mediated	VBN	ccomp	O
via	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
inhibition	NN	nmod	O
,	,	punct	O
unlike	IN	case	O
that	DT	nmod	O
seen	VBN	acl	O
with	IN	case	O
other	JJ	amod	O
antioxidants	NNS	nmod	O
.	.	punct	O

Functional	JJ	amod	O
Myc-Max	NN	compound	B-protein
heterodimer	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
activation-induced	JJ	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
hybridomas	NNS	nmod	I-cell_line
.	.	punct	O

Here	RB	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
microbial	JJ	amod	B-protein
lipoproteins	NNS	nsubj	I-protein
are	VBP	cop	O
potent	JJ	amod	O
stimulators	NNS	ccomp	O
of	IN	case	O
IL-12	NN	compound	B-protein
production	NN	nmod	O
by	IN	case	O
human	JJ	amod	O
macrophages	NNS	nmod	B-cell_type
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
induction	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
Toll-like	JJ	amod	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
TLRs	NNS	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Blood	NN	compound	B-cell_type
monocytes	NNS	nsubj	I-cell_type
spontaneously	RB	advmod	O
activate	VBP	ROOT	O
endothelial	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
leading	VBG	advcl	O
to	TO	case	O
adhesion	NN	nmod	O
of	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
onto	IN	case	O
the	DT	det	O
endothelial	JJ	amod	O
surface	NN	nmod	O
and	CC	cc	O
overproduction	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	O
proteins	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
von	NN	compound	B-protein
Willebrand	NN	compound	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
vWf	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
plasminogen	NN	compound	B-protein
activator	NN	compound	I-protein
inhibitor	NN	compound	I-protein
type	NN	conj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
PAI-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Glutathione-S-transferase	NN	compound	B-protein
(	-LRB-	punct	I-protein
GST	NN	compound	I-protein
)	-RRB-	punct	I-protein
-Grb2	NN	amod	I-protein
fusion	NN	compound	I-protein
proteins	NNS	nsubjpass	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
identify	VB	xcomp	O
the	DT	det	O
potential	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
Grb2-binding	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
platelet	NN	compound	B-cell_type
activation	NN	nmod	O
by	IN	case	O
the	DT	det	O
platelet	NN	compound	B-protein
low-affinity	NN	compound	I-protein
IgG	NN	compound	I-protein
receptor	NN	nmod	I-protein
,	,	punct	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
RIIA	NN	appos	I-protein
.	.	punct	O

Cotransfection	NN	nsubjpass	O
of	IN	case	O
CMV	NN	compound	B-DNA
IE	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
IL-6	NN	compound	B-DNA
chloramphenicol	NN	compound	I-DNA
acetyl	NN	compound	I-DNA
transferase	NN	conj	I-DNA
(	-LRB-	punct	I-DNA
CAT	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
or	CC	cc	I-DNA
IL-6	NN	compound	I-DNA
luciferase	NN	compound	I-DNA
constructs	NNS	conj	I-DNA
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
IL-6	NN	compound	B-protein
promoter	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-5	CD	nummod	I-protein
with	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
activates	VBZ	ccomp	O
Lyn	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	dobj	I-protein
within	IN	case	O
1	CD	nummod	O
min	NN	nmod	O
and	CC	cc	O
Jak2	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	conj	I-protein
within	IN	case	O
1-3	CD	nummod	O
min	NN	nmod	O
.	.	punct	O

Major	JJ	amod	O
STAT	NN	compound	B-protein
complexes	NNS	nsubj	I-protein
activated	VBN	acl	O
by	IN	case	O
G-CSF-R/IL-7R	NN	amod	B-protein
alpha	NN	nmod	I-protein
contained	VBD	ROOT	O
STAT1	NN	dobj	B-protein
or	CC	cc	O
STAT5	NN	conj	B-protein
,	,	punct	O
while	IN	mark	O
some	DT	det	O
formation	NN	nsubjpass	O
of	IN	case	O
STAT3-containing	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
was	VBD	auxpass	O
also	RB	advmod	O
seen	VBN	advcl	O
.	.	punct	O

We	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
CMV	NN	compound	O
infection	NN	nsubj	O
increased	VBD	ccomp	O
both	CC	cc:preconj	O
IL-6	NN	compound	B-protein
protein	NN	dobj	I-protein
and	CC	cc	O
mRNA	NN	conj	B-RNA
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Although	IN	mark	O
corticosteroids	NNS	nsubj	O
are	VBP	cop	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	amod	O
therapeutic	JJ	amod	O
agents	NNS	advcl	O
used	VBN	acl	O
for	IN	case	O
this	DT	det	O
disease	NN	nmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
anti-inflammatory	JJ	amod	O
effect	NN	nsubj	O
differs	VBZ	ROOT	O
from	IN	case	O
patient	NN	nmod	O
to	TO	case	O
patient	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
determined	VBD	ROOT	O
that	IN	mark	O
an	DT	det	O
initiator-like	JJ	amod	B-DNA
sequence	NN	nsubjpass	I-DNA
present	JJ	amod	O
at	IN	case	O
the	DT	det	O
cap	NN	compound	B-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
an	DT	det	O
Ets	NN	compound	B-DNA
consensus	NN	compound	I-DNA
sequence	NN	conj	I-DNA
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
full	JJ	amod	O
promoter	NN	compound	B-DNA
function	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
OTF-1	NN	compound	B-protein
-enriched	JJ	amod	O
protein	NN	compound	O
fractions	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
DRA	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	dobj	O
although	IN	mark	O
it	PRP	nsubj	O
functionally	RB	advmod	O
enhanced	VBD	advcl	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
another	DT	det	O
gene	NN	nmod	O
.	.	punct	O

Retinoic	JJ	amod	O
acid	NN	compound	O
(	-LRB-	punct	O
RA	NN	appos	O
)	-RRB-	punct	O
resistance	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
serious	JJ	amod	O
problem	NN	ROOT	O
for	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
APL	NN	appos	O
)	-RRB-	punct	O
who	WP	nsubj	O
are	VBP	aux	O
receiving	VBG	acl:relcl	O
all-trans	JJ	amod	O
RA	NN	dobj	O
.	.	punct	O

It	PRP	nsubj	O
contains	VBZ	ROOT	O
two	CD	nummod	O
potential	JJ	amod	O
Ets	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
conserved	VBN	acl	O
in	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
gammac	NN	compound	I-DNA
promoter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
one	CD	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
was	VBD	auxpass	O
found	VBN	acl:relcl	O
essential	JJ	xcomp	O
for	IN	case	O
functional	JJ	amod	O
promoter	NN	compound	O
activity	NN	nmod	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
mutational	JJ	amod	O
analysis	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
combined	JJ	amod	O
treatment	NN	nsubj	O
with	IN	case	O
PDTC	NN	nmod	O
and	CC	cc	O
PMA	NN	conj	O
,	,	punct	O
two	CD	nummod	O
agents	NNS	appos	O
that	WDT	nsubj	O
synergize	VBP	acl:relcl	O
on	IN	case	O
AP-1	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
persistent	JJ	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
ERK-2	NN	nmod	B-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
this	DT	det	O
signaling	NN	compound	O
pathway	NN	nsubj	O
appears	VBZ	ROOT	O
not	RB	neg	O
to	TO	mark	O
rely	VB	xcomp	O
on	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
.	.	punct	O

Since	IN	mark	O
PDTC	NN	nsubj	O
has	VBZ	advcl	O
both	CC	cc:preconj	O
antioxidant	JJ	dobj	O
and	CC	cc	O
metal-ion	NN	conj	O
chelating	NN	dep	O
activities	NNS	dep	O
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
N-acetyl-L-cysteine	NN	nmod	O
(	-LRB-	punct	O
NAC	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
antioxidant	JJ	appos	O
)	-RRB-	punct	O
or	CC	cc	O
o-phenanthroline	NN	conj	O
(	-LRB-	punct	O
OP	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
metal-ion	NN	compound	O
chelator	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Flow	NN	compound	O
cytometric	JJ	amod	O
analysis	NN	nsubj	O
also	RB	advmod	O
showed	VBD	ROOT	O
that	IN	mark	O
at	IN	case	O
72	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
virus	NN	compound	O
exposure	NN	nmod	O
fewer	JJR	amod	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
from	IN	case	O
the	DT	det	O
elderly	JJ	nmod	O
produced	VBN	ccomp	O
interferon-gamma	NN	dobj	B-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
link	NN	dobj	O
between	IN	case	O
the	DT	det	O
magnitude	NN	nmod	O
of	IN	case	O
the	DT	dep	O
Fos	NN	nmod	B-protein
and	CC	cc	O
Jun	NN	conj	B-protein
and	CC	cc	O
IFN-gamma	NN	conj	B-protein
responses	NNS	dep	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
Z	NN	compound	B-protein
gene	NN	compound	I-protein
product	NN	nsubj	I-protein
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
AP-1	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
as	IN	case	O
a	DT	det	O
homodimer	NN	nmod	O
and	CC	cc	O
has	VBZ	conj	O
sequence	NN	compound	O
similarity	NN	dobj	O
to	TO	case	O
c-Fos	NN	nmod	B-DNA
,	,	punct	O
can	MD	aux	O
efficiently	RB	advmod	O
activate	VB	ccomp	O
the	DT	det	O
EBV	NN	compound	B-DNA
early	JJ	amod	I-DNA
promoter	NN	dobj	I-DNA
,	,	punct	O
BMRF1	NN	appos	B-DNA
,	,	punct	O
in	IN	case	O
certain	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
(	-LRB-	punct	O
i.e.	FW	dep	O
,	,	punct	O
HeLa	NN	compound	B-cell_line
cells	NNS	appos	I-cell_line
)	-RRB-	punct	O
but	CC	cc	O
not	RB	cc	O
others	NNS	conj	O
(	-LRB-	punct	O
i.e.	FW	dep	O
,	,	punct	O
Jurkat	NN	compound	B-cell_line
cells	NNS	appos	I-cell_line
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
novel	JJ	amod	O
Ets-related	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nsubj	I-protein
,	,	punct	O
Elf-1	NN	appos	B-protein
,	,	punct	O
binds	VBZ	ccomp	O
specifically	RB	advmod	O
to	TO	case	O
two	CD	nummod	B-DNA
purine-rich	JJ	amod	I-DNA
motifs	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
HIV-2	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
reveal	VBP	ROOT	O
a	DT	det	O
new	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
the	DT	det	O
dopamine	NN	compound	O
system	NN	nmod	O
,	,	punct	O
cytokine	NN	compound	B-protein
signaling	NN	compound	O
pathway	NN	conj	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
via	IN	case	O
the	DT	det	O
involvement	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
PBMC	NN	conj	B-cell_type
.	.	punct	O

The	DT	det	O
OBF-1	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
highly	RB	advmod	O
cell-specific	JJ	amod	O
manner	NN	nmod	O
,	,	punct	O
being	VBG	cop	O
most	RBS	advmod	O
abundant	JJ	conj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
essentially	RB	advmod	O
absent	JJ	conj	O
in	IN	case	O
most	JJS	nmod	O
of	IN	case	O
the	DT	det	O
other	JJ	amod	O
cells	NNS	nmod	O
or	CC	cc	O
tissues	NNS	conj	O
tested	VBN	acl	O
.	.	punct	O

NF-ATp	NN	nsubj	B-protein
and	CC	cc	O
NF-ATc	NN	conj	B-protein
bind	VBP	ROOT	O
to	TO	case	O
two	CD	nummod	O
sites	NNS	nmod	O
around	IN	case	O
positions	NNS	nmod	B-DNA
-585	CD	dep	I-DNA
and	CC	cc	I-DNA
-650	CD	conj	I-DNA
located	JJ	xcomp	O
upstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
CD25	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

HIV-1	NN	nsubj	O
expressing	VBG	acl	O
IkappaB-alphaS32/36A	NN	dobj	B-protein
down-regulates	VBZ	ROOT	O
viral	JJ	amod	O
expression	NN	dobj	O
and	CC	cc	O
is	VBZ	auxpass	O
highly	RB	advmod	O
attenuated	VBN	conj	O
in	IN	case	O
both	CC	cc:preconj	O
Jurkat	NN	nmod	B-cell_line
and	CC	cc	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Ablation	NN	nsubj	O
of	IN	case	O
transplanted	VBN	amod	O
HTLV-I	NN	compound	O
Tax-transformed	JJ	amod	O
tumors	NNS	nmod	O
in	IN	case	O
mice	NNS	nmod	O
by	IN	case	O
antisense	JJ	amod	O
inhibition	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
[	-LRB-	punct	O
published	VBN	amod	O
erratum	NN	nsubj	O
appears	VBZ	ROOT	O
in	IN	case	O
Science	NNP	compound	O
1993	CD	nummod	O
Mar	NNP	nmod	O
12	CD	nummod	O
;	:	punct	O
259	CD	nummod	O
(	-LRB-	punct	O
5101	CD	dep	O
)	-RRB-	punct	O
:	:	punct	O
1523	CD	dep	O
]	-RRB-	punct	O

Interaction	NN	ROOT	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
RFX1	NN	dep	B-protein
and	CC	cc	O
MIBP1	NN	conj	B-protein
with	IN	case	O
the	DT	det	O
gamma	NN	compound	B-DNA
motif	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
negative	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
hepatitis	NN	compound	B-DNA
B	NN	compound	I-DNA
virus	NN	compound	I-DNA
core	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Differences	NNS	nsubj	O
in	IN	case	O
LTR	NN	compound	B-DNA
sequence	NN	nmod	I-DNA
also	RB	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
differences	NNS	nmod	O
in	IN	case	O
transcription	NN	compound	O
factor	NN	compound	O
recruitment	NN	nmod	O
to	TO	case	O
cis-acting	JJ	amod	B-DNA
sites	NNS	nmod	I-DNA
within	IN	case	O
the	DT	det	O
U3	NN	compound	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
LTR	NN	nmod	B-DNA
,	,	punct	O
as	IN	mark	O
demonstrated	VBN	advcl	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

Cbl-b	NN	nsubj	B-protein
undergoes	VBZ	ROOT	O
rapid	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
upon	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
the	DT	dep	O
TCR	NN	nmod	B-protein
and	CC	cc	O
cytokine	NN	compound	O
receptors	NNS	conj	O
[	-LRB-	punct	O
8	CD	dep	O
]	-RRB-	punct	O
[	-LRB-	punct	O
9	CD	dep	O
]	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
IL-10	NN	nmod	B-protein
was	VBD	cop	O
dose-dependent	JJ	ROOT	O
with	IN	case	O
a	DT	det	O
maximum	NN	amod	O
stimulation	NN	nmod	O
using	VBG	acl	O
100	CD	nummod	O
ng/ml	NN	dobj	O
of	IN	case	O
IL-10	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
aberrancies	NNS	nsubjpass	O
in	IN	case	O
NF-kappaB	NN	compound	B-protein
activity	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
immunopathogenesis	NN	nmod	O
of	IN	case	O
diseases	NNS	nmod	O
involving	VBG	acl	O
immune	JJ	amod	O
or	CC	cc	O
inflammatory	JJ	conj	O
processes	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
atherosclerosis	NN	nmod	O
and	CC	cc	O
HIV-1	NN	compound	O
infection	NN	conj	O
.	.	punct	O

Because	IN	mark	O
these	DT	nsubj	O
are	VBP	advcl	O
the	DT	det	O
characteristics	NNS	attr	O
of	IN	case	O
a	DT	det	O
signal	NN	compound	B-protein
transducer	NN	nmod	I-protein
and	CC	cc	I-protein
activator	NN	compound	I-protein
of	IN	amod	I-protein
transcription	NN	compound	I-protein
(	-LRB-	punct	I-protein
Stat	NN	compound	I-protein
)	-RRB-	punct	I-protein
protein	NN	conj	I-protein
,	,	punct	O
we	PRP	nsubj	O
determined	VBD	ROOT	O
whether	IN	mark	O
antibodies	NNS	nsubj	B-protein
to	TO	case	I-protein
Stat	NN	compound	I-protein
proteins	NNS	nmod	I-protein
will	MD	aux	O
interfere	VB	ccomp	O
with	IN	case	O
gel	NN	compound	O
mobility	NN	compound	O
shift	NN	nmod	O
and	CC	cc	O
found	VBD	conj	O
that	IN	mark	O
antibodies	NNS	nsubj	B-protein
to	TO	case	I-protein
IL-4	NN	compound	I-protein
Stat	NN	nmod	I-protein
,	,	punct	O
also	RB	advmod	O
known	VBN	acl	O
as	IN	case	O
Stat6	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
antibodies	NNS	conj	B-protein
to	TO	case	O
other	JJ	amod	O
Stat	NN	compound	B-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
interfere	VBP	ccomp	O
with	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-4	NN	compound	B-protein
NAF	NN	compound	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
Spi-1/PU.1	NN	nsubj	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
factor	NN	compound	O
Spi-B	NN	conj	B-protein
bound	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
PU-box	NN	nmod	B-DNA
in	IN	case	O
B-cells	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
rate	NN	nsubjpass	O
of	IN	case	O
constitutive	JJ	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
neutrophils	NNS	nmod	I-cell_type
and	CC	cc	O
eosinophils	NNS	conj	B-cell_type
is	VBZ	auxpass	O
greatly	RB	advmod	O
accelerated	VBN	ccomp	O
in	IN	case	O
both	CC	cc:preconj	O
a	DT	det	O
rapid	JJ	amod	O
and	CC	cc	O
concentration-dependent	JJ	conj	O
manner	NN	nmod	O
by	IN	case	O
the	DT	det	O
fungal	JJ	amod	O
metabolite	NN	compound	O
gliotoxin	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
its	PRP$	nmod:poss	O
inactive	JJ	amod	O
analog	NN	compound	O
methylthiogliotoxin	NN	conj	O
.	.	punct	O

In	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
subjects	NNS	nmod	O
,	,	punct	O
dexamethasone	NN	nsubj	O
was	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
suppress	VB	xcomp	O
plasma	NN	compound	O
cortisol	NN	dobj	O
.	.	punct	O

Many	JJ	amod	O
studies	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
monoamine	NN	compound	B-protein
oxidase	NN	compound	I-protein
B	NN	nsubj	I-protein
in	IN	case	O
blood	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
a	DT	det	O
biological	JJ	amod	O
marker	NN	ccomp	O
for	IN	case	O
personality	NN	compound	O
characteristics	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
sensation	NN	compound	O
seeking	NN	nmod	O
.	.	punct	O

T-helper-cell	JJ	amod	B-protein
determinants	NNS	nsubj	I-protein
in	IN	case	O
protein	NN	compound	B-protein
antigens	NNS	nmod	I-protein
are	VBP	cop	O
preferentially	RB	advmod	O
located	JJ	ROOT	O
in	IN	case	O
cysteine-rich	JJ	amod	B-protein
antigen	NN	compound	I-protein
segments	NNS	nmod	I-protein
resistant	JJ	amod	O
to	TO	case	O
proteolytic	JJ	amod	O
cleavage	NN	nmod	O
by	IN	case	O
cathepsin	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	I-protein
L	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
D	NN	conj	I-protein
.	.	punct	O

Increased	VBN	amod	O
monocyte	NN	compound	O
TF	NN	compound	B-protein
expression	NN	nsubjpass	O
in	IN	case	O
transplant	JJ	amod	O
recipients	NNS	nmod	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
adversely	RB	advmod	O
affected	VBN	xcomp	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
CsA	NN	nmod	O
:	:	punct	O
TF	NN	compound	B-protein
induction	NN	nsubjpass	O
was	VBD	auxpass	O
markedly	RB	advmod	O
reduced	VBN	parataxis	O
by	IN	case	O
CsA	NN	compound	O
serum	NN	compound	O
concentrations	NNS	nmod	O
reaching	VBG	acl	O
peak	JJ	amod	O
CsA	NN	compound	O
drug	NN	compound	O
levels	NNS	dobj	O
.	.	punct	O

The	DT	det	O
linkage	NN	ROOT	O
between	IN	case	O
T-cell	NN	nmod	O
and	CC	cc	O
dendritic	JJ	conj	O
cell	NN	compound	O
development	NN	dep	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	O
thymus	NN	nmod	O
.	.	punct	O

Both	DT	cc:preconj	O
Drosophila	FW	compound	O
Toll	NN	nsubjpass	B-protein
and	CC	cc	O
the	DT	det	O
IL-1	NN	compound	O
receptor	NN	conj	O
are	VBP	auxpass	O
known	VBN	ROOT	O
to	TO	case	O
signal	VB	xcomp	O
through	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
pathway	NN	nmod	O
.	.	punct	O

Differences	NNS	nsubj	O
in	IN	case	O
conformation	NN	nmod	O
of	IN	case	O
the	DT	det	O
hinge	NN	compound	B-protein
region	NN	nmod	I-protein
distinguish	VBP	ROOT	O
androgen-bound	JJ	dobj	B-protein
from	IN	case	O
antiandrogen-bound	JJ	amod	B-protein
receptor	NN	compound	I-protein
complexes	NNS	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
represents	VBZ	acl:relcl	O
an	DT	det	O
important	JJ	amod	O
feature	NN	dobj	O
of	IN	case	O
antiandrogen	JJ	amod	O
action	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
in	IN	case	O
this	DT	det	O
report	NN	nmod	O
that	IN	mark	O
overexpression	NN	nsubj	O
of	IN	case	O
an	DT	det	O
activated	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
Rho	NN	nmod	B-protein
enhances	VBZ	ccomp	O
AP-1	NN	compound	B-protein
activity	NN	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
activated	VBN	amod	O
Rho	NN	nsubj	B-protein
(	-LRB-	punct	O
V14Rho	NN	appos	B-protein
)	-RRB-	punct	O
has	VBZ	conj	O
little	JJ	amod	O
or	CC	cc	O
no	DT	conj	O
effect	NN	dobj	O
on	IN	case	O
NFAT	NN	nmod	B-protein
,	,	punct	O
Oct-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
NF-kappaB	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
element	NN	compound	I-DNA
activities	NNS	conj	O
under	IN	case	O
similar	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

A	DT	det	O
CD28	NN	compound	B-protein
-associated	JJ	amod	O
signaling	NN	compound	O
pathway	NN	ROOT	O
leading	VBG	acl	O
to	TO	case	O
cytokine	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
and	CC	cc	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	conj	O
without	IN	case	O
TCR	NN	compound	B-protein
engagement	NN	nmod	O
.	.	punct	O

In	IN	case	O
combination	NN	nmod	O
,	,	punct	O
EBF	NN	nsubj	B-protein
and	CC	cc	O
E47	NN	conj	B-protein
induce	VBP	ROOT	O
efficient	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
immunoglobulin	NN	compound	I-DNA
surrogate	JJ	compound	I-DNA
light	JJ	amod	I-DNA
chain	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
lambda5	NN	appos	B-DNA
and	CC	cc	O
VpreB	NN	conj	B-DNA
,	,	punct	O
whereas	IN	dep	O
other	JJ	amod	O
pre-B	JJ	amod	B-DNA
cell-specific	JJ	amod	I-DNA
genes	NNS	nsubj	I-DNA
remain	VBP	parataxis	O
silent	JJ	xcomp	O
.	.	punct	O

Further	JJ	amod	O
characterization	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
should	MD	aux	O
identify	VB	ROOT	O
factors	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
growth	NN	nmod	O
,	,	punct	O
terminal	JJ	amod	O
differentiation	NN	conj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
osteoclasts	NNS	nmod	B-cell_type
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
MAP	NN	compound	B-protein
kinase-specific	JJ	amod	I-protein
phosphatase	NN	nmod	I-protein
,	,	punct	O
MKP-1	NN	appos	B-protein
,	,	punct	O
which	WDT	nsubj	O
blocks	VBZ	acl:relcl	O
ERK	NN	compound	B-protein
activation	NN	dobj	O
,	,	punct	O
inhibited	VBD	ROOT	O
IL-2	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
and	CC	cc	O
NF-AT	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
transcription	NN	conj	O
stimulated	VBN	acl	O
by	IN	case	O
a	DT	det	O
calcium	NN	compound	O
ionophore	NN	nmod	O
and	CC	cc	O
PMA	NN	conj	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
addition	NN	nmod	O
,	,	punct	O
MKP-1	NN	nsubj	B-protein
neutralized	VBD	conj	O
the	DT	det	O
transcriptional	JJ	amod	O
enhancement	NN	dobj	O
caused	VBN	acl	O
by	IN	case	O
active	JJ	amod	O
Raf-1	NN	nmod	O
and	CC	cc	O
MEK1	NN	conj	O
expression	NN	dep	O
.	.	punct	O

The	DT	det	O
onset	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
processes	NNS	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
closely	RB	advmod	O
paralleled	VBN	xcomp	O
by	RB	advmod	O
,	,	punct	O
and	CC	cc	O
dependent	JJ	conj	O
on	IN	dep	O
,	,	punct	O
IkappaB-alpha	NN	compound	B-protein
degradation	NN	nmod	O
.	.	punct	O

A	DT	det	O
chromosomal	JJ	amod	O
translocation	NN	nsubj	O
in	IN	case	O
a	DT	det	O
T-cell	NN	compound	O
leukemia	NN	nmod	O
involving	VBG	acl	O
the	DT	det	O
short	JJ	amod	B-DNA
arm	NN	dobj	I-DNA
of	IN	case	O
human	JJ	amod	B-DNA
chromosome	NN	nmod	I-DNA
11	CD	nummod	I-DNA
at	IN	case	O
band	NN	compound	B-DNA
11p15	NN	nmod	I-DNA
disrupts	VBZ	ROOT	O
the	DT	det	O
rhombotin	NN	compound	B-DNA
gene	NN	dobj	I-DNA
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
THP-1	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
,	,	punct	O
a	DT	det	O
monocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
,	,	punct	O
were	VBD	auxpass	O
transfected	VBN	dep	O
with	IN	case	O
the	DT	det	O
CMV	NN	compound	B-DNA
IE	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

A	DT	det	O
typical	JJ	amod	O
seminoma	NN	nsubjpass	O
was	VBD	auxpass	O
removed	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
left	JJ	amod	O
adnexal	JJ	amod	O
region	NN	nmod	O
and	CC	cc	O
an	DT	det	O
immature	JJ	amod	O
testis	NN	conj	O
was	VBD	auxpass	O
identified	VBN	conj	O
separately	RB	advmod	O
as	IN	case	O
an	DT	det	O
associated	VBN	amod	O
right	JJ	amod	O
adnexal	JJ	amod	O
mass	NN	nmod	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubjpass	O
in	IN	case	O
signals	NNS	nmod	O
transduced	VBN	acl	O
through	IN	case	O
sIgM	NN	nmod	B-protein
and	CC	cc	O
sIgD	NN	conj	B-protein
in	IN	case	O
B104	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
gene	NN	nsubj	O
has	VBZ	ROOT	O
41	CD	nummod	B-DNA
small	JJ	amod	I-DNA
exons	NNS	dobj	I-DNA
spanning	VBG	acl	O
45	CD	nummod	B-DNA
kb	NN	dobj	I-DNA
of	IN	case	O
genomic	JJ	amod	B-DNA
DNA	NN	nmod	I-DNA
and	CC	cc	O
encoding	VBG	conj	O
a	DT	det	O
5.5	CD	nummod	B-RNA
kb	NN	compound	I-RNA
mRNA	NN	dobj	I-RNA
.	.	punct	O

Both	CC	cc:preconj	O
limiting-component	JJ	amod	O
transcription	NN	compound	O
assays	NNS	nsubj	O
and	CC	cc	O
DNA	NN	compound	O
binding	NN	compound	O
assays	NNS	conj	O
identified	VBD	ROOT	O
the	DT	det	O
class	NN	compound	B-protein
III	CD	nummod	I-protein
gene	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	dobj	I-protein
TFIIIB	NN	dep	B-protein
as	IN	case	O
the	DT	det	O
principle	NN	amod	O
target	NN	nmod	O
of	IN	case	O
Tax	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Ten	CD	nummod	O
atopic	JJ	amod	O
asthmatic	JJ	amod	O
subjects	NNS	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	dep	O
with	IN	case	O
FP	NN	compound	O
250	CD	nummod	O
microg	NN	nmod	O
twice	RB	advmod	O
daily	RB	advmod	O
for	IN	case	O
4	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

A	DT	det	O
cell	NN	compound	B-cell_line
culture	NN	compound	I-cell_line
system	NN	nsubjpass	I-cell_line
was	VBD	auxpass	O
then	RB	advmod	O
employed	VBN	ROOT	O
that	WDT	nsubj	O
permitted	VBD	ccomp	O
the	DT	det	O
differentiation	NN	dobj	O
of	IN	case	O
Th	NN	compound	B-protein
effectors	NNS	nmod	I-protein
from	IN	case	O
resting	VBG	amod	B-cell_type
memory	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
short	JJ	amod	O
term	NN	compound	O
priming	NN	nmod	O
.	.	punct	O

The	DT	det	O
cytokine	NN	compound	B-protein
pattern	NN	nsubjpass	I-protein
on	IN	case	O
viral	JJ	amod	O
antigen	NN	compound	O
recognition	NN	nmod	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
to	TO	mark	O
exert	VB	xcomp	O
a	DT	det	O
profound	JJ	amod	O
influence	NN	dobj	O
on	IN	case	O
the	DT	det	O
resolution	NN	nmod	O
of	IN	case	O
viral	JJ	amod	O
infections	NNS	nmod	O
and	CC	cc	O
viral	JJ	amod	O
clearance	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
more	RBR	advmod	O
immature	JJ	amod	O
,	,	punct	O
multipotent	JJ	dep	O
EML	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
we	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
this	DT	det	O
RXR	NN	compound	B-protein
-specific	JJ	amod	O
agonist	NN	nsubj	O
is	VBZ	cop	O
inactive	JJ	ccomp	O
either	CC	cc:preconj	O
in	IN	mark	O
potentiating	VBG	advcl	O
IL-3	NN	compound	B-protein
-mediated	JJ	amod	O
commitment	NN	dobj	O
of	IN	case	O
EML	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
the	DT	det	O
granulocyte	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
or	CC	cc	O
in	IN	mark	O
transactivating	VBG	advcl	O
RAR-RXR	NN	compound	B-DNA
response	NN	compound	I-DNA
elements	NNS	dobj	I-DNA
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
AP-1	NN	compound	B-protein
activity	NN	nmod	O
using	VBG	acl	O
gel	NN	compound	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	dobj	O
confirms	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
requirements	NNS	nsubjpass	O
for	IN	case	O
synergy	NN	nmod	O
in	IN	case	O
c-fos	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
induction	NN	nmod	O
are	VBP	auxpass	O
paralleled	VBN	ccomp	O
by	IN	case	O
requirements	NNS	nmod	O
for	IN	case	O
synergy	NN	nmod	O
in	IN	case	O
induction	NN	nmod	O
of	IN	case	O
AP-1	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

Previous	JJ	amod	O
protein-DNA	JJ	amod	O
binding	NN	compound	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
HS-40	NN	nsubj	B-DNA
consists	VBZ	ccomp	O
of	IN	case	O
multiple	JJ	amod	O
nuclear	JJ	amod	B-DNA
factor	NN	compound	I-DNA
binding	NN	compound	I-DNA
motifs	NNS	nmod	I-DNA
that	WDT	nsubjpass	O
are	VBP	auxpass	O
occupied	VBN	acl:relcl	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
an	DT	det	O
erythroid	JJ	amod	O
lineage-	NN	amod	O
and	CC	cc	O
developmental	JJ	amod	O
stage-specific	JJ	conj	O
manner	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
blocking	VBG	csubj	O
TNF	NN	dobj	B-protein
,	,	punct	O
itself	PRP	appos	O
a	DT	det	O
positive	JJ	amod	O
regulator	NN	dep	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
,	,	punct	O
with	IN	case	O
neutralizing	VBG	amod	B-protein
antibodies	NNS	nmod	I-protein
renders	VBZ	ROOT	O
the	DT	det	O
cells	NNS	dobj	O
more	RBR	advmod	O
susceptible	JJ	amod	O
to	TO	case	O
anti-Fas-mediated	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
differences	NNS	nsubj	O
in	IN	case	O
patterns	NNS	nmod	O
of	IN	case	O
expression	NN	nmod	O
between	IN	case	O
Spi-B	NN	nmod	B-protein
and	CC	cc	O
PU.1	NN	conj	B-protein
distinguish	VBP	ccomp	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
each	DT	det	O
protein	NN	nmod	O
during	IN	case	O
development	NN	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

The	DT	det	O
physiologic	JJ	amod	O
relevance	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
increase	NN	nmod	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
advantage	NN	nmod	O
provided	VBN	acl	O
by	IN	case	O
EC	NN	nmod	B-cell_type
to	TO	case	O
PBL	NN	nmod	B-cell_type
suboptimally	RB	advmod	O
stimulated	VBN	acl	O
with	IN	case	O
mAb	NN	compound	B-protein
OKT3	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
gene	NN	nsubjpass	O
encoding	VBG	acl	O
a	DT	det	O
chicken	NN	compound	B-protein
cytokine	NN	dobj	I-protein
with	IN	case	O
T-cell	NN	compound	O
proliferative	JJ	amod	O
activity	NN	nmod	O
was	VBD	auxpass	O
cloned	VBN	ROOT	O
,	,	punct	O
sequenced	VBN	conj	O
,	,	punct	O
and	CC	cc	O
mapped	VBN	conj	O
.	.	punct	O

In	IN	case	O
DNA	NN	compound	O
binding	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
both	CC	cc:preconj	O
PMA	NN	nsubj	O
plus	CC	cc	O
anti-CD28	JJ	conj	B-protein
and	CC	cc	O
PMA	NN	conj	O
plus	CC	cc	O
ionomycin	NN	conj	O
resulted	VBD	ROOT	O
in	IN	case	O
nuclear	JJ	amod	B-protein
NFAT	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
ETS1	NN	nsubj	B-protein
can	MD	aux	O
transactivate	VB	ccomp	O
GM-CSF	NN	dobj	B-protein
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
but	CC	cc	O
only	RB	advmod	O
after	IN	case	O
the	DT	det	O
cells	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
stimulated	VBN	conj	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
PMA	NN	nmod	O
and	CC	cc	O
ionomycin	NN	conj	O
,	,	punct	O
agents	NNS	dobj	O
that	WDT	nsubj	O
mimic	VBP	acl:relcl	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
TCR/CD3	NN	nsubj	B-protein
and	CC	cc	O
IL-2	NN	conj	B-protein
induce	VBP	ccomp	O
Stat3	NN	compound	B-protein
activation	NN	dobj	O
via	IN	case	O
distinct	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
address	VB	advcl	O
possible	JJ	amod	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
could	MD	aux	O
explain	VB	acl:relcl	O
this	DT	det	O
selective	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
c-ErbB	NN	nmod	B-protein
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
these	DT	det	O
receptors	NNS	nmod	O
to	TO	mark	O
activate	VB	acl	O
the	DT	det	O
different	JJ	amod	O
members	NNS	dobj	O
of	IN	case	O
the	DT	det	O
Stat	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
family	NN	nmod	I-protein
.	.	punct	O

Dexamethasone	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
membrane	NN	compound	O
structural	JJ	amod	O
order	NN	nmod	O
at	IN	case	O
concentrations	NNS	nmod	O
of	IN	case	O
about	RB	advmod	O
10	CD	nummod	O
(	-LRB-	punct	O
-6	CD	appos	O
)	-RRB-	punct	O
M	NN	nmod	O
in	IN	case	O
a	DT	det	O
concentration-dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
M-CSF	NN	nsubj	B-protein
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
its	PRP$	nmod:poss	O
own	JJ	amod	O
gene	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
exogenous	JJ	amod	O
PGE2	NN	nsubj	O
mimics	VBZ	ccomp	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
FCM	NN	nmod	O
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
an	DT	det	O
immediate-early	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
induced	VBN	acl	O
in	IN	case	O
adherent	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
that	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
I	NN	nmod:npmod	B-protein
kappa	NN	nmod:npmod	I-protein
B	NN	nmod:npmod	I-protein
-like	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

This	DT	det	O
adhesion	NN	compound	O
molecule	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
expressed	VBN	ROOT	O
by	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
obtained	VBN	acl	O
from	IN	case	O
one	CD	nummod	O
patient	NN	nmod	O
with	IN	case	O
HTLV-1-associated	JJ	amod	O
myelopathy/tropical	JJ	amod	O
spastic	JJ	amod	O
paraparesis	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
isolated	VBN	acl	O
from	IN	case	O
one	CD	nummod	O
normal	JJ	amod	O
blood	NN	compound	O
donor	NN	nmod	O
.	.	punct	O

Cells	NNS	nsubj	O
treated	VBN	acl	O
with	IN	case	O
5	CD	compound	O
nM	NN	amod	O
D3	NN	nmod	O
showed	VBD	ROOT	O
little	JJ	amod	O
response	NN	dobj	O
,	,	punct	O
but	CC	cc	O
differentiated	VBD	conj	O
maximally	RB	advmod	O
with	IN	case	O
5	CD	compound	O
nM	NN	amod	O
D3	NN	nmod	O
and	CC	cc	O
10	CD	compound	O
nM	NN	amod	O
RA	NN	conj	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
good	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
thrombin	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
latter	JJ	amod	O
three	CD	nummod	O
proteins	NNS	nmod	O
and	CC	cc	O
Ca2+	NN	compound	O
mobilization	NN	conj	O
.	.	punct	O

OBJECTIVE	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
in	IN	case	O
extrinsic	JJ	amod	O
asthma	NN	nmod	O
or	CC	cc	O
in	IN	case	O
cases	NNS	conj	O
of	IN	case	O
markedly	RB	advmod	O
elevated	JJ	amod	O
IgE	NN	nmod	B-protein
(	-LRB-	punct	O
ie	FW	advmod	O
,	,	punct	O
hyperimmunoglobulin	NN	compound	O
E	NN	dep	O
[	-LRB-	punct	O
HIE	NN	appos	O
]	-RRB-	punct	O
)	-RRB-	punct	O
increased	VBN	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
IgE	NN	nmod	B-protein
may	MD	aux	O
be	VB	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
cytokine	NN	compound	B-protein
levels	NNS	nmod	O
or	CC	cc	O
the	DT	det	O
activation	NN	conj	O
of	IN	case	O
Stat6	NN	nmod	B-protein
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
of	IN	case	O
constitutive	JJ	amod	O
NF-kappaB	NN	compound	B-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
HIV1	NN	compound	B-cell_type
-infected	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
phosphorylation	NN	dobj	O
and	CC	cc	O
turnover	NN	conj	O
of	IN	case	O
IkappaBalpha	NN	compound	B-protein
protein	NN	nmod	O
,	,	punct	O
the	DT	det	O
activity	NN	appos	O
of	IN	case	O
the	DT	det	O
double-stranded	JJ	amod	B-protein
RNA-dependent	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
PKR	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
intracellular	JJ	amod	O
levels	NNS	conj	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
subunits	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
PLB-985	NN	compound	B-cell_line
and	CC	cc	O
U937	NN	conj	B-cell_line
myeloid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
models	NNS	nmod	I-cell_line
.	.	punct	O

By	IN	mark	O
screening	VBG	advcl	O
a	DT	det	O
T	NN	compound	O
cell	NN	compound	O
cDNA	NN	compound	B-DNA
library	NN	dobj	I-DNA
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
a	DT	det	O
novel	JJ	amod	B-protein
ets	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	dobj	I-protein
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
RBTN-2	NN	dobj	B-protein
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
run-on	JJ	amod	O
assays	NNS	dobj	O
,	,	punct	O
ACLA	NN	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
an	DT	det	O
enhancement	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
erythroid	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
including	VBG	case	O
gamma-globin	NN	nmod	B-protein
,	,	punct	O
PBGD	NN	conj	B-protein
,	,	punct	O
erythropoietin	NN	compound	B-protein
receptor	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
GATA-1	NN	compound	B-protein
transcription	NN	compound	B-protein
factor	NN	conj	I-protein
.	.	punct	O

Disturbance	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
immune	JJ	amod	O
surveillance	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
viral	JJ	amod	B-DNA
gene	NN	compound	I-DNA
regulation	NN	conj	O
may	MD	aux	O
result	VB	ROOT	O
in	IN	case	O
EBV-associated	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O

Delayed	VBN	amod	O
administration	NN	nsubj	O
of	IN	case	O
rBPI21	NN	nmod	B-protein
also	RB	advmod	O
affected	VBD	ROOT	O
LPS-mediated	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
PRE-I	NN	nsubj	B-DNA
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
differential	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
IL-4	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

Similar	JJ	amod	O
complexes	NNS	nsubjpass	O
are	VBP	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
tyrosine-phosphorylated	JJ	amod	O
peptides	NNS	nsubj	O
containing	VBG	acl	O
Tyr374	NN	dobj	O
or	CC	cc	O
Tyr396	NN	conj	O
did	VBD	aux	O
not	RB	neg	O
interact	VB	ROOT	O
with	IN	case	O
Stat3	NN	nmod	B-protein
or	CC	cc	O
block	VB	conj	O
Stat3	NN	compound	B-protein
activation	NN	dobj	O
.	.	punct	O

Through	IN	case	O
this	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
regulation	NN	nmod	O
,	,	punct	O
YY1	NN	nsubj	B-protein
and	CC	cc	O
LSF	NN	conj	B-protein
could	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
establishment	NN	nmod	O
and	CC	cc	O
maintenance	NN	conj	O
of	IN	case	O
a	DT	det	O
population	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
stably	RB	advmod	O
but	CC	advmod	O
nonproductively	RB	advmod	O
infected	VBN	conj	O
with	IN	case	O
HIV-1	NN	nmod	O
.	.	punct	O

Rather	RB	advmod	O
,	,	punct	O
helenalin	NN	nsubj	O
modifies	VBZ	ROOT	O
the	DT	det	O
NF-kappaB/IkappaB	NN	compound	B-protein
complex	NN	dobj	I-protein
,	,	punct	O
preventing	VBG	advcl	O
the	DT	det	O
release	NN	dobj	O
of	IN	case	O
IkappaB	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
by	IN	mark	O
quantitating	VBG	advcl	O
the	DT	det	O
nuclear	JJ	amod	B-protein
proteins	NNS	dobj	I-protein
binding	VBG	acl	O
to	TO	case	O
an	DT	det	O
oligonucleotide	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
consensus	NN	compound	B-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
binding	NN	compound	I-DNA
sequence	NN	dobj	I-DNA
(	-LRB-	punct	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
cotransfection	NN	nsubj	O
of	IN	case	O
this	DT	det	O
LTR	NN	nmod	B-DNA
with	IN	case	O
a	DT	det	O
mutated	VBN	amod	O
IkappaBalpha	NN	compound	B-protein
molecule	NN	nmod	I-protein
formally	RB	advmod	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
LTR	NN	compound	B-DNA
transactivation	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ccomp	O
by	IN	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Rel/NF-kappaB	NN	compound	B-protein
family	NN	nmod	I-protein
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
found	VBN	ROOT	O
a	DT	det	O
cis-acting	JJ	amod	B-DNA
region	NN	dobj	I-DNA
spanning	VBG	acl	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	compound	I-DNA
region	NN	dobj	I-DNA
(	-LRB-	punct	O
positions	NNS	dep	O
-95	CD	nummod	O
to	TO	dep	O
+27	CD	nummod	O
)	-RRB-	punct	O
that	WDT	nsubj	O
confers	VBZ	acl:relcl	O
inducibility	NN	dobj	O
to	TO	case	O
reporter	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
transient	JJ	amod	O
transfection	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

Precursor	NN	compound	O
frequency	NN	nsubjpass	O
was	VBD	auxpass	O
calculated	VBN	ROOT	O
by	IN	mark	O
limiting	VBG	advcl	O
dilution	NN	compound	O
analysis	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
68	CD	nummod	O
triple-labellings	NNS	nsubjpass	O
with	IN	case	O
mAbs	NNS	nmod	B-protein
were	VBD	auxpass	O
performed	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
of	IN	case	O
each	DT	det	O
volunteer	NN	nmod	O
to	TO	mark	O
possibly	RB	advmod	O
generate	VB	xcomp	O
further	JJ	amod	O
hypotheses	NNS	dobj	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
no	DT	neg	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
HS1	NN	nmod	B-protein
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
mitogenic	JJ	amod	B-cell_type
pairs	NNS	nmod	I-cell_type
of	IN	case	O
anti-CD2	JJ	amod	B-protein
mAbs	NNS	nmod	I-protein
capable	JJ	amod	O
of	IN	mark	O
activating	VBG	advcl	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NFAT	NN	dobj	I-protein
(	-LRB-	punct	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
can	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
distinguished	VBN	ROOT	O
from	IN	case	O
other	JJ	amod	O
previously	RB	advmod	O
described	VBN	amod	O
lymphocyte-specific	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
Jagged1	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
Rel/NF-kappaB-responsive	JJ	amod	B-DNA
gene	NN	ccomp	I-DNA
.	.	punct	O

Interleukin-5	NN	compound	B-protein
signaling	NN	nsubj	O
in	IN	case	O
human	JJ	amod	B-cell_type
eosinophils	NNS	nmod	I-cell_type
involves	VBZ	ROOT	O
JAK2	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	dobj	I-protein
and	CC	cc	O
Stat1	NN	compound	B-protein
alpha	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
an	DT	det	O
active	JJ	amod	O
CRE	NN	compound	B-DNA
site	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
bcl-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
implies	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
regulation	NN	nsubjpass	O
of	IN	case	O
bcl-2	NN	compound	B-protein
expression	NN	nmod	O
is	VBZ	auxpass	O
linked	VBN	ccomp	O
to	TO	case	O
a	DT	det	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
CIITA	NN	nsubj	B-DNA
is	VBZ	cop	O
an	DT	det	O
MHC	NN	compound	B-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
gene-specific	JJ	amod	I-DNA
transcription	NN	compound	I-DNA
activator	NN	ccomp	I-DNA
.	.	punct	O

When	WRB	advmod	O
18C7	NN	nsubjpass	B-protein
was	VBD	auxpass	O
incubated	VBN	advcl	O
with	IN	case	O
liganded	JJ	amod	B-protein
MR	NN	nmod	I-protein
,	,	punct	O
it	PRP	nsubj	O
was	VBD	cop	O
able	JJ	ROOT	O
to	TO	case	O
partly	RB	advmod	O
displace	VB	xcomp	O
(	-LRB-	punct	O
20	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
the	DT	det	O
hormone	NN	conj	O
from	IN	case	O
its	PRP$	nmod:poss	O
binding	VBG	amod	O
site	NN	nmod	O
.	.	punct	O

No	DT	neg	O
genomic	JJ	amod	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
CAT	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
with	IN	case	O
the	DT	det	O
CD18	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
was	VBD	cop	O
inactive	JJ	conj	O
in	IN	case	O
the	DT	det	O
3	CD	nmod	O
of	IN	case	O
them	PRP	nmod	O
,	,	punct	O
again	RB	advmod	O
suggesting	VBG	advcl	O
lack	NN	dobj	O
of	IN	case	O
(	-LRB-	punct	O
a	LS	det	O
)	-RRB-	punct	O
transcriptional	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
necessary	JJ	amod	O
for	IN	case	O
CD18	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

Constitutive	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
primary	JJ	amod	B-cell_type
adult	JJ	amod	I-cell_type
T-cell	NN	compound	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Transcription	NN	compound	B-protein
factor	NN	compound	I-protein
E2F	NN	nsubj	B-protein
binds	VBZ	ROOT	O
to	TO	case	O
cellular	JJ	amod	B-DNA
promoters	NNS	nmod	I-DNA
of	IN	case	O
certain	JJ	amod	O
growth-	NN	nmod	B-DNA
and	CC	cc	I-DNA
cell	NN	nmod:npmod	I-DNA
cycle-controlling	JJ	conj	I-DNA
genes	NNS	dep	I-DNA
and	CC	cc	O
forms	VBZ	conj	O
distinct	JJ	amod	O
heteromeric	JJ	amod	B-protein
complexes	NNS	dobj	I-protein
with	IN	case	O
other	JJ	amod	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

When	WRB	advmod	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
semiquantitated	VBN	advcl	O
using	VBG	xcomp	O
densitometry	NN	dobj	O
,	,	punct	O
significant	JJ	amod	O
decreases	NNS	nsubj	O
of	IN	case	O
TCRzeta	NN	nmod	B-protein
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	ROOT	O
0.029	CD	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
p56	NN	conj	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0.029	CD	dobj	O
)	-RRB-	punct	O
but	CC	cc	O
not	RB	neg	O
CD3epsilon	NN	conj	B-protein
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0.131	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
control	NN	compound	O
levels	NNS	advcl	O
,	,	punct	O
were	VBD	auxpass	O
found	VBN	parataxis	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
DRA	NN	compound	B-DNA
promoter	NN	nsubj	I-DNA
discriminates	VBZ	ROOT	O
against	IN	case	O
OTF-1	NN	compound	B-protein
activation	NN	nmod	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
DNA	NN	compound	O
binding	NN	nmod	O
in	IN	case	O
the	DT	det	O
glioblastoma	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

DESIGN	NN	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
all-trans	JJ	nmod	O
and	CC	cc	O
9-cis	JJ	conj	O
RA	NN	dep	O
on	IN	case	O
HIV-1	NN	compound	O
production	NN	nmod	O
in	IN	case	O
T-lymphoid	JJ	nmod	B-cell_line
(	-LRB-	punct	O
H9	NN	dep	B-cell_line
,	,	punct	I-cell_line
CEM	NN	appos	I-cell_line
)	-RRB-	punct	O
and	CC	cc	O
monocytoid	NN	conj	B-cell_line
(	-LRB-	punct	I-cell_line
U937	NN	compound	I-cell_line
,	,	punct	I-cell_line
THP-1	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
was	VBD	auxpass	O
measured	VBN	dep	O
during	IN	case	O
acute	JJ	amod	O
and	CC	cc	O
chronic	JJ	conj	O
infection	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
contrasts	VBZ	ROOT	O
with	IN	case	O
induction	NN	nmod	O
of	IN	case	O
c-fos	NN	nmod	B-DNA
by	IN	case	O
both	CC	cc:preconj	O
CD40	NN	nmod	B-protein
and	CC	cc	O
sIg	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
PKC	NN	nmod:npmod	B-protein
independent	JJ	acl:relcl	O
and	CC	cc	O
indicates	VBZ	conj	O
that	IN	mark	O
CD40	NN	nsubj	B-protein
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	case	O
signaling	VBG	nmod	O
through	IN	case	O
PKC	NN	nmod	B-protein
or	CC	cc	O
a	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
kinase	NN	conj	B-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
IRE	NN	compound	B-RNA
motif	NN	nsubj	I-RNA
in	IN	case	O
the	DT	det	O
ALAS	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
is	VBZ	cop	O
functional	JJ	ccomp	O
and	CC	cc	O
imply	VBP	conj	O
that	IN	mark	O
translation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
mRNA	NN	nmod	B-RNA
is	VBZ	auxpass	O
controlled	VBN	ccomp	O
by	IN	case	O
cellular	JJ	amod	O
iron	NN	compound	O
availability	NN	nmod	O
during	IN	case	O
erythropoiesis	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
Gs	NN	compound	B-protein
(	-LRB-	punct	I-protein
alpha	NN	nmod	I-protein
)	-RRB-	punct	I-protein
enhances	VBZ	ROOT	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
adenylyl	JJ	amod	B-protein
cyclase	NN	compound	I-protein
signal	NN	compound	O
transduction	NN	compound	O
cascade	NN	nmod	O
.	.	punct	O

The	DT	det	O
c-Jun	NN	compound	B-protein
delta-domain	NN	nsubj	I-protein
inhibits	VBZ	ROOT	O
neuroendocrine	JJ	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
DNA	NN	compound	O
sequence-	NN	amod	O
and	CC	cc	O
pituitary-specific	JJ	conj	O
manner	NN	nmod	O
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
retinoblastoma	NN	compound	B-protein
protein	NN	nmod	I-protein
by	IN	case	O
cyclin-dependent	JJ	amod	B-protein
kinases	NNS	nmod	I-protein
4	CD	nummod	I-protein
and	CC	cc	I-protein
6	CD	conj	I-protein
prevents	VBZ	ROOT	O
its	PRP$	nmod:poss	O
interaction	NN	dobj	O
with	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
E2F	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
subsequently	RB	advmod	O
promotes	VBZ	acl:relcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
S	NN	compound	B-DNA
phase	NN	compound	I-DNA
regulated	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
thymidine	NN	compound	B-protein
kinase	NN	nmod	I-protein
.	.	punct	O

Peroxisome	NN	compound	B-protein
proliferator-activated	JJ	amod	I-protein
receptors	NNS	nsubj	I-protein
(	-LRB-	punct	O
PPAR	NNS	appos	B-protein
)	-RRB-	punct	O
control	VBP	ROOT	O
discrete	JJ	amod	O
genes	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
fatty	JJ	amod	O
acid	NN	nmod	O
and	CC	cc	O
lipid	NN	compound	O
metabolism	NN	conj	O
.	.	punct	O

Evidence	NN	ROOT	O
for	IN	case	O
repression	NN	nmod	O
of	IN	case	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
activation	NN	nmod	O
in	IN	case	O
anergic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
three	CD	nummod	O
jun	NN	compound	B-DNA
genes	NNS	nsubj	I-DNA
showed	VBD	ROOT	O
a	DT	det	O
similar	JJ	amod	O
time	NN	compound	O
course	NN	dobj	O
in	IN	case	O
their	PRP$	nmod:poss	O
induction	NN	nmod	O
by	IN	case	O
PMA	NN	nmod	O
,	,	punct	O
maximal	JJ	amod	O
mRNA	NN	compound	O
levels	NNS	nsubjpass	O
being	VBG	auxpass	O
reached	VBN	advcl	O
after	IN	case	O
60	CD	nummod	O
min	NN	nmod	O
of	IN	case	O
induction	NN	nmod	O
.	.	punct	O

Mental	JJ	amod	O
retardation	NN	nsubjpass	O
and	CC	cc	O
a	DT	det	O
constellation	NN	conj	O
of	IN	case	O
congenital	JJ	amod	O
malformations	NNS	nmod	O
not	RB	neg	O
usually	RB	advmod	O
associated	VBN	nsubjpass	O
with	IN	case	O
Turner	NN	compound	O
syndrome	NN	nmod	O
are	VBP	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
some	DT	det	O
females	NNS	nmod	O
with	IN	case	O
a	DT	det	O
mosaic	JJ	amod	O
45	CD	nmod	O
,	,	punct	O
X/46	NN	conj	O
,	,	punct	O
X	NN	conj	O
,	,	punct	O
r	NN	compound	O
(	-LRB-	punct	O
X	NN	compound	O
)	-RRB-	punct	O
karyotype	NN	dep	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
these	DT	det	O
mAECA	NNS	nsubj	B-protein
stimulated	VBD	ROOT	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
preferential	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
c-jun	NN	nmod	B-DNA
by	IN	case	O
H2O2	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
represent	VB	ROOT	O
redox	NN	compound	O
stabilization	NN	dobj	O
of	IN	case	O
mRNA	NN	compound	B-RNA
transcripts	NNS	nmod	I-RNA
,	,	punct	O
and	CC	cc	O
oxidative	JJ	amod	O
signals	NNS	nsubj	O
closely	RB	advmod	O
resembled	VBD	conj	O
PHA/PMA	NN	compound	O
stimulation	NN	dobj	O
by	IN	mark	O
effectively	RB	advmod	O
transactivating	VBG	advcl	O
the	DT	det	O
full	JJ	amod	O
length	NN	compound	O
c-jun	NN	compound	B-DNA
promoter	NN	dobj	O
via	IN	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
jun1	NN	compound	I-DNA
tumor	NN	compound	I-DNA
promoter-responsive	JJ	amod	I-DNA
element	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
TRE	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-like	JJ	amod	I-DNA
promoter	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Whereas	IN	mark	O
overexpression	NN	nsubj	O
of	IN	case	O
BCL2	NN	nmod	B-protein
abrogates	VBZ	advcl	O
the	DT	det	O
apoptotic	JJ	amod	O
response	NN	dobj	O
,	,	punct	O
Stat3	NN	compound	B-protein
-independent	JJ	amod	O
signals	NNS	nsubj	O
appear	VBP	ROOT	O
to	TO	mark	O
downregulate	VB	xcomp	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
BCL2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

High-dose	JJ	amod	O
estrogen	NN	compound	O
administration	NN	nsubj	O
induces	VBZ	ROOT	O
anemia	NN	dobj	O
in	IN	case	O
mammals	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
overexpression	NN	nsubj	O
of	IN	case	O
IkappaB-alpha	NN	nmod	B-protein
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
using	VBG	acl	O
a	DT	det	O
recombinant	JJ	amod	O
adenovirus	NN	dobj	O
prevented	VBD	ccomp	O
tumor	NN	nmod:npmod	B-protein
necrosis	NN	nmod:npmod	I-protein
factor-alpha	NN	nmod:npmod	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
-induced	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
IkappaB-alpha	NN	nmod	B-protein
and	CC	cc	O
suppressed	VBD	conj	O
the	DT	det	O
upregulation	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
(	-LRB-	punct	O
VCAM-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
(	-LRB-	punct	O
ICAM-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
E-selectin	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
and	CC	cc	O
surface	NN	compound	O
protein	NN	compound	O
expression	NN	conj	O
and	CC	cc	O
the	DT	det	O
upregulation	NN	conj	O
of	IN	case	O
transcripts	NNS	nmod	O
for	IN	case	O
the	DT	det	O
chemokines	NNS	nmod	B-protein
monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein	NN	dep	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
MCP-1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
growth-related	JJ	amod	B-protein
activity-alpha	NN	conj	I-protein
(	-LRB-	punct	O
GRO-alpha	NN	appos	B-protein
)	-RRB-	punct	O
by	IN	case	O
TNF-alpha	NN	nmod	B-protein
.	.	punct	O

Consistent	JJ	advcl	O
with	IN	case	O
the	DT	det	O
diagnosis	NN	nmod	O
of	IN	case	O
PEL	NN	nmod	B-cell_line
,	,	punct	O
both	CC	cc:preconj	O
CRO-AP/3	NN	nsubj	B-cell_line
and	CC	cc	O
CRO-AP/5	NN	conj	B-cell_line
expressed	VBD	ROOT	O
indeterminate	JJ	amod	O
(	-LRB-	punct	O
i.e.	FW	dep	O
non-B	JJ	amod	O
,	,	punct	O
non-T	JJ	dep	O
)	-RRB-	punct	O
phenotypes	NNS	dobj	O
although	IN	mark	O
immunogenotypic	JJ	amod	O
studies	NNS	nsubj	O
documented	VBD	advcl	O
their	PRP$	nmod:poss	O
B-cell	NN	compound	B-cell_type
origin	NN	dobj	I-cell_type
.	.	punct	O

Their	PRP$	nmod:poss	O
affinity	NN	nsubj	O
for	IN	case	O
the	DT	det	O
vitamin	NN	compound	B-protein
D-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
increased	VBD	ROOT	O
up	RP	prt	O
to	TO	advmod	O
4-fold	RB	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
for	IN	case	O
the	DT	det	O
clonal	JJ	amod	O
expansion	NN	nmod	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
T-cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
characteristic	JJ	amod	O
result	NN	acl:relcl	O
of	IN	case	O
HTLV-I	NN	compound	O
infection	NN	nmod	O
,	,	punct	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	dep	O
CREB/ATF	NN	nmod	O
and	CC	cc	O
SRF	NN	conj	O
pathways	NNS	dep	O
is	VBZ	auxpass	O
also	RB	advmod	O
required	VBN	ROOT	O
.	.	punct	O

Functional	JJ	amod	O
association	NN	ROOT	O
of	IN	case	O
Nmi	NN	nmod	B-protein
with	IN	case	O
Stat5	NN	nmod	B-protein
and	CC	cc	O
Stat1	NN	conj	B-protein
in	IN	case	O
IL-2	NN	compound	B-protein
-and	NN	compound	O
IFNgamma	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
signaling	NN	nmod	O
.	.	punct	O

FasL-dependent	JJ	amod	B-DNA
reporter	NN	compound	I-DNA
constructs	NNS	nsubj	I-DNA
in	IN	case	O
MRL-lpr/lpr	NN	intj	B-cell_line
and	CC	cc	I-cell_line
C3H-gld/gld	JJ	conj	I-cell_line
CD4	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
-	:	punct	I-cell_line
)	-RRB-	punct	I-cell_line
CD8	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
-	:	punct	I-cell_line
)	-RRB-	punct	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
were	VBD	cop	O
constitutively	RB	advmod	O
active	JJ	ROOT	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
largely	RB	advmod	O
prevented	VBN	conj	O
by	IN	case	O
mutation	NN	nmod	O
of	IN	case	O
the	DT	det	O
critical	JJ	amod	O
Egr	NN	compound	B-DNA
family	NN	compound	I-DNA
binding	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

A	DT	det	O
constitutive	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
in	IN	case	O
mature	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
through	IN	case	O
the	DT	det	O
differential	JJ	amod	O
use	NN	nmod	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
promoter	NN	compound	B-DNA
element	NN	nmod	I-DNA
,	,	punct	O
the	DT	det	O
composite	JJ	amod	B-DNA
kappa	NN	compound	I-DNA
3/CRE	NN	compound	I-DNA
site	NN	appos	I-DNA
,	,	punct	O
the	DT	det	O
TNF-alpha	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
cell-type-specific	JJ	amod	O
manner	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
extracellular	JJ	amod	O
signal	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
383-bp	JJ	nmod	B-DNA
(	-LRB-	punct	I-DNA
delta383	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
and	CC	cc	I-DNA
99-bp	JJ	conj	I-DNA
(	-LRB-	punct	I-DNA
delta99	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
sequences	NNS	dep	I-DNA
containing	VBG	acl	O
the	DT	det	O
PYBF-binding	JJ	amod	B-DNA
site	NN	dobj	I-DNA
on	IN	case	O
transcription	NN	nmod	O
from	IN	case	O
various	JJ	amod	O
globin	NN	nmod	O
and	CC	cc	O
non-globin	JJ	conj	O
promoters	NNS	dep	O
,	,	punct	O
using	VBG	advcl	O
a	DT	det	O
transient	JJ	amod	O
assay	NN	dobj	O
with	IN	case	O
the	DT	det	O
cat	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
murine	JJ	amod	B-cell_line
erythroleukemia	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
MEL	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
a	DT	det	O
cell	NN	compound	O
line	NN	appos	O
with	IN	case	O
abundant	JJ	amod	O
PYBF	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

Composite	JJ	amod	B-DNA
elements	NNS	nsubj	I-DNA
are	VBP	cop	O
regulatory	JJ	amod	B-DNA
modules	NNS	ROOT	I-DNA
of	IN	case	O
promoters	NNS	nmod	B-DNA
or	CC	cc	O
enhancers	NNS	conj	B-DNA
that	WDT	nsubj	O
consist	VBP	acl:relcl	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
of	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
but	CC	cc	O
synergizing	VBG	conj	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
BAT	NN	compound	B-DNA
box	NN	nsubjpass	I-DNA
and	CC	cc	O
Oct-2	NN	conj	B-protein
were	VBD	auxpass	O
also	RB	advmod	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
CD20	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
pre-B	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
PB-697	NN	appos	B-cell_line
,	,	punct	O
via	IN	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
.	.	punct	O

The	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	compound	I-DNA
CBF	NN	compound	I-DNA
site	NN	compound	I-DNA
TGTGGTCA	NN	nsubj	O
is	VBZ	cop	O
located	JJ	ROOT	O
51	CD	nummod	B-DNA
bp	NN	nmod:npmod	I-DNA
upstream	RB	advmod	I-DNA
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
also	RB	advmod	O
overlaps	VBZ	conj	O
a	DT	det	O
YY-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
promoters	NNS	nmod	B-DNA
dependent	JJ	amod	O
on	IN	case	O
these	DT	det	O
elements	NNS	nmod	O
is	VBZ	cop	O
inhibitable	JJ	ROOT	O
by	IN	case	O
the	DT	det	O
immunosuppressants	NNS	nmod	O
cyclosporin	NN	compound	O
A	NN	dep	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
tacrolimus	NN	conj	O
(	-LRB-	punct	O
FK-506	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
cytokine	NN	nsubj	O
or	CC	cc	O
phorbol	NN	compound	O
ester	NN	compound	O
stimulation	NN	conj	O
of	IN	case	O
KG1	NN	nmod	B-cell_line
is	VBZ	cop	O
a	DT	det	O
model	NN	ccomp	O
of	IN	case	O
human	JJ	amod	B-cell_line
CD34+	JJ	amod	I-cell_line
HPC	NN	compound	I-cell_line
to	TO	dep	O
DC	NN	compound	B-cell_type
differentiation	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
specific	JJ	amod	O
intracellular	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nsubj	O
mediate	VBP	ccomp	O
specific	JJ	amod	O
events	NNS	dobj	O
in	IN	case	O
DC	NN	compound	B-cell_type
lineage	NN	compound	O
commitment	NN	nmod	O
.	.	punct	O

LYSP100	NN	compound	B-protein
-associated	JJ	amod	O
nuclear	JJ	amod	O
domains	NNS	ROOT	O
(	-LRB-	punct	O
LANDs	NNS	appos	O
)	-RRB-	punct	O
:	:	punct	O
description	NN	dep	O
of	IN	case	O
a	DT	det	O
new	JJ	amod	O
class	NN	nmod	O
of	IN	case	O
subnuclear	JJ	amod	O
structures	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
relationship	NN	conj	O
to	TO	case	O
PML	NN	compound	O
nuclear	JJ	amod	O
bodies	NNS	nmod	O
.	.	punct	O

Over-expression	NN	nsubj	O
of	IN	case	O
both	DT	det	O
genes	NNS	nmod	O
was	VBD	aux	O
restricted	JJ	ROOT	O
to	TO	case	O
monocytes	NNS	nmod	B-cell_type
from	IN	case	O
II-2	NN	nmod	B-cell_line
and	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
observed	VBN	conj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
from	IN	case	O
the	DT	det	O
clinically	RB	advmod	O
unaffected	JJ	amod	O
family	NN	compound	O
members	NNS	nmod	O
,	,	punct	O
unlike	IN	case	O
that	DT	nmod	O
of	IN	case	O
SR	NN	nmod	B-protein
.	.	punct	O

p65	NN	nsubjpass	B-protein
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
of	IN	case	O
FDC	NN	nmod	B-cell_type
,	,	punct	O
whereas	IN	dep	O
nuclei	NNS	nsubj	O
were	VBD	cop	O
negative	JJ	parataxis	O
.	.	punct	O

The	DT	det	O
IE2	NN	compound	B-protein
gene	NN	compound	I-protein
product	NN	nsubj	I-protein
of	IN	case	O
human	JJ	amod	O
cytomegalovirus	NN	nmod	O
(	-LRB-	punct	O
HCMV	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
a	DT	det	O
few	JJ	amod	O
viral	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
expressed	VBN	acl	O
immediately	RB	advmod	O
upon	IN	case	O
infection	NN	nmod	O
of	IN	case	O
the	DT	det	O
host	NN	compound	B-cell_type
cell	NN	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
positive	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
PAFR	NN	compound	B-protein
gene	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
PAF	NN	nmod	B-protein
through	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
possibly	RB	advmod	O
by	IN	case	O
a	DT	det	O
phosphorylation	NN	compound	O
reaction	NN	nmod	O
involving	VBG	acl	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	dobj	I-protein
by	IN	case	O
PAF	NN	nmod	B-protein
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
their	PRP$	nmod:poss	O
normal	JJ	amod	O
cell	NN	compound	O
counterparts	NNS	dobj	O
microdissected	VBN	acl	O
from	IN	case	O
a	DT	det	O
reactive	JJ	amod	O
tonsil	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
internal	JJ	amod	O
sites	NNS	nsubjpass	O
of	IN	case	O
oxidant	JJ	amod	O
production	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
cytokine	NN	compound	B-protein
-stimulated	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
since	IN	mark	O
tyrosine	NN	compound	O
kinase	NN	nsubjpass	O
and	CC	cc	O
phosphatase	NN	compound	O
activities	NNS	conj	O
are	VBP	auxpass	O
known	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
altered	VBN	xcomp	O
by	IN	case	O
oxidants	NNS	nmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
intracellular	JJ	amod	O
redox	NN	compound	O
status	NN	nsubj	O
controls	VBZ	ccomp	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
by	IN	mark	O
regulating	VBG	advcl	O
tyrosine	NN	compound	O
phosphorylation	NN	compound	O
event	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
within	IN	case	O
the	DT	det	O
common	JJ	amod	O
step	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
a	DT	det	O
potential	JJ	amod	O
mechanism	NN	dobj	O
for	IN	case	O
these	DT	det	O
differences	NNS	nmod	O
in	IN	case	O
function	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
(	-LRB-	punct	I-protein
PKC	NN	compound	I-protein
)	-RRB-	punct	I-protein
isoforms	NNS	nmod	I-protein
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
majority	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
were	VBD	auxpass	O
expressed	VBN	ccomp	O
at	IN	case	O
comparable	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
U-937	NN	compound	B-cell_line
and	CC	cc	O
HeLa	NN	conj	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Spi-C	NN	compound	B-RNA
RNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
mature	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
at	IN	case	O
lower	JJR	amod	O
levels	NNS	conj	O
in	IN	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
Tax	NN	compound	B-protein
mutants	NNS	nmod	I-protein
showed	VBD	ROOT	O
that	IN	mark	O
two	CD	nummod	O
mutants	NNS	nsubj	O
,	,	punct	O
IEXC29S	NN	appos	B-protein
and	CC	cc	O
IEXL320G	NN	conj	B-protein
,	,	punct	O
were	VBD	cop	O
unable	JJ	ccomp	O
to	TO	mark	O
significantly	RB	advmod	O
transactivate	VB	xcomp	O
the	DT	det	O
c-sis/PDGF-B	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

Gel	NN	compound	O
retardation	NN	compound	O
assays	NNS	nsubj	O
with	IN	case	O
STAT-binding	JJ	amod	O
oligonucleotides	NNS	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
IL-7	NN	nsubj	B-protein
induces	VBZ	ccomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
major	JJ	amod	O
STAT	NN	compound	B-protein
complexes	NNS	nmod	I-protein
in	IN	case	O
BCP-ALL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Neither	DT	nsubj	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
toxins	NNS	nmod	O
affected	VBD	ROOT	O
kappaB	NN	compound	B-protein
binding	NN	compound	O
activity	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
TNFalpha	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
cdc2	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nsubj	O
is	VBZ	cop	O
related	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
cell	NN	compound	O
cycling	NN	nmod	O
of	IN	case	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
hematopoietic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
that	IN	mark	O
E2F	NN	nsubj	B-protein
plays	VBZ	conj	O
some	DT	det	O
roles	NNS	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
expression	NN	nmod	O
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
priming	NN	nsubj	O
under	IN	case	O
those	DT	det	O
conditions	NNS	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
Th2	NN	compound	O
differentiation	NN	nmod	O
in	IN	case	O
only	RB	advmod	O
9	CD	nummod	O
of	IN	advmod	O
24	CD	nummod	O
RA	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
between	IN	case	O
NGAL	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
disease-free	JJ	amod	O
or	CC	cc	O
overall	JJ	conj	O
survival	NN	conj	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
resting	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
NFAT	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
targeted	VBN	ccomp	O
to	TO	case	O
a	DT	det	O
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
calcineurin	NN	compound	B-protein
catalytic	JJ	amod	I-protein
domain	NN	nmod	I-protein
that	WDT	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
overlap	VB	acl:relcl	O
the	DT	det	O
calcineurin	NN	compound	B-protein
active	JJ	amod	I-protein
site	NN	dobj	I-protein
.	.	punct	O

STAT3	NN	compound	B-protein
expression	NN	nsubjpass	O
in	IN	case	O
particular	JJ	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
Abl	NN	nmod	B-protein
,	,	punct	O
Src	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
HTLV-1	NN	compound	O
transformation	NN	conj	O
of	IN	case	O
normal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
this	DT	det	O
synergism	NN	nmod	O
was	VBD	cop	O
perceptible	JJ	ROOT	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
a	DT	det	O
process	NN	appos	O
critical	JJ	amod	O
for	IN	case	O
T	NN	compound	O
cell	NN	compound	O
growth	NN	nmod	O
.	.	punct	O

IL-7	NN	nsubj	B-protein
reconstitutes	VBZ	ROOT	O
multiple	JJ	amod	O
aspects	NNS	dobj	O
of	IN	case	O
v-Abl	NN	compound	B-protein
-mediated	JJ	amod	O
signaling	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
erythropoietin	NN	compound	I-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
by	IN	case	O
proteins	NNS	nmod	O
binding	VBG	acl	O
to	TO	case	O
GATA-1	NN	compound	B-DNA
and	CC	cc	I-DNA
Sp1	NN	conj	I-DNA
motifs	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
cross-linking	NN	nsubj	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
CD4	NN	nmod	I-protein
by	IN	case	O
gp120-anti-gp120	NN	compound	B-protein
immune	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
or	CC	cc	O
heat-inactivated	JJ	amod	O
HIV-1	NN	conj	O
(	-LRB-	punct	O
iHIV-1	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
trigger	VB	xcomp	O
activation	NN	compound	O
signals	NNS	dobj	O
leading	VBG	acl	O
to	TO	case	O
virus	NN	compound	O
reactivation	NN	nmod	O
(	-LRB-	punct	O
9	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
BXB	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
constitutive	JJ	amod	O
active	JJ	amod	O
version	NN	appos	O
of	IN	case	O
c-Raf	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
of	IN	case	O
further	JJ	amod	O
members	NNS	conj	O
of	IN	case	O
the	DT	det	O
Ras	NN	compound	B-protein
-	HYPH	punct	O
Raf	NNP	compound	B-protein
-	HYPH	punct	O
Erk	NN	compound	B-protein
signal	NN	compound	O
cascade	NN	nmod	O
exerted	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
of	IN	case	O
GABP	NN	compound	B-protein
-mediated	JJ	amod	O
promoter-enhancer	JJ	amod	O
induction	NN	nmod	O
.	.	punct	O

Transfection	NN	compound	O
experiments	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
Stat1alpha	NN	nsubj	B-protein
and	CC	cc	O
Stat3	NN	conj	B-protein
inhibited	VBD	ccomp	O
the	DT	det	O
induction	NN	dobj	O
by	IN	case	O
EPO	NN	nmod	B-protein
of	IN	case	O
gamma-globin	NN	nmod	B-RNA
and	CC	cc	I-RNA
erythroid-specific	JJ	amod	I-RNA
5-aminolevulinate	JJ	amod	I-RNA
synthetase	NN	compound	I-RNA
transcripts	NNS	dep	I-RNA
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
of	IN	case	O
the	DT	det	O
percentage	NN	nmod	O
of	IN	case	O
hemoglobin-positive	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
eosinophils	NNS	nsubj	B-cell_type
infiltrating	VBG	acl	O
into	IN	case	O
different	JJ	amod	O
pathologic	JJ	amod	O
processes	NNS	nmod	O
elaborate	VBP	ccomp	O
TGF-alpha	NN	dobj	B-protein
and	CC	cc	O
TGF-beta1	NN	conj	B-protein
.	.	punct	O

Preliminary	JJ	amod	O
experiments	NNS	nsubj	O
yielded	VBD	ROOT	O
a	DT	det	O
Km	NN	compound	O
value	NN	dobj	O
of	IN	case	O
about	RB	advmod	O
0.8	CD	nummod	O
microM	NN	nmod	O
for	IN	case	O
dUTP	NN	nmod	O
.	.	punct	O

Primary	JJ	amod	O
Sjogren	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	nsubj	O
(	-LRB-	punct	O
SS	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
autoimmune	JJ	amod	O
rheumatic	JJ	amod	O
disease	NN	ROOT	O
characterized	VBN	acl	O
by	IN	case	O
T	NN	compound	O
cell	NN	compound	O
hypoactivity	NN	nmod	O
.	.	punct	O

Double	JJ	amod	O
staining	NN	nsubjpass	O
for	IN	case	O
Bcl-6/CD20	NN	nmod	B-protein
,	,	punct	O
Bcl-6/CD3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Bcl-6/CD57	NN	conj	B-protein
was	VBD	auxpass	O
performed	VBN	ROOT	O
in	IN	case	O
selected	VBN	amod	O
cases	NNS	nmod	O
.	.	punct	O

LPS-stimulated	JJ	amod	O
translocation	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
CHO/CD14	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
resembled	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
response	NN	dobj	O
in	IN	case	O
the	DT	det	O
murine	JJ	amod	B-cell_line
macrophage-like	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
RAW	NN	dep	B-cell_line
264.7	CD	nummod	I-cell_line
.	.	punct	O

Ligand-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
STATs	NNS	nmod	B-protein
promotes	VBZ	ROOT	O
their	PRP$	nmod:poss	O
homodimer	NN	dobj	O
and	CC	cc	O
heterodimer	NN	conj	O
formation	NN	conj	O
and	CC	cc	O
subsequent	JJ	amod	O
nuclear	JJ	amod	O
translocation	NN	conj	O
.	.	punct	O

The	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
cycloheximide	NN	nmod	O
completely	RB	advmod	O
blocked	VBD	ROOT	O
the	DT	det	O
VitD3	NN	compound	O
induction	NN	dobj	O
of	IN	case	O
CD14	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
induction	NN	nsubj	O
was	VBD	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
ongoing	JJ	amod	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
binding	NN	compound	O
studies	NNS	nsubjpass	O
with	IN	case	O
(	-LRB-	punct	O
3H	NN	compound	O
)	-RRB-	punct	O
dexamethasone	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
dissociation	NN	compound	O
constant	NN	dobj	O
(	-LRB-	punct	O
Kd	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
receptor	NN	compound	O
numbers	NNS	conj	O
(	-LRB-	punct	O
Ro	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
monocytes	NNS	nmod	B-cell_type
of	IN	case	O
these	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
of	IN	case	O
subjects	NNS	nmod	O
.	.	punct	O

Precise	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
MHC	NN	compound	B-cell_type
class	NN	compound	I-cell_type
II	CD	nummod	I-cell_type
expression	NN	nmod	O
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Several	JJ	amod	O
cell	NN	compound	O
lines	NNS	nsubj	O
of	IN	case	O
hematopoietic	JJ	amod	O
origin	NN	nmod	O
including	VBG	case	O
the	DT	det	O
leukemic	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
HPB.ALL	NN	nmod	I-cell_line
and	CC	cc	O
the	DT	det	O
erythroleukemic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
K562	NN	conj	I-cell_line
were	VBD	cop	O
responsive	JJ	ROOT	O
to	TO	case	O
thrombin	NN	nmod	B-protein
,	,	punct	O
whereas	IN	mark	O
others	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
THP1	NN	nmod	B-cell_line
,	,	punct	O
a	DT	det	O
myelomonocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
,	,	punct	O
and	CC	cc	O
BL2	NN	conj	B-cell_line
,	,	punct	I-cell_line
a	DT	det	O
Burkitt	NN	compound	B-cell_line
lymphoma	NN	nsubj	I-cell_line
were	VBD	cop	O
refractory	JJ	advcl	O
to	TO	case	O
thrombin	NN	nmod	B-protein
or	CC	cc	O
TRP	NN	compound	O
stimulation	NN	conj	O
.	.	punct	O

The	DT	det	O
mutated	VBN	amod	B-DNA
human	JJ	amod	I-DNA
CIITA	NN	compound	I-DNA
constructs	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
tested	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
pig	NN	nmod	O
.	.	punct	O

Stimulation	NN	nsubj	O
with	IN	case	O
either	CC	cc:preconj	O
PAF	NN	nmod	B-protein
or	CC	cc	O
FMLP	NN	conj	B-protein
resulted	VBD	ROOT	O
in	IN	case	O
equivalent	JJ	amod	O
phosphorylation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	prep	I-protein
(	-LRB-	punct	I-protein
MAPk	NN	appos	I-protein
)	-RRB-	punct	I-protein
homologue	NN	nmod	I-protein
38-kD	JJ	amod	B-protein
murine	JJ	amod	I-protein
MAP	NN	compound	I-protein
kinase	NN	dep	I-protein
homologous	JJ	amod	O
to	TO	case	O
HOG-1	NN	compound	B-protein
(	-LRB-	punct	I-protein
p38	NN	compound	I-protein
)	-RRB-	punct	I-protein
MAPk	NN	nmod	I-protein
.	.	punct	O

T	NN	compound	O
helper	NN	compound	O
differentiation	NN	nsubj	O
proceeds	VBZ	ROOT	O
through	IN	case	O
Stat1-dependent	JJ	amod	O
,	,	punct	O
Stat4-dependent	JJ	conj	O
and	CC	cc	O
Stat4-independent	JJ	conj	O
phases	NNS	nmod	O
.	.	punct	O

The	DT	det	O
functional	JJ	amod	O
domains	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
Thy-1	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
a	DT	det	O
DNA-binding/immunoprecipitation	JJ	amod	O
assay	NN	dobj	O
to	TO	mark	O
analyze	VB	advcl	O
the	DT	det	O
capacity	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
hGR	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
generated	VBN	acl	O
in	IN	case	O
rabbit	NN	compound	O
reticulocyte	NN	compound	O
lysates	NNS	nmod	O
,	,	punct	O
to	TO	mark	O
bind	VB	advcl	O
DNA	NN	dobj	O
.	.	punct	O

Next	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
these	DT	det	O
viral	JJ	amod	O
ligands	NNS	nsubj	O
directly	RB	advmod	O
up-regulated	VBD	ccomp	O
monocyte	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
upon	IN	case	O
their	PRP$	nmod:poss	O
binding	NN	nmod	O
to	TO	case	O
their	PRP$	nmod:poss	O
appropriate	JJ	amod	O
cellular	JJ	amod	O
receptors	NNS	nmod	O
.	.	punct	O

Precise	JJ	amod	O
alignment	NN	ROOT	B-DNA
of	IN	case	I-DNA
sites	NNS	nmod	I-DNA
required	VBN	acl	O
for	IN	case	O
mu	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
activation	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

p130	NN	nsubjpass	B-protein
,	,	punct	O
p107	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
pRb	NN	conj	B-protein
are	VBP	auxpass	O
differentially	RB	advmod	O
regulated	VBN	ROOT	O
in	IN	case	O
proliferating	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
during	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
arrest	NN	conj	O
by	IN	case	O
alpha-interferon	NN	nmod	B-protein
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
MHC	NN	compound	B-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
promoters	NNS	nmod	I-DNA
requires	VBZ	ROOT	O
binding	NN	dobj	O
of	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
distinct	JJ	amod	O
multi-protein	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
(	-LRB-	punct	O
RFX	NN	dep	B-protein
,	,	punct	O
X2BP	NN	conj	B-protein
and	CC	cc	O
NF-Y	NN	conj	B-protein
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
RelA	NN	compound	B-protein
(	-LRB-	punct	I-protein
p65	NN	compound	I-protein
)	-RRB-	punct	I-protein
subunit	NN	nsubj	I-protein
was	VBD	cop	O
barely	RB	advmod	O
detectable	JJ	ROOT	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
level	NN	nsubj	O
increased	VBD	conj	O
markedly	RB	advmod	O
in	IN	case	O
MDMs	NNS	nmod	B-cell_type
.	.	punct	O

Next	RB	nsubjpass	O
is	VBZ	auxpass	O
presented	VBN	ROOT	O
a	DT	det	O
discussion	NN	dobj	O
of	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
embryonic	JJ	amod	B-cell_type
stem	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
analysis	NN	nmod	O
of	IN	case	O
hematopoietic	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
use	NN	conj	O
of	IN	case	O
targeted	VBN	amod	O
gene	NN	compound	O
disruption	NN	nmod	O
to	TO	mark	O
analyze	VB	acl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
in	IN	case	O
hematopoiesis	NN	nmod	O
.	.	punct	O

This	DT	det	O
mechanism	NN	nsubj	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
delayed	VBN	amod	O
progression	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	O
infection	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
on	IN	case	O
a	DT	det	O
computer	NN	compound	O
algorithm	NN	nmod	O
capable	JJ	amod	O
of	IN	mark	O
predicting	VBG	advcl	O
the	DT	det	O
location	NN	dobj	O
of	IN	case	O
T-helper-cell	JJ	compound	B-protein
epitopes	NNS	nmod	I-protein
in	IN	case	O
protein	NN	compound	B-protein
antigen	NN	nmod	I-protein
(	-LRB-	punct	O
Ag	NN	appos	B-protein
)	-RRB-	punct	O
by	IN	mark	O
analysing	VBG	advcl	O
the	DT	det	O
Ag	NN	compound	B-protein
amino	NN	compound	B-protein
acid	NN	compound	I-protein
sequence	NN	dobj	I-protein
.	.	punct	O

The	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
eukaryotic	JJ	amod	O
transcription	NN	compound	B-protein
factor	NN	ROOT	I-protein
.	.	punct	O

Cyclosporine	NN	nsubj	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
both	CC	cc:preconj	O
a	DT	det	O
clinical	JJ	amod	O
immunosuppressive	JJ	amod	O
drug	NN	ROOT	O
and	CC	cc	O
a	DT	det	O
probe	NN	conj	O
to	TO	mark	O
dissect	VB	acl	O
intracellular	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	dobj	O
.	.	punct	O

Functional	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
Pb	NN	nmod	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
using	VBG	xcomp	O
primary	JJ	amod	B-cell_line
CD4+	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	dobj	I-cell_line
transfected	VBN	acl	O
with	IN	case	O
an	DT	det	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
dependent	JJ	amod	I-DNA
reporter	NN	compound	I-DNA
gene	NN	compound	I-DNA
construct	NN	nmod	I-DNA
.	.	punct	O

Late	JJ	amod	O
gene	NN	compound	O
expression	NN	nsubj	O
from	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
BcLF1	NN	compound	B-DNA
and	CC	cc	I-DNA
BFRF3	NN	conj	I-DNA
promoters	NNS	nmod	I-DNA
does	VBZ	aux	O
not	RB	neg	O
require	VB	ROOT	O
DNA	NN	compound	O
replication	NN	dobj	O
in	IN	case	O
cis	NN	nmod	O
.	.	punct	O

Recently	RB	advmod	O
this	DT	det	O
leukemia	NN	nsubjpass	O
was	VBD	auxpass	O
further	RB	advmod	O
characterized	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
exquisite	JJ	amod	O
sensitivity	NN	nmod	O
to	TO	case	O
all-trans	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nmod:poss	O
's	POS	case	O
differentiation	NN	compound	O
effect	NN	nmod	O
and	CC	cc	O
the	DT	det	O
production	NN	conj	O
of	IN	case	O
a	DT	det	O
fusion	NN	compound	B-DNA
gene	NN	nmod	I-DNA
altering	VBG	acl	O
the	DT	det	O
gene	NN	dobj	O
of	IN	case	O
RARalpha	NN	nmod	B-protein
and	CC	cc	O
a	DT	det	O
novel	JJ	amod	B-DNA
gene	NN	compound	I-DNA
PML	NN	conj	I-DNA
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
flavonoids	NNS	nmod	O
on	IN	case	O
NFkappaB	NN	compound	B-protein
/inhibitor-kappaB	NN	compound	O
(	-LRB-	punct	O
IkappaB	NN	compound	B-protein
)	-RRB-	punct	O
system	NN	nmod	O
in	IN	case	O
ECV304	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
activated	VBN	acl	O
with	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNFalpha	NN	appos	B-protein
)	-RRB-	punct	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
.	.	punct	O

Using	VBG	advcl	O
the	DT	det	O
coiled-coil	JJ	amod	O
region	NN	dobj	O
of	IN	case	O
Stat5b	NN	nmod	B-protein
as	IN	case	O
the	DT	det	O
bait	NN	nmod	O
in	IN	case	O
a	DT	det	O
yeast	NN	compound	O
two-hybrid	JJ	amod	O
screen	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
the	DT	det	O
association	NN	dobj	O
of	IN	case	O
Nmi	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
protein	NN	appos	O
of	IN	case	O
unknown	JJ	amod	O
function	NN	nmod	O
previously	RB	advmod	O
reported	VBN	acl	O
as	IN	case	O
an	DT	det	O
N-Myc	NN	compound	B-protein
interactor	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
a	DT	det	O
human	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubj	I-cell_line
,	,	punct	I-cell_line
B104	NN	appos	I-cell_line
,	,	punct	O
expressed	VBD	ccomp	O
surface	NN	compound	B-protein
IgM	NN	dobj	I-protein
(	-LRB-	punct	O
sIgM	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
surface	NN	compound	B-protein
IgD	NN	conj	I-protein
(	-LRB-	punct	O
sIgD	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
crosslinking	NN	nsubj	O
of	IN	case	O
sIgM	NN	nmod	B-protein
and	CC	cc	O
sIgD	NN	conj	B-protein
by	IN	case	O
anti-IgM	JJ	amod	B-protein
antibody	NN	nmod	I-protein
(	-LRB-	punct	I-protein
Ab	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
anti-IgD	JJ	amod	B-protein
Ab	NN	conj	I-protein
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
induced	VBD	conj	O
Ca2+	NN	compound	O
influx	NN	dobj	O
to	TO	case	O
almost	RB	advmod	O
the	DT	det	O
same	JJ	amod	O
degree	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
only	RB	advmod	O
sIgM	NN	compound	B-protein
-crosslinking	NN	nsubj	O
caused	VBD	advcl	O
B104	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
death	NN	dobj	O
.	.	punct	O

Elucidation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
involved	VBN	acl	O
in	IN	case	O
this	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
IgE	NN	compound	B-protein
production	NN	nmod	O
shows	VBZ	ROOT	O
that	IN	mark	O
epsilon	NN	compound	O
germline	NN	compound	B-DNA
transcription	NN	nsubjpass	O
is	VBZ	auxpass	O
decreased	VBN	ccomp	O
by	IN	case	O
RA	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
production	NN	nsubjpass	O
of	IN	case	O
interferon-gamma	NN	nmod	B-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
not	RB	neg	O
enhanced	VBN	parataxis	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
RA	NN	nmod	O
.	.	punct	O

Germ	NN	compound	B-RNA
line	NN	compound	I-RNA
C	NN	compound	I-RNA
transcripts	NNS	nsubjpass	I-RNA
can	MD	aux	O
be	VB	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
IL-4	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
BL-2	NN	appos	B-cell_line
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
tyloxapol	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
antioxidant	NN	ccomp	O
for	IN	case	O
hydroxyl	NN	compound	O
radicals	NNS	nmod	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
bcl-6	JJ	compound	B-protein
protein	NN	nmod	I-protein
on	IN	case	O
normal	JJ	amod	O
epidermis	JJ	nmod	O
,	,	punct	O
benign	JJ	conj	O
,	,	punct	O
and	CC	cc	O
malignant	JJ	amod	O
tumors	NNS	conj	O
originating	VBG	acl	O
from	IN	case	O
epidermal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
squamous	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
carcinoma	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
SCC	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
are	VBP	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
asked	VBD	ROOT	O
whether	IN	mark	O
dexamethasone	NN	nsubj	O
(	-LRB-	punct	O
Dex	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cyclosporin	NN	compound	O
A	NN	conj	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
inhibit	VBP	ccomp	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	dobj	O
by	IN	mark	O
interfering	VBG	advcl	O
with	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
IL-2	NN	compound	O
promoter	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
human	JJ	amod	B-cell_type
erythroid	JJ	amod	I-cell_type
precursors	NNS	nsubjpass	I-cell_type
can	MD	aux	O
be	VB	auxpass	O
expanded	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
in	IN	case	O
sufficient	JJ	amod	O
numbers	NNS	nmod	O
and	CC	cc	O
purity	NN	conj	O
to	TO	mark	O
allow	VB	advcl	O
its	PRP$	nmod:poss	O
usage	NN	dobj	O
in	IN	case	O
signal	NN	compound	O
transduction	NN	compound	O
studies	NNS	nmod	O
.	.	punct	O

In	IN	case	O
some	DT	det	O
donors	NNS	nmod	O
,	,	punct	O
increased	VBN	amod	O
IL-6	NN	compound	B-protein
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
activity	NN	nsubjpass	O
also	RB	advmod	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
after	IN	case	O
R24	NN	compound	B-protein
treatment	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
submitted	VBN	advcl	O
to	TO	case	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
CD4	NN	compound	B-protein
cross-linking	NN	nmod	O
by	IN	case	O
iHIV-1	NN	nmod	O
,	,	punct	O
PBMCs	NNS	nsubjpass	B-cell_type
from	IN	case	O
HIV-1-infected	JJ	amod	O
patients	NNS	nmod	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
produce	VB	xcomp	O
virus	NN	dobj	O
.	.	punct	O

The	DT	det	O
age-associated	JJ	amod	O
immune	JJ	amod	O
dysfunction	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
implicated	VBN	ROOT	O
to	IN	case	O
some	DT	det	O
degree	NN	nmod	O
in	IN	case	O
the	DT	det	O
extreme	JJ	amod	O
susceptibility	NN	nmod	O
of	IN	case	O
the	DT	det	O
elderly	JJ	nmod	O
to	TO	case	O
infection	NN	nmod	O
and	CC	cc	O
neoplasia	NN	conj	O
and	CC	cc	O
may	MD	aux	O
even	RB	advmod	O
participate	VB	conj	O
in	IN	case	O
various	JJ	amod	O
aspects	NNS	nmod	O
of	IN	case	O
senescence	NN	nmod	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
the	DT	det	O
protein	NN	compound	O
synthesis	NN	compound	O
inhibitor	NN	compound	O
cycloheximide	NN	dobj	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
G	NN	compound	O
(	-LRB-	punct	O
Anh	NN	compound	O
)	-RRB-	punct	O
MTetra-induced	JJ	amod	O
IL-6	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nsubj	O
depends	VBZ	ccomp	O
on	IN	case	O
the	DT	det	O
synthesis	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
protein	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
G	NN	compound	O
(	-LRB-	punct	O
Anh	NN	appos	O
)	-RRB-	punct	O
MTetra-induced	JJ	amod	O
IL-1	NN	compound	B-protein
beta	NN	compound	I-protein
mRNA	NN	compound	O
accumulation	NN	nsubj	O
does	VBZ	parataxis	O
not	RB	neg	O
.	.	punct	O

Compared	VBN	case	O
with	IN	case	O
monocytes	NNS	nmod	O
in	IN	case	O
suspension	NN	nmod	O
or	CC	cc	O
adherent	JJ	conj	O
on	IN	case	O
plastic	JJ	amod	O
surfaces	NNS	nmod	O
,	,	punct	O
monocytes	NNS	nsubj	O
adherent	JJ	amod	O
to	TO	case	O
fibronectin	NN	nmod	B-protein
or	CC	cc	O
RGD	NN	conj	O
exhibited	VBD	ROOT	O
a	DT	det	O
greater	JJR	amod	O
than	IN	dep	O
threefold	JJ	dep	O
increase	NN	dobj	O
in	IN	case	O
steady	JJ	amod	O
state	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
IFN-gamma-induced	JJ	amod	B-RNA
mRNA	NN	nmod	I-RNA
for	IN	case	O
the	DT	det	O
high	JJ	amod	B-protein
affinity	NN	compound	I-protein
Fc	NN	compound	I-protein
gammaRI	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
A	NN	compound	I-protein
signaling	NN	compound	O
pathway	NN	nmod	O
may	MD	aux	O
inhibit	VB	ccomp	O
NF-kappaB	NN	compound	B-protein
-mediated	JJ	amod	O
transcription	NN	dobj	O
by	IN	mark	O
phosphorylating	VBG	advcl	O
proteins	NNS	dobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
CREB	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
compete	VBP	acl:relcl	O
for	IN	case	O
limiting	VBG	amod	O
amounts	NNS	nmod	O
of	IN	case	O
the	DT	det	O
coactivator	NN	nmod	O
CBP	NN	dep	B-protein
.	.	punct	O

Pentoxifylline	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
trisubstituted	JJ	amod	O
xanthine	NN	compound	O
derivative	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
decrease	VB	xcomp	O
blood	NN	compound	O
viscosity	NN	dobj	O
and	CC	cc	O
is	VBZ	auxpass	O
reasonably	RB	advmod	O
well	RB	advmod	O
tolerated	VBN	conj	O
by	IN	case	O
most	JJS	amod	O
recipients	NNS	nmod	O
of	IN	case	O
the	DT	det	O
drug	NN	nmod	O
.	.	punct	O

CsA	NN	nsubj	O
and	CC	cc	O
FK506	NN	conj	O
are	VBP	cop	O
powerful	JJ	amod	O
suppressors	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
most	RBS	advmod	O
notably	RB	advmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
transfection	NN	nsubjpass	O
of	IN	case	O
CREB	NN	compound	B-protein
protein	NN	nmod	I-protein
and	CC	cc	O
protein	NN	compound	B-DNA
kinase	NN	compound	I-DNA
A	NN	compound	I-DNA
expression	NN	compound	I-DNA
vectors	NNS	conj	I-DNA
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
Zp	NN	dobj	B-DNA
in	IN	case	O
Jurkat	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
phosphorylated	JJ	amod	O
form	NN	nsubj	O
of	IN	case	O
CREB	NN	compound	B-protein
protein	NN	nmod	I-protein
can	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
determining	VBG	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
EBV	NN	compound	O
reactivation	NN	compound	O
process	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
potentiation	NN	nsubj	O
of	IN	case	O
nonphlogistic	JJ	amod	O
clearance	NN	nmod	O
of	IN	case	O
apoptotic	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
by	IN	case	O
phagocytes	NNS	nmod	B-cell_type
is	VBZ	cop	O
a	DT	det	O
hitherto	RB	advmod	O
unrecognized	JJ	amod	O
property	NN	ccomp	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
that	WDT	nsubj	O
has	VBZ	acl:relcl	O
potential	JJ	amod	O
implications	NNS	dobj	O
for	IN	case	O
therapies	NNS	nmod	O
aimed	VBN	acl	O
at	IN	mark	O
promoting	VBG	advcl	O
the	DT	det	O
resolution	NN	dobj	O
of	IN	case	O
inflammatory	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
culture	NN	nmod	O
of	IN	case	O
leukemia	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

5.	LS	dep	O
Neutrophil	NN	compound	O
apoptosis	NN	nsubjpass	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
neutrophil	NN	compound	O
function	NN	nmod	O
were	VBD	auxpass	O
induced	VBN	ROOT	O
at	IN	case	O
lower	JJR	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
SMX-NHOH	NN	nmod	O
and	CC	cc	O
SMX-NO	NN	conj	O
than	IN	case	O
those	DT	nmod	O
inducing	VBG	acl	O
loss	NN	dobj	O
of	IN	case	O
membrane	NN	compound	O
viability	NN	nmod	O
,	,	punct	O
with	IN	case	O
SMX	NN	nmod	O
having	VBG	acl	O
no	DT	neg	O
effect	NN	dobj	O
.	.	punct	O

A	DT	det	O
second	JJ	amod	O
complex	NN	nsubj	O
contains	VBZ	ROOT	O
hsp90	NN	dobj	B-protein
bound	VBN	acl	O
to	TO	case	O
p23	NN	nmod	B-protein
plus	CC	cc	O
the	DT	det	O
three	CD	nummod	O
immunophilins	NNS	conj	B-protein
and	CC	cc	O
some	DT	det	O
hsp70	NN	conj	B-protein
.	.	punct	O

Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	compound	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	I-protein
EBNA2	NN	compound	I-protein
)	-RRB-	punct	I-protein
-oestrogen	NN	compound	I-protein
receptor	NN	compound	I-protein
fusion	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
complement	VBP	ROOT	O
the	DT	det	O
EBNA2-deficient	JJ	amod	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
strain	NN	dobj	O
P3HR1	NN	dep	O
in	IN	case	O
transformation	NN	nmod	O
of	IN	case	O
primary	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
suppress	VBP	conj	O
growth	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

NFkappaB	NN	compound	B-protein
activity	NN	nsubj	O
is	VBZ	cop	O
independent	JJ	ROOT	O
from	IN	case	O
FADD	NN	nmod	B-protein
,	,	punct	O
caspases	NNS	conj	B-protein
,	,	punct	O
and	CC	cc	O
apoptosis	NN	compound	O
induction	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
direct	JJ	amod	O
contribution	NN	dobj	O
of	IN	case	O
EBV	NN	nmod	O
to	TO	case	O
chronic	JJ	amod	O
rheumatoid	JJ	amod	O
arthritis	NN	compound	O
pathogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
myeloid-cell-specific	JJ	amod	B-DNA
c-fes	NN	compound	I-DNA
promoter	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
Sp1	NN	nmod	B-protein
,	,	punct	O
PU.1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
novel	JJ	amod	O
transcription	NN	compound	B-protein
factor	NN	conj	I-protein
.	.	punct	O

A	DT	det	O
dimerization	NN	compound	B-protein
cofactor	NN	nsubjpass	I-protein
of	IN	case	O
HNF-1	NN	compound	B-protein
alpha	NN	nmod	I-protein
(	-LRB-	punct	O
DCoH	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
that	WDT	nsubj	O
displayed	VBD	ccomp	O
a	DT	det	O
restricted	JJ	amod	O
tissue	NN	compound	O
distribution	NN	dobj	O
and	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
bind	VB	conj	O
to	TO	case	O
DNA	NN	nmod	O
,	,	punct	O
but	CC	cc	O
,	,	punct	O
rather	RB	advmod	O
,	,	punct	O
selectively	RB	advmod	O
stabilized	VBD	amod	O
HNF-1	NN	compound	B-protein
alpha	NN	compound	I-protein
dimers	NNS	dobj	I-protein
.	.	punct	O

Half-maximal	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
GR	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
and	CC	cc	O
protein	NN	conj	O
in	IN	case	O
6TG1.1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
10-100	CD	compound	O
nM	NN	amod	O
dexamethasone	NN	nmod	O
,	,	punct	O
and	CC	cc	O
inclusion	NN	nsubj	O
of	IN	case	O
1	CD	nummod	O
microM	NN	compound	O
RU	NN	nmod	O
38486	CD	nummod	O
completely	RB	advmod	O
blocked	VBD	conj	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
100	CD	compound	O
nM	NN	amod	O
dexamethasone	NN	nmod	O
,	,	punct	O
demonstrating	VBG	advcl	O
that	IN	mark	O
positive	JJ	amod	O
autoregulation	NN	nsubj	O
of	IN	case	O
GR	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
6TG1.1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	cop	O
a	DT	det	O
receptor-mediated	JJ	amod	O
response	NN	ccomp	O
.	.	punct	O

The	DT	det	O
estrogen	NN	compound	B-protein
receptor	NN	nsubj	I-protein
(	-LRB-	punct	O
ER	NN	appos	B-protein
)	-RRB-	punct	O
repressed	VBD	ROOT	O
erythroid	JJ	amod	O
differentiation	NN	dobj	O
and	CC	cc	O
erythroid-specific	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	conj	O
.	.	punct	O

Moreover	RB	advmod	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	nsubj	O
was	VBD	aux	O
unaffected	JJ	ROOT	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	mark	O
blocking	VBG	acl	O
Abs	NNS	dobj	B-protein
to	TO	case	O
both	CC	cc:preconj	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
IL-2	NN	compound	B-protein
receptor	NN	conj	I-protein
,	,	punct	O
demonstrating	VBG	xcomp	O
that	IN	mark	O
this	DT	det	O
form	NN	nsubj	O
of	IN	case	O
costimulation	NN	nmod	O
by	IN	case	O
CD28	NN	nmod	B-protein
was	VBD	cop	O
independent	JJ	ccomp	O
of	IN	case	O
IL-2	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
monoclonal	JJ	amod	B-protein
antibodies	NNS	nsubj	I-protein
were	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
discriminate	VB	xcomp	O
between	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
of	IN	case	O
Categories	NNPS	compound	B-cell_line
Va	NNP	nmod	I-cell_line
,	,	punct	I-cell_line
VI	NN	conj	I-cell_line
and	CC	cc	I-cell_line
DFR	NN	conj	I-cell_line
but	CC	cc	I-cell_line
not	RB	cc	I-cell_line
Category	NN	compound	I-cell_line
III	CD	nummod	I-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

T.	FW	compound	B-cell_type
annulata-infected	JJ	amod	I-cell_type
leucocytes	NNS	nsubj	I-cell_type
produce	VBP	ROOT	O
a	DT	det	O
number	NN	dobj	O
of	IN	case	O
novel	JJ	amod	O
metalloproteinase	NN	compound	B-protein
activities	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
RAR	NN	compound	B-protein
)	-RRB-	punct	O
alpha	NN	nsubj	O
is	VBZ	cop	O
able	JJ	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
in	FW	compound	O
vitro	FW	advmod	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
the	DT	det	O
complex	NN	nmod	O
between	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
AP-1	NN	compound	B-protein
/OAP	NN	nmod	B-protein
and	CC	cc	O
its	PRP$	nmod:poss	O
specific	JJ	amod	O
binding	VBG	amod	O
site	NN	conj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
interference	NN	nmod	O
with	IN	case	O
Oct-2	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
cis-regulatory	JJ	amod	O
function	NN	nmod	O
of	IN	case	O
this	DT	det	O
AP-1	NN	compound	B-protein
element	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Regulation	NN	ROOT	O
of	IN	case	O
intracellular	JJ	amod	O
cholesterol	NN	compound	O
synthesis	NN	nmod	O
in	IN	case	O
hypercholesterolemia	NN	nmod	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
]	-RRB-	punct	O

Inhibitory	JJ	amod	O
action	NN	ROOT	O
of	IN	case	O
nm23	NN	compound	B-protein
proteins	NNS	nmod	I-protein
on	IN	case	O
induction	NN	nmod	O
of	IN	case	O
erythroid	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Low	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
c-jun	NN	compound	B-protein
transcripts	NNS	nmod	I-protein
were	VBD	cop	O
detectable	JJ	ROOT	O
in	IN	case	O
resting	VBG	amod	B-cell_type
human	JJ	amod	I-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
despite	IN	case	O
high	JJ	amod	O
ligand	NN	compound	O
binding	NN	compound	O
affinity	NN	nmod	O
,	,	punct	O
the	DT	det	O
prototypic	NN	amod	O
dissociated	VBD	amod	O
compound	NN	nsubj	O
,	,	punct	O
RU24858	NN	appos	O
,	,	punct	O
acted	VBD	acl	O
as	IN	case	O
a	DT	det	O
weak	JJ	amod	O
agonist	NN	nmod	O
and	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
efficiently	RB	advmod	O
antagonize	VB	ROOT	O
dexamethasone-induced	JJ	amod	O
transcription	NN	dobj	O
in	IN	case	O
transfected	VBN	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Although	IN	mark	O
phenotypically	RB	advmod	O
normal	JJ	advcl	O
,	,	punct	O
the	DT	det	O
proliferative	JJ	amod	O
response	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
childrens	NNS	nmod:poss	O
'	POS	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
strongly	RB	advmod	O
reduced	VBN	ROOT	O
but	CC	cc	O
could	MD	aux	O
be	VB	auxpass	O
improved	VBN	conj	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
interleukin-2	NN	nmod	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
hypothesize	VBP	ROOT	O
that	IN	mark	O
interference	NN	nsubj	O
in	IN	case	O
DNA-binding	JJ	amod	O
activities	NNS	nmod	O
of	IN	case	O
GATA-1	NN	nmod	B-protein
and	CC	cc	O
CACCC-binding	JJ	amod	B-protein
proteins	NNS	conj	I-protein
is	VBZ	cop	O
the	DT	det	O
mechanism	NN	ccomp	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
ER	NN	nsubj	B-protein
inhibits	VBZ	acl:relcl	O
regulation	NN	dobj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
.	.	punct	O

This	DT	det	O
difference	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
seen	VBN	ROOT	O
at	IN	case	O
the	DT	det	O
mRNA	NN	compound	O
level	NN	nmod	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
B	NN	nmod:npmod	O
cell-restricted	JJ	amod	O
activity	NN	nsubjpass	O
,	,	punct	O
required	VBN	acl	O
for	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
octamer	NN	nmod:npmod	B-DNA
/	:	punct	O
Oct	NN	nmod:npmod	B-DNA
-dependent	JJ	amod	O
transcription	NN	nmod	O
from	IN	case	O
an	DT	det	O
immunoglobulin	NN	compound	B-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IgH	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
system	NN	nmod	O
consisting	VBG	acl	O
of	IN	case	O
HeLa	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
-derived	JJ	amod	O
extracts	NNS	nmod	O
complemented	VBN	acl	O
with	IN	case	O
fractionated	VBN	amod	B-protein
B	NN	compound	I-protein
cell	NN	compound	I-protein
nuclear	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
loss	NN	nsubj	O
of	IN	case	O
GATA-3	NN	compound	B-protein
expression	NN	nmod	O
by	IN	mark	O
developing	VBG	acl	O
Th1	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
requires	VBZ	ccomp	O
IL-12	NN	compound	B-protein
signaling	NN	dobj	O
through	IN	case	O
Stat4	NN	nmod	B-protein
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
simply	RB	advmod	O
result	VB	conj	O
from	IN	case	O
an	DT	det	O
absence	NN	nmod	O
of	IN	case	O
IL-4	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
prostaglandin	NN	compound	B-protein
E2	NN	nmod	I-protein
(	-LRB-	punct	O
PGE2	NN	appos	B-protein
)	-RRB-	punct	O
on	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
the	DT	det	O
CD4+	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
helper	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
clone	NN	compound	I-cell_line
SP-B21	NN	nmod	I-cell_line
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

Wp	NN	nsubjpass	O
is	VBZ	auxpass	O
exclusively	RB	advmod	O
utilized	VBN	ROOT	O
during	IN	case	O
the	DT	det	O
initial	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
infection	NN	nmod	O
of	IN	case	O
primary	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
followed	VBN	advcl	O
by	IN	case	O
a	DT	det	O
switch	NN	nmod	O
to	TO	case	O
Cp	NN	compound	B-DNA
usage	NN	nmod	O
.	.	punct	O

NGAL	NN	compound	B-protein
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
stratified	VBN	ROOT	O
as	IN	case	O
high	JJ	nmod	O
or	CC	cc	O
low	JJ	conj	O
in	IN	case	O
breast	NN	compound	O
cancers	NNS	nmod	O
from	IN	case	O
a	DT	det	O
cohort	NN	nmod	O
of	IN	case	O
node-positive	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
known	JJ	amod	O
outcome	NN	nmod	O
.	.	punct	O

HIV	NN	compound	B-protein
glycoprotein	NN	nsubj	I-protein
120	CD	nummod	I-protein
enhances	VBZ	ROOT	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	compound	I-protein
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
glial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Plasma	NN	compound	O
aldosterone	NN	nsubj	O
and	CC	cc	O
cortisol	NN	conj	O
and	CC	cc	O
lymphocyte	NN	compound	B-cell_type
subsets	NNS	conj	I-cell_type
were	VBD	cop	O
not	RB	neg	O
different	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
BAT	NN	compound	B-protein
box	NN	compound	I-protein
binding	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
are	VBP	cop	O
important	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
B	NN	compound	O
cell	NN	compound	O
specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
CD20	NN	nmod	B-protein
and	CC	cc	O
perhaps	RB	advmod	O
CD21	NN	conj	B-protein
.	.	punct	O

After	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
progesterone	NN	nmod	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
receptors	NNS	nmod	O
was	VBD	auxpass	O
augmented	JJ	ROOT	O
2-3	CD	nummod	O
times	NNS	npadvmod	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
these	DT	det	O
studies	NNS	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
modulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
proliferation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
obtained	VBN	acl	O
from	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
by	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
DEX	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
isoproterenol	NN	conj	O
(	-LRB-	punct	O
ISO	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
prostaglandin	NN	compound	O
E2	NN	conj	O
(	-LRB-	punct	O
PGE2	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
unlike	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
,	,	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
beta	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
constitutively	RB	advmod	O
phosphorylated	VBN	ccomp	O
and	CC	cc	O
resynthesized	VBD	conj	O
as	IN	case	O
a	DT	det	O
hypophosphorylated	JJ	amod	B-protein
form	NN	nmod	I-protein
.	.	punct	O

CONCLUSION	NN	dep	O
:	:	punct	O
IL-5	NN	compound	B-protein
synthesis	NN	nsubjpass	O
by	IN	case	O
human	JJ	amod	B-cell_type
helper	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
at	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

T-cell	NN	compound	B-DNA
functional	JJ	amod	I-DNA
regions	NNS	ROOT	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-3	NN	compound	I-DNA
proximal	JJ	amod	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
PRE-I	NN	nsubj	B-DNA
interacts	VBZ	ccomp	O
with	IN	case	O
PMA	NN	compound	O
-and	NN	nmod	O
PMA/ionomycin-inducible	NN	dep	O
,	,	punct	O
cyclosporin	NN	nmod:npmod	O
A-sensitive	JJ	amod	O
nuclear	JJ	amod	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

The	DT	det	O
oligo	JJ	amod	O
sequence	NN	nsubj	O
I	NN	nsubj	O
stimulated	VBD	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
T	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
,	,	punct	I-cell_type
to	TO	case	I-cell_type
a	DT	det	I-cell_type
lesser	JJR	amod	I-cell_type
extent	NN	nmod	I-cell_type
,	,	punct	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

IFN-gamma-primed	JJ	amod	B-cell_line
lung	NN	compound	I-cell_line
fibroblasts	NNS	nsubj	I-cell_line
costimulate	VBP	ROOT	O
T	NN	compound	O
lymphocyte	NN	compound	O
proliferation	NN	dobj	O
utilizing	VBG	acl	O
CD40	NN	dobj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
well-studied	JJ	amod	O
costimulatory	JJ	amod	B-protein
molecules	NNS	conj	I-protein
B7-1	NN	dep	B-protein
and	CC	cc	O
B7-2	NN	conj	B-protein
.	.	punct	O

Fusion	NN	nsubj	O
of	IN	case	O
anergic	JJ	amod	B-cell_type
murine	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
human	JJ	amod	B-cell_type
Jurkat	NN	compound	I-cell_type
T	NN	compound	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
formation	NN	conj	O
of	IN	case	O
heterokaryons	NNS	nmod	B-cell_line
failed	VBD	ROOT	O
to	TO	mark	O
result	VB	xcomp	O
in	IN	case	O
a	DT	det	O
complementation	NN	nmod	O
of	IN	case	O
this	DT	det	O
signaling	NN	compound	O
defect	NN	nmod	O
and	CC	cc	O
restoration	NN	conj	O
of	IN	case	O
murine	JJ	amod	B-RNA
IL-2	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
inducibility	NN	nmod	O
.	.	punct	O

The	DT	det	O
development	NN	nsubj	O
of	IN	case	O
chronic	JJ	amod	O
eosinophilic	JJ	amod	O
inflammation	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
interleukin-5	NN	nmod	B-protein
(	-LRB-	punct	O
IL-5	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
selective	JJ	amod	B-protein
eosinophil-activating	JJ	amod	I-protein
factor	NN	appos	I-protein
,	,	punct	O
produced	VBN	acl	O
by	IN	case	O
helper	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
two	CD	nummod	O
VDR	NN	compound	B-DNA
3'-UTR	NN	compound	I-DNA
haplotypes	NNS	nsubj	O
conferred	VBD	ROOT	O
an	DT	det	O
identical	JJ	amod	O
half-life	NN	dobj	O
on	IN	case	O
a	DT	det	O
heterologous	JJ	amod	B-DNA
beta-globin	NN	compound	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
in	IN	case	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
assay	NN	nmod	O
.	.	punct	O

CD23	NN	compound	B-protein
expression	NN	nsubjpass	O
and	CC	cc	O
IgE	NN	compound	B-protein
synthesis	NN	conj	O
by	IN	case	O
IL-4	NN	nmod	B-protein
were	VBD	auxpass	O
augmented	JJ	ROOT	O
in	IN	case	O
Ile50-bearing	JJ	amod	B-cell_line
PBMC	NN	nmod	I-cell_line
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
those	DT	advcl	O
bearing	VBG	acl	O
Val50	NN	dobj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
RB	NN	compound	B-protein
status	NN	dobj	O
of	IN	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
B-cell	NN	compound	O
mutants	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
defective	JJ	acl:relcl	O
in	IN	case	O
class	NN	compound	O
II	CD	nummod	O
expression	NN	nmod	O
,	,	punct	O
generated	VBN	advcl	O
either	CC	advmod	O
in	FW	compound	O
vitro	FW	dep	O
or	CC	cc	O
derived	VBN	conj	O
from	IN	case	O
Bare	NNP	compound	O
Lymphocyte	NN	compound	O
Syndrome	NN	compound	O
(	-LRB-	punct	O
BLS	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
alpha-tocopherol	NN	nmod	O
(	-LRB-	punct	O
alpha-tcp	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
one	CD	nummod	O
cellular	JJ	amod	O
event	NN	nmod	O
in	IN	case	O
atherosclerotic	JJ	amod	O
plaque	NN	compound	O
development	NN	nmod	O
,	,	punct	O
monocyte	NN	compound	O
adhesion	NN	conj	O
to	TO	case	O
stimulated	VBN	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
ECs	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
ras	NN	compound	O
mutation	NN	compound	O
frequency	NN	nsubj	O
varies	VBZ	ROOT	O
between	IN	case	O
95	CD	nummod	O
%	NN	nmod	O
in	IN	case	O
pancreatic	JJ	amod	O
cancer	NN	nmod	O
and	CC	cc	O
5	CD	nummod	O
%	NN	conj	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
PBMCs	NNS	nsubjpass	B-cell_type
and	CC	cc	O
sera	NNS	conj	O
from	IN	case	O
8	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
extrinsic	JJ	amod	O
asthma	NN	nmod	O
(	-LRB-	punct	O
mean	JJ	amod	O
IgE	NN	compound	B-protein
,	,	punct	O
285+/-100	CD	nummod	O
IU/mL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
3	CD	nummod	O
patients	NNS	conj	O
with	IN	case	O
HIE	NN	nmod	O
(	-LRB-	punct	O
mean	JJ	amod	O
IgE	NN	dep	B-protein
,	,	punct	O
7050+/-1122	CD	nummod	O
IU/mL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
14	CD	nummod	O
nonatopic	JJ	amod	O
control	JJ	amod	O
subjects	NNS	conj	O
(	-LRB-	punct	O
mean	JJ	amod	O
IgE	NN	nsubjpass	B-protein
,	,	punct	O
112+/-28	CD	nummod	O
IU/mL	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
analyzed	VBN	dep	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
NF-ATp	NN	nmod	B-protein
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
prominent	JJ	amod	O
members	NNS	nmod	O
of	IN	case	O
family	NN	nmod	O
of	IN	case	O
NF-AT	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
in	IN	case	O
T	NN	compound	O
cell	NN	nmod	O
activation	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
we	PRP	nsubj	O
created	VBD	ROOT	O
NF-ATp	NN	compound	B-protein
-deficient	JJ	amod	O
mice	NNS	dobj	O
by	IN	case	O
gene	NN	compound	O
targeting	NN	nmod	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
composition	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-1	NN	nmod	B-protein
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	O
molecular	JJ	amod	O
mechanism	NN	ccomp	O
for	IN	mark	O
increasing	VBG	acl	O
IL-2	NN	compound	B-protein
transcription	NN	dobj	O
and	CC	cc	O
may	MD	aux	O
underlie	VB	conj	O
the	DT	det	O
phenomenon	NN	dobj	O
of	IN	case	O
costimulation	NN	nmod	O
by	IN	case	O
EC	NN	nmod	B-cell_type
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
2-4	CD	compound	O
fold	JJ	dep	O
increase	NN	nsubjpass	O
of	IN	case	O
c-fos	NN	compound	B-DNA
expression	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
within	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
of	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
IL-10	NN	nmod	B-protein
(	-LRB-	punct	O
p	NN	dep	O
<	JJR	dep	O
0.01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
regulation	NN	nsubjpass	O
of	IN	case	O
apoptosis	NN	nmod	O
is	VBZ	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
Vpr	NN	compound	B-protein
suppression	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
via	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
,	,	punct	O
an	DT	det	O
inhibitor	NN	appos	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
mutations	NNS	nsubj	O
R217A	NN	dep	O
and	CC	cc	O
R294A	NN	conj	O
caused	VBD	ROOT	O
an	DT	det	O
increased	VBN	amod	O
binding	NN	compound	O
efficiency	NN	dobj	O
for	IN	case	O
antagonists	NNS	nmod	O
but	CC	cc	O
no	DT	neg	O
change	NN	conj	O
in	IN	case	O
agonist	NN	compound	O
binding	NN	nmod	O
.	.	punct	O

The	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	nsubj	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
EBNA2	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
protein	NN	appos	O
required	VBN	acl	O
for	IN	case	O
B	NN	compound	B-cell_type
lymphocyte	NN	compound	I-cell_type
immortalization	NN	nmod	O
,	,	punct	O
induces	VBZ	ROOT	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
type	NN	compound	B-protein
I	CD	nummod	I-protein
interferon	NN	nmod	I-protein
in	IN	case	O
Burkitt	NN	nmod:poss	B-cell_line
's	POS	case	I-cell_line
lymphoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Immunohistochemical	JJ	amod	O
staining	NN	nsubj	O
demonstrated	VBD	ROOT	O
RelB	NN	dobj	B-protein
within	IN	case	O
the	DT	det	O
differentiated	VBN	amod	B-cell_type
lymph	NN	compound	I-cell_type
node	NN	nmod	I-cell_type
interdigitating	VBG	acl	I-cell_type
DC	NN	dobj	I-cell_type
and	CC	cc	O
follicular	JJ	amod	B-cell_type
DC	NN	conj	I-cell_type
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
undifferentiated	JJ	amod	B-cell_type
DC	NN	conj	I-cell_type
in	IN	case	O
normal	JJ	amod	O
skin	NN	nmod	O
.	.	punct	O

In	IN	case	O
granulocyte	NN	compound	B-cell_line
colonies	NNS	nmod	I-cell_line
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
two	CD	nummod	O
different	JJ	amod	O
X-inactivation	NN	compound	O
patterns	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
patients	NNS	nmod	O
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
non-clonal	JJ	amod	B-cell_type
progenitor	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
remained	VBD	ccomp	O
in	IN	case	O
the	DT	det	O
bone	NN	compound	O
marrow	NN	nmod	O
.	.	punct	O

Synergism	NN	ROOT	O
between	IN	case	O
the	DT	det	O
CD3	NN	compound	O
antigen-	NN	amod	O
and	CC	cc	O
CD2	NN	nmod:npmod	O
antigen-derived	JJ	conj	O
signals	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
detected	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	dobj	O
of	IN	case	O
the	DT	det	O
GR	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
in	IN	case	O
the	DT	det	O
endobronchial	JJ	amod	O
biopsy	NN	compound	O
specimens	NNS	nmod	O
after	IN	case	O
FP	NN	compound	O
treatment	NN	nmod	O
(	-LRB-	punct	O
36.6	CD	nummod	O
+/-	CC	cc	O
23.1	CD	conj	O
and	CC	cc	O
25.0	CD	conj	O
+/-	CC	cc	O
10.9	CD	conj	O
amol	NN	compound	O
GR	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
/microg	NN	compound	O
RNA	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
;	:	punct	O
P	NN	compound	O
<	ADD	parataxis	O
.01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
X	NN	compound	B-DNA
box	NN	compound	I-DNA
region	NN	nsubj	I-DNA
is	VBZ	cop	O
critical	JJ	ROOT	O
for	IN	mark	O
directing	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
major	JJ	amod	I-DNA
histocompatibility	NN	compound	I-DNA
complex	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
GCRbeta	NN	compound	B-protein
expression	NN	nsubj	O
in	IN	case	O
GC-insensitive	JJ	amod	O
asthma	NN	nmod	O
was	VBD	cop	O
particularly	RB	advmod	O
high	JJ	ROOT	O
in	IN	case	O
airway	NN	compound	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
thought	VBN	acl:relcl	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
asthma	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
IL-4	NN	nsubj	B-protein
and	CC	cc	O
anti-	NN	amod	O
CD40	NN	compound	B-protein
mAb	NN	conj	I-protein
induced	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
phosphatidylinositol	NN	compound	B-protein
3-kinase	NN	nmod	I-protein
(	-LRB-	punct	O
PI3-kinase	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
translocation	NN	dobj	O
of	IN	case	O
a	DT	det	O
zeta	NN	compound	O
isoform	NN	nmod	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
nuclear	JJ	amod	O
expression	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
this	DT	det	O
genetic	JJ	amod	O
variant	NN	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
predisposes	VBZ	acl:relcl	O
to	TO	case	O
low	JJ	amod	O
bone	NN	compound	O
mineral	JJ	amod	O
density	NN	nmod	O
in	IN	case	O
many	JJ	amod	O
populations	NNS	nmod	O
,	,	punct	O
may	MD	aux	O
confer	VB	ROOT	O
resistance	NN	dobj	O
to	TO	case	O
certain	JJ	amod	O
infectious	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

RU-486	NN	nsubj	O
(	-LRB-	punct	O
10	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
prevents	VBZ	acl:relcl	O
translocation	NN	dobj	O
of	IN	case	O
ligated	VBN	amod	O
hGR	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
dissociation	NN	dobj	O
of	IN	case	O
hGR	NN	nmod	B-protein
from	IN	case	O
heat	NN	compound	O
shock	NN	compound	O
protein	NN	nmod	O
90	CD	nummod	O
,	,	punct	O
completely	RB	advmod	O
aborted	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
dexamethasone	NN	nmod	O
on	IN	case	O
adhesiveness	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	dep	O
0.0005	CD	dep	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	dep	O
3	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
first	JJ	nsubj	O
(	-LRB-	punct	O
-445/-366	CD	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
positive	JJ	amod	O
element	NN	ROOT	O
active	JJ	amod	O
in	IN	case	O
both	CC	cc:preconj	O
basophils	NNS	nmod	B-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

After	IN	case	O
weight	NN	compound	O
gain	NN	nmod	O
(	-LRB-	punct	O
14	CD	compound	O
+/-	CC	cc	O
2	CD	conj	O
to	TO	dep	O
16	CD	nummod	O
+/-	CC	cc	O
2	CD	conj	O
kg/m2	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
receptor	NN	compound	O
numbers	NNS	nsubj	O
were	VBD	cop	O
8421	CD	ROOT	O
+/-	CC	cc	O
2126	CD	conj	O
(	-LRB-	punct	O
pre	JJ	dep	O
)	-RRB-	punct	O
and	CC	cc	O
9011	CD	conj	O
+/-	CC	cc	O
500	CD	conj	O
(	-LRB-	punct	O
post	JJ	dep	O
)	-RRB-	punct	O
sites/cell	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
not	RB	neg	O
significantly	RB	advmod	O
different	JJ	acl:relcl	O
(	-LRB-	punct	O
P	NN	dep	O
greater	JJR	amod	O
than	IN	case	O
0.2	CD	nmod	O
)	-RRB-	punct	O
;	:	punct	O
the	DT	det	O
Kd	NN	nsubj	O
was	VBD	cop	O
unchanged	JJ	parataxis	O
(	-LRB-	punct	O
9.3	CD	nummod	O
+/-	CC	cc	O
2.6	CD	conj	O
vs	CC	cc	O
9.2	CD	conj	O
+/-	CC	cc	O
2.4	CD	conj	O
nM	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

Okadaic	JJ	amod	O
acid	NN	nsubj	O
,	,	punct	O
an	DT	det	O
inhibitor	NN	appos	O
of	IN	case	O
phosphatases	NNS	nmod	B-protein
1	CD	dep	I-protein
and	CC	cc	I-protein
2A	NN	conj	I-protein
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
overcome	VB	ROOT	O
the	DT	det	O
defect	NN	dobj	O
in	IN	case	O
these	DT	det	O
subclones	NNS	nmod	O
.	.	punct	O

A	DT	det	O
kappa	NN	compound	B-DNA
B-site	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
promoter	NN	nmod	O
of	IN	case	O
the	DT	det	O
intercellular	JJ	amod	B-DNA
adhesion	NN	compound	I-DNA
molecule-1	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
ICAM-1	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
ICAM-1	NN	compound	B-protein
expression	NN	nmod	O
by	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
glucocorticoids	NNS	conj	O
.	.	punct	O

TCP	NN	compound	O
succinate	JJ	nsubj	O
(	-LRB-	punct	O
20	CD	nummod	O
microM	NN	dep	O
,	,	punct	O
72	CD	nummod	O
h	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
TCP	NN	conj	O
(	-LRB-	punct	O
200	CD	nummod	O
microM	NN	dep	O
,	,	punct	O
72	CD	nummod	O
h	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
reduced	VBD	ROOT	O
U-937	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
adhesion	NN	dobj	O
to	TO	case	O
TNF-alpha-stimulated	JJ	amod	B-cell_line
(	-LRB-	punct	I-cell_line
10	CD	nummod	I-cell_line
U/ml	NN	nmod	I-cell_line
,	,	punct	I-cell_line
6	CD	nummod	I-cell_line
h	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
HUVEC	NN	dobj	I-cell_line
by	IN	case	O
30	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	amod	O
0.025	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
to	TO	case	O
IL-1	NN	nmod:npmod	B-cell_line
beta-stimulated	JJ	amod	I-cell_line
HUVEC	NN	conj	I-cell_line
by	IN	case	O
56	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	-LRB-	compound	O
0.010	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
oxidative	JJ	amod	O
signals	NNS	nsubj	O
can	MD	aux	O
positively	RB	advmod	O
and	CC	advmod	O
negatively	RB	advmod	O
regulate	VB	ccomp	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
transcriptional	JJ	amod	O
events	NNS	dobj	O
and	CC	cc	O
that	IN	mark	O
changes	NNS	nsubj	O
in	IN	case	O
cellular	JJ	amod	O
redox	NN	nmod	O
can	MD	aux	O
uncouple	VB	conj	O
AP-1	NN	compound	B-protein
regulation	NN	dobj	O
of	IN	case	O
c-jun	NN	nmod	B-DNA
from	IN	case	O
transcriptional	JJ	amod	O
up-regulation	NN	nmod	O
of	IN	case	O
IL-2	NN	nmod	B-protein
via	IN	case	O
NF-AT	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
overexpressed	VBD	ROOT	O
AML1a	NNS	dobj	B-protein
(	-LRB-	punct	O
without	IN	case	O
the	DT	det	O
transcription-activating	JJ	amod	B-protein
domain	NN	dep	I-protein
)	-RRB-	punct	O
and	CC	cc	O
AML1b	NNS	conj	B-protein
(	-LRB-	punct	O
with	IN	case	O
the	DT	det	O
domain	NN	compound	O
)	-RRB-	punct	O
proteins	NNS	dobj	O
in	IN	case	O
K562	NN	compound	B-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
induced	VBN	acl:relcl	O
to	TO	mark	O
differentiate	VB	xcomp	O
into	IN	case	O
hemoglobin-producing	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
megakaryocytes	NNS	conj	B-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
AP1	NN	nmod	B-protein
by	IN	case	O
okadaic	JJ	amod	O
acid	NN	nmod	O
occurs	VBZ	ROOT	O
predominantly	RB	advmod	O
by	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
jun	NN	compound	B-DNA
and	CC	cc	I-DNA
fos	NN	conj	I-DNA
family	NN	nmod	I-DNA
of	IN	case	O
proto-oncogenes	NNS	nmod	B-DNA
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
hypoxia	NN	nsubj	O
constitutes	VBZ	ccomp	O
a	DT	det	O
stimulus	NN	dobj	O
for	IN	case	O
leukocyte	NN	compound	O
chemotaxis	NN	nmod	O
and	CC	cc	O
tissue	NN	compound	O
leukostasis	NN	conj	O
.	.	punct	O

PCR	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
spontaneous	JJ	amod	B-cell_line
EBV-transformed	JJ	amod	I-cell_line
lymphoblastoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
(	-LRB-	punct	O
LCL	NNS	appos	B-cell_line
)	-RRB-	punct	O
from	IN	case	O
three	CD	nummod	O
individuals	NNS	nmod	O
with	IN	case	O
primary	JJ	amod	O
infection	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
two	CD	nsubjpass	O
were	VBD	auxpass	O
infected	VBN	ccomp	O
with	IN	case	O
type	NN	compound	O
A	NN	nmod	O
and	CC	cc	O
one	CD	conj	O
with	IN	case	O
type	NN	compound	O
B	NN	compound	O
EBV	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
binding	NN	ROOT	O
in	IN	case	O
three	CD	nummod	O
different	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
in	IN	case	O
major	JJ	amod	O
depressive	JJ	amod	O
disorder	NN	nmod	O
:	:	punct	O
lack	NN	dep	O
of	IN	case	O
evidence	NN	nmod	O
of	IN	case	O
receptor	NN	compound	O
binding	NN	compound	O
defect	NN	nmod	O
.	.	punct	O

Upon	IN	case	O
mitogenic	JJ	amod	O
stimulation	NN	nmod	O
,	,	punct	O
the	DT	det	O
binding	NN	compound	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
novel	JJ	amod	O
NF-AT-binding	JJ	amod	B-protein
factor	NN	nmod	I-protein
is	VBZ	auxpass	O
rapidly	RB	advmod	O
down-regulated	VBN	ROOT	O
in	IN	case	O
normal	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
persists	VBZ	conj	O
at	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
Ipr	JJ	compound	B-cell_line
CD4-8-	JJ	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Between	IN	prep	O
12	CD	nummod	O
and	CC	cc	O
14	CD	conj	O
months	NNS	pobj	O
of	IN	prep	O
age	NN	pobj	O
,	,	punct	O
10	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
them	PRP	nmod	O
develop	VBP	ROOT	O
a	DT	det	O
form	NN	dobj	O
of	IN	case	O
acute	JJ	amod	O
leukemia	NN	nmod	O
with	IN	case	O
a	DT	det	O
differentiation	NN	compound	O
block	NN	nmod	O
at	IN	case	O
the	DT	det	O
promyelocytic	JJ	amod	O
stage	NN	nmod	O
that	WDT	nsubj	O
closely	RB	advmod	O
mimics	VBZ	acl:relcl	O
human	JJ	amod	O
APL	NN	dobj	O
even	RB	advmod	O
in	IN	case	O
its	PRP$	nmod:poss	O
response	NN	nmod	O
to	TO	case	O
retinoic	JJ	amod	O
acid	NN	nmod	O
.	.	punct	O

Transient-transfection	JJ	compound	O
assays	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
bcl-x	NN	compound	B-DNA
promoter	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
transactivated	VBN	ccomp	O
by	IN	case	O
wild-type	JJ	amod	B-protein
Tax	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
PAX-5	NN	compound	I-DNA
gene	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
recently	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
participate	VB	xcomp	O
together	RB	advmod	O
with	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
locus	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
chromosomal	JJ	amod	O
translocation	NN	compound	O
t	NN	nmod	B-DNA
(	-LRB-	punct	I-DNA
9	CD	dep	I-DNA
;	:	punct	I-DNA
14	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
(	-LRB-	punct	I-DNA
p13	NN	dep	I-DNA
;	:	punct	I-DNA
q32	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
cytotoxic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocyte	NN	compound	I-cell_type
(	-LRB-	punct	O
CTL	NN	appos	B-cell_type
)	-RRB-	punct	O
response	NN	nsubj	O
to	TO	case	O
Ad	NN	nmod	O
could	MD	aux	O
limit	VB	ROOT	O
the	DT	det	O
effectiveness	NN	dobj	O
of	IN	case	O
such	JJ	amod	O
approaches	NNS	nmod	O
.	.	punct	O

No	DT	neg	O
group	NN	compound	O
differences	NNS	nsubjpass	O
in	IN	case	O
cortisol	NN	compound	O
levels	NNS	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
,	,	punct	O
nor	CC	cc	O
were	VBD	cop	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
number	NN	nsubj	O
and	CC	cc	O
cortisol	NN	compound	O
levels	NNS	conj	O
correlated	VBD	conj	O
.	.	punct	O

Cross-linking	NN	nsubj	O
of	IN	case	O
this	DT	det	O
lymphocyte-specific	JJ	amod	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
designated	VBN	acl	O
TACI	NN	xcomp	B-protein
(	-LRB-	punct	O
transmembrane	JJ	amod	B-protein
activator	NN	dep	I-protein
and	CC	cc	I-protein
CAML-interactor	NN	conj	I-protein
)	-RRB-	punct	O
,	,	punct	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
transfected	VBN	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
TACI-specific	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
led	VBD	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
NF-AT	NN	dep	B-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
NFkappaB	NN	conj	B-protein
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
contains	VBZ	ROOT	O
Fos	NN	dobj	B-protein
and	CC	cc	O
Jun	NN	conj	B-protein
.	.	punct	O

Gel	NN	compound	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nsubj	O
detected	VBD	ROOT	O
an	DT	det	O
induced	VBN	amod	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
LPS	NN	nmod	O
.	.	punct	O

Tax	NN	nsubj	O
activates	VBZ	ROOT	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
through	IN	case	O
the	DT	det	O
CK-1	NN	compound	B-DNA
/CD28RE	NN	compound	B-DNA
region	NN	nmod	O
and	CC	cc	O
also	RB	advmod	O
activates	VBZ	conj	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	compound	I-protein
binding	NN	dobj	O
to	TO	case	O
this	DT	det	O
region	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
may	MD	aux	O
also	RB	advmod	O
provide	VB	ROOT	O
a	DT	det	O
clue	NN	dobj	O
to	TO	case	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
process	NN	nmod	O
of	IN	case	O
AIDS	NN	compound	O
pathogenesis	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
possible	JJ	amod	O
biochemical	JJ	amod	O
intervention	NN	conj	O
.	.	punct	O

The	DT	det	O
cytoplasmic	JJ	amod	B-protein
domain	NN	nsubj	I-protein
of	IN	case	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
GM-CSF	NN	compound	I-protein
)	-RRB-	punct	I-protein
receptor	NN	compound	I-protein
alpha	NN	compound	I-protein
subunit	NN	nmod	I-protein
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
both	CC	cc:preconj	O
GM-CSF	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
growth	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Classification	NN	ROOT	O
of	IN	case	O
IVS1-10T	NN	nmod	O
--	:	punct	O
>	NN	amod	O
C	NN	appos	O
as	IN	case	O
a	DT	det	O
polymorphism	NN	nmod	O
of	IN	case	O
BRCA1	NN	nmod	B-DNA
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
number	NN	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
from	IN	case	O
the	DT	det	O
six	CD	nummod	O
nonresponders	NNS	nmod	O
,	,	punct	O
five	CD	nummod	O
responders	NNS	conj	O
,	,	punct	O
and	CC	cc	O
ten	CD	nummod	O
healthy	JJ	amod	O
controls	NNS	conj	O
were	VBD	cop	O
4922	CD	appos	O
(	-LRB-	punct	O
range	NN	dep	O
,	,	punct	O
4484-5643	CD	amod	O
)	-RRB-	punct	O
,	,	punct	O
3413	CD	conj	O
(	-LRB-	punct	O
range	NN	dep	O
,	,	punct	O
3183-4450	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
3610	CD	conj	O
(	-LRB-	punct	O
range	NN	dep	O
,	,	punct	O
2594-3979	CD	appos	O
)	-RRB-	punct	O
binding	NN	compound	O
sites/cell	NNS	dep	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Thus	RB	advmod	O
CTL	NN	compound	B-cell_line
clones	NNS	nsubj	I-cell_line
that	WDT	nsubj	O
recognized	VBD	acl:relcl	O
the	DT	det	O
viral	JJ	amod	O
,	,	punct	O
self	NN	conj	O
,	,	punct	O
and	CC	cc	O
bacterial	JJ	conj	O
peptides	NNS	dobj	O
expressed	VBD	ROOT	O
a	DT	det	O
highly	RB	advmod	O
restricted	JJ	amod	O
alphabeta	NN	compound	O
TCR	NN	compound	B-protein
phenotype	NN	dobj	O
.	.	punct	O

This	DT	det	O
proteolytic	JJ	amod	O
event	NN	nsubj	O
liberates	VBZ	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
,	,	punct	O
permitting	VBG	advcl	O
its	PRP$	nmod:poss	O
rapid	JJ	amod	O
translocation	NN	dobj	O
into	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
where	WRB	advmod	O
it	PRP	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
its	PRP$	nmod:poss	O
cognate	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
CD4	NN	compound	B-protein
signaling	NN	nsubj	O
mediates	VBZ	ccomp	O
HIV-induced	JJ	amod	O
apoptosis	NN	dobj	O
by	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
independent	JJ	amod	O
of	IN	case	O
Fas	NN	compound	B-protein
-Fas	JJ	compound	B-protein
ligand	NN	compound	I-protein
interaction	NN	nmod	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
require	VB	conj	O
p56	NN	compound	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
signaling	NN	dobj	O
,	,	punct	O
and	CC	cc	O
may	MD	aux	O
involve	VB	conj	O
a	DT	det	O
critical	JJ	amod	O
region	NN	dobj	O
for	IN	case	O
CD4	NN	compound	B-protein
dimerization	NN	nmod	O
.	.	punct	O

Chromosome	NN	compound	B-DNA
1	CD	nummod	I-DNA
abnormalities	NNS	nsubjpass	O
with	IN	case	O
loss	NN	nmod	O
of	IN	case	O
1p36	NN	nmod	B-DNA
have	VBP	aux	O
been	VBN	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
95	CD	nummod	O
breast-cancer	NN	amod	O
samples	NNS	nmod	O
by	IN	case	O
means	NNS	dep	O
of	IN	case	O
a	DT	det	O
dual-target	JJ	amod	O
fluorescence	NN	compound	O
in-situ	FW	compound	O
hybridization	NN	compound	O
(	-LRB-	punct	O
FISH	NN	appos	O
)	-RRB-	punct	O
technique	NN	nmod	O
using	VBG	acl	O
the	DT	det	O
pUC	NN	compound	B-DNA
1.77	CD	nummod	I-DNA
and	CC	cc	O
p1-79	NN	conj	B-DNA
probes	NNS	dobj	I-DNA
,	,	punct	O
specific	JJ	amod	O
for	IN	case	O
the	DT	det	O
1q12	NN	compound	B-DNA
and	CC	cc	I-DNA
1p36	NN	conj	I-DNA
regions	NNS	nmod	I-DNA
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Cell	NN	compound	O
activation	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
delayed	VBN	amod	O
induction	NN	nmod	O
of	IN	case	O
STAT	NN	compound	B-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
sustained	JJ	acl:relcl	O
for	IN	case	O
several	JJ	amod	O
days	NNS	nmod	O
,	,	punct	O
was	VBD	auxpass	O
composed	VBN	conj	O
predominantly	RB	advmod	O
of	IN	case	O
Stat1	NN	nmod	B-protein
and	CC	cc	O
Stat3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
was	VBD	auxpass	O
blocked	VBN	conj	O
by	IN	case	O
cycloheximide	NN	nmod	O
and	CC	cc	O
actinomycin	NN	compound	O
D	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
ectopic	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
EBF	NN	nmod	B-protein
in	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
activated	VBD	ROOT	O
a	DT	det	O
B29	NN	nmod:npmod	B-DNA
promoter-controlled	JJ	amod	I-DNA
reporter	NN	compound	I-DNA
construct	NN	dobj	I-DNA
13-fold	RB	advmod	O
and	CC	cc	O
induced	VBD	conj	O
a	DT	det	O
low	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
expression	NN	nmod	O
from	IN	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
B29	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
the	DT	det	O
genetic	JJ	amod	O
control	NN	nsubjpass	O
of	IN	case	O
major	JJ	amod	B-DNA
histocompatibility	NN	compound	I-DNA
complex	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
MHC	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
during	IN	case	O
the	DT	det	O
transition	NN	nmod	O
from	IN	case	O
B	NN	compound	B-cell_type
cell	NN	nmod	I-cell_type
to	TO	case	O
plasma	NN	compound	B-cell_type
cell	NN	nmod	I-cell_type
has	VBZ	aux	O
been	VBN	auxpass	O
analyzed	VBN	ROOT	O
.	.	punct	O

TPA	NN	compound	O
induction	NN	nsubj	O
increases	VBZ	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
ubiquitous	JJ	amod	B-protein
AP-1	NN	compound	I-protein
factors	NNS	nmod	I-protein
to	TO	case	O
this	DT	det	O
element	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
systemic	JJ	amod	O
(	-LRB-	punct	O
PBMC	NN	compound	O
)	-RRB-	punct	O
hGR	NN	compound	B-protein
levels	NNS	nsubj	O
of	IN	case	O
corticosteroid-treated	JJ	amod	O
IBD	NN	compound	O
patients	NNS	nmod	O
were	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	appos	O
than	IN	case	O
those	DT	nmod	O
of	IN	case	O
control	JJ	amod	O
subjects	NNS	nmod	O
(	-LRB-	punct	O
59.6	CD	nummod	O
+/-	CC	cc	O
57.1	CD	conj	O
dpm	NN	compound	O
mg-1	NN	compound	O
cytosol	NN	compound	B-protein
protein	NN	dep	I-protein
vs	CC	cc	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
Egr-1	NN	nsubj	B-protein
bound	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
Sp	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
cloned	VBN	amod	O
TCF-1	NN	compound	B-protein
alpha	NN	compound	I-protein
protein	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
transcriptional	JJ	amod	B-protein
activator	NN	ROOT	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
TCR	NN	compound	I-DNA
alpha	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
nonlymphoid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
endogenous	JJ	amod	B-protein
protein	NN	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
is	VBZ	cop	O
strongly	RB	advmod	O
dependent	JJ	parataxis	O
on	IN	case	O
an	DT	det	O
additional	JJ	amod	O
T	NN	nmod:npmod	B-cell_line
cell-specific	JJ	amod	I-cell_line
protein	NN	nmod	I-cell_line
that	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
the	DT	det	O
core	NN	compound	O
enhancer	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
dexamethasone	NN	nsubj	O
(	-LRB-	punct	O
DEX	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
synthetic	JJ	amod	O
glucocorticoid	NN	appos	O
,	,	punct	O
causes	VBZ	ccomp	O
apoptosis	NN	dobj	O
in	IN	case	O
mature	JJ	amod	B-cell_line
Th	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	O
death	NN	nmod	O
is	VBZ	auxpass	O
prevented	VBN	conj	O
by	IN	case	O
specific	JJ	amod	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
namely	RB	advmod	O
,	,	punct	O
by	IN	case	O
IL-2	NN	nmod	B-protein
in	IN	case	O
Th1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
by	IN	case	O
IL-4	NN	conj	B-protein
in	IN	case	O
Th2	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Second	RB	advmod	O
,	,	punct	O
tyrphostin	NN	nsubj	O
,	,	punct	O
a	DT	det	O
tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
impaired	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
first	JJ	nmod	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
second	JJ	amod	O
junB	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
peak	NN	dep	O
.	.	punct	O

Overall	RB	advmod	O
,	,	punct	O
the	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
some	DT	det	O
environmental	JJ	amod	O
estrogens	NNS	nsubj	O
that	WDT	nsubj	O
display	VBP	acl:relcl	O
agonist	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
reproductive	JJ	amod	O
tissue	NN	nmod	O
also	RB	advmod	O
have	VBP	ccomp	O
an	DT	det	O
effect	NN	dobj	O
on	IN	case	O
IL-1	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
in	IN	case	O
hemopoietic-derived	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O

IL-12	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
powerful	JJ	amod	O
skewer	NN	ROOT	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
responses	NNS	nmod	O
toward	IN	case	O
the	DT	det	O
Th1	NN	compound	O
phenotype	NN	nmod	O
by	IN	mark	O
inducing	VBG	advcl	O
IFN-gamma	NN	compound	B-protein
production	NN	dobj	O
in	IN	case	O
naive	JJ	amod	B-cell_line
Th	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
molecular	JJ	amod	O
mediator	NN	ccomp	O
of	IN	case	O
Pb-induced	JJ	amod	O
immunotoxicity	NN	nmod	O
.	.	punct	O

Human	JJ	amod	O
immunodeficiency	NN	nmod:npmod	O
virus-associated	JJ	amod	O
Hodgkin	NN	nmod:poss	O
's	POS	case	O
disease	NN	nsubj	O
derives	VBZ	ROOT	O
from	IN	case	O
post-germinal	JJ	amod	B-cell_type
center	NN	compound	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Using	VBG	advcl	O
antibodies	NNS	dobj	O
against	IN	case	O
the	DT	det	O
p50	NN	compound	B-protein
and	CC	cc	O
p65	NN	conj	B-protein
subunits	NNS	nmod	I-protein
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
EMSAs	NNS	nmod	O
,	,	punct	O
the	DT	det	O
involvement	NN	nsubjpass	O
of	IN	case	O
both	CC	cc:preconj	O
p50	NN	compound	B-protein
and	CC	cc	O
p65	NN	conj	B-protein
proteins	NNS	nmod	I-protein
was	VBD	auxpass	O
further	RB	advmod	O
demonstrated	VBN	ROOT	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
ZEBRA	NN	nmod	O
,	,	punct	O
the	DT	det	O
product	NN	nsubj	O
of	IN	case	O
BZLF1	NN	nmod	B-DNA
,	,	punct	O
is	VBZ	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
disrupt	VB	xcomp	O
latency	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
epithelial	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
by	IN	mark	O
stimulating	VBG	advcl	O
expression	NN	dobj	O
of	IN	case	O
lytic	JJ	amod	B-DNA
cycle	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
including	VBG	case	O
BRLF1	NN	nmod	B-DNA
.	.	punct	O

X	NN	compound	B-DNA
chromosome	NN	compound	I-DNA
inactivation	NN	compound	O
patterns	NNS	nsubjpass	O
at	IN	case	O
the	DT	det	O
androgen	NN	compound	O
receptor	NN	compound	O
locus	NN	nmod	O
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
clonality	NN	dobj	O
in	IN	case	O
microdissected	JJ	amod	O
lesional	JJ	amod	O
tissue	NN	nmod	O
and	CC	cc	O
in	IN	case	O
leukocytes	NNS	conj	B-cell_type
from	IN	case	O
2	CD	nummod	O
women	NNS	nmod	O
with	IN	case	O
Dupuytren	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
cis-acting	JJ	amod	B-DNA
elements	NNS	nsubjpass	I-DNA
GM-kappa	NN	compound	B-DNA
B/GC-box	NN	dep	I-DNA
and	CC	cc	O
CLE0	NN	conj	B-DNA
,	,	punct	O
of	IN	case	O
the	DT	det	O
granulocyte-macrophage	JJ	amod	B-DNA
colony-stimulating	JJ	amod	I-DNA
factor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
GM-CSF	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
maximal	JJ	amod	O
induction	NN	nmod	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
costimulation	NN	nmod	O
with	IN	case	O
phorbol-12-myristate	NN	compound	O
acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
Ca2+	NN	compound	O
ionophore	NN	conj	O
(	-LRB-	punct	O
A23187	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
vincristine-selected	JJ	amod	O
,	,	punct	O
multidrug	JJ	dep	O
resistance	NN	nmod	O
on	IN	case	O
12-O-tetradecanoylphorbol-13-acetate	NN	compound	O
(	-LRB-	punct	O
TPA	NN	compound	O
)	-RRB-	punct	O
-induced	JJ	amod	O
HL-60	NN	compound	O
cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
activity	NN	nsubj	O
of	IN	case	O
plasma	NN	compound	O
IL-1	NN	nmod	B-protein
in	IN	case	O
aged	JJ	amod	O
long-distance	JJ	amod	O
runner	NN	nmod	O
was	VBD	cop	O
209	CD	nummod	O
%	NN	ccomp	O
,	,	punct	O
223	CD	nummod	O
%	NN	conj	O
and	CC	cc	O
145	CD	nummod	O
%	NN	conj	O
of	IN	case	O
the	DT	det	O
control	NN	nmod	O
at	IN	case	O
14.7-18.7	CD	amod	O
,	,	punct	O
3.8-7.0	CD	conj	O
and	CC	cc	O
1.5-2.6	CD	conj	O
KD	NN	conj	O
fractions	NNS	nmod	O
.	.	punct	O

Viral	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
fragments	NNS	nsubjpass	I-DNA
that	WDT	nsubj	O
potentially	RB	advmod	O
contain	VBP	acl:relcl	O
oriP	NN	dobj	B-DNA
were	VBD	auxpass	O
cloned	VBN	ROOT	O
into	IN	case	O
a	DT	det	O
plasmid	NN	nmod	B-DNA
that	WDT	nsubj	O
contains	VBZ	acl:relcl	O
the	DT	det	O
hygromycin	NN	compound	B-DNA
resistance	NN	compound	I-DNA
gene	NN	dobj	I-DNA
.	.	punct	O

Both	CC	cc:preconj	O
sIgM-	NN	nsubj	O
and	CC	cc	O
sIgD-crosslinking	NN	conj	O
with	IN	case	O
antibodies	NNS	nmod	O
induced	VBD	ROOT	O
elevation	NN	dobj	O
of	IN	case	O
cAMP	NN	compound	O
levels	NNS	nmod	O
,	,	punct	O
phosphatidylinositol	NN	compound	O
turnover	NN	dobj	O
,	,	punct	O
PKC	NN	compound	B-protein
activation	NN	conj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
Egr-1	NN	compound	B-RNA
and	CC	cc	I-RNA
c-fos	NN	conj	I-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
although	IN	mark	O
sIgM	NN	compound	B-protein
-crosslinking	NN	nsubj	O
was	VBD	cop	O
more	RBR	advmod	O
effective	JJ	advcl	O
than	IN	case	O
sIgD	NN	compound	B-protein
-crosslinking	NN	nmod	O
,	,	punct	O
presumably	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
higher	JJR	amod	O
expression	NN	nmod	O
of	IN	case	O
sIgM	NN	nmod	B-protein
than	IN	case	O
of	IN	case	O
sIgD	NN	nmod	B-protein
.	.	punct	O

Using	VBG	advcl	O
deletion	NN	compound	O
mutants	NNS	dobj	O
and	CC	cc	O
specific	JJ	amod	O
CD4	NN	compound	B-DNA
promoter	NN	compound	I-DNA
mutants	NNS	conj	I-DNA
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
an	DT	det	O
ATF/CRE	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
located	JJ	amod	O
at	IN	case	O
nucleotides	NNS	nmod	B-DNA
-67	CD	nummod	I-DNA
to	TO	dep	I-DNA
-60	CD	nummod	I-DNA
upstream	JJ	advmod	I-DNA
of	IN	case	O
the	DT	det	O
CD4	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	compound	I-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
that	WDT	nsubj	O
is	VBZ	cop	O
important	JJ	acl:relcl	O
for	IN	case	O
HHV-6	NN	compound	O
transactivation	NN	nmod	O
.	.	punct	O

They	PRP	nsubj	O
are	VBP	ROOT	O
in	IN	case	O
particular	JJ	nmod	O
able	JJ	acomp	O
to	TO	mark	O
inhibit	VB	xcomp	O
most	JJS	dobj	O
of	IN	case	O
the	DT	det	O
pro-inflammatory	JJ	amod	O
functions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
eosinophils	NNS	nmod	B-cell_type
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
cytoplasmic	JJ	amod	O
acidification	NN	nsubj	O
facilitated	VBD	ccomp	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
by	IN	case	O
both	CC	cc:preconj	O
TNF	NN	compound	B-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
PKC	NN	conj	B-protein
,	,	punct	O
by	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
that	WDT	nsubj	O
increases	VBZ	acl:relcl	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
/I	JJ	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
dissociation	NN	dobj	O
without	IN	mark	O
affecting	VBG	advcl	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	compound	O
step	NN	dobj	O
.	.	punct	O

JunB	NN	nsubj	B-protein
also	RB	advmod	O
upregulated	VBD	ROOT	O
IL-4	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
immunization	NN	nmod	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
a	DT	det	O
markedly	RB	advmod	O
reduced	VBN	amod	O
thymic	JJ	amod	O
cellularity	NN	nmod	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
distribution	NN	nsubj	O
of	IN	case	O
the	DT	det	O
remaining	VBG	amod	O
cells	NNS	nmod	O
is	VBZ	cop	O
normal	JJ	advcl	O
based	VBN	case	O
on	IN	case	O
evaluation	NN	nmod	O
of	IN	case	O
the	DT	dep	O
CD4	NN	nmod	B-protein
and	CC	cc	O
CD8	NN	conj	B-protein
cell	NN	compound	B-protein
surface	NN	compound	I-protein
antigens	NNS	dep	I-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
used	VBN	acl:relcl	O
to	TO	mark	O
gauge	VB	xcomp	O
T	NN	compound	O
cell	NN	compound	O
development	NN	dobj	O
.	.	punct	O

Studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
abnormalities	NNS	dobj	O
of	IN	case	O
the	DT	det	O
CD3/T-cell	NN	compound	B-protein
antigen	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
TCR	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
pathways	NNS	conj	O
of	IN	case	O
signal	NN	compound	O
transduction	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
from	IN	case	O
animals	NNS	nmod	O
and	CC	cc	O
patients	NNS	conj	O
with	IN	case	O
advanced	JJ	amod	O
malignancy	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
therefore	RB	advmod	O
investigated	VBD	ROOT	O
whether	IN	mark	O
NF-kappaB/Rel	NN	compound	B-protein
proteins	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
human	JJ	amod	B-cell_type
neutrophils	NNS	nmod	I-cell_type
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
their	PRP$	nmod:poss	O
fate	NN	conj	O
on	IN	case	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Blockade	NN	nsubj	O
of	IN	case	O
the	DT	det	O
DNA-binding	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
with	IN	case	O
an	DT	det	O
anti-Fos	JJ	amod	B-protein
mAb	NN	nmod	I-protein
demonstrated	VBD	ROOT	O
a	DT	det	O
direct	JJ	amod	O
participation	NN	dobj	O
of	IN	case	O
c-Fos	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-protein
complexes	NNS	nmod	I-protein
induced	VBN	acl	O
by	IN	case	O
anti-AIM	JJ	compound	B-protein
mAb	NN	nmod	I-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
short-term	JJ	amod	O
incubation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
oxLDL	NN	nmod	B-protein
activated	VBD	ccomp	I-protein
p50/p65	NN	dobj	I-protein
containing	VBG	acl	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
dimers	NNS	dobj	I-protein
and	CC	cc	O
induced	VBD	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
target	NN	compound	B-DNA
gene	NN	compound	I-DNA
IL-8	NN	nmod	I-DNA
.	.	punct	O

Th2	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
could	MD	aux	O
be	VB	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
healthy	JJ	amod	O
controls	NNS	nmod	O
by	IN	mark	O
priming	VBG	advcl	O
with	IN	case	O
anti-CD28	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
TCR	NN	compound	B-protein
ligation	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
communication	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
present	VBP	ROOT	O
evidence	NN	dobj	O
to	TO	mark	O
show	VB	acl	O
that	IN	mark	O
these	DT	det	O
proteins	NNS	nsubj	O
inhibit	VBP	ccomp	O
tumor	NN	compound	O
cell	NN	compound	O
proliferation	NN	dobj	O
by	IN	mark	O
participating	VBG	advcl	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
tumor	NN	compound	O
cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

In	IN	case	O
both	DT	det	O
diseases	NNS	nmod	O
a	DT	det	O
strong	JJ	amod	O
correlation	NN	nsubjpass	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0.79	CD	dobj	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	compound	O
0.001	CD	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
percentage	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
in	IN	case	O
the	DT	det	O
synovial	JJ	amod	O
lining	NN	nmod	O
that	WDT	nsubj	O
were	VBD	cop	O
positive	JJ	acl:relcl	O
for	IN	case	O
nuclear	JJ	amod	B-protein
C/EBP	NN	compound	I-protein
beta	NN	nmod	I-protein
and	CC	cc	O
lining	JJ	conj	O
cell	NN	compound	O
depth	NN	dobj	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
sepsis	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
CoCl2	NN	nsubj	O
caused	VBD	ROOT	O
a	DT	det	O
two-	CD	compound	O
to	TO	dep	O
threefold	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
rate	NN	nmod	O
of	IN	case	O
transendothelial	JJ	amod	O
migration	NN	nmod	O
of	IN	case	O
monocyte-like	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
a	DT	det	O
twentyfold	JJ	amod	O
increase	NN	conj	O
in	IN	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
platelet	NN	compound	B-protein
endothelial	JJ	amod	I-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecules	NNS	nmod	I-protein
(	-LRB-	punct	O
PECAM-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Within	IN	case	O
this	DT	det	O
region	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
several	JJ	amod	O
sequences	NNS	dobj	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
DNA	NN	compound	O
protein	NN	compound	O
interactions	NNS	nmod	O
as	IN	mark	O
shown	VBN	advcl	O
in	IN	case	O
DNAse	NN	compound	B-protein
I	NN	nummod	I-protein
footprints	NNS	nmod	O
and	CC	cc	O
gel	NN	compound	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

X	NN	compound	O
chromosome	NN	compound	O
inactivation	NN	nsubjpass	O
and	CC	cc	O
polymorphism	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
androgen	NN	compound	I-DNA
receptor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
HUMARA	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
applied	VBN	ROOT	O
for	IN	mark	O
analyzing	VBG	advcl	O
the	DT	det	O
clonality	NN	dobj	O
of	IN	case	O
blood	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Bacterially	RB	advmod	O
expressed	VBN	amod	O
RP1	NN	compound	B-protein
protein	NN	nsubj	I-protein
revealed	VBD	ROOT	O
specific	JJ	amod	O
binding	NN	dobj	O
to	TO	case	O
wild-type	JJ	nmod	B-protein
but	CC	cc	O
not	RB	neg	O
to	TO	case	O
mutated	VBN	amod	B-protein
APC	NN	compound	I-protein
protein	NN	conj	I-protein
.	.	punct	O

Tissue-specific	JJ	amod	O
activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
gammac	NN	compound	B-DNA
chain	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
depends	VBZ	ROOT	O
upon	IN	case	O
an	DT	det	O
Ets	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
is	VBZ	auxpass	O
regulated	VBN	conj	O
by	IN	case	O
GA-binding	JJ	amod	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

With	IN	case	O
the	DT	det	O
antibodies	NNS	nmod	O
Ki-67	NN	dep	B-protein
and	CC	cc	O
anti-p-145	NN	conj	B-protein
an	DT	det	O
increased	VBN	amod	O
rate	NN	nsubj	O
of	IN	case	O
nuclear	JJ	amod	O
and	CC	cc	O
nucleolar	JJ	conj	O
staining	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
cells	NNS	nmod	O
from	IN	case	O
highly	RB	advmod	O
malignant	JJ	amod	O
lymphomas	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
found	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
conserved	VBN	amod	B-DNA
motif	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
promoters	NNS	nmod	B-DNA
of	IN	case	O
several	JJ	amod	O
T-cell-expressed	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
[	-LRB-	punct	O
human	JJ	amod	B-protein
interleukin-2	NN	dep	I-protein
,	,	punct	I-protein
-4	CD	conj	I-protein
,	,	punct	I-protein
-5	CD	conj	I-protein
and	CC	cc	I-protein
-13	CD	conj	I-protein
and	CC	cc	O
human	JJ	amod	B-protein
and	CC	cc	I-protein
mouse	NN	conj	I-protein
granulocyte/macrophage-colony	NN	compound	I-protein
stimulating	NN	compound	I-protein
factor	NN	conj	I-protein
(	-LRB-	punct	O
GM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
]	-RRB-	punct	O
.	.	punct	O

STAT1	NN	compound	B-protein
pathway	NN	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
caprine	NN	compound	O
arthritis-encephalitis	JJ	compound	B-DNA
virus	NN	compound	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Thus	RB	advmod	O
increased	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
GCRbeta	NN	nmod	B-protein
could	MD	aux	O
account	VB	ROOT	O
for	IN	case	O
glucocorticoid	NN	compound	O
insensitivity	NN	nmod	O
.	.	punct	O

These	DT	det	O
regulators	NNS	nsubjpass	O
are	VBP	auxpass	O
targeted	VBN	ROOT	O
by	IN	case	O
negative	JJ	amod	O
growth	NN	compound	O
regulatory	JJ	amod	O
signals	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
that	DT	nmod	O
provided	VBN	acl	O
by	IN	case	O
TGF-beta	NN	nmod	B-protein
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
p50/p65/c-Rel	NN	nsubjpass	B-protein
and	CC	cc	O
STAT-6	NN	conj	B-protein
are	VBP	auxpass	O
effectively	RB	advmod	O
induced	VBN	ccomp	O
by	IN	case	O
CD40L	NN	nmod	B-protein
and	CC	cc	O
IL-4	NN	conj	B-protein
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
and	CC	cc	O
bind	VBP	conj	O
to	TO	case	O
specific	JJ	amod	O
DNA	NN	compound	B-DNA
motifs	NNS	nmod	I-DNA
within	IN	case	O
the	DT	det	O
ECS	NN	nmod	B-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	nsubj	I-protein
activated	VBN	acl	O
by	IN	case	O
interferon-gamma	NN	nmod	O
also	RB	advmod	O
interacts	VBZ	ccomp	O
with	IN	case	O
the	DT	det	O
IL-4RE	NN	nmod	B-DNA
.	.	punct	O

29	CD	nummod	O
asthma	NN	compound	O
patients	NNS	nsubjpass	O
with	IN	case	O
forced	VBN	amod	O
expiratory	JJ	amod	O
volume	NN	nmod	O
in	IN	case	O
1	CD	nummod	O
s	NNS	nmod	O
(	-LRB-	punct	O
FEV1	NN	appos	O
)	-RRB-	punct	O
<	:	dep	O
70	CD	nummod	O
%	NN	nsubjpass	O
predicted	VBN	acl	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
regulating	VBG	acl	O
this	DT	det	O
activation	NN	dobj	O
remains	VBZ	ROOT	O
unknown	JJ	xcomp	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
estradiol	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
plasma	NN	nmod	I-cell_type
,	,	punct	O
which	WDT	dobj	O
PMNs	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
drawn	VBN	acl:relcl	O
,	,	punct	O
showed	VBD	ROOT	O
a	DT	det	O
close	JJ	amod	O
,	,	punct	O
inverse	JJ	dep	O
correlation	NN	dobj	O
with	IN	case	O
the	DT	det	O
PMNs	NNS	compound	B-cell_type
chemotaxis	NN	nmod	O
to	TO	case	O
FMLP	NN	nmod	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
-0.821	CD	nummod	O
p	NN	dep	O
<	CD	dep	O
0.001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

PAO	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
effective	JJ	xcomp	O
even	RB	advmod	O
when	WRB	advmod	O
added	VBN	amod	O
3	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
TNF	NN	nmod	B-protein
,	,	punct	O
suggesting	VBG	xcomp	O
a	DT	det	O
rapid	JJ	amod	O
mode	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
this	DT	det	O
inhibitor	NN	nmod	O
.	.	punct	O

Transcriptional	JJ	amod	O
activation	NN	nsubj	O
by	IN	case	O
this	DT	det	O
mutant	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
membrane-bound	JJ	amod	B-protein
DeltaE	NN	nmod	I-protein
was	VBD	cop	O
approximately	RB	advmod	O
equivalent	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
produced	VBN	acl	O
by	IN	case	O
intranuclear	JJ	amod	B-protein
ICN	NN	nmod	I-protein
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
analyze	VB	advcl	O
potential	JJ	amod	O
cross	NN	compound	O
points	NNS	dobj	O
between	IN	mark	O
positively	RB	advmod	O
and	CC	advmod	O
negatively	RB	advmod	O
regulating	VBG	advcl	O
signaling	NN	compound	O
pathways	NNS	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
activators	NNS	nmod	O
of	IN	case	O
the	DT	det	O
adenylate	NN	compound	B-protein
cyclase	NN	nmod	I-protein
or	CC	cc	O
PKA	NN	conj	B-protein
on	IN	case	O
two	CD	nummod	O
parallel	JJ	amod	O
mitogen-activated	JJ	amod	O
protein	NN	compound	O
kinase	NN	compound	O
signaling	NN	compound	O
pathways	NNS	nmod	O
mediated	VBN	acl	O
by	IN	case	O
extracellular	JJ	amod	B-protein
signal-regulated	JJ	amod	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
ERK	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
c-Jun	NN	compound	B-protein
N-terminal	JJ	amod	I-protein
kinase	NN	conj	I-protein
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
spontaneous	JJ	amod	O
production	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
other	JJ	amod	O
pro-inflammatory	JJ	amod	B-protein
cytokines	NNS	conj	I-protein
is	VBZ	cop	O
NF-kappaB	NN	nmod:npmod	B-protein
-dependent	JJ	ccomp	O
in	IN	case	O
rheumatoid	JJ	amod	O
synovial	JJ	amod	O
tissue	NN	nmod	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
main	JJ	amod	O
anti-inflammatory	JJ	amod	B-protein
mediators	NNS	nmod	I-protein
,	,	punct	O
like	IN	case	O
IL-10	NN	nmod	B-protein
and	CC	cc	I-protein
-11	CD	conj	I-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
IL-1	NN	compound	B-protein
receptor	NN	compound	I-protein
antagonist	NN	conj	I-protein
.	.	punct	O

Heat-shock	NN	nsubj	O
for	IN	case	O
2	CD	nummod	O
hours	NNS	nmod	O
at	IN	case	O
42	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
,	,	punct	O
or	CC	cc	O
the	DT	det	O
administration	NN	conj	O
for	IN	case	O
3	CD	nummod	O
hours	NNS	nmod	O
of	IN	prep	O
100	CD	pobj	O
or	CC	cc	O
150	CD	conj	O
microM	NN	compound	O
cadmium	NN	compound	O
chloride	NN	nmod	O
,	,	punct	O
inhibited	VBD	ROOT	O
the	DT	det	O
subsequent	JJ	amod	B-cell_line
proliferation	NN	compound	I-cell_line
activity	NN	dobj	I-cell_line
,	,	punct	O
induced	VBD	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
functional	JJ	amod	O
differentiation	NN	compound	B-protein
markers	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
caused	VBD	conj	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
amount	NN	nmod	O
of	IN	case	O
the	DT	det	O
stress-responsive	JJ	amod	B-protein
HSP70	NN	compound	I-protein
protein	NN	nmod	I-protein
in	IN	case	O
U-937	NN	compound	B-cell_line
human	JJ	amod	I-cell_line
promonocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Precursors	NNS	nsubj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nmod	O
enhance	VBP	ROOT	O
HIV-1	NN	compound	O
replication	NN	dobj	O
in	IN	case	O
proportion	NN	nmod	O
to	TO	case	O
their	PRP$	nmod:poss	O
affinity	NN	nmod	O
for	IN	case	O
the	DT	det	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25	CD	conj	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
intracellular	JJ	amod	I-protein
receptor	NN	nmod	I-protein
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
influences	VBZ	ccomp	O
HIV-1	NN	compound	O
replication	NN	dobj	O
by	IN	case	O
mechanisms	NNS	nmod	O
involving	VBG	acl	O
this	DT	det	O
receptor	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
women	NNS	nmod	O
,	,	punct	O
unlike	IN	case	O
previous	JJ	amod	O
observations	NNS	nmod	O
in	IN	case	O
men	NNS	nmod	O
,	,	punct	O
these	DT	det	O
platelet	NN	compound	O
parameters	NNS	nsubjpass	O
are	VBP	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
blood	NN	compound	O
pressure	NN	nmod	O
and	CC	cc	O
serum	NN	compound	B-protein
lipoproteins	NNS	conj	I-protein
.	.	punct	O

LR1	NN	nsubj	B-protein
contains	VBZ	ROOT	O
two	CD	nummod	O
polypeptides	NNS	dobj	O
,	,	punct	O
of	IN	case	O
106	CD	nummod	O
kDa	NN	nmod	O
and	CC	cc	O
45	CD	nummod	O
kDa	NN	conj	O
,	,	punct	O
and	CC	cc	O
here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	conj	O
that	IN	mark	O
the	DT	det	O
106-kDa	JJ	amod	B-protein
component	NN	nsubj	I-protein
of	IN	case	O
LR1	NN	nmod	B-protein
is	VBZ	cop	O
nucleolin	NN	ccomp	B-protein
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
gamma-IFN	NN	compound	B-DNA
responsive	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
scavenger	NN	compound	O
receptor	NN	compound	O
over-expressing	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
xanthomatosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nsubj	I-DNA
,	,	punct	O
HIV-1-LTR	NN	appos	B-DNA
,	,	punct	O
contains	VBZ	ROOT	O
binding	VBG	amod	O
sites	NNS	dobj	O
for	IN	case	O
several	JJ	amod	O
cellular	JJ	amod	O
transcription	NN	compound	O
factors	NNS	nmod	O
which	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
HIV-1	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
replication	NN	nmod	O
by	IN	case	O
a	DT	det	O
Tat-activated	JJ	amod	B-DNA
,	,	punct	I-DNA
transduced	VBN	dep	I-DNA
interferon	NN	compound	I-DNA
gene	NN	nmod	I-DNA
:	:	punct	O
targeted	VBN	amod	O
expression	NN	dep	O
to	TO	case	O
human	JJ	amod	B-cell_type
immunodeficiency	NN	compound	I-cell_type
virus	NN	compound	I-cell_type
type	NN	compound	I-cell_type
1-infected	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
provide	VBP	ROOT	O
a	DT	det	O
potential	JJ	amod	O
mechanism	NN	dobj	O
through	IN	case	O
which	WDT	nmod	O
CD30	NN	nsubj	B-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
other	JJ	amod	O
TRAF-binding	JJ	amod	B-protein
members	NNS	conj	I-protein
of	IN	case	O
the	DT	det	O
TNFR	NN	compound	B-protein
superfamily	NN	nmod	I-protein
,	,	punct	O
can	MD	aux	O
negatively	RB	advmod	O
regulate	VB	acl:relcl	O
cell	NN	compound	O
survival	NN	dobj	O
.	.	punct	O

That	DT	nsubj	O
is	VBZ	ROOT	O
,	,	punct	O
a	DT	det	O
dominant	JJ	amod	B-protein
negative	JJ	amod	I-protein
GSK-3beta	NN	nsubj	I-protein
does	VBZ	aux	O
not	RB	neg	O
specifically	RB	advmod	O
activate	VB	ccomp	O
Tcf	NN	advmod	O
transcription	NN	dobj	O
and	CC	cc	O
stimuli	NNS	conj	O
(	-LRB-	punct	O
lithium	NN	dep	O
or	CC	cc	O
phytohemagglutinin	NN	conj	B-protein
)	-RRB-	punct	O
that	WDT	nsubj	O
inhibit	VBP	ccomp	O
GSK-3beta	NN	compound	B-protein
activity	NN	dobj	O
also	RB	advmod	O
do	VBP	aux	O
not	RB	neg	O
activate	VB	dep	O
Tcf	NN	dep	B-DNA
reporter	NN	compound	I-DNA
genes	NNS	dobj	I-DNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubj	O
and	CC	cc	O
strategies	NNS	conj	O
to	TO	mark	O
overcome	VB	acl	O
RA	NN	compound	O
resistance	NN	dobj	O
by	IN	case	O
APL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
are	VBP	cop	O
still	RB	advmod	O
unclear	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
CRO-AP/3	NN	nsubj	B-cell_line
and	CC	cc	O
CRO-AP/5	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
may	MD	aux	O
provide	VB	ROOT	O
a	DT	det	O
valuable	JJ	amod	O
model	NN	dobj	O
for	IN	mark	O
clarifying	VBG	acl	O
the	DT	det	O
pathogenesis	NN	dobj	O
of	IN	case	O
PEL	NN	nmod	B-cell_line
.	.	punct	O

This	DT	nsubj	O
may	MD	aux	O
explain	VB	ROOT	O
the	DT	det	O
strong	JJ	amod	O
cyto-differentiating	JJ	amod	O
potential	NN	dobj	O
of	IN	case	O
AM580	NN	nmod	O
in	IN	case	O
PML-RAR-containing	JJ	amod	B-cell_type
leukemic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Two	CD	nummod	O
types	NNS	nsubjpass	O
of	IN	case	O
helper	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
Th	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
clones	NNS	nmod	I-cell_line
(	-LRB-	punct	O
Th1	NN	appos	B-cell_line
and	CC	cc	O
Th2	NN	conj	B-cell_line
)	-RRB-	punct	O
are	VBP	auxpass	O
defined	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
patterns	NNS	nmod	O
of	IN	case	O
cytokine	NN	compound	B-protein
(	-LRB-	punct	O
lymphokine	NN	appos	B-protein
)	-RRB-	punct	O
secretion	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
initiated	VBD	ROOT	O
this	DT	det	O
study	NN	dobj	O
to	TO	mark	O
determine	VB	advcl	O
1	LS	dobj	O
)	-RRB-	punct	O
the	DT	det	O
prevalence	NN	dobj	O
of	IN	case	O
one	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
breast	NN	compound	O
tissue	NN	compound	O
abnormalities	NNS	nmod	O
in	IN	case	O
a	DT	det	O
group	NN	nmod	O
of	IN	case	O
women	NNS	nmod	O
at	IN	case	O
high	JJ	amod	O
risk	NN	nmod	O
for	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
,	,	punct	O
and	CC	cc	O
2	LS	conj	O
)	-RRB-	punct	O
if	IN	mark	O
the	DT	det	O
prevalence	NN	nsubj	O
of	IN	case	O
biomarker	NN	compound	O
abnormalities	NNS	nmod	O
is	VBZ	cop	O
greater	JJR	advcl	O
in	IN	case	O
high	JJ	amod	O
risk	NN	nmod	O
than	IN	case	O
in	IN	case	O
low	JJ	amod	O
risk	NN	compound	O
women	NNS	nmod	O
.	.	punct	O

In	IN	case	O
line	NN	nmod	O
with	IN	case	O
this	DT	det	O
conclusion	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
cut/CDP	NN	compound	B-protein
protein	NN	nsubj	I-protein
,	,	punct	O
a	DT	det	O
transcriptional	JJ	amod	O
repressor	NN	appos	O
that	WDT	nsubj	O
inhibits	VBZ	acl:relcl	O
gpc91-phox	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
by	IN	mark	O
preventing	VBG	advcl	O
NF-Y	NN	compound	B-protein
binding	NN	dobj	O
to	TO	case	O
the	DT	det	O
CAAT	NN	compound	B-DNA
box	NN	nmod	I-DNA
,	,	punct	O
is	VBZ	cop	O
absent	JJ	ccomp	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

HL-60	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
express	VB	xcomp	O
mafK	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
,	,	punct	O
indicating	VBG	xcomp	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
genuine	JJ	amod	O
NF-E2	NN	compound	B-protein
complex	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
generated	VBN	ROOT	O
transgenic	JJ	amod	O
mice	NNS	dobj	O
that	WDT	nsubj	O
express	VBP	acl:relcl	O
a	DT	det	O
catalytically	RB	advmod	B-protein
inactive	JJ	amod	I-protein
form	NN	dobj	I-protein
of	IN	case	O
Ca2+/calmodulin-dependent	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
IV	CD	nummod	I-protein
(	-LRB-	punct	O
CaMKIV	NN	appos	B-protein
)	-RRB-	punct	O
specifically	RB	advmod	O
in	IN	case	O
thymic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Dimerization	NN	nsubj	O
of	IN	case	O
NF-KB2	NN	nmod	B-protein
with	IN	case	O
RelA	NN	nmod	B-protein
(	-LRB-	punct	I-protein
p65	NN	appos	I-protein
)	-RRB-	punct	I-protein
regulates	VBZ	ROOT	O
DNA	NN	compound	O
binding	NN	dobj	O
,	,	punct	O
transcriptional	JJ	amod	O
activation	NN	conj	O
,	,	punct	O
and	CC	cc	O
inhibition	NN	conj	O
by	IN	case	O
an	DT	det	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B-alpha	NN	nmod	I-protein
(	-LRB-	punct	O
MAD-3	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

OBJECTIVE	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
aimed	VBD	ROOT	O
to	TO	mark	O
find	VB	xcomp	O
the	DT	det	O
transcriptional	JJ	amod	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
the	DT	det	O
IL-5	NN	compound	B-protein
gene	NN	dobj	O
to	TO	mark	O
selectively	RB	advmod	O
control	VB	xcomp	O
IL-5	NN	compound	B-protein
synthesis	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
its	PRP$	nmod:poss	O
precise	JJ	amod	O
mode	NN	nsubj	O
of	IN	case	O
action	NN	nmod	O
remains	VBZ	advcl	O
elusive	JJ	xcomp	O
,	,	punct	O
curcumin	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
suppress	VB	xcomp	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-protein
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
in	IN	case	O
cells	NNS	nmod	O
stimulated	VBN	acl	O
to	TO	mark	O
proliferate	VB	xcomp	O
.	.	punct	O

Interleukin-2	NN	nsubj	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
rapidly	RB	advmod	O
activated	VBD	ROOT	O
Stat5	NN	dobj	B-protein
in	IN	case	O
fresh	JJ	amod	O
PBL	NN	nmod	B-cell_type
,	,	punct	O
and	CC	cc	O
Stat3	NN	conj	B-protein
and	CC	cc	O
Stat5	NN	conj	B-protein
in	IN	case	O
preactivated	JJ	amod	B-cell_type
PBL	NN	nmod	I-cell_type
.	.	punct	O

Both	CC	cc:preconj	O
haemin	NN	nsubj	O
and	CC	cc	O
delta-ALA	NN	conj	O
caused	VBD	ROOT	O
a	DT	det	O
de	FW	amod	O
novo	FW	dep	O
increase	NN	dobj	O
in	IN	case	O
alpha-globin	NN	compound	B-protein
expression	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
enhancing	VBG	acl	O
Epo	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
beta-globin	NN	compound	B-protein
expression	NN	dobj	O
,	,	punct	O
leading	VBG	acl	O
to	TO	case	O
a	DT	det	O
marked	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
haemoglobin	NN	compound	O
production	NN	nmod	O
.	.	punct	O

Immunofluorescence	NN	compound	O
studies	NNS	nsubj	O
using	VBG	acl	O
an	DT	det	O
Ab	NN	dobj	O
to	TO	case	O
the	DT	det	O
RelA	NN	compound	B-protein
(	-LRB-	punct	I-protein
p65	NN	compound	I-protein
)	-RRB-	punct	I-protein
subunit	NN	nmod	I-protein
of	IN	case	O
nuclear	JJ	amod	O
factor-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
revealed	VBD	ROOT	O
that	IN	mark	O
iNO	NN	nsubj	O
inhibited	VBD	ccomp	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
magnitude	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
functional	JJ	amod	O
responses	NNS	nmod	O
is	VBZ	auxpass	O
greatly	RB	advmod	O
augmented	JJ	ROOT	O
when	WRB	advmod	O
T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
activated	VBN	advcl	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
of	IN	case	O
IL-12	NN	nmod	B-protein
and	CC	cc	O
IL-2	NN	conj	B-protein
.	.	punct	O

Transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor-beta	NN	nsubj	I-protein
(	-LRB-	punct	O
TGF-beta	NN	appos	B-protein
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
Ig	NN	compound	B-protein
secretion	NN	dobj	O
and	CC	cc	O
reduces	VBZ	conj	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
membrane	NN	compound	O
Ig	NN	compound	B-protein
expression	NN	dobj	O
.	.	punct	O

Bcl-2	NN	ROOT	B-protein
:	:	punct	O
a	DT	det	O
repressor	NN	dep	O
of	IN	case	O
lymphocyte	NN	compound	B-cell_type
death	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
exploited	VBD	ROOT	O
this	DT	det	O
ability	NN	dobj	O
of	IN	case	O
Hsp70	NN	nmod	B-protein
to	TO	mark	O
deliver	VB	acl	O
NF-kappaB	NN	dobj	B-protein
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
transcriptional	JJ	amod	O
regulator	NN	appos	O
of	IN	case	O
inflammatory	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
mild	JJ	amod	O
oxidation	NN	nsubj	O
with	IN	case	O
glucose	NN	compound	B-protein
oxidase	NN	nmod	I-protein
selectively	RB	advmod	O
inhibits	VBZ	ROOT	O
p75	NN	compound	B-protein
and	CC	cc	O
p85	NN	conj	B-protein
binding	NN	dobj	O
while	IN	mark	O
not	RB	neg	O
blocking	VBG	advcl	O
p50	NN	compound	B-protein
and	CC	cc	O
p55	NN	conj	B-protein
interactions	NNS	dobj	O
.	.	punct	O

NF-kappaB	NN	compound	B-protein
activation	NN	nsubj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
inflammatory	JJ	amod	O
signals	NNS	nmod	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
upon	IN	case	O
degradation	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
associated	VBN	amod	O
inhibitory	JJ	amod	O
peptide	NN	nmod	O
,	,	punct	O
inhibitory	JJ	amod	B-protein
kappaB-alpha	NN	appos	I-protein
(	-LRB-	punct	O
IkappaB-alpha	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
phenomenon	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
,	,	punct	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
through	IN	case	O
inducible	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
CXC	NN	compound	B-protein
chemokine	NN	nmod	I-protein
,	,	punct	O
interleukin-8	NN	appos	B-protein
(	-LRB-	punct	O
IL-8	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Specific	JJ	amod	O
mRNAs	NNS	nsubj	B-RNA
for	IN	case	O
c-fos	NN	nmod	B-DNA
and	CC	cc	O
c-jun	NN	conj	B-DNA
were	VBD	cop	O
detectable	JJ	ROOT	O
within	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
after	IN	case	O
cell	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
reached	VBD	conj	O
maximal	JJ	amod	O
levels	NNS	dobj	O
within	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
``	``	punct	B-protein
two-handed	JJ	amod	I-protein
''	''	punct	I-protein
zinc	NN	compound	I-protein
finger	NN	compound	I-protein
protein	NN	dobj	I-protein
,	,	punct	O
denoted	VBN	acl	O
ZEB	NN	xcomp	B-protein
,	,	punct	O
the	DT	det	O
DNA-binding	JJ	amod	O
specificity	NN	nsubj	O
of	IN	case	O
which	WDT	nmod	O
mimics	VBZ	parataxis	O
that	DT	dobj	O
of	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-protein
repressor	NN	nmod	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
Ets	NN	compound	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
that	WDT	nsubj	O
regulated	VBD	acl:relcl	O
GPIX	NN	compound	B-DNA
promoter	NN	compound	I-DNA
expression	NN	dobj	O
was	VBD	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
raise	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
NF-kappaB/Rel	NN	nsubj	B-protein
may	MD	aux	O
participate	VB	ccomp	O
in	IN	case	O
the	DT	det	O
growth	NN	compound	O
control	NN	nmod	O
of	IN	case	O
HTLV-I-transformed	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
by	IN	mark	O
regulating	VBG	advcl	O
genes	NNS	dobj	O
driven	VBN	acl	O
by	IN	case	O
both	CC	cc:preconj	O
kappaB	NN	nmod	B-DNA
and	CC	cc	O
certain	JJ	amod	O
STAT	NN	compound	B-DNA
enhancers	NNS	conj	I-DNA
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
FCM	NN	nmod	O
on	IN	case	O
the	DT	det	O
LPS-induced	JJ	amod	O
DNA-binding	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
,	,	punct	O
by	IN	case	O
means	NNS	advcl	O
of	IN	case	O
electrophoretic	JJ	amod	O
shift	NN	compound	O
assay	NN	nmod	O
(	-LRB-	punct	O
EMSA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Reverse	JJ	amod	O
transcription-PCR	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
all	DT	det	O
seven	CD	nummod	O
EBV-positive	JJ	amod	O
tumour	NN	compound	O
tissues	NNS	nsubj	O
constitutively	RB	advmod	O
expressed	VBD	ccomp	O
EBV	NN	compound	B-RNA
nuclear	JJ	amod	I-RNA
antigen	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
EBNA	NN	appos	I-RNA
)	-RRB-	punct	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	dobj	I-RNA
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
EBNA2	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
erythroid	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
transcriptionally	RB	advmod	O
by	IN	case	O
ACLA	NN	nmod	O
and	CC	cc	O
mainly	RB	advmod	O
posttranscriptionally	RB	advmod	O
by	IN	case	O
DOX	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
cotransfection	NN	compound	O
studies	NNS	nsubj	O
with	IN	case	O
an	DT	det	O
NF-AT	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
showed	VBD	ROOT	O
that	IN	mark	O
NF-AT	NN	nsubj	B-protein
may	MD	aux	O
confer	VB	ccomp	O
a	DT	det	O
strong	JJ	amod	O
inducible	JJ	amod	O
activity	NN	dobj	O
to	TO	case	O
the	DT	det	O
CD95L	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
at	IN	case	O
this	DT	det	O
regulatory	JJ	amod	B-DNA
region	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
histamine	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
agonists	NNS	conj	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	dep	O
c-fos	NN	nmod	B-DNA
and	CC	cc	I-DNA
c-myc	NN	conj	I-DNA
proto-oncogenes	NNS	dep	I-DNA
at	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
and	CC	cc	O
translational	JJ	conj	O
levels	NNS	nmod	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
promonocytic	JJ	amod	I-cell_line
U937	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
ascorbate	NN	nmod	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
by	IN	case	O
tumour	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
in	IN	case	O
T-cells	NNS	nmod	B-cell_type
.	.	punct	O

Compared	VBN	case	O
to	TO	case	O
normal	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
MOLT-4	NN	nsubj	B-cell_line
and	CC	cc	I-cell_line
CEM	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
exhibited	VBD	ROOT	O
an	DT	det	O
altered	JJ	amod	O
cell	NN	compound	O
cycle	NN	compound	O
regulation	NN	dobj	O
of	IN	case	O
thymidine	NN	compound	B-protein
kinase	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
much	RB	advmod	O
higher	JJR	amod	O
intracellular	JJ	amod	O
activity	NN	appos	O
of	IN	case	O
this	DT	det	O
enzyme	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
higher	JJR	amod	O
thymidine	NN	compound	B-RNA
kinase	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
expression	NN	conj	O
.	.	punct	O

mRNA	NN	nsubjpass	O
for	IN	case	O
c-fes	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
detected	VBN	ROOT	O
exclusively	RB	advmod	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
vascular	JJ	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
in	IN	case	O
adult	JJ	amod	O
mammals	NNS	nmod	O
.	.	punct	O

Surface	NN	compound	O
marker	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
HMBA-induced	JJ	amod	B-cell_line
cells	NNS	nsubj	I-cell_line
expressed	VBD	ccomp	O
reduced	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
glycophorin	NN	compound	B-protein
A	NN	nmod	I-protein
,	,	punct	O
CD5	NN	conj	B-protein
,	,	punct	O
CD7	NN	conj	B-protein
and	CC	cc	O
CD11b	NN	conj	B-protein
.	.	punct	O

From	IN	case	O
these	DT	det	O
observations	NNS	nmod	O
we	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
free	JJ	amod	O
thiols	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
IL-1RI	NN	compound	B-protein
complex	NN	nmod	I-protein
are	VBP	cop	O
essential	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-1RI-associated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
process	NN	nsubj	O
is	VBZ	cop	O
mandatory	JJ	conj	O
for	IN	case	O
IL-1	NN	compound	B-protein
signaling	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
.	.	punct	O

Immunofluorescence	NN	compound	O
studies	NNS	nsubj	O
on	IN	case	O
thymic	JJ	amod	B-cell_type
populations	NNS	nmod	I-cell_type
of	IN	case	O
mice	NNS	nmod	O
carrying	VBG	acl	O
transgenes	NNS	dobj	O
in	IN	case	O
various	JJ	amod	O
combinations	NNS	nmod	O
of	IN	case	O
these	DT	det	O
regulatory	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
revealed	VBD	ROOT	O
that	IN	mark	O
thymocytes	NNS	nsubj	B-cell_type
control	VBP	ccomp	O
the	DT	det	O
CD4	NN	compound	B-DNA
gene	NN	dobj	I-DNA
in	IN	case	O
a	DT	det	O
different	JJ	amod	O
manner	NN	nmod	O
than	IN	case	O
mature	JJ	amod	O
peripheral	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
deduced	VBN	amod	O
amino	NN	compound	O
acid	NN	compound	O
sequence	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
related	JJ	xcomp	O
to	TO	mark	O
fungal	JJ	xcomp	B-protein
C8-C7	NN	compound	I-protein
sterol	NN	compound	I-protein
isomerase	NN	dobj	I-protein
,	,	punct	O
encoded	VBN	advcl	O
by	IN	case	O
the	DT	det	O
ERG2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

A	DT	det	O
later	JJ	amod	O
result	NN	nsubj	O
of	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
this	DT	det	O
activation	NN	compound	O
pathway	NN	nmod	O
by	IN	case	O
p21	NN	nmod	B-protein
(	-LRB-	punct	I-protein
ras	NN	appos	I-protein
)	-RRB-	punct	I-protein
was	VBD	cop	O
down-regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-1	NN	nmod	B-protein
and	CC	cc	O
subsequent	JJ	amod	O
coordinate	JJ	amod	O
reductions	NNS	conj	O
in	IN	case	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
and	CC	cc	O
protein	NN	compound	O
production	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
rapamycin-controlled	JJ	amod	O
processes	NNS	nsubj	O
involved	VBN	acl	O
in	IN	case	O
E2F	NN	compound	B-protein
regulation	NN	nmod	O
appear	VBP	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
by	IN	case	O
p70	NN	nmod	B-protein
(	-LRB-	punct	I-protein
s6k	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
TFIIA	NN	nsubj	B-protein
facilitates	NNS	ROOT	O
Tax	NN	compound	B-protein
transactivation	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
response	NN	nsubj	O
of	IN	case	O
LFA-3	NN	nmod	B-protein
to	TO	case	O
TaxI	NN	compound	B-protein
induction	NN	nmod	O
was	VBD	cop	O
,	,	punct	O
on	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nsubj	O
,	,	punct	O
relatively	RB	advmod	O
slow	JJ	ROOT	O
and	CC	cc	O
weak	JJ	conj	O
,	,	punct	O
and	CC	cc	O
might	MD	aux	O
be	VB	auxpass	O
indirect	JJ	conj	O
.	.	punct	O

The	DT	det	O
levels	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
apoptosis	NN	compound	O
effector	NN	compound	O
proteins	NNS	nmod	O
Bak	NN	dep	B-protein
and	CC	cc	O
Bad	NN	conj	B-protein
were	VBD	auxpass	O
enhanced	VBN	ROOT	O
,	,	punct	O
whereas	IN	dep	O
there	EX	expl	O
was	VBD	parataxis	O
a	DT	det	O
slight	JJ	amod	O
down-regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
apoptosis	NN	compound	B-protein
suppressor	NN	compound	I-protein
protein	NN	compound	I-protein
Bcl-2	NN	nmod	B-protein
after	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
PDBu	NN	nmod	O
and	CC	cc	O
DMSO	NN	conj	O
.	.	punct	O

Single	JJ	amod	O
strand	NN	compound	O
conformation	NN	compound	O
polymorphism	NN	compound	O
analysis	NN	ROOT	O
of	IN	case	O
androgen	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	compound	I-DNA
mutations	NNS	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
androgen	NN	compound	O
insensitivity	NN	compound	O
syndromes	NNS	nmod	O
:	:	punct	O
application	NN	dep	O
for	IN	case	O
diagnosis	NN	nmod	O
,	,	punct	O
genetic	JJ	amod	O
counseling	NN	conj	O
,	,	punct	O
and	CC	cc	O
therapy	NN	conj	O
.	.	punct	O

Chromosomal	JJ	amod	O
translocations	NNS	nsubjpass	O
involving	VBG	acl	O
the	DT	det	O
genes	NNS	dobj	O
encoding	VBG	acl	O
the	DT	det	O
alpha	NN	compound	B-protein
and	CC	cc	I-protein
beta	NN	conj	I-protein
subunits	NNS	dobj	I-protein
of	IN	case	O
the	DT	det	O
Pebp2/Cbf	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
human	JJ	amod	O
acute	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	nmod	O
and	CC	cc	O
the	DT	det	O
preleukemic	JJ	amod	O
condition	NN	conj	O
,	,	punct	O
myelodysplasia	NN	appos	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
studies	NNS	nsubj	O
define	VBP	ROOT	O
a	DT	det	O
critical	JJ	amod	O
signal	NN	compound	O
response	NN	compound	O
domain	NN	dobj	O
in	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
that	WDT	nsubj	O
coordinately	RB	advmod	O
controls	VBZ	acl:relcl	O
the	DT	det	O
biologic	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
viral	JJ	amod	O
and	CC	cc	O
immune	JJ	conj	O
stimuli	NNS	nmod	O
.	.	punct	O

Polyubiquitinylated	VBN	amod	O
c-Jun	NN	compound	B-protein
,	,	punct	O
wbFos	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
wbJun	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
E220K-ubiquitinylated	JJ	conj	B-protein
c-Jun	NN	nsubjpass	I-protein
,	,	punct	O
were	VBD	auxpass	O
readily	RB	advmod	O
degraded	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
ATP-dependent	JJ	amod	B-protein
26	CD	nummod	I-protein
S	NN	compound	I-protein
multicatalytic	JJ	amod	I-protein
proteases	NNS	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
parasite-induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
survival	NN	nmod	O
of	IN	case	O
T.	FW	compound	B-cell_type
parva-transformed	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	mark	O
conveying	VBG	advcl	O
protection	NN	dobj	O
against	IN	case	O
an	DT	det	O
apoptotic	JJ	amod	O
signal	NN	nmod	O
that	WDT	nsubj	O
accompanies	VBZ	acl:relcl	O
parasite-mediated	JJ	amod	O
transformation	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
ability	NN	nsubj	O
to	TO	mark	O
suppress	VB	acl	O
IL-1RI	NN	dobj	O
and	CC	cc	O
IL-1RII	NN	conj	B-protein
mRNA	NN	compound	O
levels	NNS	dep	O
was	VBD	cop	O
not	RB	neg	O
unique	JJ	ROOT	O
to	TO	case	O
IFN-gamma	NN	nmod	B-protein
because	IN	mark	O
IL-10	NN	nsubj	B-protein
also	RB	advmod	O
inhibited	VBD	advcl	O
expression	NN	dobj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
in	IN	case	O
IL-4/IL-13-stimulated	JJ	amod	B-cell_line
monocytes	NNS	nmod	I-cell_line
.	.	punct	O

Screening	NN	nsubj	O
of	IN	case	O
a	DT	det	O
library	NN	nmod	O
of	IN	case	O
compounds	NNS	nmod	O
using	VBG	acl	O
transactivation	NN	dobj	O
and	CC	cc	O
AP-1	NN	compound	B-protein
transrepression	NN	compound	O
models	NNS	conj	O
in	IN	case	O
transiently	RB	advmod	O
transfected	VBN	amod	O
cells	NNS	nmod	O
identified	VBN	ROOT	O
dissociated	VBD	amod	O
glucocorticoids	NNS	dobj	O
,	,	punct	O
which	WDT	nsubj	O
exert	VBP	acl:relcl	O
strong	JJ	amod	O
AP-1	NN	compound	B-protein
inhibition	NN	dobj	O
but	CC	cc	O
little	JJ	amod	O
or	CC	cc	O
no	DT	conj	O
transactivation	NN	conj	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
HIV-1	NN	nsubj	O
isolate	NN	ROOT	O
containing	VBG	xcomp	O
alterations	NNS	dobj	O
affecting	VBG	acl	O
the	DT	det	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
element	NN	dobj	I-DNA
.	.	punct	O

Ii	NN	compound	B-DNA
kappa	NN	compound	I-DNA
B-1	NN	nsubj	I-DNA
is	VBZ	cop	O
a	DT	det	O
positive	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	ROOT	I-DNA
in	IN	case	O
B-cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
the	DT	det	O
Ii-expressing	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
,	,	punct	O
H9	NN	appos	B-cell_line
,	,	punct	O
but	CC	cc	O
acts	VBZ	conj	O
as	IN	case	O
a	DT	det	O
negative	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	nmod	I-DNA
in	IN	case	O
myelomonocytic	JJ	nmod	B-cell_line
and	CC	cc	I-cell_line
glia	NN	conj	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dep	I-cell_line
.	.	punct	O

VSMC-myc	JJ	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
maintained	VBN	acl	O
in	IN	case	O
serum	NN	nmod	O
generated	VBD	ROOT	O
less	RBR	amod	O
thrombin	NN	dobj	B-protein
than	IN	case	O
after	IN	case	O
serum	NN	compound	O
withdrawal	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.0002	NN	dep	O
for	IN	case	O
AUC	NN	nmod	O
and	CC	cc	O
PT	NN	conj	O
)	-RRB-	punct	O
.	.	punct	O

Permanent	JJ	amod	O
occupancy	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
enhancer	NN	nmod	I-DNA
by	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
is	VBZ	auxpass	O
needed	VBN	ROOT	O
for	IN	case	O
persistent	JJ	amod	O
viral	JJ	amod	O
replication	NN	nmod	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

This	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
differentiation	NN	nmod	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
adherence	NN	nmod	O
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
expression/repression	NN	conj	O
of	IN	case	O
differentiation-associated	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

For	IN	case	O
one	CD	nsubj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
,	,	punct	O
p57	NN	appos	B-protein
,	,	punct	O
binding	VBG	acl	O
to	TO	case	O
the	DT	det	O
IRES	NN	nmod	B-DNA
correlates	VBZ	ROOT	O
with	IN	case	O
translation	NN	nmod	O
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
NF-MATp35	NN	nmod	B-protein
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
depend	VB	xcomp	O
on	IN	case	O
de	FW	amod	O
novo	FW	dep	O
protein	NN	compound	O
synthesis	NN	nmod	O
and	CC	cc	O
was	VBD	cop	O
restricted	JJ	conj	O
to	TO	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubj	O
received	VBD	acl:relcl	O
a	DT	det	O
mitogenic	JJ	amod	O
combination	NN	dobj	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
stimuli	NNS	nmod	O
,	,	punct	O
not	RB	neg	O
necessarily	RB	conj	O
including	VBG	case	O
CD28	NN	compound	B-protein
signaling	NN	nmod	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
DMSO	NN	nsubj	O
has	VBZ	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
inducible	JJ	amod	O
Rel	NN	compound	B-protein
A	NN	compound	I-protein
binding	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
of	IN	case	O
a	DT	det	O
child	NN	nmod	O
with	IN	case	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	nmod	O
are	VBP	cop	O
defective	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
lymphokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
that	WDT	nsubj	O
include	VBP	acl:relcl	O
IL2	NN	dobj	B-DNA
,	,	punct	O
IL3	NN	conj	B-DNA
,	,	punct	O
IL4	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
IL5	NN	conj	B-DNA
,	,	punct	O
which	WDT	nsubj	O
encode	VBP	acl:relcl	O
interleukins	NNS	dobj	B-protein
2	CD	dep	O
,	,	punct	O
3	CD	conj	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
and	CC	cc	O
5	CD	conj	O
(	-LRB-	punct	O
IL-2	NN	dep	B-protein
,	,	punct	O
-3	CD	conj	B-protein
,	,	punct	O
-4	CD	conj	B-protein
,	,	punct	O
and	CC	cc	O
-5	CD	conj	B-protein
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
targeting	VBG	nsubj	O
IFN	NN	compound	B-protein
synthesis	NN	dobj	O
to	TO	case	O
HIV-1-infected	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	cop	O
an	DT	det	O
attainable	JJ	amod	O
goal	NN	ccomp	O
and	CC	cc	O
that	IN	mark	O
autocrine	JJ	amod	O
IFN	NN	compound	B-protein
synthesis	NN	nsubj	O
results	VBZ	conj	O
in	IN	case	O
a	DT	det	O
long-lasting	JJ	amod	O
and	CC	cc	O
permanent	JJ	conj	O
suppression	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
.	.	punct	O

Differential	JJ	amod	O
contribution	NN	ROOT	O
of	IN	case	O
herpes	NN	compound	B-protein
simplex	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
gene	NN	compound	I-protein
products	NNS	nmod	I-protein
and	CC	cc	O
cellular	JJ	amod	B-protein
factors	NNS	conj	I-protein
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
provirus	NN	nmod	O
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
signaling	NN	nmod	O
by	IN	case	O
mitogen-activated	JJ	amod	B-protein
protein	NN	nmod:npmod	I-protein
kinase-targeted	JJ	amod	I-protein
hematopoietic	JJ	amod	I-protein
tyrosine	NN	compound	I-protein
phosphatase	NN	nmod	I-protein
(	-LRB-	punct	O
HePTP	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
cell-free	JJ	amod	B-protein
synthesized	VBN	amod	I-protein
hGR	NN	nsubj	I-protein
was	VBD	cop	O
capable	JJ	ROOT	O
of	IN	case	O
specific	JJ	amod	O
binding	NN	nmod	O
to	TO	case	O
glucocorticoid	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
GRE	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-containing	JJ	amod	I-DNA
DNA	NN	compound	I-DNA
fragments	NNS	nmod	I-DNA
.	.	punct	O

Elucidation	NN	nsubj	O
of	IN	case	O
IL-5	NN	compound	B-protein
-specific	JJ	amod	O
regulatory	JJ	amod	O
mechanisms	NNS	nmod	O
may	MD	aux	O
facilitate	VB	ROOT	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
novel	JJ	amod	O
treatments	NNS	nmod	O
for	IN	case	O
allergic	JJ	amod	O
diseases	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
eosinophilic	JJ	amod	O
inflammation	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
cultures	NNS	nmod	O
of	IN	case	O
HIV-infected	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
by	IN	mark	O
using	VBG	advcl	O
neutralizing	VBG	amod	O
anti-TNF-alpha	JJ	amod	B-protein
antibodies	NNS	dobj	I-protein
or	CC	cc	O
TNF-alpha	NN	conj	B-protein
.	.	punct	O

Early	JJ	amod	O
studies	NNS	nsubj	O
in	IN	case	O
murine	JJ	amod	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
indicated	VBD	ROOT	O
that	IN	mark	O
transcriptional	JJ	amod	O
transactivation	NN	compound	O
functions	NNS	nsubjpass	O
encoded	VBN	acl	O
in	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
GR	NN	compound	I-protein
)	-RRB-	punct	I-protein
N-terminal	JJ	amod	I-protein
domain	NN	nmod	I-protein
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
glucocorticoid-mediated	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

Activated	VBN	amod	O
Stat	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
form	VBP	ROOT	O
homo-	JJ	dobj	O
or	CC	cc	O
heterodimers	NNS	conj	O
,	,	punct	O
translocate	VBP	conj	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
and	CC	cc	O
induce	VBP	conj	O
transcription	NN	dobj	O
from	IN	case	O
responsive	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
NF-kappaB	NN	nsubjpass	B-protein
may	MD	aux	O
be	VB	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
human	JJ	amod	O
CD34	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
clonogenic	JJ	amod	O
function	NN	conj	O
and	CC	cc	O
survival	NN	conj	O
.	.	punct	O

The	DT	det	O
E3-dependent	JJ	amod	O
ubiquitinylation	NN	nsubjpass	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
upon	IN	case	O
the	DT	det	O
heterodimerization	NN	nmod	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
with	IN	case	O
c-Fos	NN	nmod	B-protein
.	.	punct	O

Efficient	JJ	amod	O
transcription	NN	ROOT	O
and	CC	cc	O
replication	NN	conj	O
of	IN	case	O
simian	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	compound	B-DNA
and	CC	cc	I-DNA
Sp1	NN	conj	I-DNA
binding	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
anionic	JJ	amod	O
phosphatidylserine	NN	nsubjpass	O
is	VBZ	auxpass	O
exposed	VBN	ccomp	O
by	IN	case	O
rat	NN	compound	B-cell_type
vascular	JJ	amod	I-cell_type
smooth	NN	amod	I-cell_type
muscle	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
VSMCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
undergoing	VBG	acl	O
apoptosis	NN	dobj	O
after	IN	case	O
serum	NN	compound	O
withdrawal	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
DSE	NN	compound	B-DNA
and	CC	cc	O
TRE	NN	conj	B-DNA
sites	NNS	nsubj	O
can	MD	aux	O
not	RB	neg	O
bind	VB	advcl	O
CREB/ATF	NN	compound	B-protein
homodimers	NNS	dobj	I-protein
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
a	DT	det	O
mechanism	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
HIV-1	NN	nsubj	O
DSE	NN	dep	B-DNA
bind	VBP	acl:relcl	O
heterodimers	NNS	dobj	B-protein
composed	VBN	acl	O
of	IN	case	O
both	CC	cc:preconj	O
AP-1	NN	nmod	B-protein
and	CC	cc	I-protein
CREB/ATF	NN	conj	I-protein
proteins	NNS	dep	I-protein
.	.	punct	O

T-lymphocytes	NNS	nsubj	B-cell_type
from	IN	case	O
individuals	NNS	nmod	O
with	IN	case	O
filarial	JJ	amod	O
inflammatory	JJ	amod	O
disease	NN	nmod	O
have	VBP	aux	O
increased	VBN	ROOT	O
transendothelial	JJ	amod	O
migration	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

In	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
staurosporine	NN	nsubj	O
achieved	VBN	ROOT	O
approximately	RB	advmod	O
90	CD	nummod	O
%	NN	amod	O
inhibition	NN	dobj	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	O
antigen	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
heat	NN	compound	B-cell_line
shock-treated	JJ	amod	I-cell_line
OM10.1	NN	nmod	I-cell_line
at	IN	case	O
a	DT	det	O
non-toxic	JJ	amod	O
concentration	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
assessed	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
anti-inflammatory	JJ	amod	O
glucocorticoids	NNS	nmod	O
on	IN	case	O
this	DT	det	O
leukocyte	NN	compound	O
clearance	NN	compound	O
mechanism	NN	nmod	O
.	.	punct	O

IL-2	NN	nsubj	B-protein
and	CC	cc	O
IL-7	NN	conj	B-protein
induce	VBP	ROOT	O
heterodimerization	NN	dobj	O
of	IN	case	O
STAT5	NN	compound	B-protein
isoforms	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
.	.	punct	O

Following	VBG	case	O
an	DT	det	O
initial	JJ	amod	O
genotype	NN	compound	O
screening	NN	nsubjpass	O
of	IN	case	O
85	CD	nummod	O
normal	JJ	amod	O
volunteers	NNS	nmod	O
by	IN	case	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
or	CC	cc	O
restriction	NN	compound	B-DNA
fragment	NN	compound	I-DNA
length	NN	compound	I-DNA
polymorphism	NN	compound	I-DNA
analysis	NN	conj	O
,	,	punct	O
14	CD	nummod	O
individuals	NNS	conj	O
with	IN	case	O
the	DT	det	O
Bb	NN	compound	O
genotype	NN	nmod	O
,	,	punct	O
12	CD	appos	O
with	IN	case	O
the	DT	det	O
bb	NN	nummod	O
genotype	NN	nmod	O
,	,	punct	O
and	CC	cc	O
12	CD	conj	O
with	IN	case	O
the	DT	det	O
BB	NN	compound	O
genotype	NN	nmod	O
were	VBD	auxpass	O
selected	VBN	ROOT	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
the	DT	det	O
modulation	NN	nsubj	O
of	IN	case	O
corticosensitivity	NN	nmod	O
in	IN	case	O
TNFalpha-	NN	amod	B-cell_line
and	CC	cc	I-cell_line
IL-10-pretreated	JJ	conj	I-cell_line
U937	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	cop	O
related	JJ	ccomp	O
to	TO	case	O
a	DT	det	O
change	NN	nmod	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
concentration	NN	nmod	O
and	CC	cc	O
affinity	NN	conj	O
.	.	punct	O

The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
IL-1	NN	nmod	B-protein
was	VBD	auxpass	O
expressed	VBN	ROOT	O
as	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
stimulate	VB	acl	O
3H-TdR	NN	compound	B-protein
incorporation	NN	dobj	O
in	IN	case	O
the	DT	det	O
thymocytes	NNS	nmod	B-cell_type
of	IN	case	O
C57	NN	compound	O
mice	NNS	nmod	O
.	.	punct	O

Intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nsubj	I-protein
and	CC	cc	O
P-selectin-specific	JJ	amod	B-protein
monoclonal	JJ	amod	I-protein
antibodies	NNS	conj	I-protein
attenuated	VBD	ROOT	O
the	DT	det	O
increased	VBN	amod	O
neutrophil	NN	compound	B-cell_type
adhesion	NN	dobj	O
during	IN	case	O
both	DT	det	O
phases	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
an	DT	det	O
anti-E-selectin	JJ	amod	B-protein
monoclonal	JJ	amod	I-protein
antibody	NN	nsubj	I-protein
also	RB	advmod	O
attenuated	VBD	parataxis	O
the	DT	det	O
phase	NN	compound	O
2	CD	nummod	O
response	NN	dobj	O
.	.	punct	O

IL-2	NN	compound	B-protein
secretion	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
more	JJR	advmod	O
than	IN	mwe	O
twofold	RB	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
primary	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
stimulated	VBN	acl	O
by	IN	case	O
extracellular	JJ	amod	B-protein
HIV-1	NN	compound	I-protein
Tat	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
studies	NNS	nsubjpass	O
described	VBN	acl	O
herein	RB	advmod	O
were	VBD	auxpass	O
undertaken	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
immunotoxicity	NN	dobj	O
of	IN	case	O
one	CD	nummod	O
member	NN	nmod	O
of	IN	case	O
this	DT	det	O
family	NN	nmod	O
,	,	punct	O
dimethyldithiocarbamate	NN	conj	O
(	-LRB-	punct	O
DMDTC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Using	VBG	advcl	O
antigen	NN	compound	O
peptide	NN	compound	O
analogs	NNS	dobj	O
with	IN	case	O
different	JJ	amod	O
mutations	NNS	nmod	O
of	IN	case	O
known	JJ	amod	O
DQ2-anchor	NN	amod	O
residues	NNS	nmod	O
,	,	punct	O
T	NN	compound	O
cell	NN	compound	O
response	NN	nsubjpass	O
was	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
an	DT	det	O
peptide-affinity	NN	nmod	O
and	CC	cc	O
-	HYPH	conj	O
concentration	NN	nmod:npmod	O
specific	JJ	dep	O
manner	NN	dep	O
.	.	punct	O

Binding	NN	nsubjpass	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
,	,	punct	O
NF-kappaB	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
AP-1	NN	conj	B-protein
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
T-cell	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
TcR	NN	appos	B-protein
)	-RRB-	punct	O
stimulation	NN	nmod	O
,	,	punct	O
although	IN	mark	O
there	EX	expl	O
was	VBD	advcl	O
no	DT	neg	O
significant	JJ	amod	O
upregulation	NN	nsubj	O
of	IN	case	O
binding	NN	nmod	O
by	IN	case	O
IL-2	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

MNDA	NN	nsubj	B-protein
(	-LRB-	punct	O
myeloid	JJ	amod	B-protein
cell	NN	compound	I-protein
nuclear	JJ	amod	I-protein
differentiation	NN	compound	I-protein
antigen	NN	appos	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
interferon	NN	nmod:npmod	B-protein
alpha	NN	nmod:npmod	I-protein
regulated	VBD	amod	I-protein
nuclear	JJ	amod	I-protein
protein	NN	ROOT	I-protein
expressed	VBN	acl	O
only	RB	advmod	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_type
myelomonocytic	JJ	amod	I-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
growth-factor-dependent	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubj	I-cell_line
derived	VBN	acl	O
from	IN	case	O
mouse	NN	compound	B-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
contains	VBZ	ROOT	O
progenitors	NNS	dobj	O
endowed	JJ	acl	O
with	IN	case	O
high	JJ	amod	O
proliferative	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

The	DT	det	O
decrease	NN	nsubj	O
of	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
type	NN	compound	O
IIa	NN	compound	O
hyperlipidemia	NN	nmod	O
seems	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
compensatory	JJ	amod	O
response	NN	xcomp	O
of	IN	case	O
cells	NNS	nmod	O
culminating	VBG	acl	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
endogenous	JJ	amod	O
cholesterol	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
protein	NN	compound	I-protein
EBNA2	NN	nsubj	I-protein
acts	VBZ	ROOT	O
as	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	B-protein
activator	NN	nmod	I-protein
of	IN	case	O
cellular	JJ	amod	B-DNA
and	CC	cc	I-DNA
viral	JJ	conj	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
plays	VBZ	conj	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
immortalization	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
primary	JJ	amod	I-cell_type
B-cells	NNS	nmod	I-cell_type
by	IN	case	O
EBV	NN	nmod	O
.	.	punct	O

The	DT	det	O
direct	JJ	amod	O
coupling	NN	nsubj	O
between	IN	case	O
cytokine	NN	compound	B-protein
receptor	NN	nmod	I-protein
and	CC	cc	O
transcription	NN	compound	B-protein
factor	NN	conj	I-protein
helps	VBZ	ROOT	O
to	TO	mark	O
explain	VB	xcomp	O
how	WRB	advmod	O
different	JJ	amod	O
cytokines	NNS	nsubj	B-protein
elicit	VBP	ccomp	O
distinct	JJ	amod	O
patterns	NNS	dobj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
TPA	NN	nmod	B-protein
,	,	punct	O
bryostatin	NN	conj	B-protein
1	CD	nummod	I-protein
,	,	punct	O
and	CC	cc	O
retinoic	JJ	amod	O
acid	NN	conj	O
on	IN	case	O
PO-B	NN	nmod	B-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
AP-2	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	conj	O
during	IN	case	O
HL-60	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Copyright	NN	dep	O
1998	CD	ROOT	O
Academic	NNP	compound	O
Press	NNP	dep	O
.	.	punct	O

These	DT	det	O
stimuli	NNS	nsubj	O
result	VBP	ROOT	O
in	IN	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
CREB	NN	nmod	B-protein
at	IN	case	O
serine	NN	nmod	O
133	CD	nummod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
reported	VBD	acl	O
on	IN	case	O
the	DT	det	O
constitutive	JJ	amod	O
interferon-gamma	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
IFN-gammaR	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	nmod	O
on	IN	case	O
eosinophils	NNS	nmod	B-cell_type
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
high-level	JJ	amod	O
IL-4	NN	compound	B-protein
production	NN	nsubjpass	O
in	IN	case	O
atopic	JJ	amod	B-cell_type
Th2	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
selective	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
suppressive	JJ	amod	O
NFAT1	NN	compound	B-protein
activity	NN	nmod	O
at	IN	case	O
the	DT	det	O
IL-4	NN	compound	B-DNA
P0	NN	compound	I-DNA
element	NN	nmod	I-DNA
and	CC	cc	O
that	IN	mark	O
some	DT	det	O
patients	NNS	nsubj	O
with	IN	case	O
this	DT	det	O
multifactorial	JJ	amod	O
disease	NN	nmod	O
may	MD	aux	O
have	VB	conj	O
a	DT	det	O
putative	JJ	amod	O
systemic	JJ	amod	O
disorder	NN	dobj	O
at	IN	case	O
this	DT	det	O
level	NN	nmod	O
.	.	punct	O

This	DT	det	O
finding	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
phospholipase	NN	compound	B-protein
A2	NN	nsubjpass	I-protein
and	CC	cc	O
5-lipoxygenase	NN	conj	B-protein
are	VBP	auxpass	O
also	RB	advmod	O
involved	VBN	ccomp	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
to	TO	mark	O
bind	VB	acl	O
to	TO	case	O
GRE	NN	nmod	B-DNA
is	VBZ	cop	O
impaired	JJ	ccomp	O
in	IN	case	O
steroid-resistant	JJ	amod	O
patients	NNS	nmod	O
because	IN	case	O
of	IN	mwe	O
a	DT	det	O
reduced	VBN	amod	O
number	NN	nmod	O
of	IN	case	O
receptors	NNS	nmod	B-protein
available	JJ	amod	O
for	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
DNA	NN	nmod	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
patients	NNS	nmod	O
a	DT	det	O
marked	JJ	amod	O
decrease	NN	nsubj	O
in	IN	case	O
IL-2-producing	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	conj	O
in	IN	case	O
well-differentiated	JJ	amod	O
Th1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubj	O
produced	VBD	acl:relcl	O
IFN-gamma	NN	dobj	B-protein
but	CC	cc	O
not	RB	cc	O
IL-2	NN	conj	B-protein
were	VBD	cop	O
evident	JJ	ROOT	O
after	IN	mark	O
priming	VBG	advcl	O
with	IN	case	O
anti-CD3	JJ	nmod	B-protein
and	CC	cc	O
anti-CD28	NN	conj	B-protein
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
the	DT	det	O
presence	NN	dobj	O
in	IN	case	O
vaginal	JJ	amod	O
fluid	NN	nmod	O
of	IN	case	O
agent	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
derived	VBN	acl	O
from	IN	case	O
indigenous	JJ	amod	O
bacteria	NNS	nmod	O
that	WDT	nsubj	O
can	MD	aux	O
activate	VB	acl:relcl	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	dobj	I-DNA
,	,	punct	O
cytokine	NN	compound	B-protein
production	NN	conj	O
,	,	punct	O
and	CC	cc	O
NF-kappaB	NN	conj	B-protein
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
,	,	punct	O
with	IN	case	O
possible	JJ	amod	O
influence	NN	nmod	O
on	IN	case	O
vaginal	JJ	amod	O
physiology	NN	nmod	O
and	CC	cc	O
host	NN	compound	O
defense	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
cloned	VBN	ROOT	O
the	DT	det	O
CD14	NN	compound	B-DNA
5	CD	nummod	I-DNA
'	``	punct	I-DNA
upstream	JJ	amod	I-DNA
sequence	NN	dobj	I-DNA
and	CC	cc	O
demonstrated	VBD	conj	O
its	PRP$	nmod:poss	O
tissue-specific	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
.	.	punct	O

Translational	JJ	amod	O
initiation	NN	nsubj	O
of	IN	case	O
encephalomyocarditis	NN	compound	B-RNA
virus	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
EMCV	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	nmod	I-RNA
occurs	VBZ	ROOT	O
by	IN	case	O
ribosomal	JJ	amod	O
entry	NN	nmod	O
into	IN	case	O
the	DT	det	O
5	CD	nummod	B-DNA
'	''	punct	I-DNA
nontranslated	VBN	amod	I-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
EMCV	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
rather	RB	cc	O
than	IN	mwe	O
by	IN	case	O
ribosomal	JJ	amod	O
scanning	NN	conj	O
.	.	punct	O

Cytokine	NN	compound	B-protein
signal	NN	compound	I-protein
networks	NNS	ROOT	I-protein
and	CC	cc	O
a	DT	det	O
new	JJ	amod	O
era	NN	conj	O
in	IN	prep	O
biomedical	JJ	amod	O
research	NN	pobj	O
.	.	punct	O

The	DT	det	O
negative-acting	JJ	amod	B-DNA
sequences	NNS	nsubj	I-DNA
repress	VBP	ROOT	O
enhancer	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
position-	NN	amod	O
and	CC	cc	O
orientation-independent	JJ	conj	O
manner	NN	nmod	O
at	IN	case	O
the	DT	det	O
pre-B-cell	JJ	amod	O
stage	NN	nmod	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
mineralocorticoids	NNS	nmod	O
in	IN	case	O
the	DT	det	O
pathophysiology	NN	nmod	O
of	IN	case	O
PIH	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
plasma	NN	compound	O
aldosterone	NN	dobj	O
and	CC	cc	O
18-hydroxy-corticosterone	NN	conj	O
(	-LRB-	punct	O
18-OH-B	NN	appos	O
)	-RRB-	punct	O
levels	NNS	conj	O
in	IN	case	O
25	CD	nummod	O
women	NNS	nmod	O
with	IN	case	O
PIH	NN	nmod	O
and	CC	cc	O
in	IN	case	O
25	CD	nummod	O
healthy	JJ	amod	O
pregnant	JJ	amod	O
women	NNS	conj	O
.	.	punct	O

Although	IN	mark	O
four	CD	nummod	O
specific	JJ	amod	O
complexes	NNS	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
detected	VBN	advcl	O
binding	VBG	xcomp	O
to	TO	case	O
this	DT	det	O
sequence	NN	nmod	O
,	,	punct	O
only	RB	advmod	O
one	CD	nsubj	O
of	IN	case	O
these	DT	det	O
complexes	NNS	nmod	O
is	VBZ	cop	O
specific	JJ	ROOT	O
for	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
CD28RE	NN	nmod	B-DNA
and	CC	cc	O
the	DT	det	O
adjacent	JJ	amod	B-DNA
AP-1	NN	compound	I-DNA
site	NN	conj	I-DNA
.	.	punct	O

TN	NN	nsubj	B-protein
also	RB	advmod	O
inhibits	VBZ	ROOT	O
proliferation	NN	dobj	O
driven	VBN	acl	O
by	IN	case	O
alpha	NN	compound	B-protein
CD3/IL-2	NN	nmod	I-protein
or	CC	cc	O
by	IN	case	O
phorbol	NN	compound	B-protein
ester/IL-2	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	O
it	PRP	nsubj	O
prevents	VBZ	conj	O
high	JJ	amod	O
level	NN	compound	O
induction	NN	dobj	O
of	IN	case	O
IL-2R	NN	nmod	B-protein
.	.	punct	O

T-cell	NN	compound	O
prolymphocytic	JJ	amod	O
leukemia	NN	nsubjpass	O
(	-LRB-	punct	O
T-PLL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
rare	JJ	amod	O
form	NN	appos	O
of	IN	case	O
mature	JJ	amod	O
T-cell	NN	compound	O
leukemias	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
ataxia	NN	compound	O
telangiectasia	NN	compound	O
clonal	JJ	amod	O
proliferation	NN	conj	O
,	,	punct	O
a	DT	det	O
related	JJ	amod	O
condition	NN	appos	O
occurring	VBG	acl	O
in	IN	case	O
patients	NNS	nmod	O
suffering	VBG	acl	O
from	IN	case	O
ataxia	NN	compound	O
telangiectasia	NN	nmod	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
to	TO	case	O
translocations	NNS	nmod	O
involving	VBG	acl	O
the	DT	det	O
14q32.1	NN	dobj	B-DNA
or	CC	cc	O
Xq28	NN	compound	B-DNA
regions	NNS	conj	I-DNA
,	,	punct	O
where	WRB	advmod	O
are	VBP	cop	O
located	JJ	acl:relcl	O
the	DT	det	O
TCL1	NN	compound	B-DNA
and	CC	cc	I-DNA
MTCP1	NN	conj	I-DNA
putative	JJ	amod	I-DNA
oncogenes	NNS	dobj	I-DNA
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
base	NN	compound	O
exchange	NN	nsubj	O
at	IN	case	O
-509	CD	nmod	O
(	-LRB-	punct	O
from	IN	case	O
the	DT	det	O
transcription	NN	compound	O
initiation	NN	compound	O
site	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
TGF-beta	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
also	RB	advmod	O
linked	VBN	ROOT	O
to	TO	case	O
elevated	JJ	amod	O
total	JJ	amod	O
IgE	NN	nmod	B-protein
(	-LRB-	punct	O
p	NN	dep	O
<	JJR	dep	O
0.01	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

In	FW	amod	O
situ	FW	dep	O
hybridizations	NNS	nsubj	O
of	IN	case	O
adult	JJ	amod	O
murine	JJ	amod	O
tissues	NNS	nmod	O
demonstrate	VBP	ROOT	O
Spi-B	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
in	IN	case	O
the	DT	det	O
medulla	NN	nmod	O
of	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
,	,	punct	O
the	DT	det	O
white	JJ	amod	O
pulp	NN	dobj	O
of	IN	case	O
the	DT	det	O
spleen	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
germinal	JJ	amod	O
centers	NNS	conj	O
of	IN	case	O
lymph	NN	compound	O
nodes	NNS	nmod	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
pathway	NN	nmod	O
by	IN	case	O
inflammatory	JJ	amod	O
stimuli	NNS	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
neutrophils	NNS	nmod	I-cell_type
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
point	VBP	ROOT	O
to	TO	case	O
a	DT	det	O
novel	JJ	amod	O
alternative	JJ	amod	O
mechanism	NN	nmod	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
alpha-tcp	NN	nmod	O
.	.	punct	O

Naturally	RB	advmod	O
processed	VBN	amod	O
forms	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
structures	NNS	nmod	O
are	VBP	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
occur	VB	xcomp	O
given	VBN	dep	O
the	DT	det	O
importance	NN	dobj	O
and	CC	cc	O
frequency	NN	conj	O
of	IN	case	O
deamidation	NN	nmod	O
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Glucocorticoids	NNS	nsubjpass	O
are	VBP	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
downregulate	VB	xcomp	O
interleukin-1	NN	compound	B-protein
beta	NN	compound	I-protein
production	NN	dobj	O
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
mechanims	NNS	nmod	O
:	:	punct	O
direct	JJ	amod	O
inhibition	NN	dep	O
of	IN	case	O
the	DT	det	O
gene	NN	compound	O
transcription	NN	nmod	O
and	CC	cc	O
destabilization	NN	conj	O
of	IN	case	O
the	DT	det	O
preformed	JJ	amod	O
interleukin-1	NN	compound	B-RNA
beta	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Peripheral	JJ	amod	B-DNA
leucocyte	NN	compound	I-DNA
genomic	JJ	amod	I-DNA
DNAs	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
obtained	VBN	ROOT	O
from	IN	case	O
41	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
primary	JJ	amod	O
ovarian	JJ	amod	O
carcinoma	NN	nmod	O
and	CC	cc	O
83	CD	nummod	O
controls	NNS	conj	O
from	IN	case	O
Ireland	NNP	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
from	IN	case	O
26	CD	nummod	O
primary	JJ	amod	O
ovarian	JJ	amod	O
carcinoma	NN	compound	O
patients	NNS	conj	O
and	CC	cc	O
101	CD	nummod	O
controls	NNS	conj	O
in	IN	case	O
Germany	NNP	nmod	O
.	.	punct	O

NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
DNA-binding	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
factor	NN	ROOT	I-protein
able	JJ	amod	O
to	TO	mark	O
control	VB	xcomp	O
transcription	NN	dobj	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
HIV	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
depletion	NN	nsubj	O
of	IN	case	O
Sp1	NN	nmod	B-protein
(	-LRB-	punct	O
A1	NN	appos	B-protein
)	-RRB-	punct	O
from	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
specifically	RB	advmod	O
decreases	VBZ	ccomp	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	compound	O
activity	NN	dobj	O
on	IN	case	O
GM-CSF	NN	compound	B-protein
templates	NNS	nmod	O
.	.	punct	O

Leiomyosarcoma	NN	ROOT	O
of	IN	case	O
the	DT	det	O
vulva	NN	nmod	O
:	:	punct	O
report	NN	dep	O
of	IN	prep	O
a	DT	det	O
case	NN	pobj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
investigators	NNS	nsubj	O
have	VBP	aux	O
hypothesized	VBN	ROOT	O
that	IN	mark	O
CD14	NN	compound	B-protein
-mediated	JJ	amod	O
signaling	NN	nsubjpass	O
is	VBZ	auxpass	O
effected	VBN	ccomp	O
through	IN	case	O
a	DT	det	O
receptor-associated	JJ	amod	O
tyrosine	NN	compound	B-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
TK	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
suggesting	VBG	xcomp	O
a	DT	det	O
multicomponent	JJ	amod	O
receptor	NN	compound	O
model	NN	dobj	O
of	IN	case	O
LPS	NN	compound	O
signaling	NN	nmod	O
.	.	punct	O

Both	DT	nsubj	O
of	IN	case	O
these	DT	det	O
parameters	NNS	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
change	VB	ROOT	O
significantly	RB	advmod	O
after	IN	case	O
mitogen	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Receptor	NN	compound	B-protein
activator	NN	nsubj	I-protein
of	IN	case	I-protein
NF-kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
RANK	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
recently	RB	advmod	O
identified	VBN	amod	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
receptor	NN	compound	I-protein
superfamily	NN	nmod	I-protein
and	CC	cc	O
is	VBZ	auxpass	O
expressed	VBN	conj	O
on	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
dendritic	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

PMA	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
increase	VB	xcomp	O
the	DT	det	O
AP-1	NN	compound	O
enhancer	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
elevation	NN	nsubj	O
of	IN	case	O
Ca2+	NN	nmod	O
or	CC	cc	O
cAMP	NN	conj	O
had	VBD	parataxis	O
only	RB	advmod	O
minor	JJ	amod	O
effects	NNS	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
implicate	VBP	ROOT	O
two	CD	nummod	O
members	NNS	dobj	O
of	IN	case	O
the	DT	det	O
Ets	NN	compound	B-protein
family	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
IgH	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
cultured	VBD	ROOT	O
M-TAT	NN	compound	B-cell_line
cells	NNS	compound	I-cell_line
long	JJ	amod	O
term	NN	dobj	O
(	-LRB-	punct	O
>	NN	intj	O
1	CD	nummod	O
year	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
continuous	JJ	amod	O
presence	NN	nmod	O
of	IN	case	O
erythropoietin	NN	nmod	B-protein
(	-LRB-	punct	O
EPO	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	conj	I-protein
(	-LRB-	punct	O
GM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
stem	NN	compound	B-protein
cell	NN	compound	I-protein
factor	NN	conj	I-protein
(	-LRB-	punct	O
SCF	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
the	DT	det	O
requirement	NN	nmod	O
for	IN	case	O
PC4	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
reconstituted	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
OCA-B	NN	nsubjpass	B-protein
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
interact	VB	xcomp	O
directly	RB	advmod	O
with	IN	case	O
PC4	NN	nmod	B-protein
.	.	punct	O

ER	NN	compound	B-protein
variants	NNS	nsubjpass	O
,	,	punct	O
generated	VBN	acl	O
by	IN	case	O
alternative	JJ	amod	O
splicing	NN	nmod	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
in	IN	case	O
normal	JJ	amod	O
mammary	JJ	amod	O
glands	NNS	conj	O
,	,	punct	O
therefore	RB	advmod	O
their	PRP$	nmod:poss	O
role	NN	nsubjpass	O
in	IN	case	O
tumorigenesis	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
questioned	VBN	parataxis	O
.	.	punct	O

Transcription	NN	compound	O
factor	NN	compound	O
Egr-1	NN	compound	B-protein
activity	NN	nsubj	O
down-regulates	VBZ	ROOT	O
Fas	NN	compound	O
and	CC	cc	O
CD23	NN	conj	O
expression	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Twenty-two	CD	nummod	O
patients	NNS	nsubjpass	O
with	IN	case	O
severe	JJ	amod	O
restrictive	JJ	amod	O
anorexia	NN	compound	O
nervosa	NN	nmod	O
,	,	punct	O
10	CD	nummod	O
patients	NNS	appos	O
with	IN	case	O
active	JJ	amod	O
Cushing	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
,	,	punct	O
and	CC	cc	O
24	CD	nummod	O
healthy	JJ	amod	O
volunteers	NNS	conj	O
without	IN	case	O
psychiatric	JJ	amod	O
disorders	NNS	nmod	O
or	CC	cc	O
mood	NN	compound	O
alterations	NNS	conj	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

Potent	JJ	amod	O
gene	NN	nmod:npmod	O
regulatory	JJ	amod	O
and	CC	cc	O
antiproliferative	JJ	conj	O
activities	NNS	ROOT	O
of	IN	case	O
20-methyl	JJ	amod	O
analogues	NNS	nmod	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
PB1	NN	compound	B-DNA
element	NN	nsubj	I-DNA
alone	RB	advmod	O
confers	VBZ	ccomp	O
inducibility	NN	dobj	O
on	IN	case	O
a	DT	det	O
heterologous	JJ	amod	O
promoter	NN	nmod	O
following	VBG	case	O
transfection	NN	nmod	O
into	IN	case	O
human	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
was	VBD	cop	O
gene	NN	nmod:npmod	O
selective	JJ	ROOT	O
and	CC	cc	O
not	RB	conj	O
due	JJ	case	O
to	TO	mwe	O
general	JJ	amod	O
effects	NNS	conj	O
on	IN	case	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

Regulation	NN	nsubjpass	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
GR	NN	appos	O
)	-RRB-	punct	O
expression	NN	nmod	O
by	IN	case	O
its	PRP$	nmod:poss	O
cognate	JJ	amod	O
ligand	NN	nmod	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
glucocorticoid-sensitive	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
leukemic	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
6TG1.1	NN	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
B-cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
IM-9	NN	conj	I-cell_line
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
cross-linking	NN	nsubj	O
of	IN	case	O
CD30	NN	nmod	B-protein
leads	VBZ	ROOT	O
to	TO	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
and	CC	cc	O
enhanced	VBN	conj	O
HIV	NN	compound	O
transcription	NN	dobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
examine	VBP	ROOT	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
controlling	VBG	acl	O
the	DT	det	O
pattern	NN	dobj	O
of	IN	case	O
alpha	NN	compound	B-protein
4	CD	nummod	I-protein
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
aspirin	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
lower	VB	xcomp	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
myocardial	JJ	amod	O
infarction	NN	nmod	O
in	IN	case	O
men	NNS	nmod	O
.	.	punct	O

Overall	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Calphostin	NN	compound	O
C	NN	nsubj	O
prevents	VBZ	ccomp	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-1beta	NN	compound	B-DNA
gene	NN	nmod	I-DNA
thereby	RB	advmod	O
inhibiting	VBG	acl	O
protein	NN	compound	O
synthesis	NN	dobj	O
.	.	punct	O

p49	NN	nsubj	B-protein
has	VBZ	ROOT	O
a	DT	det	O
approximately	RB	advmod	O
18-fold-lower	JJ	amod	O
affinity	NN	dobj	O
for	IN	case	O
the	DT	det	O
HIV	NN	compound	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
site	NN	nmod	I-DNA
(	-LRB-	punct	O
KD	NN	nsubj	O
=	JJ	acl:relcl	O
69.1	CD	nummod	O
pM	NN	dobj	O
)	-RRB-	punct	O
than	IN	mark	O
does	VBZ	cop	O
the	DT	det	O
approximately	RB	advmod	O
50-kDa	JJ	amod	O
protein	NN	compound	O
NFKB1	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
p50	NN	appos	I-protein
)	-RRB-	punct	I-protein
derived	VBN	acl	O
from	IN	case	O
p105	NN	nmod	B-protein
(	-LRB-	punct	O
KD	NN	nsubj	O
=	JJ	conj	O
3.9	CD	nummod	O
pM	NN	dobj	O
)	-RRB-	punct	O
.	.	punct	O

CCAAT/enhancer	NN	compound	B-protein
binding	NN	compound	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
C/EBP	NN	compound	I-protein
)	-RRB-	punct	I-protein
epsilon	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
recently	RB	advmod	O
cloned	VBN	amod	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
C/EBP	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
and	CC	cc	O
is	VBZ	auxpass	O
expressed	VBN	conj	O
exclusively	RB	advmod	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
hematopoietic	JJ	amod	O
origin	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	nsubj	O
was	VBD	cop	O
completely	RB	advmod	O
resistant	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
actions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
immunosuppressant	JJ	amod	O
cyclosporin	NN	compound	O
A	NN	nmod	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
by	IN	case	O
protein-affinity	JJ	amod	O
chromatography	NN	nmod	O
that	IN	mark	O
Rb	NN	nsubj	B-protein
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
or	CC	cc	O
produced	VBN	conj	O
by	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
translation	NN	nmod	O
directly	RB	advmod	O
bound	VBD	acl:relcl	O
to	TO	case	O
IE2	NN	nmod	B-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
complexes	NNS	nmod	O
to	TO	mark	O
regulate	VB	acl	O
gene	NN	compound	O
expression	NN	dobj	O
is	VBZ	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
increased	VBN	amod	O
transcription	NN	nmod	O
from	IN	case	O
an	DT	det	O
AP-1	NN	compound	B-DNA
driven	VBN	amod	I-DNA
reporter	NN	compound	I-DNA
construct	NN	nmod	I-DNA
and	CC	cc	O
marked	JJ	amod	O
increases	NNS	conj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
endogenous	JJ	amod	B-DNA
AP-1	NN	compound	I-DNA
regulated	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
results	NNS	nsubj	O
constitute	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
direct	JJ	amod	O
evidence	NN	dobj	O
of	IN	case	O
a	DT	det	O
positive	JJ	amod	O
role	NN	nmod	O
for	IN	case	O
the	DT	det	O
lymphoid-specific	JJ	amod	B-protein
octamer-binding	JJ	amod	I-protein
factor	NN	nmod	I-protein
in	IN	case	O
DRA	NN	compound	O
gene	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
idea	NN	dobj	O
that	IN	mark	O
superoxide	NN	compound	O
anion	NN	compound	O
radical	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
c-fos	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
reporter	NN	compound	O
transgenic	JJ	amod	O
mice	NNS	dobj	O
to	TO	mark	O
show	VB	xcomp	O
that	IN	mark	O
DNA	NN	compound	O
binding	NN	nsubjpass	O
and	CC	cc	O
transcriptional	JJ	amod	O
activities	NNS	conj	O
of	IN	case	O
NFAT	NN	nmod	B-protein
are	VBP	auxpass	O
transiently	RB	advmod	O
induced	VBN	ccomp	O
during	IN	case	O
the	DT	det	O
differentiation	NN	nmod	O
of	IN	case	O
pTh	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
into	IN	case	O
either	CC	cc:preconj	O
eTh1	NN	nmod	B-cell_type
or	CC	cc	O
eTh2	JJ	compound	B-cell_type
cells	NNS	conj	I-cell_type
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
as	IN	case	O
a	DT	det	O
common	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
in	IN	case	O
both	DT	det	O
pathways	NNS	nmod	O
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
Tax	NN	nsubj	B-protein
increased	VBD	ccomp	O
the	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
Sp1	NN	nmod	B-protein
and	CC	cc	O
NGFI-A/Egr-1	NN	conj	B-protein
using	VBG	xcomp	O
a	DT	det	O
TRE1	NN	compound	B-DNA
probe	NN	dobj	I-DNA
.	.	punct	O

Using	VBG	advcl	O
the	DT	det	O
1G5	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
harbouring	VBG	acl	O
the	DT	det	O
luciferase	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	dobj	I-DNA
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
first	RB	advmod	O
found	VBN	ROOT	O
that	IN	mark	O
culture	NN	compound	O
protein	NN	compound	O
filtrates	NNS	nsubj	O
(	-LRB-	punct	O
CFP	NN	appos	O
)	-RRB-	punct	O
from	IN	case	O
M.	FW	compound	O
tuberculosis	FW	nmod	O
or	CC	cc	O
purified	VBN	amod	O
ManLAM	NN	conj	O
could	MD	aux	O
activate	VB	ccomp	O
HIV-1	NN	compound	B-DNA
LTR-dependent	JJ	amod	I-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
unlike	IN	case	O
similarly	RB	advmod	O
prepared	VBN	amod	O
CFP	NN	compound	O
extracts	NNS	nmod	O
devoid	JJ	amod	O
of	IN	case	O
ManLAM	NN	nmod	O
.	.	punct	O

Constitutive	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
specific	JJ	amod	O
interferon	NN	compound	B-protein
isotypes	NNS	nmod	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
leukocytes	NNS	nmod	I-cell_type
from	IN	case	O
normal	JJ	amod	O
individuals	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
promonocytic	JJ	amod	B-cell_line
U937	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

In	IN	case	O
turn	NN	nmod	O
,	,	punct	O
assembly	NN	nsubj	O
of	IN	case	O
this	DT	det	O
complex	NN	nmod	O
mediates	VBZ	ROOT	O
the	DT	det	O
enzymatic	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
p21-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
1	CD	nummod	I-protein
and	CC	cc	O
facilitates	VBZ	conj	O
actin	NN	compound	B-protein
polymerization	NN	dobj	O
.	.	punct	O

Nuclear	JJ	amod	O
translocation	NN	nsubj	O
of	IN	case	O
cytosolic	JJ	amod	B-protein
c-Rel/p65	NN	compound	I-protein
heterodimers	NNS	nmod	I-protein
and	CC	cc	O
other	JJ	amod	O
members	NNS	conj	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B/Rel	NN	compound	I-protein
family	NN	nmod	I-protein
requires	VBZ	ROOT	O
dissociation	NN	dobj	O
and	CC	cc	O
proteolytic	JJ	amod	O
degradation	NN	conj	O
of	IN	case	O
the	DT	det	O
inhibitor	NN	compound	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	appos	I-protein
.	.	punct	O

Co-stimulation	NN	nsubj	O
of	IN	case	O
T-lymphocytes	NNS	nmod	B-cell_type
by	IN	case	O
T-cell	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
TcR	NN	appos	B-protein
)	-RRB-	punct	O
occupancy	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
CD28	NN	compound	B-protein
surface	NN	compound	I-protein
molecule	NN	nmod	I-protein
results	VBZ	ROOT	O
in	IN	case	O
enhanced	VBN	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
production	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
initial	JJ	amod	O
steps	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
1	CD	nmod	O
,	,	punct	O
25D3	NN	nummod	O
signaling	NN	compound	O
pathway	NN	nmod	O
are	VBP	cop	O
intact	JJ	ccomp	O
in	IN	case	O
B	NN	compound	O
series	NN	compound	O
resistant	JJ	amod	O
cells	NNS	nmod	O
and	CC	cc	O
lead	VB	conj	O
to	TO	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
early	JJ	amod	O
markers	NNS	nmod	O
of	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

None	NN	nsubj	O
of	IN	case	O
these	DT	det	O
polymorphisms	NNS	nmod	B-DNA
change	VBP	ROOT	O
the	DT	det	O
translated	VBN	amod	B-protein
protein	NN	dobj	I-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
regard	NN	nmod	O
,	,	punct	O
anti-inflammatory	JJ	amod	B-protein
cytokines	NNS	nsubj	I-protein
inhibited	VBD	ROOT	O
LPS	NN	compound	O
plus	CC	cc	O
GM-CSF	NN	nmod:npmod	B-protein
-stimulated	JJ	conj	O
HIV	NN	compound	O
expression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
effect	NN	nsubj	O
closely	RB	advmod	O
correlated	VBD	conj	O
with	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
IL-1	NN	compound	B-protein
beta	NN	compound	I-protein
release	NN	nmod	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
with	IN	case	O
up-regulation	NN	nmod	O
of	IN	case	O
endogenous	JJ	amod	O
IL-1ra	NN	amod	O
production	NN	nmod	O
.	.	punct	O

Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
infection	NN	nsubj	O
of	IN	case	O
mature	JJ	amod	O
,	,	punct	O
resting	VBG	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
drives	VBZ	ROOT	O
them	PRP	dobj	O
to	TO	aux	O
become	VB	xcomp	O
lymphoblasts	NNS	dobj	O
expressing	VBG	acl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
cell	NN	compound	O
surface	NN	compound	O
molecules	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
CD48	NN	nmod	B-protein
,	,	punct	O
characteristically	RB	advmod	O
expressed	VBN	advcl	O
on	IN	case	O
normal	JJ	amod	B-cell_type
activated	VBN	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

When	WRB	advmod	O
the	DT	det	O
supplemented	VBN	amod	O
cytokine	NN	nsubjpass	B-protein
was	VBD	auxpass	O
switched	VBN	advcl	O
from	IN	case	O
GM-CSF	NN	nmod	B-protein
to	TO	case	O
EPO	NN	nmod	B-protein
,	,	punct	O
hemoglobin	NN	compound	B-protein
synthesis	NN	conj	O
in	IN	case	O
M-TAT/GM-CSF	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
increased	VBD	ROOT	O
rapidly	RB	advmod	O
(	-LRB-	punct	O
within	IN	case	O
5	CD	nummod	O
h	NN	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
GATA-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
increased	VBD	conj	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
a	DT	det	O
phosphorylation-defective	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
Rb	NN	nmod	B-protein
inhibited	VBD	ROOT	O
Elf-1	NN	compound	B-protein
-dependent	JJ	amod	O
transcription	NN	dobj	O
during	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
.	.	punct	O

Dysregulation	NN	ROOT	O
of	IN	case	O
monocytic	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
factor-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
by	IN	case	O
oxidized	VBN	amod	O
low-density	JJ	amod	B-protein
lipoprotein	NN	nmod	I-protein
.	.	punct	O

Two	CD	nummod	O
new	JJ	amod	O
isoforms	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
that	WDT	nsubj	O
generate	VBP	ccomp	O
novel	JJ	amod	O
amino-	NN	dobj	B-protein
or	CC	cc	I-protein
carboxy-terminal	JJ	conj	I-protein
sequences	NNS	dep	I-protein
.	.	punct	O

Despite	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
LPS	NN	nmod	O
,	,	punct	O
disruption	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
signaling	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
precursor	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
led	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
loss	NN	nmod	O
of	IN	case	O
inducible	JJ	amod	O
Oct-2	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
the	DT	det	O
suppression	NN	conj	O
of	IN	case	O
Oct-2	NN	compound	B-protein
-directed	JJ	amod	O
transcription	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
whereas	IN	mark	O
both	CC	cc:preconj	O
Tax	NN	nsubj	B-protein
and	CC	cc	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	conj	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
able	JJ	advcl	O
to	TO	mark	O
efficiently	RB	advmod	O
induce	VB	xcomp	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
to	TO	case	O
the	DT	det	O
IL-2R	NN	compound	B-DNA
alpha	NN	compound	I-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
site	NN	nmod	I-DNA
,	,	punct	O
PMA	NN	nsubj	O
is	VBZ	cop	O
functionally	RB	advmod	O
inactive	JJ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
identified	VBN	ROOT	O
and	CC	cc	O
cloned	VBN	conj	O
a	DT	det	O
human	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	dobj	I-protein
,	,	punct	O
TCF-1	NN	appos	B-protein
,	,	punct	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
a	DT	det	O
functional	JJ	amod	O
element	NN	nmod	O
in	IN	case	O
the	DT	det	O
T	NN	nmod:npmod	O
lymphocyte-specific	JJ	amod	O
enhancer	NN	nmod	O
of	IN	case	O
CD3-epsilon	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
upstream	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	dobj	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-4	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

20-Epi	NN	compound	O
analogues	NNS	nsubj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
are	VBP	cop	O
highly	RB	advmod	O
potent	JJ	amod	O
inducers	NNS	ROOT	O
of	IN	case	O
DRIP	NN	compound	B-protein
coactivator	NN	compound	I-protein
complex	NN	nmod	I-protein
binding	VBG	acl	O
to	TO	case	O
the	DT	det	O
vitamin	NN	compound	B-protein
D3	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

IL-4	NN	nsubj	B-protein
activates	VBZ	ROOT	O
gene	NN	compound	O
expression	NN	dobj	O
by	IN	mark	O
inducing	VBG	advcl	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
,	,	punct	O
homodimerization	NN	conj	O
,	,	punct	O
and	CC	cc	O
nuclear	JJ	amod	O
translocation	NN	conj	O
of	IN	case	O
the	DT	det	O
latent	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
STAT6	NN	appos	B-protein
(	-LRB-	punct	O
signal	NN	compound	B-protein
transducer	NN	dep	I-protein
and	CC	cc	I-protein
activator	NN	conj	I-protein
of	IN	case	I-protein
transcription-6	NN	nmod	I-protein
)	-RRB-	punct	O
.	.	punct	O

Apoptosis	NN	nsubjpass	O
,	,	punct	O
or	CC	cc	O
programmed	VBN	amod	O
cell	NN	compound	O
death	NN	conj	O
,	,	punct	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
mode	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
death	NN	nmod	O
by	IN	mark	O
using	VBG	advcl	O
the	DT	det	O
TUNEL	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
detects	VBZ	acl:relcl	O
single	JJ	amod	O
strand	NN	compound	O
nicks	NNS	dobj	O
in	IN	case	O
DNA	NN	nmod	O
,	,	punct	O
or	CC	cc	O
by	IN	case	O
the	DT	det	O
Nicoletti	NN	compound	O
technique	NN	conj	O
demonstrating	VBG	acl	O
a	DT	det	O
subdiploid	JJ	amod	O
population	NN	dobj	O
by	IN	case	O
DNA	NN	compound	O
staining	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
ascorbate	NN	nmod	O
,	,	punct	O
AFR	NN	conj	O
and	CC	cc	O
dehydroascorbate	NN	conj	O
(	-LRB-	punct	O
DHA	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T-cells	NNS	nmod	I-cell_line
stimulated	VBN	acl	O
by	IN	case	O
tumour	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Functional	JJ	amod	O
studies	NNS	nsubj	O
in	IN	case	O
extra-renal	JJ	amod	B-cell_type
,	,	punct	I-cell_type
nonepithelial	JJ	dep	I-cell_type
cells	NNS	nmod	I-cell_type
such	JJ	case	O
as	IN	mwe	O
smooth	JJ	amod	B-cell_type
muscle	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
more	RBR	advmod	O
recently	RB	advmod	O
circulating	VBG	amod	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	conj	I-cell_type
have	VBP	aux	O
provided	VBN	ROOT	O
increasing	VBG	amod	O
evidence	NN	dobj	O
that	IN	mark	O
aldosterone	NN	nsubj	O
produces	VBZ	ccomp	O
not	RB	neg	O
only	RB	cc:preconj	O
classical	JJ	amod	O
genomic	JJ	amod	O
effects	NNS	dobj	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
rapid	JJ	amod	O
non-genomic	JJ	amod	O
effects	NNS	conj	O
on	IN	case	O
transmembrane	JJ	amod	O
electrolyte	NN	compound	O
movements	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
constitute	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
formal	JJ	amod	O
demonstration	NN	dobj	O
that	IN	mark	O
these	DT	det	O
genes	NNS	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	ccomp	O
by	IN	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
rel/NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
family	NN	nmod	I-protein
.	.	punct	O

Contrary	JJ	advmod	O
to	IN	prep	O
the	DT	det	O
idea	NN	pobj	O
that	IN	mark	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
TCR	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
,	,	punct	O
high	JJ	amod	O
doses	NNS	nsubj	O
of	IN	case	O
staurosporine	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
interfere	VB	ROOT	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
by	IN	case	O
PHA	NN	nmod	B-protein
,	,	punct	O
while	IN	mark	O
the	DT	det	O
same	JJ	amod	O
dose	NN	nsubj	O
of	IN	case	O
staurosporine	NN	nmod	O
completely	RB	advmod	O
blocked	VBD	advcl	O
activation	NN	dobj	O
by	IN	case	O
PMA	NN	nmod	O
.	.	punct	O

These	DT	det	O
synthetic	JJ	amod	O
ligands	NNS	nsubj	O
specifically	RB	advmod	O
inhibit	VBP	ROOT	O
DNA-binding	NN	dobj	O
of	IN	case	O
each	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
and	CC	cc	O
HIV	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
transcription	NN	conj	O
in	IN	case	O
cell-free	JJ	amod	O
assays	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
tyloxapol	NN	nsubj	O
is	VBZ	cop	O
potentially	RB	advmod	O
useful	JJ	ccomp	O
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
antiinflammatory	JJ	amod	O
therapy	NN	nmod	O
for	IN	case	O
CF	NN	compound	O
lung	NN	compound	O
disease	NN	nmod	O
,	,	punct	O
and	CC	cc	O
could	MD	aux	O
possibly	RB	advmod	O
promote	VB	conj	O
clearance	NN	dobj	O
of	IN	case	O
secretions	NNS	nmod	O
in	IN	case	O
the	DT	det	O
CF	NN	compound	O
airway	NN	nmod	O
.	.	punct	O

Human	JJ	amod	B-DNA
15-lipoxygenase	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	ROOT	I-DNA
:	:	punct	O
analysis	NN	dep	O
and	CC	cc	O
identification	NN	conj	O
of	IN	case	O
DNA	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
for	IN	case	O
IL-13-induced	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
factors	NNS	nmod	I-protein
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Three	CD	nsubj	O
of	IN	case	O
these	DT	det	O
mutants	NNS	nmod	O
contained	VBD	ROOT	O
targeted	VBN	amod	O
disruptions	NNS	dobj	O
of	IN	case	O
potential	JJ	amod	O
functional	JJ	amod	O
motifs	NNS	nmod	O
:	:	punct	O
the	DT	det	O
acidic	JJ	amod	B-protein
activation	NN	compound	I-protein
domain	NN	dobj	I-protein
,	,	punct	O
a	DT	det	O
putative	JJ	amod	O
GTP-binding	JJ	amod	B-protein
motif	NN	appos	I-protein
and	CC	cc	O
two	CD	nummod	O
leucine	NN	compound	B-protein
charged	JJ	amod	I-protein
domains	NNS	conj	I-protein
(	-LRB-	punct	O
LCD	NNS	compound	B-protein
motifs	NNS	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
model	NN	nsubj	O
should	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
for	IN	mark	O
exploring	VBG	advcl	O
the	DT	det	O
molecular	JJ	amod	O
pathogenesis	NN	dobj	O
of	IN	case	O
APL	NN	nmod	O
and	CC	cc	O
the	DT	det	O
mechanisms	NNS	conj	O
of	IN	case	O
the	DT	det	O
therapeutic	JJ	amod	O
response	NN	nmod	O
to	TO	case	O
retinoic	JJ	amod	O
acid	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
for	IN	case	O
preclinical	JJ	amod	O
studies	NNS	conj	O
of	IN	case	O
therapeutic	JJ	amod	O
regimens	NNS	nmod	O
.	.	punct	O

A	DT	det	O
human	JJ	amod	B-DNA
putative	JJ	amod	I-DNA
lymphocyte	NN	compound	I-DNA
G0/G1	NN	compound	I-DNA
switch	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
containing	VBG	acl	O
a	DT	det	O
CpG-rich	JJ	amod	B-DNA
island	NN	dobj	I-DNA
encodes	VBZ	ROOT	O
a	DT	det	O
small	JJ	amod	B-protein
basic	JJ	amod	I-protein
protein	NN	dobj	I-protein
with	IN	case	O
the	DT	det	O
potential	NN	nmod	O
to	TO	mark	O
be	VB	auxpass	O
phosphorylated	VBN	acl	O
.	.	punct	O

NFAT	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
constitute	VBP	ROOT	O
a	DT	det	O
family	NN	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
involved	VBN	acl	O
in	IN	mark	O
mediating	VBG	advcl	O
signal	NN	compound	O
transduction	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
OCA-B	NN	nsubj	B-protein
binds	VBZ	ccomp	O
DNA	NN	dobj	O
directly	RB	advmod	O
in	IN	case	O
the	DT	det	O
major	JJ	amod	O
groove	NN	nmod	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
subdomains	NNS	nmod	O
of	IN	case	O
the	DT	det	O
POU	NN	compound	B-DNA
domain	NN	nmod	I-DNA
,	,	punct	O
requiring	VBG	advcl	O
both	CC	cc:preconj	O
an	DT	det	O
A	NN	dobj	O
at	IN	case	O
the	DT	det	O
fifth	JJ	amod	B-DNA
position	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
octamer	NN	compound	B-DNA
element	NN	nmod	I-DNA
and	CC	cc	O
contact	NN	conj	O
with	IN	case	O
the	DT	det	O
POU	NN	compound	B-DNA
domain	NN	nmod	I-DNA
.	.	punct	O

As	IN	case	O
a	DT	det	O
result	NN	nmod	O
,	,	punct	O
G1-S-associated	JJ	amod	B-DNA
DNA	NN	nsubjpass	I-DNA
and	CC	cc	O
mRNA	NN	compound	O
synthesis	NN	conj	O
is	VBZ	auxpass	O
inhibited	VBN	ROOT	O
,	,	punct	O
growth	NN	conj	O
uncoupled	VBD	acl	O
from	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
maturation	NN	nsubj	O
enabled	VBD	conj	O
to	TO	mark	O
proceed	VB	xcomp	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
focused	VBN	ROOT	O
on	IN	case	O
atypical	JJ	amod	O
PKC	NN	compound	B-protein
isoenzymes	NNS	nmod	I-protein
.	.	punct	O

p60	NN	compound	B-protein
phosphorylation	NN	nsubj	O
was	VBD	cop	O
time	NN	ROOT	O
and	CC	cc	O
PMA	NN	compound	O
dose	NN	nmod:npmod	O
dependent	JJ	conj	O
,	,	punct	O
and	CC	cc	O
was	VBD	auxpass	O
induced	VBN	conj	O
by	IN	case	O
cell-permeable	JJ	amod	O
diacylglycerol	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
inactive	JJ	amod	O
phorbol	NN	compound	O
esters	NNS	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
the	DT	det	O
phenotype	NN	dobj	O
of	IN	case	O
mouse	NN	compound	B-cell_line
transgenic	JJ	amod	I-cell_line
lines	NNS	nmod	I-cell_line
obtained	VBN	acl	O
by	IN	mark	O
inducing	VBG	advcl	O
tal-1	NN	compound	B-protein
protein	NN	compound	I-protein
expression	NN	dobj	O
in	IN	case	O
lymphoid	JJ	amod	O
tissues	NNS	nmod	O
using	VBG	acl	O
the	DT	det	O
LCK	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
a	DT	det	O
component	NN	nsubjpass	O
of	IN	case	O
LDL	NN	nmod:npmod	B-protein
-enhanced	JJ	amod	O
endothelial	JJ	amod	O
recruitment	NN	nmod	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
is	VBZ	auxpass	O
attributed	VBN	ROOT	O
to	TO	case	O
VCAM-1	NN	compound	B-protein
expression	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
through	IN	case	O
AP-1	NN	nmod	B-protein
and	CC	cc	O
GATA	NN	conj	B-protein
.	.	punct	O

Ligand	NN	compound	O
binding	VBG	nsubj	O
to	TO	case	O
the	DT	det	O
ligand	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
these	DT	det	O
receptors	NNS	nmod	B-protein
induces	VBZ	ROOT	O
conformational	JJ	amod	O
changes	NNS	dobj	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
evidenced	VBN	acl:relcl	O
by	IN	case	O
an	DT	det	O
increased	VBN	amod	O
resistance	NN	nmod	O
of	IN	case	O
this	DT	det	O
domain	NN	nmod	O
to	TO	case	O
proteases	NNS	nmod	B-protein
.	.	punct	O

In	IN	case	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
hybridomas	NNS	nmod	I-cell_line
,	,	punct	O
both	CC	cc:preconj	O
T	NN	compound	O
cell	NN	compound	O
activators	NNS	nsubj	O
and	CC	cc	O
glucocorticoids	NNS	conj	O
induce	VBP	ROOT	O
apoptosis	NN	dobj	O
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Costimulation	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_line
CD4+	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
LFA-3	NN	nmod	B-protein
and	CC	cc	O
B7	NN	conj	B-protein
induce	VBP	ROOT	O
distinct	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
AP-1	NN	nmod	O
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

The	DT	det	O
OCT-1-binding	JJ	amod	O
genotype	NN	nsubjpass	O
,	,	punct	O
found	VBN	acl	O
in	IN	case	O
approximately	RB	advmod	O
5	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
Africans	NNS	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
fourfold	RB	advmod	O
increased	VBN	amod	O
susceptibility	NN	nmod	O
to	TO	case	O
cerebral	JJ	amod	O
malaria	NN	nmod	O
in	IN	case	O
large	JJ	amod	O
case-control	JJ	amod	O
studies	NNS	nmod	O
of	IN	case	O
West	JJ	compound	O
African	JJ	amod	O
and	CC	cc	O
East	JJ	compound	O
African	JJ	conj	O
populations	NNS	nmod	O
,	,	punct	O
after	IN	case	O
correction	NN	nmod	O
for	IN	case	O
other	JJ	amod	O
known	JJ	amod	O
TNF	NN	compound	O
polymorphisms	NNS	nmod	O
and	CC	cc	O
linked	VBN	amod	O
HLA	NN	compound	B-DNA
alleles	NNS	conj	I-DNA
.	.	punct	O

TCC	NN	nsubj	B-protein
also	RB	advmod	O
stimulate	VBP	ROOT	O
a	DT	det	O
variety	NN	dobj	O
of	IN	case	O
cellular	JJ	amod	O
activities	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
include	VBP	acl:relcl	O
cytokine	NN	compound	B-protein
synthesis	NN	dobj	O
,	,	punct	O
proto-oncogene	NN	compound	B-DNA
activation	NN	conj	O
,	,	punct	O
and	CC	cc	O
mitotic	JJ	amod	O
signaling	NN	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
phospholipase	NN	compound	B-protein
C	NN	compound	I-protein
gamma	NN	nmod	I-protein
1	CD	nummod	I-protein
,	,	punct	O
ligation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
receptor	NN	nmod	O
also	RB	advmod	O
seems	VBZ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
a	DT	det	O
calcium-independent	JJ	amod	O
,	,	punct	O
CD28	NN	nmod:npmod	B-protein
-specific	JJ	dep	O
pathway	NN	dobj	O
.	.	punct	O

Following	VBG	case	O
stimulation	NN	nmod	O
,	,	punct	O
P-CREB	NN	amod	B-protein
levels	NNS	nsubj	O
remain	VBP	ROOT	O
elevated	JJ	xcomp	O
in	IN	case	O
PBMC	NN	nmod	B-cell_type
for	IN	case	O
up	RB	advmod	O
to	TO	dep	O
24	CD	nummod	O
hours	NNS	nmod	O
whereas	IN	mark	O
CREB	NN	nsubjpass	O
is	VBZ	auxpass	O
dephosphorylated	VBN	advcl	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
within	IN	case	O
4	CD	nummod	O
hours	NNS	nmod	O
following	VBG	case	O
stimulation	NN	nmod	O
.	.	punct	O

Cell	NN	compound	O
lines	NNS	nsubj	O
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
MNDA	NN	dobj	B-protein
exhibited	VBD	ROOT	O
myeloid	JJ	amod	O
cell	NN	compound	O
features	NNS	dobj	O
and	CC	cc	O
granulocyte	NN	compound	O
or	CC	cc	O
monocyte	NN	conj	O
differentiation	NN	conj	O
could	MD	aux	O
be	VB	auxpass	O
induced	VBN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
while	IN	mark	O
cell	NN	compound	O
lines	NNS	nsubj	O
exhibiting	VBG	acl	O
properties	NNS	dobj	O
of	IN	case	O
very	RB	advmod	O
early	JJ	amod	O
stage	NN	compound	O
cells	NNS	nmod	O
or	CC	cc	O
multipotential	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
did	VBD	aux	O
not	RB	neg	O
express	VB	advcl	O
MNDA	NN	dobj	B-protein
.	.	punct	O

Human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type-1	NN	compound	O
transcription	NN	ROOT	O
:	:	punct	O
role	NN	dep	O
of	IN	case	O
the	DT	det	O
5'-untranslated	JJ	amod	O
leader	NN	compound	O
region	NN	nmod	O
(	-LRB-	punct	O
review	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
an	DT	det	O
abnormality	NN	compound	O
of/or	NN	nsubj	O
influencing	VBG	acl	O
NF-AT	NN	dobj	B-protein
may	MD	aux	O
underlie	VB	ccomp	O
the	DT	det	O
multiple	JJ	amod	O
lymphokine	NN	compound	B-protein
deficiency	NN	dobj	O
in	IN	case	O
this	DT	det	O
patient	NN	nmod	O
.	.	punct	O

Leukotriene	NN	compound	O
B4	NN	nsubj	O
transcriptionally	RB	advmod	O
activates	VBZ	ROOT	O
interleukin-6	NN	compound	B-protein
expression	NN	dobj	O
involving	VBG	acl	O
NK-chi	NN	compound	B-protein
B	NN	dobj	I-protein
and	CC	cc	O
NF-IL6	NN	conj	B-protein
.	.	punct	O

A	DT	det	O
direct	JJ	amod	O
interaction	NN	nsubj	O
between	IN	case	O
the	DT	det	O
adaptor	NN	compound	B-protein
protein	NN	compound	I-protein
Cbl-b	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
kinase	NN	compound	B-protein
zap-70	NN	conj	B-protein
induces	VBZ	ROOT	O
a	DT	det	O
positive	JJ	amod	O
signal	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
characterize	VB	advcl	O
further	RB	advmod	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
the	DT	det	O
intracellular	JJ	amod	B-protein
vitamin	NN	compound	I-protein
D	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
VDR	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
developed	VBN	ROOT	O
stable	JJ	amod	B-cell_line
transfectant	JJ	amod	I-cell_line
variants	NNS	dobj	I-cell_line
of	IN	case	O
a	DT	det	O
vitamin	NN	compound	B-cell_line
D-responsive	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
(	-LRB-	punct	O
U937	NN	appos	B-cell_line
)	-RRB-	punct	O
which	WDT	nsubj	O
express	VBP	acl:relcl	O
either	CC	cc:preconj	O
decreased	VBN	amod	O
or	CC	cc	O
increased	VBN	conj	O
numbers	NNS	dobj	O
of	IN	case	O
VDR	NN	nmod	B-protein
.	.	punct	O

Mutations	NNS	nsubj	O
and	CC	cc	O
deletions	NNS	conj	O
of	IN	case	O
both	DT	det	O
sites	NNS	nmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
only	RB	advmod	O
the	DT	det	O
association	NN	nsubj	O
of	IN	case	O
CCACC/Sp1	NN	compound	B-protein
and	CC	cc	O
GATA	NN	conj	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
can	MD	aux	O
drive	VB	ccomp	O
efficient	JJ	amod	O
and	CC	cc	O
tissue-specific	JJ	conj	O
expression	NN	dobj	O
of	IN	case	O
this	DT	det	O
R-PK	NN	compound	B-protein
minimal	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
extracts	NNS	nsubjpass	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
retard	VB	acl	O
the	DT	det	O
migration	NN	dobj	O
of	IN	case	O
radiolabeled	VBN	amod	O
double	JJ	amod	O
stranded	JJ	amod	O
oligomers	NNS	compound	O
representative	NN	nmod	O
of	IN	case	O
the	DT	det	O
VDREs	NNS	nmod	B-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
osteocalcin	NN	nmod	I-DNA
and	CC	cc	I-DNA
the	DT	det	I-DNA
mouse	NN	compound	I-DNA
osteopontin	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoters	NNS	conj	I-DNA
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
these	DT	det	O
studies	NNS	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
identify	VB	xcomp	O
whether	IN	mark	O
transcription	NN	compound	O
factors	NNS	nsubj	O
,	,	punct	O
associated	VBN	acl	O
with	IN	case	O
cytokine	NN	compound	O
signalling	NN	nmod	O
,	,	punct	O
affected	VBN	ccomp	O
promoter	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
corticotropin	NN	compound	B-DNA
releasing	VBG	compound	I-DNA
hormone	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CRH	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
human	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
myeloid	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
differentiate	VBP	ccomp	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
nitric	JJ	amod	O
oxide	NN	nsubj	O
(	-LRB-	punct	O
NO	NN	appos	O
)	-RRB-	punct	O
activates	VBZ	ccomp	O
p21ras	NN	dobj	B-DNA
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
GTP-bound	JJ	amod	B-protein
p21ras	NN	nmod	I-protein
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
STAT	NN	compound	O
proteins	NNS	nmod	O
during	IN	case	O
growth	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
granulocytes	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
differentiation	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-cell_line
CD34+	JJ	amod	I-cell_line
hematopoietic	JJ	amod	I-cell_line
stem	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
ex	FW	compound	O
vivo	FW	advmod	O
toward	IN	case	O
eosinophils	NNS	nmod	B-cell_type
and	CC	cc	O
neutrophils	NNS	conj	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
in	IN	case	O
anorexia	NN	compound	O
nervosa	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
p105	NN	conj	B-protein
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
persistently	RB	advmod	O
infected	VBN	acl	O
with	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
IL-2	NN	compound	B-protein
production	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
CD3	NN	compound	B-protein
(	-LRB-	punct	O
+	CC	dep	O
)	-RRB-	punct	O
T-lymphocyte	NN	compound	O
cytoplasm	NN	nmod	O
as	RB	cc	O
early	RB	mwe	O
as	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
activation	NN	nmod	O
by	IN	case	O
PMA+ionomycin	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
an	DT	det	O
intragenic	JJ	amod	O
promoter	NN	nmod	O
driving	VBG	acl	O
an	DT	det	O
IFN-gamma	NN	compound	B-protein
-inducible	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
CIITA	NN	nmod	B-protein
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
memory	NN	compound	O
cells	NNS	nsubj	O
,	,	punct	O
either	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	B-cell_line
activated	VBN	amod	I-cell_line
helper	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
reverting	VBG	acl	O
to	TO	case	O
a	DT	det	O
resting	JJ	amod	O
state	NN	nmod	O
,	,	punct	O
or	CC	cc	O
CD4+	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
memory	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
clones	NNS	conj	I-cell_line
,	,	punct	O
or	CC	cc	O
CD4+CD45RO+	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
isolated	VBD	acl	O
ex	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
no	RB	neg	O
longer	RB	advmod	O
have	VBP	ROOT	O
a	DT	det	O
silencer	NN	dobj	B-DNA
.	.	punct	O

The	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
secreted	VBN	amod	O
IL-1beta	NN	nmod	B-protein
,	,	punct	O
TNF-alpha	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-6	NN	conj	B-protein
during	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
stimulation	NN	nmod	O
were	VBD	cop	O
comparable	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
induced	VBN	acl	O
by	IN	case	O
Escherichia	FW	compound	O
coli	FW	compound	O
lipopolysaccharide	NN	nmod	O
at	IN	case	O
1	CD	nummod	O
microg/ml	NN	nmod	O
.	.	punct	O

EBV	NN	nsubj	O
encodes	VBZ	ROOT	O
a	DT	det	O
unique	JJ	amod	O
transcriptional	JJ	amod	O
activator	NN	dobj	O
,	,	punct	O
known	VBN	acl	O
as	IN	case	O
ZEBRA	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
can	MD	aux	O
disrupt	VB	acl:relcl	O
viral	JJ	amod	O
latency	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
induce	VB	conj	O
lytic	JJ	amod	O
viral	JJ	amod	O
replication	NN	dobj	O
.	.	punct	O

This	DT	det	O
activity	NN	nsubj	O
seems	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
increased	VBN	amod	O
cAMP	NN	compound	O
levels	NNS	xcomp	O
because	IN	mark	O
forskolin	NN	nsubj	O
and	CC	cc	O
IBMX	NN	conj	O
mimic	VBP	advcl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
PGE2	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
activation	NN	nsubjpass	O
of	IN	case	O
c-fos	NN	nmod	B-DNA
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
IL	NN	compound	B-protein
6	CD	nummod	I-protein
-induced	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
SKW	NN	compound	B-cell_line
6.4	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
into	IN	case	O
IgM-secreting	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
immunodeficiency	NN	compound	I-protein
virus	NN	compound	I-protein
(	-LRB-	punct	I-protein
HIV-1	NN	compound	I-protein
)	-RRB-	punct	I-protein
Nef	NN	compound	I-protein
protein	NN	nmod	I-protein
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	compound	O
pathways	NNS	nmod	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
Jurkat	NN	compound	B-cell_line
CD4+	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
stably	RB	advmod	O
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
Nef	NN	compound	O
expression	NN	compound	O
vector	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
recent	JJ	amod	O
demonstration	NN	conj	O
of	IN	case	O
JAK	NN	compound	B-protein
phosphorylation	NN	nmod	O
by	IN	case	O
IL-12	NN	nmod	B-protein
,	,	punct	O
identify	VBP	ROOT	O
a	DT	det	O
rapid	JJ	amod	O
signal-transduction	NN	compound	O
pathway	NN	dobj	O
likely	JJ	advmod	O
to	TO	mark	O
mediate	VB	xcomp	O
IL-12	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
establish	VBP	ROOT	O
that	IN	mark	O
ATF/CREB	NN	compound	B-protein
factors	NNS	nsubj	I-protein
functionally	RB	advmod	O
modulate	VBP	ccomp	O
histone	NN	compound	B-DNA
H4	NN	compound	I-DNA
gene	NN	compound	I-DNA
transcription	NN	dobj	O
at	IN	case	O
distal	JJ	amod	B-DNA
and	CC	cc	I-DNA
proximal	JJ	conj	I-DNA
promoter	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
therefore	RB	advmod	O
examined	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
phorbol	NN	compound	O
ester	NN	compound	O
PMA	NN	nmod	O
(	-LRB-	punct	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	appos	O
)	-RRB-	punct	O
which	WDT	nsubj	O
stimulates	VBZ	acl:relcl	O
PKC	NN	dobj	B-protein
and	CC	cc	O
a	DT	det	O
combination	NN	conj	O
of	IN	case	O
the	DT	det	O
adenosine	NN	compound	B-protein
receptor	NN	compound	I-protein
agonist	NN	compound	O
NECA	NN	nmod	O
(	-LRB-	punct	O
5'-	JJ	compound	O
(	-LRB-	punct	O
N-ethyl	NN	compound	O
)	-RRB-	punct	O
-carboxamido	JJ	amod	O
adenosine	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
forskolin	NN	conj	O
to	TO	mark	O
raise	VB	xcomp	O
cAMP	NN	dobj	O
,	,	punct	O
on	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
c-Fos	NN	nmod	B-protein
and	CC	cc	O
Jun	NN	conj	B-protein
and	CC	cc	O
on	IN	case	O
the	DT	dep	O
binding	NN	conj	O
and	CC	cc	O
transcriptional	JJ	amod	O
activity	NN	conj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
activator	NN	compound	B-protein
protein-1	NN	conj	I-protein
(	-LRB-	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
gene	NN	nsubj	O
contains	VBZ	ROOT	O
a	DT	det	O
proximal	JJ	amod	B-DNA
functional	JJ	amod	I-DNA
promoter	NN	compound	I-DNA
region	NN	dobj	I-DNA
(	-LRB-	punct	O
-620	CD	nummod	B-DNA
to	TO	dep	I-DNA
+34	CD	appos	I-DNA
)	-RRB-	punct	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
powerful	JJ	amod	O
enhancer	NN	conj	B-DNA
located	JJ	amod	O
3	CD	nummod	O
kb	NN	nmod:npmod	O
upstream	RB	advmod	O
,	,	punct	O
both	DT	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
response	NN	nmod	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
to	TO	case	O
TCR	NN	compound	B-protein
activation	NN	nmod	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
both	CC	cc:preconj	O
p65	NN	compound	B-protein
and	CC	cc	O
p50	NN	conj	B-protein
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
components	NNS	nmod	I-protein
in	IN	case	O
LPS-activated	JJ	amod	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
specific	JJ	amod	O
antibody	NN	compound	O
induction	NN	nmod	O
of	IN	case	O
supershifts	NNS	nmod	O
in	IN	case	O
mobility	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

Single	JJ	amod	O
strand	NN	compound	O
conformation	NN	compound	O
polymorphism	NN	compound	O
(	-LRB-	punct	O
SSCP	NN	appos	O
)	-RRB-	punct	O
analysis	NN	nsubj	O
again	RB	advmod	O
showed	VBD	ROOT	O
the	DT	det	O
heterozygous	JJ	amod	O
status	NN	dobj	O
of	IN	case	O
the	DT	det	O
twins	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
normal	JJ	amod	O
pattern	NN	conj	O
in	IN	case	O
their	PRP$	nmod:poss	O
parents	NNS	nmod	O
.	.	punct	O

Unlike	IN	case	O
this	DT	det	O
physiologically	RB	advmod	O
relevant	JJ	amod	O
stimulation	NN	nmod	O
,	,	punct	O
PHA	NN	nsubj	B-protein
stimulates	VBZ	ROOT	O
productive	JJ	amod	O
LAI	NN	compound	O
replication	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
naive	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
memory	NN	conj	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
sought	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
activities	NNS	dobj	O
of	IN	case	O
various	JJ	amod	O
environmental	JJ	amod	O
estrogens	NNS	nmod	O
on	IN	case	O
the	DT	det	O
modulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
interleukin-1beta	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
IL-1beta	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
a	DT	det	O
model	NN	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
hER	NN	appos	B-cell_line
+	CC	cc	I-cell_line
IL-1beta-CAT+	NN	conj	I-cell_line
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
hypothesized	VBN	ROOT	O
that	IN	mark	O
alpha-tcp	NN	nsubj	O
acts	VBZ	ccomp	O
as	IN	case	O
an	DT	det	O
anti-atherosclerotic	JJ	amod	O
molecule	NN	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
generation	NN	dobj	O
of	IN	case	O
oxidized	VBN	amod	O
LDL	NN	nmod	O
--	:	punct	O
a	DT	det	O
putative	JJ	amod	O
triggering	VBG	amod	O
molecule	NN	appos	O
in	IN	case	O
the	DT	det	O
atherosclerotic	JJ	amod	O
process	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
M-CSF	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
fos-related	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
fra-1	NN	appos	B-DNA
,	,	punct	O
was	VBD	auxpass	O
delayed	VBN	ROOT	O
compared	VBN	xcomp	O
to	TO	case	O
that	DT	nmod	O
for	IN	case	O
both	CC	cc:preconj	O
c-fos	NN	nmod	B-DNA
and	CC	cc	O
fos-B	NN	conj	B-DNA
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
this	DT	det	O
domain	NN	nsubj	O
conferred	VBD	ROOT	O
enhancing	NN	compound	O
activity	NN	dobj	O
when	WRB	advmod	O
fused	VBN	advcl	O
to	TO	case	O
the	DT	det	O
Oct1	NN	compound	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
by	IN	case	O
itself	PRP	nmod	O
was	VBD	cop	O
unable	JJ	acl:relcl	O
to	TO	mark	O
stimulate	VB	xcomp	O
from	IN	case	O
a	DT	det	O
remote	JJ	amod	O
position	NN	nmod	O
.	.	punct	O

Full	JJ	amod	O
activity	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
restored	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
combined	JJ	amod	O
action	NN	nmod	O
of	IN	case	O
recombinant	JJ	amod	O
PC4	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
PC4	NN	compound	B-protein
-depleted	JJ	amod	O
USA	NN	compound	O
fraction	NN	conj	O
,	,	punct	O
thus	RB	advmod	O
suggesting	VBG	advcl	O
a	DT	det	O
joint	JJ	amod	O
requirement	NN	dobj	O
for	IN	case	O
PC4	NN	nmod	B-protein
and	CC	cc	O
another	DT	det	O
,	,	punct	O
USA-derived	JJ	amod	O
component	NN	compound	O
(	-LRB-	punct	O
s	NNS	conj	O
)	-RRB-	punct	O
for	IN	case	O
optimal	JJ	amod	O
function	NN	nmod	O
of	IN	case	O
Oct-1	NN	compound	B-protein
/OCA-B	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
reconstituted	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
blockade	NN	nsubj	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
activity	NN	nmod	O
,	,	punct	O
using	VBG	acl	O
a	DT	det	O
dominant	JJ	amod	B-protein
negative	JJ	amod	I-protein
IkappaBalpha	NN	dobj	I-protein
,	,	punct	O
has	VBZ	ccomp	O
opposite	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
these	DT	det	O
two	CD	nummod	O
apoptotic	JJ	amod	O
signals	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
thymocytes	NNS	nsubj	B-cell_type
have	VBP	ccomp	O
a	DT	det	O
constitutively	RB	advmod	B-protein
active	JJ	amod	I-protein
form	NN	dobj	I-protein
of	IN	case	O
NF-kB	NN	nmod	B-protein
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
they	PRP	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	ccomp	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
plasma	NN	nmod:npmod	O
cell-specific	JJ	amod	O
repressor	NN	compound	O
function	NN	intj	O
,	,	punct	O
designated	VBN	acl	O
SIR	NN	compound	B-DNA
(	-LRB-	punct	O
suppressor	NN	xcomp	B-DNA
of	IN	case	I-DNA
immune	JJ	amod	I-DNA
response	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
)	-RRB-	punct	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
act	VB	ccomp	O
directly	RB	advmod	O
on	IN	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
but	CC	cc	O
instead	RB	advmod	O
on	IN	case	O
the	DT	det	O
transcription	NN	conj	O
of	IN	case	O
the	DT	det	O
AIR-1	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
whose	WP$	nmod:poss	O
product	NN	nsubj	O
,	,	punct	O
the	DT	det	O
class	NN	compound	B-protein
II	CD	nummod	I-protein
transactivator	NN	appos	I-protein
(	-LRB-	punct	O
CIITA	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	cop	O
fundamental	JJ	acl:relcl	O
for	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
constitutive	JJ	amod	O
and	CC	cc	O
inducible	JJ	conj	O
expression	NN	nmod	O
of	IN	case	O
MHC	NN	compound	B-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

ML-9-induced	JJ	amod	O
differentiation	NN	nsubj	O
was	VBD	cop	O
also	RB	advmod	O
reversible	JJ	ROOT	O
when	WRB	advmod	O
the	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
cultured	VBN	advcl	O
with	IN	mark	O
cultured	VBN	nmod	O
with	IN	case	O
ML-9	NN	nmod	O
plus	CC	cc	O
an	DT	det	O
anti-cancer	JJ	amod	O
drug	NN	conj	O
such	JJ	case	O
as	IN	mwe	O
1-beta-D-arabino-furanosylcytosine	NN	nmod	O
or	CC	cc	O
daunomycin	NN	conj	O
.	.	punct	O

As2O3	NN	nsubj	O
may	MD	aux	O
prove	VB	ROOT	O
useful	JJ	xcomp	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	O
lymphoproliferative	JJ	amod	O
disorders	NNS	nmod	O
.	.	punct	O

Binding	NN	ROOT	O
and	CC	cc	O
cooperative	JJ	conj	O
interactions	NNS	dep	O
between	IN	case	O
two	CD	nummod	O
B	NN	nmod:npmod	B-protein
cell-specific	JJ	amod	I-protein
transcriptional	JJ	amod	I-protein
coactivators	NNS	nmod	I-protein
.	.	punct	O

From	IN	case	O
analyses	NNS	nmod	O
of	IN	case	O
mice	NNS	nmod	O
deficient	JJ	amod	O
in	IN	case	O
transcription	NN	compound	B-DNA
factor	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
from	IN	case	O
the	DT	det	O
characterizations	NNS	conj	O
of	IN	case	O
chromosome	NN	compound	B-DNA
breakpoints	NNS	nmod	I-DNA
in	IN	case	O
human	JJ	amod	O
leukemias	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
has	VBZ	aux	O
become	VBN	ROOT	O
evident	JJ	xcomp	O
that	IN	mark	O
transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
are	VBP	cop	O
important	JJ	amod	O
regulators	NNS	ccomp	O
of	IN	case	O
hematopoiesis	NN	nmod	O
.	.	punct	O

Interleukin-4	NN	nsubj	B-protein
(	-LRB-	punct	O
IL-4	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
immunomodulatory	JJ	amod	O
cytokine	NN	ROOT	O
secreted	VBN	acl	O
by	IN	case	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
basophils	NNS	conj	B-cell_type
,	,	punct	O
and	CC	cc	O
mast	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
IFN-gamma	NN	compound	B-protein
-independent	JJ	amod	O
component	NN	nsubj	O
of	IN	case	O
the	DT	det	O
target	NN	compound	O
cell	NN	compound	O
HLA-DR	NN	compound	B-protein
expression	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
lymphocyte	NN	compound	O
adhesion	NN	nmod	O
uses	VBZ	ccomp	O
a	DT	det	O
signaling	NN	compound	O
pathway	NN	dobj	O
that	WDT	nsubj	O
is	VBZ	cop	O
distinct	JJ	acl:relcl	O
from	IN	case	O
the	DT	det	O
IFN-gamma	NN	compound	B-protein
-dependent	JJ	amod	O
mechanism	NN	nmod	O
and	CC	cc	O
also	RB	advmod	O
suggest	VBP	conj	O
that	IN	mark	O
CIITA	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	ccomp	O
.	.	punct	O

The	DT	det	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
site	NN	nsubjpass	I-DNA
at	IN	case	O
positions	NNS	nmod	O
-206	CD	compound	B-DNA
to	TO	dep	I-DNA
-195	CD	nummod	I-DNA
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
was	VBD	auxpass	O
required	VBN	ROOT	O
but	CC	cc	O
not	RB	cc	O
sufficient	JJ	conj	O
for	IN	case	O
the	DT	det	O
Tat	NN	compound	B-protein
effect	NN	nmod	O
.	.	punct	O

This	DT	det	O
effect	NN	nsubj	O
is	VBZ	cop	O
detectable	JJ	ROOT	O
within	IN	case	O
15	CD	nummod	O
min	NN	nmod	O
and	CC	cc	O
peaks	VBZ	conj	O
1	CD	nummod	O
h	NN	dobj	O
after	IN	case	O
exposure	NN	dep	O
to	TO	case	O
IL-2	NN	nmod	B-protein
.	.	punct	O

All	DT	det	O
factors	NNS	nsubjpass	O
are	VBP	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
upon	IN	case	O
activation	NN	nmod	O
with	IN	case	O
mitogens	NNS	nmod	B-protein
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
exogenous	JJ	amod	B-protein
IL-2	NN	compound	I-protein
growth	NN	compound	I-protein
factor	NN	conj	I-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubj	I-cell_line
,	,	punct	O
IARC	NN	appos	B-cell_line
301	CD	nummod	I-cell_line
,	,	punct	O
expresses	VBZ	ROOT	O
these	DT	det	O
two	CD	nummod	O
genes	NNS	dobj	O
constitutively	RB	advmod	O
and	CC	cc	O
we	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
demonstrated	VBN	conj	O
that	IN	mark	O
its	PRP$	nmod:poss	O
growth	NN	nsubj	O
depends	VBZ	ccomp	O
on	IN	case	O
the	DT	det	O
autocrine	JJ	amod	O
production	NN	nmod	O
of	IN	case	O
this	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
growth	NN	compound	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
high	JJ	amod	B-protein
affinity	NN	compound	I-protein
IL-2R	NN	conj	I-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
GRbeta	NN	nsubj	B-protein
did	VBD	aux	O
not	RB	neg	O
antagonize	VB	ROOT	O
the	DT	det	O
repressive	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
GRalpha	NN	nmod	B-protein
on	IN	case	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

A	DT	det	O
R-PK	NN	compound	B-DNA
DNA	NN	compound	I-DNA
fragment	NN	nsubj	I-DNA
extending	VBG	acl	O
from	IN	case	O
-870	CD	nmod	O
to	TO	case	O
+54	CD	nmod	O
relative	JJ	case	O
to	TO	case	O
the	DT	det	O
cap	NN	compound	B-DNA
site	NN	nmod	I-DNA
confers	VBZ	ROOT	O
erythroid	JJ	amod	O
specificity	NN	dobj	O
to	TO	case	O
a	DT	det	O
reporter	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Thrombin	NN	compound	B-protein
stimulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-cell_line
leukemic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
Jurkat	NN	nmod	I-cell_line
induced	VBD	ROOT	O
a	DT	det	O
transient	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
[	-LRB-	punct	O
Ca2+	NN	nmod	O
]	-RRB-	punct	O
i	LS	nummod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
gp130	NN	compound	B-protein
-induced	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
reporter	NN	compound	B-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
abrogated	VBN	ROOT	O
by	IN	case	O
Stat3EE	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
mutant	JJ	amod	O
Stat3	NN	appos	B-protein
incapable	JJ	amod	O
of	IN	case	O
binding	VBG	amod	O
DNA	NN	nmod	O
.	.	punct	O

DNA-binding	JJ	amod	O
assays	NNS	nsubj	O
with	IN	case	O
cotranslated	VBN	amod	O
wild-type	JJ	amod	O
and	CC	cc	O
truncated	JJ	conj	O
forms	NNS	nmod	O
of	IN	case	O
EBF	NN	nmod	B-protein
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
protein	NN	nsubj	O
interacts	VBZ	ccomp	O
with	IN	case	O
its	PRP$	nmod:poss	O
site	NN	nmod	O
as	IN	case	O
a	DT	det	O
homodimer	NN	nmod	B-protein
.	.	punct	O

All	PDT	det:predet	O
the	DT	det	O
tumors	NNS	nsubj	O
exhibited	VBD	ROOT	O
very	RB	advmod	O
low	JJ	amod	O
proliferative	JJ	amod	O
activity	NN	dobj	O
,	,	punct	O
fewer	JJR	amod	O
than	IN	advmod	O
10	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	O
cell	NN	compound	O
nuclei	NNS	nmod	O
being	VBG	auxpass	O
stained	VBN	conj	O
by	IN	case	O
the	DT	det	O
antibody	NN	compound	B-protein
MIB-1	NN	nmod	I-protein
(	-LRB-	punct	O
Ki-67	NN	compound	B-protein
antigen	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Seventeen	CD	nummod	O
microsatellite	NN	compound	B-DNA
markers	NNS	nsubjpass	I-DNA
that	WDT	nsubj	O
span	VBP	acl:relcl	O
the	DT	det	O
common	JJ	amod	O
deleted	VBN	amod	O
region	NN	dobj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
search	VB	xcomp	O
for	IN	case	O
loss	NN	nmod	O
of	IN	case	O
heterozygosity	NN	nmod	O
in	IN	case	O
granulocyte	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
.	.	punct	O

No	DT	neg	O
difference	NN	nsubjpass	O
in	IN	case	O
plasma	NN	compound	O
cortisol	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
healthy	JJ	amod	O
subjects	NNS	conj	O
(	-LRB-	punct	O
P	NN	dep	O
>	NN	amod	O
0.05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
proximal	JJ	amod	B-DNA
promoter	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
a	DT	det	O
region	NN	dobj	O
termed	VBN	acl	O
CLEO	NN	xcomp	B-DNA
(	-LRB-	punct	O
-54	CD	nummod	B-DNA
to	TO	dep	I-DNA
-31	CD	appos	I-DNA
)	-RRB-	punct	O
that	WDT	nsubj	O
consists	VBZ	acl:relcl	O
of	IN	case	O
a	DT	det	O
purine-rich	JJ	amod	B-DNA
element	NN	nmod	I-DNA
abutting	VBG	acl	O
an	DT	det	O
activator	NN	compound	B-DNA
protein-1	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
AP-1	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-like	JJ	amod	I-DNA
site	NN	dobj	I-DNA
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
an	DT	det	O
upstream	JJ	amod	B-DNA
nuclear	JJ	amod	I-DNA
factor-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
site	NN	conj	I-DNA
(	-LRB-	punct	O
-85	CD	nummod	B-DNA
to	TO	dep	I-DNA
-76	CD	appos	I-DNA
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
CK-1	NN	compound	B-DNA
element	NN	conj	I-DNA
(	-LRB-	punct	O
-101	CD	nummod	B-DNA
to	TO	dep	I-DNA
-92	CD	appos	I-DNA
)	-RRB-	punct	O
.	.	punct	O

Using	VBG	advcl	O
human	JJ	amod	B-cell_line
B-	NN	compound	I-cell_line
or	CC	cc	I-cell_line
T-cell	NN	conj	I-cell_line
lines	NNS	dobj	I-cell_line
transfected	VBN	acl	O
with	IN	case	O
ZpCat	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
region	NN	nsubj	O
designated	VBN	acl	O
the	DT	det	O
ZII	NN	compound	B-DNA
domain	NN	dobj	I-DNA
of	IN	case	O
Zp	NN	nmod	B-DNA
is	VBZ	cop	O
the	DT	det	O
target	NN	ccomp	O
of	IN	case	O
HHV-6	NN	compound	O
transactivation	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
model	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
CD30	NN	nsubj	B-protein
limits	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
own	JJ	amod	O
ability	NN	dobj	O
to	TO	mark	O
transduce	VB	acl	O
cell	NN	compound	O
survival	NN	compound	O
signals	NNS	dobj	O
through	IN	case	O
signal-coupled	JJ	amod	O
depletion	NN	nmod	O
of	IN	case	O
TRAF2	NN	nmod	B-protein
.	.	punct	O

A	DT	det	O
gst-EBNA-2	NN	compound	B-protein
fusion	NN	compound	I-protein
protein	NN	nsubj	I-protein
specifically	RB	advmod	O
depleted	VBD	ROOT	O
PU.1	NN	dobj	B-protein
from	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
and	CC	cc	O
bound	VBD	conj	O
in	FW	compound	O
vitro	FW	advmod	O
translated	VBN	amod	O
PU.1	NN	dobj	B-protein
,	,	punct	O
providing	VBG	advcl	O
biochemical	JJ	amod	O
evidence	NN	dobj	O
for	IN	case	O
a	DT	det	O
direct	JJ	amod	O
EBNA-2	NN	compound	B-protein
-PU.1	CD	compound	B-protein
interaction	NN	nmod	O
.	.	punct	O

To	TO	mark	O
identify	VB	advcl	O
potential	JJ	amod	O
cellular	JJ	amod	O
homologues	NNS	dobj	O
of	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
that	WDT	nsubj	O
might	MD	aux	O
regulate	VB	acl:relcl	O
calcium	NN	compound	O
signalling	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
cloned	VBN	ROOT	O
human	JJ	amod	O
genes	NNS	dobj	O
encoding	VBG	acl	O
cyclophilin	NN	compound	B-protein
B-binding-proteins	NNS	dobj	I-protein
using	VBG	advcl	O
the	DT	det	O
yeast	NN	compound	O
two-hybrid	JJ	amod	O
system	NN	dobj	O
.	.	punct	O

Differentiation	NN	ROOT	O
of	IN	case	O
U-937	NN	compound	B-cell_line
promonocytic	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
etoposide	NN	nmod	O
and	CC	cc	O
ICRF-193	NN	conj	O
,	,	punct	O
two	CD	nummod	O
antitumour	NN	amod	O
DNA	NN	compound	B-protein
topoisomerase	NN	compound	I-protein
II	CD	nummod	I-protein
inhibitors	NNS	appos	O
with	IN	case	O
different	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
action	NN	nmod	O
.	.	punct	O

Tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nsubj	I-protein
(	-LRB-	punct	O
TNF	NN	compound	B-protein
alpha	NN	appos	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
particularly	RB	advmod	O
important	JJ	ROOT	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
because	IN	case	O
of	IN	mwe	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
regulate	VB	acl	O
other	JJ	amod	O
inflammatory	JJ	amod	O
mediators	NNS	dobj	O
in	IN	case	O
an	DT	det	O
autocrine	JJ	amod	O
and	CC	cc	O
paracrine	JJ	conj	O
fashion	NN	nmod	O
.	.	punct	O

FGF-1	NN	nsubj	B-protein
alone	RB	advmod	O
induces	VBZ	ROOT	O
modest	JJ	amod	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
kappaB-binding	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
this	DT	det	O
translocation	NN	nsubjpass	O
is	VBZ	auxpass	O
enhanced	VBN	conj	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
of	IN	case	O
anti-CD3	NN	nmod	B-protein
and	CC	cc	O
FGF-1	NN	conj	B-protein
.	.	punct	O

A	DT	det	O
synthetic	JJ	amod	O
thrombin	NN	compound	B-protein
receptor	NN	compound	I-protein
agonist	NN	compound	O
peptide	NN	nsubjpass	O
(	-LRB-	punct	O
TRP	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
7	CD	nummod	O
residues	NNS	nmod	O
(	-LRB-	punct	O
SFLLRNP	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
as	RB	advmod	O
effective	JJ	xcomp	O
as	IN	case	O
thrombin	NN	nmod	B-protein
for	IN	case	O
[	-LRB-	punct	O
Ca2+	NN	nmod	O
]	-RRB-	punct	O
i	CD	det	O
mobilization	NN	dep	O
,	,	punct	O
and	CC	cc	O
both	DT	det	O
agonists	NNS	nsubj	O
induced	VBD	conj	O
Ca2+	NN	compound	O
release	NN	dobj	O
exclusively	RB	advmod	O
from	IN	case	O
internal	JJ	amod	O
stores	NNS	nmod	O
.	.	punct	O

The	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
antisense	JJ	amod	O
oligonucleotides	NNS	nmod	O
to	TO	case	O
c-fos	NN	nmod	B-DNA
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
IL	NN	compound	B-protein
6	CD	nummod	I-protein
-induced	JJ	amod	O
IgM	NN	compound	B-protein
production	NN	dobj	O
by	IN	case	O
SKW	NN	compound	B-cell_line
6.4	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
control	NN	amod	O
oligonucleotides	NNS	nsubj	O
had	VBD	parataxis	O
no	DT	neg	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

The	DT	det	O
restricted	JJ	amod	O
pattern	NN	nsubj	O
of	IN	case	O
SCL	NN	compound	B-protein
protein	NN	compound	I-protein
synthesis	NN	nmod	O
is	VBZ	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
restricted	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
SCL	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
documented	VBN	acl	O
previously	RB	advmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
antigenic	JJ	amod	O
specificity	NN	dobj	O
of	IN	case	O
47	CD	nummod	O
HSV-specific	JJ	amod	B-cell_line
CD4+	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
clones	NNS	nmod	I-cell_line
recovered	VBN	acl	O
from	IN	case	O
the	DT	det	O
HSV-2	NN	compound	O
buttock	NN	nmod	O
and	CC	cc	O
thigh	NN	amod	O
lesions	NNS	conj	O
of	IN	case	O
five	CD	nummod	O
patients	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
induction	NN	nsubjpass	O
of	IN	case	O
differentiation	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
proliferation	NN	conj	O
was	VBD	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
25-	CD	compound	O
to	TO	dep	O
30-fold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
suppressor	NN	compound	I-protein
proteins	NNS	nmod	I-protein
p53	NN	dep	I-protein
(	-LRB-	punct	O
wild	JJ	amod	O
type	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
pRb	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p130/Rb2	NN	conj	B-protein
and	CC	cc	O
of	IN	case	O
the	DT	det	O
p53-dependent	JJ	amod	B-protein
cyclin	NN	compound	I-protein
kinase	NN	compound	I-protein
inhibitor	NN	compound	I-protein
p21/Cip1	NN	conj	B-protein
.	.	punct	O

Whereas	IN	mark	O
AP-1	NN	nsubj	B-protein
,	,	punct	O
NF-kappa	NN	compound	O
B	NN	conj	O
,	,	punct	O
Oct	NN	conj	B-protein
,	,	punct	O
CREB	NN	conj	B-protein
and	CC	cc	O
SP1	NN	conj	B-protein
displayed	VBD	advcl	O
normal	JJ	amod	O
binding	NN	compound	O
activities	NNS	dobj	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
,	,	punct	O
the	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
to	TO	case	O
its	PRP$	nmod:poss	O
IL-2	NN	compound	B-protein
promoter	NN	compound	O
response	NN	compound	O
element	NN	nmod	O
was	VBD	cop	O
barely	RB	advmod	O
detectable	JJ	ROOT	O
both	CC	cc:preconj	O
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
T	NN	compound	O
cell	NN	compound	O
stimulation	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
ATRA	NN	nsubj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
VD	NN	conj	O
efficiently	RB	advmod	O
increases	VBZ	ccomp	O
the	DT	det	O
nuclear	JJ	amod	O
abundance	NN	dobj	O
of	IN	case	O
VD	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
VDR	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
promotes	VBZ	conj	O
monocytic	JJ	amod	O
differentiation	NN	dobj	O
.	.	punct	O

Three	CD	nummod	O
molecular	JJ	amod	O
clones	NNS	nsubj	O
of	IN	case	O
HIV-1	NN	nmod	O
,	,	punct	O
derived	VBN	acl	O
from	IN	case	O
a	DT	det	O
single	JJ	amod	O
isolate	NN	nmod	O
(	-LRB-	punct	O
AL1	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
exhibited	VBD	ROOT	O
distinct	JJ	amod	O
replicative	JJ	amod	O
and	CC	cc	O
cytopathic	JJ	conj	O
properties	NNS	dobj	O
during	IN	case	O
propagation	NN	nmod	O
in	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

When	WRB	advmod	O
all	PDT	det:predet	O
the	DT	det	O
asthmatic	JJ	amod	O
patients	NNS	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
degree	NN	nmod	O
of	IN	case	O
sensitivity	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
dexamethasone	NN	nmod	O
and	CC	cc	O
the	DT	det	O
clinical	JJ	amod	O
responsiveness	NN	conj	O
to	TO	case	O
prednisolone	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.01	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
the	DT	det	O
high	JJ	amod	O
specificity	NN	nmod	O
of	IN	case	O
this	DT	det	O
compound	NN	nmod	O
for	IN	case	O
PKC	NN	nmod	B-protein
,	,	punct	O
we	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
PKC	NN	nsubj	B-protein
is	VBZ	cop	O
necessary	JJ	ccomp	O
for	IN	case	O
FN	NN	compound	B-protein
-induced	JJ	amod	O
IL-1beta	NN	compound	B-protein
protein	NN	compound	O
production	NN	nmod	O
.	.	punct	O

TPA-GR	NN	compound	O
synergism	NN	nsubjpass	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
to	TO	mark	O
have	VB	aux	O
occurred	VBN	xcomp	O
at	IN	case	O
the	DT	det	O
GR-responsive	JJ	amod	B-DNA
element	NN	compound	I-DNA
(	-LRB-	punct	O
GRE	NN	compound	B-DNA
)	-RRB-	punct	O
level	NN	nmod	O
by	IN	case	O
functional	JJ	amod	O
analysis	NN	nmod	O
of	IN	case	O
deletion	NN	compound	B-DNA
mutants	NNS	nmod	I-DNA
or	CC	cc	O
synthetic	JJ	amod	B-DNA
GRE	NN	compound	I-DNA
oligonucleotides	NNS	conj	I-DNA
driving	VBG	acl	O
chloramphenicol	NN	compound	B-protein
acetyl-transferase	NN	compound	I-protein
expression	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
MIP-1alpha	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
selectively	RB	advmod	O
expressed	VBN	ccomp	O
and	CC	cc	O
secreted	VBN	conj	O
in	IN	case	O
the	DT	det	O
tax	NN	compound	B-cell_line
transfected	JJ	amod	I-cell_line
Jurkat	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
upon	IN	case	O
mitogen	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Previously	RB	advmod	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
heterologous	JJ	amod	B-protein
activation	NN	compound	I-protein
domains	NNS	nsubj	I-protein
can	MD	aux	O
fully	RB	advmod	O
substitute	VB	ccomp	O
for	IN	case	O
the	DT	det	O
ZEBRA	NN	compound	B-protein
activation	NN	compound	I-protein
domain	NN	nmod	I-protein
.	.	punct	O

Lastly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
p38	NN	compound	B-protein
kinase	NN	compound	O
activity	NN	nsubj	O
played	VBD	ccomp	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
IL-1beta	NN	compound	B-protein
production	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
rapidly	RB	advmod	O
up-regulated	VBN	conj	O
following	VBG	case	O
infection	NN	nmod	O
.	.	punct	O

Cellular	JJ	amod	O
regulation	NN	nsubjpass	O
of	IN	case	O
BZLF1	NN	compound	B-protein
transcription	NN	nmod	O
is	VBZ	auxpass	O
therefore	RB	advmod	O
thought	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
stringency	NN	dobj	O
of	IN	case	O
viral	JJ	amod	O
latency	NN	nmod	O
.	.	punct	O

In	IN	case	O
combination	NN	nmod	O
with	IN	case	O
TNF-alpha	NN	nmod	B-protein
,	,	punct	O
IL-10	NN	nsubj	B-protein
stimulated	VBD	ROOT	O
activating	VBG	amod	B-protein
protein-1	NN	dobj	I-protein
(	-LRB-	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappa	NN	compound	I-protein
B	NN	compound	I-protein
binding	NN	compound	O
activities	NNS	conj	O
and	CC	cc	O
cooperated	VBD	conj	O
to	TO	mark	O
increase	VB	xcomp	O
HIV-1	NN	compound	O
steady-state	JJ	amod	O
mRNA	NN	compound	O
levels	NNS	dobj	O
and	CC	cc	O
enhance	VBP	conj	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod:npmod	I-DNA
-directed	JJ	amod	O
transcription	NN	dobj	O
through	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
IL-10	NN	compound	B-protein
effect	NN	dobj	O
occurs	VBZ	conj	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
at	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

The	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
NFAT	NN	nmod	B-protein
by	IN	case	O
TCR	NN	compound	B-protein
signals	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
well	RB	advmod	O
described	VBN	ROOT	O
for	IN	case	O
interleukin-2	NN	nmod	O
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
IL-4	NN	compound	O
gene	NN	compound	O
transcription	NN	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
PML	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
fused	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
retinoic	JJ	amod	B-DNA
acid	NN	compound	I-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
(	-LRB-	punct	O
RAR	NN	compound	B-DNA
alpha	NN	appos	I-DNA
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
APL	NN	appos	O
)	-RRB-	punct	O
15	CD	nummod	O
;	:	punct	O
17	CD	nummod	O
translocation	NN	dep	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
PML-RAR	NN	compound	B-protein
alpha	NN	nsubj	I-protein
and	CC	cc	O
PLZF-RAR	NN	compound	B-protein
alpha	NN	conj	I-protein
have	VBP	ccomp	O
similar	JJ	amod	O
(	-LRB-	punct	O
inhibitory	JJ	dep	O
)	-RRB-	punct	O
effects	NNS	dobj	O
on	IN	case	O
RA-independent	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
opposite	JJ	conj	O
(	-LRB-	punct	O
stimulatory	JJ	dep	O
or	CC	cc	O
inhibitory	JJ	conj	O
)	-RRB-	punct	O
effects	NNS	conj	O
on	IN	case	O
RA-dependent	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
they	PRP	nsubj	O
behave	VBP	conj	O
in	FW	compound	O
vivo	FW	advmod	O
as	IN	case	O
RA-dependent	JJ	amod	B-DNA
enhancers	NNS	nmod	I-DNA
or	CC	cc	O
inhibitors	NNS	conj	O
of	IN	case	O
RA-responsive	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Antisense	JJ	amod	O
experiments	NNS	nsubj	O
that	WDT	nsubj	O
knocked	VBD	acl:relcl	O
out	RP	dep	O
endogenous	JJ	amod	O
Sp3	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
myelomocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
HL60	NN	appos	B-cell_line
,	,	punct	O
revealed	VBD	ROOT	O
that	IN	mark	O
Sp3	NN	nsubj	B-protein
participates	VBZ	ccomp	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	dep	O
CD11c	NN	nmod	B-DNA
and	CC	cc	I-DNA
CD11b	NN	conj	I-DNA
promoters	NNS	dep	I-DNA
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Steel	NN	compound	B-protein
factor	NN	nsubj	I-protein
is	VBZ	cop	O
one	CD	attr	O
of	IN	case	O
the	DT	det	O
growth	NN	compound	B-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
controls	VBZ	acl:relcl	O
the	DT	dep	O
proliferation	NN	dobj	O
and	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
SCL	NN	conj	B-protein
,	,	punct	O
also	RB	advmod	O
known	VBN	acl	O
as	IN	case	O
Tcl-5	NN	nmod	B-protein
or	CC	cc	O
Tal-1	NN	conj	B-protein
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	ROOT	I-protein
involved	VBN	acl	O
in	IN	case	O
erythropoiesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
serine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
STATs	NNS	nmod	B-protein
was	VBD	cop	O
a	DT	det	O
continuous	JJ	amod	O
process	NN	ROOT	O
,	,	punct	O
as	IN	mark	O
incubation	NN	nsubj	O
of	IN	case	O
CLL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
the	DT	det	O
kinase	NN	compound	B-protein
inhibitor	NN	compound	I-protein
H7	NN	nmod	I-protein
led	VBD	advcl	O
to	TO	case	O
the	DT	det	O
dephosphorylation	NN	nmod	O
of	IN	case	O
these	DT	det	O
serine	NN	compound	O
residues	NNS	nmod	O
.	.	punct	O

Fas	NN	nsubj	B-protein
(	-LRB-	punct	O
CD95	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
Fas	NN	compound	B-protein
ligand	NN	conj	I-protein
(	-LRB-	punct	O
CD95L	NN	appos	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
an	DT	det	O
interacting	VBG	amod	O
receptor-ligand	JJ	amod	O
pair	NN	ROOT	O
required	VBN	acl	O
for	IN	case	O
immune	JJ	amod	O
homeostasis	NN	nmod	O
.	.	punct	O

